Admission	O
Date	O
:	O

2013-11-21	O

Discharge	O
Date	O
:	O

2013-11-26	O

Date	O
of	O
Birth	O
:	O

1949-07-18	O

Sex	O
:	O

F	O

Service	O
:	O

PLASTIC	O

Allergies	O
:	O

Trazodone	O
/	O
Ambien	O
/	O
Sinequan	O

Attending	O
:	O
Bobby	O
Z.S.	O
Ruiz	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

ACQUIRED	B-disease
DEFECT	I-disease
FROM	O
BASAL	O
CELL	O
CARCINOMA	O
RESECTION	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

RIGHT	O
NOSE	O
/	O
ALA	O
RECONSTRUCTION	O
USING	O
RIGHT	O
CHEEK	O
ADVANCEMENT	O
AND	O
FOREHEAD	O
LOCAL	O
FLAP	O

History	O
of	O
Present	O
Illness	O
:	O

MS.	O
Marshall	O
IS	O
A	O
64-YEAR	O
OLD	O
,	O
MENTALLY	B-disease
RETARDED	I-disease
,	O
FEMALE	O
WHO	O
PRESENTED	O
WITH	O
AN	B-disease
AQUIRED	I-disease
DEFECT	I-disease
OF	I-disease
THE	I-disease
RIGHT	I-disease
NASAL	I-disease
ALA	I-disease
AND	I-disease
MEDIAL	I-disease
CHEEK	I-disease
REGION	I-disease
AFTER	O
BASAL	B-disease
CELL	I-disease
CARCINOMA	I-disease
WAS	O
RESECTED	O
BY	O
DERMATOLOGY	O
.	O

Past	O
Medical	O
History	O
:	O

MENTAL	B-disease
RETARDATION	I-disease

DIABETES	B-disease

BIPOLAR	B-disease
DISORDER	I-disease

Social	O
History	O
:	O

LIVES	O
IN	O
A	O
NURSING	O
HOME	O
,	O
HAS	O
A	O
BROTHER	O
WHO	O
IS	O
THE	O
HEALTH	O
CARE	O
PROXY	O
.	O

NO	O
Tifany	O
,	O
ETOH	O
,	O
OR	O
REC	O
DRUG	O
USE	O
.	O

Physical	O
Exam	O
:	O

ON	O
PRESENTATION	O
,	O
PT	O
WAS	O
AFEBRILE	B-disease
WITH	O
NORMAL	O
VITAL	O
SIGNS	O

GEN	O
:	O
NO	O
ACUTE	B-disease
DISTRESS	I-disease
,	O
ABLE	O
TO	O
COMMUNICATE	O
AND	O
FOLLOW	O
ORDERS	O

HEAD	O
AND	O
NECK	O
:	O
5	B-disease
CM	I-disease
CIRCULAR	I-disease
FULL	I-disease
THICKNESS	I-disease
DEFECT	I-disease
AT	O
THE	O
JUNCTION	O
OF	O
THE	O
RIGHT	O
ALA	O
AND	O
CHEEK	O

HEART	O
:	O
REGULAR	O
RATE	O
AND	O
RHYTHM	O

LUNGS	O
:	O
CLEAR	O
TO	O
ASCULATION	O

ABDOMEN	O
:	O
SOFT	O
,	O
NON-TENDER	B-disease
,	O
NON-DISTENDED	B-disease

EXTREMITIES	O
:	O
NO	O
EDEMA	B-disease
,	O
CYANOSIS	B-disease
,	O
FULL	O
RANGE	O
OF	O
MOTION	O

Brief	O
Hospital	O
Course	O
:	O

UPON	O
ADMISSION	O
,	O
THE	O
PATIENT	O
WAS	O
PRE-OP	O
'D	O
AND	O
MADE	O
NPO	O
/	O
IVF	O
.	O

SHE	O
WENT	O
TO	O
SURGERY	O
THE	O
NEXT	O
MORNING	O
AND	O
TOLERATED	O
THE	O
SURGERY	O
WELL	O
.	O

HOWEVER	O
,	O
SHE	O
WAS	O
SLOW	O
TO	O
AWAKE	O
FROM	O
ANESTHESIA	O
,	O
AND	O
WAS	O
ADMITTED	O
TO	O
THE	O
CMED	O
CCU	O
OBSERVATION	O
.	O

SHE	O
WAS	O
TRANSFERED	O
TO	O
THE	O
FLOOR	O
POST-OP	O
DAY	O
2	O
WHERE	O
SHE	O
HAD	O
BEEN	O
AFEBRILE	B-disease
WITH	O
NORMAL	O
VITALS	O
,	O
MAKING	O
GOOD	O
URINE	O
,	O
AND	O
TOLERATING	O
A	O
REGULAR	O
DIET	O
.	O

HER	B-disease
WOUND	I-disease
HAS	O
REMAIND	O
DRY	O
AND	O
CLOSED	O
,	O
WITHOUT	O
EVIDENCE	O
OF	O
INFECTION	B-disease
OR	O
BREAKDOWN	B-disease
.	O

SHE	O
HAS	O
BEEN	O
WATCHED	O
BY	O
A	O
SITTER	O
AT	O
ALL	O
TIMES	O
.	O

SHE	O
WILL	O
BE	O
DISCHARGED	O
TODAY	O
BACK	O
TO	O
HER	O
NURSING	O
HOME	O
IN	O
GOOD	O
CONDITION	O
,	O
ON	O
PAIN	O
MEDS	O
,	O
ANTIBIOTICS	O
,	O
AND	O
WITH	O
ANTICIPATED	O
1:1	O
WATCH	O
.	O

SHE	O
WILL	O
FOLLOW	O
UP	O
WITH	O
DR.	O
Karen	O
IN	O
1	O
WEEK	O
.	O

STAGE	O
TWO	O
OF	O
HER	O
SURGERY	O
WILL	O
BE	O
DONE	O
IN	O
3	O
WEEKS	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Paroxetine	O
HCl	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
AM	O
().	O

2.	O
Multivitamin	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

3.	O
Divalproex	O
Sodium	O
500	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
QAM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
morning	O
)).	O

4.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
:	O
constipation	B-disease
.	O

Disp	O
:*	O
30	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Triamcinolone	O
Acetonide	O
0.1	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

6.	O
Divalproex	O
Sodium	O
Oral	O

7.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

8.	O
Oxybutynin	O
Chloride	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QPM	O
(	O
once	O
a	O
day	O
(	O
in	O
the	O
evening	O
)).	O

9.	O
Hydrocodone-Acetaminophen	O
5-500	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
).	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Bacitracin-Polymyxin-Neosp	O
HC	O
Ointment	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Topical	O
three	O
times	O
a	O
day	O
.	O

Disp	O
:*	O
1	O
500	O
/	O
gram	O
*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

AQUIRED	B-disease
DEFORMITY	I-disease
OF	I-disease
THE	I-disease
RIGHT	I-disease
ALA	I-disease
/	I-disease
NOSE	I-disease
AND	I-disease
MEDIAL	I-disease
CHEEK	I-disease
FROM	O
BASAL	O
CELL	O
CARCINOMA	O
RESECTION	O

Discharge	O
Condition	O
:	O

GOOD	O

Discharge	O
Instructions	O
:	O

PLEASE	O
GIVE	O
PATIENT	O
MEDICATIONS	O
AS	O
PRESCRIBED	O
AND	O
READ	O
WARNING	O
LABELS	O
CAREFULLY	O
.	O

IF	O
SIGNS	B-disease
AND	I-disease
SYMPTOMS	I-disease
OF	O
INFECTION	B-disease
,	O
SUCH	O
AS	O
FEVERS	B-disease
/	O
CHILLS	B-disease
,	O
PURULENT	B-disease
DISCHARGE	I-disease
FROM	I-disease
WOUND	I-disease
/	I-disease
INCISION	I-disease
SITE	I-disease
,	O
INCREASED	B-disease
REDNESS	I-disease
,	O
INCREASED	B-disease
PAIN	I-disease
,	O
PLEASE	O
CALL	O
OR	O
GO	O
TO	O
THE	O
EMERGENCY	O
ROOM	O
.	O

REMEMBER	O
TO	O
CALL	O
TO	O
SCHEDULE	O
HER	O
FOLLOW	O
UP	O
APPOINTMENT	O
(	O
BELOW	O
).	O

LIGHT	O
ACTIVITIES	O
UNTIL	O
SEEN	O
IN	O
CLINIC	O
.	O

STAGE	O
2	O
OF	O
THE	O
SURGERY	O
WILL	O
BE	O
DONE	O
IN	O
3	O
WEEKS	O
.	O

MAY	O
SHOWER	O
--	O
DAB	O
DRY	O
,	O
DO	O
NOT	O
SCRUB	O
.	O

PLEASE	O
CLEAN	O
INCISION	B-disease
SITE	I-disease
WITH	O
NORMAL	O
SALINE	O
OR	O
CLEAN	O
WATER	O
THREE	O
TIMES	O
A	O
DAY	O
AND	O
PLACE	O
ANTIBIOTIC	O
OINTMENT	O
(	O
GIVEN	O
)	O
ON	O
TOP	O
OF	O
WOUND	B-disease
.	O

PLEASE	O
KEEP	O
PATIENT	O
AWAY	O
FROM	O
THE	O
SUN	O
.	O

MOST	O
IMPORTANTLY	O
,	O
THE	O
PATIENT	O
MUST	O
BE	O
WATCH	O
ONE-ON-ONE	O
SO	O
THAT	O
SHE	O
DOES	O
NOT	O
PICK	O
AT	O
HER	B-disease
WOUND	I-disease
.	O

Followup	O
Instructions	O
:	O

PLEASE	O
CALL	O
DR.Parson	O
OFFICE	O
FOR	O
A	O
FOLLOW	O
UP	O
(	O
989-5361	O
Mauricio	O
(	O
540-4644	O

Nancy	O
Lois	O
MD	O
88-449	O

Completed	O
by	O
:	O
Mary	O
Lisa	O
MD	O
53-914	O
2013-11-26	O
@	O
1134	O

Signed	O
electronically	O
by	O
:	O
DR.	O
David	O
Randazzo	O
on	O
:	O
MON	O
2013-12-16	O
7:25	O
AM	O

(	O
End	O
of	O
Report	O
)	O

262182942	O

BH	O

2513486	O

923091	O

05/08/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

JEM	O
,	O
ON	O

MRN	O
:	O

2513486	O

Age	O
:	O

74y	O

REGISTRATION	O
DATE	O
:	O

05/08/2000	O
07:57	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
JEM	O
,	O
ON	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Bri	O
Health	O
on	O
05/08/2000	O
07:57	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
IV	O
FLUIDS	O
.	O

Following	O
triage	O
,	O
the	O
patient	O
LEFT	O
WITHOUT	O
TREATMENT	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
442-025-0303	O
.	O

PCP	O
Name	O
:	O

ACKCA	O
,	O
SLAINEAEE	O
L	O

Provider	O
Number	O
:	O

78369	O

245096078	O

FIH	O

9174858	O

12/February	O

997359	O

11/3/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

11/3/92	O

DISCHARGE	O
DATE	O
:	O

12/6/92	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
68	O
year	O
old	O
,	O
right	O
handed	O
caucasian	O
female	O
,	O
former	O
R.N.	O
who	O
complained	O
of	O
several	O
days	O
of	O
vertigo	B-disease
,	O
one	O
day	O
of	O
double	B-disease
vision	I-disease
,	O
dysarthria	B-disease
and	O
worsening	O
of	O
vertigo	B-disease
.	O

She	O
was	O
seen	O
at	O
the	O
outside	O
hospital	O
and	O
put	O
on	O
aspirin	O
for	O
two	O
days	O
.	O

An	O
magnetic	O
resonance	O
imaging	O
study	O
showed	O
basilar	B-disease
artery	I-disease
disease	I-disease
,	O
questionable	O
aneurysm	B-disease
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
.	O

An	O
angiogram	O
on	O
11/3	O
was	O
consistent	O
with	O
thrombosis	B-disease
at	I-disease
the	I-disease
mid	I-disease
basilar	I-disease
artery	I-disease
.	O

The	O
patient	O
was	O
put	O
on	O
heparin	O
and	O
was	O
stable	O
since	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-disease
for	O
20	O
years	O
,	O
high	B-disease
cholesterol	I-disease
,	O
coronary	B-disease
artery	I-disease
disease	I-disease
with	O
episodes	O
of	O
angina	B-disease
,	O
no	O
history	O
of	O
myocardial	B-disease
infarction	I-disease
,	O
exercise	O
treadmill	O
or	O
evaluation	O
.	O

She	O
has	O
had	O
an	O
inguinal	O
hernia	O
repair	O
.	O

A	O
left	O
breast	O
lumpectomy	O
was	O
reportedly	O
benign	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Mevicor	O
60	O
mg.	O
PO	O
q.d.	O
,	O
Cardizem	O
90	O
mg.	O
w	O
release	O
PO	O
q.d.	O
,	O
Questran	O
one	O
pack	O
q.i.d.	O
,	O
Niacin	O
500	O
mg.	O
PO	O
b.i.d.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
a	O
one	O
pack	O
per	O
day	O
smoker	O
for	O
the	O
last	O
forty	O
years	O
,	O
denies	O
alcohol	O
,	O
is	O
a	O
former	O
nurse	O
with	O
the	O
Storm	O
Mor	O
Hospital	O
And	O
Medical	O
Center	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Her	O
blood	O
pressure	O
was	O
190/90	O
when	O
I	O
first	O
saw	O
her	O
on	O
her	O
second	O
hospital	O
day	O
.	O

She	O
was	O
afebrile	B-disease
,	O
in	O
sinus	O
rhythm	O
,	O
pulse	O
60	O
.	O

Neck	O
supple	O
.	O

Lungs	O
clear	O
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
without	O
ectopy	B-disease
.	O

A	B-disease
II	I-disease
/	I-disease
VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
is	O
at	O
the	O
base	O
,	O
minimal	B-disease
radiation	I-disease
to	I-disease
the	I-disease
carotids	I-disease
.	O

Abdomen	O
:	O

soft	O
,	O
without	O
hepatosplenomegaly	B-disease
.	O

Extremities	O
:	O

normal	O
pulses	O
,	O
no	O
clubbing	B-disease
,	O
cyanosis	B-disease
or	O
edema	B-disease
.	O

The	O
neurological	O
examination	O
:	O

post	O
angiogram	O
her	O
eyes	O
were	O
closed	O
.	O

She	O
was	O
very	O
responsive	O
,	O
somewhat	O
sleepy	O
,	O
she	O
complained	O
of	O
chest	B-disease
pain	I-disease
,	O
which	O
was	O
diffuse	O
,	O
non-localizing	O
without	O
electrocardiogram	O
changes	O
and	O
persisted	O
for	O
several	O
days	O
and	O
then	O
went	O
away	O
completely	O
.	O

She	O
was	O
oriented	O
to	O
person	O
,	O
place	O
,	O
time	O
and	O
purpose	O
,	O
she	O
recalled	O
three	O
out	O
of	O
three	O
objects	O
at	O
five	O
minutes	O
,	O
she	O
is	O
able	O
to	O
do	O
calculations	O
.	O

She	O
maintained	O
her	O
fixation	O
on	O
the	O
conversation	O
well	O
.	O

The	O
cranial	O
nerve	O
exam	O
:	O

pupils	O
reactive	O
to	O
light	O
,	O
extra	O
ocular	O
movements	O
show	O
good	O
upgaze	O
up	O
to	O
3	O
mm.	O
,	O
good	O
down	O
gaze	O
.	O

Right	O
lateral	O
gaze	O
,	O
the	O
right	O
eye	O
had	O
2	O
mm.	O
of	O
sclera	O
showing	O
,	O
the	O
left	O
eye	O
was	O
normal	O
,	O
and	O
there	O
are	O
a	O
few	O
beats	O
of	O
right	B-disease
beading	I-disease
nystagmus	I-disease
.	O

The	O
left	O
lateral	O
gaze	O
,	O
the	O
left	O
eye	O
had	O
1	O
mm.	O
of	O
lateral	O
sclera	O
showing	O
.	O

Disks	O
were	O
flat	O
.	O

Sensory	O
limb	O
of	O
the	O
right	O
eye	O
corneal	O
reflex	O
is	O
slowed	O
,	O
otherwise	O
normal	O
.	O

Seventh	B-disease
nerve	I-disease
weakness	I-disease
on	O
the	O
right	O
in	O
a	O
central	O
pattern	O
is	O
present	O
.	O

Soft	O
palate	O
was	O
in	O
the	O
midline	O
and	O
moved	O
upward	O
nicely	O
,	O
but	O
did	O
not	O
respond	O
to	O
gag	O
.	O

Tongue	O
protrudes	O
2	O
cm.	O
with	O
slight	O
deviation	O
to	O
the	O
right	O
.	O

Sensory	O
exam	O
was	O
not	O
remarkable	O
,	O
cerebellar	O
exam	O
was	O
not	O
possible	O
.	O

Motor	O
exam	O
showed	O
greater	O
than	O
4+	O
strength	O
bilateral	O
upper	O
extremities	O
and	O
psoas	O
unable	O
to	O
lift	O
off	O
bed	O
.	O

Quadraceps	O
2+	O
on	O
the	O
left	O
and	O
3+	O
on	O
the	O
right	O
.	O

Gastroc.	O
3	O
on	O
the	O
left	O
and	O
4+	O
on	O
the	O
right	O
.	O

Tibialis	O
3	O
on	O
the	O
left	O
,	O
5+	O
on	O
the	O
right	O
.	O

Reflexes	O
were	O
diffuse	O
3+	O
,	O
toes	O
upgoing	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
electrocardiogram	O
showed	O
less	O
than	O
1	O
mm.	O
of	O
ST	B-disease
depression	I-disease
in	I-disease
V4	I-disease
to	I-disease
V6	I-disease
,	O
which	O
is	O
likely	O
the	O
patient	O
&apos;s	O
baseline	O
.	O

CK	O
&apos;s	O
were	O
mildly	B-disease
elevated	I-disease
but	O
the	O
MB	O
fractions	O
were	O
not	O
remarkable	O
.	O

A	O
chest	O
X-ray	O
showed	O
some	B-disease
left	I-disease
lower	I-disease
lobe	I-disease
atelectasis	I-disease
.	O

Admitting	O
creatinine	O
was	O
.7	O
,	O
glucose	O
131	O
,	O
white	O
blood	O
count	O
was	O
10,000	O
,	O
hematocrit	O
was	O
40	O
,	O
liver	O
enzymes	O
normal	O
range	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Intensive	O
Care	O
Unit	O
after	O
her	O
angiogram	O
.	O

She	O
was	O
aggressively	O
anticoagulated	O
with	O
heparin	O
.	O

A	B-disease
small	I-disease
intimal	I-disease
tear	I-disease
in	O
the	O
arch	O
of	O
the	O
aorta	O
during	O
the	O
angiogram	O
,	O
was	O
without	O
sequelae	B-disease
.	O

She	O
was	O
doing	O
well	O
with	O
at	O
least	O
4+	O
strength	O
in	O
all	O
of	O
her	O
extremities	O
,	O
when	O
on	O
11/13	O
,	O
she	O
had	O
an	B-disease
acute	I-disease
drop	I-disease
in	O
her	O
systolic	O
blood	O
pressure	O
to	O
70	O
for	O
unclear	O
reasons	O
and	O
without	O
evidence	O
of	O
acute	B-disease
sepsis	I-disease
.	O

This	O
was	O
accompanied	O
by	O
substantial	B-disease
decrement	I-disease
in	I-disease
neurologic	I-disease
function	I-disease
.	O

For	O
a	O
short	O
time	O
,	O
she	O
seemed	O
&quot;	B-disease
locked	I-disease
in	I-disease
&quot;	I-disease
.	O

She	O
has	O
made	O
slow	O
progress	O
since	O
then	O
and	O
at	O
the	O
time	O
of	O
discharge	O
has	O
4-strength	O
at	O
the	O
left	O
elbow	O
and	O
4+	O
in	O
the	O
left	O
wrist	O
and	O
hand	O
.	O

Trace	O
movement	O
of	O
the	O
right	O
elbow	O
and	O
4-strength	O
of	O
the	O
right	O
wrist	O
and	O
hand	O
.	O

4-to	O
4+	O
strength	O
at	O
the	O
left	O
ankle	O
,	O
4+	O
strength	O
at	O
the	O
right	O
knee	O
and	O
right	O
ankle	O
.	O

She	O
is	O
unable	O
to	O
lift	O
either	O
foot	O
off	O
the	O
bed	O
.	O

The	O
extra	O
ocular	O
movements	O
are	O
full	O
.	O

Tongue	O
protrudes	O
4	O
cm	O
.	O

She	O
is	O
drowsy	B-disease
at	O
times	O
,	O
but	O
generally	O
alert	O
,	O
responsive	O
,	O
interactive	O
,	O
able	O
to	O
talk	O
in	O
two	O
to	O
three	O
word	O
sentences	O
when	O
she	O
wants	O
to	O
.	O

She	O
has	O
severe	B-disease
memory	I-disease
deficits	I-disease
,	O
but	O
nevertheless	O
,	O
is	O
able	O
to	O
engage	O
in	O
conversation	O
,	O
answers	O
questions	O
,	O
names	O
things	O
well	O
,	O
does	O
calculations	O
and	O
recognizes	O
family	O
members	O
and	O
states	O
preferences	O
.	O

She	O
has	O
been	O
working	O
with	O
Speech	O
Therapy	O
,	O
occupational	O
therapy	O
and	O
physical	O
therapy	O
closely	O
and	O
should	O
continue	O
to	O
show	O
improvement	O
.	O

She	O
is	O
anticoagulated	O
on	O
Coumadin	O
and	O
this	O
has	O
been	O
stable	O
.	O

She	O
is	O
do	O
not	O
resuscitate	O
in	O
agreement	O
with	O
the	O
wishes	O
of	O
her	O
multiple	O
family	O
members	O
.	O

Follow	O
up	O
computerized	O
tomography	O
scans	O
and	O
magnetic	O
resonance	O
imaging	O
studies	O
have	O
shown	O
infarction	B-disease
in	I-disease
bilateral	I-disease
basis	I-disease
pontis	I-disease
,	I-disease
mid	I-disease
brain	I-disease
,	I-disease
the	I-disease
superior	I-disease
cerebellar	I-disease
areas	I-disease
,	I-disease
left	I-disease
thalamus	I-disease
,	I-disease
bilateral	I-disease
temporal	I-disease
lobes	I-disease
medially	I-disease
and	I-disease
inferiorly	I-disease
and	I-disease
left	I-disease
posterior	I-disease
communicating	I-disease
artery	I-disease
.	O

The	O
patient	O
had	O
fevers	B-disease
sporadically	O
during	O
this	O
hospitalization	O
with	O
rising	B-disease
white	I-disease
blood	I-disease
counts	I-disease
.	O

A	O
chest	O
X-ray	O
documented	O
a	B-disease
progressing	I-disease
left	I-disease
lower	I-disease
lobe	I-disease
infiltrate	I-disease
.	O

Initially	O
this	O
improved	O
on	O
Clindamycin	O
and	O
Cefotetan	O
,	O
but	O
fevers	B-disease
recurred	O
on	O
this	O
antibiotic	O
regimen	O
.	O

Sputum	O
grew	O
out	O
Klebsiella	B-disease
pneumoniae	I-disease
,	O
and	O
she	O
was	O
treated	O
with	O
Gentamicin	O
and	O
Ancef	O
for	O
14	O
days	O
intravenous	O
(	O
bug	B-disease
being	O
sensitive	O
to	O
these	O
two	O
drugs	O
)	O
.	O

A	B-disease
left	I-disease
pleural	I-disease
effusion	I-disease
developed	O
and	O
this	O
was	O
tapped	O
with	O
ultrasound	O
guidance	O
,	O
and	O
found	O
to	O
be	O
sterile	O
,	O
and	O
without	O
evidence	O
of	O
empyema	B-disease
.	O

The	O
patient	O
is	O
on	O
Ciprofloxacin	O
.	O

The	O
day	O
of	O
discharge	O
is	O
day	O
#3	O
of	O
7	O
,	O
after	O
which	O
antibiotics	O
should	O
be	O
totally	O
discontinued	O
.	O

She	O
has	O
developed	O
bad	B-disease
thrush	I-disease
in	O
this	O
setting	O
,	O
she	O
is	O
not	O
yet	O
able	O
to	O
swallow	O
and	O
so	O
she	O
is	O
on	O
Nystatin	O
swish	O
and	O
spit	O
five	O
times	O
a	O
day	O
.	O

She	O
also	O
gets	O
Peridex	O
to	O
clean	O
out	O
her	O
mouth	O
.	O

Once	O
her	O
liver	O
enzymes	O
are	O
completely	O
normal	O
,	O
a	O
seven	O
day	O
course	O
of	O
Fluconazol	O
may	O
be	O
helpful	O
if	O
the	B-disease
thrush	I-disease
is	O
not	O
spontaneously	O
resolving	O
off	O
of	O
antibiotics	O
.	O

She	O
has	O
been	O
afebrile	B-disease
for	O
greater	O
than	O
10	O
days	O
,	O
including	O
several	O
days	O
on	O
oral	O
antibiotics	O
.	O

The	O
patient	O
&apos;s	O
liver	O
enzymes	O
were	O
noted	O
to	O
be	O
elevated	O
mid	O
way	O
through	O
her	O
hospital	O
course	O
,	O
to	O
about	O
three	O
times	O
normal	O
,	O
especially	O
the	O
SGOT	O
and	O
SGPT	O
.	O

These	O
have	O
spontaneously	O
reversed	O
,	O
and	O
are	O
nearly	O
normal	O
at	O
the	O
time	O
of	O
discharge	O
.	O

A	O
right	O
upper	O
quadrant	O
ultrasound	O
documented	O
gallstones	B-disease
,	O
without	O
evidence	O
of	O
common	B-disease
bile	I-disease
duct	I-disease
dilatation	I-disease
or	O
active	B-disease
cholecystitis	I-disease
.	O

The	O
exact	O
cause	O
of	O
her	B-disease
liver	I-disease
enzyme	I-disease
elevation	I-disease
is	O
unclear	O
,	O
but	O
we	O
are	O
being	O
careful	O
about	O
administering	O
drugs	O
,	O
which	O
might	O
irritate	O
the	O
liver	O
.	O

The	O
patient	O
had	O
a	B-disease
steady	I-disease
decline	I-disease
in	O
her	O
hematocrit	O
during	O
this	O
hospitalization	O
.	O

Iron	O
studies	O
are	O
all	O
entirely	O
normal	O
,	O
her	B-disease
anemia	I-disease
is	O
attributed	O
to	O
anemia	B-disease
or	O
chronic	B-disease
disease	I-disease
with	O
hypoproliferation	B-disease
as	O
well	O
as	O
multiple	O
phlebotomies	O
.	O

The	O
plan	O
is	O
to	O
give	O
her	O
folic	O
acid	O
,	O
but	O
not	O
iron	O
.	O

The	O
patient	O
&apos;s	O
potassiums	O
have	O
been	O
repeatedly	O
low	O
and	O
require	O
daily	O
checks	O
and	O
repletion	O
.	O

This	O
is	O
thought	O
due	O
to	O
the	O
extensive	O
course	O
of	O
Gentamicin	O
which	O
she	O
received	O
.	O

This	O
must	O
be	O
carefully	O
checked	O
despite	O
the	O
standing	O
order	O
for	O
potassium	O
.	O

The	O
patient	O
has	O
had	O
low	B-disease
sodiums	I-disease
during	O
this	O
hospitalization	O
.	O

This	O
may	O
due	O
to	O
her	B-disease
central	I-disease
nervous	I-disease
system	I-disease
process	I-disease
or	O
her	B-disease
pulmonary	I-disease
process	I-disease
,	O
with	O
fluids	O
administered	O
as	O
described	O
,	O
she	O
should	O
not	O
have	O
any	B-disease
problems	I-disease
from	O
this	O
.	O

Her	O
sodiums	O
were	O
never	O
below	O
130	O
.	O

She	O
does	O
well	O
with	O
tube	O
feeds	O
.	O

Her	O
tube	O
feeds	O
orders	O
are	O
as	O
follow	O
:	O

full	O
strength	O
Replete	O
with	O
fiber	O
at	O
70	O
cc.	O
per	O
hour	O
.	O

In	O
addition	O
,	O
the	O
patient	O
gets	O
250	O
cc.	O
of	O
juice	O
(	O
not	O
water	O
)	O
three	O
times	O
a	O
day	O
.	O

She	O
also	O
gets	O
Lactinex	O
granules	O
three	O
packages	O
in	O
each	O
bottle	O
of	O
tube	O
feeds	O
.	O

She	O
also	O
gets	O
Metamucil	O
one	O
teaspoon	O
with	O
the	O
first	O
bolus	O
of	O
juice	O
each	O
day	O
.	O

Please	O
note	O
that	O
evaluation	O
by	O
the	O
swallowing	O
therapist	O
,	O
showed	O
that	O
the	O
patient	O
is	O
aspirating	O
at	O
this	O
time	O
,	O
but	O
there	O
is	O
great	O
hope	O
from	O
the	O
nature	O
of	O
her	B-disease
deficit	I-disease
and	O
the	O
good	O
movements	O
of	O
her	O
tongue	O
that	O
normal	O
swallowing	O
should	O
return	O
soon	O
.	O

It	O
is	O
for	O
this	O
reason	O
that	O
she	O
is	O
discharged	O
with	O
an	O
nasogastric	O
tube	O
and	O
that	O
no	O
plans	O
for	O
G	O
tube	O
placement	O
are	O
made	O
at	O
this	O
time	O
.	O

She	O
has	O
a	O
history	O
of	O
of	O
angina	B-disease
without	O
myocardial	B-disease
infarction	I-disease
that	O
has	O
not	O
been	O
worked	O
up	O
.	O

She	O
did	O
have	O
brief	B-disease
chest	I-disease
pain	I-disease
twice	O
during	O
this	O
admission	O
that	O
did	O
not	O
correlate	O
with	O
electrocardiogram	O
changes	O
.	O

In	O
the	O
first	O
week	O
of	O
November	O
,	O
her	O
electrocardiogram	O
showed	O
T	B-disease
wave	I-disease
inversions	I-disease
in	I-disease
the	I-disease
lateral	I-disease
leads	I-disease
,	O
correlating	O
with	O
an	B-disease
increase	I-disease
in	O
the	O
LDH	O
,	O
but	O
not	O
CK	O
.	O

This	O
did	O
not	O
normalize	O
with	O
administration	O
of	O
Isordil	O
and	O
the	O
patient	O
denied	O
chest	B-disease
pain	I-disease
at	O
this	O
time	O
.	O

As	O
of	O
4/7	O
,	O
her	O
electrocardiogram	O
had	O
reverted	O
back	O
to	O
normal	O
and	O
there	O
is	O
no	O
evidence	O
of	O
congestive	B-disease
heart	I-disease
failure	I-disease
or	O
continued	O
electrocardiogram	O
changes	O
,	O
and	O
chest	B-disease
pain	I-disease
is	O
absent	O
.	O

Her	O
cholesterol	O
was	O
350	O
here	O
.	O

She	O
has	O
been	O
off	O
of	O
her	O
hypercholesterol	O
medicines	O
.	O

These	O
can	O
be	O
restarted	O
when	O
it	O
is	O
deemed	O
reasonable	O
,	O
in	O
view	O
of	O
her	B-disease
acute	I-disease
disease	I-disease
and	O
recently	B-disease
elevated	I-disease
liver	I-disease
enzymes	I-disease
.	O

Note	O
that	O
the	O
liver	O
enzymes	O
were	O
normal	O
on	O
admission	O
,	O
at	O
which	O
time	O
she	O
was	O
taking	O
all	O
of	O
the	O
above	O
cholesterol	O
medicines	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Metamucil	O
1	O
teaspoon	O
q.d.	O
,	O
with	O
first	O
bolus	O
of	O
juice	O
,	O
juice	O
250	O
cc.	O
down	O
nasogastric	O
tube	O
t.i.d.	O
,	O
tube	O
feeds	O
as	O
above	O
,	O
Lactinex	O
as	O
above	O
,	O
Tagamet	O
800	O
mg.	O
nasogastric	O
tube	O
qhs	O
,	O
Nystatin	O
swish	O
and	O
spit	O
10	O
cc.	O
five	O
times	O
a	O
day	O
,	O
Cardizem	O
slow	O
release	O
90	O
mg.	O
PO	O
q.d.	O
,	O
Folic	O
Acid	O
1	O
mg.	O
PO	O
q.d.	O
,	O
Ciprofloxacin	O
500	O
mg.	O
PO	O
b.i.d.	O
,	O
discontinue	O
on	O
12/10/92	O
KayCiel	O
30	O
mEq.	O
down	O
nasogastric	O
tube	O
q.d.	O
,	O
Peridex	O
10	O
cc.	O
swish	O
and	O
spit	O
q.i.d.	O
,	O
Coumadin	O
4	O
mg.	O
nasogastric	O
tube	O
on	O
odd	O
days	O
,	O
alternating	O
with	O
5	O
mg.	O
nasogastric	O
tube	O
on	O
even	O
days	O
,	O
once	O
daily	O
,	O
Tylenol	O
650	O
mg.	O
PO	O
and	O
PR	O
q6hours	O
PRN	O
pain	B-disease
,	O
Nystatin	O
powder	O
to	O
axilla	O
and	O
groin	O
as	O
needed	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Basilar	B-disease
artery	I-disease
stenosis	I-disease
with	O
basilar	B-disease
thrombosis	I-disease
and	O
&quot;	B-disease
top	I-disease
of	I-disease
the	I-disease
basilar	I-disease
&quot;	I-disease
syndrome	I-disease
.	O

Includes	O
recent	B-disease
infarct	I-disease
to	I-disease
pons	I-disease
,	I-disease
mid	I-disease
brain	I-disease
,	I-disease
left	I-disease
thalamus	I-disease
,	I-disease
bilateral	I-disease
temporal	I-disease
lobes	I-disease
and	I-disease
left	I-disease
visual	I-disease
cortex	I-disease
,	O
on	O
Coumadin	O
.	O

The	O
patient	O
is	O
do	O
not	O
resuscitate	O
at	O
family	O
&apos;s	O
request	O
.	O

Left	B-disease
lower	I-disease
lobe	I-disease
pneumonia	I-disease
,	O
resolving	O
now	O
on	O
oral	O
antibiotics	O
.	O

Gallstones	B-disease
,	O
thought	O
to	O
be	O
inactive	O
.	O

Improving	O
liver	B-disease
enzyme	I-disease
elevation	I-disease
.	O

Anemia	B-disease
,	O
discharge	O
hematocrit	O
28	O
,	O
not	O
iron	B-disease
deficient	I-disease
.	O

Low	B-disease
potassium	I-disease
,	O
thought	O
due	O
to	O
Gentamicin	O
.	O

Low	B-disease
sodium	I-disease
,	O
responsive	O
to	O
fluid	O
restriction	O
.	O

History	O
of	O
coronary	B-disease
artery	I-disease
disease	I-disease
.	O

Thrush	B-disease
.	O

High	B-disease
cholesterol	I-disease
.	O

The	O
patient	O
needs	O
prothrombin	O
time	O
checked	O
daily	O
,	O
patient	O
needs	O
potassium	O
checked	O
daily	O
,	O
patient	O
needs	O
sodium	O
checked	O
at	O
least	O
every	O
other	O
day	O
.	O

DO	O
JOASSCCHIRD	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

NAREA	O
SWALLOW	O
,	O
M.D.	O

TR	O
:	O

sw	O
/	O
bmot	O

DD	O
:	O

12/6/92	O

TD	O
:	O

12/06/92	O

CC	O
:	O

Dr.	O
Namarce	O
May	O
STAT	O

Admission	O
Date	O
:	O

2012-04-20	O

Discharge	O
Date	O
:	O

2012-05-01	O

Date	O
of	O
Birth	O
:	O

1952-06-24	O

Sex	O
:	O

M	O

Service	O
:	O

Medicine	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
59	O
year	O
old	O
male	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
an	O
atrioseptal	O
defect	O
repair	O
at	O
age	O
18	O
,	O
congestive	B-disease
heart	I-disease
failure	I-disease
with	O
an	O
ejection	O
fraction	O
of	O
45%	O
and	O
a	B-disease
recent	I-disease
cardiac	I-disease
myocardial	I-disease
infarction	I-disease
,	O
pulmonary	B-disease
hypertension	I-disease
and	O
mitral	B-disease
regurgitation	I-disease
,	O
and	O
atrial	B-disease
fibrillation	I-disease
.	O

He	O
was	O
seen	O
by	O
his	O
primary	O
care	O
physician	O
the	O
day	O
before	O
admission	O
and	O
complained	O
of	O
two	O
weeks	O
of	O
increasing	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
fatigue	B-disease
,	O
weight	B-disease
gain	I-disease
and	O
abdominal	B-disease
fullness	I-disease
.	O

He	O
was	O
sent	O
to	O
the	O
Emergency	O
Department	O
for	O
further	O
evaluation	O
.	O

The	O
patient	O
reported	O
feeling	O
at	O
his	O
baseline	O
with	O
chronic	B-disease
mild	I-disease
dyspnea	I-disease
on	O
exertion	O
until	O
two	O
weeks	O
prior	O
to	O
admission	O
.	O

During	O
this	O
period	O
he	O
had	O
also	O
been	O
weaned	O
off	O
of	O
his	O
Digoxin	O
starting	O
early	O
in	O
February	O
.	O

Over	O
the	O
two	O
weeks	O
prior	O
to	O
admission	O
he	O
had	O
noticed	O
an	B-disease
increasing	I-disease
heart	I-disease
rate	I-disease
from	O
his	O
baseline	O
in	O
the	O
60s	O
to	O
a	O
heart	O
rate	O
in	O
the	O
120s	O
.	O

He	O
had	O
also	O
some	B-disease
increased	I-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
a	B-disease
10	I-disease
pound	I-disease
weight	I-disease
gain	I-disease
and	O
new	O
three	O
to	O
four	O
pillow	B-disease
orthopnea	I-disease
with	O
a	B-disease
dry	I-disease
cough	I-disease
.	O

He	O
denied	O
fevers	B-disease
,	O
chills	B-disease
,	O
nausea	B-disease
or	O
vomiting	B-disease
,	O
chest	B-disease
pain	I-disease
or	O
diaphoresis	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Atrioseptal	O
defect	O
repair	O
in	O
1970	O
,	O
cardiomyopathy	B-disease
,	O
right-sided	B-disease
congestive	I-disease
heart	I-disease
failure	I-disease
,	O
pulmonary	B-disease
hypertension	I-disease
,	O
history	O
of	O
atrial	B-disease
fibrillation	I-disease
and	O
atrial	B-disease
flutter	I-disease
,	O
history	O
of	O
prostate	B-disease
cancer	I-disease
,	O
status	O
post	O
brachytherapy	O
,	O
history	O
of	O
rectal	B-disease
bleeding	I-disease
,	O
obstructive	B-disease
sleep	I-disease
apnea	I-disease
on	O
CPAP	O
.	O

ALLERGIES	O
:	O

ACE	O
inhibitors	O
,	O
possible	O
allergy	B-disease
to	O
barium	O
reported	O
by	O
the	O
patient	O
during	O
a	O
barium	O
swallow	O
25	O
years	O
ago	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Digoxin	O
0.125	O
,	O
discontinued	O
one	O
month	O
prior	O
to	O
admission	O
,	O
Toprol	O
XL	O
100	O
mg	O
daily	O
,	O
Trazodone	O
50	O
mg	O
once	O
daily	O
,	O
Lipitor	O
10	O
mg	O
daily	O
,	O
Diovan	O
40	O
mg	O
daily	O
,	O
Atrovent	O
/	O
Albuterol	O
prn	O
,	O
Pulmicort	O
,	O
Coumadin	O
2.5	O
mg	O
daily	O
,	O
Vitamin	O
E	O
,	O
Vitamin	O
C	O
,	O
iron	O
supplement	O
.	O

SOCIAL	O
HISTORY	O
:	O

Remote	O
history	O
of	O
tobacco	O
,	O
occasional	O
alcohol	O
use	O
.	O

He	O
is	O
a	O
retired	O
fire	O
fighter	O
.	O

LABORATORY	O
DATA	O
:	O

White	O
blood	O
cell	O
count	O
10.5	O
,	O
hematocrit	O
38.1	O
,	O
platelets	O
254	O
,	O
INR	O
1.8	O
.	O

Sodium	O
140	O
,	O
potassium	O
5.2	O
,	O
BUN	O
38	O
,	O
creatinine	O
.7	O
,	O
TSH	O
1.8	O
,	O
Digoxin	O
level	O
less	O
than	O
0.2	O
.	O

Serial	O
cardiac	O
enzymes	O
negative	O
.	O

ALT	O
14	O
,	O
AST	O
31	O
,	O
alkaline	O
phosphatase	O
283	O
,	O
total	O
bilirubin	O
1.0	O
,	O
amylase	O
71	O
,	O
glucose	O
tolerance	O
test	O
317	O
.	O

Electrocardiogram	O
showed	O
atrial	B-disease
fibrillation	I-disease
with	O
rapid	B-disease
ventricular	I-disease
response	I-disease
and	O
atrial	B-disease
flutter	I-disease
.	O

Echocardiogram	O
showed	O
moderate	B-disease
dilated	I-disease
left	I-disease
atrium	I-disease
,	O
no	O
atrioseptal	B-disease
defect	I-disease
,	O
severe	B-disease
global	I-disease
left	I-disease
ventricular	I-disease
hypokinesis	I-disease
with	O
severe	B-disease
left	I-disease
ventricular	I-disease
systolic	I-disease
function	I-disease
and	O
moderately	B-disease
dilated	I-disease
right	I-disease
ventricle	I-disease
.	O

There	O
was	O
global	B-disease
hypokinesis	I-disease
apical	I-disease
throughout	I-disease
the	I-disease
right	I-disease
ventricle	I-disease
and	O
abnormal	B-disease
septal	I-disease
motion	I-disease
consistent	O
with	O
right	B-disease
ventricular	I-disease
volume	I-disease
overload	I-disease
.	O

Moderate	B-disease
to	I-disease
severe	I-disease
3+	I-disease
mitral	I-disease
regurgitation	I-disease
and	O
3+	B-disease
tricuspid	I-disease
regurgitation	I-disease
along	O
with	O
moderate	B-disease
pulmonary	I-disease
early	I-disease
systolic	I-disease
hypertension	I-disease
.	O

Of	O
note	O
,	O
this	O
echocardiogram	O
was	O
performed	O
when	O
the	O
patient	O
was	O
tachycardiac	B-disease
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Hypotension	B-disease
-	O
The	O
patient	O
was	O
initially	O
mildly	B-disease
hypotensive	I-disease
with	O
systolic	O
blood	O
pressures	O
in	O
the	O
80s	O
.	O

Upon	O
admission	O
it	O
was	O
unclear	O
whether	O
or	O
not	O
the	O
patient	O
was	O
volume	B-disease
overloaded	I-disease
or	O
volume	B-disease
depleted	I-disease
.	O

Initially	O
he	O
was	O
treated	O
with	O
intravenous	O
fluids	O
with	O
a	O
dramatic	O
response	O
in	O
his	O
systolic	O
blood	O
pressure	O
.	O

However	O
,	O
subsequent	O
it	O
was	O
determined	O
that	O
the	B-disease
patient	I-disease
's	I-disease
hypotension	I-disease
may	O
have	O
been	O
related	O
to	O
his	B-disease
rapid	I-disease
ventricular	I-disease
response	I-disease
and	O
right	B-disease
heart	I-disease
failure	I-disease
.	O

Therefore	O
the	O
focus	O
of	O
treatment	O
was	O
changed	O
to	O
controlling	O
his	O
rate	O
.	O

2.	O
Atrial	B-disease
fibrillation	I-disease
-	O
The	O
patient	O
's	O
Digoxin	O
had	O
been	O
weaned	O
off	O
prior	O
to	O
his	O
admission	O
.	O

It	O
was	O
felt	O
that	O
this	O
potentially	O
had	O
lead	O
to	O
his	B-disease
atrial	I-disease
flutter	I-disease
and	O
atrial	B-disease
fibrillation	I-disease
with	O
rapid	B-disease
ventricular	I-disease
response	I-disease
.	O

The	O
patient	O
was	O
loaded	O
once	O
again	O
with	O
Digoxin	O
and	O
his	O
beta	O
blocker	O
was	O
increased	O
to	O
100	O
mg	O
of	O
Lopressor	O
,	O
three	O
times	O
a	O
day	O
.	O

In	O
addition	O
the	O
patient	O
was	O
started	O
on	O
Verapamil	O
since	O
his	O
heart	O
rate	O
had	O
remained	O
mildly	B-disease
tachycardiac	I-disease
in	O
the	O
low	O
100s	O
.	O

3.	O
Congestive	B-disease
heart	I-disease
failure	I-disease
-	O
During	O
the	O
initial	O
course	O
of	O
the	O
patient	O
's	O
admission	O
,	O
it	O
was	O
unclear	O
as	O
to	O
whether	O
or	O
not	O
he	O
was	O
volume	B-disease
overloaded	I-disease
or	O
volume	B-disease
depleted	I-disease
.	O

The	O
patient	O
was	O
initially	O
treated	O
with	O
intravenous	O
fluids	O
,	O
however	O
,	O
subsequently	O
he	O
was	O
diuresed	O
when	O
he	O
became	O
symptomatic	B-disease
and	O
short	B-disease
of	I-disease
breath	I-disease
.	O

Chest	O
x-rays	O
revealed	O
evidence	O
of	O
congestive	B-disease
heart	I-disease
failure	I-disease
.	O

The	O
decision	O
was	O
made	O
to	O
have	O
the	O
patient	O
undergo	O
a	O
cardiac	O
catheterization	O
to	O
fully	O
evaluate	O
the	O
hemodynamics	O
to	O
determine	O
the	O
etiology	O
of	O
the	B-disease
patient	I-disease
's	I-disease
heart	I-disease
failure	I-disease
.	O

In	O
addition	O
,	O
plans	O
were	O
made	O
to	O
evaluate	O
the	O
patient	O
's	O
cardiac	O
arteries	O
to	O
determine	O
if	O
he	O
had	O
any	O
component	O
of	O
ischemic	B-disease
cardiomyopathy	I-disease
.	O

4.	O
Abnormal	O
liver	O
function	O
tests	O
-	O
The	O
patient	O
had	O
an	B-disease
isolated	I-disease
,	I-disease
elevated	I-disease
alkaline	I-disease
phosphatase	I-disease
with	O
a	B-disease
confirmatory	I-disease
elevation	I-disease
in	O
his	O
gamma	O
glutamyl	O
transferase	O
.	O

An	O
ultrasound	O
of	O
the	O
right	O
upper	O
quadrant	O
did	O
not	O
reveal	O
any	B-disease
cholelithiasis	I-disease
or	O
cholecystitis	B-disease
,	O
however	O
,	O
an	B-disease
irregular	I-disease
hepatic	I-disease
contour	I-disease
was	O
seen	O
which	O
is	O
suggestive	O
of	O
underlying	B-disease
chronic	I-disease
liver	I-disease
disease	I-disease
.	O

There	O
was	O
some	O
concern	O
that	O
the	O
patient	O
may	O
have	O
a	B-disease
partial	I-disease
biliary	I-disease
obstruction	I-disease
and	O
the	O
patient	O
was	O
sent	O
for	O
an	O
magnetic	O
resonance	O
cholangiopancreatography	O
to	O
further	O
evaluate	O
the	O
biliary	O
system	O
.	O

Magnetic	O
resonance	O
cholangiopancreatography	O
did	O
not	O
reveal	O
any	O
evidence	O
of	O
biliary	B-disease
dilatation	I-disease
or	O
of	O
any	B-disease
obstructing	I-disease
pancreatic	I-disease
mass	I-disease
.	O

Again	O
seen	O
was	O
a	B-disease
slightly	I-disease
irregular	I-disease
contour	I-disease
of	I-disease
the	I-disease
liver	I-disease
with	O
dilated	B-disease
hepatic	I-disease
veins	I-disease
suggesting	O
chronic	B-disease
hepatic	I-disease
vascular	I-disease
congestion	I-disease
.	O

The	O
patient	O
also	O
revealed	O
a	O
prior	O
history	O
of	O
heavy	O
alcohol	O
use	O
for	O
approximately	O
20	O
years	O
,	O
during	O
the	O
mid	O
1950s	O
to	O
mid	O
1970s	O
.	O

It	O
was	O
felt	O
that	O
he	O
may	O
have	O
had	O
some	O
component	O
of	O
vascular	B-disease
congestion	I-disease
from	O
his	B-disease
congestive	I-disease
heart	I-disease
failure	I-disease
as	O
well	O
as	O
possibly	O
some	B-disease
mild	I-disease
cirrhotic	I-disease
changes	I-disease
secondary	O
to	O
his	O
previous	O
alcohol	O
use	O
.	O

5.	O
Fall	O
-	O
The	O
patient	O
had	O
a	O
mechanical	O
fall	O
during	O
his	O
admission	O
.	O

He	O
did	O
not	O
sleep	O
at	O
all	O
the	O
night	O
before	O
and	O
was	O
extremely	B-disease
fatigued	I-disease
.	O

He	O
was	O
walking	O
in	O
the	O
hall	O
,	O
dragging	O
his	O
intravenous	O
pole	O
when	O
he	O
tripped	O
over	O
the	O
foot	O
of	O
the	O
pole	O
and	O
lost	O
his	O
balance	O
.	O

He	O
fell	O
backwards	O
,	O
landing	O
on	O
his	O
buttocks	O
and	O
bumped	O
his	O
head	O
.	O

His	O
neurological	O
examination	O
at	O
that	O
time	O
was	O
nonfocal	O
and	O
the	O
head	O
was	O
atraumatic	B-disease
without	O
any	O
evidence	O
of	O
a	B-disease
hematoma	I-disease
.	O

A	O
computerized	O
axial	O
tomography	O
scan	O
of	O
his	O
head	O
at	O
that	O
time	O
did	O
not	O
reveal	O
any	B-disease
extra	I-disease
or	I-disease
intracranial	I-disease
hemorrhage	I-disease
.	O

6.	O
Rectal	B-disease
bleeding	I-disease
-	O
The	O
patient	O
has	O
a	O
history	O
of	O
rectal	B-disease
bleeding	I-disease
,	O
ever	O
since	O
his	O
brachytherapy	O
for	O
his	B-disease
prostate	I-disease
cancer	I-disease
.	O

The	O
patient	O
has	O
been	O
treated	O
with	O
Argon	O
laser	O
therapy	O
in	O
the	O
past	O
for	O
his	B-disease
rectal	I-disease
bleeding	I-disease
and	O
it	O
is	O
recommended	O
that	O
he	O
follow	O
up	O
with	O
his	O
gastroenterologist	O
for	O
repeat	O
Argon	O
laser	O
therapy	O
.	O

The	O
remainder	O
of	O
the	O
hospital	O
course	O
will	O
be	O
dictated	O
by	O
the	O
covering	O
intern	O
.	O

Sheila	O
Providence	O
,	O
M.D.	O
50-442	O

Dictated	O
By	O
:	O
Marjorie	O
I.	O
Taylor	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-05-01	O
22:34	O

T	O
:	O
2012-05-02	O
06:55	O

JOB	O
#:	O
79270	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jane	O
Nix	O
on	O
:	O
MON	O
2012-05-07	O
9:28	O
AM	O

(	O
End	O
of	O
Report	O
)	O

384729825	O

FIH	O

0670582	O

899158	O

790156	O

11/20/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

BREUNDAIL	O
,	O
NETFA	O

MRN	O
:	O

0670582	O

Age	O
:	O

91y	O

REGISTRATION	O
DATE	O
:	O

11/20/2002	O
02:02	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
BREUNDAIL	O
,	O
NETFA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
on	O
11/20/2002	O
02:02	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SDH	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
FAIRM	O
OF	O
IJORDCOMPMAC	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
GLYNCRED	O
,	O
NABETH	O
N	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
SDH	B-disease
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
834-226-3369	O
.	O

PCP	O
Name	O
:	O

TRIEVA	O
,	O
WINGENE	O
R	O

Provider	O
Number	O
:	O

03519	O

037945397	O
RWH	O

2690633	O

194867	O

151887	O

10/17/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

FYFEVAIA	O
,	O
LORERINDIL	O

MRN	O
:	O

2690633	O

Age	O
:	O

77y	O

REGISTRATION	O
DATE	O
:	O

10/17/2001	O
01:36	O
PM	O

Provider	O
:	O

CH	O
KOTEKOLL	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O

MD	O
:	O

Yes	O
-	O
Direct	O
contact	O
with	O
PCP	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Date	O
/	O
Time	O
:	O

10/17/2001	O
16:28	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

NEAR	B-disease
SYNCOPE	I-disease
Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
dizziness	B-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

near	B-disease
syncope	I-disease
,	O
dehydration	B-disease
vs	O
cardiogenic	B-disease

Treatment	O
Rendered	O
:	O

IVF	O
,	O
cbc	O
(	O
hct	O
36	O
)	O
,	O
normal	O
chem	O
7	O
,	O
negative	O
cardiac	O
enzymes	O
,	O
negative	O
stool	O
guaiac	O
,	O
normal	O
CXR	O

Discharge	O
Medications	O
:	O

none	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Patient	O
will	O
follow-up	O
with	O
his	O
PCP	O
,	O
Dr.	O
Foutchner	O
,	O
on	O
Monday	O
.	O

Dr.	O
Foutchner	O
will	O
arrange	O
for	O
an	O
outpatient	O
Holter	O
monitor	O
.	O

The	O
patient	O
is	O
to	O
return	O
to	O
the	O
ED	O
for	O
recurrent	B-disease
dizziness	I-disease
,	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
or	O
weakness	B-disease
.	O

PCP	O
Name	O
:	O

SUMCHIRDKAYSMAVVEINDREPS	O
,	O
YERTREY	O

Provider	O
Number	O
:	O

12298	O

This	O
report	O
was	O
created	O
by	O
KOTEKOLL	O
,	O
CH	O
10/17/2001	O
07:08	O
PM	O

143748600	O
SC	O

43243309	O

095342	O

09/30/2000	O
12:00:00	O
AM	O

atypical	B-disease
chest	I-disease
pain	I-disease

DIS	O

Admission	O
Date	O
:	O

09/30/2000	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

10/01/2000	O

******	O
DISCHARGE	O
ORDERS	O
******	O

FALC	O
,	O
COLL	O
891-57-52-0	O
T37	O

Room	O
:	O

53X-785	O

Service	O
:	O

CAR	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

10/01/00	O
AT	O
03:30	O
PM	O

CONTINGENT	O
UPON	O

ETT	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

KOTEZUSTLEEB	O
,	O
LIJO	O
LIFLE	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

ALBUTEROL	O
INHALER	O
2	O
PUFF	O
INH	O
QID	O

Instructions	O
:	O

PLEASE	O
USE	O
WITH	O
SPACER	O
(	O
PLEASE	O
INSTRUCT	O
PATIENT	O
)	O
ECASA	O
(	O
ASPIRIN	O
ENTERIC	O
COATED	O
)	O
325	O
MG	O
PO	O
QD	O
WELLBUTRIN	O
(	O
BUPROPION	O
HCL	O
)	O
150	O
MG	O
PO	O
BID	O
GEMFIBROZIL	O
600	O
MG	O
PO	O
BID	O
ZESTRIL	O
(	O
LISINOPRIL	O
)	O
20	O
MG	O
PO	O
QD	O
ZANTAC	O
(	O
RANITIDINE	O
HCL	O
)	O
150	O
MG	O
PO	O
BID	O
SERZONE	O
(	O
NEFAZODONE	O
)	O
300	O
MG	O
PO	O
QHS	O
ZYPREXA	O
(	O
OLANZAPINE	O
)	O
5	O
MG	O
PO	O
QHS	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

4	O

GLUCOPHAGE	O
(	O
METFORMIN	O
)	O
850	O
MG	O
PO	O
TID	O
Starting	O
ON	O
10/03/00	O
(	O
10/03	O
)	O
ACTOS	O
30	O
MG	O
PO	O
QD	O

DIET	O
:	O

House	O
/	O
ADA	O
2100	O
cals	O
/	O
dy	O

RETURN	O
TO	O
WORK	O
:	O

Immediately	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Rotrysbreunkorc	O
1-2	O
weeks	O
,	O

ALLERGY	O
:	O

Penicillins	O

ADMIT	O
DIAGNOSIS	O
:	O

atypical	B-disease
cp	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
atypical	B-disease
chest	I-disease
pain	I-disease

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
dm	B-disease
(	I-disease
diabetes	I-disease
mellitus	I-disease
)	I-disease
anxiety	B-disease
(	I-disease
anxiety	I-disease
)	I-disease
htn	B-disease
(	I-disease
hypertension	I-disease
)	I-disease
gerd	B-disease
(	I-disease
esophageal	I-disease
reflux	I-disease
)	I-disease

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

41	O
yo	O
man	O
with	O
CRFs	B-disease
of	O
DM	B-disease
Type	I-disease
II	I-disease
,	O
high	B-disease
cholesterol	I-disease
,	O
smoking	O
history	O
,	O
family	O
hx	O
,	O
HTN	B-disease
p	O
/	O
w	O
episodes	B-disease
of	I-disease
atypical	I-disease
CP	I-disease
x	I-disease
1	I-disease
week	I-disease
,	O
with	O
rest	O
and	O
exertion	O
.	O

also	O
has	O
h	O
/	O
o	O
anxiety	B-disease
and	O
GERD	B-disease
.	O

No	O
assoicated	B-disease
Sx	I-disease
.	O

Here	O
,	O
had	O
T	B-disease
wave	I-disease
flattening	I-disease
laterally	I-disease
and	I-disease
inferiorly	I-disease
with	O
pain	B-disease
that	O
resolved	O
pain	B-disease
free	O
,	O
but	O
not	O
clear	O
that	O
lead	O
placement	O
is	O
the	O
same	O
.	O

Had	O
Chest	O
CT	O
to	O
r	O
/	O
o	O
dissection	B-disease
(	O
due	O
to	O
back	B-disease
pain	I-disease
)	O
which	O
was	O
neg.	O

Ruled	O
out	O
for	O
MI	B-disease
.	O

Will	O
plan	O
on	O
ETT	O
.	O

Holding	O
Metformin	O
until	O
Friday	O
due	O
to	O
CT	O
with	O
contrast	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

smoking	O
cessation	O
group	O
will	O
contact	O
you	O
at	O
home	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

you	O
will	O
be	O
contacted	O
at	O
home	O
by	O
the	O
smoking	O
cessation	O
program	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

WIERST	O
,	O
STO	O
L.	O
,	O
M.D.	O
(	O
RR86	O
)	O
10/01/00	O
02:33	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

320422564	O

CTMC	O

09300549	O

340424	O

06/16/1997	O
12:00:00	O
AM	O

BILIARY	B-disease
OBSTRUCTION	I-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/16/1997	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

06/18/1997	O

PROBLEM	O
LIST	O
:	O

1.	O
RECTAL	B-disease
CARCINOMA	I-disease
,	O
STATUS	O
POST	O
PARTIAL	O
COLECTOMY	O
.	O

2.	O
METASTATIC	B-disease
COLON	I-disease
CARCINOMA	I-disease
.	O

3.	O
HYPERTENSION	B-disease
.	O

4.	O
AORTIC	B-disease
STENOSIS	I-disease
WITH	O
PORCINE	O
VALVE	O
.	O

5.	O
URINARY	B-disease
TRACT	I-disease
INFECTION	I-disease
.	O

6.	O
CHOLANGITIS	B-disease
.	O

7.	O
ANEMIA	B-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
70	O
year	O
old	O
gentleman	O
with	O
metastatic	B-disease
rectal	I-disease
cancer	I-disease
who	O
presented	O
with	O
biliary	B-disease
obstruction	I-disease
.	O

In	O
the	O
past	O
,	O
he	O
had	O
biliary	O
stents	O
placed	O
which	O
clotted	O
off	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Short	O
Stay	O
Unit	O
for	O
further	O
evaluation	O
.	O

The	O
day	O
prior	O
,	O
the	O
patient	O
had	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
done	O
with	O
dilated	B-disease
ducts	I-disease
times	O
two	O
and	O
eventually	O
had	O
interventional	O
radiology	O
attempt	O
to	O
place	O
percutaneous	O
drains	O
to	O
decompress	O
his	B-disease
biliary	I-disease
tree	I-disease
.	O

The	O
patient	O
had	O
two	O
drains	O
placed	O
after	O
a	O
prolonged	O
course	O
and	O
difficult	O
procedure	O
.	O

After	O
being	O
transferred	O
from	O
the	O
interventional	O
radiology	O
table	O
to	O
the	O
stretcher	O
,	O
one	O
of	O
his	O
lateral	O
percutaneous	O
drains	O
had	O
been	O
pulled	O
out	O
inadvertently	O
.	O

He	O
was	O
admitted	O
to	O
the	O
Short	O
Stay	O
Unit	O
,	O
given	O
Ancef	O
and	O
Gentamicin	O
per	O
the	O
team	O
for	O
antibiotic	O
prophylaxis	O
and	O
observed	O
overnight	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
above	O
.	O

ALLERGIES	O
:	O

None	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Cipro	O
500	O
mg	O
p.o.	O
b.i.d.	O
,	O
Vasotec	O
10	O
mg	O
q.d.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denies	O
any	O
alcohol	O
or	O
tobacco	O
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
colon	B-disease
carcinoma	I-disease
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Unremarkable	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	O
was	O
99.1	O
,	O
blood	O
pressure	O
132/74	O
,	O
heart	O
rate	O
80	O
,	O
respirations	O
18	O
,	O
02	O
sat	O
99%	O
on	O
room	O
air	O
.	O

The	O
patient	O
was	O
an	O
alert	O
,	O
jaundiced	O
gentleman	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

LUNGS	O
:	O

were	O
clear	O
to	O
auscultation	O
.	O

HEART	O
:	O

had	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
a	B-disease
II	I-disease
/	I-disease
VI	I-disease
systolic	I-disease
murmur	I-disease
at	I-disease
the	I-disease
right	I-disease
sternal	I-disease
border	I-disease
.	O

ABDOMEN	O
:	O

was	O
soft	O
,	O
nontender	B-disease
,	O
with	O
good	O
bowel	O
sounds	O
.	O

He	O
had	O
midline	O
catheter	O
that	O
was	O
still	O
in	O
place	O
and	O
was	O
draining	O
bile	O
.	O

EXTREMITIES	O
:	O

were	O
without	O
edema	B-disease
.	O

NEUROLOGICAL	O
:	O

exam	O
within	O
normal	O
limits	O
.	O

LABORATORY	O
:	O

White	O
count	O
was	O
8.2	O
,	O
hematocrit	O
35	O
.	O

AST	O
was	O
175	O
,	O
ALT	O
76	O
,	O
LDH	O
454	O
.	O

Total	O
bilirubin	O
was	O
12	O
and	O
direct	O
bilirubin	O
8	O
.	O

Alkaline	O
phosphatase	O
was	O
372	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Short	O
Stay	O
Unit	O
and	O
continued	O
to	O
receive	O
antibiotics	O
overnight	O
.	O

The	O
next	O
morning	O
,	O
he	O
was	O
doing	O
well	O
with	O
the	O
intact	O
drain	O
draining	O
bilious	B-disease
material	I-disease
without	O
any	O
difficulty	O
.	O

The	O
patient	O
was	O
doing	O
well	O
with	O
minimal	O
to	O
no	O
belly	B-disease
pain	I-disease
and	O
no	O
nausea	B-disease
or	O
vomiting	B-disease
.	O

The	O
patient	O
was	O
taken	O
back	O
to	O
surgery	O
by	O
the	O
interventional	O
radiology	O
team	O
and	O
had	O
a	O
second	O
drain	O
placed	O
without	O
any	O
difficulty	O
and	O
was	O
transferred	O
back	O
to	O
the	O
Short	O
Stay	O
Unit	O
.	O

The	O
patient	O
was	O
observed	O
overnight	O
without	O
any	B-disease
problems	I-disease
.	O

He	O
was	O
tolerating	O
p.o.	O
and	O
feeling	O
back	O
to	O
his	O
baseline	O
.	O

He	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Same	O
as	O
admission	O
.	O

He	O
will	O
continue	O
Cipro	O
p.o.	O
for	O
prophylaxis	O
.	O

FOLLOW-UP	O
:	O

Follow-up	O
with	O
Dr.	O
Loydsadd	O
in	O
one	O
to	O
two	O
weeks	O
.	O

He	O
is	O
also	O
to	O
have	O
AH	O
for	O
his	O
home	O
stent	O
care	O
.	O

Dictated	O
By	O
:	O

Attending	O
:	O

LILLBI	O
FYFEBREUN	O
,	O
M.D.	O
KE15	O
TB326/0625	O

Batch	O
:	O

56777	O

Index	O
No.	O
M2ZRS51Y3Q	O

D	O
:	O

06/18/97	O

T	O
:	O

06/21/97	O

373254497	O
PUMC	O

6211697	O

433913	O

209987	O

3/5/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SHUFFJESC	O
,	O
NANORA	O

MRN	O
:	O

6211697	O

Age	O
:	O

36y	O

REGISTRATION	O
DATE	O
:	O

03/05/2002	O
10:11	O
PM	O

Provider	O
:	O

QUELOISEVIER	O
DREWEILLTRIEVKEMME	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

03/06/2002	O
06:23	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

ABD	B-disease
PAIN/	I-disease
PELVIC	B-disease
PAIN	I-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
abdominal	B-disease
pain	I-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Abdominal	B-disease
pain	I-disease
Treatment	O
Rendered	O
:	O

Ct	O
scan	O
shows	O
ovarian	B-disease
cyst	I-disease

Discharge	O
Medications	O
:	O

Vicodin	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
follow	O
up	O
with	O
Dr.	O
Wires	O
on	O
Monday	O
.	O

If	O
you	O
have	O
continued	O
fevers	B-disease
,	O
worsening	B-disease
abdominal	I-disease
pain	I-disease
,	O
discharge	B-disease
or	O
other	B-disease
worrisome	I-disease
symptoms	I-disease
,	O
please	O
return	O
to	O
the	O
emergency	O
department	O
.	O

PCP	O
Name	O
:	O

WIRES	O
,	O
PEANTSALL	O
A	O

Provider	O
Number	O
:	O

16986	O

This	O
report	O
was	O
created	O
by	O
DREWEILLTRIEVKEMME	O
,	O
QUELOISEVIER	O
03/06/2002	O
06:28	O
AM	O

Admission	O
Date	O
:	O

2012-01-07	O

Discharge	O
Date	O
:	O

2012-03-10	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

M	O

Service	O
:	O

Since	O
2012-02-26	O
,	O
the	O
patient	O
has	O
been	O
stable	O
.	O

The	O
Whidden	O
Memorial	O
Hospital	O
hospital	O
course	O
has	O
been	O
smooth	O
with	O
the	O
patient	O
progressively	O
improving	O
.	O

The	O
patient	O
was	O
initially	O
on	O
several	O
antibiotics	O
included	O
Cefepime	O
,	O
Vancomycin	O
,	O
Ciprofloxacin	O
,	O
Ambazone	O
and	O
Flagyl	O
.	O

The	O
patient	O
's	O
HSV	O
antibody	O
titer	O
was	O
found	O
to	O
be	O
negative	O
and	O
the	O
patient	O
's	O
Acyclovir	O
was	O
not	O
restarted	O
.	O

Infectious	O
disease	O
continued	O
to	O
follow	O
and	O
on	O
2012-02-29	O
,	O
the	O
patient	O
spiked	O
again	O
which	O
at	O
that	O
time	O
was	O
felt	O
to	O
be	O
due	O
to	O
his	O
central	O
line	O
and	O
the	O
central	O
line	O
was	O
resited	O
on	O
the	O
left	O
side	O
and	O
the	O
patient	O
was	O
started	O
on	O
intravenous	O
Vancomycin	O
.	O

Over	O
the	O
following	O
days	O
until	O
discharge	O
,	O
the	O
patient	O
remained	O
afebrile	B-disease
and	O
on	O
2012-03-09	O
,	O
in	O
fact	O
all	O
the	O
patient	O
's	O
antibiotics	O
were	O
discontinued	O
.	O

As	O
for	O
the	O
patient	O
's	O
ALL	B-disease
and	O
AML	B-disease
,	O
the	O
patient	O
was	O
started	O
on	O
a	O
new	O
chemotherapy	O
protocol	O
called	O
hyper-CVAD	O
on	O
2012-03-06	O
.	O

After	O
the	O
patient	O
began	O
on	O
this	O
protocol	O
,	O
his	O
white	O
blood	O
cell	O
count	O
steadily	O
began	O
to	O
climb	O
.	O

The	O
patient	O
became	O
no	O
longer	O
neutropenic	B-disease
.	O

The	O
patient	O
's	O
also	O
began	O
to	O
climb	O
and	O
the	O
percent	O
blasts	O
in	O
his	O
differential	O
decreased	O
significantly	O
.	O

The	O
patient	O
had	O
no	O
further	B-disease
complaints	I-disease
and	O
on	O
2012-03-10	O
,	O
his	O
white	O
blood	O
cell	O
count	O
was	O
2.3	O
,	O
neutrophils	O
50%	O
,	O
bands	O
2%	O
,	O
lymphocytes	O
5%	O
,	O
monocytes	O
40%	O
,	O
and	O
blasts	O
1%	O
.	O

Platelet	O
count	O
was	O
759,000	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
with	O
instructions	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
,	O
2012-03-12	O
,	O
for	O
follow-up	O
and	O
laboratory	O
checks	O
.	O

The	O
patient	O
was	O
also	O
given	O
instructions	O
to	O
be	O
prudent	O
and	O
stay	O
away	O
from	O
public	O
places	O
as	O
well	O
as	O
small	O
children	O
.	O

The	O
patient	O
was	O
also	O
told	O
to	O
continue	O
on	O
a	O
neutropenic	O
diet	O
.	O

The	O
patient	O
was	O
also	O
told	O
that	O
he	O
would	O
have	O
to	O
be	O
admitted	O
for	O
several	O
days	O
during	O
his	O
next	O
cycle	O
of	O
CVAD	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
good	O
condition	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Bactrim	O
double	O
strength	O
one	O
tablet	O
q.	O
Monday	O
,	O
Wednesday	O
and	O
Friday	O
.	O

2.	O
Compazine	O
10	O
mg	O
p.o.	O
q	O
6hours	O
p.r.n.	O
nausea	B-disease
.	O

3.	O
Anzemet	O
100	O
mg	O
p.o.	O
once	O
daily	O
p.r.n.	O
nausea	B-disease
.	O

The	O
patient	O
is	O
to	O
return	O
to	O
the	O
hospital	O
on	O
Monday	O
for	O
follow-up	O
.	O

DR.	O
Esparza	O
,	O
Gail	O
18-714	O

Dictated	O
By	O
:	O
Cristobal	O
C.	O
Reid	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-03-10	O
22:44	O

T	O
:	O
2012-03-11	O
10:08	O

JOB	O
#:	O

24313	O

1	O

1	O

1	O

OMR	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
C.	O
Massey	O
on	O
:	O
MON	O
2012-04-23	O
1:02	O
PM	O

(	O
End	O
of	O
Report	O
)	O

825330116	O

HLGMC	O

6051380	O

10615/2646	O

8/15/1993	O
12:00:00	O
AM	O

ACUTE	B-disease
MYOCARDIAL	I-disease
INFARCTION	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

8-15-93	O

DISCHARGE	O
DATE	O
:	O

08-22-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Acute	B-disease
myocardial	I-disease
infarction	I-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

1.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
,	O

2.	O
unstable	B-disease
angina	I-disease
(	I-disease
postmyocardial	I-disease
infarction	I-disease
angina	I-disease
)	I-disease
,	O

3.	O
Parkinson	B-disease
&apos;s	I-disease
disease	I-disease
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

1.	O
Percutaneous	O
transluminal	O
coronary	O
angioplasty	O
and	O
coronary	O
atherectomy	O
of	O
the	O
left	O
anterior	O
descending	O
,	O
8-17-93	O
,	O

2.	O
relook	O
coronary	O
angiogram	O
,	O
08-18-93	O
.	O

DOCTORS	O
DISCHARGE	O
ORDERS	O
AND	O
MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Ecotrin	O
1	O
tablet	O
PO	O
qd	O
,	O
Captopril	O
6.25	O
mg	O
PO	O
tid	O
,	O
K-Dur	O
20	O
mEq.	O
PO	O
qd	O
,	O
Lasix	O
20	O
mg	O
PO	O
qd	O
,	O
Isordil	O
10	O
mg	O
PO	O
tid	O
,	O
Sinemet	O
1/2	O
tablet	O
PO	O
bid	O
,	O
Symmetrel	O
100	O
mg	O
PO	O
bid	O
,	O
Parloder	O
2.5mg	O
PO	O
qd	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
58	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
Parkinson	B-disease
&apos;s	I-disease
disease	I-disease
for	O
more	O
than	O
twenty	O
years	O
who	O
presented	O
to	O
the	O
Gemenadentoolpai	O
Medical	O
Center	O
with	O
a	B-disease
revolving	I-disease
anterolateral	I-disease
wall	I-disease
myocardial	I-disease
infarction	I-disease
on	O
08-01-93	O
.	O

She	O
has	O
been	O
under	O
the	O
care	O
of	O
Dr.	O
Aalv	O
Manual	O
and	O
was	O
referred	O
here	O
for	O
further	O
therapy	O
.	O

She	O
had	O
no	O
prior	O
significant	O
cardiac	O
history	O
and	O
presented	O
to	O
her	O
local	O
medical	O
doctor	O
&apos;s	O
office	O
with	O
an	O
episode	O
of	O
severe	B-disease
retrosternal	I-disease
chest	I-disease
pain	I-disease
.	O

Her	O
electrocardiogram	O
showed	O
a	B-disease
new	I-disease
right	I-disease
bundle	I-disease
branch	I-disease
block	I-disease
and	O
left	B-disease
anterior	I-disease
hemiblock	I-disease
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Gemenadentoolpai	O
Medical	O
Center	O
and	O
was	O
admitted	O
.	O

Her	O
hospital	O
course	O
was	O
remarkable	O
for	O
ruling	O
in	O
for	O
a	B-disease
myocardial	I-disease
infarction	I-disease
with	O
a	O
peak	O
CPK	O
of	O
9,379	O
units	O
with	O
a	O
5.9%	O
MB	O
fraction	O
.	O

In	O
addition	O
,	O
on	O
telemetry	O
she	O
developed	O
complete	B-disease
heart	I-disease
block	I-disease
and	O
hypotension	B-disease
requiring	O
temporary	O
pacing	O
wire	O
and	O
then	O
a	O
permanent	O
pacemaker	O
implantation	O
on	O
08-03-93	O
.	O

She	O
developed	O
congestive	B-disease
heart	I-disease
failure	I-disease
and	O
required	O
pressor	O
support	O
.	O

She	O
underwent	O
cardiac	O
catheterization	O
on	O
8-15-93	O
and	O
was	O
found	O
to	O
have	O
a	O
left	O
ventricular	O
end	O
diastolic	O
pressure	O
of	O
28	O
millimeters	O
of	O
mercury	O
.	O

She	O
had	O
a	B-disease
dominant	I-disease
right	I-disease
coronary	I-disease
artery	I-disease
with	O
minor	B-disease
disease	I-disease
.	O

The	O
main	O
left	O
coronary	O
artery	O
had	O
a	B-disease
20%	I-disease
stenosis	I-disease
.	O

The	O
left	O
anterior	O
descending	O
had	O
a	B-disease
severe	I-disease
80%	I-disease
proximal	I-disease
stenosis	I-disease
with	O
a	B-disease
filling	I-disease
defect	I-disease
consistent	O
with	O
intraluminal	B-disease
thrombus	I-disease
.	O

The	O
circumflex	O
artery	O
had	O
a	B-disease
minor	I-disease
40%	I-disease
stenosis	I-disease
.	O

Cine	O
left	O
ventriculogram	O
revealed	O
a	B-disease
dilated	I-disease
left	I-disease
ventricle	I-disease
with	O
an	B-disease
area	I-disease
of	I-disease
anterolateral	I-disease
,	I-disease
apical	I-disease
,	I-disease
and	I-disease
septal	I-disease
akinesis	I-disease
.	O

The	O
left	O
ventricular	O
ejection	O
fraction	O
was	O
estimated	O
to	O
38%	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
Heaonboburg	O
Linpack	O
Grant	O
Medical	O
Center	O
for	O
consideration	O
of	O
coronary	O
angioplasty	O
.	O

CARDIAC	O
RISK	O
FACTORS	O
:	O

Her	B-disease
risk	I-disease
factors	I-disease
for	O
coronary	B-disease
artery	I-disease
disease	I-disease
included	O
a	B-disease
positive	I-disease
family	I-disease
history	I-disease
and	O
an	B-disease
elevated	I-disease
cholesterol	I-disease
level	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Her	O
past	O
medical	O
history	O
is	O
remarkable	O
for	O
a	O
history	O
of	O
Parkinson	B-disease
&apos;s	I-disease
disease	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Her	O
physical	O
examination	O
at	O
the	O
time	O
of	O
admission	O
revealed	O
a	O
pleasant	O
lady	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

The	O
blood	O
pressure	O
was	O
120/70	O
millimeters	O
of	O
mercury	O
.	O

Her	O
pulse	O
was	O
regular	O
at	O
80	O
beats	O
per	O
minute	O
.	O

The	O
jugular	O
venous	O
pressure	O
was	O
elevated	O
at	O
6	O
cm	O
above	O
the	O
sternal	O
angle	O
.	O

The	O
carotids	O
were	O
normal	O
.	O

The	O
chest	O
was	O
clear	O
.	O

The	O
cardiac	O
examination	O
revealed	O
anapical	B-disease
impulse	I-disease
in	I-disease
the	I-disease
fifth	I-disease
left	I-disease
intercostal	I-disease
space	I-disease
,	O
left	O
to	O
mid	O
clavicular	O
line	O
.	O

The	O
first	O
sound	O
was	O
normal	O
.	O

The	O
second	O
sound	O
was	O
normally	O
split	O
.	O

She	O
had	O
no	O
murmurs	B-disease
and	O
no	O
gallops	B-disease
.	O

The	O
examination	O
the	O
abdomen	O
was	O
benign	O
.	O

The	O
examination	O
of	O
the	O
extremities	O
showed	O
no	O
edema	B-disease
.	O

She	O
had	O
good	O
pulses	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

Her	O
electrocardiogram	O
revealed	O
normal	O
sinus	O
rhythm	O
,	O
left	B-disease
atrial	I-disease
enlargement	I-disease
,	O
left	B-disease
axis	I-disease
deviation	I-disease
,	O
poor	B-disease
R-wave	I-disease
progression	I-disease
in	O
V1	O
through	O
V4	O
,	O
consistent	O
with	O
marked	O
clockwise	O
rotation	O
,	O
cannot	O
rule	O
out	O
an	B-disease
old	I-disease
anteroseptal	I-disease
wall	I-disease
myocardial	I-disease
infarction	I-disease
.	O

There	O
were	O
prominent	B-disease
Q-waves	I-disease
in	I-disease
AVL	I-disease
,	O
consistent	O
with	O
lateral	B-disease
myocardial	I-disease
infarction	I-disease
.	O

There	O
were	O
non-specific	B-disease
ST-T	I-disease
wave	I-disease
abnormalities	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Medical	O
Service	O
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
by	O
the	O
Neurology	O
Department	O
because	O
of	O
the	O
history	O
of	O
Parkinson	B-disease
&apos;s	I-disease
disease	I-disease
.	O

The	O
patient	O
was	O
maintained	O
on	O
intravenous	O
heparin	O
.	O

On	O
8-17-93	O
,	O
she	O
was	O
taken	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
where	O
she	O
underwent	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
of	O
the	O
proximal	O
left	O
anterior	O
descending	O
.	O

Following	O
balloon	O
angioplasty	O
,	O
there	O
was	O
a	O
local	O
dissection	O
with	O
evidence	O
of	O
intraluminal	B-disease
thrombus	I-disease
,	O
with	O
a	B-disease
greater	I-disease
than	I-disease
10%	I-disease
loss	I-disease
in	I-disease
the	I-disease
initial	I-disease
gain	I-disease
following	O
coronary	O
angioplasty	O
.	O

Therefore	O
,	O
directional	O
coronary	O
atherectomy	O
was	O
performed	O
with	O
an	O
excellent	O
angiographic	O
outcome	O
,	O
and	O
a	B-disease
less	I-disease
than	I-disease
10%	I-disease
residual	I-disease
narrowing	I-disease
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

She	O
was	O
maintained	O
on	O
intravenous	O
heparin	O
and	O
was	O
brought	O
back	O
to	O
the	O
cardiac	O
catheterization	O
laboratory	O
on	O
08-18-93	O
for	O
a	O
relook	O
coronary	O
angiography	O
.	O

Coronary	O
angiography	O
demonstrated	O
ongoing	O
benefit	O
of	O
the	O
initial	O
coronary	O
atherectomy	O
.	O

Specifically	O
,	O
there	O
was	O
no	O
decrease	O
in	O
the	O
initial	O
gain	O
that	O
she	O
achieved	O
after	O
directional	O
atherectomy	O
.	O

The	O
patient	O
remained	O
stable	O
during	O
the	O
rest	O
of	O
the	O
hospitalization	O
.	O

She	O
was	O
transferred	O
in	O
stable	O
condition	O
to	O
the	O
Pasi	O
for	O
further	O
rehabilitation	O
therapy	O
.	O

RENLAN	O
FYFEZEIS	O
,	O
M.D.	O

Dr.	O
Aalv	O
Lorjes	O
Salv	O
Manual	O
Pasi	O

TR	O
:	O

jb	O
/	O
bmot	O

DD	O
:	O

9-17-93	O

TD	O
:	O

09/19/93	O

CC	O
:	O

745431641	O
WGH	O

2464448	O

333887	O

3473372	O

9/16/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KOTEA	O
,	O
TORTHEOA	O

MRN	O
:	O

2464448	O

Age	O
:	O

59y	O

REGISTRATION	O
DATE	O
:	O

09/16/2004	O
09:22	O
AM	O

Provider	O
:	O

YERTREY	O
SUMCHIRDKAYSMAVVEINDREPS	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Yes	O
-	O
Direct	O
contact	O
with	O
PCP	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Date	O
/	O
Time	O
:	O

09/16/2004	O
17:48	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

CP	B-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
chest	B-disease
pain	I-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Noncardiac	B-disease
chest	I-disease
pain	I-disease

Treatment	O
Rendered	O
:	O

Labs	O
stable	O
,	O
NTG	O
sublingual	O
,	O
stress	O
MIBI	O
was	O
negative	O
for	O
ischemia	B-disease
.	O

Discharge	O
Medications	O
:	O

Continue	O
current	O
medication	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Follow	O
up	O
as	O
scheduled	O
with	O
Dr.	O
Fyfechird	O
.	O

Return	O
to	O
the	O
ED	O
for	O
worsening	B-disease
chest	I-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
nausea	B-disease
/	O
vomiting	B-disease
,	O
fever	B-disease
/	O
chills	B-disease
,	O
weakness	B-disease
/	O
dizziness/numbness	B-disease
,	O
or	O
any	B-disease
other	I-disease
problems	I-disease
.	O

PCP	O
Name	O
:	O

SLANDTIF	O
,	O
ASTHEO	O
D	O

Provider	O
Number	O
:	O

49422	O

This	O
report	O
was	O
created	O
by	O
SUMCHIRDKAYSMAVVEINDREPS	O
,	O
YERTREY	O
09/16/2004	O
05:53	O
PM	O

788268693	O
DH	O

7258512	O

020586	O

0831510	O

4/30/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

FREIERMDREPS	O
,	O
RI	O

MRN	O
:	O

7258512	O

Age	O
:	O

44y	O

REGISTRATION	O
DATE	O
:	O

04/30/2005	O
02:55	O
PM	O

Provider	O
:	O

RONRIN	O
SHUFF	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

04/30/2005	O
15:49	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

R	B-disease
ELBOW	I-disease
INJURY	I-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
sprains	B-disease
,	O
fractures	B-disease
and	O
bruises	B-disease
(	O
English	O
)	O
.	O

The	O
patient	O
was	O
given	O
a	O
work	O
note	O
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

R	B-disease
elbow	I-disease
strain	I-disease

Treatment	O
Rendered	O
:	O

xray	O
-	O
no	O
evidence	O
of	O
effusion	B-disease
or	O
fracture	B-disease

Discharge	O
Medications	O
:	O

motrin	O
400-600	O
mg	O
every	O
8	O
hours	O
as	O
needed	O
for	O
pain	B-disease

Follow	O
up	O
Service	O
:	O

It	O
is	O
recommended	O
that	O
you	O
receive	O
follow-up	O
care	O
with	O
the	O
Department	O
of	O
Orthopaedics	O
if	O
your	B-disease
symptoms	I-disease
are	O
not	O
improved	O
in	O
5-7	O
days	O
.	O

Please	O
call	O
(	O
890	O
)	O
541-3008	O
to	O
schedule	O
an	O
appointment	O
.	O

For	O
managed	O
care	O
plans	O
,	O
check	O
with	O
your	O
PCP	O
before	O
making	O
this	O
appointment	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Use	O
ice	O
to	O
sore	B-disease
areas	I-disease
for	O
the	O
next	O
few	O
days	O
.	O

Do	O
no	O
strenuous	O
activity	O
until	O
your	B-disease
symptoms	I-disease
are	O
improved	O
.	O

Do	O
gentle	O
range	O
of	O
motion	O
exercises	O
for	O
the	O
next	O
few	O
days	O
.	O

PCP	O
Name	O
:	O

CREDKOTE	O
,	O
ALEN	O

Provider	O
Number	O
:	O

18160	O

This	O
report	O
was	O
created	O
by	O
SHUFF	O
,	O
RONRIN	O
04/30/2005	O
03:52	O
PM	O

424729395	O
DH	O

0011649	O

07013	O

908447	O

6/14/2001	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

XARAH	O
RATIA	O
SERVICE	O

UNIT	O
NUMBER	O
:	O

642-07-90	O

ADMISSION	O
DATE	O
:	O

20010614	O

DISCHARGE	O
DATE	O
:	O

20010616	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Abnormal	B-disease
Fetal	I-disease
Heart	I-disease
Rate	I-disease
/	I-disease
Rhythm	I-disease
-	O
Delivered	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Abnormal	B-disease
Pap	I-disease
Test	I-disease
,	O
history	O
of	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Vacuum	O
Extraction	O

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Routine	O
Post	O
Partum	O
Care	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Active	B-disease
Labor	I-disease

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	O
49	O
HEENT	O
NORMAL	O
MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
COR	O
NORMAL	O
ABDOMEN	O
NORMAL	O
gravid	O
,	O
+	O
FHR	O
,	O
NT	O
EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
NORMAL	O
CERVIX	O
NORMAL	O
4-5/100%	O
OS	O
NORMAL	O
closed	O
,	O
firm	O
,	O
-CMT	O
ADNEXAE	O
NORMAL	O
UTERUS	O
NORMAL	O
term	O
7-7.5	O
#	O
vtx	O
UTERINE	O
SIZE	O
IN	O
WEEKS	O
NORMAL	O
term	O

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
23	O
year	O
old	O
Gravida	O
2	O
Para	O
1001	O
was	O
admitted	O
to	O
the	O
Naliheall	O
County	O
Memorial	O
Hospital	O
Obstetrical	O
service	O
on	O
06/14/2001	O
at	O
01:29	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

active	B-disease
labor	I-disease
.	O

She	O
delivered	O
a	O
3263	O
gram	O
female	O
infant	O
at	O
06/14/2001	O
at	O
06:40	O
pm	O
with	O
apgar	O
scores	O
of	O
8	O
and	O
8	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
40.3	O
weeks	O
gestation	O
via	O
vacuum	O
extraction	O
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

fetal	B-disease
bradycardia	I-disease
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

nuchal	B-disease
cord	I-disease
,	O
times	O
two	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
06/16/2001	O
at	O
12:00	O
pm	O
in	O
stable	O
condition	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Burnrise	O
Memorial	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS/RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

Electronically	O
Signed	O
:	O

American	O
,	O
06/16/2001	O
5:14:05	O
PM	O

Admission	O
Date	O
:	O

2014-10-14	O

Discharge	O
Date	O
:	O

2014-10-17	O

Date	O
of	O
Birth	O
:	O

1959-12-09	O

Sex	O
:	O

M	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
55	O
-	O
year-old	O
Caucasian	O
speaking	O
male	O
who	O
is	O
a	O
smoker	O
and	O
has	O
a	O
family	O
history	O
of	O
coronary	B-disease
artery	I-disease
disease	I-disease
,	O
as	O
well	O
as	O
a	O
personal	O
history	O
of	O
hypertension	B-disease
,	O
who	O
experienced	O
multiple	O
episodes	O
of	O
10/10	B-disease
substernal	I-disease
chest	I-disease
pain	I-disease
radiating	O
down	O
his	O
left	O
arm	O
last	O
night	O
with	O
his	O
daily	O
activities	O
.	O

Each	B-disease
episode	I-disease
lasted	O
approximately	O
15	O
minutes	O
in	O
duration	O
and	O
resolved	O
on	O
their	O
own	O
.	O

This	O
morning	O
while	O
landscaping	O
the	O
patient	O
had	O
unremitting	B-disease
12-05	I-disease
pain	I-disease
with	O
shortness	B-disease
of	I-disease
breath	I-disease
and	O
diaphoresis	B-disease
.	O

He	O
presented	O
to	O
Deaconess-Nashoba	O
Hospital	O
Hospital	O
and	O
the	O
first	O
EKG	O
was	O
found	O
to	O
have	O
ST	B-disease
elevations	I-disease
in	I-disease
V1-V3	I-disease
of	O
1-2	O
mm	O
with	O
T	B-disease
wave	I-disease
inversions	I-disease
in	O
V4-6	O
,	O
I	O
and	O
L	O
,	O
which	O
progressed	O
to	O
3-0167	O
W.	O
Seventh	O
Ave.	O
elevations	O
within	O
20	O
minutes	O
.	O

Heparin	O
and	O
nitroglycerin	O
drip	O
were	O
started	O
with	O
10	O
mg	O
of	O
IV	O
Retavase	O
half	O
dose	O
.	O

He	O
was	O
transferred	O
to	O
the	O
North	O
Adams	O
Regional	O
Hospital	O
for	O
catheterization	O
.	O

Once	O
at	O
Hahnemann	O
General	O
Hospital	O
he	O
received	O
heparin	O
and	O
Integrilin	O
.	O

Coronary	O
angiography	O
revealed	O
left	O
main	O
,	O
left	O
circumflex	O
and	O
RCA	O
normal	O
and	O
left	B-disease
LAD	I-disease
with	I-disease
99%	I-disease
midstenosis	I-disease
.	O

A	O
Hepacoat	O
stent	O
was	O
placed	O
with	O
no	O
residuals	O
but	O
good	O
flow	O
after	O
nitroglycerin	O
and	O
diltiazem	O
.	O

The	B-disease
chest	I-disease
pain	I-disease
persisted	O
afterwards	O
and	O
a	O
relook	O
catheterization	O
was	O
performed	O
that	O
revealed	O
no	O
occlusions	B-disease
.	O

The	O
right	O
heart	O
catheterization	O
revealed	O
a	O
cardiac	O
output	O
index	O
of	O
4.11	O
and	O
2.15	O
respectively	O
.	O

RA	O
pressure	O
was	O
13	O
,	O
RV	O
pressure	O
45/7	O
,	O
wedge	O
27	O
and	O
PA	O
pressures	O
of	O
42/21	O
.	O

He	O
was	O
transferred	O
to	O
the	O
CC	O
for	O
monitoring	O
and	O
he	O
denied	O
having	O
further	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
nausea	B-disease
or	O
vomiting	B-disease
.	O

At	O
baseline	O
the	O
patient	O
denies	O
any	O
previous	B-disease
chest	I-disease
pain	I-disease
,	O
pressure	B-disease
,	O
dyspnea	B-disease
on	O
exertion	O
,	O
orthopnea	B-disease
,	O
PND	B-disease
or	O
palpitations	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Only	O
hypertension	B-disease
.	O

MEDICATIONS	O
:	O

Antihypertensive	O
medications	O
that	O
the	O
patient	O
could	O
not	O
identify	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
denies	O
having	O
any	B-disease
drug	I-disease
allergies	I-disease
.	O

FAMILY	O
HISTORY	O
:	O

Significant	O
for	O
a	O
brother	O
who	O
had	O
an	B-disease
MI	I-disease
at	O
age	O
61	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
has	O
two	O
kids	O
,	O
works	O
as	O
a	O
landscaper	O
and	O
as	O
a	O
school	O
custodian	O
in	O
Ware	O
.	O

He	O
has	O
a	O
15	O
to	O
20	O
pack-year	O
history	O
.	O

Smokes	O
1	O
pack-per-day	O
for	O
15	O
years	O
but	O
had	O
quit	O
for	O
20	O
years	O
and	O
recently	O
restarted	O
.	O

He	O
drinks	O
two	O
glasses	O
of	O
wine	O
per	O
day	O
and	O
denies	O
any	O
use	O
of	O
illicit	O
substances	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
was	O
afebrile	B-disease
.	O

Blood	O
pressure	O
156/67	O
,	O
pulse	O
80	O
and	O
respiratory	O
rate	O
14	O
.	O

Appearance	O
:	O

He	O
was	O
laying	O
flat	O
,	O
very	B-disease
tense	I-disease
.	O

Skin	O
was	O
strong	O
build	O
and	O
was	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

HEENT	O
:	O

He	O
was	O
anicteric	B-disease
with	O
moist	O
mucous	O
membranes	O
.	O

No	O
JVD	B-disease
or	O
increased	B-disease
JVP	I-disease
was	O
appreciated	O
at	O
0	O
degrees	O
.	O

The	O
patient	O
did	O
not	O
have	O
any	B-disease
carotid	I-disease
bruits	I-disease
,	O
abdominal	B-disease
bruits	I-disease
or	O
femoral	B-disease
bruits	I-disease
.	O

His	O
PMI	O
was	O
two	O
finger	O
breath	O
width	O
in	O
the	O
fifth	O
intercostal	O
space	O
lateral	O
to	O
the	O
midclavicular	O
line	O
.	O

There	O
were	O
no	O
lifts	B-disease
or	O
heaves	B-disease
on	O
examination	O
.	O

His	O
heart	O
was	O
regular	O
with	O
no	O
murmurs	B-disease
,	O
rubs	B-disease
or	O
gallops	B-disease
and	O
his	O
radial	O
and	O
DP	O
pulses	O
were	O
both	O
2+	O
bilaterally	O
and	O
equal	O
.	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	O
.	O

His	O
abdomen	O
was	O
scaphoid	B-disease
,	O
nondistended	B-disease
,	O
nontender	B-disease
with	O
positive	O
bowel	O
sounds	O
.	O

His	O
extremities	O
were	O
warm	O
,	O
pink	O
with	O
no	O
edema	B-disease
.	O

The	O
right	O
calf	O
site	O
had	O
minimal	B-disease
ooze	I-disease
and	O
no	O
hematomas	B-disease
or	O
bruits	B-disease
.	O

ELECTROCARDIOGRAM	O
:	O

Significant	O
for	O
what	O
was	O
stated	O
in	O
the	O
HPI	O
.	O

OVERALL	O
IMPRESSION	O
:	O

This	O
is	O
a	O
54	O
-	O
year-old	O
man	O
with	O
significant	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
risk	I-disease
factors	I-disease
,	O
positive	O
family	O
history	O
,	O
smoking	O
history	O
,	O
hypertension	B-disease
and	O
gender	O
who	O
presented	O
with	O
an	B-disease
ST	I-disease
elevation	I-disease
MI	I-disease
status	O
post	O
LAD	O
stent	O
,	O
complicated	O
by	O
no	O
residuals	B-disease
requiring	O
nitroglycerin	O
and	O
diltiazem	O
for	O
good	O
flow	O
.	O

The	O
patient	O
was	O
pain	B-disease
free	O
and	O
doing	O
well	O
.	O

HOSPITAL	O
COURSE	O
:	O

For	O
his	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
,	O
aspirin	O
was	O
started	O
at	O
325	O
.	O

Plavix	O
was	O
started	O
at	O
75	O
mg	O
a	O
day	O
,	O
Lipitor	O
20	O
mg	O
per	O
day	O
,	O
metoprolol	O
25	O
mg	O
twice	O
a	O
day	O
to	O
be	O
titrated	O
up	O
as	O
tolerated	O
and	O
on	O
day	O
two	O
of	O
admission	O
an	O
ACE	O
inhibitor	O
was	O
started	O
.	O

Captopril	O
6.2	O
3	O
x	O
a	O
day	O
and	O
titrated	O
up	O
.	O

A	O
lipid	O
panel	O
was	O
checked	O
and	O
found	O
to	O
be	O
within	O
normal	O
limits	O
,	O
although	O
it	O
was	O
noted	O
this	O
was	O
in	O
the	O
post	O
MI	O
setting	O
and	O
the	O
lipid	O
panel	O
could	O
be	O
falsely	O
low	O
.	O

Serial	O
CK	O
s	O
were	O
followed	O
with	O
a	O
CK	O
peak	O
of	O
433	O
.	O

Hypertension	B-disease
was	O
managed	O
with	O
beta	O
blocker	O
and	O
ACE	O
inhibitor	O
and	O
Integrilin	O
was	O
continued	O
post	O
MI	B-disease
for	O
18	O
hours	O
.	O

Rhythm	O
was	O
maintained	O
at	O
normal	O
sinus	O
,	O
monitored	O
on	O
telemetry	O
without	O
ectopy	B-disease
.	O

EKG	O
s	O
were	O
followed	O
for	O
normalization	O
.	O

The	O
patient	O
had	O
an	O
echocardiogram	O
on	O
day	O
two	O
of	O
admission	O
,	O
which	O
revealed	O
a	B-disease
mildly	I-disease
dilated	I-disease
left	I-disease
atrium	I-disease
,	O
mild	B-disease
symmetric	I-disease
LVH	I-disease
,	O
normal	O
LV	O
cavity	O
size	O
,	O
mild	B-disease
region	I-disease
LV	I-disease
systolic	I-disease
dysfunction	I-disease
,	O
arresting	B-disease
regional	I-disease
wall	I-disease
motion	I-disease
abnormality	I-disease
including	O
focal	B-disease
apical	I-disease
hypokinesis	I-disease
,	O
a	O
normal	O
right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
,	O
a	B-disease
moderately	I-disease
dilated	I-disease
aortic	I-disease
root	I-disease
,	O
a	B-disease
mildly	I-disease
dilated	I-disease
ascending	I-disease
aorta	I-disease
,	O
normal	O
aortic	O
valve	O
leaflet	O
,	O
normal	O
mitral	O
valve	O
leaflet	O
and	O
no	O
pericardial	B-disease
effusions	I-disease
.	O

The	O
patient	O
was	O
normal	O
volume	O
and	O
displayed	O
no	O
evidence	O
CHF	B-disease
signs	I-disease
or	I-disease
symptoms	I-disease
.	O

The	B-disease
risk	I-disease
factors	I-disease
were	O
addressed	O
.	O

The	O
patient	O
was	O
told	O
repeatedly	O
that	O
he	O
needed	O
to	O
stop	O
smoking	O
and	O
was	O
given	O
a	O
nicotine	O
patch	O
and	O
his	O
primary	O
care	O
provider	O
was	O
called	O
to	O
discuss	O
outpatient	O
plans	O
to	O
help	O
the	O
patient	O
stop	O
smoking	O
.	O

The	O
patient	O
was	O
advised	O
to	O
have	O
a	O
low	O
fat	O
/	O
low	O
cholesterol	O
diet	O
,	O
was	O
cleared	O
by	O
PT	O
and	O
advised	O
to	O
do	O
cardiac	O
rehabilitation	O
.	O

He	O
was	O
advised	O
the	O
importance	O
of	O
each	O
of	O
his	O
and	O
compliance	O
with	O
each	O
of	O
these	O
medications	O
and	O
was	O
told	O
he	O
needed	O
close	O
followup	O
with	O
a	O
cardiologist	O
.	O

For	O
renal	O
,	O
his	O
creatinine	O
was	O
monitored	O
and	O
the	O
dye	O
load	O
and	O
the	O
catheterization	O
.	O

It	O
was	O
normal	O
and	O
did	O
not	O
increase	O
.	O

Gastrointestinal	O
:	O

The	O
patient	O
was	O
given	O
a	O
low	O
fat	O
/	O
low	O
cholesterol	O
diet	O
.	O

His	O
electrolytes	O
were	O
monitored	O
and	O
repleted	O
carefully	O
.	O

He	O
had	O
normal	O
bowel	O
movements	O
and	O
had	O
GI	O
prophylaxis	O
throughout	O
his	O
stay	O
.	O

For	O
hematology	O
,	O
the	O
patient	O
's	O
hematocrit	O
and	O
platelets	O
were	O
monitored	O
after	O
the	O
catheterization	O
.	O

They	O
were	O
normal	O
and	O
did	O
not	O
change	O
and	O
the	O
patient	O
received	O
pneumatic	O
boots	O
for	O
DVT	O
prophylaxis	O
.	O

On	O
day	O
two	O
of	O
admission	O
,	O
the	O
patient	O
ambulated	O
with	O
PT	O
and	O
was	O
moved	O
to	O
the	O
regular	O
floor	O
.	O

On	O
day	O
three	O
of	O
admission	O
,	O
the	O
patient	O
felt	O
that	O
his	O
strength	O
was	O
back	O
to	O
baseline	O
.	O

He	O
denied	O
ever	O
having	O
any	B-disease
chest	I-disease
pain	I-disease
,	O
chest	B-disease
pressure	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
dyspnea	B-disease
on	O
exertion	O
and	O
he	O
was	O
discharged	O
to	O
home	O
.	O

He	O
was	O
told	O
to	O
return	O
to	O
the	O
emergency	O
department	O
if	O
he	O
had	O
any	B-disease
chest	I-disease
pain	I-disease
,	O
pressure	B-disease
,	O
difficulty	B-disease
breathing	I-disease
,	O
nausea	B-disease
,	O
light-headiness	B-disease
or	O
dizziness	B-disease
.	O

He	O
was	O
advised	O
to	O
take	O
all	O
of	O
his	O
medications	O
.	O

An	O
appointment	O
was	O
established	O
for	O
him	O
to	O
see	O
his	O
primary	O
care	O
doctor	O
,	O
Dr.	O
Stella	O
Booth	O
on	O
Maynard	O
,	O
2014-10-20	O
and	O
the	O
patient	O
was	O
referred	O
to	O
Dr.	O
Granville	O
Hamers	O
,	O
at	O
Ware	O
in	O
cardiology	O
to	O
be	O
seen	O
in	O
two	O
weeks	O
.	O

Dr	O
Marcus	O
assistant	O
was	O
called	O
and	O
she	O
stated	O
that	O
she	O
would	O
call	O
the	O
patient	O
with	O
an	O
appointment	O
.	O

FINAL	O
DIAGNOSES	O
:	O

1.	O
ST	B-disease
elevation	I-disease
myocardial	I-disease
infarction	I-disease
.	O

2.	O
Hypertension	B-disease
.	O

MAJOR	O
SURGICAL	O
AND	O
INVASIVE	O
PROCEDURES	O
:	O

Cardiac	O
catheterization	O
and	O
stent	O
placement	O
in	O
the	O
mid	O
left	O
anterior	O
descending	O
artery	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Good	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Aspirin	O
325	O
mg	O
q.d.	O
,	O
Plavix	O
75	O
mg	O
q.d.	O
,	O
Lipitor	O
20	O
mg	O
q.d.	O
,	O
nitroglycerin	O
0.3	O
mg	O
sublingually	O
p.r.n.	O
chest	B-disease
pain	I-disease
or	O
pressure	B-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
lisinopril	O
hydrochlorothiazide	O
20	O
/	O
12.5	O
mg	O
q.d.	O
,	O
atenolol	O
25	O
mg	O
q.d.	O

The	O
patient	O
was	O
told	O
he	O
could	O
return	O
to	O
work	O
after	O
two	O
weeks	O
of	O
rest	O
,	O
given	O
that	O
his	O
work	O
required	O
a	O
high	O
level	O
of	O
exertion	O
and	O
the	O
patient	O
was	O
also	O
given	O
a	O
prescription	O
for	O
a	O
transdermal	O
nicotine	O
patch	O
14	O
mg	O
the	O
be	O
used	O
for	O
up	O
to	O
2	O
weeks	O
until	O
cravings	B-disease
remitted	O
.	O

Antonio	O
PINTO	O
,	O
M.D.	O
52-057	O

Dictated	O
By	O
:	O
Salvador	O
BX	O
Hernandez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2014-10-18	O
12:39	O

T	O
:	O
2014-10-21	O
12:42	O

JOB	O
#:	O
78572	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Steve	O
PINTO	O
on	O
:	O
SUN	O
2014-11-02	O
8:39	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-06-13	O

Discharge	O
Date	O
:	O

2017-06-17	O

Date	O
of	O
Birth	O
:	O

1956-02-17	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	O
Drugs	O

Attending:Jordan	O
U	O
Kostohryz	O
,	O
M.D.	O

Chief	O
Complaint:	O
recent	B-disease
mild	I-disease
angina	I-disease
with	O
exertion	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

emergency	O
CABG	O
X	O
3	O
(	O
2017-06-13	O
)(	O
LIMA	O
to	O
LAD	O
,	O
SVG	O
to	O
ramus	O
,	O
SVG	O
to	O
OM	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

61	O
yo	O
African-American-Hispanic	O
male	O
had	O
abnormal	B-disease
EKG	I-disease
found	O
as	O
part	O
of	O
pre-op	O
eval.	O
for	O
ventral	O
hernia	O
repair	O
.	O

Had	O
subsequent	O
abnormal	B-disease
stress	I-disease
test	I-disease
and	O
pefusion	O
imaging	O
showed	O
EF	O
38%	O
with	O
perfusion	B-disease
defects	I-disease
.	O

Echo	O
prior	O
to	O
scheduled	O
cath	O
showed	O
mild	B-disease
LVH	I-disease
,	O
inferior	B-disease
HK	I-disease
,	O
EF	O
40%	O
,	O
mild	B-disease
MR	I-disease
,	O
mild	B-disease
LAE	I-disease
.	O

Cath	O
at	O
Kindred/North	O
Shore	O
today	O
showed	O
80%	B-disease
LM	I-disease
lesion	I-disease
with	O
normal	O
LAD	O
,	O
CX	O
,	O
RCA	O
.	O

Severe	B-disease
systolic	I-disease
HTN	I-disease
also	O
noted	O
.	O

Transferred	O
in	O
urgently	O
for	O
cabg	O
with	O
Dr.	O
Howard	O
.	O

Past	O
Medical	O
History	O
:	O

ventral	B-disease
hernia	I-disease

HTN	B-disease
elev.	B-disease
chol.	I-disease
right	B-disease
facial	I-disease
droop	I-disease
with	O
metal	O
plate	O
secondary	O
to	O
GSW	B-disease
to	O
face	O
right	O
nephrectomy	O

Social	O
History	O
:	O

current	O
smoker	O

Family	O
History	O
:	O

not	O
given	O

Physical	O
Exam:	O

Not	O
done	O
,	O
taken	O
to	O
OR	O
direct	O
from	O
ambulance	O
transfer	O
.	O

Pertinent	O
Results:	O

2017-06-14	O
02:06AM	O
BLOOD	O

WBC	O
-	O
9.4	O
RBC	O
-	O
3.61*	O
Hgb	O
-	O
10.4*	O
Hct	O
-	O
29.9*	O
MCV	O
-	O
83	O
MCH	O
-	O
28.8	O
MCHC	O
-	O
34.8	O
RDW	O
-	O
14.3	O
Plt	O
Ct	O
-	O
154	O

2017-06-17	O
05:14AM	O
BLOOD	O

Hct	O
-	O
25.2*	O

2017-06-14	O
02:06AM	O
BLOOD	O

Plt	O
Ct	O
-	O
154	O

2017-06-13	O
08:05PM	O
BLOOD	O

PT	O
-	O
13.6*	O
PTT	O
-	O
33.3	O
INR	O
(	O
PT	O
)	O
-	O
1.2*	O

2017-06-17	O
05:14AM	O
BLOOD	O

UreaN	O
-	O
25*	O
Creat	O
-	O
1.0	O
K	O
-	O
3.9	O

2017-06-15	O
02:02PM	O
BLOOD	O

Mg	O
-	O
2.1	O

FINAL	O
REPORT	O

TWO	O
VIEW	O
CHEST	O
,	O
2017-06-17	O

COMPARISON	O
:	O

2017-06-14	O
.	O

INDICATION	O
:	O

Status	O
post	O
coronary	O
bypass	O
surgery	O
.	O

There	O
has	O
been	O
removal	O
of	O
a	O
Swan-Ganz	O
catheter	O
and	O
placement	O
of	O
a	O
right	O
internal	O
jugular	O
vascular	O
catheter	O
,	O
with	O
the	O
tip	O
terminating	O
in	O
the	O
proximal	O
right	O
atrium	O
just	O
below	O
the	O
junction	O
with	O
the	O
superior	O
vena	O
cava	O
.	O

Cardiac	O
and	O
mediastinal	O
contours	O
are	O
stable	O
in	O
the	O
postoperative	O
period	O
.	O

Previously	O
reported	O
interstitial	B-disease
edema	I-disease
has	O
resolved	O
.	O

There	O
has	O
been	O
interval	O
improvement	O
in	O
left	B-disease
basilar	I-disease
atelectasis	I-disease
.	O

Right	B-disease
basilar	I-disease
atelectasis	I-disease
has	O
slightly	O
worsened	O
.	O

Bilateral	B-disease
pleural	I-disease
effusions	I-disease
are	O
unchanged	O
.	O

IMPRESSION	O
:	O

1.	O
Vascular	O
catheter	O
tip	O
terminates	O
in	O
proximal	O
right	O
atrium	O
.	O

2.	O
Bibasilar	B-disease
minor	I-disease
atelectasis	I-disease
,	O
worse	O
on	O
the	O
right	O
and	O
improved	O
on	O
the	O
left	O
.	O

Persistent	B-disease
pleural	I-disease
effusions	I-disease
.	O

DR.	O
John	O
S.	O
Beauchamp	O

Approved	O
:	O

SAT	O
2017-06-17	O
8:20	O
PM	O

Procedure	O
Date:2017-06-17	O

PRE-CPB	O
:	O

The	O
left	O
atrium	O
is	O
mildly	B-disease
dilated	I-disease
.	O

No	O
spontaneous	B-disease
echo	I-disease
contrast	I-disease
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium	O
.	O

No	O
spontaneous	B-disease
echo	I-disease
contrast	I-disease
or	O
thrombus	B-disease
is	O
seen	O
in	O
the	O
body	O
of	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

No	O
mass/thrombus	B-disease
is	O
seen	O
in	O
the	O
left	O
atrium	O
or	O
left	O
atrial	O
appendage	O
.	O

No	O
atrial	B-disease
septal	I-disease
defect	I-disease
is	O
seen	O
by	O
2D	O
or	O
color	O
Doppler	O
.	O

There	O
is	O
mild	B-disease
symmetric	I-disease
left	I-disease
ventricular	I-disease
hypertrophy	I-disease
with	O
normal	O
cavity	O
size	O
.	O

There	O
is	O
mild	B-disease
symmetric	I-disease
left	I-disease
ventricular	I-disease
hypertrophy	I-disease
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

No	O
left	B-disease
ventricular	I-disease
aneurysm	I-disease
is	O
seen	O
.	O

There	O
is	O
mild	B-disease
regional	I-disease
left	I-disease
ventricular	I-disease
systolic	I-disease
dysfunction	I-disease
.	O

Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	B-disease
depressed	I-disease
.	O

There	O
is	O
no	O
ventricular	B-disease
septal	I-disease
defect	I-disease
.	O

Resting	B-disease
regional	I-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
include	O
mild	B-disease
inferior	I-disease
hypokinesis	I-disease
.	O

Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

The	O
right	O
ventricular	O
cavity	O
is	O
mildly	B-disease
dilated	I-disease
.	O

There	O
are	O
simple	B-disease
atheroma	I-disease
in	O
the	O
aortic	O
root	O
.	O

There	O
are	O
simple	B-disease
atheroma	I-disease
in	O
the	O
ascending	O
aorta	O
.	O

There	O
are	O
simple	B-disease
atheroma	I-disease
in	O
the	O
aortic	O
arch	O
.	O

There	O
are	O
simple	B-disease
atheroma	I-disease
in	O
the	O
descending	O
thoracic	O
aorta	O
.	O

There	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

No	O
masses	B-disease
or	O
vegetations	B-disease
are	O
seen	O
on	O
the	O
aortic	O
valve	O
.	O

There	O
is	O
no	O
aortic	B-disease
valve	I-disease
stenosis	I-disease
.	O

Trace	B-disease
aortic	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

No	O
mass	B-disease
or	O
vegetation	B-disease
is	O
seen	O
on	O
the	O
mitral	O
valve	O
.	O

Trivial	B-disease
mitral	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

There	O
is	O
no	O
pericardial	B-disease
effusion	I-disease
.	O

POST-CPB	O
:	O

Preserved	O
LV	O
systolic	O
function	O
on	O
phenylephrine	O
.	O

LVEF	O
now	O
50%	O
.	O

Trace	B-disease
MR	I-disease
,	O
AI	B-disease
as	O
described	O
.	O

Normal	O
aortic	O
contours	O
.	O

I	O
certify	O
that	O
I	O
was	O
present	O
for	O
this	O
procedure	O
in	O
compliance	O
with	O
HCFA	O
regulations	O
.	O

Electronically	O
signed	O
by	O
Tracy	O
Kimball	O
,	O
MD	O
,	O
Interpreting	O
physician	O

Brief	O
Hospital	O
Course:	O

Admitted	O
directly	O
to	O
OR	O
from	O
ambulance	O
transfer	O
and	O
underwent	O
cabg	O
x3	O
with	O
Dr.	O
Howard	O
on	O
06-13	O
.	O

Transferred	O
to	O
the	O
CSRU	O
in	O
stable	O
condition	O
on	O
phenylephrine	O
and	O
propofol	O
drips	O
.	O

Extubated	O
early	O
the	O
next	O
morning	O
and	O
chest	O
tubes	O
removed	O
.	O

Gentle	O
diuresis	O
and	O
beta	O
blockade	O
started	O
,	O
and	O
he	O
was	O
transferred	O
to	O
the	O
floor	O
to	O
begin	O
increasing	O
his	O
activity	O
level	O
.	O

Foley	O
removed	O
on	O
POD	O
#2	O
and	O
had	O
scattered	B-disease
rales	I-disease
with	O
temp	O
101.2	O
.	O

Afebrile	B-disease
the	O
next	O
day	O
and	O
pacing	O
wires	O
removed	O
without	O
incident	O
.	O

He	O
made	O
excellent	O
progress	O
and	O
was	O
discharged	O
to	O
home	O
with	O
VNA	O
services	O
on	O
POD	O
#4	O
.	O

He	O
is	O
to	O
follow	O
up	O
with	O
providers	O
as	O
per	O
discharge	O
instructions	O
.	O

Medications	O
on	O
Admission	O
:	O

bisoprolol	O
5	O
mg	O
daily	O
crestor	O
20	O
mg	O
daily	O

HCTZ	O
25	O
mg	O
daily	O
lisinopril	O
40	O
mg	O
daily	O

Discharge	O
Medications:	O

1.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

2.	O
Potassium	O
Chloride	O
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
)	O
for	O
7	O
days	O
.	O

Disp	O
:	O
*28	O
Capsule	O
,	O
Sustained	O
Release(	O
s	O
)*	O

Refills	O
:	O
*0*	O

3.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Capsule(	O
s	O
)*	O

Refills	O
:	O
*2*	O

4.	O
Ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:	O
*60	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

5.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O

Refills	O
:	O
*2*	O

6.	O
Oxycodone-Acetaminophen	O
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-disease
.	O

Disp	O
:	O
*50	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

7.	O
Rosuvastatin	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:	O
*30	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*2*	O

8.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

Disp	O
:	O
*14	O
Tablet(	O
s	O
)*	O

Refills	O
:	O
*0*	O

Discharge	O
Disposition:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis:	O

CAD	B-disease

HTN	B-disease
ventral	B-disease
hernia	I-disease
right	O
nephrectomy	O
s/p	O
right	O
facial	O
plating	O

Discharge	O
Condition	O
:	O
good	O

Discharge	O
Instructions	O
:	O
may	O
shower	O
,	O
no	O
bathing	O
or	O
swimming	O
for	O
1	O
month	O
no	O
creams	O
,	O
lotions	O
or	O
powders	O
to	O
any	B-disease
incisions	I-disease
no	O
driving	O
for	O
1	O
month	O
no	O
lifting	O
>	O
10	O
#	O
for	O
10	O
weeks	O

A.	O
Instructions	O
:	O
with	O
Dr.	O
Matthew	O
in	O
2-3	O
weeks	O
with	O
Dr.	O
Dellinger	O
in	O
2-3	O
weeks	O
with	O
Dr.	O
les	O
Gokey	O
in	O
4	O
weeks	O

Curtis	O
van	O
den	O
Moreno	O
MD	O
07-506	O

Completed	O
by	O
:	O

Scott	O
Robert	O
NP	O
80-AUM	O
2017-06-29	O
@	O
1121	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Barbara	O
van	O
de	O
Tate	O
on	O
:	O

FRI	O
2017-07-28	O
1:55	O
PM	O

(	O
End	O
of	O
Report	O
)	O

242460787	O
DH	O

5950242	O

67766054	O

86004855	O

09/26/2004	O
12:00:00	O
AM	O

Face	O
Sheet	O
/	O
Discharge	O
Order	O

SIGNED	O

DIS	O

[	O
report	O
_	O
end	O
]	O

Admission	O
Date	O
:	O

2011-10-28	O

Discharge	O
Date	O
:	O

2011-12-01	O

Date	O
of	O
Birth	O
:	O

1964-04-14	O

Sex	O
:	O

F	O

Service	O
:	O

Bone	O
marrow	O
transplant	O
service	O

Again	O
,	O
this	O
was	O
a	O
47-year-old	O
female	O
admitted	O
with	O
Berkitt's	B-disease
lymphoma	I-disease
.	O

HOSPITAL	O
COURSE	O
OVER	O
THESE	O
PREVIOUS	O
DAYS	O
:	O

1.	O
Liver	B-disease
lesions	I-disease
:	O

The	O
patient	O
went	O
for	O
a	O
repeat	O
MRI	O
which	O
showed	O
no	O
change	O
in	O
the	B-disease
previously	I-disease
noted	I-disease
enumerable	I-disease
hepatic	I-disease
cyst	I-disease
in	I-disease
her	I-disease
liver	I-disease
.	O

A	O
Hepatology	O
consult	O
was	O
obtained	O
who	O
felt	O
that	O
the	O
most	O
likely	O
etiology	O
of	O
these	B-disease
cysts	I-disease
were	O
from	O
hepatic	B-disease
candidiasis	I-disease
,	O
although	O
one	O
could	O
not	O
rule	O
out	O
lymphoma	B-disease
involving	O
from	O
Burkitt's	B-disease
.	O

She	O
will	O
be	O
discharged	O
on	O
AmBisome	O
300	O
mg	O
IV	O
q.d.	O
for	O
treatment	O
of	O
her	B-disease
hepatic	I-disease
candidiasis	I-disease
.	O

This	O
regimen	O
,	O
that	O
being	O
AmBisome	O
,	O
was	O
recommended	O
by	O
the	O
Infectious	O
Disease	O
physicians	O
,	O
who	O
felt	O
that	O
AmBisome	O
was	O
a	O
better	O
drug	O
of	O
choice	O
as	O
compared	O
to	O
fluconazole	O
.	O

2.	O
Heme	O
:	O

The	O
patient	O
's	O
platelets	O
,	O
white	O
count	O
,	O
and	O
hematocrit	O
have	O
all	O
been	O
stable	O
.	O

Her	O
white	O
count	O
remained	O
elevated	B-disease
despite	O
discontinuing	O
her	O
G-CSF	O
.	O

However	O
,	O
the	O
patient	O
is	O
not	O
febrile	B-disease
and	O
her	O
white	O
count	O
should	O
be	O
continued	O
to	O
be	O
watched	O
.	O

3.	O
On	O
the	O
morning	O
of	O
12-01	O
,	O
the	O
patient	O
had	O
some	O
transient	O
episodes	O
of	O
hypotension	B-disease
with	O
SBP	O
s	O
in	O
the	O
70	O
s.	O

Her	O
captopril	O
was	O
discontinued	O
,	O
and	O
she	O
was	O
given	O
two	O
IV	O
fluid	O
boluses	O
with	O
appropriate	O
response	O
.	O

Her	O
blood	O
pressures	O
and	O
all	O
of	O
her	O
vital	O
signs	O
are	O
stable	O
.	O

4.	O
FEN	O
:	O

The	O
patient	O
was	O
continued	O
on	O
TPN	O
over	O
the	O
past	O
couple	O
days	O
.	O

She	O
is	O
also	O
started	O
on	O
marinol	O
2.5	O
mg	O
p.o.	O
b.i.d.	O
and	O
encouraged	O
p.o.	O
intake	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Guarded	B-disease
,	O
but	O
stable	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Burkitt's	B-disease
lymphoma	I-disease
.	O

2.	O
Hepatic	B-disease
candidiasis	I-disease
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
an	O
outside	O
hospital	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
AmBisome	O
300	O
mg	O
IV	O
q.d.	O

2.	O
Marinol	O
2.5	O
mg	O
p.o.	O
b.i.d.	O
before	O
breakfast	O
and	O
dinner	O
.	O

3.	O
Atarax	O
25	O
mg	O
IV	O
/	O
p.o.	O
q.	O
4-6	O
h.	O
prn	O
for	O
itching	B-disease
.	O

4.	O
Colace	O
100	O
mg	O
p.o.	O
b.i.d.	O

5.	O
Protonix	O
40	O
mg	O
p.o.	O
/	O
IV	O
q.d.	O

6.	O
Nystatin	O
06-18	O
mL	O
swish	O
and	O
swallow	O
q.6.	O
prn	O
.	O

7.	O
Peridex	O
15	O
mL	O
swish	O
and	O
swallow	O
prn	O
.	O

Maria	O
Scheer	O
,	O
M.D.12.699	O

Dictated	O
By	O
:	O
Inez	O
Q	O
Hubbard	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-12-01	O
13:09	O

T	O
:	O
2011-12-01	O
13:20	O

JOB	O
#:	O

66182	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Richard	O
Blakey	O
on	O
:	O
FRI	O
2011-12-23	O
9:54	O
AM	O

(	O
End	O
of	O
Report	O
)	O

176318078_a	O

FIH	O

4189699	O

28872/d70h	O

094756	O

11/03/1993	O
12:00:00	O
AM	O

MITRAL	B-disease
STENOSIS	I-disease

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

11-03-93	O

DISCHARGE	O
DATE	O
:	O

11-06-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Mitral	B-disease
stenosis	I-disease

ASSOCIATED	O
DIAGNOSIS	O
:	O

Tricuspid	B-disease
regurgitation	I-disease
,	O
heart	B-disease
failure	I-disease
,	O
chronic	B-disease
atrial	I-disease
fibrillation	I-disease
,	O
chronic	B-disease
ventricular	I-disease
ectopy	I-disease
,	O
chronic	B-disease
obstructive	I-disease
lung	I-disease
disease	I-disease
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

Epistaxis	B-disease
to	O
Coumadin	O
in	O
the	O
past	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Cardiac	O
catheterization	O
11/03	O
.	O

OTHER	O
PROCEDURE	O
:	O

Pulmonary	O
function	O
test	O
11/04	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
68-year-old	O
patient	O
of	O
Dr.	O
Naka	O
Jesc	O
had	O
two	O
episodes	O
of	O
rheumatic	B-disease
fever	I-disease
as	O
a	O
teenager	O
.	O

She	O
has	O
had	O
chronic	B-disease
atrial	I-disease
fibrillation	I-disease
.	O

Coumadin	O
has	O
caused	O
bleeding	B-disease
from	I-disease
the	I-disease
mouth	I-disease
and	I-disease
nose	I-disease
on	O
two	O
occasions	O
,	O
on	O
one	O
occasion	O
with	O
prothrombin	O
time	O
13	O
,	O
and	O
has	O
been	O
replaced	O
by	O
anti-platelet	O
agents	O
.	O

She	O
has	O
had	O
recurrent	B-disease
syncope	I-disease
since	O
age	O
6	O
.	O

She	O
has	O
now	O
had	O
progressive	B-disease
heart	I-disease
failure	I-disease
.	O

A	O
Holter	O
showed	O
atrial	B-disease
fibrillation	I-disease
with	O
period	O
of	O
ventricular	B-disease
bigemini	I-disease
.	O

She	O
cut	O
down	O
dramatically	O
on	O
smoking	O
two	O
years	O
ago	O
,	O
but	O
has	O
continued	O
to	O
smoke	O
,	O
although	O
,	O
very	O
recently	O
,	O
she	O
admits	O
to	O
only	O
&quot;	O
two	O
puffs	O
&quot;	O
per	O
day	O
.	O

She	O
has	O
not	O
had	O
hypertension	B-disease
or	O
diabetes	B-disease
,	O
and	O
says	O
he	O
has	O
lowered	O
her	O
cholesterol	O
from	O
333	O
to	O
197	O
by	O
changing	O
her	O
diet	O
.	O

There	O
is	O
no	O
family	O
history	O
of	O
heart	B-disease
disease	I-disease
.	O

She	O
has	O
been	O
treated	O
with	O
Vanceril	O
for	O
chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
.	O

She	O
has	O
had	O
one	O
gram	O
per	O
day	O
proteinuria	O
with	O
normal	O
creatinine	O
.	O

She	O
had	O
a	O
partial	O
gastrectomy	O
in	O
1972	O
for	O
a	B-disease
&quot;	I-disease
tumor	I-disease
&quot;	I-disease
.	O

She	O
has	O
had	O
an	O
appendectomy	O
and	O
cholecystectomy	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Digoxin	O
0.125	O
mg	O
po	O
q.d.	O
,	O
Lasix	O
40	O
mg	O
b.i.d.	O
,	O
aspirin	O
held	O
,	O
and	O
Vanceril	O
three	O
puffs	O
b.i.d.	O

ALLERGIES	O
:	O

Transdermal	O
nitroglycerin	O
caused	O
headache	B-disease
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
does	O
not	O
drink	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Heart	O
rate	O
86	O
,	O
irregularly	O
irregular	O
,	O
blood	O
pressure	O
142/86	O
.	O

Neck	B-disease
veins	I-disease
distended	I-disease
.	O

Carotids	O
normal	O
.	O

Chest	O
clear	O
.	O

Apical	O
impulse	O
not	O
palpable	O
.	O

Right	B-disease
ventricular	I-disease
heave	I-disease
.	O

S1	O
normal	O
.	O

S2	O
narrowly	B-disease
physiologically	I-disease
split	I-disease
with	O
accentuation	B-disease
of	O
P2	O
.	O

No	O
S3	B-disease
or	O
opening	B-disease
snap	I-disease
.	O

Grade	B-disease
II	I-disease
systolic	I-disease
murmur	I-disease
at	I-disease
the	I-disease
left	I-disease
lower	I-disease
sternal	I-disease
border	I-disease
.	O

Grade	B-disease
II	I-disease
decrescendo	I-disease
diastolic	I-disease
murmur	I-disease
at	I-disease
the	I-disease
left	I-disease
lower	I-disease
sternal	I-disease
border	I-disease
.	O

Diastolic	B-disease
rumble	I-disease
at	I-disease
the	I-disease
apex	I-disease
.	O

Liver	B-disease
slightly	I-disease
pulsatile	I-disease
but	O
no	O
enlarged	B-disease
.	O

Pulses	O
normal	O
to	O
the	O
femorals	O
with	O
weak	B-disease
dorsalis	I-disease
pedis	I-disease
pulses	I-disease
.	O

Superficial	B-disease
varicose	I-disease
veins	I-disease
.	O

No	O
edema	B-disease
.	O

LABORATORY	O
DATA	O
:	O

Hematocrit	O
44	O
,	O
potassium	O
4.0	O
,	O
BUN	O
23	O
,	O
creatinine	O
1.2	O
,	O
blood	O
sugar	O
115	O
,	O
Digoxin	O
1.4	O
.	O

Electrocardiogram	O
showed	O
atrial	B-disease
fibrillation	I-disease
,	O
moderate	B-disease
ventricular	I-disease
response	I-disease
,	O
incomplete	B-disease
right	I-disease
bundle	I-disease
branch	I-disease
block	I-disease
,	O
right	B-disease
axis	I-disease
deviation	I-disease
,	O
right	B-disease
ventricular	I-disease
hypertrophy	I-disease
and	O
possible	O
apical	B-disease
infarction	I-disease
.	O

Chest	O
x-ray	O
showed	O
left	B-disease
atrial	I-disease
,	I-disease
right	I-disease
ventricular	I-disease
and	I-disease
pulmonary	I-disease
arterial	I-disease
enlargement	I-disease
and	O
interstitial	B-disease
edema	I-disease
with	O
small	B-disease
,	I-disease
bilateral	I-disease
effusions	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

Cardiac	O
catheterization	O
was	O
performed	O
without	O
complication	B-disease
from	O
the	O
right	O
neck	O
and	O
right	O
groin	O
on	O
the	O
day	O
of	O
admission	O
.	O

Right	O
atrial	O
pressure	O
was	O
12	O
with	O
a	O
wave	O
form	O
consistent	O
with	O
tricuspid	B-disease
regurgitation	I-disease
.	O

There	O
was	O
no	O
tricuspid	B-disease
valve	I-disease
gradient	I-disease
.	O

Pulmonary	O
artery	O
pressure	O
was	O
markedly	B-disease
elevated	I-disease
at	O
120/60	O
.	O

Pulmonary	O
capillary	O
wedge	O
pressure	O
was	O
markedly	B-disease
elevated	I-disease
at	O
38	O
,	O
with	O
a	B-disease
very	I-disease
large	I-disease
mitral	I-disease
valve	I-disease
gradient	I-disease
.	O

There	O
was	O
little	O
or	O
no	O
aortic	B-disease
valve	I-disease
gradient	I-disease
.	O

Fich	O
cardiac	O
output	O
was	O
3.0	O
and	O
indexed	O
2.0	O
.	O

Arterial	O
oxygen	O
saturation	O
was	O
85	O
percent	O
.	O

There	O
was	O
minimal	B-disease
mitral	I-disease
valve	I-disease
calcification	I-disease
,	O
normal	O
left	O
ventricular	O
contraction	O
,	O
and	O
2+	B-disease
mitral	I-disease
regurgitation	I-disease
into	I-disease
a	I-disease
large	I-disease
left	I-disease
atrium	I-disease
.	O

There	O
was	O
minimal	B-disease
aortic	I-disease
valve	I-disease
calcification	I-disease
,	O
mild	B-disease
______________	I-disease
thickening	I-disease
,	O
normal	O
open	O
,	O
and	O
mild	B-disease
aortic	I-disease
regurgitation	I-disease
.	O

There	O
was	O
mild	B-disease
atherosclerosis	I-disease
of	I-disease
the	I-disease
mid	I-disease
left	I-disease
anterior	I-disease
descending	I-disease
.	O

FVC	O
was	O
1.6	O
or	O
58	O
percent	O
of	O
predicted	O
and	O
FEV1	O
0.95	O
or	O
45	O
percent	O
of	O
predicted	O
.	O

Room	O
air	O
arterial	O
blood	O
gas	O
was	O
56/40/7.45	O
.	O

Because	O
it	O
would	O
be	O
ideal	O
to	O
place	O
a	O
mechanical	O
valve	O
if	O
valve	O
replacement	O
rather	O
that	O
commissurotomy	O
is	O
needed	O
,	O
she	O
was	O
seen	O
by	O
Dr.	O
Ca	O
Shuff	O
of	O
ENT	O
for	O
her	O
history	O
of	O
epistaxis	B-disease
.	O

He	O
identified	O
no	O
bleeding	B-disease
source	I-disease
,	O
but	O
felt	O
that	O
the	O
risk	O
of	O
nasal	B-disease
hemorrhage	I-disease
on	O
Coumadin	O
could	O
be	O
minimized	O
interventional	O
neuroradiology	O
occlusion	O
of	O
the	O
arteries	O
to	O
the	O
nose	O
bilaterally	O
.	O

The	O
patient	O
was	O
therefore	O
referred	O
to	O
the	O
Dr.	O
A	O
Eu	O
Wave	O
.	O

The	O
procedure	O
could	O
not	O
be	O
scheduled	O
during	O
this	O
admission	O
.	O

The	O
patient	O
is	O
,	O
therefore	O
,	O
discharged	O
after	O
a	O
three	O
day	O
hospitalization	O
,	O
with	O
plans	O
for	O
re-admission	O
for	O
the	O
neuroradiology	O
procedure	O
.	O

This	O
will	O
be	O
followed	O
by	O
a	O
trial	O
of	O
Coumadin	O
,	O
and	O
then	O
by	O
mitral	O
commissurotomy	O
or	O
replacement	O
and	O
probable	O
tricuspid	O
annuloplasty	O
by	O
Dr.	O
Riemund	O
C.	O
Wave	O
.	O

In	O
the	O
meantime	O
,	O
Lasix	O
dosage	O
is	O
increased	O
.	O

Potassium	O
replacement	O
has	O
caused	O
,	O
according	O
to	O
the	O
patient	O
,	O
marked	B-disease
hyperkalemia	I-disease
in	O
the	O
past	O
.	O

DISCHARGE	O
REGIMEN	O
:	O

Digoxin	O
0.125	O
mg	O
q.d.	O
,	O
Lasix	O
80	O
mg	O
q.a.m.	O
and	O
40	O
mg	O
q.p.m.	O
aspirin	O
1	O
q.d.	O
,	O
and	O
Vanceril	O
three	O
puffs	O
b.i.d.	O

CA	O
SHUFF	O
,	O
M.D.	O

TR	O
:	O

vw	O
/	O
bmot	O

DD	O
:	O

11-06-93	O

TD	O
:	O

11/07/93	O

CC	O
:	O

Copies	O
to	O
Dr.	O
Bodejove	O
at	O
Valtawnprinceel	O
Community	O
Memorial	O
Hospital	O
,	O
Dr.	O
A	O
Eu	O
Wave	O
,	O
Dr.	O
Riemund	O
C.	O
Wave	O
,	O
and	O
three	O
copies	O
to	O
Dr.	O
Ca	O
Shuff	O
edited	O
12/31/93	O
qm	O

Admission	O
Date	O
:	O

2016-08-08	O

Discharge	O
Date	O
:	O

2016-08-15	O

Date	O
of	O
Birth	O
:	O

1978-08-02	O

Sex	O
:	O

F	O

Service:	O

PROCEDURE	O
:	O

Cadaveric	O
pancreas	O
transplantation	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
37	O
year	O
old	O
lady	O
with	O
type	B-disease
1	I-disease
diabetes	I-disease
mellitus	I-disease
,	O
who	O
is	O
four	O
months	O
postcadaveric	O
kidney	O
transplantation	O
and	O
now	O
has	O
good	O
graft	O
function	O
.	O

She	O
presents	O
for	O
cadaveric	O
pancreas	O
transplantation	O
.	O

Her	B-disease
diabetes	I-disease
mellitus	I-disease
has	O
been	O
complicated	O
by	O
retinopathy	B-disease
and	O
nephropathy	B-disease
as	O
well	O
as	O
peripheral	B-disease
neuropathy	I-disease
.	O

She	O
takes	O
14	O
units	O
of	O
NPH	O
insulin	O
twice	O
a	O
day	O
supplementing	O
with	O
a	O
sliding	O
scale	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	O
,	O
she	O
is	O
in	O
no	O
apparent	B-disease
distress	I-disease
and	O
is	O
alert	O
and	O
oriented	O
.	O

Her	O
chest	O
and	O
cardiovascular	O
examinations	O
are	O
unremarkable	O
.	O

She	O
is	O
afebrile	B-disease
with	O
stable	O
vital	O
signs	O
.	O

Her	O
abdomen	O
is	O
soft	O
and	O
nontender	B-disease
with	O
a	B-disease
well	I-disease
healed	I-disease
left	I-disease
lower	I-disease
quadrant	I-disease
incision	I-disease
from	O
her	O
kidney	O
transplantation	O
.	O

She	O
has	O
good	O
femoral	O
pulses	O
bilaterally	O
.	O

HOSPITAL	O
COURSE	O
:	O

She	O
underwent	O
cadaveric	O
pancreas	O
transplantation	O
without	O
complication	B-disease
.	O

She	O
received	O
induction	O
therapy	O
with	O
thymoglobulin	O
intraoperative	O
and	O
postoperatively	O
for	O
five	O
days	O
.	O

She	O
was	O
kept	O
on	O
a	O
similar	O
immunosuppressive	O
regimen	O
as	O
with	O
her	O
kidney	O
transplant	O
.	O

She	O
had	O
excellent	O
pancreas	O
graft	O
function	O
immediately	O
.	O

Her	O
renal	O
function	O
also	O
remained	O
stable	O
in	O
the	O
perioperative	O
period	O
.	O

She	O
was	O
quickly	O
placed	O
on	O
a	O
diet	O
and	O
advanced	O
to	O
regular	O
diet	O
.	O

She	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
on	O
postoperative	O
day	O
six	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

She	O
will	O
begin	O
weekly	O
follow-up	O
in	O
the	O
Transplant	O
Center	O
.	O

She	O
is	O
to	O
not	O
lift	O
anything	O
greater	O
than	O
ten	O
pounds	O
for	O
six	O
weeks	O
.	O

She	O
is	O
to	O
continue	O
monitoring	O
her	O
blood	O
sugar	O
twice	O
a	O
day	O
.	O

She	O
has	O
undergone	O
full	O
teaching	O
in	O
regards	O
to	O
immunosuppressant	O
medications	O
.	O

In	O
addition	O
,	O
she	O
will	O
take	O
Valganciclovir	O
for	O
three	O
months	O
posttransplant	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Status	O
post	O
cadaveric	O
pancreas	O
transplant	O
.	O

2.	O
Type	B-disease
1	I-disease
diabetes	I-disease
mellitus	I-disease
.	O

3.	O
End	B-disease
stage	I-disease
renal	I-disease
disease	I-disease
,	O
status	O
post	O
kidney	O
transplantation	O
.	O

Dictated	O
By	O
:	O
Jon	O
O	O
Shappy	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2016-11-10	O
18:28	O

T	O
:	O
2016-11-12	O
11:51	O

JOB	O
#	O
:	O
63429	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jacob	O
Butler	O
on	O
:	O
WED	O
2016-11-16	O
7:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2009-12-28	O

Discharge	O
Date	O
:	O

2009-12-31	O

Date	O
of	O
Birth	O
:	O

1964-03-23	O

Sex	O
:	O

F	O

Service	O
:	O

NEUROMEDIC	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Wisniewski	O
is	O
a	O
45-year-old	O
woman	O
with	O
multiple	B-disease
familial	I-disease
cavernous	I-disease
hemangiomas	I-disease
.	O

She	O
is	O
right-handed	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
one	O
and	O
a	O
half	O
weeks	O
prior	O
to	O
admission	O
.	O

She	O
developed	O
an	B-disease
ear	I-disease
ache	I-disease
,	O
for	O
which	O
she	O
saw	O
her	O
primary	O
care	O
physician	O
,	O
Evelyn	O
was	O
prescribed	O
cortisone	O
drops	O
.	O

A	O
few	O
days	O
later	O
she	O
complained	O
of	O
dizziness	B-disease
.	O

This	O
was	O
mostly	O
described	O
as	O
feeling	O
unsteady	B-disease
on	I-disease
her	I-disease
feet	I-disease
.	O

She	O
stated	O
that	O
she	O
had	O
trouble	O
knowing	O
if	O
her	O
feet	O
were	O
touching	O
the	O
ground	O
.	O

She	O
was	O
seen	O
again	O
by	O
primary	O
care	O
physician	O
,	O
Roderick	O
since	O
she	O
had	O
complaints	O
of	O
dizziness	B-disease
,	O
as	O
well	O
as	O
a	O
new	O
complaint	O
of	O
decreased	B-disease
hearing	I-disease
and	O
the	O
sensation	O
of	O
static	B-disease
in	I-disease
her	I-disease
ears	I-disease
,	O
meniere	B-disease
's	I-disease
disease	I-disease
was	O
considered	O
.	O

She	O
was	O
given	O
an	O
oral	O
prednisone	O
taper	O
.	O

This	B-disease
unsteady	I-disease
gait	I-disease
progressed	O
,	O
and	O
then	O
she	O
subsequently	O
started	O
to	O
develop	O
a	B-disease
pins	I-disease
and	I-disease
needle	I-disease
feeling	I-disease
in	I-disease
the	I-disease
face	I-disease
,	I-disease
hands	I-disease
and	I-disease
feet	I-disease
bilaterally	I-disease
.	O

Her	O
hearing	O
got	O
progressively	B-disease
worse	I-disease
and	O
the	B-disease
sound	I-disease
of	I-disease
static	I-disease
increased	O
.	O

She	O
was	O
very	B-disease
fatigued	I-disease
.	O

At	O
an	O
outside	O
hospital	O
,	O
head	O
CT	O
revealed	O
a	B-disease
1.5	I-disease
cm	I-disease
diameter	I-disease
hyperdense	I-disease
mass	I-disease
in	I-disease
the	I-disease
pons	I-disease
,	O
slightly	O
off	O
center	O
to	O
the	O
right	O
.	O

She	O
was	O
transferred	O
here	O
for	O
further	O
care	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Notable	O
for	O
multiple	B-disease
cavernous	I-disease
hemangiomas	I-disease
.	O

She	O
has	O
had	O
at	B-disease
least	I-disease
two	I-disease
bleeding	I-disease
episodes	I-disease
in	O
the	O
past	O
,	O
mostly	O
described	O
as	O
being	O
accompanied	O
by	O
generalized	B-disease
weakness	I-disease
.	O

She	O
has	O
had	O
at	B-disease
least	I-disease
two	I-disease
generalized	I-disease
seizures	I-disease
in	O
the	O
past	O
,	O
but	O
she	O
has	O
not	O
had	O
one	O
since	O
she	O
was	O
26	O
years	O
old	O
.	O

She	O
was	O
never	O
on	O
an	O
anticonvulsant	O
due	O
to	O
her	O
former	O
beliefs	O
as	O
N.	O
Derk	O
Scientist	O
.	O

She	O
no	O
longer	O
observes	O
that	O
belief	O
system	O
.	O

MEDICATIONS	O
:	O

Prednisone	O
taper	O
as	O
above	O
.	O

ALLERGIES	O
:	O

None	O
.	O

FAMILY	O
HISTORY	O
:	O

Strong	O
maternal	O
history	O
of	O
hemangiomas	B-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	O
99.2	O
.	O

Pulse	O
60	O
.	O

Blood	O
pressure	O
120/80	O
.	O

Respiratory	O
rate	O
14	O
.	O

In	O
general	O
,	O
she	O
was	O
a	O
thin	O
well-appearing	O
woman	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Sclera	O
were	O
anicteric	B-disease
.	O

Neck	O
was	O
supple	O
.	O

Chest	O
was	O
clear	O
.	O

Cardiovascular	O
exam	O
revealed	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-disease
,	O
rubs	B-disease
or	O
gallops	B-disease
.	O

Abdomen	O
soft	O
,	O
nontender	B-disease
and	O
distended	B-disease
.	O

Extremities	O
showed	O
no	O
edema	B-disease
.	O

Neurologically	O
,	O
she	O
was	O
awoken	O
from	O
sleep	O
by	O
voice	O
,	O
cooperative	O
,	O
but	O
mildly	B-disease
drowsy	I-disease
.	O

She	O
became	O
more	O
alert	O
during	O
the	O
remainder	O
of	O
the	O
exam	O
.	O

Speech	O
was	O
fluent	O
but	O
slow	B-disease
,	O
and	O
there	O
was	O
long	B-disease
response	I-disease
latencies	I-disease
before	O
she	O
would	O
initiate	O
speech	O
.	O

She	O
otherwise	O
had	O
normal	O
spontaneous	O
movements	O
and	O
facial	O
expression	O
and	O
did	O
not	O
appear	O
to	O
be	O
abulic	B-disease
.	O

She	O
had	O
normal	O
comprehension	O
.	O

She	O
was	O
able	O
to	O
give	O
a	O
detailed	O
history	O
in	O
an	O
organized	O
manner	O
.	O

There	O
was	O
no	O
dysarthria	B-disease
.	O

Language	O
was	O
normal	O
.	O

There	O
was	O
no	O
evidence	O
of	O
any	B-disease
special	I-disease
neglect	I-disease
.	O

Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Visual	O
fields	O
were	O
full	O
.	O

Extraocular	O
movements	O
were	O
full	O
with	O
normal	O
smooth	O
pursuit	O
to	O
the	O
left	O
.	O

Pursuit	O
was	O
interrupted	O
by	O
>.....<	O
when	O
tracking	O
from	O
left	O
to	O
right	O
.	O

She	O
had	O
sustained	B-disease
gaze	I-disease
holding	I-disease
nystagmus	I-disease
in	O
both	O
horizontal	O
directions	O
.	O

There	O
was	O
no	O
rotary	B-disease
component	I-disease
.	O

She	O
had	O
a	B-disease
mildly	I-disease
widened	I-disease
right	I-disease
palpable	I-disease
fissure	I-disease
.	O

There	O
was	O
decreased	B-disease
excursion	I-disease
of	I-disease
the	I-disease
right	I-disease
mouth	I-disease
and	O
flattening	B-disease
of	I-disease
the	I-disease
right	I-disease
nasolabial	I-disease
fold	I-disease
(	I-disease
mild	I-disease
)	I-disease
.	O

Light	O
touch	O
was	O
subjectively	B-disease
abnormal	I-disease
on	O
both	O
sides	O
of	O
the	O
face	O
.	O

Hearing	O
was	O
diminished	B-disease
for	O
conversational	O
speech	O
.	O

Palate	O
and	O
tongue	O
moved	O
normally	O
in	O
the	O
midline	O
.	O

There	O
was	O
a	B-disease
mild	I-disease
left	I-disease
pronator	I-disease
drift	I-disease
.	O

Finger	O
tapping	O
and	O
rapid	O
alternating	O
movements	O
were	O
slow	B-disease
on	I-disease
the	I-disease
left	I-disease
and	O
she	O
had	O
trouble	B-disease
isolating	I-disease
individual	I-disease
finger	I-disease
movements	I-disease
.	O

There	O
was	O
mild	B-disease
finger-to-nose	I-disease
dysmetria	I-disease
on	I-disease
the	I-disease
left	I-disease
.	O

Power	O
was	O
mildly	B-disease
diminished	I-disease
in	I-disease
the	I-disease
finger	I-disease
extensors	I-disease
and	O
hand	O
intrinsics	O
on	O
the	O
left	O
,	O
otherwise	O
,	O
power	O
was	O
full	O
throughout	O
.	O

Reflexes	O
were	O
brisk	O
in	O
the	O
legs	O
with	O
4-5	O
beats	O
of	O
clonus	B-disease
at	I-disease
the	I-disease
ankles	I-disease
bilaterally	I-disease
.	O

She	O
had	O
bilateral	B-disease
upgoing	I-disease
toes	I-disease
.	O

She	O
made	O
mistakes	B-disease
with	I-disease
position	I-disease
sense	I-disease
,	O
roughly	O
at	O
chance	O
level	O
with	O
both	O
great	O
toes	O
and	O
the	O
left	O
first	O
finger	O
,	O
position	O
sense	O
in	O
the	O
right	O
limb	O
seems	O
preserved	O
.	O

Gait	O
was	O
wide	B-disease
based	I-disease
,	O
very	B-disease
unsteady	I-disease
,	O
veering	O
to	O
the	O
left	O
and	O
to	O
the	O
right	O
.	O

She	O
retropulsed	B-disease
and	O
would	O
have	O
pitched	O
backwards	O
without	O
the	O
assistance	O
of	O
the	O
examiner	O
.	O

LABORATORIES	O
:	O

White	O
blood	O
cell	O
count	O
7.8	O
with	O
86%	O
polymorphonuclear	O
cells	O
,	O
11.1	O
lymphocytes	O
,	O
hemoglobin	O
14.3	O
,	O
hematocrit	O
40.5	O
,	O
MCV	O
88	O
,	O
INR	O
1.0	O
,	O
PTT	O
24.7	O
,	O
PT	O
12.3	O
,	O
platelet	O
count	O
295,000	O
,	O
glucose	O
81	O
,	O
BUN	O
15	O
,	O
creatinine	O
0.8	O
,	O
sodium	O
142	O
,	O
potassium	O
4.2	O
,	O
chloride	O
104	O
,	O
CO2	O
26	O
,	O
calcium	O
9.3	O
,	O
phosphate	O
4.8	O
,	O
magnesium	O
2.3	O
.	O

MRI	O
of	O
the	O
brain	O
revealed	O
multiple	B-disease
foci	I-disease
susceptibility	I-disease
artifact	I-disease
within	I-disease
the	I-disease
brain	I-disease
.	O

These	O
were	O
seen	O
best	O
in	O
gradient	O
echocardiogram	O
images	O
.	O

There	O
was	O
a	O
large	O
focus	O
of	O
subacute	B-disease
blood	I-disease
products	I-disease
in	I-disease
the	I-disease
mid	I-disease
to	I-disease
low	I-disease
pons	I-disease
suggesting	O
recent	B-disease
hemorrhage	I-disease
into	I-disease
a	I-disease
cavernous	I-disease
angioma	I-disease
.	O

There	O
was	O
some	B-disease
mild	I-disease
surrounding	I-disease
edema	I-disease
.	O

There	O
are	O
also	O
tiny	B-disease
foci	I-disease
artifact	I-disease
within	I-disease
the	I-disease
cerebellum	I-disease
and	I-disease
base	I-disease
of	I-disease
the	I-disease
pons	I-disease
.	O

There	O
was	O
a	O
larger	O
area	O
of	O
susceptibility	B-disease
artifact	I-disease
in	I-disease
the	I-disease
left	I-disease
temporal	I-disease
lobe	I-disease
,	I-disease
right	I-disease
frontal	I-disease
lobe	I-disease
,	I-disease
and	I-disease
the	I-disease
splenius	I-disease
of	I-disease
the	I-disease
corpus	I-disease
collasum	I-disease
.	O

The	O
brain	O
parenchyma	O
was	O
otherwise	O
normal	O
.	O

There	O
was	O
mild	B-disease
enhancement	I-disease
of	I-disease
the	I-disease
pontine	I-disease
hemorrhagic	I-disease
mass	I-disease
but	O
none	O
elsewhere	O
.	O

There	O
was	O
no	O
areas	B-disease
of	I-disease
restricted	I-disease
diffusion	I-disease
to	O
indicate	O
infarction	B-disease
.	O

MRA	O
of	O
the	O
brain	O
was	O
unremarkable	O
.	O

There	O
was	O
no	O
communication	O
>.......<	O
in	O
the	O
visualized	O
vessels	O
and	O
the	O
angiomas	B-disease
.	O

Follow-up	O
CT	O
was	O
obtained	O
the	O
second	O
day	O
of	O
admission	O
.	O

There	O
was	O
no	O
evidence	O
of	O
developing	B-disease
hydrocephalus	I-disease
,	O
which	O
was	O
a	O
concern	O
due	O
to	O
the	B-disease
surrounding	I-disease
edema	I-disease
,	O
and	O
possible	O
suppression	B-disease
of	I-disease
the	I-disease
fourth	I-disease
ventricle	I-disease
.	O

There	O
was	O
no	O
significant	B-disease
change	I-disease
in	I-disease
size	I-disease
of	O
the	B-disease
subacute	I-disease
pontine	I-disease
hemorrhage	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

Mrs.	O
Wisniewski	O
is	O
a	O
45	O
-	O
year-old	O
woman	O
with	O
a	O
strong	O
family	O
history	O
of	O
cavernous	B-disease
angiomas	I-disease
.	O

She	O
has	O
had	O
several	B-disease
prior	I-disease
bleeding	I-disease
events	I-disease
and	O
presented	O
with	O
a	B-disease
subacute	I-disease
bleed	I-disease
in	I-disease
the	I-disease
mid	I-disease
to	I-disease
lower	I-disease
pons	I-disease
.	O

There	O
was	O
relatively	O
central	O
in	O
location	O
,	O
with	O
only	O
a	B-disease
slight	I-disease
right-sided	I-disease
predominance	I-disease
.	O

Her	O
physical	O
examination	O
remained	O
relatively	O
unchanged	O
,	O
with	O
resolution	O
of	O
the	B-disease
subtle	I-disease
left	I-disease
hand	I-disease
weakness	I-disease
and	O
right	B-disease
facial	I-disease
weakness	I-disease
.	O

Her	O
gait	O
remained	O
severely	B-disease
ataxic	I-disease
,	O
likely	O
secondary	O
to	O
sensory	B-disease
deafferentation	I-disease
,	O
as	O
well	O
as	O
involvement	O
of	O
crossing	B-disease
pontine	I-disease
cerebellar	I-disease
fibers	I-disease
.	O

Therefore	O
,	O
it	O
was	O
recommended	O
that	O
she	O
have	O
aggressive	O
Physical	O
Therapy	O
at	O
an	O
Acute	O
Rehabilitation	O
Center	O
.	O

The	O
case	O
was	O
discussed	O
with	O
Dr.	O
Harold	O
from	O
the	O
Falmouth	O
Hospital	O
.	O

He	O
has	O
followed	O
this	O
family	O
in	O
the	O
past	O
and	O
will	O
see	O
her	O
in	O
follow-up	O
.	O

We	O
will	O
arrange	O
to	O
have	O
a	O
copy	O
of	O
the	O
MRI	O
scans	O
sent	O
to	O
him	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Familial	B-disease
cavernous	I-disease
hemangiomas	I-disease
,	O
status	O
post	O
a	B-disease
subacute	I-disease
pontine	I-disease
hemorrhage	I-disease
.	O

2.	O
Severe	B-disease
gait	I-disease
ataxia	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Gabapentin	O
100	O
mg	O
po	O
t.i.d.	O
for	O
paresthesias	B-disease
.	O

2.	O
Colace	O
100	O
mg	O
po	O
b.i.d.	O

3.	O
Zantac	O
150	O
mg	O
po	O
b.i.d.	O

4.	O
Prednisone	O
taper	O
completed	O
.	O

Andre	O
R.	O
RATAN	O
,	O
M.D.	O

23-397	O

Dictated	O
By	O
:	O
Maria	O
A	O
Singler	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-12-31	O
14:05	O

T	O
:	O
2009-12-31	O
14:57	O

JOB	O
#:	O
71678	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Juan	O
R.	O
RATAN	O
on	O
:	O
TUE	O
2010-03-02	O
8:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

959086752	O

PUOMC	O

6824024	O

094907	O

812890	O

2/1/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

RATHELIFE	O
,	O
TIEANAKI	O
B	O

UNIT	O
NUMBER	O
:	O

342-07-28	O

ADMISSION	O
DATE	O
:	O

02/01/2000	O

DISCHARGE	O
DATE	O
:	O

02/08/2000	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Non-healing	B-disease
ulcer	I-disease
on	I-disease
the	I-disease
right	I-disease
leg	I-disease
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Right	O
fem	O
to	O
below	O
knee	O
pop	O
bypass	O
graft	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
patient	O
is	O
an	O
seventy	O
eight	O
year	O
old	O
female	O
with	O
history	O
of	O
peripheral	B-disease
vascular	I-disease
disease	I-disease
who	O
is	O
status	O
post	O
above	O
knee	O
to	O
fem	O
pop	O
bypass	O
graft	O
with	O
6	O
millimeter	O
PTFE	O
.	O

This	O
operation	O
was	O
performed	O
for	O
two	O
months	O
of	O
increased	B-disease
rest	I-disease
pain	I-disease
.	O

Her	B-disease
pain	I-disease
resolved	O
after	O
surgery	O
and	O
she	O
has	O
been	O
doing	O
well	O
since	O
,	O
although	O
at	O
baseline	O
now	O
she	O
is	O
minimally	B-disease
ambulatory	I-disease
from	O
bed	O
to	O
commode	O
.	O

For	O
the	O
past	O
couple	O
of	O
months	O
the	O
patient	O
has	O
had	O
a	B-disease
non-healing	I-disease
right	I-disease
dorsal	I-disease
foot	I-disease
ulcer	I-disease
which	O
has	O
been	O
increasing	O
in	O
size	O
and	O
started	O
as	O
a	B-disease
pin	I-disease
hole	I-disease
and	O
she	O
does	O
not	O
recollect	O
any	B-disease
trauma	I-disease
,	O
as	O
similar	B-disease
small	I-disease
ulcers	I-disease
developed	O
on	O
the	O
left	O
foot	O
as	O
well	O
around	O
the	O
same	O
time	O
,	O
but	O
that	O
has	O
subsequently	O
healed	O
.	O

The	B-disease
ulcer	I-disease
was	O
managed	O
conservatively	O
at	O
Har	O
Hospital	O
by	O
Dr.	O
Holes	O
with	O
Silvadene	O
b.i.d.	O
lower	O
extremity	O
non-invasive	O
study	O
obtained	O
at	O
that	O
time	O
showed	O
poor	B-disease
distal	I-disease
right	I-disease
extremity	I-disease
perfusion	I-disease
.	O

The	O
patient	O
was	O
referred	O
back	O
to	O
Dr.	O
Pop	O
for	O
the	O
possibility	O
of	O
a	O
revascularization	O
procedure	O
.	O

She	O
is	O
status	O
post	O
angiography	O
today	O
.	O

She	O
has	O
just	O
finished	O
a	O
ten	O
day	O
course	O
of	O
Ciprofloxacin	O
.	O

She	O
denies	O
any	O
fevers	B-disease
or	O
chills	B-disease
.	O

She	O
does	O
have	O
rest	B-disease
pain	I-disease
in	I-disease
the	I-disease
right	I-disease
foot	I-disease
and	I-disease
ankle	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
Guillain-Barr	B-disease
syndrome	I-disease
,	O
Lupus	B-disease
,	O
status	O
post	O
multiple	B-disease
decubiti	I-disease
,	O
peripheral	B-disease
vascular	I-disease
disease	I-disease
,	O
status	O
post	O
right	O
total	O
knee	O
replacement	O
and	O
status	O
post	O
cholecystectomy	O
,	O
status	O
post	O
hysterectomy	O
,	O
status	O
post	O
goiter	B-disease
and	O
left	B-disease
lung	I-disease
fibrosis	I-disease
,	O
status	O
post	O
methicillin	B-disease
resistant	I-disease
Staphylococcus	I-disease
aureus	I-disease
pneumonia	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Prednisone	O
5	O
every	O
other	O
day	O
,	O
alternating	O
with	O
ten	O
every	O
other	O
day	O
.	O

Trental	O
400	O
milligrams	O
t.i.d.	O
,	O
Cytotec	O
100	O
milligrams	O
t.i.d.	O
,	O
Ativan	O
2	O
milligrams	O
q.h.s.	O
Darvon	O
65	O
milligrams	O
two	O
q.i.d	O
,	O
Relafen	O
500	O
milligrams	O
b.i.d	O
,	O
Vitamin	O
E	O
,	O
Prilosec	O
20	O
milligrams	O
once	O
a	O
day	O
,	O
Zantac	O
150	O
milligrams	O
b.i.d	O
,	O
Lasix	O
120	O
milligrams	O
every	O
other	O
day	O
PRN	O
edema	B-disease
.	O

Didronel	O
1	O
q	O
day	O
which	O
has	O
been	O
on	O
hold	O
.	O

Proventil	O
inhaler	O
via	O
nebulizers	O
0.5	O
milligrams	O
with	O
Atrovent	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-disease
Ampicillin	O
,	O
Tylenol	O
,	O
Clinoril	O
,	O
Biaxin	O
,	O
Codeine	O
,	O
Sulfa	O
and	O
Aminophylline	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
afebrile	O
,	O
her	O
vital	O
signs	O
are	O
stable	O
.	O

Her	O
pupils	O
equal	O
round	O
reactive	O
to	O
light	O
and	O
accomodation	O
,	O
normocephalic	O
,	O
atraumatic	O
,	O
extraocular	O
muscles	O
intact	O
.	O

Neck	O
,	O
she	O
has	O
II+	O
bilateral	O
carotids	O
,	O
no	O
bruits	B-disease
,	O
no	O
jugular	B-disease
venous	I-disease
distention	I-disease
.	O

Lungs	O
decreased	B-disease
breath	I-disease
sounds	I-disease
at	I-disease
bilateral	I-disease
bases	I-disease
with	O
minimal	B-disease
expiratory	I-disease
crackles	I-disease
on	I-disease
the	I-disease
right	I-disease
.	O

Abdomen	O
,	O
soft	O
,	O
non-tender	B-disease
,	O
non-distended	B-disease
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
on	O
the	O
right	O
,	O
she	O
has	O
a	O
II+	O
femoral	O
,	O
no	O
distal	B-disease
pulses	I-disease
beyond	O
that	O
.	O

On	O
the	O
left	O
she	O
has	O
a	O
II+	O
femoral	O
and	O
II+	O
popliteal	O
,	O
no	O
distal	B-disease
pulses	I-disease
beyond	O
that	O
.	O

She	O
has	O
on	O
her	O
right	O
ankle	O
anteriorly	O
a	B-disease
four	I-disease
centimeter	I-disease
ulcer	I-disease
with	I-disease
necrotic	I-disease
base	I-disease
.	O

Minimal	B-disease
surrounding	I-disease
erythema	I-disease
.	O

She	O
is	O
able	O
to	O
wiggle	O
her	O
toes	O
bilaterally	O
.	O

Sensation	O
is	O
intact	O
bilaterally	O
.	O

Her	O
legs	O
are	O
tender	O
to	O
touch	O
bilaterally	O
.	O

Her	O
angiography	O
showed	O
a	B-disease
right	I-disease
proximal	I-disease
popliteal	I-disease
occlusion	I-disease
,	O
anterior	B-disease
tibial	I-disease
dominant	I-disease
foot	I-disease
vessel	I-disease
.	O

Small	B-disease
posterior	I-disease
tibial	I-disease
occlusion	I-disease
on	I-disease
the	I-disease
distal	I-disease
calf	I-disease
and	O
a	B-disease
small	I-disease
peroneal	I-disease
goes	O
down	O
to	O
the	O
ankle	O
.	O

On	O
a	O
rectal	O
examination	O
she	O
is	O
guaiac	O
negative	O
,	O
no	O
masses	B-disease
and	O
no	O
gluteal	B-disease
ulcers	I-disease
or	O
decubiti	B-disease
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
and	O
taken	O
to	O
the	O
operating	O
room	O
on	O
the	O
following	O
day	O
and	O
she	O
underwent	O
a	O
right	O
fem	O
to	O
below	O
knee	O
popliteal	O
bypass	O
graft	O
using	O
a	O
six	O
millimeter	O
ring	O
PTFE	O
.	O

She	O
had	O
a	O
strong	O
popliteal	O
doppler	O
pulse	O
intraoperatively	O
and	O
good	O
PVR	O
on	O
the	O
right	O
postoperatively	O
.	O

The	O
patient	O
did	O
well	O
in	O
the	O
postoperative	O
period	O
.	O

She	O
was	O
afebrile	O
,	O
her	O
vital	O
signs	O
were	O
stable	O
.	O

She	O
was	O
making	O
adequate	O
urine	O
output	O
anywhere	O
between	O
20	O
to	O
50	O
ccs	O
an	O
hour	O
.	O

Her	O
hematocrit	O
was	O
26.8	O
and	O
she	O
was	O
transfused	O
1	O
unit	O
of	O
packed	O
red	O
blood	O
cells	O
.	O

Her	O
diet	O
was	O
advanced	O
from	O
clears	O
to	O
a	O
diet	O
as	O
tolerated	O
.	O

On	O
postoperative	O
day	O
two	O
the	O
patient	O
was	O
noted	O
to	O
have	O
some	B-disease
swelling	I-disease
in	I-disease
her	I-disease
left	I-disease
lower	I-disease
extremity	I-disease
and	O
this	O
was	O
felt	O
to	O
be	O
a	B-disease
hematoma	I-disease
secondary	O
to	O
her	O
PVR	O
cuff	O
.	O

There	O
is	O
mild	O
amount	O
of	O
surrounding	B-disease
erythema	I-disease
and	O
the	O
patient	O
was	O
started	O
on	O
Ancef	O
at	O
that	O
time	O
.	O

The	O
patient	O
was	O
seen	O
by	O
physical	O
therapy	O
.	O

The	O
area	O
of	O
erythema	B-disease
on	I-disease
her	I-disease
left	I-disease
leg	I-disease
enlarged	O
slightly	O
and	O
the	O
patient	O
was	O
placed	O
on	O
Vancomycin	O
for	O
several	O
days	O
after	O
which	O
time	O
her	B-disease
erythema	I-disease
again	O
began	O
to	O
decrease	O
.	O

Her	O
right	O
foot	O
remained	O
warm	O
.	O

She	O
had	O
wounds	B-disease
which	O
were	O
clean	O
,	O
dry	O
and	O
intact	O
and	O
the	O
patient	O
was	O
stable	O
from	O
a	O
respiratory	O
standpoint	O
using	O
her	O
respirator	O
at	O
night	O
.	O

The	O
patient	O
required	O
an	O
additional	O
blood	O
transfusion	O
during	O
her	O
hospital	O
stay	O
as	O
her	O
hematocrit	O
had	O
decreased	O
to	O
27	O
on	O
postoperative	O
day	O
three	O
.	O

The	O
patient	O
while	O
in	O
bed	O
had	O
her	O
legs	O
elevated	O
.	O

The	O
patient	O
was	O
tolerating	O
a	O
general	O
diet	O
,	O
she	O
was	O
voiding	O
on	O
her	O
own	O
and	O
the	O
patient	O
was	O
discharged	O
to	O
home	O
as	O
her	O
daughter	O
is	O
a	O
nurse	O
.	O

She	O
was	O
discharged	O
with	O
PO	O
Keflex	O
that	O
she	O
was	O
to	O
take	O
for	O
the	O
next	O
ten	O
days	O
.	O

The	O
patient	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Pop	O
in	O
one	O
week	O
and	O
the	O
patient	O
was	O
afebrile	O
with	O
stable	O
vital	O
signs	O
at	O
the	O
time	O
of	O
discharge	O
.	O

LAYMIE	O
ASLINKE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
EDRY	O
R	O
YELLOW	O
,	O
M.D.	O

03/16/2000	O
13:21	O

_____________________________	O
EDRY	O
YELLOW	O
,	O
M.D.	O

TR	O
:	O

nw	O

DD	O
:	O

02/09/2000	O

TD	O
:	O

02/12/2000	O
1:41	O
P	O

cc	O
:	O

EDRY	O
R	O
YELLOW	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2014-03-31	O

Discharge	O
Date	O
:	O

2014-04-09	O

Date	O
of	O
Birth	O
:	O

1964-04-26	O

Sex	O
:	O

M	O

Service	O
:	O

Liver	O
Transplant	O
Surgery	O
Service	O

ADMISSION	O
DIAGNOSIS	O
:	O

Hepatitis	B-disease
C	I-disease
cirrhosis	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
49	O
year-old	O
man	O
with	O
hepatitis	B-disease
C	I-disease
cirrhosis	I-disease
complicated	O
by	O
encephalopathy	B-disease
,	O
positive	B-disease
esophageal	I-disease
varices	I-disease
,	O
now	O
with	O
worsening	B-disease
confusion	I-disease
and	O
lethargy	B-disease
.	O

The	O
patient	O
has	O
been	O
admitted	O
5	O
x	O
in	O
the	O
past	O
to	O
Nantucket	O
Cottage	O
Hospital	O
since	O
11-30	O
for	O
encephalopathy	B-disease
.	O

Most	O
recently	O
admitted	O
on	O
2014-03-19	O
to	O
2014-03-22	O
.	O

Infectious	O
work-up	O
was	O
negative	O
.	O

Trazodone	O
stopped	O
.	O

Patient	O
was	O
started	O
on	O
Lactulose	O
and	O
Rifaximine	O
which	O
improved	O
his	O
mental	O
status	O
.	O

Today	O
,	O
on	O
2014-03-03	O
,	O
the	O
patient	O
was	O
seen	O
in	O
clinic	O
with	O
increased	B-disease
lethargy	I-disease
,	O
confusion	B-disease
.	O

Wife	O
reports	O
that	O
the	O
patient	O
has	O
a	O
history	O
of	O
lethargy	B-disease
and	O
confusion	B-disease
,	O
similar	O
to	O
the	B-disease
symptoms	I-disease
for	O
which	O
the	O
patient	O
was	O
recently	O
admitted	O
.	O

The	O
patient	O
also	O
reports	O
that	O
he	O
has	O
had	O
"	O
yellowish	B-disease
eyes	I-disease
,	O
some	B-disease
shaking	I-disease
and	O
his	O
breath	O
smelled	O
more	O
like	O
ammonia	O
over	O
the	O
past	O
3	O
days	O
."	O

The	O
patient	O
has	O
been	O
compliant	O
with	O
his	O
medications	O
.	O

He	O
has	O
had	O
one	O
bowel	O
movement	O
today	O
which	O
is	O
on	O
2014-03-31	O
.	O

He	O
has	O
had	O
night	B-disease
sweats	I-disease
for	O
the	O
past	O
2	O
weeks	O
.	O

He	O
denies	O
any	B-disease
abdominal	I-disease
pain	I-disease
.	O

He	O
gets	O
cold	B-disease
easily	O
but	O
denies	O
fevers	B-disease
.	O

His	O
stools	O
have	O
been	O
brown	O
to	O
green	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

HCV	B-disease
cirrhosis	I-disease
.	O

Underwent	O
treatment	O
with	O
Interferon	O
10	O
years	O
ago	O
.	O

He	O
stopped	O
secondary	O
to	O
aggressive	B-disease
behavior	I-disease
.	O

History	O
of	O
hepatic	B-disease
encephalopathy	I-disease
.	O

Esophageal	B-disease
varices	I-disease
.	O

EGD	O
on	O
2013-12-08	O
demonstrated	O
5	B-disease
cores	I-disease
of	I-disease
varices	I-disease
,	O
grade	O
1	O
to	O
2	O
at	O
the	O
lower	O
third	O
of	O
the	O
esophagus	O
.	O

Four	O
bands	O
were	O
placed	O
without	O
difficulty	O
.	O

Also	O
,	O
the	O
patient	O
has	O
a	O
past	O
medical	O
history	O
of	O
hypertension	B-disease
,	O
glucose	B-disease
intolerance	I-disease
,	O
peripheral	B-disease
neuropathy	I-disease
.	O

The	O
patient	O
was	O
taken	O
off	O
of	O
Neurontin	O
because	O
it	O
started	O
to	O
worsen	O
his	O
mental	O
status	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Nadolol	O
20	O
mg	O
q.	O
Day	O
.	O

Protonix	O
20	O
mg	O
q.	O
24	O
hours	O
.	O

Osamine	O
200	O
mg	O
t.i.d.	O

Lactulose	O
30	O
mg	O
q.i.d.	O

Lasix	O
40	O
mg	O
q.	O
Day	O
.	O

Insulin	O
regular	O
.	O

Amlodipine	O
5	O
mg	O
q.	O
Day	O
.	O

Retazepine	O
50	O
mg	O
q	O
h.s.	O

Testosterone	O
4	O
mg	O
q.	O
24	O
hours	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
and	O
lives	O
with	O
his	O
wife	O
.	O

Previously	O
employed	O
as	O
a	O
security	O
guard	O
at	O
a	O
nuclear	O
power	O
plant	O
.	O

Quit	O
tobacco	O
20	O
years	O
ago	O
and	O
currently	O
denies	O
any	O
cigarette	O
.	O

Alcohol	O
:	O
No	O
alcohol	O
use	O
.	O

The	O
patient	O
contracted	O
HCV	B-disease
20	O
years	O
ago	O
secondary	O
to	O
IV	O
drug	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O
Father	O
died	O
of	O
metastatic	B-disease
colon	I-disease
cancer	I-disease
.	O

Mother	O
died	O
of	O
end	B-disease
stage	I-disease
renal	I-disease
disease	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
were	O
stable	O
.	O

Weight	O
was	O
122.5	O
.	O

General	O
:	O
Patient	O
is	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Lethargic	B-disease
,	O
occasionally	O
falling	O
asleep	O
.	O

HEENT	O
:	O
Pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Sclera	B-disease
mildly	I-disease
icteric	I-disease
.	O

Neck	O
:	O
No	O
LAD	B-disease
.	O

Lungs	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

CV	O
:	O
Regular	O
rate	O
and	O
rhythm	O
.	O

Normal	O
S1	O
and	O
S2	O
without	O
murmurs	B-disease
or	O
rubs	B-disease
.	O

Positive	B-disease
gynecomastia	I-disease
.	O

Abdomen	O
:	O
Positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
nondistended	B-disease
,	O
nontender	B-disease
.	O

Obvious	B-disease
ascites	I-disease
.	O

1+	B-disease
edema	I-disease
bilaterally	I-disease
.	O

Neurologic	O
:	O
Awake	O
,	O
alert	O
and	O
oriented	O
x3	O
.	O

Cranial	O
nerves	O
2	O
through	O
12	O
intact	O
.	O

There	O
was	O
mild	B-disease
asterixis	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
.	O

Patient	O
continued	O
on	O
Lactulose	O
.	O

The	O
goal	O
was	O
3	O
to	O
4	O
stools	O
per	O
day	O
.	O

Continue	O
on	O
Rifaximine	O
.	O

Continue	O
Lasix	O
.	O

Physical	O
therapy	O
was	O
consulted	O
on	O
2014-04-01	O
.	O

On	O
2014-04-02	O
,	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
,	O
taking	O
Lactulose	O
.	O

Difficulty	B-disease
with	I-disease
word	I-disease
finding	I-disease
at	O
times	O
.	O

Denies	O
any	B-disease
pain	I-disease
or	O
discomfort	B-disease
.	O

Abdomen	O
:	O
Slightly	B-disease
distended	I-disease
,	O
nontender	B-disease
.	O

Positive	O
bowel	O
sounds	O
.	O

Positive	O
flatus	O
.	O

Good	O
op	O
site	O
.	O

Ultrasound	O
was	O
performed	O
on	O
2014-04-01	O
demonstrating	O
severe	B-disease
portal	I-disease
hypertension	I-disease
with	O
massive	B-disease
peri	I-disease
splenic	I-disease
varices	I-disease
and	O
splenorenal	O
shunt	O
.	O

Portal	O
vein	O
was	O
fully	O
patent	O
.	O

Repeat	B-disease
hepato	I-disease
fungal	I-disease
flare	I-disease
.	O

On	O
2014-04-04	O
,	O
the	O
transplant	O
service	O
was	O
consulted	O
because	O
the	O
patient	O
was	O
possibly	O
going	O
to	O
the	O
operating	O
room	O
for	O
transplant	O
on	O
2014-04-04	O
.	O

The	O
patient	O
did	O
go	O
to	O
operating	O
room	O
on	O
2014-04-04	O
and	O
the	O
patient	O
had	O
cadaveric	O
liver	O
transplant	O
performed	O
by	O
Dr.	O
Michael	O
Sanders	O
.	O

Please	O
see	O
detailed	O
operative	O
note	O
for	O
more	O
information	O
about	O
the	O
procedure	O
.	O

Postoperatively	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
ICU	O
.	O

The	O
patient	O
received	O
MMF	O
1	O
gram	O
b.i.d.	O
,	O
Flagyl	O
500	O
mg	O
IV	O
x1	O
.	O

The	O
patient	O
also	O
received	O
Unasyn	O
for	O
2	O
days	O
,	O
Fluconazole	O
,	O
heparin	O
,	O
Protonix	O
,	O
insulin	O
,	O
morphine	O
,	O
Bactrim	O
.	O

The	O
patient	O
was	O
on	O
Propofol	O
for	O
2	O
days	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
2014-04-04	O
,	O
labs	O
were	O
as	O
follows	O
:	O

WBC	O
of	O
8.3	O
;	O
hematocrit	O
of	O
30.6	O
;	O
platelets	O
69	O
;	O
sodium	O
132	O
;	O
3.9	O
,	O
102	O
,	O
22	O
,	O
serum	O
creatinine	O
of	O
13	O
and	O
1.1	O
.	O

Glucose	O
114	O
.	O

AST	O
87	O
.	O

ALT	O
44	O
.	O

Alkaline	O
phosphatase	O
169	O
.	O

PT	O
of	O
20.6	O
.	O

PTT	O
of	O
38.7	O
.	O

INR	O
of	O
2.0	O
.	O

On	O
postoperative	O
day	O
number	O
1	O
,	O
duplex	O
ultrasound	O
of	O
the	O
patient	O
's	O
liver	O
was	O
performed	O
demonstrating	O
normal	O
appearing	O
portal	O
veins	O
and	O
hepatic	O
arteries	O
.	O

There	O
was	O
normal	O
flow	O
within	O
the	O
middle	O
hepatic	O
vein	O
.	O

There	O
appears	O
to	O
be	O
a	B-disease
decreased	I-disease
and	I-disease
sluggish	I-disease
flow	I-disease
within	I-disease
the	I-disease
right	I-disease
and	I-disease
left	I-disease
hepatic	I-disease
veins	I-disease
with	O
loss	B-disease
of	I-disease
normal	I-disease
respiratory	I-disease
variations	I-disease
,	I-disease
wave	I-disease
forms	I-disease
and	I-disease
the	I-disease
intrahepatic	I-disease
portion	I-disease
.	O

Additionally	O
,	O
there	O
is	O
diminished	B-disease
color	I-disease
flow	I-disease
with	O
confluence	O
of	O
the	O
hepatic	O
veins	O
.	O

These	O
findings	O
may	O
reflect	O
thrombus	B-disease
within	I-disease
the	I-disease
left	I-disease
and	I-disease
right	I-disease
hepatic	I-disease
veins	I-disease
.	O

Caval	B-disease
narrowing	I-disease
is	O
seen	O
,	O
most	O
likely	O
correlation	O
to	O
clinical	O
history	O
is	O
recommended	O
and	O
further	O
evaluation	O
of	O
the	O
CT	O
or	O
short-term	O
ultrasounds	O
for	O
follow-up	O
was	O
recommended	O
.	O

The	O
Feeney	O
Gann-Burlington	O
drain	O
on	O
postoperative	O
day	O
number	O
demonstrated	O
medial	O
output	O
of	O
780	O
with	O
lateral	O
output	O
of	O
150	O
.	O

Patient	O
went	O
to	O
the	O
floor	O
and	O
patient	O
was	O
on	O
the	O
floor	O
on	O
2014-04-07	O
.	O

Patient	O
continued	O
getting	O
Acyclovir	O
,	O
Prednisone	O
,	O
MMF	O
one	O
gram	O
b.i.d	O
.	O

The	O
patient	O
was	O
on	O
FK	O
2	O
and	O
2	O
that	O
was	O
started	O
on	O
postoperative	O
day	O
number	O
2	O
.	O

Diet	O
was	O
advanced	O
.	O

Patient	O
was	O
ambulating	O
.	O

Waltham-Ludlow	O
drains	O
put	O
out	O
on	O
the	O
13th	O
620	O
and	O
380	O
.	O

Physical	O
therapy	O
was	O
re	O
consulted	O
.	O

Omalley	O
was	O
consulted	O
on	O
2014-04-08	O
for	O
better	O
glucose	O
control	O
since	O
the	O
patient	O
was	O
on	O
steroids	O
.	O

Social	O
work	O
was	O
consulted	O
.	O

Patient	O
continued	O
to	O
do	O
very	O
well	O
,	O
ambulating	O
,	O
following	O
the	O
diet	O
.	O

Patient	O
was	O
transfused	O
1	O
unit	O
of	O
platelets	O
on	O
2014-04-08	O
for	O
platelet	O
count	O
of	O
66	O
.	O

A	O
heparin	O
independent	O
antibody	O
was	O
sent	O
off	O
on	O
2014-04-07	O
which	O
was	O
unremarkable	O
.	O

On	O
2014-04-09	O
,	O
patient	O
continued	O
to	O
do	O
very	O
well	O
,	O
ambulating	O
,	O
tolerating	O
a	O
diet	O
,	O
urinating	O
without	O
difficulty	B-disease
.	O

Drains	O
continued	O
to	O
put	O
out	O
significant	O
amount	O
of	O
fluid	O
.	O

Patient	O
's	O
labs	O
from	O
2014-04-10	O
were	O
the	O
following	O
:	O

7.1	O
,	O
hematocrit	O
of	O
30.8	O
,	O
platelets	O
90	O
.	O

Sodium	O
of	O
138	O
;	O
potassium	O
3.5	O
;	O
106	O
,	O
28	O
,	O
31	O
,	O
1.0	O
,	O
glucose	O
134	O
.	O

AST	O
82	O
.	O

ALT	O
176	O
.	O

Alkaline	O
phosphatase	O
78	O
which	O
all	O
have	O
significantly	O
decreased	O
since	O
postoperative	O
day	O
number	O
1	O
.	O

Total	O
bilirubin	O
was	O
0.9	O
.	O

On	O
2014-04-09	O
,	O
FK	O
level	O
was	O
10.3	O
.	O

Patient	O
left	O
on	O
2014-04-09	O
with	O
VNA	O
to	O
home	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Protonix	O
40	O
mg	O
q.	O
24	O
.	O

Moltipine	O
5	O
mg	O
q.	O
Day	O
.	O

Fluconazole	O
400	O
mg	O
q.	O
24	O
hours	O
.	O

Prednisone	O
20	O
mg	O
q.	O
Day	O
.	O

MMF	O
1000	O
mg	O
b.i.d.	O
.	O

Lopressor	O
50	O
m	O
b.i.d.	O

Percocet	O
1	O
to	O
2	O
tabs	O
q.	O
4	O
to	O
6	O
hours	O
prn	O
.	O

Colace	O
100	O
mg	O
b.i.d.	O

Bactrim	O
SS	O
1	O
tab	O
q.	O
Day	O
.	O

Tacrolimus	O
3	O
mg	O
b.i.d.	O

Lasix	O
20	O
mg	O
b.i.d.	O

Valcyte	O
900	O
mg	O
q.	O
Day	O
.	O

Patient	O
is	O
on	O
insulin	O
sliding	O
scale	O
with	O
fixed	O
dose	O
.	O

FOLLOW	O
UP	O
:	O

The	O
patient	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Amanda	O
Pepper	O
on	O
the	O
following	O
dates	O
:	O

2014-04-14	O
at	O
9	O
a.m.	O
,	O
2014-04-24	O
at	O
10:20	O
a.m.	O
and	O
2014-05-01	O
at	O
10:20	O
a.m.	O

If	O
the	O
patient	O
can	O
not	O
make	O
those	O
appointments	O
or	O
has	O
any	O
questions	O
about	O
the	O
appointments	O
,	O
please	O
call	O
787-984-9608	O
.	O

The	O
patient	O
is	O
to	O
call	O
787-984-9608	O
if	O
any	O
fevers	B-disease
,	O
chills	B-disease
,	O
nausea	B-disease
and	O
vomiting	B-disease
,	O
abdominal	B-disease
pain	I-disease
,	O
inability	B-disease
to	I-disease
take	I-disease
medications	I-disease
,	O
inability	B-disease
to	I-disease
eat	I-disease
or	I-disease
drink	I-disease
.	O

Patient	O
needs	O
to	O
have	O
labs	O
every	O
Monday	O
and	O
Thursday	O
including	O
a	O
CBC	O
,	O
chem-10	O
,	O
AST	O
,	O
ALT	O
,	O
alkaline	O
phosphatase	O
,	O
albumin	O
,	O
total	O
bilirubin	O
and	O
Prograf	O
level	O
need	O
to	O
be	O
obtained	O
.	O

Please	O
fax	O
results	O
to	O
(	O
728	O
)	O
250-3265	O
.	O

All	O
cultures	O
have	O
been	O
unremarkable	O
.	O

Cultures	O
were	O
obtained	O
on	O
2014-03-31	O
.	O

Urine	O
culture	O
and	O
blood	O
culture	O
have	O
been	O
unremarkable	O
on	O
2014-04-03	O
.	O

Hepatitis	O
viral	O
load	O
was	O
76,500	O
.	O

Pathology	O
demonstrates	O
that	O
the	O
pathology	O
results	O
of	O
the	O
liver	O
were	O
not	O
finalized	O
.	O

Darrell	O
Diiorio	O
,	O
MD	O
,	O
PHD	O
02-366	O

Dictated	O
By	O
:	O
Deborah	O
JP	O
Allen	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2014-04-11	O
14:30:39	O

T	O
:	O
2014-04-11	O
15:05:40	O

Job	O
#:	O

88167	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Greg	O
Jones	O
on	O
:	O
FRI	O
2014-04-25	O
2:37	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-05-21	O

Discharge	O
Date	O
:	O

2012-05-25	O

Date	O
of	O
Birth	O
:	O

1957-01-05	O

Sex	O
:	O

F	O

Service	O
:	O

CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
55-year-old	O
female	O
with	O
multiple	O
prior	O
admissions	O
for	O
pneumonia	B-disease
,	O
COPD	B-disease
,	O
asthma	B-disease
exacerbation	I-disease
,	O
over	O
3	O
weeks	O
of	O
upper	B-disease
respiratory	I-disease
like	I-disease
infection	I-disease
unremitting	O
with	O
increased	O
nebulizer	O
treatments	O
at	O
home	O
.	O

The	O
patient	O
saw	O
her	O
PCP	O
and	O
was	O
known	O
to	O
have	O
an	O
oxygen	O
saturation	O
of	O
82	O
to	O
85	O
percent	O
on	O
room	O
air	O
.	O

She	O
was	O
referred	O
to	O
the	O
Emergency	O
Department	O
.	O

In	O
the	O
Emergency	O
Department	O
,	O
the	O
patient	O
received	O
Zithromax	O
,	O
ceftriaxone	O
,	O
and	O
Flagyl	O
.	O

Chest	O
x-ray	O
was	O
remarkable	O
for	O
a	O
questionable	O
left	B-disease
lower	I-disease
lobe	I-disease
infiltrate	I-disease
.	O

The	O
patient	O
received	O
nebulizer	O
treatment	O
with	O
oxygen	O
saturations	O
increasing	O
up	O
to	O
98	O
percent	O
on	O
room	O
air	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Asthma	B-disease
/	O
COPD	B-disease
on	O
BiPAP	O
,	O
history	O
of	O
intubation	O
.	O

Restrictive	B-disease
lung	I-disease
disease	I-disease
.	O

Chronic	B-disease
inflammatory	I-disease
demyelinating	I-disease
polyradiculopathy	I-disease
.	O

Gastritis	B-disease
and	O
duodenitis	B-disease
.	O

Question	O
of	O
Tyrone	B-disease
esophagus	I-disease
.	O

Chronic	B-disease
abdominal	I-disease
pain	I-disease
.	O

Neurogenic	B-disease
bladder	I-disease
.	O

Chronic	B-disease
muscle	I-disease
spasms	I-disease
.	O

Coronary	B-disease
artery	I-disease
disease	I-disease
status	O
post	O
negative	O
stress	O
echo	O
on	O
10-12	O
.	O

History	O
of	O
syncope	B-disease
.	O

Adrenal	B-disease
insufficiency	I-disease
.	O

Hypercholesterolemia	B-disease
.	O

Depression	B-disease
and	O
anxiety	B-disease
.	O

Hyperthyroidism	B-disease
.	O

IgG	B-disease
deficiency	I-disease
.	O

Status	O
post	O
cholecystectomy	O
and	O
appendectomy	O
.	O

Anemia	B-disease
of	O
chronic	B-disease
disease	I-disease
.	O

ALLERGIES	O
:	O

AZMACORT	O
,	O
CLINDAMYCIN	O
,	O
VERSED	O
,	O
FENTANYL	O
,	O
and	O
MORPHINE	O
.	O

SOCIAL	O
HISTORY	O
:	O

History	O
of	O
20-to-30-pack-year	O
smoking	O
,	O
quit	O
approximately	O
15	O
years	O
ago	O
.	O

She	O
denies	O
any	O
alcohol	O
or	O
drug	O
use	O
.	O

Married	O
with	O
children	O
,	O
wheelchair	B-disease
bound	I-disease
mostly	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

From	O
admission	O
,	O
vital	O
signs	O
98.3	O
,	O
blood	O
pressure	O
128/74	O
,	O
68	O
to	O
112	O
is	O
her	O
heart	O
rate	O
,	O
respiratory	O
rate	O
24	O
,	O
100	O
percent	O
on	O
room	O
air	O
.	O

General	O
:	O

She	O
is	O
a	O
chronically	O
ill-appearing	O
female	O
,	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

HEENT	O
:	O

Benign	O
.	O

Cardiac	O
exam	O
:	O

Normal	O
.	O

Pulmonary	O
exam	O
:	O

Diffuse	B-disease
bronchial	I-disease
breath	I-disease
sounds	I-disease
,	O
no	O
wheezes	B-disease
.	O

Abdominal	O
exam	O
:	O

Benign	O
.	O

Extremity	O
exam	O
:	O

No	O
edema	B-disease
.	O

Left	B-disease
lower	I-disease
extremity	I-disease
and	I-disease
left	I-disease
upper	I-disease
extremity	I-disease
weaker	I-disease
at	O
3/5	O
compared	O
to	O
right	O
upper	O
extremity	O
and	O
right	O
lower	O
extremity	O
,	O
chronic	O
according	O
to	O
the	O
patient	O
.	O

MEDICATIONS	O
:	O

On	O
admission	O

1.	O
Vitamin	O
D	O
400	O
mg	O
q.d.	O

2.	O
Levoxyl	O
50	O
mcg	O
q.d.	O

3.	O
Baclofen	O
20	O
mg	O
p.o.	O
t.i.d.	O

4.	O
Florinef	O
0.1	O
mg	O
p.o.	O
q.a.m.	O

5.	O
Klonopin	O
2	O
mg	O
t.i.d.	O

6.	O
BuSpar	O
10	O
mg	O
t.i.d.	O

7.	O
Zanaflex	O
8	O
mg	O
q.4	O
h.	O

8.	O
Oxazepam	O
30	O
mg	O
p.r.n.	O

9.	O
Singulair	O
10	O
mg	O
q.p.m.	O

10.	O
Lipitor	O
10	O
mg	O
q.p.m.	O

11.	O
Ativan	O
2	O
mg	O
p.r.n.	O

12.	O
Protonix	O
20	O
mg	O
p.o.	O
b.i.d.	O

13.	O
Sucralfate	O
2	O
mg	O
b.i.d.	O

14.	O
Albuterol	O
nebulizer	O
q.03-14	O
h.	O
p.r.n.	O

15.	O
Pamidronate	O
30	O
mg	O
IV	O
every	O
month	O
.	O

HOSPITAL	O
COURSE	O
:	O

Shortness	B-disease
of	I-disease
breath	I-disease
.	O

The	O
patient	O
was	O
maintained	O
on	O
albuterol	O
nebulizer	O
treatments	O
and	O
Ipratropium	O
nebulizer	O
treatments	O
,	O
as	O
this	O
was	O
apparently	O
thought	O
to	O
be	O
related	O
to	O
her	B-disease
chronic	I-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
.	O

Given	O
the	O
presence	O
of	O
consolidation	B-disease
on	O
chest	O
x-ray	O
,	O
however	O
,	O
and	O
previous	O
history	O
of	O
pneumonia	B-disease
,	O
the	O
patient	O
was	O
maintained	O
on	O
antibiotics	O
of	O
Zithromax	O
500	O
mg	O
daily	O
and	O
ceftriaxone	O
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
Solu-Medrol	O
IV	O
for	O
active	B-disease
airway	I-disease
disease	I-disease
component	I-disease
of	O
her	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
.	O

The	O
patient	O
was	O
maintained	O
on	O
supplemental	O
oxygen	O
and	O
sputum	O
production	O
was	O
maximized	O
with	O
the	O
help	O
of	O
an	O
Acapella	O
device	O
and	O
respiratory	O
therapy	O
.	O

Mucomyst	O
was	O
also	O
considered	O
as	O
a	O
mucolytic	O
component	O
towards	O
secretions	B-disease
.	O

Adrenal	B-disease
insufficiency	I-disease
.	O

The	O
patient	O
was	O
maintained	O
on	O
IV	O
Solu	O
-	O
Medrol	O
60	O
mg	O
q.	O
8	O
h.	O

Chest	B-disease
soreness	I-disease
.	O

The	O
patient	O
describes	O
chest	B-disease
discomfort	I-disease
without	O
any	B-disease
significant	I-disease
EKG	I-disease
changes	I-disease
.	O

The	O
patient	O
was	O
maintained	O
on	O
Percocet	O
p.r.n.	O
for	O
pain	O
relief	O
.	O

This	O
was	O
thought	O
to	O
be	O
related	O
to	O
musculoskeletal	O
.	O

There	O
was	O
no	O
evidence	O
of	O
acute	B-disease
rib	I-disease
factors	I-disease
on	O
her	O
chest	O
x-ray	O
.	O

GI	O
.	O

The	O
patient	O
was	O
maintained	O
on	O
PPI	O
for	O
reflux	B-disease
disease	I-disease
and	O
known	B-disease
gastritis	I-disease
.	O

CMED	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
neurogenic	B-disease
bladder	I-disease
and	O
,	O
therefore	O
,	O
she	O
required	O
a	O
Foley	O
catheterization	O
.	O

Endocrine	O
.	O

The	O
patient	O
was	O
on	O
Levoxyl	O
at	O
home	O
as	O
her	O
home	O
dose	O
for	O
hyperthyroidism	B-disease
.	O

CMED	O
CSRU	O
transfer	O
.	O

The	O
patient	O
was	O
transferred	O
on	O
the	O
evening	O
of	O
2012-05-22	O
to	O
the	O
ICU	O
given	O
persistent	B-disease
carbon	I-disease
dioxide	I-disease
retention	I-disease
and	O
respiratory	B-disease
acidosis	I-disease
and	O
the	B-disease
intermittent	I-disease
mental	I-disease
status	I-disease
changes	I-disease
.	O

The	O
patient	O
had	O
had	O
ABG	O
on	O
the	O
floor	O
,	O
which	O
prompted	O
her	O
to	O
transfer	O
to	O
the	O
ICU	O
.	O

Her	O
pH	O
was	O
7.23	O
,	O
PCO2	O
73	O
,	O
PO2	O
146	O
on	O
a	O
nonrebreather	O
.	O

The	O
patient	O
had	O
BiPAP	O
initiated	O
once	O
she	O
reached	O
the	O
unit	O
,	O
but	O
did	O
not	O
tolerate	O
it	O
,	O
becoming	O
apneic	B-disease
and	O
obstructing	B-disease
.	O

The	O
patient	O
was	O
switched	O
to	O
2	O
liters	O
nasal	O
cannula	O
and	O
oxygen	O
saturating	O
at	O
98	O
to	O
100	O
percent	O
.	O

After	O
BiPAP	O
was	O
initiated	O
,	O
the	O
patient	O
became	O
hypotensive	B-disease
down	O
to	O
75/28	O
and	O
bradycardiac	B-disease
,	O
responding	O
to	O
3	O
fluid	O
boluses	O
over	O
the	O
course	O
of	O
the	O
night	O
.	O

The	O
patient	O
was	O
started	O
on	O
Florinef	O
for	O
concern	O
of	O
adrenal	B-disease
insufficiency	I-disease
;	O
however	O
,	O
she	O
was	O
hemodynamically	O
stable	O
that	O
morning	O
and	O
was	O
transferred	O
back	O
out	O
to	O
the	O
floor	O
.	O

It	O
was	O
thought	O
that	O
the	O
patient	O
may	O
have	O
been	O
mucous	B-disease
plugging	I-disease
during	O
her	O
stay	O
in	O
the	O
ICU	O
.	O

Hematologic	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
high	B-disease
MCV	I-disease
and	O
megaloblastic	B-disease
cells	I-disease
on	O
smear	O
in	O
the	O
setting	O
of	O
anemia	B-disease
;	O
question	O
B12	B-disease
deficiency	I-disease
,	O
the	O
patient	O
also	O
has	O
a	O
history	O
of	O
borderline	B-disease
low	I-disease
B12	I-disease
levels	I-disease
.	O

The	O
patient	O
was	O
diagnosed	O
for	O
B12	B-disease
deficiency	I-disease
due	O
to	O
her	O
long	O
history	O
of	O
poor	B-disease
p.o.	I-disease
intake	I-disease
.	O

Methylmalonic	O
acid	O
levels	O
were	O
sent	O
,	O
the	O
results	O
are	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Asthma	B-disease
flare	I-disease
and	O
bronchitis	B-disease
.	O

Chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
.	O

Demyelinating	B-disease
polyradiculopathy	I-disease
.	O

Anxiety	B-disease
disorder	I-disease
.	O

Chronic	B-disease
abdominal	I-disease
pain	I-disease
.	O

DISCHARGE	O
STATUS	O
:	O

The	O
patient	O
will	O
be	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
CONDITION	O
:	O

The	O
patient	O
is	O
stable	O
without	O
an	B-disease
oxygen	I-disease
requirement	I-disease
.	O

DISCHARGE	O
FOLLOWUP	O
:	O

The	O
patient	O
is	O
instructed	O
to	O
followup	O
with	O
her	O
doctor	O
in	O
1	O
to	O
2	O
weeks	O
of	O
discharge	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Cholecalciferol	O
.	O

2.	O
Vitamin	O
D	O
.	O

3.	O
Levothyroxine	O
50	O
mcg	O
p.o.	O
q.d.	O

4.	O
Baclofen	O
10	O
mg	O
p.o.	O
t.i.d.	O

5.	O
Clonazepam	O
1	O
mg	O
p.o.	O
t.i.d.	O

6.	O
Buspirone	O
10	O
mg	O
p.o.	O
t.i.d.	O

7.	O
Montelukast	O
sodium	O
10	O
mg	O
p.o.	O
q.h.s.	O

8.	O
Atorvastatin	O
10	O
mg	O
p.o.	O
q.h.s.	O

9.	O
Protonix	O
40	O
mg	O
p.o.	O
q.d.	O

10.	O
Albuterol	O
sulfate	O
solution	O
q.05-15	O
h.	O
p.r.n.	O
for	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

11.	O
Tizanidine	O
8	O
mg	O
p.o.	O
q.6	O
h.	O

12.	O
Acetaminophen	O
p.r.n.	O

13.	O
Prednisone	O
taper	O
for	O
3	O
days	O
.	O

14.	O
Levofloxacin	O
500	O
mg	O
p.o.	O
q.d.	O
for	O
10	O
more	O
days	O
.	O

15.	O
Florinef	O
Acetate	O
0.1	O
mg	O
p.o.	O
q.d.	O

James	O
Grunow	O
,	O
M.D.	O
53-506	O

Dictated	O
By	O
:	O
Elizabeth	O
A	O
Eaton	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-08-01	O
12:27:33	O

T	O
:	O
2012-08-01	O
20:27:59	O

Job	O
#:	O

33698	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kenneth	O
Wilford	O
on	O
:	O
Maxine	O
2012-08-16	O
12:22	O
PM	O

(	O
End	O
of	O
Report	O
)	O

7901625	O

Admission	O
Date	O
:	O

2015-03-16	O

Discharge	O
Date	O
:	O

2015-03-19	O

Date	O
of	O
Birth	O
:	O

Sex	O
:	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
82	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
hypertension	B-disease
,	O
remote	O
tobacco	O
abuse	O
,	O
chronic	B-disease
renal	I-disease
insufficiency	I-disease
,	O
and	O
a	O
history	O
of	O
a	B-disease
TIA	I-disease
who	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
five	O
nights	O
prior	O
to	O
admission	O
when	O
he	O
awoke	O
at	O
midnight	O
with	O
severe	B-disease
epigastric	I-disease
pain	I-disease
radiating	O
to	O
both	O
arms	O
.	O

He	O
also	O
had	O
bilateral	B-disease
arm	I-disease
numbness	I-disease
.	O

The	B-disease
symptoms	I-disease
were	O
associated	O
with	O
diaphoresis	B-disease
and	O
shortness	B-disease
of	I-disease
breath	I-disease
but	O
no	O
nausea	B-disease
or	O
vomiting	B-disease
.	O

After	O
approximately	O
one	O
hour	O
,	O
he	O
presented	O
to	O
the	O
Bristol	O
County	O
Tuberculosis	O
Hospital	O
Dana-Farber	O
Cancer	O
Institute	O
Campus	O
where	O
he	O
ruled	O
in	O
for	O
a	B-disease
non-ST	I-disease
elevation	I-disease
MI	I-disease
with	O
a	O
CK	O
of	O
438	O
with	O
a	O
peak	O
CK	O
MB	O
of	O
19.8	O
and	O
troponin	O
that	O
peaked	O
at	O
10.2	O
.	O

He	O
was	O
started	O
on	O
nitrates	O
there	O
as	O
well	O
as	O
heparin	O
and	O
Integrelin	O
and	O
remained	O
pain-free	B-disease
.	O

He	O
denied	O
any	O
history	O
of	O
similar	B-disease
symptoms	I-disease
in	O
the	O
past	O
and	O
has	O
had	O
no	O
prior	O
history	O
of	O
angina	B-disease
or	O
myocardial	B-disease
infarction	I-disease
.	O

The	O
patient	O
was	O
subsequently	O
transferred	O
to	O
Youville	O
Hospital	O
for	O
cardiac	O
catheterization	O
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
he	O
was	O
initially	O
admitted	O
to	O
the	O
CMI	O
Service	O
after	O
undergoing	O
cardiac	O
catheterization	O
which	O
revealed	O
a	B-disease
long	I-disease
LAD	I-disease
lesion	I-disease
that	O
was	O
angioplastied	O
without	O
stent	O
placement	O
,	O
and	O
a	B-disease
total	I-disease
occlusion	I-disease
of	I-disease
the	I-disease
RCA	I-disease
with	O
collaterals	O
.	O

He	O
subsequently	O
became	O
hypotensive	B-disease
and	O
bradycardiac	B-disease
in	O
the	O
Catheterization	O
Laboratory	O
which	O
responded	O
to	O
IV	O
fluids	O
,	O
dopamine	O
,	O
Atropine	O
,	O
and	O
he	O
was	O
then	O
transferred	O
to	O
the	O
CCU	O
for	O
further	O
monitoring	O
.	O

He	O
had	O
a	O
bedside	O
transthoracic	O
echocardiogram	O
done	O
in	O
the	O
Cardiac	O
Catheterization	O
laboratory	O
without	O
evidence	O
of	O
an	B-disease
effusion	I-disease
.	O

A	O
Swan	O
was	O
also	O
placed	O
.	O

There	O
were	O
no	O
stents	O
deployed	O
at	O
all	O
throughout	O
the	O
catheterization	O
.	O

By	O
the	O
time	O
he	O
was	O
admitted	O
,	O
he	O
was	O
off	O
pressors	O
and	O
hemodynamically	O
stable	O
and	O
pain-free	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

TIA	B-disease
in	O
1998	O
.	O

COPD	B-disease
with	O
2	O
liters	O
dependence	O
of	O
home	O
02	O
.	O

BPH	B-disease
.	O

Chronic	B-disease
renal	I-disease
insufficiency	I-disease
.	O

Gastritis	B-disease
.	O

Asthma	B-disease
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lis	O
currently	O
widowed	O
.	O

He	O
lives	O
in	O
senior	O
apartment	O
housing	O
in	O
Cambridge	O
on	O
the	O
second	O
floor	O
.	O

He	O
is	O
very	O
active	O
.	O

He	O
uses	O
a	O
cane	O
p.r.n.	O
for	O
walking	O
.	O

He	O
denied	O
any	O
falls	O
at	O
home	O
.	O

His	O
only	O
family	O
member	O
is	O
a	O
niece	O
in	O
Missouri	O
.	O

He	O
is	O
currently	O
retired	O
.	O

He	O
has	O
a	O
remote	O
tobacco	O
history	O
and	O
reports	O
occasional	O
alcohol	O
use	O
.	O

He	O
denied	O
any	O
other	O
drug	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Noncontributory	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Aspirin	O
325	O
mg	O
q.d.	O

2.	O
Metoprolol	O
50	O
mg	O
b.i.d.	O

3.	O
Lipitor	O
10	O
mg	O
q.d.	O

4.	O
MDI	O
p.r.n.	O

5.	O
Heparin	O
drip	O
on	O
transfer	O
.	O

6.	O
Integrelin	O
drip	O
on	O
transfer	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
:	O

Heart	O
rate	O
91	O
,	O
regular	O
,	O
blood	O
pressure	O
169/81	O
from	O
a	O
right	O
groin	O
A	O
line	O
,	O
respirations	O
12	O
,	O
oxygen	O
saturation	O
of	O
97	O
percent	O
on	O
2	O
liters	O
nasal	O
cannula	O
.	O

General	O
:	O

He	O
was	O
a	O
well	O
appearing	O
male	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

HEENT	O
:	O

Crusting	B-disease
around	I-disease
the	I-disease
right	I-disease
eyelid	I-disease
but	O
the	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

He	O
was	O
edentulous	B-disease
.	O

Neck	O
:	O

The	O
neck	O
was	O
supple	O
without	O
lymphadenopathy	B-disease
or	O
thyromegaly	B-disease
.	O

Cardiovascular	O
:	O

His	O
heart	O
was	O
regular	O
with	O
a	O
normal	O
S1	O
and	O
S2	O
.	O

He	O
had	O
no	O
murmurs	B-disease
,	O
rubs	B-disease
,	O
or	O
gallops	B-disease
.	O

Lungs	O
:	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
Anteriorly	O
and	O
laterally	O
.	O

Abdomen	O
:	O

Soft	O
,	O
obese	B-disease
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

He	O
had	O
normoactive	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

There	O
was	O
a	O
right	O
groin	O
A	O
line	O
and	O
a	O
left	O
groin	O
venous	O
sheath	O
with	O
a	O
Swan	O
.	O

He	O
had	O
no	O
evident	B-disease
edema	I-disease
.	O

He	O
had	O
2+	O
dorsalis	O
pedis	O
and	O
posterior	O
tibial	O
pulses	O
bilaterally	O
.	O

Neurologic	O
:	O

He	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
moving	O
all	O
extremities	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
,	O
the	O
CBC	O
revealed	O
a	O
white	O
count	O
of	O
7.4	O
,	O
hematocrit	O
39.7	O
,	O
and	O
platelets	O
of	O
217,000	O
.	O

Serum	O
chemistries	O
revealed	O
a	O
sodium	O
of	O
135,	O
potassium	O
4.0	O
,	O
chloride	O
102	O
,	O
bicarbonate	O
26	O
,	O
BUN	O
29	O
,	O
creatinine	O
1.6	O
,	O
and	O
glucose	O
of	O
111	O
.	O

The	O
initial	O
EKG	O
showed	O
normal	O
sinus	O
rhythm	O
at	O
a	O
rate	O
of	O
71	O
with	O
a	O
normal	O
axis	O
and	O
evidence	O
of	O
first-degree	B-disease
AV	I-disease
block	I-disease
with	O
prolonged	B-disease
PR	I-disease
interval	I-disease
of	O
238	O
milliseconds	O
.	O

He	O
also	O
had	O
a	B-disease
widened	I-disease
QRS	I-disease
of	O
153	O
milliseconds	O
,	O
an	B-disease
old	I-disease
right	I-disease
bundle	I-disease
branch	I-disease
block	I-disease
,	O
and	O
no	O
acute	B-disease
ST	I-disease
or	I-disease
T	I-disease
wave	I-disease
changes	I-disease
.	O

The	O
EKG	O
was	O
prior	O
to	O
catheterization	O
and	O
the	O
one	O
post	O
PTCA	O
was	O
no	O
different	O
.	O

He	O
had	O
a	O
bedside	O
echocardiogram	O
done	O
in	O
the	O
Catheterization	O
Laboratory	O
which	O
showed	O
normal	O
LV	O
wall	O
thickness	O
and	O
normal	O
LV	O
cavity	O
size	O
.	O

There	O
was	O
no	O
evidence	O
of	O
effusion	B-disease
.	O

It	O
was	O
difficult	O
to	O
assess	O
free	O
wall	O
motion	O
.	O

Cardiac	O
catheterization	O
revealed	O
a	B-disease
totally	I-disease
occluded	I-disease
RCA	I-disease
with	O
collaterals	O
,	O
an	B-disease
80	I-disease
percent	I-disease
LAD	I-disease
lesion	I-disease
extending	O
distally	O
which	O
was	O
angioplastied	O
but	O
no	O
stent	O
was	O
placed	O
.	O

Hemodynamics	O
:	O

The	O
right	O
heart	O
catheterization	O
revealed	O
pulmonary	O
capillary	O
wedge	O
pressure	O
of	O
4	O
,	O
cardiac	O
output	O
of	O
8	O
,	O
and	O
cardiac	O
index	O
of	O
3.8	O
,	O
he	O
had	O
an	O
RA	O
pressure	O
of	O
10	O
,	O
RV	O
pressure	O
of	O
43/4	O
,	O
PA	O
pressure	O
of	O
37/10	O
.	O

ASSESSMENT	O
:	O

This	O
is	O
an	O
82	O
-	O
year-old	O
male	O
with	O
a	O
history	O
of	O
prior	O
tobacco	O
use	O
,	O
hypertension	B-disease
,	O
chronic	B-disease
renal	I-disease
insufficiency	I-disease
,	O
COPD	B-disease
,	O
gastritis	B-disease
,	O
and	O
TIA	B-disease
who	O
initially	O
presented	O
to	O
Braintree	O
with	O
a	B-disease
non-ST	I-disease
elevation	I-disease
MI	I-disease
and	O
Guaiac	B-disease
positive	I-disease
stools	I-disease
,	O
transferred	O
to	O
St.	O
Margaret's	O
Center	O
for	O
Women	O
&	O
Infants	O
for	O
cardiac	O
catheterization	O
with	O
PTCA	O
to	O
mid	B-disease
LAD	I-disease
lesion	I-disease
complicated	O
by	O
hypotension	B-disease
and	O
bradycardia	B-disease
requiring	O
Atropine	O
,	O
IV	O
fluids	O
and	O
transient	O
dopamine	O
possibly	O
secondary	O
to	O
vagal	B-disease
reaction	I-disease
,	O
subsequently	O
transferred	O
to	O
CCU	O
for	O
close	O
monitoring	O
,	O
hemodynamically	O
stable	O
at	O
the	O
time	O
of	O
admission	O
to	O
the	O
CCU	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
CARDIOVASCULAR	O
:	O

As	O
summarized	O
above	O
,	O
the	O
patient	O
had	O
a	B-disease
non-ST	I-disease
elevation	I-disease
MI	I-disease
with	O
evidence	O
of	O
an	B-disease
80	I-disease
percent	I-disease
mid	I-disease
LAD	I-disease
lesion	I-disease
for	O
which	O
he	O
underwent	O
angioplasty	O
without	O
stent	O
placement	O
.	O

He	O
was	O
initially	O
continued	O
on	O
aspirin	O
,	O
Plavix	O
,	O
beta	O
blocker	O
,	O
statin	O
,	O
and	O
ACE	O
inhibitor	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
his	O
Plavix	O
was	O
held	O
due	O
to	O
Guaiac	B-disease
positive	I-disease
stools	I-disease
and	O
hematocrit	B-disease
drop	I-disease
throughout	O
admission	O
.	O

He	O
had	O
a	O
transthoracic	O
echocardiogram	O
the	O
day	O
after	O
admission	O
showing	O
an	O
ejection	O
fraction	O
of	O
greater	O
than	O
60	O
percent	O
.	O

No	O
focal	B-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
.	O

He	O
had	O
no	O
recurrent	B-disease
chest	I-disease
pain	I-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease
throughout	O
admission	O
.	O

In	O
regards	O
to	O
his	O
rhythm	O
,	O
he	O
has	O
an	B-disease
underlying	I-disease
right	I-disease
bundle	I-disease
branch	I-disease
block	I-disease
and	O
first-degree	B-disease
AV	I-disease
block	I-disease
which	O
were	O
stable	O
throughout	O
this	O
admission	O
.	O

He	O
will	O
be	O
followed-up	O
by	O
his	O
cardiologist	O
after	O
discharge	O
.	O

1.	O
PULMONARY	O
:	O

He	O
had	O
a	O
history	O
of	O
COPD	B-disease
for	O
which	O
he	O
is	O
on	O
baseline	O
2	O
liters	O
of	O
02	O
by	O
nasal	O
cannula	O
at	O
home	O
and	O
Albuterol	O
and	O
Atrovent	O
MDI	O
s	O
p.r.n.	O
at	O
home	O
.	O

He	O
is	O
also	O
on	O
Flovent	O
MDI	O
at	O
home	O
as	O
well	O
.	O

He	O
was	O
continued	O
on	O
his	O
MDI	O
and	O
was	O
at	O
his	B-disease
baseline	I-disease
02	I-disease
requirement	I-disease
throughout	O
admission	O
.	O

1.	O
RENAL	O
:	O

He	O
has	O
a	O
history	O
of	O
chronic	B-disease
renal	I-disease
insufficiency	I-disease
likely	O
secondary	O
to	O
hypertension	B-disease
and	O
was	O
admitted	O
with	O
a	O
creatinine	O
of	O
1.6	O
.	O

His	O
ACE	O
inhibitor	O
post	O
MI	B-disease
was	O
initially	O
held	O
due	O
to	O
his	O
creatinine	O
.	O

However	O
,	O
this	O
responded	O
to	O
IV	O
fluids	O
and	O
his	O
ACE	O
inhibitor	O
was	O
restarted	O
at	O
the	O
time	O
of	O
discharge	O
.	O

He	O
will	O
need	O
close	O
monitoring	O
of	O
his	O
creatinine	O
post	O
discharge	O
in	O
the	O
setting	O
of	O
reinstitution	O
of	O
his	O
ACE	O
inhibitor	O
.	O

1.	O
GASTROINTESTINAL	O
:	O

His	O
stools	O
were	O
noted	O
to	O
be	O
Guaiac	B-disease
positive	I-disease
at	O
the	O
outside	O
hospital	O
and	O
there	O
was	O
still	O
concern	O
for	O
possible	O
GI	B-disease
bleed	I-disease
given	O
continued	O
Guaiac	B-disease
positive	I-disease
stools	I-disease
during	O
this	O
admission	O
and	O
a	B-disease
slight	I-disease
drop	I-disease
in	I-disease
his	I-disease
hematocrit	I-disease
from	O
39	O
to	O
33	O
.	O

It	O
was	O
felt	O
most	O
appropriate	O
for	O
him	O
to	O
have	O
an	O
outpatient	O
GI	O
workup	O
,	O
and	O
his	O
PCP	O
was	O
contacted	O
and	O
will	O
arrange	O
for	O
outpatient	O
colonoscopy	O
.	O

His	O
Plavix	O
was	O
held	O
at	O
the	O
time	O
of	O
discharge	O
due	O
to	O
a	O
question	O
of	O
GI	B-disease
bleed	I-disease
and	O
in	O
the	O
setting	O
of	O
not	O
having	O
a	O
stent	O
placed	O
at	O
the	O
time	O
of	O
catheterization	O
.	O

He	O
was	O
continued	O
on	O
his	O
aspirin	O
,	O
however	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Coronary	B-disease
artery	I-disease
disease	I-disease
,	O
status	O
post	O
non-ST	B-disease
elevation	I-disease
myocardial	I-disease
infarction	I-disease
with	O
80	B-disease
percent	I-disease
mid	I-disease
LAD	I-disease
lesion	I-disease
,	O
now	O
status	O
post	O
angioplasty	O
.	O

Hypertension	B-disease
.	O

Chronic	B-disease
renal	I-disease
insufficiency	I-disease
.	O

Chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
.	O

Guaiac	B-disease
positive	I-disease
stools	I-disease
.	O

Anemia	B-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lipitor	O
10	O
mg	O
q.d.	O

2.	O
Lisinopril	O
2.5	O
mg	O
q.d.	O

3.	O
Flovent	O
110	O
micrograms	O
aerosol	O
two	O
puffs	O
b.i.d.	O

4.	O
Aspirin	O
325	O
mg	O
q.d.	O

5.	O
Combivent	O
MDI	O
p.r.n.	O

6.	O
Toprol	O
XL	O
100	O
mg	O
q.d.	O

DISPOSITION	O
:	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
's	O
vital	O
signs	O
were	O
stable	O
and	O
he	O
was	O
without	O
complaints	B-disease
.	O

DISCHARGE	O
STATUS	O
:	O

He	O
will	O
be	O
discharged	O
to	O
home	O
and	O
was	O
cleared	O
by	O
Physical	O
Therapy	O
.	O

FOLLOW	O
UP	O
:	O

He	O
has	O
been	O
scheduled	O
for	O
follow-up	O
with	O
Dr.	O
Martha	O
on	O
2015-03-25	O
at	O
11:00	O
a.m.	O

It	O
was	O
discussed	O
with	O
him	O
the	O
need	O
to	O
schedule	O
follow-up	O
for	O
colonoscopy	O
with	O
his	O
PCP	O
as	O
well	O
.	O

He	O
will	O
call	O
the	O
Cardiology	O
Division	O
at	O
Addison	O
Gilbert	O
Hospital	O
Greenfield	O
to	O
schedule	O
a	O
follow-up	O
with	O
his	O
cardiologist	O
there	O
within	O
the	O
next	O
week	O
.	O

Lucile	O
Minor	O
Etta	O
,	O
MD	O

12ADA	O

Dictated	O
By	O
:	O
Emily	O
M.	O
Cassidy	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-07-29	O
17:03:53	O

T	O
:	O
2015-07-29	O
22:08:30	O

Job	O
#:	O
81504	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Brenda	O
JM.	O
Espinosa	O
on	O
:	O
Maxine	O
2015-09-10	O
1:57	O
PM	O

(	O
End	O
of	O
Report	O
)	O

388755206	O
SC	O

28741969	O

9895112	O

12/1/2003	O
12:00:00	O
AM	O

s	O
/	O
p	O
cesarean	O

DIS	O

Admission	O
Date	O
:	O

12/01/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

12/06/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

STENOBE	O
,	O
LANDEM	O
847-02-84-0	O
J73	O

Room	O
:	O

GHA74-9086	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

12/06/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Attending	O
evaluation	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

CLOZPLU	O
,	O
A	O
A	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

COLACE	O
(	O
DOCUSATE	O
SODIUM	O
)	O
100	O
MG	O
PO	O
BID	O
IBUPROFEN	O
600	O
MG	O
PO	O
Q6H	O
PRN	O
PAIN	O
ALDOMET	O
(	O
METHYLDOPA	O
)	O
250	O
MG	O
PO	O
BID	O
PERCOCET	O
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	B-disease

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Your	O
obstetrician	O
6	O
weeks	O
,	O
No	O
Known	B-disease
Allergies	I-disease

ADMIT	O
DIAGNOSIS	O
:	O

s	O
/	O
p	O
cesarean	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
cesarean	O

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
s	O
/	O
p	O
cesarean	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	O
Vaginal	O
delivery	O
:	O

Undelivered	O
Cesarean	O
Status	O
:	O

Primary	O
Urgency	O
:	O

Emergent	O
Indications	O
:	O

Non-reassuring	B-disease
fetal	I-disease
status	I-disease
,	O
Uterine	O

incision	O
type	O
:	O

Transverse	O

Placenta	O
:	O

Delivery	O
:	O

Manual	O
Condition	O
:	O

Normal	O
Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

CLOZPLU	O
,	O
A	O
A	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

IV	O
ABX	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G9	O
T3	O
P0	O
A5	O
L3	O

Estimated	O
EDC	O
:	O

11/28/03	O

Indications	O
for	O
induction	O
:	O

Post	B-disease
dates	I-disease

Complications	O
of	O
labor	O
:	O

,	O
Other	O
-	O
bradycardia	B-disease

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-disease
abnormalities	I-disease

Baby	O
1	O

MRN	O
:	O

32859272	O

Delivery	O
date	O
:	O

12/02/03	O
03:20	O
PM	O
Apgars	O
7,8	O

Weight	O
:	O

9lb	O
15	O
oz	O
4508	O
grams	O

Sex	O
:	O

Male	O

ADDITIONAL	O
COMMENTS	O
:	O

no	O
heavy	O
lifting	O
;	O
nothing	O
in	O
the	O
vagina	O
for	O
6	O
weeks	O
--	O
no	O
intercourse	O
,	O
no	O
douching	O
,	O
no	O
tampons	O
;	O
call	O
for	O
fever	B-disease
above	I-disease
100.5	I-disease
,	O
worsening	B-disease
abdominal	I-disease
pain	I-disease
,	O
heavy	B-disease
bleeding	I-disease
,	O
or	O
any	B-disease
other	I-disease
concern	I-disease
;	O
no	O
driving	O
while	O
taking	O
percocet	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

HAXKOTE	O
,	O
A	O
N.	O
,	O
M.D.	O
(	O
ZL69	O
)	O
12/06/03	O
09:04	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

405868244	O
YC	O

70449076	O

5586564	O

11/16/2005	O
12:00:00	O
AM	O

POSTPARTUM	O

DIS	O

Admission	O
Date	O
:	O

11/16/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

11/19/2005	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

WARESIN	O
,	O
SAGAY	O
702-84-43-7	O
L06	O

Room	O
:	O

DBM62-8758	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

11/18/05	O
AT	O
02:00	O
PM	O

CONTINGENT	O
UPON	O

cnm	O
evaluation	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

OBSTETRICS	O
SERVICE	O
,	O
YC	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DOCUSATE	O
SODIUM	O
100	O
MG	O
PO	O
BID	O
PRN	O
Constipation	B-disease
IBUPROFEN	O
400-600	O
MG	O
PO	O
Q6H	O
PRN	O
Pain	B-disease

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
PRENATAL	O
MULTIVITAMINS	O
(	O
STUARTNATAL	O
)	O
1	O
TAB	O
PO	O
QD	O
MAALOX-TABLETS	O
QUICK	O
DISSOLVE	O
/	O
CHEWABLE	O
1-2	O
TAB	O
PO	O
Q6H	O
PRN	O
Upset	B-disease
Stomach	I-disease

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

BROOKSIDE	O
2	O
wks	O
,	O

ALLERGY	O
:	O

NKA	O
ADMIT	O
DIAGNOSIS	O
:	O

pregnancy	B-disease
,	I-disease
term	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

POSTPARTUM	O
OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
postpartum	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Vaginal	O
delivery	O
:	O

Spontaneous	O

Laceration	B-disease
:	O

Perineal	B-disease
,	I-disease
1st	I-disease
degree	I-disease

Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O

Condition	O
:	O

Normal	O

Certified	O
Nurse	O
Midwife	O
:	O

NEAD	O
,	O
MANERTNY	O
,	O
CNM	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

repair	O
of	O
first	B-disease
degree	I-disease
perineal	I-disease
laceration	I-disease

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G2	O
T1	O
P0	O
A0	O
L1	O
Estimated	O

EDC	O
:	O

12/02/05	O

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-disease
abnormalities	I-disease

Baby	O
1	O

MRN	O
:	O

26793023	O

Delivery	O
date	O
:	O

11/16/05	O
02:21	O
PM	O

Apgars	O
9,9	O

Weight	O
:	O

7lb	O
4.8	O
oz	O
3311	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

JESCCOT	O
,	O
LA	O
P.	O
,	O
C.N.M	O
(	O
YW8	O
)	O

11/17/05	O
08:24	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2013-12-24	O

Discharge	O
Date	O
:	O

2014-01-13	O

Date	O
of	O
Birth	O
:	O

1959-12-16	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Haldol	O
/	O
Compazine	O
/	O
Phenergan	O
/	O
Tigan	O
/	O
Flagyl	O

Attending	O
:	O
David	O
U.	O
Johnson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Chest	B-disease
Pain	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Removal	O
of	O
tunneled	O
cath	O
(	O
previously	O
used	O
for	O
tPN	O
)	O

History	O
of	O
Present	O
Illness	O
:	O

54	O
yo	O
F	O
with	O
Crohn	B-disease
's	I-disease
s/p	O
ileostomy	O
and	O
subsequent	O
short	B-disease
gut	I-disease
syndrome	I-disease
with	O
port-a-cath	O
placement	O
for	O
TPN	O
who	O
presents	O
with	O
progressive	B-disease
right	I-disease
sided	I-disease
chest	I-disease
pain	I-disease
that	O
comes	O
in	O
waves	O
.	O

The	O
pt	O
reports	O
sharp	B-disease
10/10	I-disease
chest	I-disease
pain	I-disease
under	I-disease
the	I-disease
right	I-disease
breast	I-disease
which	O
is	O
getting	O
progressively	O
worse	O
.	O

The	B-disease
pain	I-disease
is	O
worsened	O
with	O
deep	O
inspiration	O
or	O
movement	O
.	O

It	O
initially	O
started	O
one	O
day	O
previously	O
but	O
has	O
gotten	O
significantly	O
worse	O
over	O
last	O
12	O
hours	O
.	O

It	O
is	O
associated	O
with	O
SOB	B-disease
as	O
well	O
as	O
fevers	B-disease
,	O
chills	B-disease
.	O

The	O
pt	O
denies	O
abd	B-disease
pain	I-disease
,	O
n/v	B-disease
or	O
increased	B-disease
ostomy	I-disease
output	I-disease
.	O

Given	O
her	B-disease
fever	I-disease
,	O
sx	B-disease
of	I-disease
chest	I-disease
pain	I-disease
and	O
SOB	B-disease
as	O
well	O
as	O
an	B-disease
elevated	I-disease
WBC	I-disease
count	I-disease
,	O
she	O
was	O
initially	O
thought	O
to	O
have	O
a	B-disease
PNA	I-disease
.	O

She	O
was	O
therefore	O
given	O
ceftriaxone	O
1	O
g	O
IV	O
x1	O
and	O
azithromycin	O
500	O
mg	O
PO	O
x1	O
in	O
the	O
Deanna	O
.	O

As	O
the	O
CXR	O
was	O
without	O
any	O
evidence	O
of	O
PNA	B-disease
,	O
or	O
PTX	B-disease
,	O
the	O
pt	O
subsequently	O
received	O
a	O
CTA	O
to	O
evaluate	O
for	O
PE	B-disease
which	O
revealed	O
multifocal	B-disease
bilateral	I-disease
PNA	I-disease
but	O
no	O
PE	B-disease
.	O

At	O
this	O
time	O
,	O
she	O
was	O
given	O
Vancomycin	O
1	O
g	O
IV	O
x1	O
.	O

She	O
was	O
also	O
given	O
morphine	O
2	O
mg	O
x3	O
,	O
4	O
mg	O
IV	O
x2	O
,	O
dolasetron	O
12.5	O
mg	O
x2	O
and	O
ativan	O
1	O
mg	O
IV	O
x1	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Crohn	B-disease
's	I-disease
disease	I-disease
,	O
dx	O
1974	O
s/p	O
three	O
bowel	O
resections	O
and	O
eventual	O
ileostomy	O
,	O
resulting	O
in	O
short	B-disease
gut	I-disease
syndrome	I-disease

2.	O
Restless	B-disease
leg	I-disease
syndrome	I-disease

3.	O
?	O
Parkinsons	B-disease
vs.	O
EPS	B-disease
side	I-disease
effects	I-disease
from	O
risperdal	O

4.	O
Chronic	B-disease
idiopathic	I-disease
pancreatitis	I-disease
,	O
as	O
demonstrated	O
on	O
CT	O
in	O
09-01	O

5.	O
Arthritis	B-disease
s/p	O
"	O
pin	O
placement	O
"	O
in	O
left	O
foot	O
05-01	O

6.	O
Degenerative	B-disease
disc	I-disease
disease	I-disease
s/p	O
two	O
back	O
surgeries	O
in	O
80	O
's	O

7.	O
Benzo	O
and	O
opiod	O
addiction	O

8.	O
Paranoia	B-disease
/	O
Depression	B-disease
,	O
h/o	O
auditory	B-disease
hallucinations	I-disease
,	O
?	O
mania	B-disease

9.	O
Port-a-Cath	O
placement	O
for	O
IV	O
hydration	O
in	O
setting	O
of	O
short	B-disease
gut	I-disease
syndrome	I-disease
,	O
complicated	O
by	O
clotting	B-disease
x	O
4	O
,	O
requiring	O
replacement	O

Abd	O
CT	O
performed	O
09-01	O
showed	O
multiple	B-disease
calcifications	I-disease
in	I-disease
the	I-disease
body	I-disease
and	I-disease
tail	I-disease
of	I-disease
the	I-disease
pancreas	I-disease
with	O
a	B-disease
larger	I-disease
cystic	I-disease
lesion	I-disease
in	I-disease
the	I-disease
tail	I-disease
of	I-disease
the	I-disease
pancreas	I-disease
.	O

A	B-disease
second	I-disease
9	I-disease
mm	I-disease
cystic	I-disease
lesion	I-disease
is	O
seen	O
in	O
the	O
head	O
of	O
the	O
pancreas	O
.	O

These	O
findings	O
are	O
consistent	O
with	O
chronic	B-disease
pancreatitis	I-disease
with	O
pseudocyst	B-disease
formation	I-disease

Social	O
History:	O
lives	O
w/	O
her	O
husband	O
in	O
John	O
area	O
;	O
smokes	O
05-04	O
cig	O
/d	O
(	O
30	O
pack	O
year	O
history	O
);	O
no	O
alcohol	O
or	O
recreational	O
drug	O
use	O
,	O
has	O
had	O
addiction	O
to	O
benzodiazepines	O
and	O
opioids	O
in	O
the	O
past	O

Family	O
History	O
:	O

Mother-Crohn	B-disease
's	I-disease
;	O
Daugher-IBS	B-disease
,	O
colitis	B-disease
;	O
Mother	O
--	O
breast	B-disease
CA	I-disease
,;	O

Father	O
-	O
Stephanie	B-disease
tumor	I-disease
,	O
no	O
DM	B-disease
,	O
no	O
CAD	B-disease

Physical	O
Exam	O
:	O

V	O
:	O
101.4	O
,	O
102	O
,	O
167/54	O
->	O
159/77	O
,	O
24	O
->	O
16	O
,	O
98%	O
RA	O
->	O
96%	O
RA	O

Gen	O
:	O
middle	O
aged	O
obese	O
female	O
lying	O
in	O
bed	O
on	O
her	O
left	O
side	O
asleep	O
,	O
speaking	O
slowly	O
.	O

appears	O
younger	O
than	O
stated	O
age	O

HEENT	O
:	O
PERRL	O
,	O
OP	O
clear	O
,	O
MMM	O

CV	O
:	O
RRR	O
,	O
s1	O
,	O
s2	B-disease
distant	I-disease

Chest	O
:	O
crackles	B-disease
at	I-disease
right	I-disease
base	I-disease
with	O
dec.	B-disease
air	I-disease
movement	I-disease
.	O

tender	B-disease
over	I-disease
right	I-disease
chest	I-disease

Abd	O
:	O
obese	B-disease
,	O
multiple	B-disease
surgical	I-disease
scars	I-disease
.	O

Ileostomy	O
bag	O
present	O
with	O
gas	O
and	O
stool	O
.	O

absomen	O
soft	O
,	O
tender	B-disease
to	O
palpation	O
over	O
RUQ	O
,	O
but	O
no	O
guarding	B-disease
or	O
rebound	B-disease

Ext	O
:	O
tr	B-disease
edema	I-disease
,	O
2+	O
DP	O
bilaterally	O

Pertinent	O
Results	O
:	O

2013-12-24	O
01:30	O
AM	O

GLUCOSE	O
-	O
208	O
*	O
UREA	O
N	O
-	O
21	O
*	O
CREAT	O
-	O
1.3	O
*	O
SODIUM	O
-	O
138	O
POTASSIUM	O
-	O
4.2	O
CHLORIDE	O
-	O
104	O
TOTAL	O
CO2	O
-	O
23	O
ANION	O
GAP	O
-	O
15	O

2013-12-24	O
01:30	O
AM	O

CK	O
(	O
CPK	O
)-	O
31	O

2013-12-24	O
01:30	O
AM	O

cTropnT	O
-<	O
0.01	O

2013-12-24	O
01:30	O
AM	O

WBC	O
-	O
14.4	O
*#	O
RBC	O
-	O
3.82	O
*	O
HGB	O
-	O
11.5	O
*	O
HCT	O
-	O
33.5	O
*	O
MCV	O
-	O
88	O
MCH	O
-	O
30.2	O
MCHC	O
-	O
34.5	O
RDW	O
-	O
14.7	O

2013-12-24	O
01:30	O
AM	O

NEUTS	O
-	O
78.0	O
*	O
LYMPHS	O
-	O
17.0	O
*	O
MONOS	O
-	O
4.6	O
EOS	O
-	O
0.3	O
BASOS	O
-	O
0.1	O

2013-12-24	O
01:30	O
AM	O

PLT	O
COUNT	O
-	O
128	O
*	O

2013-12-24	O
01:30	O
AM	O

PT	O
-	O
12.3	O
PTT	O
-	O
26.1	O
INR	O
(	O
PT	O
)-	O
1.0	O

CTA	O
2013-12-24	O
-	O
IMPRESSION	O
:	O

1.	O
No	O
definite	B-disease
pulmonary	I-disease
embolism	I-disease
is	O
identified	O
.	O

2.	O
Peripheral	B-disease
patchy	I-disease
opacities	I-disease
are	O
seen	O
bilaterally	O
,	O
most	O
consistent	O
with	O
multifocal	B-disease
pneumonia	I-disease
.	O

CXR	O
2013-12-24	O
-	O
There	O
are	O
faint	B-disease
ill-defined	I-disease
opacities	I-disease
within	O
the	O
right	O
lower	O
lung	O
zone	O
and	O
left	O
upper	O
lung	O
zone	O
could	O
represent	O
a	B-disease
multifocal	I-disease
pneumonic	I-disease
process	I-disease
.	O

CXR	O
2014-01-02	O
-	O
IMPRESSION	O
:	O

Multilobar	B-disease
pneumonia	I-disease
with	O
interval	B-disease
worsening	I-disease
in	I-disease
the	I-disease
left	I-disease
lung	I-disease
but	O
slight	O
improvement	O
in	O
the	O
right	O
lower	O
lobe	O
.	O

Head	O
CT	O
2014-01-09	O
-	O
Ordered	O
to	O
evaluate	O
for	O
changes	O
to	O
explain	O
delta	B-disease
MS	I-disease

CONCLUSION	O
:	O

Left	B-disease
parietal	I-disease
subcortical	I-disease
hypodensity	I-disease
,	O
likely	O
ischemic	B-disease
.	O

No	O
definite	B-disease
changes	I-disease
since	O
the	O
MR	O
of	O
in	O
2011-05-15	O
.	O

CXR	O
2014-01-09	O

IMPRESSION	O
:	O

Marked	O
improvement	O
.	O

Brief	O
Hospital	O
Course	O
:	O

54	O
yo	O
F	O
with	O
Crohn	B-disease
's	I-disease
disease	I-disease
s/p	O
ileostomy	O
with	O
subsequent	O
short	B-disease
gut	I-disease
syndrome	I-disease
with	O
port-o-cath	O
for	O
TPN	O
presents	O
with	O
acute	B-disease
onset	I-disease
pleuritic	I-disease
chest	I-disease
pain	I-disease
with	O
fever	B-disease
,	O
chills	B-disease
,	O
and	O
sob	B-disease
.	O

1.	O
Chest	B-disease
pain	I-disease
/	O
Fever	B-disease
/	O
Chills	B-disease
:	O

The	B-disease
acute	I-disease
onset	I-disease
of	I-disease
chest	I-disease
pain	I-disease
was	O
initially	O
very	O
concerning	O
for	O
a	B-disease
PE	I-disease
,	O
however	O
the	O
Chest	O
CT	O
demonstrated	O
multifocal	B-disease
consolidation	I-disease
consistent	O
with	O
a	B-disease
bacterial	I-disease
PNA	I-disease
.	O

This	O
is	O
consistent	O
with	O
the	O
remainder	O
of	O
the	O
pt	O
's	O
history	O
including	O
fever	B-disease
,	O
chills	B-disease
,	O
sob	B-disease
and	O
an	B-disease
elevated	I-disease
WBC	I-disease
count	I-disease
.	O

The	O
pt	O
was	O
given	O
ceftriaxone	O
/	O
azithromycin	O
/	O
vancomycin	O
in	O
Deanna	O
.	O

Blood	O
,	O
urine	O
and	O
sputum	O
culutres	O
were	O
sent	O
.	O

Pt	O
's	O
blood	O
cultures	O
came	O
back	O
positive	O
for	O
Staph	B-disease
Aureus	I-disease
and	O
Enterococcus	B-disease
,	O
both	O
were	O
pansensitive	O
.	O

Sputum	O
culture	O
also	O
returned	O
with	O
Staph.	B-disease
Aureus	I-disease
.	O

Ceftriaxone	O
and	O
azithro	O
were	O
discontinued	O
,	O
and	O
Vacomycin	O
was	O
continued	O
.	O

Pt	O
initially	O
was	O
hypoxic	B-disease
requiring	O
NRB	O
for	O
O2	O
sat	O
of	O
94%	O
,	O
with	O
any	O
attempt	O
to	O
wean	O
she	O
would	O
desat	O
.	O

Pt	O
was	O
intubated	O
prior	O
to	O
tunneled	O
catheter	O
removal	O
,	O
see	O
below	O
.	O

(	O
The	O
tunneled	O
catheter	O
later	O
came	O
back	O
for	O
negative	O
for	O
culture.	O
)	O

Earlier	O
that	O
day	O
pt	O
had	O
a	O
chest	O
x	O
ray	O
which	O
showed	O
diffuse	B-disease
infiltrative	I-disease
process	I-disease
concerning	O
for	O
ARDS	B-disease
.	O

Post	O
procedure	O
pt	O
remained	O
intubated	O
on	O
ARDSnet	O
protocol	O
.	O

She	O
self	O
extubated	O
the	O
first	O
day	O
and	O
was	O
reintubated	O
without	O
any	B-disease
complications	I-disease
.	O

Her	B-disease
O2	I-disease
requirement	I-disease
improved	O
on	O
the	O
vent	O
over	O
the	O
next	O
few	O
days	O
and	O
she	O
was	O
weaned	O
off	O
the	O
vent	O
on	O
2013-01-01	O
.	O

After	O
extubation	O
her	B-disease
o2	I-disease
requirement	I-disease
was	O
down	O
to	O
1L	O
NC	O
with	O
sats	O
in	O
mid	O
90s	O
.	O

She	O
was	O
transferred	O
to	O
the	O
floor	O
for	O
further	O
managment	O
.	O

The	O
patient	O
remained	O
afebrile	B-disease
when	O
she	O
transferred	O
to	O
the	O
medicine	O
service	O
.	O

She	O
was	O
weaned	O
off	O
the	O
oxygen	O
and	O
for	O
the	O
remainder	O
of	O
her	O
course	O
her	O
O2sats	O
were	O
stable	O
on	O
room	O
air	O
.	O

The	O
patient	O
had	O
completed	O
her	O
antibiotic	O
course	O
while	O
in	O
house	O
.	O

2.	O
Hx	O
of	O
multiple	B-disease
port-o-cath	I-disease
clots	I-disease
:	O

Although	O
the	O
pt	O
is	O
on	O
warfarin	O
chronically	O
,	O
her	O
INR	O
was	O
subtherapeutic	O
.	O

Goal	O
INR	O
01-31	O
.	O

Initially	O
coumadin	O
was	O
increased	O
,	O
however	O
given	O
concern	O
for	O
infected	B-disease
line	I-disease
,	O
general	O
surgery	O
was	O
consulted	O
who	O
removed	O
the	O
line	O
in	O
the	O
ICU	O
.	O

3.	O
ARF	B-disease
:	O

Pt	O
initially	O
with	O
mild	B-disease
ARI	I-disease
,	O
this	O
was	O
thought	O
to	O
be	O
due	O
to	O
dehydration	B-disease
,	O
after	O
initial	O
volume	O
repletion	O
her	O
renal	O
function	O
improved	O
to	O
her	O
baseline	O
.	O

4.	O
CMED	O
:	O

The	O
pt	O
has	O
a	O
history	O
of	O
paranoia	B-disease
/	O
depression	B-disease
.	O

ON	O
admission	O
she	O
was	O
taking	O
Quetiapine	O
300	O
mg	O
QHS	O
and	O
Clonazepam	O
1	O
mg	O
QAM	O
,	O
1	O
mg	O
Q3PM	O
,	O
2	O
mg	O
PO	O
QHS	O
.	O

Quetiapine	O
was	O
continued	O
however	O
clonipin	O
was	O
initially	O
held	O
when	O
she	O
was	O
intubated	O
on	O
fentynyl	O
/	O
versed	O
.	O

This	O
was	O
restarted	O
post	O
extubation	O
.	O

Intially	O
after	O
being	O
transferred	O
from	O
the	O
ICU	O
to	O
the	O
medicine	O
service	O
the	O
patient	O
was	O
mentating	O
appropriately	O
.	O

Her	O
course	O
later	O
became	O
complicated	O
by	O
visual	B-disease
and	I-disease
auditory	I-disease
hallucinations	I-disease
.	O

She	O
made	O
disturbing	O
comments	O
to	O
the	O
hospital	O
personnel	O
.	O

She	O
was	O
unable	B-disease
to	I-disease
sleep	I-disease
at	O
night	O
,	O
often	O
pacing	O
the	O
halls	O
.	O

She	O
required	O
a	O
1:1	O
sitter	O
.	O

Psychiatry	O
was	O
consulted	O
.	O

They	O
felt	O
that	O
her	O
presentation	O
was	O
secondary	O
to	O
delirium	B-disease
and	O
was	O
multifactorial	O
.	O

They	O
attributed	O
it	O
to	O
polypharmacy	B-disease
,	O
recent	B-disease
infection	I-disease
(	I-disease
pneumonia	I-disease
)	I-disease
and	O
insomnia	B-disease
.	O

A	O
head	O
CT	O
was	O
done	O
which	O
ruled	O
out	O
any	B-disease
acute	I-disease
processes	I-disease
.	O

The	O
patient	O
refused	O
an	O
LP	O
.	O

They	O
made	O
recommendations	O
for	O
adjustments	O
to	O
her	O
anti-psychotic	O
medications	O
.	O

At	O
discharge	O
the	O
patient	O
was	O
on	O
clonazepam	O
1	O
mg	O
tid	O
,	O
seroquel	O
300	O
BID	O
and	O
neurontin	O
600	O
QAM	O
,	O
1200	O
QPM	O
and	O
1200	O
QHS	O
.	O

The	O
Kindred	O
Hospital	O
hospital	O
course	O
was	O
prolonged	O
because	O
of	O
her	B-disease
delirium	I-disease
.	O

Once	O
her	O
mental	O
status	O
improved	O
she	O
was	O
discharged	O
.	O

5.	O
?	O
Parkinson	B-disease
's	I-disease
Disease	I-disease
/	O
Akithesia	B-disease
:	O

The	O
patient	O
was	O
maintained	O
Sinemet	O
.	O

6.	O
Pain	B-disease
:	O

In	O
addition	O
to	O
her	B-disease
usual	I-disease
neuropathy	I-disease
pain	I-disease
,	O
the	O
pt	O
initially	O
appeared	O
to	O
have	O
significant	B-disease
pain	I-disease
from	O
the	B-disease
multi-focal	I-disease
PNA	I-disease
as	O
well	O
.	O

(	O
Home	O
regimen	O
,	O
Gabapentin	O
800	O
mg	O
PO	O
QAM	O
,	O
1600	O
mg	O
PO	O
Q3PM	O
,	O
1600	O
mg	O
PO	O
QHS	O
.	O

This	O
was	O
held	O
in	O
the	O
ICU	O
and	O
she	O
was	O
given	O
diluadid	O
prn	O
for	O
pain	O
control	O
.	O

The	O
patient	O
's	O
narcotic	O
and	O
CMED	O
CCU	O
regimen	O
was	O
evaluated	O
by	O
psychiatry	O
during	O
her	B-disease
delirium	I-disease
.	O

Please	O
see	O
above	O
for	O
their	O
recommendations	O
.	O

7.	O
FEN	O
:	O

Given	O
her	O
hx	O
of	O
ileostomy	O
secondary	O
to	O
crohn	B-disease
's	I-disease
disease	I-disease
and	O
resultant	O
short	B-disease
gut	I-disease
syndrome	I-disease
,	O
the	O
pt	O
requires	O
nutritional	O
support	O
via	O
TPN	O
.	O

After	O
removal	O
of	O
tunneled	O
line	O
pt	O
was	O
given	O
tube	O
feeds	O
while	O
she	O
was	O
intubated	O
.	O

The	O
patient	O
was	O
transitioned	O
to	O
a	O
low	O
fat	O
,	O
low	O
residue	O
diet	O
.	O

8	O
.	O

PPX	O
:	O
PPI	O
and	O
heparin	O
SC	O

9.	O
Dispo	O
:	O

The	O
patient	O
was	O
discharged	O
home	O
and	O
instructed	O
to	O
follow	O
up	O
with	O
her	O
PCP	O
.	O

Louis	O
follow	O
up	O
scheduled	O
with	O
psychiatry	O
.	O

Medications	O
on	O
Admission	O
:	O

1.	O
Quetiapine	O
300	O
mg	O
QHS	O

2.	O
Clonazepam	O
1	O
mg	O
QAM	O
,	O
1	O
mg	O
Q3PM	O
,	O
2	O
mg	O
PO	O
QHS	O

3.	O
Ferrous	O
Sulfate	O
325	O
PO	O
Daily	O

4.	O
Carbidopa-Levodopa	O
25-250	O
mg	O
PO	O
5	O
TIMES	O
PER	O
DAY	O
.	O

5.	O
Gabapentin	O
800	O
mg	O
PO	O
QAM	O
,	O
1600	O
mg	O
PO	O
Q3PM	O
,	O
1600	O
mg	O
PO	O
QHS	O

6.	O
Heparin	O
Lock	O
Flush	O
10	O
unit	O
/	O
mL	O
Daily	O
as	O
needed	O
.	O

7.	O
Saline	O
Flush	O

8.	O
Prevacid	O
30	O
mg	O
PO	O
twice	O
a	O
day	O
.	O

9.	O
Vistaril	O
50	O
mg	O
once	O
a	O
day	O
as	O
needed	O
for	O
nausea	B-disease
.	O

10.	O
Zofran	O
4	O
mg	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
nausea	B-disease
.	O

11.	O
Vitamin	O
B-12	O
1,000	O
mcg	O
/	O
mL	O
One	O
Injection	O
every	O
other	O
week	O
.	O

12.	O
Vicodin	O
5-500	O
mg	O
1-2	O
Tablets	O
PO	O
every	O
six	O
(	O
6	O
)	O
hours	O
PRN	O

13.	O
Warfarin	O
1	O
mg	O
PO	O
HS	O
.	O

14.	O
TPN	O

Discharge	O
Medications	O
:	O

1.	O
Amylase-Lipase-Protease	O
33,200	O
-	O
10,000	O
-	O
37,500	O
unit	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Four	O
(	O
4	O
)	O
Cap	O
PO	O
W/	O
MEALS	O
AND	O
SNACKS	O
(	O
)	O
.	O

Disp	O
:*	O
120	O
Cap	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Carbidopa-Levodopa	O
25	O
-	O
250	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
5	O
TIMES	O
A	O
DAY	O
(	O
)	O
.	O

Disp	O
:*	O
150	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Pramipexole	O
0.125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
90	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Clonazepam	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
90	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Ferrous	O
Sulfate	O
300	O
mg	O
/	O
5	O
mL	O
Liquid	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
5	O
bottles	O
*	O
Refills	O
:*	O
2	O
*	O

6.	O
Nystatin	O
100,000	O
unit	O
/	O
g	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
3	O
tubes	O
*	O
Refills	O
:*	O
2	O
*	O

7.	O
Lansoprazole	O
30	O
mg	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Quetiapine	O
100	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
180	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Propranolol	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Neurontin	O
300	O
mg	O
Capsule	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Capsule	O
PO	O
three	O
times	O
a	O
day	O
:	O
take	O
2	O
tabs	O
in	O
the	O
morining	O
,	O
4	O
tabs	O
in	O
the	O
afternoon	O
,	O
and	O
4	O
tabs	O
in	O
the	O
evening	O
.	O

Disp	O
:*	O
100	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Pneumonia	B-disease

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

You	O
are	O
to	O
return	O
to	O
the	O
hospital	O
immediately	O
if	O
you	O
should	O
experience	O
any	B-disease
chest	I-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
fevers	B-disease
or	O
any	B-disease
other	I-disease
worrisome	I-disease
symptom	I-disease
.	O

Please	O
continue	O
taking	O
your	O
medications	O
as	O
prescribed	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O

Joyce	O
,	O
Catherine	O
PSYCHIATRY	O
CMED	O
CSRU	O
Phone	O
:(	O
405	O
)	O
582-6811	O

Date	O
/	O
Time	O
:	O
2014-01-21	O
3:30	O

Please	O
followup	O
with	O
your	O
primary	O
care	O
physician	O
Todd	O
12-30	O
weeks	O
of	O
discharge	O
.	O

Donna	O
Mcguire	O
MD	O
19-274	O

Completed	O
by	O
:	O

Mark	O
Joseph	O
MD	O
04-104	O
2014-05-18	O
@	O
2128	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Donna	O
Nance	O
on	O
:	O
WED	O
2014-06-04	O
2:21	O
PM	O

(	O
End	O
of	O
Report	O
)	O

574700124	O
RWH	O

0587585	O

896338	O

996098	O

11/26/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

CHAFFBITZ	O
,	O
TESSMONDMARV	O

MRN	O
:	O

0587585	O

Age	O
:	O

26y	O

REGISTRATION	O
DATE	O
:	O

11/26/2000	O
06:47	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
CHAFFBITZ	O
,	O
TESSMONDMARV	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
11/26/2000	O
06:47	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
ABD	B-disease
PAIN	I-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
TREATED	O
AND	O
RELEASED	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

Admission	O
Date	O
:	O

2019-06-14	O

Discharge	O
Date	O
:	O

2019-06-19	O

Date	O
of	O
Birth	O
:	O

1968-01-21	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	O
Drugs	O

Attending	O
:	O
Michael	O
A.E.	O
Adkins	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	B-disease
of	I-disease
breath	I-disease
,	O
fever	B-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Mcelveen	O
is	O
a	O
51	O
year-old	O
male	O
with	O
metastatic	B-disease
RCC	I-disease
status	O
post	O
left	O
radical	O
nephrectomy	O
in	O
2018-03-21	O
,	O
status	O
post	O
Avastin	O
and	O
sorafenib	O
,	O
most	O
recently	O
on	O
Sutent	O
monotherapy	O
since	O
2018-12-21	O
,	O
with	O
mild	B-disease
renal	I-disease
insufficiency	I-disease
,	O
who	O
presented	O
from	O
home	O
on	O
2019-06-14	O
with	O
shortness	B-disease
of	I-disease
breath	I-disease
and	O
fever	B-disease
.	O

Of	O
note	O
,	O
he	O
was	O
hospitalized	O
at	O
Dana-Farber	O
Cancer	O
Institute	O
from	O
9/25-10/6	O
with	O
chest	B-disease
pain	I-disease
,	O
at	O
which	O
time	O
he	O
reportedly	O
had	O
cardiac	O
enzymes	O
,	O
an	O
echocardiogram	O
and	O
a	O
pharmacological	O
stress	O
test	O
performed	O
.	O

It	O
is	O
unclear	O
from	O
history	O
what	O
these	O
studies	O
revealed	O
.	O

He	O
reports	O
that	O
he	O
felt	O
fatigued	B-disease
during	O
the	O
week	O
prior	O
to	O
the	O
current	O
admission	O
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
he	O
felt	O
"	O
congested	B-disease
"	O
in	O
his	O
chest	O
,	O
and	O
had	O
a	B-disease
new	I-disease
fever	I-disease
.	O

He	O
was	O
taken	O
to	O
the	O
Deanna	O
by	O
his	O
wife	O
.	O

Patrick	O
reports	O
a	B-disease
mild	I-disease
cough	I-disease
for	O
2	O
days	O
PTA	O
,	O
non-productive	B-disease
.	O

He	O
denies	O
a	O
history	O
of	O
aspiration	B-disease
events	I-disease
or	O
choking	B-disease
with	O
food	O
intake	O
.	O

He	O
describes	O
mild	B-disease
reflux	I-disease
symptoms	I-disease
at	O
night	O
.	O

Further	O
ROS	O
reveals	O
mild	B-disease
SOB	I-disease
in	O
the	O
days	O
preceding	O
admission	O
,	O
but	O
he	O
tells	O
me	O
that	O
he	O
was	O
surprised	O
to	O
find	O
out	O
about	O
his	B-disease
low	I-disease
oxygen	I-disease
saturation	I-disease
because	O
he	O
did	O
not	O
feel	O
that	O
bad	O
.	O

He	O
denies	O
chills	B-disease
,	O
no	O
chest	B-disease
pain	I-disease
,	O
no	O
LE	B-disease
swelling	I-disease
.	O

In	O
the	O
Deanna	O
,	O
Tmax	O
102.8	O
,	O
BP	O
100	O
-	O
140/60	O
s,	O
HR	O
80	O
s,	O
RR	O
20	O
s,	O
Sat	O
75%	O
on	O
RA	O
in	O
triage	O
,	O
up	O
to	O
100%	O
on	O
NRB	O
.	O

CXR	O
with	O
bibasilar	B-disease
consolidations	I-disease
.	O

He	O
was	O
given	O
Levo	O
750	O
mg	O
PO	O
X1	O
,	O
and	O
Flagyl	O
500	O
mg	O
PO	O
X1	O
.	O

His	O
BP	O
decreased	O
to	O
100	O
systolic	O
despite	O
hydration	O
with	O
2L	O
of	O
NS	O
.	O

He	O
was	O
subsquently	O
admitted	O
to	O
the	O
ICU	O
for	O
further	O
care	O
.	O

He	O
was	O
placed	O
on	O
Levo	O
and	O
Ceftriaxone	O
.	O

A	O
cosyntropin	O
stimulation	O
test	O
revealed	O
cortisol	O
32.1	O
-->	O
36.4	O
.	O

His	B-disease
oxygen	I-disease
requirement	I-disease
decreased	O
,	O
and	O
his	O
overall	O
status	O
improved	O
quickly	O
.	O

He	O
is	O
being	O
transferred	O
to	O
the	O
floor	O
for	O
ongoing	O
care	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Metastatic	B-disease
renal	I-disease
cell	I-disease
carcinoma	I-disease
,	O
diagnosed	O
in	O
2018-03-21	O
,	O
status	O
post	O
left	O
radical	O
nephrectomy	O
at	O
St.	O
Margaret's	O
Center	O
for	O
Women	O
&	O
Infants	O
in	O
03/2006	O
.	O

Path	O
consistent	O
with	O
renal	B-disease
cell	I-disease
carcinoma	I-disease
of	I-disease
chromophobe	I-disease
type	I-disease
with	O
Carter	B-disease
nuclear	I-disease
grade	I-disease
of	O
4/4	O
.	O

Lymphovascular	B-disease
invasion	I-disease
was	O
present	O
.	O

He	O
later	O
presented	O
with	O
increasing	B-disease
back	I-disease
pain	I-disease
,	O
and	O
metastatic	B-disease
disease	I-disease
was	O
documented	O
.	O

He	O
is	O
status	O
post	O
Avastin	O
plus	O
sorafenib	O
,	O
protocol	O
#04-393	O
,	O
discontinued	O
in	O
the	O
setting	O
of	O

ongoing	B-disease
grade	I-disease
III	I-disease
rash	I-disease
,	O
involving	O
the	O
hands	O
and	O
feet	O
in	O
addition	O
proteinuria	B-disease
secondary	O
to	O
the	O
Avastin	O
.	O

He	O
has	O
been	O
maintained	O
on	O
single	O
Timlin	O
therapy	O
with	O
Sutent	O
50	O
mg	O
daily	O
as	O
of	O
2018-12-21	O
and	O
has	O
completed	O
nearly	O
6	O
cycles	O
.	O

He	O
has	O
mild	B-disease
renal	I-disease
insufficiency	I-disease
in	O
the	O
setting	O
of	O
Sutent	O
.	O

2.	O
Seasonal	B-disease
allergies	I-disease

Social	O
History	O
:	O

He	O
lives	O
at	O
home	O
with	O
his	O
wife	O
and	O
son	O
,	O
who	O
is	O
7	O
years	O
old	O
.	O

He	O
works	O
in	O
real	O
estate	O
development	O
and	O
invests	O
in	O
stockmarket	O
.	O

HE	O
is	O
a	O
lifelong	O
non-smoker	O
.	O

Family	O
History	O
:	O

Not	O
reviewed	O
with	O
patient	O
.	O

Physical	O
Exam	O
:	O

VITALS	O
:	O
T	O
96.9	O
,	O
BP	O
110/70	O
,	O
HR	O
84	O
,	O
RR	O
20	O
,	O
Sat	O
97%	O
on	O
4L	O
.	O

GEN	O
:	O
In	O
NAD	B-disease
.	O

HEENT	O
:	O
Flushed	B-disease
cheeks	I-disease
.	O

Slightly	B-disease
dry	I-disease
MM	I-disease
.	O

NECK	O
:	O
JVP	O
not	O
elevated	B-disease
.	O

RESP	O
:	O
Decreased	B-disease
air	I-disease
entry	I-disease
and	O
crackles	B-disease
at	I-disease
both	I-disease
lung	I-disease
bases	I-disease
.	O

+	O
Egophony	B-disease
.	O

CVS	O
:	O
RRR	O
.	O
Normal	O
S1	O
,	O
S2	O
.	O

No	O
S3	B-disease
,	O
S4	B-disease
.	O

No	O
murmur	B-disease
or	O
rub	B-disease
.	O

GI	O
:	O
BS	O
NA	O
.	O

Abdomen	O
soft	O
and	O
non-tender	B-disease
.	O

EXT	O
:	O
Without	O
edema	B-disease
.	O

Good	O
pedal	O
pulses	O
.	O

Pertinent	O
Results	O
:	O

Laboratory	O
results	O
:	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
WBC	O
-	O
8.0	O
RBC	O
-	O
4.22	O
*	O
Hgb	O
-	O
12.9	O
*	O
Hct	O
-	O
41.7	O
MCV	O
-	O
99	O
*	O
MCH	O
-	O
30.5	O
MCHC	O
-	O
30.8	O
*	O
RDW	O
-	O
16.8	O
*	O
Plt	O
Ct	O
-	O
797	O
*#	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
WBC	O
-	O
11.1	O
*	O
RBC	O
-	O
3.47	O
*	O
Hgb	O
-	O
10.9	O
*	O
Hct	O
-	O
34.1	O
*	O
MCV	O
-	O
98	O
MCH	O
-	O
31.3	O
MCHC	O
-	O
31.9	O
RDW	O
-	O
16.7	O
*	O
Plt	O
Ct	O
-	O
604	O
*	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
PT	O
-	O
11.2	O
PTT	O
-	O
23.9	O
INR(PT)	O
-	O
0.9	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
Plt	O
Ct	O
-	O
797	O
*#	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
Glucose	O
-	O
134	O
*	O
UreaN	O
-	O
39	O
*	O
Creat	O
-	O
2.1	O
*	O
Na	O
-	O
133	O
K	O
-	O
7.9	O
*	O
Cl	O
-	O
94	O
*	O
HCO3	O
-	O
28	O
AnGap	O
-	O
19	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Glucose	O
-	O
73	O
UreaN	O
-	O
20	O
Creat	O
-	O
1.1	O
Na	O
-	O
136	O
K	O
-	O
5.0	O
Cl	O
-	O
101	O
HCO3	O
-	O
27	O
AnGap	O
-	O
13	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
ALT	O
-	O
34	O
AST	O
-	O
167	O
*	O
CK(CPK)	O
-	O
313	O
*	O
AlkPhos	O
-	O
383	O
*	O
Amylase	O
-	O
44	O
TotBili	O
-	O
0.7	O

2019-06-14	O
06:03	O
PM	O
BLOOD	O
CK(CPK)	O
-	O
194	O
*	O

2019-06-14	O
10:30	O
AM	O
BLOOD	O
CK-MB	O
-	O
3	O
cTropnT	O
-	O
0.05	O
*	O

2019-06-14	O
06:03	O
PM	O
BLOOD	O
CK-MB	O
-4	O
cTropnT	O
-	O
0.03	O
*	O

2019-06-17	O
05:30	O
AM	O
BLOOD	O
proBNP	O
-	O
258	O
*	O

2019-06-14	O
06:03	O
PM	O
BLOOD	O
Calcium	O
-	O
8.3	O
*	O
Phos	O
-	O
4.3	O
Mg	O
-	O
1.9	O

2019-06-18	O
07:55	O
AM	O
BLOOD	O
calTIBC	O
-	O
229	O
Ferritn	O
-	O
GREATER	O
TH	O
TRF	O
-	O
176	O
*	O

2019-06-16	O
07:35	O
AM	O
BLOOD	O
TSH	O
-	O
43	O
*	O

2019-06-16	O
07:35	O
AM	O
BLOOD	O
Free	O
T4	O
-	O
0.36	O
*	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
WBC	O
-	O
11.1	O
*	O
RBC	O
-	O
3.47	O
*	O
Hgb	O
-	O
10.9	O
*	O
Hct	O
-	O
34.1	O
*	O
MCV	O
-	O
98	O
MCH	O
-	O
31.3	O
MCHC	O
-	O
31.9	O
RDW	O
-	O
16.7	O
*	O
Plt	O
Ct	O
-	O
604	O
*	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Neuts	O
-	O
77.0	O
*	O
Bands	O
-	O
5.0	O
Lymphs	O
-	O
11.0	O
*	O
Monos	O
-	O
3.0	O
Eos	O
-	O
0	O
Baso	O
-	O
0	O
Atyps	O
-	O
1.0	O
*	O
Metas	O
-	O
2.0	O
*	O
Myelos	O
-	O
1.0	O
*	O

2019-06-18	O
07:55	O
AM	O
BLOOD	O
PT	O
-	O
11.5	O
INR(PT)	O
-	O
1.0	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Glucose	O
-	O
73	O
UreaN	O
-	O
20	O
Creat	O
-	O
1.1	O
Na	O
-	O
136	O
K	O
-	O
5.0	O
Cl	O
-	O
101	O
HCO3	O
-	O
27	O
AnGap	O
-	O
13	O

2019-06-19	O
07:20	O
AM	O
BLOOD	O
Calcium	O
-	O
8.0	O
*	O
Phos	O
-	O
3.3	O
Mg	O
-	O
2.0	O

Relevant	O
Imaging	O
:	O

1)	O
Bilateral	O
LE	O
doppler	O
(	O
06-14	O
):	O
No	O
evidence	O
of	O
deep	B-disease
venous	I-disease
thrombosis	I-disease
in	I-disease
the	I-disease
lower	I-disease
extremities	I-disease
bilaterally	I-disease
.	O

2)	O
Cxray	O
(	O
06-14	O
):	O
New	B-disease
bibasilar	I-disease
consolidations	I-disease
are	O
demonstrated	O
accompanied	O
by	O
bilateral	B-disease
small	I-disease
pleural	I-disease
effusion	I-disease
.	O

The	O
lung	O
volumes	O
are	O
slightly	B-disease
increased	I-disease
.	O

There	O
is	O
no	O
pneumothorax	B-disease
identified	O
.	O

3)	O
CT	O
Torso	O
(	O
06-17	O
):	O

1.	O
Marked	B-disease
interval	I-disease
enlargement	I-disease
of	I-disease
the	I-disease
cardiac	I-disease
silhouette	I-disease
.	O

Together	O
with	O
the	O
interval	O
development	O
of	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
,	O
this	O
indicates	O
cardiac	B-disease
insufficiency	I-disease
(	O
or	O
alternatively	O
volume	B-disease
overload	I-disease
)	O
and	O
an	O
echocardiogram	O
may	O
be	O
indicated	O
for	O
further	O
evaluation	O
.	O

2.	O
Bilateral	B-disease
basilar	I-disease
compressive	I-disease
atelectasis	I-disease
.	O

Superimposed	B-disease
infectious	I-disease
consolidation	I-disease
is	O
likely	O
.	O

3.	O
Interval	O
development	O
of	O
tree-in-Eric	B-disease
nodular	I-disease
opacities	I-disease
and	O
scattered	B-disease
ground	I-disease
glass	I-disease
opacities	I-disease
involving	I-disease
the	I-disease
right	I-disease
lung	I-disease
,	O
concerning	O
for	O
an	B-disease
infectious	I-disease
process	I-disease
.	O

The	O
differential	O
diagnosis	O
of	O
this	O
is	O
wide	O
including	O
viral	B-disease
,	I-disease
fungal	I-disease
and	I-disease
atypical	I-disease
mycobacterial	I-disease
infections	I-disease
.	O

Drug	B-disease
toxicity	I-disease
would	O
be	O
a	O
consideration	O
,	O
although	O
somewhat	O
less	O
likely	O
given	O
the	O
unilaterality	O
of	O
the	O
findings	O
.	O

4.	O
New	B-disease
jejunal	I-disease
wall	I-disease
thickening	I-disease
with	O
persistent	B-disease
distal	I-disease
ileal	I-disease
wall	I-disease
thickening	I-disease
and	O
diffuse	B-disease
mesenteric	I-disease
stranding	I-disease
,	O
most	O
likely	O
reflecting	O
an	B-disease
infectious	I-disease
etiology	I-disease
.	O

5.	O
Overall	O
stability	O
in	O
metastatic	B-disease
burden	I-disease
.	O

4)	O
ECHO	O
(	O
06-18	O
):	O
Mild	B-disease
symmetric	I-disease
left	I-disease
ventricular	I-disease
hypertrophy	I-disease
with	O
preserved	O
biventricular	O
systolic	O
function	O
.	O

Mild	B-disease
posterior	I-disease
mitral	I-disease
valve	I-disease
prolapse	I-disease
with	O
mild	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

Small	B-disease
(	I-disease
0.6	I-disease
cm	I-disease
)	I-disease
circumferential	I-disease
pericardial	I-disease
effusion	I-disease
,	O
largest	O
around	O
the	O
left	O
atrium	O
.	O

5)	O
L	O
femur	O
xray	O
(	O
06-18	O
):	O
Predominantly	B-disease
sclerotic	I-disease
lesion	I-disease
with	O
interval	B-disease
periosteal	I-disease
new	I-disease
bone	I-disease
formation	I-disease
involving	O
the	O
intertrochanteric	O
and	O
subtrochanteric	O
regions	O
.	O

No	O
displaced	B-disease
fracture	I-disease
is	O
demonstrated	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Mcelveen	O
51	O
year-old	O
male	O
with	O
metastatic	B-disease
RCC	I-disease
on	O
Sutent	O
since	O
2018-12-21	O
,	O
admitted	O
with	O
fever	B-disease
,	O
hypoxemia	B-disease
,	O
and	O
bibasilar	B-disease
pneumonia	I-disease
.	O

1)	O
Bibasilar	B-disease
pneumonia	I-disease
:	O
Patient	O
was	O
treated	O
for	O
community-acquired	B-disease
pneumonia	I-disease
.	O

He	O
was	O
initially	O
placed	O
on	O
Ceftriaxone	O
,	O
Levaquin	O
,	O
and	O
Flagyl	O
in	O
the	O
ICU	O
but	O
then	O
changed	O
to	O

Azithromycin	O
&	O
CTX	O
at	O
time	O
of	O
transfer	O
to	O
the	O
oncology	O
service	O
.	O

He	O
continued	O
to	O
have	O
an	B-disease
oxygen	I-disease
requirement	I-disease
and	O
CT	O
scan	O
suggested	O
ground	B-disease
glass	I-disease
opacities	I-disease
,	O
suggestive	O
of	O
an	B-disease
underlying	I-disease
infectious	I-disease
process	I-disease
.	O

ECHO	O
was	O
done	O
and	O
confirmed	O
normal	O
ejection	O
fraction	O
.	O

His	O
respiratory	O
status	O
improved	O
slowly	O
,	O
oxygen	O
was	O
weaned	O
off	O
,	O
and	O
he	O
was	O
discharged	O
on	O
course	O
of	O
Levaquin	O
.	O

2)	O
Metastatic	B-disease
RCC	I-disease
:	O
Sutent	O
was	O
held	O
on	O
admission	O
in	O
light	O
of	O
acute	B-disease
infection	I-disease
.	O

He	O
underwent	O
a	O
staging	O
CT	O
scan	O
torso	O
which	O
suggested	O
no	O
significant	B-disease
increase	I-disease
in	I-disease
tumor	I-disease
burden	I-disease
.	O

Patient	O
was	O
also	O
found	O
to	O
have	O
abnormal	B-disease
TFTs	I-disease
on	O
Sutent	O
and	O
was	O
started	O
on	O
replacement	O

therapy	O
.	O

He	O
will	O
need	O
follow-up	O
bloodwork	O
as	O
an	O
outpatient	O
.	O

Recent	O
CT	O
scan	O
showed	O
destruction	B-disease
of	I-disease
L	I-disease
femoral	I-disease
neck	I-disease
.	O

He	O
underwent	O
an	O
xray	O
of	O
the	O
L	O
femur	O
which	O
did	O
not	O
suggest	O
an	B-disease
acute	I-disease
fracture	I-disease
.	O

No	O
limitations	O
were	O
placed	O
in	O
regards	O
to	O
weightbearing	O
status	O
.	O

Patient	O
was	O
instructed	O
to	O
restart	O
Sutent	O
next	O
Monday	O
.	O

3)	O
Renal	B-disease
insufficiency	I-disease
:	O
Creatinine	O
improved	O
from	O
2.1	O
to	O
1.3	O
at	O
time	O
of	O
discharge	O
.	O

Likely	O
related	O
to	O
underlying	B-disease
malignancy	I-disease
as	O
well	O
as	O
prerenal	B-disease
component	I-disease
given	O
improvement	O
with	O
gentle	O
hydration	O
.	O

Medications	O
on	O
Admission	O
:	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O
He	O
takes	O
Imodium	O
and	O
Lomotil	O
while	O
on	O
Sutent	O
for	O
diarrhea	B-disease
.	O

He	O
has	O
not	O
had	O
a	O
BM	O
in	O
3	O
days	O
now	O
.	O

He	O
is	O
also	O
on	O
MS	O
Contin	O
45	O
mg	O
PO	O
q12	O
hours	O
(	O
confirmed	O
with	O
wife	O
)	O
and	O
MSIR	O
15	O
mg	O
every	O
4	O
hours	O
as	O
needed	O
.	O

MEDICATIONS	O
ON	O
TRANSFER	O
:	O

Heparin	O
5000	O
UNIT	O
SC	O
TID	O

Albuterol	O
0.083%	O
Neb	O
Soln	O
1	O
NEB	O
IH	O
Q6H	O

Ipratropium	O
Bromide	O
Neb	O
1	O
NEB	O
IH	O
Q6H	O

CeftriaXONE	O
1	O
gm	O
IV	O
Q24H	O

Levofloxacin	O
500	O
mg	O
PO	O
Q24H	O

Morphine	O
Sulfate	O
2-4	O
mg	O
IV	O
Q4H	O
:	O
PRN	O

Docusate	O
Sodium	O
100	O
mg	O
PO	O
BID	O

Pantoprazole	O
40	O
mg	O
PO	O
Q24H	O

Fluticasone	O
Propionate	O
110mcg	O
2	O
PUFF	O
IH	O
BID	O

Discharge	O
Medications	O
:	O

1.	O
Levothyroxine	O
50	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Levofloxacin	O
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
for	O
4	O
days	O
:	O
last	O
dose	O
will	O
be	O
Nolen	O
,	O
06-23	O
.	O

Disp	O
:*	O
4	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
Take	O
as	O
necessary	O
for	O
constipation	B-disease
.	O

4.	O
SUTENT	O
50	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Every	O
other	O
day	O
:	O
Please	O
restart	O
on	O
Wallace	O
,	O
06-24	O
.	O

5.	O
Morphine	O
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
Pain	B-disease
.	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Morphine	O
15	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

Disp	O
:*	O
90	O
Tablet	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnoses	O
:	O

1)	O
Pneumonia	B-disease

2)	O
Acute	B-disease
renal	I-disease
failure	I-disease

3)	O
Metastatic	B-disease
renal	I-disease
cell	I-disease
carcinoma	I-disease

4)	O
Hypoxemia	B-disease

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

1)	O
Please	O
take	O
all	O
medications	O
as	O
listed	O
in	O
the	O
discharge	O
instructions	O
.	O

2)	O
You	O
were	O
admitted	O
to	O
the	O
hospital	O
and	O
started	O
on	O
an	O
antibiotic	O
called	O
Levaquin	O
for	O
a	B-disease
pneumonia	I-disease
.	O

You	O
should	O
continue	O
taking	O
this	O
medication	O
and	O
your	O
last	O
day	O
will	O
be	O
Nolen	O
,	O
06-23	O
.	O

3)	O
When	O
you	O
were	O
admitted	O
to	O
the	O
hospital	O
your	O
Sutent	O
was	O
stopped	O
.	O

You	O
should	O
resume	O
this	O
medication	O
starting	O
Wallace	O
,	O
06-24	O
.	O

You	O
should	O
take	O
this	O
medication	O
every	O
other	O
day	O
.	O

4)	O
During	O
your	O
hospital	O
stay	O
you	O
were	O
also	O
found	O
to	O
have	O
low	B-disease
thyroid	I-disease
hormone	I-disease
levels	I-disease
.	O

As	O
a	O
result	O
,	O
you	O
were	O
started	O
on	O
thyroid	O
supplements	O
.	O

You	O
should	O
have	O
follow-up	O
blood	O
tests	O
by	O
your	O
primary	O
care	O
physician	O
B	O
3	O
months	O
.	O

5)	O
Please	O
attend	O
all	O
appointments	O
as	O
listed	O
below	O
.	O

6)	O
If	O
you	O
experience	O
any	O
fevers	B-disease
,	O
chills	B-disease
,	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
dizziness	B-disease
or	O
any	B-disease
other	I-disease
concerning	I-disease
symptoms	I-disease
please	O
return	O
to	O
the	O
emergency	O
department	O
.	O

Followup	O
Instructions	O
:	O

1)	O
Provider	O
:	O
Yolanda	O
Joyce	O
,	O
MD	O
Phone	O
:	O
337	O
2567	O

Date	O
/	O
Time	O
:	O
2019-07-03	O
3:30	O

2)	O
Provider	O
:	O
Peter	O
Helen	O
Braddy	O
,	O
MD	O
Phone	O
:	O
337	O
2567	O

Date	O
/	O
Time	O
:	O
2019-07-03	O
3:30	O

Philip	O
Glenn	O
MD	O
60-385	O

Completed	O
by	O
:	O
Eva	O
Susan	O
MD	O
54-940	O
2019-07-27	O
@	O
1700	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Patrick	O
B	O
Santiago	O
on	O
:	O
MON	O
2019-07-29	O
9:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

745701560	O
WGH	O

2217927	O

991462	O

4257841	O

10/23/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SMANTVERGE	O
,	O
TAWNEN	O

MRN	O
:	O

2217927	O

Age	O
:	O

78y	O

REGISTRATION	O
DATE	O
:	O

10/23/2005	O
09:30	O
AM	O

Provider	O
:	O

VONNELIBRY	O
POUSSCROOKESSEILLE	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O

Date	O
/	O
Time	O
:	O

10/23/2005	O
10:35	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

APPT	O
VONNELIBRY	O
POUSSCROOKESSEILLE	O

Diagnosis	O
:	O

Anxiety	B-disease
NOS	I-disease

Treatment	O
Rendered	O
:	O

psychological	O
assessment	O
,	O
past	O
medication	O
responses	O
discussed	O
.	O

No	O
new	O
meds	O
for	O
now	O

Discharge	O
Medications	O
:	O

None	O
today	O
Disposition	O
,	O

Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Keep	O
follow-up	O
medical	O
appointments	O
with	O
Dr	O
Trosgaugh	O
.	O

Continuing	O
taking	O
meds	O
she	O
prescribed	O
.	O

PCP	O
Name	O
:	O

TROSGAUGH	O
,	O
NACOLE	O

Provider	O
Number	O
:	O

16660	O

This	O
report	O
was	O
created	O
by	O
POUSSCROOKESSEILLE	O
,	O
VONNELIBRY	O
10/23/2005	O
10:51	O
AM	O

348301810	O

CTMC	O

65055310	O

421501	O

2/19/1991	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Admission	O
Date	O
:	O

02/19/1991	O

Report	O
Status	O
:	O

Unsigned	O

Discharge	O
Date	O
:	O

02/25/1991	O

ADMISSION	O
DIAGNOSIS	O
:	O

ENDOMETRIAL	B-disease
CANCER	I-disease
.	O

OPERATION	O
:	O

Total	O
abdominal	O
hysterectomy	O
,	O
bilateral	O
salpingo	O
oophorectomy	O
2-19-91	O
by	O
Dr.	O
Lako	O
Coma	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
81-year-old	O
who	O
presented	O
with	O
postmenopausal	B-disease
spotting	I-disease
and	O
had	O
an	O
endometrial	O
biopsy	O
which	O
was	O
read	O
at	O
the	O
Etearal	O
Etsystems/	O
Hospital	O
as	O
showing	O
grade	B-disease
I	I-disease
adenocarcinoma	I-disease
.	O

Accordingly	O
she	O
presents	O
for	O
operative	O
therapy	O
at	O
this	O
time	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Negative	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

None	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
is	O
somewhat	O
obese	O
elderly	O
female	O
.	O

HEENT	O
unremarkable	O
.	O

Lungs	O
clear	O
.	O

Abdomen	B-disease
obese	I-disease
,	O
no	O
scars	B-disease
.	O

Pelvic	O
exam	O
showed	O
a	O
small	O
mobile	O
uterus	O
.	O

Extremities	O
show	O
no	O
edema	B-disease
.	O

LABORATORY	O
DATA	O
:	O

All	O
within	O
normal	O
limits	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
brought	O
to	O
the	O
Operating	O
Room	O
on	O
2-19-91	O
where	O
she	O
had	O
an	O
exploratory	O
laparotomy	O
,	O
TAH	O
/	O
BSO	O
,	O
and	O
omental	O
biopsy	O
.	O

She	O
had	O
a	O
normal	O
abdominal	O
exploration	O
of	O
a	O
small	O
uterus	O
with	O
superficial	B-disease
invasion	I-disease
on	O
gross	O
examination	O
,	O
normal	O
ovaries	O
.	O

Washings	O
were	O
sent	O
.	O

A	O
subfascial	O
J-P	O
was	O
left	O
.	O

The	O
patient	O
did	O
well	O
postoperatively	O
and	O
had	O
a	O
regular	O
diet	O
by	O
the	O
third	O
postoperative	O
day	O
.	O

Subfascia	O
drain	O
was	O
discontinued	O
.	O

The	O
patient	O
&apos;s	O
postoperative	O
Hct	O
was	O
34	O
.	O

DISPOSITION	O
:	O

She	O
will	O
have	O
follow-up	O
with	O
Dr.	O
Lako	O
Coma	O
.	O

YM263/3597	O
LAKO	O
C.	O
COMA	O
,	O
M.D.	O
TH0	O

D	O
:	O

02/25/91	O

Batch	O
:	O

4620	O

Report	O
:	O

A5427C65	O

T	O
:	O

02/27/91	O

Dicatated	O
By	O
:	O

TA	O
K.	O
JESC	O
,	O
M.D.	O

853262744	O

OMH	O

8223316	O

121051	O

7/10/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

SCOBE	O
,	O
RYLALON	O

MRN	O
:	O

8223316	O

Age	O
:	O

87y	O

REGISTRATION	O
DATE	O
:	O

07/10/2002	O
11:45	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
SCOBE	O
,	O
RYLALON	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Oaksgekesser/	O
Memorial	O
Hospital	O
on	O
07/10/2002	O
11:45	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
SOB	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
OAKSGEKESSER/	O
MEMORIAL	O
HOSPITAL	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
BRITTSFYFEAST	O
,	O
SHER	O
T	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
S	O
/	O
SOB	B-disease
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
187-715-4303.	O

PCP	O
Name	O
:	O

NEIGHROBLIN	O
,	O
RETTE	O
R	O

Provider	O
Number	O
:	O

74337	O

333521954	O

FIH	O

9558642	O

616751	O

7916543	O

2/23/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

WIEGNEIGH	O
,	O
YLA	O

MRN	O
:	O

9558642	O

Age	O
:	O

53y	O

REGISTRATION	O
DATE	O
:	O

02/23/2005	O
05:41	O
AM	O

Provider	O
:	O

GETZSIEH	O
,	O
M.D.	O
WORK	O

PRELIMINARY	O
REPORT	O
PCP	O
notified	O
by	O

MD	O
:	O

Yes-Direct	O
contact	O
with	O
PCP	O

Discharge	O
Date	O
/	O
Time	O
:	O

02/23/2005	O
13:38	O

Discharge	O
Status	O
:	O

Discharged	O
Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

CHEST	B-disease
PAIN	I-disease
/	O
SOB	B-disease

Diagnosis	O
:	O

R	B-disease
Lung	I-disease
Mass	I-disease
,	O
likely	O
cancer	B-disease

Treatment	O
Rendered	O
:	O

Physical	O
Examination	O
,	O
Laboratory	O
Evaluation	O
,	O
CXR	O
,	O
Chest	O
CT	O

Discharge	O
Medications	O
:	O

Vicodin	O
1-2	O
TABS	O
PO	O
Q6H	O
PRN	O
pain	B-disease
,	O
#	O
50	O
,	O
no	O
refills	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Oncologist	O
,	O
Dr.	O
Ala	O
Aixknoleskaysneighslemteelenortkote	O
,	O
will	O
call	O
you	O
will	O
your	O
appt	O
.	O

You	O
can	O
call	O
576-598-7570	O
if	O
you	O
need	O
to	O
reschedule	O
.	O

We	O
are	O
scheduling	O
you	O
for	O
a	O
needle	O
biopsy	O
by	O
interventional	O
radiology	O
for	O
some	O
time	O
in	O
the	O
next	O
week	O
.	O

they	O
will	O
call	O
you	O
to	O
set	O
up	O
appt	O
.	O

PCP	O
Name	O
:	O

NIQUE	O
,	O
TOYA	O
N	O

Provider	O
Number	O
:	O

21636	O

This	O
report	O
was	O
created	O
by	O
WORK	O
,	O
SHELLBETHA	O
,	O
M.D.	O
02/23/2005	O
01:59	O
PM	O

Admission	O
Date	O
:	O

Discharge	O
Date	O
:	O

2014-01-24	O

Date	O
of	O
Birth	O
:	O

1928-11-23	O

Sex	O
:	O

F	O

Service	O
:	O

Internal	O
Medicine	O

During	O
the	O
last	O
four	O
hospital	O
days	O
,	O
the	O
continued	O
to	O
do	O
relatively	O
well	O
.	O

Her	O
renal	O
function	O
significantly	O
improved	O
,	O
and	O
her	O
discharge	O
creatinine	O
was	O
3.1	O
.	O

Of	O
note	O
,	O
her	O
blood	O
pressure	O
significantly	O
improved	O
in	O
the	O
120s-130s	O
which	O
assured	O
better	O
perfusion	O
in	O
her	O
kidneys	O
.	O

She	O
received	O
intermittent	O
doses	O
of	O
Lasix	O
to	O
assure	O
overall	O
negative	O
intakes	O
and	O
outputs	O
.	O

She	O
progressed	O
beautifully	O
with	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
and	O
was	O
able	O
to	O
ambulate	O
with	O
assistance	O
.	O

She	O
has	O
very	B-disease
mild	I-disease
left	I-disease
lower	I-disease
extremity	I-disease
pain	I-disease
which	O
is	O
largely	O
unchanged	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
.	O

2.	O
Congestive	B-disease
heart	I-disease
failure	I-disease
.	O

3.	O
Acute	B-disease
renal	I-disease
failure	I-disease
.	O

4.	O
Acute	B-disease
myocardial	I-disease
infarction	I-disease
.	O

5.	O
Osteomyelitis	B-disease
.	O

6.	O
Diabetes	B-disease
mellitus	I-disease
.	O

DISPOSITION	O
:	O

Discharged	O
to	O
a	O
rehabilitation	O
facility	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Amiodarone	O
200	O
mg	O
p.o.	O
q	O
day	O
.	O

2.	O
Warfarin	O
3	O
mg	O
p.o.	O
q	O
h.s.	O

3.	O
Renagel	O
1600	O
mg	O
p.o.	O
t.i.d.	O

4.	O
Aspirin	O
325	O
mg	O
p.o.	O
q	O
day	O
.	O

5.	O
Miconazole	O
powder	O
2%	O
t.i.d.	O

6.	O
Levofloxacin	O
250	O
mg	O
p.o.	O
q48	O
hours	O
for	O
the	O
next	O
five	O
weeks	O
for	O
osteomyelitis	B-disease
.	O

7.	O
Flagyl	O
500	O
mg	O
p.o.	O
t.i.d.	O
for	O
the	O
next	O
five	O
weeks	O
for	O
osteomyelitis	B-disease
.	O

8.	O
Protonix	O
40	O
mg	O
p.o.	O
q	O
day	O
.	O

9.	O
Magnesium	O
Oxide	O
800	O
mg	O
p.o.	O
b.i.d.	O

10.	O
Epogen	O
5000	O
units	O
two	O
times	O
weekly	O
,	O
on	O
Monday	O
and	O
Thursday	O
.	O

11.	O
Colace	O
100	O
mg	O
p.o.	O
b.i.d.	O

12.	O
Lasix	O
80	O
mg	O
p.o.	O
b.i.d.	O

13.	O
NPH	O
insulin	O
7	O
units	O
in	O
the	O
morning	O
and	O
5	O
units	O
at	O
night	O
.	O

14.	O
Regular	O
insulin	O
sliding	O
scale	O
.	O

Richard	O
U.	O
Walker	O
,	O
M.D.	O

36-781	O

Dictated	O
By	O
:	O
Levi	O
G.	O
Savage	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2014-01-24	O
13:13	O

T	O
:	O
2014-01-24	O
13:45	O

JOB	O
#:	O

12151	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kelly	O
Hunter	O
YANG	O
on	O
:	O
FRI	O
2014-01-31	O
2:04	O
PM	O

(	O
End	O
of	O
Report	O
)	O

839999049	O
YC	O

59242403	O

431924	O

11/01/2000	O
12:00:00	O
AM	O

Obstructive	B-disease
Sleep	I-disease
Apnea	I-disease

DIS	O

Admission	O
Date	O
:	O

11/01/2000	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

11/04/2000	O

******	O
DISCHARGE	O
ORDERS	O
******	O

BREUNCLONTSTREAUAYLES	O
,	O
BINTRIREE	O

766-50-79-4	O
H55	O

Room	O
:	O

42Z-770	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O
11/04/00	O
AT	O
03:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

AISTAKEFLICHSKI	O
,	O
TAINE	O
D.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

WELLBUTRIN	O
(	O
BUPROPION	O
HCL	O
)	O
150	O
MG	O
PO	O
BID	O
FOLATE	O
(	O
FOLIC	O
ACID	O
)	O
1	O
MG	O
PO	O
QD	O
ATIVAN	O
(	O
LORAZEPAM	O
)	O
1	O
MG	O
PO	O
Q12H	O
X	O
1	O
Days	O
ATIVAN	O
(	O
LORAZEPAM	O
)	O
1	O
MG	O
PO	O
QHS	O
X	O
7	O
Days	O
Starting	O
on	O
11/5	O
MVI	O
THERAPEUTIC	O
W	O
/	O
MINERALS	O
(	O
THERAP	O
VITS	O
/	O
MINERALS	O
)	O
1	O
TAB	O
PO	O
QD	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
11/03/00	O
by	O
TWADA	O
,	O
STASTERL	O
ETHESHI	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	O
and	O
NIACIN	O
,	O
VIT.	O

B-3	O
Reason	O
for	O
override	O
:	O

indicated	O
THIAMINE	O
(	O
THIAMINE	O
HCL	O
)	O
100	O
MG	O
PO	O
QD	O
SIMVASTATIN	O
40	O
MG	O
PO	O
QHS	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
11/03/00	O
by	O
TWADA	O
,	O
STASTERL	O
ETHESHI	O
,	O
M.D.	O
on	O
order	O
for	O
MVI	O
THERAPEUTIC	O
W	O
/	O
MINERALS	O
PO	O
(	O
ref	O
#	O
90299469	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	O
and	O
NIACIN	O
,	O
VIT.	O
B-3	O

Reason	O
for	O
override	O
:	O

indicated	O
LISINOPRIL	O
10	O
MG	O
PO	O
QD	O
NICOTINE	O
PATCH	O
(	O
NICOTINE	O
)	O
21	O
MG/DAY	O
TP	O
Q24H	O

DIET	O
:	O

House	O
/	O
NAS	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O
&lt;	O
FDI	O
&gt;	O

RETURN	O
TO	O
WORK	O
:	O

Immediately	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Firmert	O
Hospital	O
11/6	O
at	O
9am	O
scheduled	O
,	O
Cialneinsisters	O
Hospital	O
And	O
Medical	O
Center	O
11/16	O
at	O
8:15pm	O
scheduled	O
,	O
Dr.	O
Condnort	O
12/04	O
at	O
2pm	O
scheduled	O
,	O
Dr.	O
Lila	O
Spielbjaque	O
12/01	O
at	O
1:50pm	O
scheduled	O
,	O
No	O
Known	B-disease
Allergies	I-disease

ADMIT	O
DIAGNOSIS	O
:	O

r	O
/	O
o	O
MI	B-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
Obstructive	B-disease
Sleep	I-disease
Apnea	I-disease

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
HTN	B-disease
tobacco	O
EtOh	O
abuse	O
sinus	B-disease
bradycardia	I-disease

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

50	O
yo	O
M	O
from	O
Taheimpromong	O
admitted	O
w	O
/	O
CP	B-disease
for	O
r	O
/	O
o	O
MI	B-disease
.	O

Has	O
significant	B-disease
cardiac	I-disease

RF	O
:	O

FH	O
,	O
HTN	B-disease
,	O
tobacco	O
.	O

Presented	O
w	O
/	O
epigastric	B-disease
pain	I-disease
,	O
SOB	B-disease
at	O
work	O
.	O

ETT	O
was	O
negative	O
for	O
ischemia	B-disease
.	O

Echo	O
showed	O
ef	O
45-50%	O
,	O
with	O
mild	B-disease
dilatation	I-disease
and	O
no	O
significant	B-disease
valvular	I-disease
disease	I-disease
,	O
and	O
nl	O
PAP	O
.	O

ACE	O
team	O
consulted	O
who	O
arranged	O
for	O
pt	O
to	O
have	O
outpt	O
follow	O
up	O
.	O

During	O
this	O
hospitalization	O
,	O
pt	O
was	O
noted	O
to	O
have	O
sinus	B-disease
bradycardia	I-disease
and	O
pauses	B-disease
,	O
associated	O
with	O
desaturations	B-disease
in	I-disease
the	I-disease
70	I-disease
&apos;s	I-disease
.	O

CPAP	O
at	O
5	O
was	O
attempted	O
,	O
but	O
pt	O
did	O
not	O
tolerate	O
this	O
.	O

He	O
will	O
have	O
outpt	O
fitting	O
at	O
the	O
sleep	O
center	O
in	O
Sabo	O
.	O

Pt	O
also	O
counselled	O
re	O
:	O

quitting	O
smoking	O
,	O
and	O
he	O
appears	O
motivated	O
to	O
do	O
so	O
,	O
as	O
well	O
as	O
to	O
cut	O
down	O
on	O
his	O
drinking	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

1.	O
llame	O
a	O
su	O
doctor	O
y	O
haga	O
cita	O
para	O
verlo	O
dentro	O
de	O
1	O
semana	O
.	O

2.	O
llame	O
a	O
la	O
clinica	O
the	O
Wake	O
Valley	O
Hospital	O
442/961-2446	O
,	O
si	O
tiene	O
que	O
cambiar	O
la	O
cita	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

LARDES	O
,	O
COLNKAY	O
,	O
M.D.	O
(	O
IP09	O
)	O
11/04/00	O
03:34	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

932057504	O
DH	O

5898830	O

809200	O

356490	O

11/25/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

AGACHBRAUCH	O
,	O
RENSIAANARC	O

MRN	O
:	O

5898830	O

Age	O
:	O

44y	O

REGISTRATION	O
DATE	O
:	O

11/25/2000	O
01:36	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
AGACHBRAUCH	O
,	O
RENSIAANARC	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Daughtersvillshamen&apos;s	O
Hospital	O
on	O
11/25/2000	O
01:36	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
AF-RESOLVED	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
TREATED	O
AND	O
RELEASED	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
613-870-0699	O
.	O

920798564	O

CTMC	O

70160673	O

840502	O

3/3/1999	O
12:00:00	O
AM	O

PROSTATE	B-disease
CANCER	I-disease
AND	O
RENAL	B-disease
FAILURE	I-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

03/03/1999	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

03/08/1999	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

ACUTE	B-disease
RENAL	I-disease
FAILURE	I-disease
.	O

SIGNIFICANT	B-disease
PROBLEMS	I-disease
:	O

1.	O
METASTATIC	B-disease
PROSTATE	I-disease
CA	I-disease
.	O

2.	O
OBSTRUCTIVE	B-disease
UROPATHY	I-disease
,	O
STATUS	B-disease
POST	I-disease
LEFT	I-disease
NEPHROSTOMY	I-disease
.	O

3.	O
HYPERTENSION	B-disease
.	O

4.	O
ANEMIA	B-disease
.	O

5.	O
GASTROESOPHAGEAL	B-disease
REFLUX	I-disease
DISEASE	I-disease
.	O

CHIEF	O
COMPLAINT	O
:	O

This	O
88-year-old	O
male	O
with	O
history	O
of	O
prostate	B-disease
CA	I-disease
was	O
admitted	O
from	O
an	O
outside	O
hospital	O
secondary	O
to	O
persistent	B-disease
hematuria	I-disease
status	O
post	O
nephrostomy	O
tube	O
placement	O
transferred	O
to	O
Retelk	O
County	O
Medical	O
Center	O
for	O
further	O
management	O
.	O

HISTORY	O
OF	O
PRESENT	B-disease
ILLNESS	I-disease
:	O

Mr.	O
Prehekote	O
is	O
an	O
88-year-old	O
Portuguese	O
speaking	O
only	O
male	O
who	O
was	O
diagnosed	O
with	O
adenocarcinoma	B-disease
of	I-disease
the	I-disease
prostate	I-disease
in	O
1998	O
.	O

He	O
received	O
transurethral	O
resection	O
of	O
the	O
prostate	O
one	O
year	O
ago	O
because	O
of	O
persistent	B-disease
urinary	I-disease
retention	I-disease
.	O

After	O
that	O
,	O
he	O
was	O
on	O
Lupron	O
and	O
Nilandron	O
hormone	O
therapy	O
.	O

The	O
patient	O
was	O
admitted	O
on	O
February	O
23	O
,	O
1999	O
to	O
Eifro	O
Medical	O
Center	O
because	O
of	O
failure	B-disease
to	I-disease
thrive	I-disease
and	O
decreased	B-disease
hematocrit	I-disease
.	O

He	O
was	O
noted	O
to	O
have	O
elevated	B-disease
BUN	I-disease
and	O
creatinine	O
.	O

BUN	O
was	O
34	O
and	O
creatinine	O
was	O
2.6	O
,	O
up	O
from	O
his	O
baseline	O
of	O
1.0	O
.	O

Prostate	O
specific	O
antigen	O
increased	O
from	O
77.9	O
to	O
88	O
,	O
and	O
the	O
patient	O
also	O
had	O
urinary	B-disease
incontinence	I-disease
and	O
body	B-disease
weight	I-disease
loss	I-disease
.	O

Further	O
evaluation	O
of	O
his	B-disease
renal	I-disease
failure	I-disease
showed	O
that	O
the	O
patient	O
has	O
bilateral	B-disease
hydronephrosis	I-disease
,	O
most	O
likely	O
obstructive	B-disease
uropathy	I-disease
due	O
to	O
prostate	B-disease
CA	I-disease
in	I-disease
the	I-disease
pelvic	I-disease
area	I-disease
.	O

Because	O
of	O
the	B-disease
increasing	I-disease
creatinine	I-disease
to	O
8.0	O
on	O
February	O
28	O
,	O
1999	O
,	O
a	O
left	O
nephrostomy	O
tube	O
was	O
placed	O
.	O

However	O
after	O
the	O
procedure	O
,	O
the	B-disease
patient	I-disease
&apos;s	I-disease
hematocrit	I-disease
dropped	I-disease
to	O
24	O
and	O
he	O
was	O
transfused	O
two	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
.	O

His	O
hematocrit	O
increased	O
to	O
about	O
30	O
,	O
but	O
he	O
continued	O
to	O
have	O
hematuria	B-disease
and	O
his	O
renal	O
function	O
only	O
improved	O
very	O
slowly	O
.	O

He	O
also	O
received	O
Kayexalate	O
for	O
hyperkalemia	B-disease
.	O

Due	O
to	O
the	B-disease
persistent	I-disease
blood	I-disease
in	I-disease
the	I-disease
urine	I-disease
,	O
he	O
was	O
transferred	O
from	O
Eifro	O
Medical	O
Center	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
angiographic	O
studies	O
to	O
rule	O
out	O
any	O
vascular	B-disease
injuries	I-disease
.	O

The	O
patient	O
was	O
transferred	O
to	O
Genearocktemp	O
Ry	O
Health	O
on	O
March	O
3	O
,	O
1999	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
patient	O
had	O
constipation	B-disease
with	O
dysuria	B-disease
,	O
but	O
no	O
fever	B-disease
or	O
chills	B-disease
.	O

No	O
cough	B-disease
.	O

No	O
chest	B-disease
pain	I-disease
.	O

No	O
palpitations	B-disease
,	O
history	O
of	O
epigastric	B-disease
pain	I-disease
and	O
body	B-disease
weight	I-disease
loss	I-disease
.	O

No	O
headache	B-disease
.	O

No	O
bone	B-disease
pain	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Hypertension	B-disease
.	O

2)	O
Gastroesophageal	B-disease
reflux	I-disease
disease	I-disease
.	O

3)	O
Anemia	B-disease
.	O

4)	O
Prostate	B-disease
CA	I-disease
.	O

ALLERGIES	B-disease
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
:	O

Clonidine	O
2.5	O
milligrams	O
topical	O
q.	O
week	O
,	O
Nitropaste	O
2	O
inches	O
q.4h.	O
,	O
Nilandron	O
50	O
milligrams	O
p.o.	O
q.d.	O
,	O
Lupron	O
,	O
Dulcolax	O
p.r.n.	O
,	O
Colace	O
100	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
Ferrous	O
sulfate	O
300	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
Lansopiacole	O
15	O
milligrams	O
p.o.	O
q.d.	O
,	O
bethanechol	O
25	O
milligrams	O
p.o.	O
t.i.d.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
been	O
living	O
in	O
the	O
Kansas	O
for	O
more	O
than	O
20	O
years	O
.	O

He	O
was	O
originally	O
from	O
Wark	O
and	O
he	O
speaks	O
Portuguese	O
only	O
.	O

He	O
is	O
now	O
living	O
with	O
his	O
son	O
and	O
daughter	O
,	O
and	O
five	O
other	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
a	O
frail	O
looking	O
elderly	O
male	O
lying	O
in	O
bed	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Temperature	O
95.4	O
,	O
pulse	O
120	O
,	O
blood	O
pressure	O
150/80	O
,	O
respiratory	O
rate	O
24	O
,	O
95%	O
on	O
room	O
air	O
.	O

Conjunctiva	O
were	O
not	O
pale	O
.	O

Sclera	O
nonicteric	O
.	O

Pupils	O
:	O

Isocoric	B-disease
cataract	I-disease
bilaterally	I-disease
.	O

Mouth	O
:	O

Mucous	B-disease
membranes	I-disease
slightly	I-disease
dry	I-disease
.	O

No	O
oral	B-disease
ulcers	I-disease
.	O

Neck	O
:	O

Supple	O
.	O

Jugular	O
vein	O
not	O
engorged	O
.	O

Carotid	O
pulses	O
bounding	O
very	O
strongly	O
.	O

No	O
thyromegaly	B-disease
.	O

Chest	O
examination	O
showed	O
some	B-disease
basilar	I-disease
crackles	I-disease
at	I-disease
the	I-disease
right	I-disease
lung	I-disease
base	I-disease
.	O

Heart	O
initially	O
tachycardia	B-disease
,	O
grade	B-disease
II	I-disease
/	I-disease
VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
at	I-disease
the	I-disease
left	I-disease
sternal	I-disease
border	I-disease
.	O

Abdomen	O
:	O

Soft	O
.	O

Liver	O
and	O
spleen	O
were	O
not	O
palpable	O
.	O

Bowel	O
sounds	O
normoactive	O
.	O

Extremities	O
:	O

Traced	B-disease
pitting	I-disease
edema	I-disease
.	O

No	O
cyanosis	B-disease
and	O
no	O
clubbing	B-disease
.	O

Peripheral	O
pulses	O
were	O
very	O
strong	O
and	O
bounding	O
.	O

No	O
calf	B-disease
tenderness	I-disease
.	O

Homan	O
&apos;s	O
sign	O
negative	O
.	O

Neurologic	O
:	O

Examination	O
was	O
limited	O
because	O
the	O
patient	O
speaks	O
only	O
Portuguese	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
the	O
patient	O
&apos;s	O
biochemistry	O
showed	O
sodium	O
of	O
140	O
,	O
potassium	O
4.0	O
,	O
chloride	O
107	O
,	O
bicarb	O
14	O
,	O
BUN	O
63	O
,	O
creatinine	O
5.8	O
,	O
blood	O
sugar	O
133	O
.	O

Liver	O
function	O
test	O
showed	O
AST	O
21	O
,	O
alkaline	O
phosphatase	O
70	O
,	O
total	O
bilirubin	O
0.3	O
,	O
total	O
protein	O
6.5	O
,	O
albumin	O
3.9	O
,	O
globulin	O
2.6	O
.	O

CBC	O
:	O

WBC	O
8.4	O
,	O
hematocrit	O
32.6	O
,	O
platelet	O
count	O
194,000	O
.	O

PT	O
11.9	O
,	O
INR	O
1.0	O
,	O
PTT	O
28.4	O
.	O

Chest	O
x-ray	O
showed	O
no	O
evidence	O
of	O
cardiomegaly	B-disease
.	O

No	O
lung	B-disease
infiltrate	I-disease
.	O

CT	O
scan	O
of	O
the	O
renal	O
area	O
showed	O
right	B-disease
hydronephrosis	I-disease
which	O
extends	O
to	O
an	B-disease
asymmetrically	I-disease
thickened	I-disease
urinary	I-disease
bladder	I-disease
wall	I-disease
.	O

A	B-disease
mass	I-disease
like	I-disease
thickening	I-disease
of	I-disease
the	I-disease
urinary	I-disease
bladder	I-disease
suggestive	O
of	O
either	O
detrusor	B-disease
hypertrophy	I-disease
or	O
possibly	O
tumor	B-disease
.	O

The	O
CT	O
scan	O
showed	O
a	B-disease
cavitary	I-disease
lung	I-disease
lesion	I-disease
in	I-disease
the	I-disease
right	I-disease
lower	I-disease
lobe	I-disease
compatible	O
with	O
metastatic	O
or	O
septic	B-disease
embolus	I-disease
.	O

EKG	O
showed	O
atrial	B-disease
fibrillation	I-disease
,	O
left	B-disease
axis	I-disease
deviation	I-disease
,	O
LVH	B-disease
,	O
nonspecific	B-disease
ST-T	I-disease
changes	I-disease
either	O
due	O
to	O
digitalis	B-disease
affect	I-disease
.	O

CK	O
enzymes	O
146	O
.	O

Repeated	O
three	O
times	O
and	O
remained	O
flat	O
.	O

Troponin	O
I	O
on	O
the	O
second	O
day	O
of	O
admission	O
was	O
1.18	O
.	O

HOSPITAL	O
COURSE	O
:	O

After	O
admission	O
,	O
urology	O
,	O
nephrology	O
as	O
well	O
as	O
interventional	O
radiology	O
was	O
consulted	O
about	O
the	O
management	O
of	O
this	O
patient	O
.	O

The	O
specialist	O
concluded	O
that	O
because	O
the	B-disease
patient	I-disease
&apos;s	I-disease
hematuria	I-disease
seemed	O
to	O
be	O
stable	O
and	O
hematocrit	O
to	O
maintain	O
at	O
about	O
29-30	O
,	O
there	O
is	O
no	O
urgent	O
need	O
to	O
do	O
an	O
arteriogram	O
which	O
may	O
cause	O
further	B-disease
damage	I-disease
to	I-disease
the	I-disease
patient	I-disease
&apos;s	I-disease
kidney	I-disease
.	O

Urology	O
consultation	O
thinks	O
that	O
cystoscopy	O
would	O
not	O
add	O
any	O
benefit	O
to	O
the	O
management	O
and	O
only	O
would	O
consider	O
a	O
right	O
nephrostomy	O
if	O
renal	B-disease
function	I-disease
failed	O
to	O
improve	O
.	O

After	O
admission	O
,	O
the	O
patient	O
was	O
treated	O
conservatively	O
to	O
correct	O
his	B-disease
electrolyte	I-disease
and	I-disease
metabolic	I-disease
acidosis	I-disease
.	O

He	O
was	O
given	O
blood	O
transfusion	O
,	O
two	O
units	O
when	O
his	O
hematocrit	O
dropped	O
to	O
29.4	O
.	O

After	O
transfusion	O
,	O
the	O
patient	O
&apos;s	O
hematocrit	O
rose	O
to	O
37.7	O
on	O
the	O
day	O
of	O
discharge	O
.	O

The	O
patient	O
was	O
also	O
given	O
sodium	O
bicarbonate	O
to	O
correct	O
his	B-disease
metabolic	I-disease
acidosis	I-disease
.	O

He	O
continued	O
to	O
pass	O
about	O
1500-2000	O
cc	O
of	O
urine	O
a	O
day	O
and	O
his	O
renal	O
function	O
improved	O
slowly	O
with	O
creatinine	O
decreased	O
to	O
4.2	O
on	O
the	O
day	O
of	O
discharge	O
.	O

During	O
this	O
admission	O
,	O
the	O
patient	O
also	O
developed	O
atrial	B-disease
fibrillation	I-disease
with	O
ventricular	O
rate	O
of	O
about	O
70-80	O
.	O

CPK	O
was	O
tracked	O
,	O
but	O
was	O
totally	O
normal	O
.	O

No	O
beta	O
blockers	O
were	O
given	O
.	O

A	O
long	O
discussion	O
amongst	O
the	O
specialist	O
,	O
nephrology	O
,	O
urology	O
,	O
interventional	O
radiology	O
,	O
primary	O
oncology	O
as	O
well	O
with	O
the	O
family	O
lead	O
to	O
the	O
conclusion	O
that	O
conservative	O
management	O
may	O
give	O
the	O
patient	O
more	O
comfort	O
than	O
crisis	O
treatment	O
in	O
this	B-disease
well	I-disease
advanced	I-disease
prostate	I-disease
CA	I-disease
.	O

Dr.	O
Lucreamull	O
discussed	O
the	O
patient	O
&apos;s	O
clinical	O
status	O
and	O
overall	O
situation	O
with	O
the	O
patient	O
&apos;s	O
family	O
and	O
the	O
family	O
decided	O
that	O
Mr.	O
Prehekote	O
could	O
return	O
home	O
with	O
hospice	O
.	O

The	O
patient	O
&apos;s	O
primary	O
care	O
physician	O
,	O
Dr.	O
Tomedankell	O
Flowayles	O
will	O
manage	O
the	O
hospice	O
issues	O
.	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
for	O
hospice	O
on	O
March	O
8	O
,	O
1999	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Bethanechol	O
25	O
milligrams	O
p.o.	O
t.i.d.	O
,	O
Clonidine	O
2.5	O
milligrams	O
topical	O
q.	O
week	O
,	O
apply	O
every	O
Sunday	O
,	O
Colace	O
100	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
Haldol	O
0.5-1	O
milligrams	O
p.o.	O
q.6-8h.	O
p.r.n.	O
agitation	B-disease
,	O
Niferex	O
150	O
milligrams	O
p.o.	O
b.i.d.	O
,	O
nitroglycerin	O
paste	O
2%	O
,	O
2	O
inches	O
topical	O
q.8h.	O
,	O
Prilosec	O
20	O
milligrams	O
p.o.	O
q.d.	O
,	O
Senna	O
tablets	O
2	O
tablets	O
b.i.d.	O
,	O
sodium	O
bicarbonate	O
650	O
milligrams	O
p.o.	O
t.i.d.	O
for	O
five	O
days	O
,	O
Proscar	O
5	O
milligrams	O
p.o.	O
q.d.	O
,	O
Casodex	O
50	O
milligrams	O
p.o.	O
q.d.	O
,	O
Nephrocaps	O
1	O
tablets	O
p.o.	O
q.d.	O

COMPLICATIONS	O
:	O

None	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Fair	O
.	O

DISPOSITION	O
:	O

Home	O
with	O
hospice	O
.	O

Dictated	O
By	O
:	O

KYMBELL	O
SPARDJEB	O
,	O
M.D.	O
BJ43	O

Attending	O
:	O

LAGEORG	O
LUCREAMULL	O
,	O
M.D.	O
MR28	O
PN199/1242	O

Batch	O
:	O

14667	O

Index	O
No.	O
UDFTTQ73N9	O

D	O
:	O

03/08/99	O

T	O
:	O

03/09/99	O

Admission	O
Date	O
:	O

2014-02-21	O

Discharge	O
Date	O
:	O

2014-03-25	O

Date	O
of	O
Birth	O
:	O

1928-07-25	O

Sex	O
:	O

F	O

Service	O
:	O

SURGERY	O

Allergies	O
:	O

Sulfa	O
(	O
Sulfonamides	O
)	O

Attending	O
:	O
Mattie	O
R.	O
A.	O
Hamilton	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Nausea	B-disease
,	O
vomiting	B-disease
,	O
Abdominal	B-disease
pain	I-disease
,	O
distention	B-disease
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

1.	O
Subtotal	O
colectomy	O
,	O
end	O
ileostomy	O
,	O
Hartmann's	O
pouch	O
,	O
G-tube	O

2.	O
Completion	O
sigmoid	O
colectomy	O
,	O
repair	O
of	O
colovesicular	B-disease
fistula	I-disease
,	O
small	O
bowel	O
repair	O

History	O
of	O
Present	O
Illness	O
:	O

Ms	O
Crossman	O
is	O
an	O
84	O
year	O
old	O
female	O
with	O
complaints	O
of	O
abdominal	B-disease
pain	I-disease
,	O
diarrhea	B-disease
,	O
nausea	B-disease
and	O
vomiting	B-disease
x	O
1	O
week	O
,	O
who	O
presented	O
to	O
an	O
outside	O
hospital	O
.	O

She	O
was	O
transferred	O
to	O
Arbour	O
Hospital	O
on	O
2015-02-21	O
for	O
bowel	B-disease
obstruction	I-disease
,	O
ischemia	B-disease
and	O
worsening	B-disease
abdominal	I-disease
distention	I-disease
and	O
pain	B-disease
.	O

Past	O
Medical	O
History	O
:	O

CAD	B-disease
s/p	O
MI	B-disease
,	O
HTN	B-disease
,	O
DMII	B-disease

Social	O
History	O
:	O

Lives	O
independently	O
,	O
but	O
in	O
the	O
same	O
building	O
with	O
daughter	O
.	O

Amy	O
3	O
children	O
,	O
2	O
daughters	O
and	O
1	O
son	O
.	O

Daughter	O
Lurline	O
is	O
Durable	O
Power	O
of	O
Attorney	O
.	O

The	O
other	O
daughter	O
was	O
recently	O
in	O
a	O
car	O
accident	O
and	O
underwent	O
surgery	O
at	O
Saint	O
Vincent	O
Hospital	O
.	O

Family	O
History	O
:	O

NC	O

Physical	O
Exam	O
:	O

At	O
time	O
of	O
discharge	O
:	O

Afebrile	B-disease
,	O
VSS	O

A&O	O
X	O
3	O
,	O
NAD	B-disease

RRR	O

CTAB	O
,	O
mildly	B-disease
decreased	I-disease
breath	I-disease
sounds	I-disease
b/l	I-disease

Abd	O
soft	O
,	O
NT/ND	B-disease
,	O
+	O
bs	O
,	O
no	O
masses	B-disease
,	O
ostomy	O
in	O
RLQ	O
pink	O
,	O
with	O
stool	O

G-tube	O
in	O
place	O

LE	B-disease
trace	I-disease
edema	I-disease

Pertinent	O
Results	O
:	O

2014-02-21	O
12:20	O
PM	O
BLOOD	O
WBC	O
-	O
10.2	O
RBC	O
-	O
5.32	O
Hgb	O
-	O
14.9	O
Hct	O
-	O
43.4	O
MCV	O
-	O
82	O
MCH	O
-	O
28.0	O
MCHC	O
-	O
34.4	O
RDW	O
-	O
16.0	O
*	O
Plt	O
Ct	O
-	O
204	O

2014-02-21	O
12:20	O
PM	O
BLOOD	O
PT	O
-	O
12.9	O
PTT	O
-	O
32.5	O
INR(PT)	O
-	O
1.1	O

2014-02-21	O
12:20	O
PM	O
BLOOD	O
Glucose	O
-	O
345	O
*	O
UreaN	O
-	O
34	O
*	O
Creat	O
-	O
1.0	O
Na	O
-	O
137	O
K	O
-	O
4.3	O
Cl	O
-	O
99	O
HCO3	O
-	O
24	O
AnGap	O
-	O
18	O

2014-02-21	O
12:20	O
PM	O
BLOOD	O
ALT	O
-	O
17	O
AST	O
-	O
27	O
AlkPhos	O
-	O
119	O
*	O
Amylase	O
-	O
27	O
TotBili	O
-	O
0.9	O

2014-02-21	O
12:20	O
PM	O
BLOOD	O
Lipase	O
-	O
11	O

2014-02-21	O
12:20	O
PM	O
BLOOD	O
CK-MB	O
-	O
7	O
cTropnT	O
-<	O
0.01	O

2014-03-09	O
02:59	O
AM	O
BLOOD	O
cTropnT	O
-	O
0.21	O
*	O

2014-03-09	O
11:29	O
AM	O
BLOOD	O
CK-MB	O
-	O
35	O
*	O
MB	O
Indx	O
-	O
25.5	O
*	O
cTropnT	O
-	O
0.45	O
*	O

2014-03-09	O
07:52	O
PM	O
BLOOD	O
CK-MB	O
-	O
NotDone	O
cTropnT	O
-	O
0.55	O
*	O

2014-03-10	O
05:25	O
PM	O
BLOOD	O
cTropnT	O
-	O
0.42	O
*	O

2014-03-11	O
02:00	O
AM	O
BLOOD	O
cTropnT	O
-	O
0.45	O
*	O

2014-03-19	O
07:13	O
AM	O
BLOOD	O
CK-MB	O
-	O
3	O
cTropnT	O
-	O
0.19	O
*	O

2014-03-19	O
01:33	O
PM	O
BLOOD	O
CK-MB	O
-	O
NotDone	O
cTropnT	O
-	O
0.17	O
*	O

2014-03-21	O
09:58	O
AM	O
BLOOD	O
CK-MB	O
-	O
NotDone	O
cTropnT	O
-	O
0.06	O
*	O

03-07	O
wound	O
swab	O
:	O
VRE	B-disease

CT	O
Abd	O
02-21	O
:	O

1.	O
Markedly	B-disease
dilated	I-disease
colon	I-disease
throughout	O
ascending	O
,	O
transverse	O
,	O
and	O
descending	O
colon	O
with	O
air-fluid	B-disease
levels	I-disease
,	O
overall	O
unchanged	O
since	O
prior	O
study	O
performed	O
on	O
the	O
same	O
day	O
with	O
pneumatosis	B-disease
in	I-disease
the	I-disease
ascending	I-disease
colon	I-disease
.	O

Sigmoid	B-disease
diverticulosis	I-disease
with	O
focal	B-disease
narrowing	I-disease
of	I-disease
the	I-disease
sigmoid	I-disease
colon	I-disease
just	O
distal	O
to	O
the	B-disease
dilatation	I-disease
with	O
wall	B-disease
thickening	I-disease
,	O
due	O
to	O
diverticulitis	B-disease
.	O

This	O
area	O
can	O
be	O
a	O
leading	O
point	O
of	O
obstruction	B-disease
.	O

An	B-disease
underlying	I-disease
mass	I-disease
lesion	I-disease
or	O
cancer	B-disease
cannot	O
be	O
excluded	O
in	O
this	O
area	O
,	O
and	O
further	O
clinical	O
investigation	O
is	O
recommended	O
.	O

2.	O
Limited	O
evaluation	O
for	O
known	B-disease
sigmoid-vesicle	I-disease
fistula	I-disease
.	O

3.	O
Small	B-disease
amount	I-disease
of	I-disease
ascites	I-disease
,	O
somewhat	O
increased	O
anterior	O
to	O
the	O
liver	O
.	O

4.	O
Bilateral	B-disease
renal	I-disease
cysts	I-disease
.	O

5.	O
Heavy	B-disease
calcification	I-disease
of	I-disease
the	I-disease
aorta	I-disease
and	I-disease
SMA	I-disease
and	I-disease
its	I-disease
branches	I-disease
.	O

Due	O
to	O
atherosclerosis	B-disease
,	O
assessment	O
of	O
the	O
intraluminal	O
process	O
of	O
these	O
branches	O
is	O
limited	O
.	O

CTA/CT	O
abd	O
03-07	O
:	O

1.	O
No	O
evidence	O
of	O
pulmonary	B-disease
embolism	I-disease
.	O

Small	B-disease
bilateral	I-disease
pleural	I-disease
effusions	I-disease
with	O
compressive	B-disease
atelectasis	I-disease
.	O

2.	O
Left	B-disease
lower	I-disease
quadrant	I-disease
thick-walled	I-disease
peripherally	I-disease
enhancing	I-disease
fluid	I-disease
collection	I-disease
,	O
which	O
appears	O
to	O
communicate	O
with	O
the	O
sutured	O
end	O
of	O
the	O
proximal	O
sigmoid	O
colon	O
via	O
a	B-disease
small	I-disease
collection	I-disease
of	I-disease
extraluminal	I-disease
gas	I-disease
.	O

In	O
the	O
correct	O
clincial	O
setting	O
,	O
this	O
could	O
be	O
consistent	O
with	O
an	B-disease
abscess	I-disease
.	O

3.	O
Moderate	B-disease
intraabdominal	I-disease
ascites	I-disease
.	O

4.	O
Status	O
post	O
ileostomy	O
without	O
evidence	O
of	O
small-bowel	B-disease
obstruction	I-disease
.	O

5.	O
Distended	B-disease
gallbladder	I-disease
.	O

6.	O
Diverticulosis	B-disease
within	I-disease
the	I-disease
right	I-disease
remnant	I-disease
sigmoid	I-disease
colon	I-disease
.	O

03-21	O
VCUG	O
-	O
no	O
leak	B-disease

Brief	O
Hospital	O
Course	O
:	O

Ms	O
Crossman	O
was	O
admitted	O
on	O
2015-02-21	O
from	O
an	O
outside	O
hospital	O
to	O
the	O
ICU	O
.	O

Neuro	O
:	O
Developed	O
confusion	B-disease
during	O
her	O
first	O
5	O
days	O
in	O
the	O
ICU	O
.	O

Post-operatively	O
mental	O
status	O
improved	O
.	O

Intermitent	B-disease
delirium	I-disease
throughout	O
admission	O
.	O

Required	O
restraints	O
to	O
prevent	O
DC	O
of	O
pertinent	O
therapies	O
while	O
in	O
the	O
ICU	O
.	O

Currently	O
AAOx3	O
.	O

Cardiovascular	O
:	O
Complained	O
of	O
chest	B-disease
pain	I-disease
during	O
first	O
few	O
days	O
of	O
admission	O
,	O
a	O
cardiology	O
consult	O
was	O
obtained	O
.	O

She	O
recieved	O
serial	O
enzymes	O
and	O
EKGs	O
.	O

Troponins	O
remained	O
mildly	B-disease
elevated	I-disease
as	O
high	O
as	O
0.6	O
throughout	O
her	O
admission	O
,	O
and	O
most	O
recent	O
result	O
now	O
0.1	O
.	O

She	O
was	O
treated	O
in	O
IUC	O
for	O
unstable	B-disease
angina	I-disease
with	O
nitroglycerin	O
.	O

It	O
was	O
recommended	O
to	O
maximize	O
her	O
medical	O
treatment	O
with	O
Beta	O
blockers	O
,	O
aspirin	O
,	O
a	O
statin	O
and	O
an	O
ACE	O
Inhibitor	O
.	O

Required	O
diuresis	O
of	O
>	O
9	O
L	O
while	O
in	O
the	O
ICU	O
,	O
after	O
2nd	O
surgery	O
.	O

Continues	O
to	O
have	O
trace	B-disease
lower	I-disease
extremity	I-disease
edema	I-disease
,	O
and	O
recieves	O
lasix	O
po	O
.	O

Respiratory	O
:	O
She	O
was	O
intubated	O
briefly	O
post-op	O
subtotal	O
colectomy	O
and	O
again	O
for	O
several	O
days	O
after	O
second	O
surgery	O
.	O

Recieved	O
nebulizer	O
treatments	O
post-op	O
in	O
the	O
ICU	O
,	O
after	O
successfully	O
extubated	O
.	O

Gastrointestinal	O
:	O
Her	O
initial	O
CT	O
scan	O
showed	O
dilated	B-disease
Turner	I-disease
colon	I-disease
,	O
wall	B-disease
thickening	I-disease
and	O
pneumatosis	B-disease
see	O
pertinent	O
results	O
.	O

She	O
was	O
initially	O
treated	O
nonoperatively	O
with	O
IV	O
fluids	O
,	O
antibiotics	O
,	O
serial	O
exams	O
and	O
NGT	O
decompression	O
.	O

On	O
HD#5	O
flexible	O
sigmoidoscopy	O
was	O
performed	O
for	O
colonic	O
decompression	O
.	O

On	O
HD#6	O
,	O
colonscopy	O
was	O
performed	O
for	O
decompression	O
,	O
and	O
revealed	O
pseudomembrane	B-disease
and	O
friable	B-disease
colonic	I-disease
tissue	I-disease
.	O

Her	O
abdomen	O
remained	O
tender	B-disease
and	O
distended	B-disease
despite	O
attempted	O
decompression	O
.	O

She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
Subtotal	O
Colectomy	O
,	O
G	O
tube	O
and	O
ileostomy	O
due	O
to	O
unresponsiveness	B-disease
to	O
non-operative	O
treatment	O
.	O

Ileostomy	O
remains	O
pink	O
and	O
intact	O
,	O
draining	O
green-brown	O
soft	O
stool	O
.	O

Her	O
post-operative	O
course	O
continued	O
uneventfully	O
in	O
the	O
ICU	O
,	O
and	O
she	O
was	O
transferred	O
to	O
the	O
floor	O
POD#6	O
.	O

She	O
developed	O
additional	B-disease
abdominal	I-disease
tenderness	I-disease
and	O
distention	B-disease
.	O

Her	O
HCT	O
dropped	O
and	O
she	O
recieved	O
1	O
unit	O
PRBCs	O
.	O

Geriatric	O
consult	O
was	O
obtained	O
to	O
assist	O
with	O
management	O
.	O

On	O
POD#8	O
a	O
CT	O
scan	O
was	O
obtained	O
which	O
revealed	O
an	B-disease
abcess	I-disease
with	O
a	B-disease
colovesicular	I-disease
fistula	I-disease
.	O

She	O
was	O
taken	O
to	O
the	O
OR	O
for	O
exploration	O
and	O
drainage	O
.	O

She	O
recieved	O
further	O
resection	O
of	O
remaining	O
colon	O
,	O
repair	O
of	O
a	B-disease
leak	I-disease
from	I-disease
Relaford	I-disease
pouch	I-disease
and	O
repair	O
of	O
colovesicular	B-disease
fistula	I-disease
.	O

After	O
her	O
2nd	O
surgery	O
she	O
returned	O
to	O
the	O
ICU	O
and	O
improved	O
steadily	O
.	O

Abdomen	O
remained	O
soft	O
and	O
nontender	B-disease
.	O

She	O
remained	O
on	O
IV	O
antibiotics	O
x	O
14	O
days	O
and	O
required	O
pressors	O
for	O
the	O
first	O
few	O
days	O
post-op	O
.	O

Her	B-disease
incision	I-disease
has	O
remained	O
clean	O
,	O
dry	O
,	O
intact	O
,	O
with	O
staples	O
removed	O
on	O
POD#	O
27/18	O
.	O

Genitourinary	O
:	O
She	O
had	O
a	O
foley	O
catheter	O
from	O
the	O
time	O
of	O
admission	O
.	O

POD#	O
23/14	O
she	O
recieved	O
a	O
cystoscopy	O
which	O
revealed	O
no	O
leak	B-disease
.	O

Her	O
foley	O
was	O
subsequently	O
dc	O
'd	O
.	O

Musculoskeletal	O
:	O
Has	O
suffered	O
significant	B-disease
deconditioning	I-disease
since	O
admission	O
,	O
but	O
has	O
consisitently	O
recieved	O
PT	O
.	O

See	O
PT	O
note	O
for	O
further	O
assessment	O
and	O
discussion	O
.	O

Nutrition	O
:	O
She	O
was	O
held	O
NPO	O
at	O
admission	O
,	O
and	O
initiated	O
on	O
TPN	O
by	O
HD#3	O
.	O

Post-operatively	O
she	O
began	O
on	O
TF	O
s,	O
and	O
the	O
TPN	O
was	O
weaned	O
down	O
.	O

By	O
POD#	O
05-29	O
she	O
was	O
having	O
high	B-disease
residuals	I-disease
on	O
TF	O
s,	O
so	O
TPN	O
was	O
reinitiated	O
.	O

Tf	O
's	O
were	O
dc	O
'ed	O
prior	O
to	O
second	O
surgery	O
.	O

POD#	O
15/6	O
,	O
she	O
resumed	O
TF	O
's	O
and	O
TPN	O
was	O
tapered	O
again	O
.	O

TF	O
goals	O
were	O
achieved	O
and	O
TPN	O
dc	O
'ed.	O

A	O
diet	O
by	O
mouth	O
was	O
initiated	O
.	O

At	O
time	O
of	O
discharge	O
she	O
is	O
tolerating	O
a	O
regular	O
diet	O
with	O
TF	O
's	O
at	O
goal	O
.	O

Patient	O
is	O
an	B-disease
insulin	I-disease
dependent	I-disease
diabetic	I-disease
.	O

She	O
was	O
followed	O
by	O
Cape	O
Cod	O
Hospital	O
Clinic	O
for	O
treatment	O
of	O
persistent	B-disease
hyperglycemia	I-disease
.	O

Pain	B-disease
:	O
Her	B-disease
pain	I-disease
was	O
controlled	O
with	O
IV	O
pain	O
medicines	O
while	O
in	O
ICU	O
.	O

She	O
has	O
been	O
adequately	O
controlled	O
with	O
Tylenol	O
,	O
Motrin	O
&	O
Oxycodone	O
by	O
mouth	O
,	O
per	O
recommendations	O
by	O
Geriatrics	O
.	O

POD#	O
22/15	O
Ms	O
Crossman	O
was	O
transferred	O
to	O
3	O
North	O
where	O
she	O
continued	O
to	O
progress	O
well	O
with	O
PT	O
,	O
increasing	O
PO	O
intake	O
,	O
tolerating	O
TF	O
s,	O
and	O
weaning	O
from	O
nasal	O
cannula	O
oxygen	O
.	O

She	O
has	O
remained	O
stable	O
with	O
no	O
acute	B-disease
events	I-disease
.	O

She	O
is	O
discharged	O
to	O
rehab	O
on	O
POD#	O
27/18	O
.	O

Medications	O
on	O
Admission	O
:	O

Norvasc	O

Atenolol	O

Isosorbide	O

Lasix	O

Insulin	O

Discharge	O
Medications	O
:	O

1.	O
Heparin	O
(	O
Porcine	O
)	O
5,000	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
mL	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

2.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

3.	O
Polyvinyl	O
Alcohol	O
-	O
Povidone	O
1.4-0.6	O
%	O
Dropperette	O
Sig	O
:	O
02-25	O
Drops	O
Ophthalmic	O
PRN	O
(	O
as	O
needed	O
).	O

4.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

5.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

7.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

8.	O
Furosemide	O
40	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

9.	O
Ipratropium	O
Bromide	O
17	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
.	O

10.	O
Albuterol	O
90	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
1-2	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
.	O

11.	O
Oxycodone	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-disease
.	O

12.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

13.	O
Potassium	O
Chloride	O
20	O
mEq	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tab	O
Sust	O
.	O
Rel	O
.	O
Particle	O
/	O
Crystal	O
PO	O
once	O
a	O
day	O
.	O

14.	O
Glargine	O
Sig	O
:	O
Twenty	O
Two	O
(	O
22	O
)	O
units	O
at	O
bedtime	O
.	O

15.	O
Miconazole	O
Nitrate	O
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

16.	O
Miconazole	O
Nitrate	O
2	O
%	O
Cream	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

17.	O
Ibuprofen	O
100	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
Twenty	O
(	O
20	O
)	O
mL	O
PO	O
Q8H	O
(	O
every	O
8	O
hours	O
)	O
as	O
needed	O
.	O

18.	O
Debrox	O
6.5	O
%	O
Drops	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
Drop	O
Otic	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
5	O
days	O
:	O
both	O
ears	O
.	O

19.	O
Trazodone	O
50	O
mg	O
Tablet	O
Sig	O
:	O
1	O
/	O
2-1	O
Tablet	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Hurtado	B-disease
Colon	I-disease

Diverticulitis	B-disease

S/P	O
Subtotal	O
Colectomy	O
,	O
Ileostomy	O
,	O
Gastrostomy	O
tube	O

S/P	O
Exploratory	O
laparotomy	O
,	O
resection	O
of	O
small	O
intestine	O
with	O
primary	O
anastomosis	O
,	O
Sigmoid	O
colectomy	O
,	O
repair	O
of	O
colovesicular	B-disease
fistula	I-disease

Unstable	B-disease
Angina	I-disease

Discharge	O
Condition	O
:	O

stable	O

Discharge	O
Instructions	O
:	O

Please	O
call	O
the	O
surgeon	O
or	O
return	O
to	O
the	O
Emergency	O
Department	O
if	O
you	O
develop	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
fever	B-disease
greater	I-disease
than	I-disease
101.5	I-disease
,	O
foul	B-disease
smelling	I-disease
or	I-disease
colorful	I-disease
drainage	I-disease
from	O
your	B-disease
incisions	I-disease
,	O
redness	B-disease
or	O
swelling	B-disease
,	O
severe	B-disease
abdominal	I-disease
pain	I-disease
or	O
distention	B-disease
,	O
persistent	B-disease
nausea	I-disease
or	O
vomiting	B-disease
,	O
inability	B-disease
to	I-disease
eat	I-disease
or	I-disease
drink	I-disease
,	O
or	O
any	O

other	B-disease
symptoms	I-disease
which	O
are	O
concerning	O
to	O
you	O
.	O

No	O
tub	O
baths	O
or	O
swimming	O
.	O

You	O
may	O
shower	O
.	O

If	O
there	O
is	O
clear	B-disease
drainage	I-disease
from	O
your	B-disease
incisions	I-disease
,	O
cover	O
with	O
a	O
dry	O
dressing	O
.	O

Leave	O
white	O
strips	O
above	O
your	B-disease
incisions	I-disease
in	O
place	O
,	O
allow	O
them	O
to	O
fall	O
off	O
on	O
their	O
own	O
.	O

Activity	O
:	O
No	O
heavy	O
lifting	O
of	O
items	O
12-08	O
pounds	O
until	O
the	O
follow	O
up	O
appointment	O
with	O
your	O
doctor	O
.	O

Medications	O
:	O
Resume	O
your	O
home	O
medications	O
.	O

You	O
should	O
take	O
a	O
stool	O
softener	O
,	O
Colace	O
100	O
mg	O
twice	O
daily	O
as	O
needed	O
for	O
constipation	B-disease
.	O

You	O
will	O
be	O
given	O
pain	O
medication	O
which	O
may	O
make	O
you	O
drowsy	B-disease
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Joe	O
Kari	O
,	O
MD	O
Phone	O
:(	O
625	O
)	O
747-8259	O

Date	O
/	O
Time	O
:	O
2014-04-11	O
1:15	O

Joe	O
Kari	O
MD	O
09-697	O

Completed	O
by	O
:	O
Carol	O
Robert	O
NP	O
80-CIY	O
2014-03-25	O
@	O
0837	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marion	O
SCHNEIDER	O
on	O
:	O
Sandra	O
2014-03-25	O
12:56	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-06-12	O

Discharge	O
Date	O
:	O

2013-06-25	O

Date	O
of	O
Birth	O
:	O

1943-03-31	O

Sex	O
:	O

M	O

Service	O
:	O

TRA	O

ADDENDUM	O
:	O

This	O
is	O
a	O
discharge	O
summary	O
addendum	O
for	O
Discharge	O
Summary	O
number	O
554108	O
.	O

As	O
follows	O
.	O

Patient	O
was	O
discharged	O
to	O
rehabilitation	O
on	O
2013-06-25	O
.	O

Discharge	O
was	O
delayed	O
by	O
one	O
day	O
to	O
ensure	O
patient	O
could	O
tolerate	O
P.O.	O
which	O
patient	O
did	O
without	O
difficulty	B-disease
.	O

Please	O
see	O
original	O
Discharge	O
Summary	O
for	O
discharge	O
medications	O
.	O

Josh	O
Harry	O
,	O
Missouri	O
43478	O

Dictated	O
By	O
:	O
Joe	O
J.	O
T.	O
Gochenour	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-06-25	O
07:58:05	O

T	O
:	O
2013-06-25	O
08:07:03	O

Job	O
#:	O

79141	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Clara	O
M.	O
Odell	O
on	O
:	O
WED	O
2013-06-26	O
9:58	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2009-05-01	O

Discharge	O
Date	O
:	O

Date	O
of	O
Birth	O
:	O

1969-05-19	O

Sex	O
:	O

M	O

Service	O
:	O

Surgery	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
39	O
year-old	O
gentleman	O
admitted	O
on	O
2009-05-01	O
to	O
the	O
Jewish	O
Memorial	O
Hospital	O
referred	O
from	O
South	O
Cove	O
Community	O
Health	O
Center	O
.	O

He	O
is	O
a	O
39	O
year-old	O
gentleman	O
with	O
hyperlipidemia	B-disease
and	O
smoking	O
who	O
presented	O
with	O
acute	O
onset	O
of	O
chest	B-disease
pain	I-disease
since	O
five	O
in	O
the	O
morning	O
with	O
radiation	O
to	O
the	O
left	O
arm	O
and	O
nausea	B-disease
.	O

Symptoms	B-disease
resolved	O
spontaneously	O
.	O

He	O
was	O
taken	O
to	O
the	O

Cath	O
Lab	O
at	O
the	O
Pinewood	O
,	O
Norfolk	O
that	O
evening	O
where	O
a	O
stent	O
procedure	O
to	O
the	O
RCA	O
was	O
complicated	O
by	O
guidewire	O
entrapment	O
inside	O
of	O
a	O
stent	O
requiring	O
CT	O
surgery	O
to	O
do	O
a	O
thoracotomy	O
with	O
bypass	O
and	O
excision	O
of	O
the	O
wire	O
.	O

The	O
case	O
was	O
complicated	O
by	O
an	O
episode	O
of	O
coffee	B-disease
ground	I-disease
emesis	I-disease
and	O
a	B-disease
bleed	I-disease
from	I-disease
femoral	I-disease
access	I-disease
site	I-disease
prior	O
to	O
CT	O
surgery	O
.	O

Gastroenterology	O
was	O
consulted	O
and	O
they	O
recommended	O
Protonix	O
and	O
felt	O
it	O
was	O
due	O
to	O
peptic	B-disease
ulcer	I-disease
disease	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hepatitis	B-disease
B	I-disease
.	O

2.	O
Hypercholesterolemia	B-disease
.	O

3.	O
Fatty	B-disease
liver	I-disease
resolved	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Relatively	O
unknown	O
other	O
than	O
Lipitor	O
.	O

ALLERGIES	O
:	O
He	O
had	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
smokes	O
one	O
pack	O
per	O
day	O
.	O

He	O
works	O
as	O
a	O
jeweler	O
.	O

He	O
lives	O
at	O
home	O
with	O
his	O
wife	O
.	O

FAMILY	O
HISTORY	O
:	O
Not	O
significant	O
for	O
coronary	B-disease
artery	I-disease
disease	I-disease
.	O

Please	O
note	O
the	O
patient	O
is	O
only	O
Caucasian	O
speaking	O
and	O
information	O
is	O
second	O
hand	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
diagnosed	O
as	O
having	O
an	B-disease
acute	I-disease
myocardial	I-disease
infarction	I-disease
.	O

The	O
patient	O
was	O
taken	O
emergently	O
to	O
the	O
operating	O
room	O
on	O
2009-05-02	O
for	O
his	O
CABG	O
,	O
right	O
coronary	O
endarterectomy	O
,	O
removal	O
of	O
RCA	O
stents	O
and	O
retrieval	O
of	O
the	O
aortic	O
guidewire	O
.	O

Postoperatively	O
he	O
did	O
well	O
and	O
was	O
transferred	O
to	O
the	O
Cardiac	O
Surgery	O
Intensive	O
Care	O
Unit	O
where	O
he	O
was	O
on	O
pressor	O
support	O
of	O
Neo-Synephrine	O
and	O
he	O
was	O
extubated	O
.	O

The	O
patient	O
slowly	O
weaned	O
off	O
Neo-Synephrine	O
as	O
tolerated	O
.	O

He	O
was	O
transferred	O
to	O
the	O
floor	O
on	O
2009-05-04	O
.	O

His	O
chest	O
tube	O
had	O
been	O
discontinued	O
.	O

Upon	O
arrival	O
to	O
the	O
floor	O
the	O
patient	O
's	O
wires	O
were	O
discontinued	O
on	O
2009-05-05	O
and	O
his	O
Foley	O
catheter	O
was	O
discontinued	O
.	O

The	O
patient	O
was	O
seen	O
by	O
Physical	O
Therapy	O
.	O

His	O
electrolytes	O
were	O
repleted	O
and	O
the	O
patient	O
was	O
discharged	O
home	O
on	O
2009-05-06	O
after	O
tolerating	O
a	O
level	O
V	O
.	O

MEDICATIONS	O
:	O
His	O
prescriptions	O
shall	O
include	O

1.	O
Lopressor	O
25	O
milligrams	O
po	O
bid	O
.	O

2.	O
Lipitor	O
20	O
milligrams	O
po	O
q	O
HS	O
.	O

3.	O
Niferex	O
150	O
milligrams	O
caplet	O
one	O
cap	O
per	O
day	O
.	O

4.	O
Protonix	O
40	O
milligrams	O
po	O
q	O
day	O
.	O

5.	O
Colace	O
100	O
milligrams	O
po	O
bid	O
.	O

6.	O
Percocet	O
one	O
to	O
two	O
tablets	O
q	O
four	O
H	O
prn	O
for	O
pain	B-disease
.	O

He	O
will	O
get	O
60	O
of	O
those	O
.	O

7.	O
Plavix	O
75	O
milligrams	O
po	O
q	O
day	O
times	O
three	O
months	O
.	O

8.	O
Aspirin	O
325	O
milligrams	O
po	O
q	O
day	O
.	O

9.	O
Lasix	O
20	O
milligrams	O
po	O
times	O
30	O
days	O
.	O

10.	O
KCL	O
20	O
milliequivalents	O
po	O
q	O
d	O
times	O
three	O
days	O
.	O

DISCHARGE	O
FOLLOW	O
UP	O
:	O
The	O
patient	O
is	O
to	O
follow	O
up	O
with	O
Dr.	O
Debra	O
Oneal	O
,	O
his	O
PCP	O
and	O
his	O
cardiologist	O
in	O
3	O
weeks	O
.	O

Saul	O
N.	O
Keehne	O
,	O
M.D.	O

Dictated	O
By	O
:	O
Shirley	O
Y	O
Waler	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-05-06	O
11:12	O

T	O
:	O
2009-05-06	O
11:34	O

JOB	O
#:	O

20629	O

Signed	O
electronically	O
by	O
:	O
DR.	O
William	O
Spencer	O
on	O
:	O
WED	O
2009-05-06	O
12:20	O
PM	O

(	O
End	O
of	O
Report	O
)	O

101407944	O
PUMC	O

3925529	O

441763	O

2345939	O

4/30/2005	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

CAUGH	O
,	O
DI	O
K	O

UNIT	O
NUMBER	O
:	O

569-82-26	O

ADMISSION	O
DATE	O
:	O

04/30/2005	O

DISCHARGE	O
DATE	O
:	O

5/14/05	O
05/14/2005	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-disease
parietal	I-disease
occipital	I-disease
temporal	I-disease
tumor	I-disease
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

5/5/05	O
right	O
parietal	O
occipital	O
craniotomy	O
and	O
debulking	O
of	O
tumor	O
using	O
stulz	O
neuro	O
navigation	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
pleasant	O
83-year-old	O
retired	O
psychiatrist	O
who	O
presents	O
with	O
a	O
chief	O
complaint	O
of	O
gait	B-disease
difficulty	I-disease
for	O
the	O
last	O
five	O
to	O
six	O
months	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
laryngeal	B-disease
cancer	I-disease
in	O
2000	O
and	O
2001	O
,	O
CVA	B-disease
in	O
2001	O
to	O
2002	O
and	O
hypertension	B-disease
,	O
who	O
has	O
a	O
six	O
month	O
history	O
of	O
progressive	B-disease
difficulty	I-disease
in	I-disease
ambulation	I-disease
.	O

The	O
patient	O
was	O
in	O
previously	O
good	O
health	O
when	O
he	O
reports	O
starting	O
to	O
notice	O
problems	B-disease
ambulating	I-disease
about	O
six	O
months	O
ago	O
.	O

His	O
partner	O
also	O
reports	O
that	O
he	O
has	O
been	O
having	O
more	B-disease
difficulty	I-disease
with	I-disease
ADLs	I-disease
.	O

He	O
reported	O
that	O
he	O
began	O
with	O
difficulty	B-disease
buttoning	I-disease
his	I-disease
shirt	I-disease
for	O
many	O
years	O
since	O
after	O
a	B-disease
stroke	I-disease
but	O
now	O
reports	O
that	O
on	O
occasion	O
she	O
would	O
ask	O
him	O
why	O
he	O
was	O
doing	O
certain	O
things	O
and	O
he	O
could	O
not	O
give	O
a	O
concrete	O
example	O
.	O

The	O
patient	O
was	O
having	O
a	B-disease
hard	I-disease
time	I-disease
walking	I-disease
and	O
reports	O
that	O
he	O
has	O
felt	O
weaker	O
.	O

He	O
has	O
had	O
uncoordination	B-disease
of	I-disease
his	I-disease
feet	I-disease
and	O
began	O
having	O
a	O
cane	O
four	O
to	O
five	O
months	O
ago	O
with	O
the	B-disease
increasing	I-disease
weakness	I-disease
.	O

This	O
was	O
especially	O
bad	O
when	O
trying	O
to	O
arise	O
.	O

The	O
patient	O
has	O
seen	O
his	O
primary	O
care	O
physician	O
who	O
referred	O
him	O
to	O
physical	O
therapy	O
for	O
his	B-disease
gait	I-disease
weakness	I-disease
but	O
his	B-disease
symptoms	I-disease
failed	O
to	O
improve	O
.	O

He	O
continued	O
to	O
progress	O
until	O
two	O
weeks	O
prior	O
to	O
admission	O
when	O
he	O
was	O
found	O
in	O
the	O
bathtub	O
,	O
unsteady	B-disease
and	O
fell	O
trying	O
to	O
steady	O
himself	O
.	O

The	O
patient	O
could	O
not	O
be	O
moved	O
and	O
had	O
to	O
have	O
911	O
called	O
for	O
help	O
.	O

Since	O
that	O
time	O
he	O
had	O
been	O
ambulating	O
with	O
a	O
walker	O
and	O
has	O
had	O
increasing	B-disease
difficulty	I-disease
with	I-disease
falls	I-disease
in	O
the	O
last	O
two	O
weeks	O
.	O

The	O
patient	O
was	O
again	O
seen	O
by	O
his	O
primary	O
care	O
physician	O
and	O
a	O
CG	O
scan	O
revealed	O
a	B-disease
mass	I-disease
in	I-disease
the	I-disease
right	I-disease
parietal	I-disease
lobe	I-disease
.	O

The	O
patient	O
was	O
referred	O
to	O
the	O
Neurology	O
Service	O
for	O
further	O
workup	O
of	O
the	B-disease
mass	I-disease
.	O

The	O
patient	O
denied	O
blurry	B-disease
vision	I-disease
,	O
headache	B-disease
,	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
paresthesias	B-disease
,	O
pain	B-disease
in	I-disease
mental	I-disease
status	I-disease
,	O
confusion	B-disease
or	O
seizures	B-disease
.	O

The	O
patient	O
is	O
status	O
post	O
radiation	O
therapy	O
and	O
resection	O
and	O
reconstruction	O
for	O
his	B-disease
laryngeal	I-disease
cancer	I-disease
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Positive	B-disease
weakness	I-disease
,	O
otherwise	O
negative	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-disease
,	O
CVA	B-disease
2001	O
,	O
2002	O
diabetes	B-disease
,	O
laryngeal	B-disease
cancer	I-disease
,	O
right	O
CEA	O
,	O
prostatectomy	O
for	O
BPH	B-disease
,	O
total	O
knee	O
replacement	O
,	O
status	O
post	O
appendectomy	O
.	O

MEDICATIONS	O
PRIOR	O
TO	O
ADMISSION	O
:	O

Plavix	O
75	O
mg	O
every	O
day	O
,	O
Lipitor	O
40	O
mg	O
every	O
day	O
,	O
HCTZ	O
50	O
mg	O
,	O
Monopril	O
10	O
mg	O
every	O
day	O
,	O
Viagra	O
100	O
mg	O
prn	O
.	O

ALLERGIES	O
:	O

NKDA	B-disease
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
with	O
CAD	B-disease
at	O
90	O
,	O
diabetes	B-disease
,	O
CVA	B-disease
,	O
hypercholesterolemia	B-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
has	O
one	O
to	O
two	O
pack	O
x20	O
year	O
history	O
of	O
smoking	O
that	O
was	O
30	O
years	O
ago	O
.	O

He	O
reports	O
occasional	O
alcohol	O
use	O
and	O
no	O
illicits	O
.	O

The	O
patient	O
is	O
a	O
retired	O
psychiatrist	O
who	O
lives	O
in	O
Ph	O
.	O

PHYSICAL	O
EXAM	O
:	O

Afebrile	B-disease
,	O
vital	O
signs	O
stable	O
but	O
notable	O
for	O
a	O
blood	O
pressure	O
of	O
164/80	O
.	O

Generally	O
a	O
well	O
developed	O
elderly	O
man	O
in	O
no	O
apparent	B-disease
distress	I-disease
sitting	O
in	O
bed	O
.	O

HEENT	O
;	O

extraocular	O
movements	O
intact	O
.	O

Pupils	O
equally	O
round	O
and	O
reactive	O
to	O
light	O
.	O

No	O
nystagmus	B-disease
.	O

No	O
retinal	B-disease
hemorrhages	I-disease
.	O

External	O
ears	O
normal	O
.	O

Moist	O
buccal	O
mucosa	O
,	O
poor	B-disease
dentition	I-disease
,	O
no	O
erythema	B-disease
or	I-disease
exudates	I-disease
in	I-disease
the	I-disease
posterior	I-disease
pharynx	I-disease
.	O

Neck	O
supple	O
.	O

Prominent	B-disease
salivary	I-disease
glands	I-disease
bilaterally	I-disease
.	O

No	O
other	B-disease
masses	I-disease
or	O
thyromegaly	B-disease
noted	O
.	O

No	O
cervical	B-disease
,	I-disease
para-auricular	I-disease
or	I-disease
clavicular	I-disease
lymphadenopathy	I-disease
.	O

Chest	O
:	O

Crackles	B-disease
in	I-disease
the	I-disease
right	I-disease
lung	I-disease
field	I-disease
.	O

No	O
egophony	B-disease
.	O

Heart	O
:	O

no	O
palpable	B-disease
thrill	I-disease
or	O
heave	B-disease
.	O

S1	O
,	O
S2	O
.	O

3/6	B-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
heard	O
best	O
at	O
the	O
apex	O
.	O

Pulses	O
2+	O
carotids	O
bilaterally	O
,	O
2+	O
radial	O
pulses	O
,	O
2+	O
DP	O
pulses	O
bilaterally	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
positive	O
bowel	O
sounds	O
.	O

No	O
hepato	B-disease
or	O
splenomegaly	B-disease
.	O

Right	B-disease
lower	I-disease
quadrant	I-disease
scar	I-disease
and	O
inferior	B-disease
midline	I-disease
scar	I-disease
that	O
are	O
well	O
healed	O
.	O

Back	O
:	O

No	O
CVA	B-disease
tenderness	I-disease
.	O

Skin	O
:	O

No	O
petechiae	B-disease
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
grossly	O
intact	O
with	O
a	B-disease
slight	I-disease
deviation	I-disease
of	I-disease
the	I-disease
uvula	I-disease
and	I-disease
tongue	I-disease
to	O
the	O
right	O
.	O

There	O
is	O
increased	B-disease
tone	I-disease
in	I-disease
his	I-disease
right	I-disease
upper	I-disease
extremity	I-disease
with	O
a	B-disease
slight	I-disease
left	I-disease
pronator	I-disease
drift	I-disease
.	O

On	O
the	O
right	O
side	O
his	O
strength	O
was	O
5	O
out	O
5	O
.	O

On	O
the	O
left	O
side	O
it	O
is	O
4	O
out	O
of	O
5	O
in	O
the	O
lower	O
extremities	O
.	O

The	O
patient	O
has	O
an	B-disease
intention	I-disease
tremor	I-disease
with	I-disease
the	I-disease
left	I-disease
hand	I-disease
.	O

His	O
reflexes	O
were	O
symmetric	O
with	O
upgoing	O
toes	O
.	O

There	O
was	O
a	O
plantar	O
grasp	O
present	O
on	O
the	O
left	O
hand	O
.	O

Graphesthesia	O
was	O
poor	O
in	O
both	O
hands	O
.	O

His	O
gait	O
was	O
unsteady	O
and	O
he	O
was	O
unable	O
to	O
stand	O
on	O
his	O
own	O
.	O

Mental	O
status	O
:	O

he	O
was	O
alert	O
and	O
oriented	O
x3	O
.	O

RELEVANT	O
LABORATORY	O
DATA	O
:	O

White	O
blood	O
cell	O
count	O
on	O
admission	O
6.1	O
,	O
INR	O
on	O
admission	O
1.0	O
,	O
relevant	O
imaging	O
.	O

Echocardiogram	O
June	O
2004	O
showed	O
an	O
EF	O
of	O
77%	O
.	O

Chest	O
xray	O
reveals	O
no	O
consolidation	B-disease
or	O
signs	B-disease
of	I-disease
edema	I-disease
.	O

CT	O
shows	O
a	B-disease
right	I-disease
parietal	I-disease
hyperdense	I-disease
and	I-disease
heterogenously	I-disease
enhancing	I-disease
mass	I-disease
measuring	O
6.5	O
x	O
5	O
cm	O
with	O
the	B-disease
surrounding	I-disease
vasogenic	I-disease
edema	I-disease
in	O
effacement	O
of	O
the	O
right	O
lateral	O
ventricle	O
.	O

The	O
finding	O
was	O
most	O
consistent	O
with	O
metastatic	B-disease
disease	I-disease
and	O
less	O
likely	O
primary	B-disease
CNS	I-disease
neoplasm	I-disease
such	O
as	O
glioblastoma	B-disease
.	O

MRI	O
showed	O
a	B-disease
large	I-disease
heterogenous	I-disease
enhancing	I-disease
right	I-disease
parietal	I-disease
mass	I-disease
lesion	I-disease
with	O
a	O
possible	O
ependymal	B-disease
spread	I-disease
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Neurologic	O
Service	O
for	O
workup	O
of	O
his	B-disease
tumor	I-disease
.	O

The	O
neuro-oncologist	O
felt	O
that	O
because	O
of	O
the	B-disease
tremendous	I-disease
tumor	I-disease
burden	I-disease
that	O
was	O
likely	O
causing	O
his	B-disease
symptoms	I-disease
the	O
patient	O
will	O
require	O
open	O
debulking	O
as	O
well	O
as	O
obtaining	O
issue	O
for	O
a	O
pathologic	O
diagnosis	O
.	O

Thea	O
patient	O
was	O
referred	O
to	O
Dr.	O
Coma	O
of	O
the	O
Eragnes	O
Houseco	O
Ardbay	O
Memorial	O
Hospital	O
.	O

On	O
May	O
5	O
,	O
2005	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
a	O
right	O
parietal	O
occipital	O
craniotomy	O
and	O
debulking	O
of	O
the	B-disease
tumor	I-disease
using	O
stulz	O
neuro	O
navigation	O
.	O

Please	O
see	O
the	O
separately	O
dictated	O
operative	O
report	O
for	O
further	O
details	O
of	O
the	O
procedure	O
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
recovery	O
room	O
and	O
then	O
to	O
the	O
postoperative	O
floor	O
in	O
stable	O
condition	O
.	O

Of	O
note	O
the	O
patient	O
was	O
seen	O
by	O
cardiology	O
for	O
preoperative	O
assessment	O
.	O

The	O
patient	O
was	O
also	O
seen	O
by	O
physical	O
and	O
occupational	O
therapy	O
during	O
his	O
postoperative	O
course	O
and	O
they	O
recommended	O
that	O
he	O
go	O
to	O
a	O
rehabilitation	O
facility	O
for	O
his	O
recovery	O
.	O

A	O
postoperative	O
MRI	O
was	O
obtained	O
which	O
revealed	O
no	O
remarkable	B-disease
findings	I-disease
but	O
only	O
post	B-disease
surgical	I-disease
changes	I-disease
.	O

Transcranial	O
Dopplers	O
were	O
checked	O
following	O
surgery	O
and	O
the	O
patient	O
was	O
started	O
on	O
Decadron	O
4	O
mg	O
q6	O
to	O
prevent	O
swelling	B-disease
.	O

The	O
patient	O
was	O
started	O
on	O
Fragmin	O
for	O
DVT	O
prophylaxis	O
and	O
the	O
patient	O
was	O
also	O
started	O
on	O
Dilantin	O
levels	O
.	O

Of	O
note	O
on	O
5/9/05	O
the	O
patient	O
was	O
seen	O
by	O
Urology	O
due	O
to	O
an	B-disease
inability	I-disease
to	I-disease
void	I-disease
and	O
a	O
16	O
French	O
Coude	O
catheter	O
was	O
placed	O
.	O

The	O
patient	O
then	O
was	O
given	O
voiding	O
trials	O
but	O
eventually	O
he	O
needed	O
to	O
be	O
straight	O
cathed	O
prn	O
.	O

At	O
the	O
time	O
of	O
transfer	O
,	O
a	O
16	O
Coude	O
catheter	O
was	O
in	O
place	O
and	O
draining	O
well	O
.	O

The	O
patient	O
can	O
have	O
voiding	O
trials	O
at	O
rehab	O
and	O
he	O
is	O
being	O
maintained	O
on	O
Flomax	O
.	O

The	O
patient	O
had	O
a	O
relatively	O
unremarkable	O
course	O
and	O
his	O
neurologic	O
status	O
continued	O
to	O
improve	O
following	O
the	O
operation	O
.	O

At	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
was	O
alert	O
and	O
oriented	O
x3	O
and	O
able	O
to	O
swallow	O
pureed	O
and	O
thick	O
diet	O
without	O
a	O
problem	O
.	O

On	O
5/11/05	O
repeat	O
imaging	O
revealed	O
some	B-disease
edema	I-disease
and	O
mass	B-disease
affect	I-disease
.	O

The	O
patient	O
was	O
given	O
an	O
IV	O
load	O
of	O
Decadron	O
and	O
restarted	O
on	O
IV	O
Decadron	O
which	O
was	O
eventually	O
transferred	O
to	O
po	O
Decadron	O
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
Mannitol	O
.	O

His	O
pathology	O
came	O
back	O
as	O
a	B-disease
large	I-disease
grade	I-disease
IV	I-disease
glioma	I-disease
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
pain	I-disease
was	O
initially	O
controlled	O
with	O
IV	O
pain	O
medications	O
but	O
at	O
the	O
time	O
of	O
discharge	O
to	O
the	O
rehab	O
facility	O
he	O
was	O
able	O
to	O
control	O
his	B-disease
pain	I-disease
on	O
po	O
pain	O
medications	O
.	O

The	O
patient	O
did	O
have	O
a	O
postoperative	O
serum	O
sodium	O
in	O
the	O
120s	O
from	O
the	O
130s	O
three	O
days	O
postoperatively	O
.	O

An	O
endocrine	O
consult	O
was	O
obtained	O
to	O
help	O
manage	O
his	O
serum	O
electrolytes	O
.	O

The	O
patient	O
was	O
started	O
on	O
three	O
grams	O
of	O
sodium	O
,	O
3x	O
a	O
day	O
with	O
fluid	O
restriction	O
.	O

Over	O
the	O
next	O
several	O
days	O
his	O
sodium	O
levels	O
were	O
followed	O
and	O
by	O
5/12/05	O
his	O
plasma	O
sodium	O
was	O
back	O
to	O
136	O
.	O

The	O
patient	O
was	O
taken	O
off	O
fluid	O
restriction	O
.	O

On	O
5/14/05	O
Mannitol	O
was	O
tapered	O
and	O
then	O
d	O
/	O
c&apos;d.	O

At	O
the	O
time	O
of	O
transfer	O
the	O
patient	O
was	O
stable	O
and	O
needed	O
only	O
physical	O
and	O
occupational	O
therapy	O
.	O

The	O
patient	O
was	O
oriented	O
to	O
person	O
,	O
place	O
and	O
time	O
and	O
opened	O
eyes	O
appropriately	O
to	O
speech	O
when	O
asked	O
.	O

The	O
patient	O
is	O
hard	B-disease
of	I-disease
hearing	I-disease
.	O

The	O
patient	O
had	O
no	O
complaints	B-disease
of	I-disease
pain	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Lipitor	O
40	O
mg	O
po	O
every	O
day	O
.	O

2.	O
Captopril	O
12.5	O
mg	O
po	O
tid	O
.	O

3.	O
Nexium	O
40	O
mg	O
po	O
every	O
day	O
.	O

4.	O
Colace	O
100	O
mg	O
po	O
bid	O
.	O

5.	O
Ativan	O
0.5	O
mg	O
po	O
q4	O
hours	O
prn	O
for	O
anxiety	B-disease
.	O

6.	O
Allegra	O
60	O
mg	O
po	O
bid	O
.	O

7.	O
Dilantin	O
100	O
mg	O
IV	O
tid	O
which	O
can	O
be	O
changed	O
to	O
a	O
po	O
regimen	O
in	O
seven	O
days	O
.	O

8.	O
Zinc	O
220	O
mg	O
po	O
every	O
day	O
.	O

9.	O
Vitamin	O
C	O
500	O
mg	O
po	O
bid	O
.	O

10.	O
Flomax	O
0.4	O
mg	O
po	O
every	O
day	O
.	O

11.	O
Fragmin	O
2500	O
units	O
subcut	O
every	O
day	O
.	O

12.	O
Levofloxacin	O
500	O
mg	O
po	O
q	O
daily	O
x10	O
days	O
.	O

13.	O
Dexamethasone	O
4	O
mg	O
po	O
q6	O
hours	O
.	O

14.	O
The	O
steroid	O
will	O
be	O
kept	O
for	O
now	O
and	O
tapered	O
at	O
a	O
later	O
date	O
on	O
follow	O
up	O
with	O
Dr.	O
Coma	O
.	O

15.	O
Regular	O
insulin	O
sliding	O
scale	O
with	O
finger	O
sticks	O
qac	O
and	O
qhs	O
.	O

16.	O
Neutra-Phos	O
1.25	O
grams	O
po	O
as	O
needed	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
is	O
instructed	O
to	O
not	O
shower	O
or	O
bath	O
until	O
one	O
week	O
.	O

The	O
staples	O
were	O
removed	O
prior	O
to	O
discharge	O
.	O

The	O
patient	O
is	O
instructed	O
not	O
to	O
drive	O
.	O

The	O
patient	O
is	O
asked	O
to	O
see	O
a	O
physician	O
immediately	O
or	O
go	O
to	O
the	O
nearest	O
emergency	O
room	O
if	O
any	B-disease
bleeding	I-disease
,	O
wound	B-disease
infection	I-disease
,	O
fever	B-disease
greater	O
than	O
100.8	O
,	O
intractable	B-disease
nausea	I-disease
and	I-disease
vomiting	I-disease
,	O
headache	B-disease
,	O
dizziness	B-disease
,	O
numbness	B-disease
,	O
pain	B-disease
or	O
weakness	B-disease
occurs	O
.	O

The	O
patient	O
instructed	O
to	O
call	O
Dr.	O
Coma	O
&apos;s	O
office	O
at	O
496-260-3297	O
to	O
arrange	O
for	O
a	O
follow	O
up	O
appointment	O
in	O
the	O
Saintaelfoote	O
Hospital	O
at	O
the	O
first	O
available	O
time	O
,	O
one	O
to	O
two	O
months	O
after	O
surgery	O
.	O

The	O
patient	O
is	O
also	O
asked	O
to	O
call	O
the	O
Neuro	O
/	O
Oncology	O
Service	O
,	O
the	O
office	O
of	O
Dr.	O
Britts	O
at	O
430-884-2917	O
for	O
a	O
follow	O
up	O
appointment	O
in	O
three	O
weeks	O
.	O

The	O
patient	O
is	O
asked	O
to	O
take	O
a	O
course	O
of	O
Dilantin	O
for	O
ten	O
more	O
days	O
.	O

The	O
patient	O
is	O
instructed	O
not	O
to	O
undergo	O
any	O
heavy	O
lifting	O
until	O
seen	O
in	O
clinic	O
.	O

HOPETAMEMY	O
K.	O
THOREDUHEDREPS	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
ERIN	O
KENGEKOTE	O
,	O
M.D.	O

05/14/2005	O
16:02	O

_____________________________	O
ERIN	O
KENGEKOTE	O
,	O
M.D.	O

TR	O
:	O

wy	O

DD	O
:	O

05/14/2005	O

TD	O
:	O

05/14/2005	O
1:10	O
P	O
441763	O

cc	O
:	O

ERIN	O
KENGEKOTE	O
,	O
M.D.	O

627258104	O

GH	O

56900479	O

1/8/2001	O
12:00:00	O
AM	O

PANCREATIC	B-disease
CANCER	I-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/08/2001	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/30/2001	O

CHIEF	O
COMPLAINT	O
:	O

The	O
patient	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
for	O
a	O
second	O
opinion	O
regarding	O
workup	O
of	O
his	B-disease
pancreatic	I-disease
cancer	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
61	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
diabetes	B-disease
,	O
coronary	B-disease
artery	I-disease
disease	I-disease
,	O
hepatitis	B-disease
C	I-disease
,	O
and	O
asthma	B-disease
who	O
was	O
diagnosed	O
recently	O
with	O
pancreatic	B-disease
cancer	I-disease
after	O
he	O
presented	O
to	O
Seph&apos;sju	O
Memorial	O
after	O
a	O
motor	O
vehicle	O
accident	O
.	O

Chest	O
CT	O
revealed	O
a	B-disease
pulmonary	I-disease
nodule	I-disease
.	O

Abdominal	O
CT	O
revealed	O
a	B-disease
3.0	I-disease
to	I-disease
4.0	I-disease
centimeter	I-disease
lesion	I-disease
in	I-disease
the	I-disease
pancreatic	I-disease
head	I-disease
.	O

An	O
ERCP	O
performed	O
there	O
showed	O
a	B-disease
long	I-disease
segment	I-disease
of	I-disease
distal	I-disease
narrowing	I-disease
of	I-disease
the	I-disease
common	I-disease
bileduct	I-disease
and	O
a	O
transhepatic	O
biliary	O
drain	O
was	O
placed	O
there	O
on	O
December	O
29	O
.	O

On	O
January	O
1	O
,	O
a	O
chest	O
tube	O
was	O
placed	O
for	O
a	B-disease
loculated	I-disease
pleural	I-disease
effusion	I-disease
.	O

On	O
January	O
2	O
,	O
pleurodesis	O
was	O
performed	O
.	O

On	O
January	O
4	O
,	O
he	O
had	O
a	B-disease
desaturation	I-disease
.	O

VQ	O
was	O
indeterminate	O
.	O

LENIs	O
were	O
negative	O
at	O
that	O
time	O
.	O

On	O
January	O
5	O
,	O
he	O
had	O
a	O
chest	O
xray	O
with	O
a	B-disease
left	I-disease
apicalpneumothorax	I-disease
but	O
was	O
stable	O
on	O
chest	O
xray	O
of	O
January	O
7	O
.	O

Brain	O
CT	O
was	O
negative	O
,	O
as	O
was	O
a	O
bronchoscopy	O
with	O
lavage	O
.	O

His	O
CA99	O
was	O
normal	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

The	O
patient	O
had	O
reported	O
an	O
approximately	O
30	B-disease
pound	I-disease
weight	I-disease
loss	I-disease
in	I-disease
six	I-disease
weeks	I-disease
.	O

He	O
had	O
experienced	O
some	B-disease
constipation	I-disease
for	O
the	O
few	O
months	O
prior	O
with	O
lighter	B-disease
colored	I-disease
stools	I-disease
,	O
darkened	B-disease
urine	I-disease
and	O
fatigue	B-disease
for	O
months	O
with	O
increased	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
,	O
orthopnea	B-disease
and	O
dyspnea	B-disease
on	O
exertion	O
.	O

He	O
denied	O
any	O
fevers	B-disease
,	O
chills	B-disease
or	O
night	B-disease
sweats	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
recently	B-disease
diagnosed	I-disease
pancreatic	I-disease
cancer	I-disease
.	O

Diabetes	B-disease
.	O

Hypertension	B-disease
.	O

Gout	B-disease
.	O

Hypercholesterolemia	B-disease
.	O

Coronary	B-disease
artery	I-disease
disease	I-disease
with	O
congestive	B-disease
heart	I-disease
failure	I-disease
.	O

Asthma	B-disease
.	O

Hepatitis	B-disease
C	I-disease
.	O

Psoriasis	B-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lasix	O
,	O
80	O
;	O
Avandia	O
,	O
4	O
b.i.d.	O
;	O
Glipizide	O
,	O
10	O
b.i.d.;	O
Imdur	O
,	O
30	O
;	O
Allopurinol	O
;	O
Zocor	O
,	O
20	O
;	O
Prilosec	O
,	O
20	O
,	O
potassium	O
,	O
40	O
;	O
Oxycontin	O
,	O
30	O
b.i.d.;	O
subcutaneous	O
heparin	O
;	O
Unasyn	O
,	O
1.5	O
grams	O
q	O
6	O
;	O
Combivent	O
and	O
morphine	O
prn	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
a	O
hair	O
stylist	O
.	O

He	O
lives	O
by	O
himself	O
in	O
Tennessee	O
.	O

No	O
tobacco	O
.	O

Seldom	O
ETOH	O
.	O

No	O
drug	O
use	O
.	O

Heis	O
single	O
with	O
no	O
children	O
.	O

He	O
has	O
a	O
very	O
supportive	O
family	O
with	O
numerous	O
siblings	O
.	O

FAMILY	O
HISTORY	O
:	O

Mother	O
and	O
father	O
died	O
of	O
heart	B-disease
failure	I-disease
.	O

Theyalso	O
had	O
diabetes	B-disease
and	O
hypertension	B-disease
.	O

Sister	O
with	O
stomach	B-disease
cancer	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
was	O
afebrile	B-disease
.	O

Heart	O
rate	O
was	O
78	O
,	O
blood	O
pressure	O
98/50	O
,	O
respiratory	O
rate	O
of	O
32	O
,	O
satting	O
91%	O
on	O
four	O
liters	O
.	O

In	O
general	O
,	O
this	O
is	O
an	O
obese	O
male	O
in	O
mild	B-disease
respiratory	I-disease
distress	I-disease
.	O

Neck	O
was	O
supple	O
with	O
no	O
lymphadenopathy	B-disease
.	O

HEENT	O
-	O
normocephalic	O
/	O
atraumatic	B-disease
,	O
extraocular	O
movements	O
are	O
intact	O
,	O
pupils	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
and	O
accommodation	O
.	O

Chest	O
had	O
diffuse	B-disease
crackles	I-disease
bilaterally	I-disease
halfway	O
up	O
.	O

Coronary	O
-	O
irregular	B-disease
PVCs	I-disease
,	O
S1	O
,	O
S2	O
normal	O
,	O
positive	B-disease
systolic	I-disease
murmur	I-disease
at	I-disease
the	I-disease
left	I-disease
upper	I-disease
sternal	I-disease
border	I-disease
radiating	O
throughout	O
.	O

Abdomen	O
was	O
distended	B-disease
,	O
tympanitic	B-disease
,	O
mildly	B-disease
tender	I-disease
epigastrium	I-disease
and	I-disease
right	I-disease
lower	I-disease
quadrant	I-disease
.	O

No	O
rebound	B-disease
or	O
guarding	B-disease
.	O

Extremities	O
had	O
2+	B-disease
bilateral	I-disease
lower	I-disease
extremity	I-disease
edema	I-disease
to	I-disease
knees	I-disease
.	O

No	O
clubbing	B-disease
or	O
cyanosis	B-disease
.	O

Neurologic	O
examination	O
-	O
alert	O
and	O
oriented	O
x	O
3	O
,	O
slurred	B-disease
and	I-disease
slow	I-disease
speech	I-disease
,	O
distractable	B-disease
.	O

Cranial	O
nerves	O
II	O
through	O
XII	O
are	O
intact	O
.	O

Sensory	O
is	O
intact	O
to	O
soft	O
touch	O
throughout	O
.	O

Strength	O
is	O
5/5	O
throughout	O
.	O

LABORATORY	O
DATA	O
:	O

White	O
blood	O
count	O
4.36	O
,	O
hematocrit	O
26.1	O
with	O
platelets	O
of	O
107,000	O
,	O
MCV	O
81	O
.	O

Sodium	O
137	O
,	O
potassium	O
4.5	O
,	O
chloride97	O
,	O
bicarb	O
24	O
,	O
BUN	O
124	O
,	O
creatinine	O
4.1	O
,	O
glucose	O
144	O
,	O
AST	O
49	O
,	O
ALT33	O
,	O
alkaline	O
phosphatase	O
253	O
,	O
total	O
bili	O
1.6	O
,	O
calcium	O
9.2	O
,	O
magnesium	O
2.3	O
,	O
albumin	O
3.4	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
Gastrointestinal	O
.	O

The	O
patient	O
had	O
an	B-disease
elevated	I-disease
bilirubin	I-disease
on	O
admission	O
with	O
decreased	B-disease
output	I-disease
of	O
biliary	O
drain	O
.	O

The	O
drain	O
was	O
replaced	O
over	O
the	O
wire	O
,	O
8-10	O
by	O
IR	O
,	O
when	O
it	O
was	O
accidentally	O
removed	O
.	O

Increased	O
flow	O
again	O
.	O

The	O
patient	O
had	O
signs	B-disease
and	O
symptoms	B-disease
develop	O
of	O
SBP	B-disease
,	O
also	O
with	O
an	B-disease
elevated	I-disease
white	I-disease
count	I-disease
.	O

He	O
was	O
treated	O
broadly	O
with	O
amp	O
,	O
levo	O
and	O
Flagyl	O
.	O

Cultures	O
were	O
negative	O
and	O
onlyon	O
one	O
gram	O
stain	O
did	O
it	O
show	O
rare	B-disease
gram	I-disease
negative	I-disease
rods	I-disease
.	O

The	O
patient	O
&apos;s	O
abdominal	O
fluid	O
cell	O
counts	O
showed	O
2400	O
white	O
blood	O
cells	O
,	O
500	O
red	O
cells	O
with	O
82	O
polyps	O
,	O
11	O
lymphs	O
,	O
7	O
monos	O
.	O

Clinically	O
,	O
this	O
was	O
consistent	O
with	O
SBP	B-disease
,	O
although	O
unfortunately	O
,	O
fluid	O
was	O
never	O
sent	O
for	O
cytology	O
and	O
a	O
lot	O
of	O
those	B-disease
white	I-disease
cells	I-disease
are	O
most	O
likely	O
due	O
to	O
his	B-disease
cancer	I-disease
.	O

He	O
underwent	O
abdominal	O
paracentesis	O
approximately	O
two	O
times	O
a	O
week	O
for	O
therapeutic	O
.	O

This	O
had	O
to	O
be	O
performed	O
by	O
IR	O
because	O
the	B-disease
pocket	I-disease
was	O
too	O
deep	O
to	O
access	O
from	O
the	O
bedside	O
.	O

He	O
received	O
a	O
two	O
week	O
course	O
of	O
broad	O
spectrum	O
antibiotics	O
and	O
will	O
be	O
maintained	O
on	O
Levofloxacin	O
IV	O
for	O
prophylaxis	O
against	O
SBP	B-disease
.	O

2.	O
Pulmonary	O
.	O

From	O
a	O
pulmonary	O
standpoint	O
,	O
he	O
continued	O
to	O
complain	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

His	B-disease
apical	I-disease
pneumothorax	I-disease
from	O
the	O
outside	O
hospital	O
had	O
resolved	O
.	O

Chest	O
xray	O
was	O
consistent	O
with	O
pleurodesis	B-disease
.	O

However	O
,	O
with	O
persistent	B-disease
abdomen	I-disease
distention	I-disease
,	O
there	O
is	O
likely	O
restrictive	B-disease
deficit	I-disease
and	O
,	O
in	O
addition	O
,	O
after	O
each	O
tap	O
,	O
he	O
at	O
times	O
became	O
hypotensive	B-disease
and	O
with	O
some	O
mild	O
fluid	O
resuscitation	O
decompensated	O
with	O
pulmonary	B-disease
edema	I-disease
,	O
requiring	O
both	O
albumin	O
and	O
Lasix	O
to	O
try	O
to	O
mobilize	O
third	B-disease
space	I-disease
fluids	I-disease
.	O

On	O
the	O
day	O
of	O
discharge	O
,	O
he	O
is	O
stating	O
approximately	O
91	O
to	O
92%	O
on	O
three	O
to	O
four	O
liters	O
.	O

Chest	O
xray	O
is	O
still	O
consistent	O
with	O
volume	B-disease
overload	I-disease
.	O

The	O
plan	O
will	O
be	O
to	O
continue	O
to	O
try	O
to	O
alternate	O
albumin	O
and	O
Lasix	O
to	O
mobilize	O
his	B-disease
fluid	I-disease
.	O

3.	O
Cardiovascular	O
.	O

He	O
had	O
episodes	O
of	O
bradycardia	B-disease
without	O
subsequent	B-disease
fall	I-disease
in	I-disease
blood	I-disease
pressure	I-disease
at	O
the	O
beginning	O
of	O
his	O
admission	O
.	O

He	O
was	O
ruled	O
out	O
for	O
a	B-disease
myocardial	I-disease
infarction	I-disease
.	O

Echocardiogram	O
showed	O
50%	O
ejection	O
fraction	O
with	O
mild	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

He	O
did	O
not	O
show	O
any	O
episodes	O
of	O
bradycardia	B-disease
throughout	O
the	O
remainder	O
of	O
his	O
hospital	O
course	O
.	O

4.	O
Endocrine	O
.	O

Diabetes	B-disease
.	O

His	O
Avandia	O
was	O
discontinued	O
secondary	O
to	O
the	B-disease
side	I-disease
effect	I-disease
profile	I-disease
.	O

He	O
is	O
being	O
maintained	O
on	O
glipizide	O
and	O
sliding	O
scale	O
insulin	O
.	O

5.	O
Heme	O
.	O

From	O
a	O
heme	O
standpoint	O
,	O
he	O
presented	O
anemic	B-disease
and	O
with	O
an	B-disease
elevated	I-disease
PT	I-disease
INR	I-disease
.	O

He	O
required	O
a	O
few	O
transfusions	O
during	O
his	O
hospital	O
course	O
.	O

He	O
also	O
required	O
FFP	O
initially	O
to	O
reverse	O
his	B-disease
coagulopathy	I-disease
.	O

However	O
,	O
this	O
resolved	O
on	O
its	O
own	O
over	O
the	O
hospital	O
course	O
.	O

His	O
INR	O
normalized	O
,	O
however	O
,	O
unfortunately	O
,	O
he	O
developed	O
bilateral	B-disease
deep	I-disease
venous	I-disease
thromboses	I-disease
during	O
his	O
hospital	O
course	O
and	O
will	O
be	O
maintained	O
on	O
Lovenox	O
.	O

6.	O
Renal	O
.	O

He	O
had	O
a	O
creatinine	O
of	O
4.0	O
on	O
admission	O
and	O
this	O
decreased	O
down	O
to	O
the	O
mid	O
ones	O
with	O
fluid	O
,	O
currently	O
at	O
1.7	O
on	O
discharge	O
.	O

From	O
his	O
urinalysis	O
,	O
he	O
has	O
mostly	O
a	B-disease
prerenal	I-disease
state	I-disease
.	O

However	O
,	O
he	O
does	O
require	O
diuresis	O
to	O
prevent	O
increased	B-disease
volume	I-disease
overload	I-disease
in	O
his	O
lungs	O
from	O
his	B-disease
hypoalbunemic	I-disease
state	I-disease
.	O

At	O
the	O
time	O
,	O
Nutrition	O
was	O
following	O
,	O
initially	O
with	O
a	O
low	O
fat	O
,	O
low	O
cholesterol	O
,	O
low	O
sugar	O
diet	O
.	O

His	O
appetite	O
is	O
decreasing	O
somewhat	O
as	O
his	B-disease
disease	I-disease
process	I-disease
progresses	O
,	O
therefore	O
,	O
we	O
have	O
liberalized	O
his	O
diet	O
for	O
him	O
to	O
take	O
what	O
he	O
wishes	O
.	O

7.	O
ID	O
.	O

Please	O
see	O
GI	O
.	O

He	O
was	O
treated	O
with	O
broad	O
spectrum	O
antibiotics	O
for	O
a	O
14	O
day	O
course	O
for	O
clinical	B-disease
SBP	I-disease
.	O

He	O
will	O
be	O
maintained	O
on	O
Levofloxacin	O
for	O
prophylaxis	O
against	O
SBP	B-disease
.	O

Given	O
that	O
he	O
will	O
need	O
continued	O
taps,	O

8.	O
Oncology	O
.	O

The	O
patient	O
initially	O
came	O
for	O
workup	O
of	O
pancreatic	B-disease
cancer	I-disease
with	O
a	O
questions	O
of	O
palliative	O
chemotherapy	O
.	O

However	O
,	O
given	O
his	B-disease
rapid	I-disease
clinical	I-disease
decline	I-disease
,	O
this	O
was	O
deferred	O
and	O
I	O
do	O
not	O
suspect	O
that	O
he	O
will	O
be	O
a	O
candidate	O
for	O
this	O
,	O
as	O
the	O
degree	O
of	O
his	B-disease
decline	I-disease
bodes	O
a	O
poor	O
prognosis	O
for	O
him	O
.	O

His	B-disease
pain	I-disease
here	O
has	O
been	O
controlled	O
,	O
initially	O
on	O
Oxycontin	O
with	O
morphine	O
for	O
breakthrough	B-disease
pain	I-disease
.	O

As	O
he	O
becomes	O
progressively	B-disease
more	I-disease
somnolent	I-disease
,	O
this	O
will	O
likely	O
need	O
to	O
be	O
switched	O
to	O
IV	O
pain	O
medications	O
only	O
.	O

Discussion	O
,	O
at	O
that	O
point	O
in	O
time	O
,	O
should	O
occur	O
with	O
the	O
family	O
about	O
comfort	O
measures	O
and	O
about	O
weaning	O
him	O
from	O
his	O
medications	O
to	O
make	O
him	O
more	O
comfortable	O
.	O

Code	O
status	O
-	O
the	O
patient	O
is	O
a	O
DNR	O
/	O
DNI	O
.	O

This	O
is	O
an	O
unfortunate	O
case	O
but	O
Mr.	O
Po	O
does	O
have	O
an	O
incredibly	O
supportive	O
family	O
who	O
have	O
been	O
here	O
consistently	O
to	O
visit	O
him	O
and	O
that	O
offers	O
him	O
an	O
important	O
source	O
of	O
comfort	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Tylenol	O
,	O
650	O
mg	O
p.o.	O
q	O
4	O
prn	O
;	O
Allopurinol	O
,	O
100	O
mg	O
p.o.	O
q.d.	O
;	O
Peridex	O
mouthwash	O
,	O
10	O
ml	O
b.i.d.;	O
cholysteramineresin	O
,	O
4	O
grams	O
p.o.	O
q.d.	O
;	O
clotrimazole	O
,	O
one	O
troche	O
p.o.	O
q.i.d.	O
;	O
Fentanyl	O
patch	O
,	O
100	O
mcg	O
per	O
hour	O
topical	O
q	O
72	O
hours	O
;	O
glipizide	O
,	O
10	O
mg	O
p.o.	O
q.d.;	O
Atarax	O
,	O
25	O
operating	O
table	O
50	O
mg	O
p.o.	O
q	O
6	O
to	O
8	O
hours	O
prn	O
itching	B-disease
;	O
regular	O
sliding	O
scale	O
insulin	O
;	O
KBL	O
mouthwash	O
,	O
15	O
ccp	O
.o.	O
q.d.	O
prn	O
mouth	B-disease
discomfort	I-disease
;	O
Lactulose	O
,	O
30	O
ml	O
p.o.	O
q.i.d.	O
that	O
was	O
started	O
on	O
January	O
30	O
,	O
for	O
no	O
bowel	B-disease
movements	I-disease
with	O
instructions	O
to	O
continue	O
until	O
bowel	O
movement	O
and	O
then	O
decrease	O
to	O
b.i.d.	O
or	O
q.d.	O
;	O
Lidocaine	O
,	O
2%	O
,	O
10	O
ml	O
UR	O
q	O
3	O
to	O
4	O
hours	O
prn	O
for	O
pain	B-disease
around	I-disease
Foley	I-disease
site	I-disease
;	O
Ativan	O
,	O
0.25	O
to	O
0.5	O
mg	O
IV	O
q	O
4	O
to	O
6	O
hours	O
prn	O
anxiety	B-disease
with	O
instructions	O
to	O
use	O
caution	O
.	O

The	O
patient	O
gets	O
very	B-disease
somnolent	I-disease
with	O
Ativan	O
.	O

Maalox	O
Plus	O
,	O
Extra	O
Strength	O
,	O
15	O
cc	O
p.o.	O
q	O
6	O
hours	O
prn	O
indigestion	B-disease
;	O
magnesium	O
sulfate	O
;	O
sliding	O
scale	O
IV	O
and	O
potassium	O
chloride	O
,	O
sliding	O
scale	O
IV	O
.	O

He	O
is	O
also	O
on	O
Reglan	O
,	O
10	O
mg	O
p.o.	O
q	O
h	O
;	O
Miracle	O
topical	O
cream	O
to	O
affected	B-disease
area	I-disease
;	O
also	O
Sarna	O
,	O
topical	O
cream	O
,	O
b.i.d.	O

He	O
has	O
Nystatin	O
suspension	O
mouthwash	O
,	O
10	O
cc	O
swish	O
and	O
swallow	O
q.i.d.	O
He	O
gets	O
Serax	O
,	O
15	O
to	O
30	O
mg	O
p.o.	O
q	O
h.s.	O
prni	O
nsomnia	B-disease
.	O

Ocean	O
Spray	O
q.i.d.	O
to	O
nares	O
prn	O
nasal	B-disease
dryness	I-disease
.	O

Multivitamin	O
,	O
one	O
tab	O
q.d.	O
Morphine	O
immediate	O
release	O
,	O
MSIR	O
,	O
15	O
to	O
30	O
mg	O
p.o.	O
q	O
2	O
to	O
3	O
hours	O
prn	O
pain	B-disease
.	O

He	O
is	O
also	O
on	O
a	O
Fentanyl	O
patch	O
,	O
100	O
mcg	O
q	O
72	O
hours	O
.	O

The	O
morphine	O
is	O
for	O
breakthrough	B-disease
pain	I-disease
.	O

Hydrocortisone	O
,	O
1%	O
topical	O
cream	O
q	O
6	O
to	O
8	O
hours	O
prn	O
itching	B-disease
.	O

Levofloxacin	O
,	O
250	O
mg	O
p.o.	O
q.d.	O
;	O
Albuterol	O
and	O
Atrovent	O
nebs	O
q	O
4	O
to6	O
hours	O
as	O
needed	O
prn	O
wheeze	B-disease
.	O

PLAN	O
FOR	O
FOLLOWUP	O
:	O

Follow	O
up	O
will	O
be	O
with	O
Dr.	O
A	O
Flow	O
from	O
Stromware	O
St.	O
,	O
Balt	O
who	O
is	O
the	O
patient	O
&apos;s	O
primary	O
oncologist	O
there	O
.	O

Dictated	O
By	O
:	O

JIMCHARL	O
B.	O
VERGEFLOW	O
,	O
M.D.	O
XX14	O

Attending	O
:	O

LUPEVICKETTE	O
FLOW	O
,	O
M.D.	O
YA80	O
QO567/192247	O

Batch	O
:	O

8798	O

Index	O
No.	O

QFQYRB7	O
AGG	O

D	O
:	O

01/30/01	O

T	O
:	O

01/30/01	O

Admission	O
Date	O
:	O

2018-03-04	O

Discharge	O
Date	O
:	O

2018-03-09	O

Date	O
of	O
Birth	O
:	O

1957-08-17	O

Sex	O
:	O

M	O

Service	O
:	O

UROLOGY	O

Allergies	O
:	O

Sulfonamides	O
/	O
Penicillins	O
/	O
Tetracyclines	O
/	O
Azithromycin	O
/	O
Iodine	O
/	O
Shellfish	O
/	O
Ace	O
Inhibitors	O
/	O
Ciprofloxacin	O

Attending	O
:	O

Donald	O
E.	O
Jacquet	O
,	O
M.D.	O

Chief	O
Complaint:	O

Chronic	B-disease
prostatitis	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O

TURP	O

History	O
of	O
Present	O
Illness:	O

Justin	O
Searle	O
a	O
60-year-old	O
man	O
with	O
a	O
long	O
history	O
of	O
chronic	B-disease
prostatitis	I-disease
status	O
post	O
two	O
transurethral	O
resection	O
of	O
the	O
prostate	O
procedures	O
in	O
2007	O
and	O
1998	O
.	O

He	O
also	O
has	O
a	O
diagnosis	O
of	O
interstitial	B-disease
cystitis	I-disease
and	O
more	O
significantly	O
has	O
a	O
history	O
of	O
coronary	B-disease
artery	I-disease
disease	I-disease
with	O
a	O
recent	O
catheterization	O
,	O
supraventricular	B-disease
tachycardia	I-disease
,	O
and	O
a	B-disease
progressive	I-disease
mitochondrial	I-disease
myopathy	I-disease
.	O

He	O
has	O
had	O
symptoms	B-disease
of	O
dribbling	B-disease
,	O
stress	B-disease
incontinence	I-disease
,	O
hematuria	B-disease
,	O
but	O
has	O
no	O
dysuria	B-disease
.	O

He	O
was	O
preadmitted	O
for	O
cardiac	O
clearance	O
by	O
Dr.	O
Lair	O
,	O
his	O
cardiologist	O
.	O

Past	O
Medical	O
History:	O

1.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
(	O
s/p	O
stents	O
to	O
LAD	O
and	O
3rd	O
OM	O
)	O

2.	O
Supraventricular	B-disease
tachycardia	I-disease
(	O
on	O
a	O
beta	O
blocker	O
)	O
.	O

3.	O
Mitochondrial	B-disease
myopathy	I-disease
.	O

4.	O
History	O
of	O
orthostasis	B-disease
with	O
tilt	O
table	O
testing	O
done	O
in	O
the	O
past	O
.	O

5.	O
Status	O
post	O
transurethral	O
resection	O
of	O
prostate	O
times	O
two	O
(	O
in	O
2007	O
and	O
1998	O
)	O
.	O

6.	O
Interstitial	B-disease
cystitis	I-disease
.	O

7.	O
Pericarditis	B-disease
.	O

8.	O
Hypertension	B-disease
.	O

9.	O
Hypercholesterolemia	B-disease
.	O

10.	O
Gastrointestinal	B-disease
bleed	I-disease

Social	O
History	O
:	O

denies	O
any	O
tobacco.	O
Divorced	O
,	O
lives	O
in	O
Wisconsin	O

Family	O
History	O
:	O

Father	O
had	O
MI	B-disease
at	O
42	O

Mother	O
died	O
of	O
MI	B-disease
at	O
76	O

Physical	O
Exam	O
:	O

Gen	O
:	O

NAD	B-disease

HEENT	O
:	O

MMM	O

CV	O
:	O

RRR	O
,	O
no	O
m/r/g	B-disease

Lungs	O
:	O

CTAB	O

Abd	O
:	O
soft	O
,	O
+distension	B-disease
with	O
tympany	B-disease
,	O
no	O
HSM	B-disease
,	O
hyperactive	B-disease
BS	I-disease

Ext	O
:	O
no	O
c/c/e	B-disease

Neuro	O
:	O

A&O	O
x3	O
.	O

ECG	O
:	O

NSR	O
at	O
62	O
,	O
nl	O
axis	O
,	O
nl	O
intervals	O
,	O
Q	B-disease
waves	I-disease
in	I-disease
III	I-disease
,	O
avR	O
,	O
V1	O
.	O

TWI	B-disease
's	O
in	O
III	O
,	O
V1	O
.	O

Pertinent	O
Results:	O

2018-03-04	O
01:02PM	O

GLUCOSE	O
-	O
94	O
UREA	O
N	O
-	O
22*	O
CREAT	O
-	O
1.4*	O
SODIUM	O
-	O
142	O

POTASSIUM	O
-	O
5.9*	O
CHLORIDE	O
-	O
108	O
TOTAL	O
CO2	O
-	O
23	O
ANION	O
GAP	O
-	O
17	O

2018-03-04	O
01:02PM	O

CALCIUM	O
-	O
9.7	O
PHOSPHATE	O
-	O
3.9	O
MAGNESIUM	O
-	O
1.9	O

2018-03-04	O
01:02PM	O

WBC	O
-	O
7.5	O
RBC	O
-	O
5.09	O
HGB	O
-	O
15.4	O
HCT	O
-	O
43.7	O
MCV	O
-	O
86	O

MCH	O
-	O
30.2	O
MCHC	O
-	O
35.2*	O
RDW	O
-	O
13.6	O

2018-03-04	O
01:02PM	O

PLT	O
COUNT	O
-	O
257#	O

2018-03-04	O
01:02PM	O

PT	O
-	O
12.2	O
PTT	O
-	O
23.8	O
INR	O
(	O
PT	O
)	O
-	O
0.9	O

Brief	O
Hospital	O
Course:	O

On	O
HD2	O
,	O
cardiac	O
clearance	O
was	O
obtained	O
by	O
Dr.	O
Sanchez	O
.	O

Patient	O
tolerated	O
procedure	O
on	O
2018-03-05	O
and	O
was	O
transferred	O
to	O

ICU	O
for	O
24hr	O
post-op	O
cardiac	O
monitoring	O
.	O

Stay	O
was	O
uneventful	O
.	O

On	O
POD1	O
,	O
patient	O
was	O
transferred	O
out	O
of	O
FICU	O
to	O
12R	O
.	O

Catheter	O
was	O
removed	O
.	O

He	O
was	O
started	O
on	O
Pyridium	O
.	O

On	O
POD2	O
,	O
patient	O
was	O
deemed	O
suitable	O
and	O
stable	O
for	O
discharge	O
.	O

On	O
POD4	O
,	O
patient	O
was	O
discharged	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Hydroxyzine	O
HCl	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Atorvastatin	O
Calcium	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Ezetimibe	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Simethicone	O
80	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
0.5-1	O
Tablet	O
,	O
Chewable	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
indigestion/gas	B-disease
pain	I-disease
.	O

5.	O
Aluminum-Magnesium	O
Hydroxide	O
225-200	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
MLs	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
indigestion	B-disease
.	O

6.	O
Atenolol	O
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

7.	O
Hyoscyamine	O
Sulfate	O
0.125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
.	O

8.	O
Phenazopyridine	O
HCl	O
100	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
for	O
3	O
days	O
.	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Chronic	B-disease
prostatitis	I-disease

Interstitial	B-disease
cystitis	I-disease

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

Go	O
to	O
an	O
Emergency	O
Room	O
if	O
you	O
experience	O
symptoms	B-disease
including	O
,	O
but	O
not	O
necessarily	O
limited	O
to	O
:	O
new	B-disease
and	I-disease
continuing	I-disease
nausea	I-disease
,	O
vomiting	B-disease
,	O
fevers	B-disease
(	O
>101.5	O
F	O
)	O
,	O
chills	B-disease
,	O
or	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

Proceed	O
to	O
the	O
ER/EW/Monica	O
if	O
your	B-disease
wound	I-disease
becomes	O
red	B-disease
,	O
swollen	B-disease
,	O
warm	B-disease
,	O
or	O
produces	O
pus	B-disease
.	O

You	O
may	O
remove	O
your	O
dressings	O
2	O
days	O
after	O
your	O
surgery	O
if	O
they	O
were	O
not	O
removed	O
in	O
the	O
hospital	O
.	O

Leave	O
the	O
steri	O
strips	O
on	O
until	O
they	O
begin	O
to	O
peel	O
,	O
then	O
you	O
may	O
remove	O
them.	O
Staples	O
and	O
stitches	O
will	O
remain	O
until	O
your	O
follow-up	O
appointment	O
.	O

If	O
you	O
experience	O
clear	B-disease
drainage	I-disease
from	O
your	B-disease
wounds	I-disease
,	O
cover	O
them	O
with	O
a	O
clean	O
dressing	O
and	O
stop	O
showering	O
until	O
the	B-disease
drainage	I-disease
subsides	O
for	O
at	O
least	O
2	O
days	O
.	O

No	O
heavy	O
lifting	O
or	O
exertion	O
for	O
at	O
least	O
6	O
weeks	O
.	O

No	O
driving	O
while	O
taking	O
pain	O
medications	O
.	O

Narcotics	O
can	O
cause	O
constipation	B-disease
.	O

Please	O
take	O
an	O
over	O
the	O
counter	O
stool	O
softener	O
such	O
as	O
Colace	O
or	O
a	O
gentle	O
laxative	O
such	O
as	O
Milk	O
of	O
Magnesia	O
if	O
you	O
experience	O
constipation	B-disease
.	O

You	O
may	O
resume	O
your	O
regular	O
diet	O
as	O
tolerated	O
.	O

You	O
may	O
take	O
showers	O
(	O
no	O
baths	O
)	O
after	O
your	O
dressings	O
have	O
been	O
removed	O
from	O
your	B-disease
wounds	I-disease
.	O

Continue	O
taking	O
your	O
home	O
medications	O
unless	O
otherwise	O
contraindicated	O
and	O
follow	O
up	O
with	O
PCP	O
.	O

Followup	O
Instructions	O
:	O

F/U	O
with	O
Rau	O
.	O

Call	O
for	O
appointment	O

F/U	O
with	O
Dr.	O
Ross	O
in	O
2-3	O
weeks	O
.	O

Michael	O
Morgan	O
MD	O
43-508	O

Completed	O
by	O
:	O

Justin	O
RAO	O
MD	O
71-039	O
2018-03-09	O
@	O
0842	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Freddy	O
Darr	O
on	O
:	O

FRI	O
2018-03-23	O
9:45	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2019-01-19	O

Discharge	O
Date	O
:	O

2019-01-24	O

Date	O
of	O
Birth	O
:	O

1981-03-17	O

Sex	O
:	O

M	O

Service	O
:	O
MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	O
Drugs	O

Attending	O
:	O
Antonio	O
I	O
Staples	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

nausea	B-disease
and	O
vomiting	B-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

01-23	O
PORT	O
line	O
removal	O
.	O

01-23	O
PICC	O
placement	O
.	O

01-24	O
PICC	O
removal	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

This	O
is	O
a	O
37	O
y/o	O
male	O
patient	O
with	O
PMH	O
Type	B-disease
I	I-disease
DM	I-disease
,	O
HTN	B-disease
,	O
gastroparesis	B-disease
,	O
ESRD	B-disease
on	O
HD	O
(	O
last	O
in	O
12/26	O
per	O
patient	O
)	O
who	O
presents	O
to	O
CMED	O
CCU	O
with	O
hypertensive	B-disease
urgency	I-disease
unable	O
from	O
the	O
Larry	O
.	O

The	O
patient	O
early	O
this	O
morning	O
to	O
the	O
Ruthie	O
with	O
his	B-disease
usual	I-disease
nausea	I-disease
,	O
vomiting	B-disease
,	O
abdominal	B-disease
pain	I-disease
and	O
was	O
found	O
to	O
be	O
hypertensive	B-disease
to	O
256/110	O
,	O
HR	O
102	O
,	O
T	O
99.2	O
,	O
RR	O
22	O
,	O
92%	O
RA	O
.	O

History	O
is	O
difficult	O
to	O
obtain	O
from	O
patient	O
d/t	O
somnolence	B-disease
and	O
lack	B-disease
of	I-disease
desire	I-disease
to	O
participate	O
in	O
interview	O
,	O
but	O
per	O
Frank	O
note	O
he	O
was	O
diaphoretic	B-disease
and	O
'	O
writing	O
in	O
pain	B-disease
',	O
vomiting	O
clear	O
substance	O
.	O

He	O
was	O
given	O
ativan	O
a	O
total	O
of	O
4	O
mg	O
of	O
ativan	O
,	O
6	O
mg	O
of	O
dilaudid	O
,	O
labetolol	O
20	O
mg	O
IV	O
x	O
1	O
and	O
hydralazine	O
10	O
mg	O
IV	O
x	O
1	O
without	O
good	O
response	O
(	O
200/99	O
).	O

He	O
recieved	O
2L	O
NS	O
and	O
was	O
started	O
on	O
labetolol	O
gtt	O
and	O
BP	O
decreased	O
to	O
161/79	O
.	O

Tranferred	O
to	O
CMED	O
CCU	O
for	O
further	O
management	O
while	O
on	O
labetolol	O
gtt	O
.	O

Of	O
note	O
,	O
the	O
patient	O
is	O
admitted	O
to	O
hospital	O
3	O
times	O
every	O
month	O
for	O
similar	O
complaints	O
with	O
last	O
admission	O
1/20-2/1/07	O
.	O

At	O
that	O
time	O
BP	O
was	O
attributed	O
to	O
abdominal	B-disease
pain	I-disease
and	O
inability	O
to	O
take	O
PO	O
meds	O
d/t	O
nausea	B-disease
/	O
vomiting	B-disease
.	O

Also	O
had	O
labile	B-disease
blood	I-disease
sugars	I-disease
with	O
repeated	O
episodes	O
of	O
hypoglycemia	B-disease
,	O
and	O
Strickland	O
recommended	O
sugars	O
in	O
the	O
range	O
of	O
150-200	O
.	O

He	O
eloped	O
prior	O
to	O
formal	O
discharge	O
when	O
his	O
FS	O
was	O
found	O
to	O
be	O
critically	B-disease
high	I-disease
-	O
recommended	O
to	O
patient	O
that	O
he	O
stay	O
for	O
repeat	O
,	O
but	O
left	O
AMA	O
without	O
signing	O
any	O
forms	O
.	O

Upon	O
transfer	O
to	O
the	O
CMED	O
CCU	O
the	O
patient	O
appears	O
somewhat	B-disease
uncomfortable	I-disease
,	O
reporting	O
nausea	B-disease
and	O
abdominal	B-disease
pain	I-disease
,	O
but	O
when	O
questioned	O
he	O
was	O
unable	O
/	O
unwilling	O
to	O
participate	O
in	O
HPI	O
or	O
exam	O
d/t	O
sleepiness	B-disease
.	O

He	O
denied	O
CP	B-disease
,	O
SOB	B-disease
,	O
HA	B-disease
,	O
vision	B-disease
changes	I-disease
,	O
neck	B-disease
stiffness	I-disease
,	O
dysuria	B-disease
,	O
or	O
other	B-disease
symptoms	I-disease
.	O

In	O
the	O
CMED	O
CCU	O
he	O
became	O
hypotensive	B-disease
to	O
SBP	O
80	O
s.	O

Labetalol	O
was	O
stopped	O
and	O
he	O
received	O
a	O
500	O
cc	O
fluid	O
bolus	O
and	O
his	O
blood	O
pressure	O
rose	O
to	O
SBP	O
90	O
s.	O

Cardiac	O
and	O
infectious	O
sources	O
of	O
hypotension	B-disease
were	O
considered	O
,	O
but	O
cardiac	O
enzymes	O
were	O
not	O
changed	O
from	O
prior	O
studies	O
and	O
he	O
had	O
no	O
localizing	B-disease
signs	I-disease
of	I-disease
infection	I-disease
;	O
blood	O
cultures	O
were	O
sent	O
and	O
a	O
ultrasound	O
of	O
the	O
L	O
arm	O
AVF	O
ordered	O
to	O
rule	O
out	O
abscess	B-disease
at	I-disease
the	I-disease
site	I-disease
.	O

He	O
received	O
a	O
partial	O
HD	O
session	O
,	O
limited	O
by	O
hypotension	B-disease
.	O

Over	O
night	O
,	O
his	O
blood	O
pressure	O
trended	O
up	O
to	O
130	O
s	O
systolic	O
.	O

He	O
was	O
restarted	O
on	O
his	O
home	O
blood	O
pressure	O
regimen	O
.	O

Renal	O
consult	O
team	O
saw	O
him	O
2019-01-20	O
and	O
plan	O
to	O
next	O
dialyze	O
him	O
on	O
2019-01-21	O
.	O

He	O
was	O
to	O
be	O
called	O
out	O
to	O
the	O
medical	O
floor	O
on	O
2019-01-20	O
but	O
became	O
somnolent	B-disease
after	O
receiving	O
pain	O
and	O
anti-nausea	O
meds	O
,	O
so	O
he	O
stayed	O
in	O
the	O
ICU	O
for	O
closer	O
monitoring	O
of	O
respiratory	O
status	O
,	O
which	O
spontaneously	O
improved	O
.	O

His	O
blood	O
sugar	O
at	O
10	O
pm	O
was	O
low	O
at	O
22	O
and	O
he	O
was	O
disoriented	B-disease
,	O
which	O
resolved	O
with	O
two	O
glasses	O
of	O
juice	O
;	O
he	O
did	O
not	O
receive	O
his	O
standing	O
dose	O
of	O
NPH	O
that	O
evening	O
.	O

Blood	O
cultures	O
returned	O
positive	O
with	O
GPC	B-disease
in	I-disease
pairs	I-disease
and	I-disease
clusters	I-disease
,	O
so	O
a	O
TTE	O
and	O
surveillance	O
cultures	O
were	O
ordered	O
and	O
vancomycin	O
was	O
started	O
.	O

He	O
was	O
then	O
called	O
out	O
to	O
the	O
medical	O
floor	O
on	O
01-21	O
.	O

Past	O
Medical	O
History	O
:	O

1.	O
DM	B-disease
type	I-disease
I	O

2.	O
ESRD	B-disease
on	O
hemodialysis	O
started	O
2017-01-07	O
on	O
Tu	O
,	O
Th	O
,	O
Sat	O

3.	O
Severe	B-disease
autonomic	I-disease
dysfunction	I-disease
with	O
multiple	O
hospitalizations	O
for	O
hypertensive	B-disease
emergency	I-disease
,	O
gastroparesis	B-disease
,	O
and	O
orthostatic	B-disease
hypotension	I-disease
.	O

4.	O
History	O
of	O
esophageal	B-disease
erosion	I-disease
,	O
MW	B-disease
tear	I-disease

5.	O
CAD	B-disease
with	O
1-vessel	B-disease
disease	I-disease
(	O
50%	B-disease
stenosis	I-disease
D1	I-disease
in	O
2014-06-07	O
),	O
normal	O
stress	O

2015-10-07	O

6.	O
hx	O
of	O
Foot	B-disease
Ulcer	I-disease

7.	O
h/o	O
clot	B-disease
in	O
AV	O
graft	O
x2	O
(	O
March	O
and	O
2018-07-07	O
)	O

Social	O
History	O
:	O

Denies	O
alcohol	O
or	O
tobacco	O
use	O
.	O

Endorses	O
occassional	O
marijuana	O
use	O
.	O

Lives	O
with	O
his	O
Carney	O
Hospital	O
mother	O
and	O
their	O
three	O
children	O
.	O

Family	O
History	O
:	O

His	O
father	O
recently	O
died	O
of	O
ESRD	B-disease
and	O
diabetes	B-disease
.	O

His	O
mother	O
is	O
in	O
her	O
50	O
s	O
and	O
has	O
hypertension	B-disease
.	O

He	O
has	O
two	O
sisters	O
,	O
one	O
with	O
diabetes	B-disease
,	O
and	O
six	O
brothers	O
,	O
one	O
with	O
diabetes	B-disease
.	O

Physical	O
Exam	O
:	O

Vitals	O
:	O
97.4	O
,	O
164/90	O
,	O
102	O
,	O
10	O
,	O
97%	O
4L	O

General	O
:	O
sleepy	B-disease
,	O
arouses	O
to	O
voice	O
but	O
limited	O
participation	O
with	O
physical	O
exam	O

HEENT	O
:	O
PERRL	O
,	O
left	B-disease
pupil	I-disease
smaller	I-disease
than	I-disease
right	I-disease
,	O
pt	O
will	O
not	O
participate	O
in	O
EOMI	O
,	O
sclera	O
anicteric	B-disease
,	O
MM	B-disease
dry	I-disease
,	O
No	O
OP	B-disease
lesions	I-disease

Neck	O
:	O
Supple	O
,	O
no	O
JVD	B-disease

CV	O
:	O
RRR	O
,	O
nl	O
S1	O
,	O
S2	O
,	O
2/6	B-disease
systolic	I-disease
murmur	I-disease
at	I-disease
LUSB	I-disease

Lungs	O
:	O
CTAB	O
post	O

Chest	O
:	O
HD	O
line	O
in	O
place	O
without	O
erythema	B-disease

Abd	O
:	O
Soft	O
,	O
ND	B-disease
,	O
nontender	B-disease
,	O
+	O
BS	O
,	O
no	O
guarding	B-disease
,	O
no	O
rebound	B-disease
,	O
multiple	B-disease
well	I-disease
healed	I-disease
scars	I-disease

Ext	O
:	O
no	O
c/c/e	B-disease
,	O
left	B-disease
arm	I-disease
with	I-disease
fistula	I-disease
with	O
good	O
thrill	O

Skin	O
:	O
no	O
rashes	B-disease

Brief	O
Hospital	O
Course	O
:	O

Pt	O
admitted	O
to	O
medical	O
floor	O
in	O
hemodynamically	O
stable	O
condition	O
without	O
specific	B-disease
complaints	I-disease
.	O

#	O
hypertensive	B-disease
urgency	I-disease
:	O

Upon	O
presentation	O
it	O
was	O
unclear	O
when	O
last	O
time	O
was	O
that	O
patient	O
took	O
meds	O
,	O
but	O
hypertension	B-disease
likely	O
d/t	O
inability	B-disease
to	I-disease
take	I-disease
meds	I-disease
in	O
setting	O
of	O
N/V	B-disease
.	O

Also	O
contribution	O
of	O
autonomic	B-disease
dysfunction	I-disease
.	O

No	O
evidence	O
of	O
active	B-disease
end	I-disease
organ	I-disease
damage	I-disease
.	O

Pt	O
was	O
treated	O
with	O
labetalol	O
gtt	O
in	O
CMED	O
CCU	O
which	O
was	O
weaned	O
off	O
on	O
01-20	O
.	O

carduac	B-disease
enzymes	I-disease
mildly	I-disease
elevated	I-disease
,	O
felt	O
02-08	O
demand	B-disease
ischemia	I-disease
in	O
setting	O
of	O
hypertensive	B-disease
urgency	I-disease
,	O
CK	O
and	O
MB	O
trended	O
Mcewen	O
at	O
time	O
of	O
admission	O
to	O
medical	O
floor	O
.	O

Pt	B-disease
's	I-disease
hypertensive	I-disease
urgency	I-disease
was	O
resolved	O
upon	O
admission	O
to	O
the	O
medical	O
floor	O
.	O

His	O
SBP	O
s	O
ranged	O
140	O
s-	O
170	O
s	O
.	O

He	O
was	O
restarted	O
on	O
his	O
home	O
regimen	O
of	O
antihypertensives	O
without	O
difficulty	O
(	O
metoprolol	O
75	O
tid	O
,	O
clonidine	O
patch	O
and	O
oral	O
,	O
nifedipine	O
30	O
SR	O
q	O
daily	O
).	O

he	O
was	O
discharged	O
home	O
with	O
change	O
in	O
his	O
regimen	O
.	O

#	O
bacteremia	B-disease
:	O

pt	O
with	O
2/4	O
bottles	O
coag	B-disease
neg	I-disease
staph	I-disease
on	O
01-19	O
and	O
again	O
on	O
01-20	O
.	O

PORT	O
was	O
felt	O
most	O
likely	O
source	O
,	O
and	O
pt	O
has	O
had	O
at	O
least	O
2	O
sets	O
of	O
+	B-disease
blood	I-disease
cultures	I-disease
since	O
it	O
was	O
placed	O
.	O

TTE	O
was	O
obtained	O
which	O
was	O
not	O
concerning	O
for	O
endocarditis	B-disease
.	O

pt	O
without	O
stigmata	B-disease
of	I-disease
SBE	I-disease
.	O

ID	O
consult	O
obtained	O
which	O
recommended	O
removal	O
of	O
PORT	O
,	O
which	O
was	O
taken	O
out	O
on	O
01-23	O
.	O

Pt	O
will	O
compelete	O
a	O
2	O
week	O
course	O
of	O
vancomycin	O
at	O
hemodialysis	O
,	O
which	O
has	O
been	O
arranged	O
by	O
renal	O
service	O
.	O

A	O
PICC	O
was	O
breifly	O
placed	O
,	O
however	O
removed	O
as	O
it	O
is	O
unclear	O
if	O
pt	O
can	O
reliably	O
flush	O
this	O
.	O

PORT	O
will	O
be	O
replaced	O
on	O
2019-02-11	O
per	O
IR	O
(	O
Dr.	O
Welsh	O
placed	O
last	O
PORT	O
,	O
then	O
removed	O
it	O
on	O
01-23	O
),	O
ordered	O
placed	O
in	O
OMR	O
.	O

Indication	O
:	O

diabetic	B-disease
gastropathy	I-disease
causing	O
inability	B-disease
to	I-disease
toleral	I-disease
oral	I-disease
antihypertensive	I-disease
medication	I-disease
prompting	O
repeated	O
Donald	O
presentation	O
for	O
hypertensive	B-disease
urgency	I-disease
.	O

Pt	O
with	O
surveillance	O
cultures	O
and	O
port	O
tip	O
cultures	O
showing	O
NGTD	O
on	O
01-24	O
,	O
he	O
will	O
have	O
futher	O
surveillance	O
cultures	O
drawn	O
at	O
hemodialysis	O
and	O
followed	O
by	O
his	O
nephrologist	O
.	O

#	O
n/v/	B-disease
abdominal	B-disease
pain	I-disease
:	O
pt	O
with	O
multiple	O
admissions	O
with	O
similar	B-disease
complaints	I-disease
,	O
etiology	O
02-08	O
gastroparesis	B-disease
,	O
improves	O
considerably	O
with	O
ativan	O
,	O
dilaudid	O
,	O
reglan	O
,	O
pt	O
was	O
tolerating	O
PO	O
meds	O
/	O
diet	O
at	O
time	O
of	O
admission	O
to	O
medical	O
service	O
and	O
was	O
restarted	O
on	O
oral	O
reglan	O
.	O

#	O
DMI	B-disease
:	O
Pt	O
on	O
sliding	O
scale	O
as	O
inpatient	O
and	O
taking	O
NPH	O
2	O
units	O
BID	O
at	O
home	O
.	O

pt	O
with	O
two	O
episodes	O
of	O
hypoglycemia	B-disease
(	O
FSBS	O
22	O
and	O
27	O
),	O
etiology	O
unclear	O
,	O
pt	O
followed	O
by	O
Strickland	O
,	O
who	O
recommend	O
no	O
changes	O
to	O
current	O
insulin	O
regimen	O
.	O

will	O
discharge	O
pt	O
with	O
instructions	O
to	O
continue	O
NPH	O
2	O
UNITS	O
BID	O
as	O
Frederick	O
Tracey	O
recs	O
.	O

#	O
CAD	B-disease
-	O
pt	O
denied	O
cp	B-disease
/	O
sob	B-disease
throughout	O
hospitalization	O
.	O

Troponins	O
rose	O
at	O
admission	O
,	O
however	O
CK	O
and	O
MB	O
trending	O
Mcewen	O
wat	O
time	O
of	O
admission	O
to	O
medical	O
service	O
.	O

Etiology	O
felt	O
most	O
likely	O
demand	B-disease
ischemia	I-disease
in	O
setting	O
of	O
original	B-disease
hypertensive	I-disease
urgency	I-disease
with	O
persistent	B-disease
elevation	I-disease
of	I-disease
trop	I-disease
02-08	O
ESRD	B-disease
.	O

Pt	O
was	O
continued	O
on	O
aspirin	O
,	O
metoprolol	O
,	O
nifedipine	O
.	O

#	O
ESRD	B-disease
:	O
etiology	O
likely	O
02-08	O
DM	B-disease
and	O
HTN	B-disease
,	O
pt	O
tolerating	O
HD	O
well	O
,	O
and	O
underwent	O
dialysis	O
without	O
difficulty	B-disease
on	O
01-24	O
.	O

pt	O
will	O
be	O
discharged	O
home	O
with	O
plan	O
to	O
continue	O
current	O
dialysis	O
schedule	O
(	O
Tue	O
/	O
Th	O
/	O
Sat	O
).	O

In	O
addition	O
pt	O
will	O
be	O
given	O
vancomycin	O
at	O
dialysis	O
x	O
2	O
week	O
course	O
(	O
last	O
day	O
2019-02-05	O
)	O
given	O
his	B-disease
PORT	I-disease
line	I-disease
infection	I-disease
.	O

He	O
will	O
have	O
levels	O
drawn	O
at	O
dialysis	O
and	O
be	O
dosed	O
with	O
vancomycin	O
as	O
appropriate	O
.	O

Plan	O
is	O
for	O
surveillance	O
cultures	O
to	O
be	O
drawn	O
at	O
dialysis	O
.	O

If	O
negative	O
,	O
pt	O
is	O
scheduled	O
for	O
presumptively	O
replacement	O
of	O
PORT	O
on	O
2019-02-11	O
with	O
interventional	O
radiology	O
(	O
dr.	O
Arevalo	O
).	O

Pt	O
continued	O
on	O
home	O
regimen	O
of	O
calcium	O
acetate	O
667	O
mg	O
,	O
3	O
capsules	O
TID	O
.	O

#	O
AV	O
fistula	O
:	O
pt	O
with	O
h/o	O
numerous	B-disease
clots	I-disease
in	O
AV	O
fistula	O
.	O

No	O
signs	O
of	O
infection	B-disease
presently	O
,	O
and	O
tolerating	O
dialysis	O
without	O
difficulty	B-disease
.	O

Pt	O
was	O
subtherapeuticon	B-disease
INR	I-disease
on	O
admission	O
,	O
thus	O
treated	O
with	O
heparin	O
gtt	O
.	O

coumadin	O
held	O
on	O
01-22	O
for	O
PORT	O
removal	O
,	O
and	O
restarted	O
on	O
01-24	O
.	O

Pt	O
discharged	O
with	O
instructions	O
to	O
continue	O
coumadin	O
1.5	O
mg	O
po	O
q	O
daily	O
with	O
goal	O
INR	O
02-09	O
.	O

#	O
DISPO	O
:	O

pt	O
discharged	O
home	O
on	O
01-24	O
with	O
instructions	O
to	O
complete	O
2	O
week	O
course	O
of	O
vancomycin	O
at	O
hemodialysis	O
for	O
his	B-disease
PORT	I-disease
line	I-disease
infection	I-disease
.	O

an	O
appointment	O
was	O
made	O
with	O
interventional	O
radiology	O
on	O
2019-02-11	O
to	O
replace	O
his	O
PORT	O
,	O
under	O
the	O
assumption	O
that	O
his	O
surveillance	O
cultures	O
from	O
dialysis	O
remain	O
negative	O
.	O

discussed	O
this	O
plan	O
with	O
renal	O
service	O
(	O
Anthony	O
Mcknight	O
)	O
who	O
will	O
communicate	O
with	O
pt	O
's	O
outpatient	O
dialysis	O
service	O
.	O

Medications	O
on	O
Admission	O
:	O

Metoclopramide	O
10	O
mg	O
PO	O
Q6	O

Metoprolol	O
Tartrate	O
75	O
mg	O
PO	O
TID	O

Calcium	O
Acetate	O
1340	O
mg	O
tid	O
with	O
meals	O

Anzemet	O
12.5	O
IV	O
prn	O

Prochlorperazine	O
10	O
mg	O
IV	O
Q6H	O
prn	O

Ativan	O
1	O
mg	O
PO	O
Q6H	O
prn	O

Dilaudid	O
4mg	O
PO	O
Q3-4H	O
prn	O

Insulin	O
NPH	O
2	O
units	O
Subcutaneous	O
twice	O
a	O
day	O
.	O

Clonidine	O
0.3	O
mg	O
/	O
24	O
hr	O
Patch	O
Weekly	O
Transdermal	O
QTHUR	O

Clonidine	O
0.2	O
mg	O
PO	O
TID	O

Prochlorperazine	O
10	O
mg	O
q	O
6	O
h	O

Coumadin	O
1.5	O
mg	O
PO	O
QHS	O

Nifedipine	O
30	O
SR	O
mg	O
PO	O
QD	O

Bisacodyl	O
prn	O

Protonix	O
40	O
QD	O

Discharge	O
Medications	O
:	O

1.	O
Metoclopramide	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

2.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

3.	O
Calcium	O
Acetate	O
667	O
mg	O
Capsule	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Capsule	O
PO	O
TID	O
W/	O
MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
).	O

4.	O
Ativan	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
q6h	O
prn	O
.	O

5.	O
Dilaudid	O
4	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
q3-4hr	O
prn	O
.	O

6.	O
Clonidine	O
0.3	O
mg	O
/	O
24	O
hr	O
Patch	O
Weekly	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Patch	O
Weekly	O
Transdermal	O
Q	O
WED	O
(	O
every	O
Wednesday	O
).	O

7.	O
Clonidine	O
0.2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

8.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
DAILY	O
(	O
Daily	O
).	O

9.	O
Nifedipine	O
30	O
mg	O
Tablet	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
).	O

10.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

11.	O
Bisacodyl	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-disease
.	O

12.	O
Vancomycin	O
in	O
Dextrose	O
1	O
g	O
/	O
200	O
mL	O
Piggyback	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Intravenous	O
QHD	O
(	O
each	O
hemodialysis	O
):	O
2	O
week	O
course	O
to	O
be	O
given	O
at	O
dialysis	O
,	O
last	O
day	O
2019-02-05	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

13.	O
Aspirin	O
81	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

14.	O
Humalog	O
100	O
unit	O
/	O
mL	O
Solution	O
Sig	O
:	O
USE	O
AS	O
DIRECTED	O
Subcutaneous	O
four	O
times	O
a	O
day	O
:	O
please	O
use	O
attached	O
sliding	O
scale	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

15.	O
Insulin	O
NPH	O
Human	O
Recomb	O
100	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
2	O
UNITS	O
Subcutaneous	O
twice	O
a	O
day	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

primary	O
:	O

bacteremia	B-disease
02-08	O
PORT	B-disease
line	I-disease
infection	I-disease

hypertensive	B-disease
urgency	I-disease

diabetic	B-disease
gastropathy	I-disease

Discharge	O
Condition	O
:	O

stable	O
.	O

Discharge	O
Instructions	O
:	O

please	O
continue	O
to	O
take	O
all	O
of	O
your	O
medications	O
as	O
prescribed	O
.	O

you	O
were	O
started	O
on	O
a	O
2	O
week	O
course	O
of	O
vancomycin	O
to	O
be	O
given	O
at	O
hemodialysis	O
for	O
your	B-disease
line	I-disease
infection	I-disease
.	O

you	O
will	O
have	O
your	O
PORT	O
replaced	O
after	O
2	O
weeks	O
of	O
antibiotics	O
if	O
your	O
blood	O
cultures	O
remain	O
negative	O
.	O

if	O
you	O
have	O
recurrent	B-disease
fevers	I-disease
,	O
chills	B-disease
,	O
naseau	B-disease
,	O
vomitting	B-disease
,	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
or	O
other	B-disease
worrisome	I-disease
symptoms	I-disease
,	O
please	O
contact	O
your	O
primary	O
care	O
physician	O
or	O
the	O
emergency	O
department	O
.	O

Followup	O
Instructions	O
:	O

please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
within	O
4	O
weeks	O
.	O

please	O
follow-up	O
with	O
your	O
dialysis	O
physician	O
regarding	O
replacing	O
your	O
PORT	O
.	O

please	O
follow-up	O
with	O
dr.	O
Lillian	O
becker	O
in	O
gastroenterology	O
within	O
1-2	O
weeks	O
,	O
an	O
appointment	O
has	O
been	O
made	O
for	O
on	O
you	O
2019-02-11	O
at	O
3PM	O
.	O

(	O
447	O
)	O
671-2034	O
(	O
Caldwell	O
building	O
,	O
1st	O
floor	O
,	O
1718	O
S.	O
Sixth	O
Blvd.	O
).	O

upon	O
arriving	O
home	O
please	O
contact	O
the	O
King	O
and	O
arrange	O
to	O
be	O
seen	O
within	O
1-2	O
weeks	O
.	O

Adam	O
Ruth	O
MD	O
61-358	O

Completed	O
by	O
:	O
Elwood	O
Edmond	O
MD	O
68-884	O
2019-01-31	O
@	O
1141	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Pamula	O
Pugh	O
on	O
:	O
Russell	O
2019-01-31	O
12:12	O
PM	O

(	O
End	O
of	O
Report	O
)	O

262912613	O

CTMC	O

43279523	O

551881	O

6/25/1990	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/25/1990	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/05/1990	O

PRINCIPLE	O
DIAGNOSIS	O
:	O

LEFT	B-disease
KNEE	I-disease
OSTEOARTHRITIS	I-disease
.	O

PROCEDURE	O
:	O

LEFT	O
TOTAL	O
KNEE	O
ARTHROPLASTY	O
ON	O
6/26/90	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
78-year-old	O
female	O
who	O
has	O
had	O
osteoarthritis	B-disease
and	O
noted	O
the	O
sudden	O
onset	O
of	O
left	B-disease
knee	I-disease
pain	I-disease
in	O
09/89	O
.	O

Since	O
that	O
time	O
,	O
she	O
has	O
used	O
a	O
cane	O
and	O
she	O
was	O
referred	O
to	O
Dr.	O
Koors	O
.	O

MRI	O
demonstrated	O
a	B-disease
left	I-disease
femoral	I-disease
condyle	I-disease
osteonecrotic	I-disease
defect	I-disease
and	O
degenerative	B-disease
meniscus	I-disease
.	O

She	O
climbs	O
stairs	O
one	O
at	O
a	O
time	O
and	O
denied	O
rest	B-disease
pain	I-disease
.	O

She	O
can	O
one	O
walk	O
without	O
difficulties	B-disease
.	O

She	O
presented	O
for	O
an	O
elective	O
left	O
total	O
knee	O
arthroplasty	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Pneumonia	B-disease
one	O
and	O
a	O
half	O
years	O
ago	O
.	O

Hepatitis	B-disease
35	O
years	O
ago	O
.	O

Anxiety	B-disease
neurosis	I-disease
for	O
which	O
she	O
has	O
received	O
shock	O
therapy	O
in	O
the	O
past	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Total	O
abdominal	O
hysterectomy	O
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Tylenol	O
.	O

ALLERGIES	O
:	O

DOXEPIN	O
CAUSES	O
ITCHING	B-disease
.	O

HABITS	O
:	O

The	O
patient	O
does	O
not	O
smoke	O
.	O

She	O
drinks	O
one	O
to	O
two	O
glasses	O
of	O
scotch	O
per	O
day	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
was	O
only	O
significant	O
for	O
her	O
orthopaedic	O
exam	O
.	O

Her	O
left	O
knee	O
had	O
5	O
degrees	O
of	O
valgus	B-disease
,	O
120	O
degrees	O
of	O
flexion	O
,	O
full	O
extension	O
and	O
slight	B-disease
valgus	I-disease
instability	I-disease
.	O

She	O
had	O
no	O
Lachmann	O
or	O
anterior	O
drawer	O
,	O
she	O
did	O
have	O
a	B-disease
mild	I-disease
effusion	I-disease
.	O

She	O
had	O
normal	O
sensation	O
and	O
pulses	O
in	O
both	O
legs	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
included	O
a	O
hematocrit	O
of	O
34.2	O
.	O

Potassium	O
4.4	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
cleared	O
for	O
surgery	O
by	O
Dr.	O
Lupevickette	O
Ca	O
.	O

Her	O
EKG	O
was	O
normal	O
.	O

She	O
was	O
therefore	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
6/26	O
and	O
underwent	O
a	O
left	O
total	O
knee	O
arthroplasty	O
losing	O
200	O
cc	O
of	O
blood	O
in	O
the	O
procedure	O
with	O
two	O
drains	O
left	O
in	O
which	O
were	O
removed	O
on	O
the	O
first	O
postoperative	O
day	O
.	O

She	O
was	O
slightly	B-disease
agitated	I-disease
on	O
the	O
first	O
postoperative	O
day	O
but	O
this	O
resolved	O
by	O
the	O
second	O
postoperative	O
day	O
.	O

Her	O
epidural	O
catheter	O
was	O
removed	O
on	O
6/29	O
.	O

The	O
Foley	O
catheter	O
was	O
removed	O
on	O
6/29	O
and	O
she	O
had	O
no	O
difficulties	B-disease
voiding	I-disease
.	O

Psychiatry	O
Service	O
saw	O
her	O
on	O
6/28	O
and	O
recommended	O
avoiding	O
benzodiazepines	O
and	O
Haldol	O
for	O
agitation	B-disease
.	O

She	O
was	O
prophylaxed	O
with	O
Kefzol	O
perioperatively	O
and	O
with	O
Coumadin	O
postoperatively	O
.	O

She	O
was	O
also	O
given	O
whiskey	O
spirits	O
because	O
of	O
the	O
fact	O
that	O
she	O
drank	O
one	O
to	O
two	O
drinks	O
of	O
scotch	O
per	O
day	O
.	O

Her	O
hematocrit	O
was	O
31.4	O
on	O
6/29	O
with	O
a	O
PT	O
of	O
18.2	O

Her	O
PT	O
drifted	O
down	O
to	O
a	O
level	O
of	O
12.9	O
by	O
7/3	O
and	O
therefore	O
she	O
will	O
be	O
discharged	O
with	O
4	O
mg	O
of	O
Coumadin	O
per	O
day	O
to	O
be	O
followed	O
by	O
the	O
Coumadin	O
Clinic	O
at	O
Cowerin	O
Tonli	O
Medical	O
Center	O
.	O

She	O
was	O
discharged	O
with	O
a	O
prescription	O
for	O
Tylenol	O
#3	O
with	O
Physical	O
Therapy	O
.	O

She	O
did	O
quite	O
well	O
with	O
Physical	O
Therapy	O
and	O
was	O
ambulating	O
with	O
a	O
walker	O
and	O
crutches	O
by	O
7/3/90	O
.	O

She	O
was	O
able	O
to	O
flex	O
her	O
knees	O
to	O
90	O
degrees	O
by	O
that	O
time	O
.	O

She	O
developed	O
no	O
problems	O
with	O
edema	B-disease
or	O
with	O
her	B-disease
wound	I-disease
during	O
her	O
hospital	O
stay	O
.	O

She	O
will	O
follow-up	O
with	O
Dr.	O
Koors	O
in	O
approximately	O
five	O
weeks	O
.	O

________________________________	O

IA605/6041	O
DE	O
KOORS	O
,	O
M.D.	O
CU2	O

D	O
:	O

07/03/90	O

Batch	O
:	O

1726	O

Report	O
:	O

J0929X49	O

T	O
:	O

07/04/90	O

Dicatated	O
By	O
:	O

LENTNY	O
FARSTNAPPSSHEE	O
,	O
M.D.	O

869436718	O
SC	O

64806295	O

6613471	O

10/1/2003	O
12:00:00	O
AM	O

post	O
partum	O

DIS	O

Admission	O
Date	O
:	O

10/01/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

10/04/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KULRINNE	O
,	O
RYYELEGE	O
N	O

386-85-38-0	O
X32	O

Room	O
:	O

JQL5-545	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

10/04/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	O
(	O
ACETAMINOPHEN	O
)	O
650	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	B-disease

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
10/01/03	O
by	O
KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

ACETAMINOPHEN	O
and	O
ACETAMINOPHEN	O

Reason	O
for	O
override	O
:	O

ok	O

COLACE	O
(	O
DOCUSATE	O
SODIUM	O
)	O
100	O
MG	O
PO	O
BID	O
IBUPROFEN	O
600	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	B-disease

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O
MILK	O
OF	O
MAGNESIA	O
(	O
MAGNESIUM	O
HYDROXIDE	O
)	O
30	O
MILLILITERS	O
PO	O
BID	O
PRN	O
Constipation	B-disease
PERCOCET	O
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	B-disease

Override	O
Notice	O
:	O

Override	O
added	O
on	O
10/01/03	O
by	O
KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
on	O
order	O
for	O
TYLENOL	O
PO	O
650	O
MG	O
Q4H	O
(	O
ref	O
#	O
85225311	O
)	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

ACETAMINOPHEN	O
and	O
ACETAMINOPHEN	O

Reason	O
for	O
override	O
:	O

ok	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

kotejoasthoreuphkays	O
6	O
weeks	O
,	O

ALLERGY	O
:	O

Sulfa	O
,	O
Bactrim	O

ADMIT	O
DIAGNOSIS	O
:	O

Pregnancy	B-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O

post	O
partum	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

twins	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Spinal	O

Vaginal	O
delivery	O
:	O

Undelivered	B-disease

Cesarean	O
Status	O
:	O

Primary	O

Urgency	O
:	O

Scheduled	O

Indications	O
:	O

Breech	B-disease
,	O
Multiple	B-disease
gestation	I-disease
,	O

Uterine	O
incision	O
type	O
:	O

Transverse	O

Placenta	O
:	O

Delivery	O
:	O

Spontaneous	O

Condition	O
:	O

Normal	O

Staff	O
Obstetrician	O
(	O
supervising	O
)	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
Delivery	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

none	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G3	O
T1	O
P0	O
A1	O
L1	O

Estimated	O
EDC	O
:	O

10/14/03	O

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-disease
abnormalities	I-disease

Baby	O
1	O

MRN	O
:	O

76306248	O

Delivery	O
date	O
:	O

10/01/03	O
09:06	O
AM	O

Apgars	O
8,9	O

Weight	O
:	O

7lb	O
1	O
oz	O
3204	O
grams	O

Sex	O
:	O

Male	O

Baby	O
2	O

MRN	O
:	O

62685780	O

Delivery	O
date	O
:	O

10/01/03	O
09:08	O
AM	O

Apgars	O
8,8	O

Weight	O
:	O

7lb	O
0	O
oz	O
3175	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

KOTEJOASTHOREUPHKAYS	O
,	O
GAI	O
,	O
M.D.	O
(	O
CT17	O
)	O
10/04/03	O
07:11	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

837898389	O

CTMC	O

88360969	O

394521	O

11/24/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

11/24/1994	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

1)	O
RIGHT	B-disease
LOWER	I-disease
EXTREMITY	I-disease
PSEUDOMONAS	I-disease
CELLULITIS	I-disease
.	O

2)	O
PAROXYSMAL	B-disease
ATRIAL	I-disease
FIBRILLATION	I-disease
.	O

3)	O
CORD	B-disease
COMPRESSION	I-disease
.	O

4)	O
STEROID	B-disease
INDUCED	I-disease
DIABETES	I-disease
MELLITUS	I-disease
.	O

5)	O
PLASMACYTOMA	B-disease
.	O

6)	O
POOR	B-disease
NUTRITIONAL	I-disease
STATUS	I-disease
.	O

7)	O
THROMBOCYTOPENIA	B-disease
STATUS	O
POST	O
BONE	O
MARROW	O
TRANSPLANT	O
.	O

8)	O
MULTIPLE	B-disease
MYELOMA	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
59-year-old	O
white	O
male	O
.	O

The	O
patient	O
has	O
had	O
multiple	B-disease
myeloma	I-disease
since	O
1990	O
.	O

He	O
underwent	O
an	O
autologous	O
bone	O
marrow	O
transplant	O
in	O
10/92	O
at	O
Petersly	O
Hospital	O
And	O
Medical	O
Center	O
.	O

At	O
that	O
time	O
he	O
received	O
total	O
body	O
irradiation	O
of	O
1400	O
cGy	O
.	O

This	O
bone	O
marrow	O
transplant	O
did	O
not	O
produce	O
remission	O
and	O
then	O
he	O
was	O
treated	O
with	O
three	O
cycles	O
of	O
VAD	O
subsequently	O
.	O

In	O
08/94	O
,	O
the	O
patient	O
developed	O
lower	B-disease
back	I-disease
pain	I-disease
.	O

A	O
workup	O
done	O
in	O
DE	O
is	O
not	O
available	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

According	O
to	O
her	O
scanty	O
records	O
,	O
an	O
MRI	O
of	O
the	O
spine	O
showed	O
diffuse	B-disease
spinal	I-disease
column	I-disease
involvement	I-disease
with	O
lesions	B-disease
in	I-disease
T4	I-disease
and	I-disease
T8	I-disease
with	O
no	O
cord	B-disease
compression	I-disease
at	O
that	O
time	O
.	O

He	O
was	O
then	O
treated	O
with	O
radiation	O
therapy	O
from	O
T3	O
to	O
T9	O
receiving	O
2500	O
cGy	O
from	O
08/94	O
to	O
09/94	O
.	O

He	O
has	O
been	O
on	O
Decadron	O
since	O
08/94	O
.	O

About	O
two	O
weeks	O
prior	O
to	O
admission	O
the	O
patient	O
developed	O
mid	B-disease
back	I-disease
pain	I-disease
,	O
burning	O
in	O
nature	O
with	O
radiation	O
around	O
the	O
right	O
lower	O
ribs	O
.	O

He	O
also	O
began	O
to	O
develop	O
noticeably	B-disease
increasing	I-disease
bilateral	I-disease
lower	I-disease
extremity	I-disease
weakness	I-disease
and	O
possibly	O
numbness	B-disease
in	I-disease
the	I-disease
lower	I-disease
extremities	I-disease
.	O

He	O
stated	O
that	O
he	O
had	O
difficulty	B-disease
rising	I-disease
from	I-disease
a	I-disease
chair	I-disease
.	O

An	O
MRI	O
without	O
gadolinium	O
done	O
on	O
11/20/94	O
of	O
the	O
spine	O
showed	O
a	B-disease
right	I-disease
posterior	I-disease
lateral	I-disease
epidural	I-disease
mass	I-disease
extending	O
from	O
T9	O
to	O
T12	O
.	O

There	O
was	O
evidence	O
of	O
cord	B-disease
compression	I-disease
.	O

The	O
patient	O
&apos;s	O
Decadron	O
dose	O
was	O
increased	O
to	O
12	O
mg	O
q	O
day	O
and	O
he	O
was	O
also	O
started	O
on	O
MS	O
Contin	O
and	O
radiation	O
therapy	O
was	O
being	O
planned	O
and	O
arranged	O
at	O
the	O
Petersly	O
Hospital	O
And	O
Medical	O
Center	O
.	O

However	O
,	O
one	O
day	O
prior	O
to	O
admission	O
the	O
patient	O
developed	O
right	B-disease
lower	I-disease
extremity	I-disease
pain	I-disease
and	O
could	O
not	O
walk	O
secondary	O
to	O
the	B-disease
pain	I-disease
.	O

Over	O
the	O
next	O
12	O
hours	O
while	O
in	O
transit	O
to	O
the	O
hospital	O
,	O
the	O
patient	O
&apos;s	O
right	O
lower	O
extremity	O
became	O
red	B-disease
,	O
swollen	B-disease
,	O
and	O
increasingly	B-disease
painful	I-disease
.	O

He	O
has	O
had	O
chronic	B-disease
bilateral	I-disease
lower	I-disease
extremity	I-disease
swelling	I-disease
since	O
his	O
transplant	O
but	O
the	B-disease
right	I-disease
lower	I-disease
extremity	I-disease
swelling	I-disease
was	O
noticeably	O
increased	O
.	O

He	O
also	O
complained	O
of	O
some	B-disease
fecal	I-disease
incontinence	I-disease
the	O
day	O
prior	O
to	O
admission	O
without	O
urinary	B-disease
incontinence	I-disease
.	O

At	O
the	O
time	O
of	O
presentation	O
the	O
patient	O
denied	O
headache	B-disease
,	O
arm	B-disease
weakness	I-disease
,	O
changes	B-disease
in	I-disease
vision	I-disease
,	O
dysarthria	B-disease
,	O
abdominal	B-disease
pain	I-disease
,	O
nausea	B-disease
or	O
vomiting	B-disease
,	O
chest	B-disease
pain	I-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

He	O
was	O
taken	O
to	O
Huyychestleme	O
Health	O
Of	O
in	O
Scoo	O
,	O
Utah	O
where	O
he	O
had	O
a	O
temperature	O
of	O
99.9	O
,	O
blood	O
pressure	O
90/50	O
,	O
heart	O
rate	O
128	O
,	O
and	O
O2	O
sat	O
of	O
91%	O
on	O
room	O
air	O
.	O

Blood	O
cultures	O
,	O
urine	O
culture	O
,	O
and	O
UA	O
were	O
all	O
done	O
.	O

Blood	O
cultures	O
drawn	O
on	O
admission	O
subsequently	O
grew	O
Pseudomonas	B-disease
aeruginosa	I-disease
.	O

He	O
was	O
treated	O
with	O
Ceftazidime	O
,	O
gentamicin	O
,	O
and	O
Vancomycin	O
and	O
also	O
was	O
started	O
on	O
a	O
Dopamine	O
drip	O
for	O
treatment	O
of	O
his	B-disease
sepsis	I-disease
.	O

A	O
Swan	O
was	O
placed	O
and	O
initial	O
readings	O
were	O
CVP	O
of	O
6	O
,	O
wedge	O
pressure	O
of	O
10	O
to	O
12	O
,	O
cardiac	O
index	O
of	O
4.7	O
,	O
and	O
SVR	O
of	O
438	O
all	O
consistent	O
with	O
a	B-disease
Pseudomonas	I-disease
sepsis	I-disease
picture	I-disease
.	O

He	O
was	O
given	O
stress	O
steroids	O
and	O
was	O
subsequently	O
transferred	O
to	O
Lorough	O
Medical	O
Center	O
&apos;s	O
Intensive	O
Care	O
Unit	O
for	O
further	O
management	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Multiple	B-disease
myeloma	I-disease
.	O

2)	O
Paroxysmal	B-disease
atrial	I-disease
fibrillation	I-disease
.	O

3)	O
Plasmacytoma	B-disease
of	I-disease
T9	I-disease
through	I-disease
T12	I-disease
.	O

4)	O
Chronic	B-disease
renal	I-disease
insufficiency	I-disease
.	O

5)	O
Chronically	B-disease
low	I-disease
platelet	I-disease
count	I-disease
.	O

6)	O
Failed	O
autologous	O
bone	O
marrow	O
transplant	O
in	O
10/92	O
.	O

7)	O
Hypothyroidism	B-disease
.	O

FAMILY	O
HISTORY	O
:	O

Positive	O
for	O
diabetes	B-disease
mellitus	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

Married	O
to	O
a	O
very	O
supportive	O
wife	O
.	O

ALLERGIES	O
:	O

Question	O
of	O
penicillin	O
and	O
sulfa	O
drugs	O
leading	O
to	O
a	B-disease
rash	I-disease
.	O

MEDICATIONS	O
:	O

On	O
transfer	O
include	O
Vancomycin	O
,	O
Ceftazidime	O
,	O
gentamicin	O
,	O
Solu	O
Cortef	O
100	O
mg	O
q8h	O
,	O
Lasix	O
,	O
Synthroid	O
,	O
insulin	O
,	O
MS	O
Contin	O
60	O
mg	O
b.i.d.	O
,	O
MSO4	O
2	O
mg	O
p.r.n.	O
pain	B-disease
IV	O
,	O
Dopamine	O
12	O
mcg	O
per	O
minute	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
showed	O
a	O
non-toxic	O
appearing	O
male	O
with	O
temperature	O
99.5	O
,	O
blood	O
pressure	O
82/50	O
,	O
heart	O
rate	O
118	O
,	O
respiratory	O
rate	O
15	O
.	O

HEENT	O
exam	O
atraumatic	B-disease
,	O
no	O
oral	B-disease
lesions	I-disease
.	O

Neck	O
supple	O
,	O
carotids	O
without	O
bruits	B-disease
.	O

Cardiac	O
exam	O
was	O
regular	O
S1	O
and	O
S2	O
,	O
no	O
murmur	B-disease
.	O

Chest	O
clear	O
to	O
auscultation	O
with	O
a	B-disease
few	I-disease
fine	I-disease
crackles	I-disease
at	I-disease
the	I-disease
left	I-disease
base	I-disease
.	O

Abdomen	O
non-distended	B-disease
,	O
positive	O
bowel	O
sounds	O
,	O
soft	O
,	O
non-tender	B-disease
,	O
no	O
hepatosplenomegaly	B-disease
or	O
masses	B-disease
.	O

Rectal	O
normal	O
tone	O
,	O
guaiac	B-disease
positive	I-disease
brown	I-disease
stool	I-disease
,	O
no	O
perirectal	B-disease
lesions	I-disease
or	O
erythema	B-disease
.	O

Extremities	O
reveal	O
the	O
right	O
lower	O
extremity	O
was	O
tense	B-disease
,	O
purple-red	B-disease
,	O
swollen	B-disease
,	O
and	O
was	O
warm	O
from	O
the	O
knee	O
to	O
the	O
ankle	O
and	O
extremely	B-disease
tender	I-disease
.	O

There	O
was	O
pitting	B-disease
edema	I-disease
of	I-disease
both	I-disease
lower	I-disease
extremities	I-disease
but	O
no	O
evidence	O
of	O
cellulitis	B-disease
of	I-disease
the	I-disease
left	I-disease
lower	I-disease
extremity	I-disease
.	O

Neurological	O
exam	O
on	O
admission	O
revealed	O
he	O
was	O
drowsy	B-disease
but	O
easily	O
arousable	O
to	O
voice	O
,	O
oriented	O
to	O
person	O
,	O
Retelk	O
County	O
Medical	O
Center	O
,	O
and	O
date	O
,	O
able	O
to	O
say	O
no	O
but	O
mildly	B-disease
inattentive	I-disease
during	O
examination	O
.	O

Cranial	O
nerves	O
intact	O
.	O

Motor	O
exam	O
normal	O
tone	O
,	O
positive	B-disease
asterixis	I-disease
,	O
no	O
drift	O
.	O

Strength	O
was	O
decreased	O
in	O
both	O
lower	O
extremities	O
.	O

Coordination	O
was	O
normal	O
with	O
good	O
finger	O
to	O
nose	O
,	O
gait	O
was	O
not	O
tested	O
.	O

Deep	O
tendon	O
reflexes	O
were	O
2+	O
in	O
the	O
upper	O
extremities	O
,	O
1+	O
in	O
the	O
patella	O
reflexes	O
,	O
no	B-disease
reflexes	I-disease
at	I-disease
the	I-disease
ankles	I-disease
,	O
upgoing	O
Babinski	O
toes	O
bilaterally	O
.	O

LABORATORY	O
DATA	O
:	O

On	O
admission	O
revealed	O
white	O
blood	O
cell	O
count	O
4.2	O
,	O
Hct	O
27	O
,	O
platelet	O
count	O
28	O
.	O

Glucose	O
191	O
.	O

PT	O
17.6	O
,	O
PTT	O
48.7	O
,	O
fibrinogen	O
686	O
,	O
TT	O
39.2	O
.	O

Magnesium	O
1.7	O
.	O

UA	O
showed	O
no	O
white	O
blood	O
cells	O
,	O
positive	B-disease
granular	I-disease
casts	I-disease
.	O

Chest	O
x-ray	O
was	O
without	O
infiltrates	B-disease
,	O
wand	O
in	O
good	O
position	O
.	O

An	O
MRI	O
was	O
performed	O
upon	O
admission	O
and	O
showed	O
an	B-disease
epidural	I-disease
mass	I-disease
at	O
the	O
right	O
posterior	O
lateral	O
T9	O
to	O
T12	O
area	O
invading	O
the	O
neural	O
foramina	O
.	O

There	O
was	O
no	O
CSF	B-disease
density	I-disease
.	O

These	B-disease
findings	I-disease
were	O
consistent	O
with	O
the	B-disease
cord	I-disease
compression	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
problems	O
-	O

1)	O
INFECTIOUS	O
DISEASE	O
/	O
CELLULITIS	O
:	O

The	B-disease
patient	I-disease
&apos;s	I-disease
clinical	I-disease
situation	I-disease
was	O
most	O
consistent	O
with	O
a	B-disease
Pseudomonas	I-disease
cellulitis	I-disease
and	O
subsequent	B-disease
sepsis	I-disease
.	O

Blood	O
cultures	O
drawn	O
at	O
the	O
outside	O
hospital	O
grew	O
out	O
Pseudomonas	B-disease
that	O
was	O
sensitive	O
to	O
Imipenem	O
and	O
Tobramycin	O
.	O

There	O
were	O
cultures	O
obtained	O
seeping	O
from	O
the	B-disease
wound	I-disease
at	O
Retelk	O
County	O
Medical	O
Center	O
and	O
those	O
also	O
grew	O
out	O
Pseudomonas	B-disease
aeruginosa	I-disease
.	O

The	B-disease
organism	I-disease
grown	O
at	O
this	O
institution	O
was	O
sensitive	O
to	O
Imipenem	O
,	O
Ceftazidime	O
,	O
Amikacin	O
,	O
gentamicin	O
,	O
Ciprofloxacin	O
,	O
Tobramycin	O
but	O
was	O
resistant	O
to	O
Cefotetan	O
,	O
Ceftriaxone	O
,	O
Mezlocillin	O
,	O
Bactrim	O
,	O
Ampicillin	O
,	O
chloramphenicol	O
,	O
and	O
sulbactam	O
.	O

He	O
was	O
treated	O
initially	O
with	O
Ceftazidime	O
and	O
gentamicin	O
but	O
there	O
was	O
a	O
question	O
about	O
the	B-disease
organism	I-disease
&apos;s	I-disease
susceptibility	I-disease
from	O
lab	O
studies	O
done	O
at	O
the	O
outside	O
hospital	O
.	O

He	O
was	O
subsequently	O
switched	O
to	O
Imipenem	O
and	O
Tobramycin	O
and	O
was	O
maintained	O
on	O
those	O
medications	O
throughout	O
the	O
hospital	O
course	O
.	O

The	O
Tobramycin	O
and	O
Imipenem	O
were	O
started	O
on	O
11/25/94	O
.	O

In	O
addition	O
,	O
the	O
patient	O
received	O
a	O
five	O
day	O
course	O
of	O
intravenous	O
IgG	O
to	O
improve	O
infection	O
control	O
.	O

Vancomycin	O
was	O
also	O
added	O
to	O
his	O
regimen	O
on	O
11/28/94	O
and	O
this	O
was	O
primarily	O
to	O
provide	O
improved	O
MRSA	O
coverage	O
as	O
he	O
continued	O
to	O
have	O
erythema	B-disease
along	I-disease
the	I-disease
lateral	I-disease
right	I-disease
lower	I-disease
extremity	I-disease
.	O

He	O
was	O
evaluated	O
by	O
the	O
Surgery	O
Department	O
and	O
it	O
is	O
there	O
feeling	O
that	O
there	O
is	O
no	O
indication	O
for	O
surgical	O
intervention	O
/	O
amputation	O
at	O
this	O
time	O
.	O

He	O
is	O
being	O
maintained	O
with	O
twice	O
daily	O
Xeroform	O
with	O
Betadine	O
changes	O
.	O

These	O
dressing	O
changes	O
are	O
applied	O
by	O
applying	O
the	O
Xeroform	O
on	O
Betadine	O
initially	O
and	O
then	O
changing	O
it	O
with	O
sterile	O
dry	O
bandages	O
.	O

Of	O
note	O
,	O
the	O
patient	O
has	O
extreme	B-disease
pain	I-disease
with	O
these	O
dressing	O
changes	O
and	O
requires	O
parenteral	O
morphine	O
sulfate	O
for	O
pain	B-disease
control	I-disease
during	I-disease
dressing	I-disease
changes	I-disease
.	O

The	O
plan	O
is	O
to	O
complete	O
a	O
full	O
course	O
of	O
Imipenem	O
and	O
Tobramycin	O
for	O
his	B-disease
Pseudomonas	I-disease
cellulitis	I-disease
.	O

As	O
mentioned	O
earlier	O
he	O
continues	O
to	O
have	O
erythema	B-disease
tracking	O
up	O
his	O
leg	O
and	O
up	O
to	O
his	O
lateral	O
thigh	O
.	O

The	O
cause	O
of	O
this	B-disease
erythema	I-disease
is	O
not	O
know	O
at	O
this	O
time	O
but	O
has	O
not	O
shown	O
extensive	O
progression	O
.	O

2)	O
CARDIOVASCULAR	O
:	O

The	O
patient	O
was	O
initially	O
treated	O
with	O
Dopamine	O
which	O
was	O
subsequently	O
weaned	O
off	O
after	O
his	B-disease
sepsis	I-disease
improved	O
.	O

He	O
was	O
noted	O
to	O
be	O
in	O
rapid	B-disease
AF	I-disease
on	O
several	O
episodes	O
receiving	O
5	O
mg	O
IV	O
Lopressor	O
each	O
time	O
with	O
improvement	O
.	O

He	O
has	O
been	O
in	O
and	O
out	O
of	O
atrial	B-disease
fibrillation	I-disease
and	O
normal	O
sinus	O
rhythm	O
.	O

An	O
echocardiogram	O
performed	O
at	O
the	O
outside	O
hospital	O
while	O
he	O
was	O
septic	B-disease
showed	O
decreased	B-disease
global	I-disease
EF	I-disease
.	O

The	O
patient	O
is	O
being	O
maintained	O
on	O
Digoxin	O
for	O
his	B-disease
paroxysmal	I-disease
atrial	I-disease
fibrillation	I-disease
.	O

He	O
has	O
had	O
no	O
significant	O
episode	O
of	O
tachycardia	B-disease
or	O
blood	B-disease
pressure	I-disease
alteration	I-disease
during	O
the	O
final	O
days	O
of	O
hospitalization	O
.	O

The	O
plan	O
is	O
to	O
continue	O
the	O
Digoxin	O
and	O
to	O
recheck	O
an	O
echocardiogram	O
to	O
assess	O
his	O
ejection	O
fraction	O
when	O
he	O
is	O
clinically	O
better	O
.	O

3)	O
ONCOLOGY	O
:	O

The	O
patient	O
has	O
a	B-disease
plasmacytoma	I-disease
affecting	O
the	O
spine	O
.	O

He	O
has	O
been	O
receiving	O
radiation	O
therapy	O
to	O
that	O
area	O
during	O
the	O
hospital	O
stay	O
.	O

The	O
plan	O
is	O
to	O
complete	O
a	O
full	O
course	O
of	O
XRT	O
to	O
the	O
spinal	O
region	O
for	O
the	B-disease
plasmacytoma	I-disease
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
lesion	I-disease
compressing	O
his	O
thoracic	O
spine	O
was	O
never	O
biopsied	O
,	O
however	O
,	O
the	O
MRI	O
appearance	O
does	O
not	O
seem	O
to	O
be	O
infectious	B-disease
and	O
is	O
most	O
consistent	O
with	O
plasmacytoma	B-disease
for	O
which	O
he	O
is	O
receiving	O
the	O
radiation	O
therapy	O
.	O

4)	O
NEUROLOGIC	O
:	O

As	O
mentioned	O
above	O
he	O
has	O
a	B-disease
cord	I-disease
compression	I-disease
and	O
is	O
on	O
steroids	O
.	O

He	O
was	O
initially	O
treated	O
with	O
IV	O
Decadron	O
10	O
mg	O
up	O
front	O
and	O
then	O
6	O
mg	O
q6h.	O

His	O
neurological	O
exam	O
remained	O
stable	O
with	O
no	O
evidence	O
of	O
increasing	B-disease
lower	I-disease
extremity	I-disease
edema	I-disease
.	O

His	O
Decadron	O
dose	O
was	O
titrated	O
down	O
to	O
5	O
mg	O
IV	O
q6h	O
on	O
12/3/94	O
.	O

His	O
Decadron	O
dose	O
will	O
be	O
slowly	O
titrated	O
down	O
over	O
time	O
following	O
his	O
neurological	O
exam	O
closely	O
.	O

5)	O
BLOOD	O
SUGARS	O
:	O

The	O
patient	O
has	O
steroid	B-disease
induced	I-disease
diabetes	I-disease
mellitus	I-disease
.	O

He	O
has	O
been	O
on	O
increasing	O
doses	O
of	O
insulin	O
receiving	O
NPH	O
in	O
the	O
morning	O
and	O
night	O
in	O
addition	O
to	O
a	O
CZI	O
sliding	O
scale	O
on	O
a	O
q6h	O
basis	O
.	O

The	O
plan	O
is	O
to	O
continue	O
the	O
supplemental	O
insulin	O
while	O
he	O
is	O
on	O
steroids	O
and	O
while	O
his	O
sugars	O
remain	O
high	O
.	O

6)	O
RESPIRATORY	O
:	O

He	O
initially	O
required	O
a	O
face	O
mask	O
to	O
keep	O
his	O
saturation	O
above	O
90%	O
.	O

However	O
,	O
with	O
increasing	O
diuresis	O
and	O
improving	B-disease
septic	I-disease
pictures	I-disease
his	O
O2	O
saturations	O
have	O
improved	O
and	O
he	O
is	O
now	O
on	O
nasal	O
cannula	O
and	O
will	O
be	O
maintained	O
on	O
nasal	O
cannula	O
to	O
keep	O
his	O
sat	O
above	O
93%	O
.	O

He	O
can	O
be	O
given	O
intravenous	O
Lasix	O
as	O
needed	O
for	O
any	O
evidence	O
of	O
respiratory	B-disease
compromise	I-disease
or	O
increasing	B-disease
pulmonary	I-disease
edema	I-disease
.	O

7)	O
NUTRITION	O
:	O

The	O
patient	O
has	O
a	B-disease
poor	I-disease
nutritional	I-disease
status	I-disease
with	O
hypoalbuminemia	B-disease
.	O

He	O
has	O
been	O
maintained	O
on	O
tube	O
feeds	O
and	O
that	O
should	O
be	O
continued	O
.	O

He	O
should	O
also	O
be	O
encouraged	O
to	O
eat	O
as	O
much	O
as	O
possible	O
orally	O
in	O
addition	O
to	O
this	O
tube	O
feeds	O
and	O
aspiration	O
precaution	O
should	O
be	O
maintained	O
.	O

8)	O
ELEVATED	B-disease
PT	I-disease
and	I-disease
PTT	I-disease
:	O

Both	O
of	O
these	O
responded	O
to	O
three	O
day	O
course	O
of	O
vitamin	O
K	O
10	O
mg	O
each	O
day	O
.	O

His	O
PT	O
and	O
PTT	O
are	O
now	O
normal	O
,	O
however	O
,	O
he	O
continues	O
to	O
run	O
a	B-disease
low	I-disease
platelet	I-disease
count	I-disease
.	O

This	O
has	O
been	O
evident	O
since	O
the	O
time	O
of	O
his	O
bone	O
marrow	O
transplant	O
.	O

We	O
have	O
been	O
transfusing	O
him	O
with	O
platelets	O
to	O
keep	O
his	O
counts	O
above	O
20,000	O
to	O
reduce	O
his	B-disease
bleeding	I-disease
risk	I-disease
.	O

He	O
also	O
received	O
several	O
blood	O
transfusions	O
while	O
here	O
to	O
maintain	O
his	O
Hct	O
around	O
30	O
.	O

Thrombocytopenic	O
inducing	O
drugs	O
should	O
be	O
avoided	O
if	O
possible	O
on	O
this	O
patient	O
.	O

DISPOSITION	O
:	O

DISCHARGE	O
MEDICATIONS	O
:	O

Tylenol	O
650	O
mg	O
po	O
q4h	O
p.r.n.	O
,	O
Dulcolax	O
10	O
mg	O
per	O
rectum	O
b.i.d.	O
p.r.n.	O
,	O
Decadron	O
5	O
mg	O
IV	O
q6h	O
,	O
Digoxin	O
0.25	O
mg	O
po	O
q	O
day	O
,	O
Colace	O
100	O
mg	O
po	O
t.i.d.	O
,	O
Florinef	O
0.1	O
mg	O
po	O
q	O
day	O
for	O
presumed	O
adrenal	B-disease
insufficiency	I-disease
,	O
Imipenem	O
500	O
mg	O
IV	O
q6h	O
,	O
insulin	O
NPH	O
60	O
units	O
subcu	O
q	O
a.m.	O
,	O
insulin	O
NPH	O
20	O
units	O
subcu	O
q	O
p.m.	O
,	O
insulin	O
CZI	O
sliding	O
scale	O
regular	O
,	O
Synthroid	O
125	O
mcg	O
po	O
q	O
day	O
,	O
magnesium	O
sliding	O
scale	O
,	O
potassium	O
sliding	O
scale	O
today	O
,	O
morphine	O
sulfate	O
IV	O
p.r.n.	O
dressing	O
changes	O
and	O
breakthrough	B-disease
pain	I-disease
,	O
Carafate	O
1	O
gm	O
po	O
q.i.d.	O
,	O
Tobramycin	O
200	O
mg	O
IV	O
q30h	O
,	O
Vancomyin	O
1	O
mg	O
IV	O
q18h.	O

Dicatated	O
By	O
:	O

LAYMIE	O
WHITE	O
,	O
M.D.	O
WE01	O

Attending	O
:	O

TAMYRCLEO	O
N.	O
BACK	O
,	O
M.D.	O
GP0	O
EA855/4665	O

Batch	O
:	O

669	O

Index	O
No.	O
FXZQ7B8JJX	O

D	O
:	O

12/03/94	O

T	O
:	O

12/03/94	O

Admission	O
Date	O
:	O

2013-05-14	O

Discharge	O
Date	O
:	O

2013-05-18	O

Date	O
of	O
Birth	O
:	O

1953-07-27	O

Sex	O
:	O

F	O

Service	O
:	O

CMED	O
CSRU	O

CHIEF	O
COMPLAINT	O
:	O

The	O
patient	O
was	O
admitted	O
originally	O
for	O
airway	O
monitoring	O
status	O
post	O
endoscopic	O
retrograde	O

cholangiopancreatography	O
with	O
adverse	B-disease
reaction	I-disease
to	O
Fentanyl	O
and	O
tongue	B-disease
injury	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
59	O
year-old	O
female	O
status	O
post	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
on	O
the	O
day	O
of	O
admission	O
,	O
which	O
had	O
been	O
done	O
to	O
evaluate	O
for	O
possible	O
bile	B-disease
leak	I-disease
after	O
cholecystectomy	O
was	O
performed	O
four	O
days	O
ago	O
.	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
four	O
days	O
prior	O
to	O
admission	O
when	O
she	O
had	O
a	O
cholecystectomy	O
.	O

Her	O
postop	O
course	O
was	O
uneventful	O
until	O
one	O
day	O
prior	O
to	O
admission	O
when	O
she	O
developed	O
abdominal	B-disease
pain	I-disease
.	O

She	O
went	O
to	O
an	O
outside	O
hospital	O
Emergency	O
Room	O
and	O
was	O
reassured	O
and	O
sent	O
home	O
.	O

On	O
the	O
day	O
of	O
admission	O
she	O
returned	O
to	O
the	O
outside	O
hospital	O
Emergency	O
Room	O
where	O
an	O
abdominal	O
CT	O
was	O
performed	O
,	O
which	O
showed	O
"	O
thickened	B-disease
stomach	I-disease
and	O
free	B-disease
air	I-disease
."	O

She	O
was	O
sent	O
to	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
for	O
an	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
and	O
possible	O
stent	O
placement	O
.	O

She	O
had	O
a	O
successful	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
,	O
which	O
showed	O
a	B-disease
bile	I-disease
leak	I-disease
at	I-disease
the	I-disease
duct	I-disease
of	I-disease
Luschka	I-disease
.	O

A	O
stent	O
was	O
placed	O
successfully	O
.	O

After	O
her	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
the	O
patient	O
developed	O
"	O
jaw	B-disease
clenching	I-disease
,	O
biting	B-disease
tongue	I-disease
,	O
rigidity	B-disease
and	O
cold	B-disease
/	I-disease
chills	I-disease
."	O

The	O
patient	O
received	O
ampicillin	O
,	O
Gentamycin	O
and	O
Flagyl	O
empirically	O
as	O
well	O
as	O
Narcan	O
to	O
reverse	O
fentanyl	O
.	O

Because	O
of	O
the	B-disease
tongue	I-disease
injury	I-disease
and	O
tachycardia	B-disease
as	O
well	O
as	O
possible	O
infection	B-disease
given	O
her	B-disease
fevers	I-disease
or	O
chills	B-disease
the	O
GI	O
Service	O
transferred	O
the	O
patient	O
to	O
the	O
CMED	O
CCU	O
for	O
close	O
observation	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hiatal	B-disease
hernia	I-disease
.	O

2.	O
Status	O
post	O
cholecystectomy	O
four	O
days	O
prior	O
to	O
admission	O
.	O

3.	O
Urinary	B-disease
frequency	I-disease
secondary	O
to	O
interstitial	B-disease
cystitis	I-disease
.	O

4.	O
Mitral	B-disease
valve	I-disease
prolapse	I-disease
.	O

5.	O
Tubal	O
ligation	O
many	O
years	O
ago	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Prempro	O
.	O

2.	O
CMED	O
CCU	O
drops	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
at	O
the	O
time	O
of	O
admission	O
,	O
however	O
,	O
it	O
is	O
assumed	O
that	O
her	B-disease
rigidity	I-disease
and	O
jaw	B-disease
clenching	I-disease
was	O
secondary	O
to	O
Fentanyl	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
.	O

She	O
works	O
as	O
a	O
teacher	O
's	O
aid	O
in	O
Cambridge	O
.	O

She	O
denies	O
tobacco	O
or	O
alcohol	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
TO	O
THE	O
CMED	O
CCU	O
:	O

Vital	O
signs	O
temperature	O
100.6	O
.	O

Heart	O
rate	O
105	O
.	O

Blood	O
pressure	O
162/76	O
.	O

Respiratory	O
rate	O
18	O
.	O

Sating	O
98%	O
on	O
3	O
liters	O
.	O

In	O
general	O
,	O
the	O
patient	O
was	O
groggy	B-disease
status	O
post	O
anesthesia	O
,	O
shivering	B-disease
,	O
but	O
awake	O
.	O

HEENT	O
showed	O
tongue	O
with	O
laceration	B-disease
on	I-disease
the	I-disease
right	I-disease
edge	I-disease
.	O

Mucous	O
membranes	O
are	O
moist	O
.	O

Pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O

Extraocular	O
movements	O
intact	O
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Heart	O
regular	O
rate	O
and	O
rhythm	O
.	O

No	O
murmurs	B-disease
,	O
rubs	B-disease
or	O
gallops	B-disease
.	O

Abdomen	O
was	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

There	O
were	O
normoactive	O
bowel	O
sounds	O
.	O

There	O
was	O
no	O
rebound	B-disease
or	O
guarding	B-disease
.	O

There	O
were	O
post	B-disease
laparoscopic	I-disease
incisions	I-disease
without	O
erythema	B-disease
with	O
Steri-Strips	O
in	O
place	O
.	O

The	O
extremities	O
were	O
without	O
edema	B-disease
.	O

Dorsalis	O
pedis	O
pulses	O
were	O
intact	O
bilaterally	O
.	O

There	O
were	O
no	O
rashes	B-disease
.	O

LABORATORIES	O
ON	O
ADMISSION	O
:	O

White	O
blood	O
cell	O
count	O
9.0	O
,	O
hematocrit	O
39.3	O
,	O
platelets	O
296	O
,	O
neutrophil	O
count	O
82	O
,	O
lymphocytes	O
14	O
,	O
4	O
monocytes	O
,	O
troponin	O
was	O
less	O
then	O
0.3	O
.	O

Sodium	O
139	O
,	O
potassium	O
3.8	O
,	O
chloride	O
101	O
,	O
bicarb	O
26	O
,	O
BUN	O
9	O
,	O
creatinine	O
0.7	O
,	O
glucose	O
141	O
,	O
albumin	O
4.1	O
,	O
calcium	O
8.9	O
,	O
LDH	O
665	O
,	O
AST	O
44	O
,	O
ALT	O
of	O
57	O
,	O
amylase	O
41	O
,	O
CK	O
32	O
.	O

Electrocardiogram	O
showed	O
normal	O
sinus	O
rhythm	O
at	O
73	O
beats	O
per	O
minute	O
.	O

There	O
was	O
normal	O
axis	O
.	O

Normal	O
intervals	O
.	O

There	O
were	O
no	O
ST	B-disease
or	I-disease
T	I-disease
wave	I-disease
changes	I-disease
.	O

Abdominal	O
CT	O
showed	O
inflammation	B-disease
in	I-disease
the	I-disease
right	I-disease
upper	I-disease
quadrant	I-disease
,	O
small	B-disease
fluid	I-disease
in	I-disease
the	I-disease
circumferential	I-disease
thickening	I-disease
of	I-disease
the	I-disease
distal	I-disease
stomach	I-disease
.	O

There	O
was	O
a	O
question	O
of	O
a	B-disease
small	I-disease
ulcer	I-disease
.	O

There	O
was	O
a	O
tiny	O
amount	O
of	O
free	B-disease
air	I-disease
.	O

This	O
was	O
per	O
report	O
of	O
Vencor	O
Hospital	O
.	O

HOSPITAL	O
COURSE	O
:	O

In	O
summary	O
the	O
patient	O
is	O
a	O
59	O
year-old	O
female	O
who	O
was	O
admitted	O
to	O
Quincy	O
Medical	O
Center	O
for	O
an	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
for	O
possible	O
stent	O
placement	O
for	O
a	B-disease
bile	I-disease
leak	I-disease
secondary	O
to	O
cholecystectomy	O
performed	O
four	O
days	O
prior	O
to	O
admission	O
.	O

She	O
then	O
suffered	O
rigidity	B-disease
with	O
jaw	B-disease
clenching	I-disease
and	O
tongue	B-disease
biting	I-disease
secondary	O
to	O
Fentanyl	O
administration	O
and	O
was	O
transferred	O
to	O
the	O
CMED	O
CCU	O
for	O
close	O
observation	O
.	O

She	O
did	O
well	O
overnight	O
in	O
the	O
CMED	O
CCU	O
.	O

She	O
was	O
started	O
on	O
Ampicillin	O
,	O
Gentamycin	O
and	O
Flagyl	O
.	O

Her	O
liver	O
function	O
tests	O
and	O
amylase	O
and	O
lipase	O
were	O
followed	O
closely	O
.	O

On	O
the	O
second	O
hospital	O
day	O
the	O
patient	O
was	O
doing	O
much	O
better	O
and	O
was	O
stable	O
from	O
an	O
airway	O
perspective	O
,	O
so	O
she	O
was	O
transferred	O
to	O
the	O
General	O
Medical	O
Floor	O
.	O

1.	O
Gastrointestinal	O
:	O

As	O
stated	O
the	O
patient	O
was	O
status	O
post	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
with	O
stent	O

placement	O
for	O
a	B-disease
bile	I-disease
leak	I-disease
from	I-disease
the	I-disease
duct	I-disease
of	I-disease
Luschka	I-disease
.	O

The	O
patient	O
was	O
continued	O
on	O
Ampicillin	O
,	O
Gentamycin	O
and	O
Flagyl	O
,	O
which	O
had	O
been	O
started	O
at	O
the	O
time	O
of	O
transfer	O
to	O
the	O
CMED	O
CCU	O
.	O

She	O
had	O
waxing	B-disease
and	I-disease
waning	I-disease
fevers	I-disease
.	O

However	O
,	O
her	O
white	O
blood	O
cell	O
count	O
was	O
never	O
really	B-disease
elevated	I-disease
and	O
she	O
did	O
not	O
have	O
a	B-disease
bandemia	I-disease
.	O

On	O
the	O
day	O
of	O
transfer	O
to	O
the	O
General	O
Medical	O
Floor	O
the	O
patient	O
had	O
received	O
clear	O
liquids	O
.	O

She	O
did	O
not	O
tolerate	O
this	O
very	O
well	O
.	O

Her	O
amylase	O
and	O
lipase	O
on	O
the	O
day	O
following	O
the	O
endoscopic	O
retrograde	O
cholangiopancreatography	O

were	O
elevated	B-disease
.	O

Amylase	O
was	O
2304	O
with	O
lipase	O
being	O
7116	O
.	O

Therefore	O
she	O
was	O
made	O
NPO	O
and	O
given	O
aggressive	O
intravenous	O
hydration	O
.	O

On	O
the	O
second	O
hospital	O
day	O
on	O
the	O
General	O
Medical	O
Floor	O
the	O
patient	O
had	O
marked	B-disease
rebound	I-disease
to	O
palpation	O
of	O
her	O
abdomen	O
.	O

She	O
was	O
followed	O
closely	O
with	O
serial	O
abdominal	O
examinations	O
.	O

Her	O
amylase	O
and	O
lipase	O
were	O
trending	O
down	O
,	O
however	O
.	O

An	O
abdominal	O
CT	O
was	O
obtained	O
,	O
which	O
showed	O
only	O
mild	B-disease
pancreatitis	I-disease
.	O

There	O
were	O
no	O
intra-abdominal	B-disease
fluid	I-disease
collections	I-disease
,	O
which	O
required	O
any	O
drainage	O
.	O

On	O
the	O
third	O
hospital	O
day	O
the	B-disease
patient	I-disease
's	I-disease
pain	I-disease
was	O
improving	O
and	O
the	B-disease
rebound	I-disease
was	O
decreasing	O
.	O

Her	O
enzymes	O
continued	O
to	O
trend	O
down	O
.	O

She	O
received	O
clear	O
liquids	O
in	O
the	O
evening	O
and	O
tolerated	O
these	O
well	O
.	O

On	O
the	O
day	O
of	O
discharge	O
the	O
patient	O
was	O
tolerating	O
a	O
BRAT	O
diet	O
without	O
significant	O
abdominal	O

pain	B-disease
.	O

She	O
had	O
no	O
further	B-disease
rebound	I-disease
.	O

She	O
had	O
no	O
temperature	B-disease
spikes	I-disease
in	O
greater	O
then	O
24	O
hours	O
at	O
the	O
time	O
of	O
discharge	O
.	O

2.	O
Hematology	O
:	O

The	O
patient	O
's	O
hematocrit	O
was	O
34.8	O
at	O
the	O
time	O
of	O
admission	O
.	O

It	O
decreased	O
to	O
30	O
in	O
the	O
setting	O
of	O
aggressive	O
hydration	O
.	O

It	O
remained	O
stable	O
at	O
the	O
time	O
of	O
discharge	O
and	O
it	O
was	O
29.5	O
on	O
the	O
day	O
of	O
discharge	O
.	O

3.	O
FEN	O
:	O

The	O
patient	O
was	O
aggressively	O
hydrated	O
given	O
that	O
she	O
was	O
NPO	O
.	O

She	O
required	O
periodic	O
repletion	O
of	O
her	O
potassium	O
.	O

Her	O
bicarb	O
began	O
to	O
drop	O
and	O
she	O
developed	O
an	B-disease
anion	I-disease
gap	I-disease
acidosis	I-disease
.	O

This	O
was	O
most	O
likely	O
secondary	O
to	O
ketoacidosis	B-disease
as	O
she	O
had	O
no	O
dextrose	O
in	O
her	O
intravenous	O
fluids	O
.	O

This	O
was	O
added	O
on	O
the	O
evening	O
prior	O
to	O
discharge	O
and	O
on	O
the	O
day	O
of	O
discharge	O
her	B-disease
anion	I-disease
gap	I-disease
acidosis	I-disease
had	O
resolved	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Levaquin	O
500	O
mg	O
one	O
po	O
q	O
day	O
times	O
seven	O
days	O
.	O

2.	O
Protonix	O
40	O
mg	O
po	O
q	O
day	O
.	O

3.	O
Percocet	O
one	O
to	O
two	O
tablets	O
po	O
q	O
4	O
to	O
6	O
hours	O
prn	O
.	O

The	O
patient	O
was	O
given	O
a	O
prescription	O
for	O
ten	O
pills	O
.	O

4.	O
Prempro	O
as	O
the	O
patient	O
was	O
formerly	O
taking	O
.	O

5.	O
Trazodone	O
at	O
bedtime	O
.	O

DISCHARGE	O
FOLLOW	O
UP	O
:	O

The	O
patient	O
was	O
to	O
make	O
an	O
appointment	O
with	O
Dr.	O
Nicholson	O
within	O
one	O
to	O
two	O
months	O
after	O
discharge	O
for	O
removal	O
of	O
the	O
stent	O
.	O

In	O
addition	O
,	O
she	O
would	O
follow	O
up	O
with	O
her	O
primary	O
care	O
physician	O
within	O
one	O
to	O
two	O
weeks	O
following	O
discharge	O
.	O

She	O
was	O
to	O
continue	O
on	O
a	O
BRAT	O
diet	O
over	O
the	O
weekend	O
and	O
two	O
days	O
after	O
discharge	O
she	O
could	O
advance	O
to	O
a	O
low	O
fat	O
no	O
dairy	O
diet	O
.	O

She	O
could	O
slowly	O
advance	O
back	O
to	O
a	O
normal	O
diet	O
over	O
the	O
next	O
week	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Post	B-disease
endoscopic	I-disease
retrograde	I-disease
cholangiopancreatography	I-disease
pancreatitis	I-disease
.	O

2.	O
Anemia	B-disease
.	O

3.	O
Hypokalemia	B-disease
.	O

4.	O
Anion	B-disease
gap	I-disease
acidosis	I-disease
.	O

5.	O
Bile	B-disease
leak	I-disease
.	O

Thompson	O
MING	O
LI	O
,	O
M.D.	O

44-725	O

Dictated	O
By	O
:	O
Marcelene	O
R.	O
Brennan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-05-18	O
13:49	O

T	O
:	O
2013-05-20	O
08:16	O

JOB	O
#:	O

23220	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ruth	O
O.	O
Black	O
on	O
:	O
WED	O
2013-05-22	O
7:10	O
AM	O

(	O
End	O
of	O
Report	O
)	O

194442600	O
RWH	O

1642008	O

83328/rh01	O

61509	O

10/19/1993	O
12:00:00	O
AM	O

RIGHT	B-disease
CAPSULAR	I-disease
PUTAMENAL	I-disease
HEMORRHAGE	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

10/19/93	O

DISCHARGE	O
DATE	O
:	O

10/25/93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-disease
capsular	I-disease
putamenal	I-disease
hemorrhage	I-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

hypertension	B-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mrs.	O
Dua	O
is	O
a	O
34	O
year	O
old	O
white	O
female	O
with	O
an	O
unclear	O
history	O
of	O
hypertension	B-disease
for	O
at	O
least	O
five	O
years	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
around	O
12:40	O
on	O
October	O
19	O
,	O
when	O
while	O
on	O
the	O
phone	O
,	O
started	O
to	O
have	O
difficulty	B-disease
in	I-disease
talking	I-disease
.	O

Her	O
speech	O
became	O
slurred	B-disease
,	O
this	O
was	O
followed	O
a	O
few	O
seconds	O
after	O
by	O
weakness	B-disease
and	I-disease
numbness	I-disease
of	I-disease
her	I-disease
arm	I-disease
and	I-disease
leg	I-disease
.	O

She	O
did	O
not	O
complain	O
of	O
headache	B-disease
,	O
diplopia	B-disease
,	O
or	O
any	B-disease
other	I-disease
neurological	I-disease
symptoms	I-disease
.	O

She	O
was	O
seen	O
at	O
A	O
Memorial	O
Hospital	O
where	O
her	O
blood	O
pressure	O
was	O
measured	O
at	O
240/120	O
and	O
was	O
found	O
to	O
have	O
a	B-disease
mild	I-disease
left	I-disease
hemiparesis	I-disease
.	O

She	O
was	O
then	O
transferred	O
to	O
Ro	O
Woodma	O
Healthcare	O
for	O
further	O
management	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

negative	O
.	O

HABITS	O
:	O

She	O
does	O
not	O
smoke	O
,	O
does	O
not	O
use	O
birth	O
control	O
pills	O
,	O
does	O
not	O
use	O
drugs	O
.	O

Denies	O
any	O
abuse	O
of	O
alcohol	O
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
and	O
brother	O
died	O
of	O
PE	B-disease
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

negative	O
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
works	O
at	O
TackyMart	O
,	O
is	O
single	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

A	O
34	O
year	O
old	O
white	O
female	O
lying	O
in	O
bed	O
,	O
anxious	B-disease
;	O
blood	O
pressure	O
of	O
220/120	O
,	O
afebrile	B-disease
.	O

Skin	O
:	O

no	O
lesions	B-disease
.	O

HEENT	O
:	O

normocephalic	O
,	O
atraumatic	B-disease
,	O
anicteric	B-disease
.	O

Neck	O
:	O

supple	O
,	O
no	O
bruits	B-disease
.	O

Heart	O
:	O

regular	O
rhythm	O
with	O
no	O
murmur	B-disease
,	O
rub	B-disease
or	O
gallop	B-disease
.	O

Lungs	O
:	O

clear	O
to	O
auscultation	O
.	O

Abdomen	O
:	O

bowel	O
sounds	O
present	O
,	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
guaiac	O
negative	O
,	O
no	O
hepatosplenomegaly	B-disease
.	O

Extremities	O
:	O

no	O
clubbing	B-disease
,	I-disease
cyanosis	B-disease
or	O
edema	B-disease
.	O

Neurological	O
:	O

she	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Her	O
speech	O
was	O
fluent	O
with	O
no	O
phasic	B-disease
or	I-disease
praxic	I-disease
problems	I-disease
,	O
dysarthric	B-disease
.	O

Memory	O
and	O
attention	O
span	O
good	O
.	O

Visual	O
fields	O
were	O
full	O
to	O
confrontation	O
.	O

Fundi	O
were	O
flat	O
.	O

Pupils	O
were	O
2	O
millimeters	O
down	O
to	O
1	O
millimeter	O
by	O
direct	O
and	O
consensual	O
stimuli	O
.	O

Extra	O
ocular	O
movements	O
were	O
full	O
.	O

Corneals	O
diminished	O
on	O
the	O
left	O
side	O
.	O

V1	O
through	O
V3	O
,	O
diminished	O
light	O
touch	O
and	O
pinprick	O
in	O
the	O
left	O
side	O
.	O

There	O
was	O
a	B-disease
left	I-disease
central	I-disease
facial	I-disease
paresis	I-disease
.	O

Gag	O
was	O
symmetric	O
.	O

Tongue	O
deviated	O
to	O
the	O
left	O
.	O

There	O
was	O
a	B-disease
left	I-disease
arm	I-disease
pronator	I-disease
.	O

The	O
______________	O
was	O
normal	O
.	O

Strength	O
was	O
5/5	O
on	O
the	O
right	O
side	O
,	O
4/5	O
on	O
the	O
left	O
side	O
.	O

The	O
deep	O
tendon	O
reflexes	O
were	O
2+	O
on	O
the	O
left	O
side	O
,	O
1+	O
on	O
the	O
right	O
side	O
.	O

The	O
plantar	O
was	O
upgoing	O
on	O
the	O
left	O
side	O
.	O

On	O
sensory	O
exam	O
there	O
was	O
a	B-disease
mild	I-disease
diminution	I-disease
of	I-disease
light	I-disease
touch	I-disease
,	I-disease
pinprick	I-disease
,	I-disease
position	I-disease
,	I-disease
and	I-disease
vibration	I-disease
sense	I-disease
in	I-disease
the	I-disease
left	I-disease
side	I-disease
.	O

Cerebella	O
:	O

the	O
fine	O
motor	O
movements	O
of	O
the	O
left	O
hand	O
were	O
diminished	B-disease
,	O
there	O
was	O
a	B-disease
mild	I-disease
dysmetria	I-disease
on	I-disease
the	I-disease
left	I-disease
side	I-disease
to	O
finger	O
/	O
nose	O
and	O
heel	O
/	O
shin	O
.	O

The	B-disease
walk	I-disease
was	I-disease
paretic	I-disease
in	I-disease
the	I-disease
left	I-disease
side	I-disease
.	O

LABORATORY	O
DATA	O
:	O

sodium	O
140	O
,	O
potassium	O
4	O
,	O
chloride	O
107	O
,	O
CO2	O
25.4	O
,	O
BUN	O
9	O
,	O
creatinine	O
.8	O
,	O
blood	O
sugar	O
130	O
.	O

Uric	O
acid	O
4.7	O
,	O
cholesterol	O
150	O
,	O
triglycerides	O
74	O
,	O
HDL	O
44	O
,	O
LDL	O
91	O
.	O

Normal	O
liver	O
function	O
tests	O
.	O

Urine	O
and	O
serum	O
toxicology	O
screen	O
negative	O
.	O

Thyroid	O
stimulation	O
hormone	O
1.9	O
.	O

Dexamethasone	O
suppression	O
test	O
negative	O
with	O
a	O
cortisol	O
level	O
at	O
8	O
a.m.	O
of	O
1.7	O
.	O

Twenty-four	O
urine	O
for	O
catecholamine	O
,	O
metanephrines	O
,	O
and	O
VMA	O
pending	O
at	O
the	O
time	O
of	O
discharge	O
.	O

White	O
blood	O
cell	O
count	O
9.8	O
,	O
hematocrit	O
44.1	O
,	O
platelets	O
262	O
,	O
prothrombin	O
time	O
10.4/	O
10.3	O
,	O
partial	O
thromboplastin	O
time	O
25.9	O
.	O

urinalysis	O
:	O

specific	O
gravity	O
125	O
,	O
PH	O
6	O
.	O

Urine	O
culture	O
negative	O
.	O

Sedimentation	O
rate	O
2	O
,	O
antithrombin	O
3	O
.	O

Protein	O
C	O
,	O
protein	O
S	O
and	O
plasminogen	O
level	O
within	O
normal	O
limits	O
.	O

Electrocardiogram	O
:	O

sinus	O
rhythm	O
at	O
116	O
,	O
axis	O
of	O
23	O
,	O
intervals	O
of	O
.14/	O
.07/	O
.42	O
,	O
no	O
ST-segment	B-disease
abnormalities	I-disease
.	O

Chest	O
x-ray	O
negative	O
.	O

Head	O
computerized	O
tomography	O
scan	O
on	O
10/19	O
:	O
3	B-disease
centimeter	I-disease
hyperdensity	I-disease
within	O
the	O
right	O
putamenal	O
area	O
in	O
the	O
right	O
external	O
capsusle	O
consistent	O
with	O
intra-parenchymal	B-disease
hematoma	I-disease
with	O
mild	B-disease
local	I-disease
mass	I-disease
effect	I-disease
and	O
surrounding	B-disease
edema	I-disease
.	O

No	O
other	O
areas	O
of	O
hemorrhage	B-disease
identified	O
.	O

Head	O
computerized	O
tomography	O
scan	O
of	O
10/23	O
:	O

the	O
area	O
of	O
hemorrhage	B-disease
the	O
same	O
,	O
slightly	B-disease
more	I-disease
edema	I-disease
and	I-disease
mass	I-disease
effect	I-disease
.	O

Pulmonary	O
angiogram	O
:	O

no	O
evidence	O
of	O
pulmonary	B-disease
emboli	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

Given	O
the	O
localization	O
of	O
the	B-disease
hematoma	I-disease
and	O
the	O
history	O
of	O
hypertension	B-disease
,	O
the	O
most	O
likely	O
cause	O
for	O
Mrs.	O
Dua	O
&apos;s	O
cerebellar	B-disease
hemorrhage	I-disease
is	O
hypertension	B-disease
.	O

A	O
magnetic	O
resonance	O
imaging	O
study	O
will	O
be	O
scheduled	O
as	O
an	O
outpatient	O
in	O
three	O
months	O
to	O
rule	O
out	O
a	B-disease
small	I-disease
vascular	I-disease
malformation	I-disease
if	O
responsible	O
for	O
the	B-disease
hemorrhage	I-disease
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
Mrs.	O
Dua	O
has	O
had	O
a	O
remarkable	O
recovery	O
.	O

She	O
is	O
now	O
able	O
to	O
walk	O
fitfully	O
and	O
use	O
her	O
left	O
hand	O
with	O
no	O
problem	B-disease
.	O

The	O
exam	O
is	O
remarkable	O
for	O
a	B-disease
mild	I-disease
leftsided	I-disease
face	I-disease
,	O
arm	B-disease
and	I-disease
leg	I-disease
weakness	I-disease
and	O
sensory	B-disease
deficit	I-disease
that	O
should	O
further	O
improve	O
with	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
help	O
.	O

She	O
will	O
be	O
followed	O
by	O
the	O
OT	O
/	O
PT	O
dept.	O
for	O
that	O
.	O

Her	B-disease
hypertension	I-disease
was	O
difficult	O
to	O
manage	O
initially	O
and	O
required	O
three	O
days	O
of	O
Intensive	O
Care	O
Unit	O
with	O
A-line	O
and	O
Nipride	O
intravenously	O
.	O

It	O
was	O
finally	O
under	O
control	O
with	O
high	O
doses	O
of	O
Captopril	O
,	O
Nifedipine	O
,	O
and	O
hydrochlorothiazide	O
.	O

The	O
workup	O
to	O
rule	O
out	O
secondary	B-disease
cause	I-disease
of	O
hypertension	B-disease
given	O
the	O
patient	O
&apos;s	O
young	O
age	O
and	O
the	O
difficulty	O
controlling	O
the	O
blood	O
pressure	O
was	O
started	O
as	O
an	O
inpatient	O
and	O
will	O
be	O
completed	O
by	O
Dr.	O
______________as	O
an	O
outpatient	O
.	O

So	O
far	O
no	O
secondary	B-disease
causes	I-disease
of	O
hypertension	B-disease
were	O
identified	O
but	O
causes	O
like	O
lymphocytic	B-disease
?	I-disease
chromocytoma	I-disease
or	O
renal	B-disease
artery	I-disease
stenosis	I-disease
have	O
not	O
been	O
ruled	O
out	O
yet	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

hydrochlorothiazide	O
25	O
mg.	O
po	O
q.day	O
,	O
Captopril	O
75	O
mg.	O
po	O
three	O
times	O
a	O
day	O
,	O
Nifedipine	O
40	O
mg.	O
po	O
three	O
times	O
a	O
day	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

FOLLOWUP	O
:	O

The	O
patient	O
will	O
followup	O
with	O
Dr.	O
______________at	O
Omend	O
Hospital	O
and	O
with	O
Dr.	O
Deep	O
at	O
the	O
Barb	O
Memorial	O
Hospital	O
.	O

DISABILITY	O
:	O

100%	O
for	O
now	O
.	O

Will	O
be	O
reassessed	O
after	O
a	O
month	O
of	O
intensive	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
.	O

MATAANRE	O
TAG	O
,	O
M.D.	O

TR	O
:	O

ee	O
/	O
bihn	O

DD	O
:	O

10/25/93	O

TD	O
:	O

10/27/93	O

CC	O
:	O

779878634	O

TGCHO	O

9260099	O

612765	O

12/11/2003	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

A	O
,	O
REBAY	O
J	O

UNIT	O
NUMBER	O
:	O

984-98-62	O

ADMISSION	O
DATE	O
:	O

12/11/2003	O

DISCHARGE	O
DATE	O
:	O

01/08/2004	O

The	O
patient	O
has	O
a	O
known	O
history	O
of	O
pancreatic	B-disease
adenocarcinoma	I-disease
.	O

He	O
is	O
admitted	O
at	O
this	O
time	O
because	O
of	O
significant	B-disease
GI	I-disease
bleeding	I-disease
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Significant	O
for	O
fatigue	B-disease
and	O
increased	B-disease
abdominal	I-disease
discomfort	I-disease
.	O

MEDICATIONS	O
AT	O
THE	O
TIME	O
OF	O
ADMISSION	O
:	O

Insulin	O
,	O
Celexa	O
,	O
Protonix	O
,	O
Ambien	O
and	O
Pancreas	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Vital	O
signs	O
showed	O
his	O
blood	O
pressure	O
to	O
be	O
slightly	B-disease
decreased	I-disease
at	O
120/60	O
,	O
pulse	O
64	O
,	O
respirations	O
16	O
,	O
temperature	O
98.8	O
,	O
O2	O
sat	O
95	O
.	O

HEENT	O
:	O

Evidence	B-disease
of	I-disease
anemia	I-disease
with	O
being	B-disease
pale	I-disease
,	O
but	O
anicteric	O
,	O
no	O
oral	B-disease
lesions	I-disease
.	O

Neck	O
supple	O
.	O

Lungs	O
clear	O
.	O

Back	O
without	O
CVA	B-disease
or	I-disease
spinal	I-disease
tenderness	I-disease
.	O

Heart	O
regular	O
rate	O
and	O
rhythm	O
.	O

Abdomen	O
:	O

Bowel	O
sounds	O
positive	O
,	O
soft	O
,	O
mildly	B-disease
tender	I-disease
in	I-disease
the	I-disease
epigastrium	I-disease
without	O
hepatosplenomegaly	B-disease
,	O
mass	B-disease
or	O
tenderness	B-disease
.	O

Extremities	O
:	O

Trace	B-disease
edema	I-disease
without	O
cyanosis	B-disease
or	O
clubbing	B-disease
.	O

His	O
hematocrit	O
at	O
the	O
time	O
of	O
admission	O
was	O
20.5	O
,	O
after	O
having	O
been	O
32	O
one	O
week	O
earlier	O
.	O

ASSESSMENT	O
:	O

The	O
assessment	O
was	O
that	O
he	O
had	O
a	B-disease
GI	I-disease
bleed	I-disease
.	O

He	O
was	O
transfused	O
and	O
then	O
evaluated	O
by	O
GI	O
.	O

Endoscopy	O
showed	O
multiple	B-disease
angio	I-disease
ectasias	I-disease
throughout	I-disease
the	I-disease
stomach	I-disease
.	O

He	O
received	O
multiple	O
treatments	O
for	O
this	O
over	O
the	O
succeeding	O
weeks	O
.	O

In	O
addition	O
,	O
he	O
was	O
transfused	O
.	O

His	O
platelet	O
count	O
was	O
maintained	O
with	O
platelet	O
transfusion	O
as	O
necessary	O
.	O

He	O
was	O
treated	O
with	O
Octreotide	O
to	O
try	O
to	O
slow	O
down	O
the	B-disease
bleeding	I-disease
.	O

Despite	O
all	O
these	O
measures	O
,	O
his	B-disease
bleeding	I-disease
was	O
never	O
totally	O
controlled	O
.	O

He	O
then	O
had	O
an	O
angiogram	O
with	O
Gel	O
foam	O
to	O
try	O
to	O
control	O
his	B-disease
GI	I-disease
bleed	I-disease
.	O

Again	O
,	O
this	O
was	O
unsuccessful	O
.	O

At	O
that	O
point	O
he	O
had	O
a	B-disease
change	I-disease
in	I-disease
mental	I-disease
status	I-disease
and	O
was	O
no	B-disease
longer	I-disease
responsive	I-disease
.	O

Given	O
this	O
,	O
the	O
decision	O
was	O
made	O
to	O
make	O
his	O
care	O
comfort	O
measures	O
only	O
.	O

At	O
this	O
point	O
,	O
he	O
was	O
made	O
comfort	O
measures	O
and	O
expired	O
comfortably	O
.	O

The	O
cause	O
of	O
death	B-disease
was	O
a	O
combination	O
of	O
GI	B-disease
bleeding	I-disease
felt	O
to	O
be	O
ultimately	O
related	O
to	O
his	B-disease
known	I-disease
metastatic	I-disease
pancreatic	I-disease
cancer	I-disease
.	O

TA	O
KO	O
FOSSA	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
TA	O
KO	O
FOSSA	O
,	O
M.D.	O

02/05/2004	O
17:03	O

_____________________________	O
TA	O
KO	O
FOSSA	O
,	O
M.D.	O

TR	O
:	O

mb	O

DD	O
:	O

01/23/2004	O

TD	O
:	O

01/26/2004	O
2:16	O
A	O
612765	O

cc	O
:	O

TA	O
KO	O
FOSSA	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2015-10-05	O

Discharge	O
Date	O
:	O

2015-10-08	O

Date	O
of	O
Birth	O
:	O

1815-10-05	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Shellfish	O

Attending	O
:	O

Jacob	O
U.	O
Rolland	O
,	O
M.D.	O

Chief	O
Complaint:	O

Chest	B-disease
pain	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O

None	O

History	O
of	O
Present	O
Illness:	O

The	O
patient	O
is	O
a	O
91	O
yo	O
woman	O
with	O
h/o	O
HTN	B-disease
who	O
came	O
from	O
Bridgewater	O
State	O
Hospital	O
Rehab	O
with	O
substernal	B-disease
chest	I-disease
pain	I-disease
after	O
exercise	O
.	O

Pt	O
had	O
been	O
in	O
her	O
usual	O
state	O
of	O
health	O
and	O
performed	O
here	O
regular	O
exercises	O
.	O

After	O
returning	O
to	O
her	O
room	O
she	O
w	O
noted	O
SSCP	B-disease
without	O
radiation	O
.	O

No	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
diaphoresis	B-disease
.	O

They	O
did	O
an	O
ECG	O
at	O
Bridgewater	O
State	O
Hospital	O
rehab	O
which	O
demonstarted	O
new	B-disease
ST	I-disease
depressions	I-disease
in	I-disease
V1-V4	I-disease
.	O

She	O
received	O
ASA	O
81	O
mg	O
x	O
2	O
and	O
nitro	O
SL	O
x	O
2	O
with	O
partial	O
relief	O
at	O
nursing	O
home	O
.	O

On	O
presentation	O
to	O
Providence	O
Behavioral	O
Health	O
Hospital	O
Amanda	O
,	O
her	O
vitals	O
were	O
HR	O
68	O
,	O
BP	O
142/68	O
,	O
RR	O
28	O
,	O
O2	O
sat	O
100%	O
RA	O
.	O

Exam	O
was	O
notable	O
for	O
RRR	O
with	O
no	O
murmur	B-disease
,	O
bibasilar	B-disease
crackles	I-disease
,	O
guaiac	O
negative	O
.	O

EKG	O
showed	O
sinus	B-disease
brady	I-disease
,	O
with	O
old	B-disease
LAD	I-disease
and	I-disease
new	I-disease
ST	I-disease
depressions	I-disease
in	I-disease
V1-V4	I-disease
.	O

Troponin	O
was	O
0.07	O
.	O

She	O
received	O
ASA	O
,	O
nitro	O
SL	O
then	O
gtt	O
,	O
morphine	O
,	O
metoprolol	O
,	O
and	O
heparin	O
gtt	O
.	O

Cardiology	O
discussed	O
cath	O
however	O
,	O
patient	O
's	O
family	O
turned	O
down	O
.	O

Transferred	O
to	O
CCU	O
for	O
further	O
management	O
and	O
observation	O
.	O

Past	O
Medical	O
History:	O

HTN	B-disease

Hearing	B-disease
difficulty	I-disease

Blindness	B-disease
02-26	O
macular	B-disease
degeneration	I-disease

R	B-disease
ankle	I-disease
fx	I-disease
2002	O

S/p	O
hysterectomy	O

Social	O
History	O
:	O

currently	O
lives	O
at	O
Bridgewater	O
State	O
Hospital	O
Rehab;	O
no	O
tobacco	O
or	O
EtOH	O
use;	O
used	O
to	O
be	O
housewife	O

Family	O
History	O
:	O

n/c	O

Physical	O
Exam:	O

Vitals	O
:	O

T	O
97.8	O
,	O
HR	O
53	O
,	O
BP	O
156/58	O
,	O
RR	O
16	O
,	O
O2	O
sat	O
94%	O
on	O
2.5	O
L	O

Gen	O
:	O

NAD	B-disease
,	O
awake	O
,	O
alert	O
,	O
blind	B-disease
,	O
able	O
to	O
hear	O
loud	O
voices	O
at	O
L	O
ear	O

HEENT	O
:	O

MMM	O
,	O
OP	O
clear	O

Neck	O
:	O

JVP	O
11	O
cm	O

CV	O
:	O

Reg	O
rate	O
,	O
nl	O
S1	O
&	O
S2	O
,	O
no	O
m/r/g	B-disease

Pulm	O
:	O

Crackles	B-disease
at	I-disease
base	I-disease
and	I-disease
mid-lungs	I-disease
bilaterally	I-disease

Abd	O
:	O

Soft	O
,	O
NT	B-disease
,	O
ND	B-disease
,	O
BS	O
present	O
,	O
no	O
masses	B-disease

Ext	O
:	O

Trace	B-disease
ankle	I-disease
edema	I-disease
bilaterally	I-disease

Pertinent	O
Results:	O

LABS	O
on	O
admission:	O

WBC	O
-	O
11.4*	O
RBC	O
-	O
3.61*	O
Hgb	O
-	O
11.4*	O
Hct	O
-	O
32.6*	O
MCV	O
-	O
90	O
MCH	O
-	O
31.7	O

MCHC	O
-	O
35.1*	O
RDW	O
-	O
14.7	O
Plt	O
Ct	O
-	O
281	O

Glucose	O
-	O
124*	O
UreaN	O
-	O
30*	O
Creat	O
-	O
1.3*	O
Na	O
-	O
137	O
K	O
-	O
4.2	O
Cl	O
-	O
102	O
HCO3	O
-	O
27	O

AnGap	O
-	O
12	O

CK	O
(	O
CPK	O
)	O
-	O
42	O
cTropnT	O
-	O
0.07*	O

.	O

STUDIES:	O

EKG	O
:	O

sinus	B-disease
brady	I-disease
@	O
48	O
bpm	O
,	O
LAD	O
,	O
LVH	B-disease
,	O
RBBB	B-disease
,	O
Q	B-disease
wave	I-disease
in	I-disease
I	I-disease
,	O
ST	B-disease
depressions	I-disease
in	I-disease
V1-V4	I-disease
,	O
ST	B-disease
elevation	I-disease
in	I-disease
III	I-disease
,	O
aVF	B-disease
,	O
TWI	B-disease
in	I-disease
III	I-disease
,	O
V5	O
.	O

CXR	O
10-07	O
:	O

There	O
is	O
slight	B-disease
worsening	I-disease
of	O
the	B-disease
still	I-disease
mild	I-disease
pulmonary	I-disease
edema	I-disease
.	O

There	O
is	O
no	O
pneumothorax	B-disease
.	O

Small	B-disease
right	I-disease
pleural	I-disease
effusion	I-disease
is	O
stable	O
.	O

Cardiac	O
size	O
is	O
normal	O
.	O

Echo	O
:	O

LVEF	O
>70%	O
,	O
LA	O
6.1	O
cm	O
,	O
no	O
regional	B-disease
wall	I-disease
motion	I-disease
abnormality	I-disease
.	O

Cardiac	O
Enzymes	O

2015-10-05	O
09:00PM	O
BLOOD	O

CK	O
(	O
CPK	O
)	O
-	O
1471*	O
CK-MB	O
-	O
207*	O
MB	O
Indx	O
-	O
14.1*	O
cTropnT	O
-	O
6.00*	O

2015-10-06	O
04:47PM	O
BLOOD	O

CK	O
(	O
CPK	O
)	O
-	O
1288*	O
CK-MB	O
-	O
158*	O
MB	O
Indx	O
-	O
12.3*	O
cTropnT	O
-	O
6.88*	O

2015-10-07	O
07:30AM	O
BLOOD	O

CK	O
(	O
CPK	O
)	O
-	O
627*	O
CK-MB	O
-	O
55*	O
MB	O
Indx	O
-	O
8.8*	O
cTropnT	O
-	O
4.46*	O

.	O

Labs	O
on	O
Discharge	O
2015-10-08	O
08:35AM	O

WBC	O
-	O
13.8*	O
RBC	O
-	O
3.39*	O
Hgb	O
-	O
10.7*	O
Hct	O
-	O
30.2*	O
MCV	O
-	O
89	O
MCH	O
-	O
31.5	O

MCHC	O
-	O
35.3*	O
RDW	O
-	O
14.8	O
Plt	O
Ct	O
-	O
214	O

Glucose	O
-	O
120*	O
UreaN	O
-	O
30*	O
Creat	O
-	O
1.2*	O
Na	O
-	O
134	O
K	O
-	O
4.2	O
Cl	O
-	O
100	O
HCO3	O
-	O
25	O

AnGap	O
-	O
13	O

Calcium	O
-	O
8.7	O
Phos	O
-	O
2.5*	O
Mg	O
-	O
2.1	O

Brief	O
Hospital	O
Course:	O

INITIAL	O
IMPRESSION	O
:	O

90	O
year-old	O
woman	O
with	O
h/o	O
of	O
HTN	B-disease
p/w	O
substernal	B-disease
chest	I-disease
pain	I-disease
shortly	O
after	O
exercise	O
at	O
nursing	O
home	O
,	O
with	O
EKG	O
showing	O
ST	B-disease
depressions	I-disease
in	I-disease
V1-V4	I-disease
and	O
troponin	O
0.07.	O

Likely	O
NSTEMI	B-disease
.	O

.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

.	O

*	O
CV	O
:	O

The	O
patient	O
's	O
family	O
refused	O
coronary	O
artery	O
catheterization	O
.	O

The	O
patient	O
was	O
given	O
ASA	O
,	O
Plavix	O
,	O
heparin	O
drip	O
x	O
24	O
hours	O
,	O
nitro	O
drip	O
,	O
atorvastatin	O
,	O
metoprolol	O
,	O
and	O
lisinopril	O
.	O

Her	B-disease
chest	I-disease
pain	I-disease
was	O
controlled	O
with	O
morphine	O
.	O

Her	O
SBP	O
remained	O
in	O
the	O
160s-170s	O
on	O
hospital	O
day	O
1	O
and	O
she	O
was	O
gently	O
diuresed	O
.	O

On	O
hospital	O
day	O
2	O
she	O
experienced	O
atrial	B-disease
fibrillation	I-disease
with	O
HR	O
in	O
the	O
140s	O
.	O

Her	O
metoprolol	O
dose	O
was	O
increased	O
from	O
25	O
mg	O
PO	O
bid	O
to	O
50	O
mg	O
PO	O
bid	O
then	O
75	O
mg	O
PO	O
tid	O
.	O

Her	O
HR	O
decreased	O
to	O
70s-80s	O
.	O

Her	O
BP	O
remained	O
stable	O
.	O

An	O
ECHO	O
showed	O
that	O
she	O
had	O
preserved	O
EF	O
and	O
no	O
wall	B-disease
motion	I-disease
abnormalities	I-disease
.	O

We	O
decided	O
given	O
her	O
age	O
that	O
she	O
would	O
not	O
be	O
a	O
good	O
candidate	O
for	O
cardioversion	O
for	O
her	B-disease
afib	I-disease
nor	O
would	O
she	O
be	O
a	O
good	O
candidate	O
for	O
coumadin	O
.	O

Therefore	O
we	O
will	O
continue	O
rate	O
control	O
with	O
metoprolol	O
this	O
can	O
be	O
titrated	O
if	O
needed	O
,	O
and	O
aspirin	O
and	O
plavix	O
for	O
anti-coagulation	O
.	O

She	O
should	O
also	O
continue	O
on	O
lipitor	O
and	O
lisinopril	O
.	O

She	O
should	O
have	O
her	O
chem	O
7	O
checked	O
next	O
week	O
given	O
the	O
start	O
of	O
her	O
new	O
meds	O
.	O

Will	O
also	O
need	O
LFT	O
's	O
checked	O
in	O
3-6	O
months	O
.	O

.	O

*	O
Pulmonary	O
:	O

Bilateral	B-disease
crackles	I-disease
at	I-disease
bases	I-disease
and	I-disease
midlungs	I-disease
,	O
elevated	B-disease
JVP	I-disease
,	O
trace	B-disease
bilateral	I-disease
ankle	I-disease
edema	I-disease
,	O
and	O
CXR	O
with	O
diffuse	B-disease
opacities	I-disease
suggest	O
possible	O
pulmonary	B-disease
edema	I-disease
,	O
likely	O
secondary	O
to	O
acute	B-disease
MI	I-disease
.	O

Her	O
O2	O
sat	O
was	O
stable	O
at	O
94-97%	O
on	O
2.5L	O
of	O
supplemental	O
O2	O
.	O

She	O
experienced	O
no	O
respiratory	B-disease
difficulty	I-disease
during	O
the	O
hospital	O
stay	O
.	O

She	O
was	O
diuresed	O
small	O
amount	O
.	O

Her	O
CXR	O
prior	O
to	O
discharge	O
showed	O
mild	B-disease
pulm	I-disease
edema	I-disease
and	O
thus	O
was	O
given	O
40	O
of	O
lasix	O
prior	O
to	O
going	O
to	O
rehab	O
.	O

She	O
can	O
be	O
given	O
prn	O
lasix	O
for	O
weight	B-disease
gain	I-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

.	O

*	O
Leukocytosis-	B-disease
She	O
developed	O
mild	B-disease
elevated	I-disease
WBC	I-disease
.	O

UA	O
had	O
12-14	O

WBC	O
's	O
,	O
few	B-disease
bacteria	I-disease
.	O

She	O
was	O
initially	O
started	O
on	O
Bactrim	O
,	O
but	O
this	O
was	O
stopped	O
as	O
she	O
was	O
afebrile	B-disease
.	O

SHe	O
has	O
a	O
culture	O
pending	O
which	O
needs	O
to	O
be	O
followed	O
up	O
at	O
the	O
nursing	O
home	O
and	O
treated	O
if	O
positive	B-disease
.	O

.	O

*	O
Code	O
:	O

DNR/DNI	O

Medications	O
on	O
Admission	O
:	O

tylenol	O
PRN	O
lisinopril	O
5	O
mg	O
PO	O
qd	O
protonix	O
20	O
mg	O
PO	O
qd	O
artifical	O
tears	O
bid	O
metoprolol	O
25	O
mg	O
PO	O
bid	O

Discharge	O
Medications:	O

1.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

2.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-disease
.	O

3.	O
Aspirin	O
325	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

4.	O
Clopidogrel	O
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

5.	O
Atorvastatin	O
80	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
0.5	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
)	O
.	O

7.	O
Polyvinyl	O
Alcohol	O
1.4	O
%	O
Drops	O
Sig	O
:	O
1-2	O
Drops	O
Ophthalmic	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

8.	O
Lisinopril	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

9.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
Three	O
(	O
3	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
.	O

10.	O
Acetaminophen	O
325	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

11.	O
Maalox	O
225-200	O
mg/5	O
mL	O
Suspension	O
Sig	O
:	O
Five	O
(	O
5	O
)	O
mL	O
PO	O
every	O
six	O
(	O
6	O
)	O
hours	O
as	O
needed	O
for	O
indigestion	B-disease
.	O

12.	O
Lasix	O
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
as	O
needed	O
for	O
shortness	B-disease
of	I-disease
breath	I-disease
or	O
wheezing	B-disease
:	O

Can	O
give	O
40	O
lasix	O
PO	O
if	O
having	O
any	O
weight	B-disease
gain	I-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

Discharge	O
Disposition:	O

Extended	O
Care	O

Discharge	O
Diagnosis:	O

NSTEMI	B-disease

Atrial	B-disease
Fibrillation	I-disease

HTN	B-disease

Discharge	O
Condition:	O

Patient	O
without	O
chest	B-disease
pain	I-disease
,	O
heart	O
rate	O
and	O
BP	O
stable	O
.	O

Discharge	O
Instructions:	O

Please	O
take	O
all	O
medications	O
as	O
instructed	O
.	O

She	O
has	O
been	O
started	O
on	O
several	O
new	O
medications	O
which	O
are	O
important	O
to	O
protect	O
her	O
heart	O
.	O

If	O
the	O
patient	O
experiences	O
any	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
fevers	B-disease
,	O
chills	B-disease
,	O
please	O
return	O
to	O
the	O
emergency	O
room	O
.	O

Followup	O
Instructions:	O

Please	O
call	O
(	O
881-6997	O
to	O
set	O
up	O
follow	O
up	O
cardiology	O
appointment	O
in	O
2-3	O
months	O
.	O

Betty	O
Herbert	O
MD	O
43-075	O

Completed	O
by	O
:	O

Allison	O
Crystal	O
MD	O
52-741	O
2015-10-08	O
@	O
1510	O

Signed	O
electronically	O
by	O
:	O

DR.	O
Dorothy	O
Z.	O
Alderman	O
on	O
:	O

SUN	O
2015-10-11	O
11:49	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-05-09	O

Discharge	O
Date	O
:	O

2013-06-02	O

Date	O
of	O
Birth	O
:	O

1966-03-19	O

Sex	O
:	O

M	O

Service	O
:	O

Scott	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
47	O
year	O
old	O
male	O
,	O
with	O
end	B-disease
stage	I-disease
liver	I-disease
disease	I-disease
secondary	O
to	O
hepatitis	B-disease
C	I-disease
cirrhosis	I-disease
diagnosed	O
about	O
5	O
years	O
prior	O
to	O
admission	O
.	O

The	O
patient	O
had	O
undergone	O
treatment	O
with	O
interferon	O
and	O
Ribavirin	O
.	O

He	O
had	O
been	O
admitted	O
to	O
the	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
multiple	O
times	O
early	O
in	O
2013	O
for	O
management	O
of	O
encephalopathy	B-disease
and	O
ascites	B-disease
.	O

The	O
patient	O
had	O
been	O
discharged	O
from	O
the	O
St.	O
Margaret	O
's	O
Center	O
for	O
Women	O
&	O
Infants	O
on	O
2013-05-06	O
,	O
but	O
was	O
readmitted	O
on	O
2013-05-09	O
when	O
noted	O
to	O
have	O
worsening	B-disease
renal	I-disease
function	I-disease
.	O

The	O
patient	O
's	O
serum	O
creatinine	O
on	O
the	O
day	O
of	O
discharge	O
,	O
on	O
2013-05-06	O
,	O
was	O
1.9	O
,	O
but	O
was	O
noted	O
to	O
increase	O
to	O

3.2	O
on	O
2013-05-08	O
,	O
and	O
was	O
further	B-disease
elevated	I-disease
to	O
3.6	O
on	O
2013-05-09	O
.	O

The	O
patient	O
was	O
admitted	O
with	O
concern	O
for	O
hepatorenal	B-disease
syndrome	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hepatitis	B-disease
C	I-disease
cirrhosis	I-disease
for	O
which	O
the	O
patient	O
was	O
on	O
the	O
liver	O
transplant	O
list	O
.	O

2.	O
Hypertension	B-disease
.	O

3.	O
Nephrolithiasis	B-disease
.	O

4.	O
Hemorrhoids	B-disease
.	O

5.	O
Knee	O
surgeries	O
.	O

6.	O
Back	O
surgery	O
.	O

MEDICATIONS	O
:	O

1.	O
Miconazole	O
nitrate	O
powder	O
tid	O
prn	O
for	O
groin	B-disease
rash	I-disease
.	O

2.	O
Protonix	O
40	O
mg	O
po	O
bid	O
.	O

3.	O
Lactulose	O
30	O
ml	O
tid	O
(	O
titrated	O
to	O
4	O
to	O
5	O
bowel	O
movements	O
qd	O
)	O
.	O

4.	O
Vancomycin	O
1	O
gm	O
IV	O
bid	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
married	O
with	O
no	O
children	O
.	O

He	O
works	O
as	O
a	O
counselor	O
at	O
an	O
alcohol	O
and	O
drug	O
treatment	O
facility	O
for	O
teenagers	O
.	O

The	O
patient	O
was	O
previously	O
a	O
heavy	O
alcohol	O
user	O
,	O
but	O
had	O
been	O
sober	O
since	O
1996	O
.	O

The	O
patient	O
had	O
also	O
used	O
cocaine	O
in	O
the	O
past	O
,	O
but	O
had	O
also	O
stopped	O
in	O
1996	O
.	O

HOSPITAL	O
COURSE	O
:	O

(	O
Part	O
of	O
the	O
patient	O
's	O
chart	O
from	O
the	O
period	O
2013-05-09	O
to	O
2013-05-23	O
is	O
currently	O
unavailable	O
,	O
and	O
this	O
dictation	O
will	O
mainly	O
cover	O
the	O
period	O
from	O
2013-05-23	O
to	O
2013-06-02	O
)	O

As	O
previously	O
mentioned	O
,	O
the	O
patient	O
's	O
creatinine	O
at	O
the	O
time	O
of	O
admission	O
was	O
up	O
to	O
3.6	O
from	O
1.9	O
at	O
the	O
time	O
of	O
his	O
discharge	O
3	O
days	O
prior	O
.	O

Over	O
the	O
following	O
5	O
days	O
,	O
the	O
patient	O
's	O
creatinine	O
improved	O
marginally	O
to	O
2.7	O
.	O

Optimization	O
of	O
his	O
fluid	O
balance	O
was	O
managed	O
by	O
the	O
medical	O
service	O
in	O
consultation	O
with	O
hepatology	O
and	O
renal	O
.	O

The	O
patient	O
's	O
INR	O
on	O
admission	O
was	O
2.4	O
,	O
with	O
his	O
PT	O
level	O
being	O
18.9	O
.	O

The	O
patient	O
periodically	O
required	O
transfusions	O
of	O
fresh	O
frozen	O
plasma	O
,	O
as	O
well	O
as	O
platelets	O
and	O
red	O
cells	O
.	O

The	O
patient	O
was	O
thrombocytopenic	B-disease
with	O
a	O
platelet	O
count	O
of	O
49	O
on	O
the	O
23	O
.	O

The	O
patient	O
was	O
continued	O
on	O
vancomycin	O
therapy	O
for	O
his	B-disease
previously	I-disease
diagnosed	I-disease
Methicillin	I-disease
resistant	I-disease
,	I-disease
coagulase	I-disease
negative	I-disease
Staph	I-disease
bacteremia	I-disease
.	O

The	O
patient	O
's	O
nutrition	O
was	O
suboptimal	O
,	O
and	O
the	O
patient	O
was	O
started	O
on	O
tube	O
feeding	O
.	O

The	O
patient	O
underwent	O
diagnostic	O
and	O
therapeutic	O
paracentesis	O
on	O
2013-05-16	O
,	O
2013-05-21	O
,	O
and	O
2013-05-24	O
.	O

He	O
had	O
no	O
evidence	O
of	O
spontaneous	B-disease
bacterial	I-disease
peritonitis	I-disease
.	O

On	O
2013-05-25	O
,	O
a	O
liver	O
became	O
available	O
for	O
transplant	O
to	O
the	O
patient	O
.	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
and	O
underwent	O
an	O
orthotopic	O
liver	O
transplant	O
.	O

In	O
order	O
to	O
aid	O
in	O
optimization	O
of	O
the	O
patient	O
's	O
fluid	O
status	O
,	O
the	O
patient	O
was	O
on	O
continuous	O
Baker	O
Baker	O
dialysis	O
during	O
the	O
procedure	O
.	O

His	B-disease
estimated	I-disease
blood	I-disease
loss	I-disease
was	O
2	O
liters	O
.	O

The	O
patient	O
received	O
5	O
liters	O
of	O
crystalloid	O
,	O
9	O
units	O
of	O
fresh	O
frozen	O
plasma	O
,	O
9	O
units	O
of	O
red	O
cells	O
,	O
6	O
units	O
of	O
platelets	O
,	O
as	O
well	O
as	O
1	O
liter	O
of	O
Cell	O
Saver	O
.	O

The	O
procedure	O
proceeded	O
without	O
complications	B-disease
,	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
intensive	O
care	O
unit	O
while	O
still	O
intubated	O
following	O
the	O
procedure	O
.	O

The	O
patient	O
underwent	O
an	O
uncomplicated	O
recovery	O
in	O
the	O
intensive	O
care	O
unit	O
.	O

By	O
postop	O
day	O
1	O
,	O
the	O
patient	O
was	O
awake	O
,	O
in	O
no	O
distress	B-disease
,	O
and	O
appeared	O
lucid	O
prior	O
to	O
extubation	O
.	O

The	O
patient	O
was	O
extubated	O
on	O
postop	O
day	O
1	O
without	O
any	B-disease
problems	I-disease
.	O

The	O
patient	O
was	O
on	O
a	O
Lasix	O
drip	O
to	O
aid	O
in	O
diuresis	O
,	O
and	O
was	O
ultimately	O
converted	O
to	O
oral	O
Lasix	O
on	O
postop	O
day	O
1	O
.	O

The	O
patient	O
's	O
pain	O
control	O
was	O
with	O
morphine	O
.	O

The	O
patient	O
required	O
2	O
units	O
of	O
fresh	O
frozen	O
plasma	O
on	O
the	O
night	O
following	O
surgery	O
,	O
and	O
1	O
unit	O
of	O
platelets	O
on	O
postop	O
day	O
1	O
,	O
but	O
otherwise	O
required	O
no	O
blood	O
products	O
following	O
the	O
liver	O
transplant	O
.	O

The	O
patient	O
was	O
started	O
on	O
sips	O
on	O
postop	O
day	O
2	O
,	O
and	O
advanced	O
to	O
clear	O
liquids	O
on	O
postop	O
day	O
3	O
.	O

He	O
was	O
advanced	O
to	O
a	O
regular	O
house	O
diet	O
later	O
on	O
postop	O
day	O
3	O
.	O

The	O
patient	O
was	O
advanced	O
per	O
protocol	O
to	O
an	O
immunosuppressive	O
regimen	O
of	O
prednisone	O
,	O
Neoral	O
,	O
and	O
CellCept	O
.	O

The	O
patient	O
's	O
mental	O
status	O
remained	O
essentially	O
clear	O
throughout	O
the	O
entire	O
postoperative	O
period	O
.	O

The	O
patient	O
started	O
ambulating	O
with	O
the	O
assistance	O
of	O
physical	O
therapy	O
following	O
transfer	O
to	O
the	O
surgical	O
floor	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
was	O
independent	O
,	O
ambulating	O
,	O
and	O
functioning	O
well	O
.	O

The	O
patient	O
's	O
appetite	O
improved	O
significantly	O
,	O
and	O
at	O
the	O
time	O
of	O
discharge	O
the	O
patient	O
was	O
on	O
a	O
regular	O
diet	O
with	O
no	O
tube	O
feed	O
supplements	O
deemed	O
necessary	O
.	O

The	O
patient	O
's	O
liver	O
function	O
tests	O
all	O
improved	O
appropriately	O
by	O
the	O
time	O
of	O
discharge	O
.	O

The	B-disease
patient	I-disease
's	I-disease
surgical	I-disease
incision	I-disease
was	O
also	O
healing	O
well	O
by	O
the	O
time	O
of	O
discharge	O
with	O
no	O
evidence	O
of	O
infection	B-disease
.	O

The	O
patient	O
was	O
ultimately	O
deemed	O
ready	O
for	O
discharge	O
on	O
postoperative	O
day	O
8	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Bactrim	O
single	O
strength	O
1	O
tablet	O
po	O
qd	O
.	O

2.	O
Protonix	O
40	O
mg	O
po	O
qd	O
.	O

3.	O
Metoprolol	O
25	O
mg	O
po	O
bid	O
.	O

4.	O
Fluconazole	O
200	O
mg	O
po	O
qd	O
.	O

5.	O
CellCept	O
1	O
gm	O
po	O
bid	O
.	O

6.	O
Prednisone	O
20	O
mg	O
po	O
qd	O
.	O

7.	O
Dilaudid	O
prn	O
.	O

8.	O
Neoral	O
500	O
mg	O
po	O
bid	O
.	O

9.	O
Valcyte	O
450	O
mg	O
po	O
qod	O
.	O

10.	O
Lasix	O
40	O
mg	O
bid	O
x	O
21	O
days	O
.	O

11.	O
Colace	O
100	O
mg	O
po	O
bid	O
.	O

FOLLOW	O
UP	O
:	O

1.	O
The	O
patient	O
was	O
to	O
follow-up	O
with	O
Dr.	O
Ronald	O
in	O
the	O
Transplant	O
Center	O
3	O
days	O
following	O
discharge	O
.	O

2.	O
The	O
patient	O
was	O
to	O
follow-up	O
with	O
Dr.	O
Lueras	O
of	O
hepatology	O
following	O
discharge	O
.	O

MAJOR	O
SURGICAL	O
PROCEDURES	O
:	O

Liver	O
transplant	O
on	O
2013-05-25	O
.	O

Elinor	O
Nicole	O
,	O
New	O
York	O
12428	O

Dictated	O
By	O
:	O
Elizabeth	O
F.	O
Wells	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2013-06-05	O
08:29:54	O

T	O
:	O
2013-06-06	O
10:40:21	O

Job	O
#	O
:	O
34705	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Charles	O
Y.S.	O
Warnock	O
on	O
:	O
Maxine	O
2013-06-20	O
5:29	O
PM	O

(	O
End	O
of	O
Report	O
)	O

915093496	O
RWH	O

0802338	O

045989	O

2923113	O

12/13/2002	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

GIENGBEENEA	O
,	O
NAA	O

UNIT	O
NUMBER	O
:	O

799-54-08	O

ADMISSION	O
DATE	O
:	O

12/13/2002	O

DISCHARGE	O
DATE	O
:	O

12/14/2002	O

ADMITTING	O
DIAGNOSIS	O
:	O

1.	O
Undesired	B-disease
fertility	I-disease
.	O

2.	O
Undesired	B-disease
adiposity	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
30	O
-year-old	O
Gravida	O
III	O
,	O
Para	O
II	O
who	O
presented	O
desiring	O
definitive	O
surgical	O
sterilization	O
.	O

She	O
was	O
extensively	O
counseled	O
regarding	O
other	O
methods	O
of	O
birth	O
control	O
and	O
desired	O
to	O
proceed	O
with	O
definitive	O
surgical	O
therapy	O
.	O

In	O
addition	O
,	O
the	O
patient	O
desired	O
liposuction	O
of	O
varying	O
areas	O
as	O
well	O
.	O

The	O
patient	O
was	O
consented	O
for	O
both	O
procedures	O
and	O
brought	O
to	O
the	O
Operating	O
Room	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Appendectomy	O
at	O
the	O
age	O
of	O
14	O
,	O
open	O
.	O

PAST	O
OBSTETRIC	O
HISTORY	O
:	O

Spontaneous	B-disease
vaginal	I-disease
delivery	I-disease
x	O
2	O
.	O

PAST	O
GYN	O
HISTORY	O
:	O

Regular	O
menses	O
,	O
on	O
Ortho-Tri-Cyclen	O
.	O

No	O
history	O
of	O
sexually	B-disease
transmitted	I-disease
disease	I-disease
,	O
no	O
history	O
of	O
domestic	O
violence	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Ortho	O
Tri-Cyclen	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Height	O
5	O
&apos;	O
1	O
&quot;	O
,	O
weight	O
138	O
lb.	O

Blood	O
pressure	O
:	O

130/82	O
and	O
heart	O
rate	O
80	O
.	O

Breasts	O
:	O

no	O
masses	B-disease
.	O

Lungs	O
:	O

clear	O
to	O
auscultation	O
and	O
percussion	O
bilaterally	O
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
S1-S2	O
.	O

Abdomen	O
:	O

soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

Extremities	O
:	O

within	O
normal	O
.	O

Pelvic	O
exam	O
revealed	O
normal	O
vulva	O
,	O
vagina	O
normal	O
,	O
cervix	O
normal	O
,	O
uterus	O
anteverted	O
,	O
small	O
,	O
nontender	B-disease
.	O

Adnexa	O
:	O

no	O
masses	B-disease
or	O
tenderness	B-disease
.	O

Rectal	O
:	O

deferred	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Operating	O
Room	O
where	O
she	O
underwent	O
an	O
unremarkable	O
laparoscopic	O
tubal	O
ligation	O
.	O

This	O
was	O
done	O
with	O
Falope	O
rings	O
.	O

The	B-disease
estimated	I-disease
blood	I-disease
loss	I-disease
was	O
minimal	O
and	O
the	O
patient	O
received	O
600	O
cc.	O
of	O
intravenous	O
fluid	O
.	O

Of	O
note	O
,	O
the	O
patient	O
had	O
a	O
negative	O
urine	O
pregnancy	O
test	O
prior	O
to	O
the	O
surgery	O
.	O

The	O
patient	O
then	O
underwent	O
liposuction	O
of	O
her	O
abdomen	O
,	O
inner	O
thighs	O
,	O
hips	O
,	O
flanks	O
,	O
chest	O
and	O
arms	O
with	O
Dr.	O
Chain	O
.	O

She	O
did	O
well	O
and	O
was	O
admitted	O
to	O
the	O
GYN	O
Service	O
postoperatively	O
because	O
the	O
patient	O
had	O
persistent	B-disease
pain	I-disease
.	O

On	O
postoperative	O
day	O
#one	O
,	O
she	O
was	O
then	O
stable	O
with	O
no	O
complaints	B-disease
.	O

She	O
remained	O
afebrile	B-disease
.	O

Her	O
Foley	O
was	O
removed	O
.	O

Her	O
diet	O
was	O
advanced	O
without	O
difficulty	O
and	O
the	O
patient	O
was	O
stable	O
for	O
discharge	O
.	O

The	O
patient	O
was	O
to	O
follow	O
up	O
in	O
several	O
days	O
time	O
with	O
Dr.	O
Chain	O
of	O
the	O
Plastics	O
Clinic	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Motrin	O
and	O
Percocet	O
as	O
needed	O
.	O

PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O
04/25/2003	O
09:50	O

_____________________________	O
PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O

TR	O
:	O

wwi	O

DD	O
:	O

04/17/2003	O

TD	O
:	O

04/18/2003	O
8:28	O
A	O
045989	O

cc	O
:	O

PADA	O
MARONNESSGRE	O
CHAIN	O
,	O
M.D.	O

433651389	O

CTMC	O

81247987	O

625670	O

08/16/1998	O
12:00:00	O
AM	O

MENTAL	B-disease
STATUS	I-disease
CHANGE	I-disease
,	O
CELLULITIS	B-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

08/16/1998	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

08/18/1998	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

MENTAL	B-disease
STATUS	I-disease
CHANGES	I-disease
.	O

OTHER	O
DIAGNOSES	O
:	O

1)	O
AORTIC	B-disease
STENOSIS	I-disease
.	O

2)	O
MITRAL	B-disease
REGURGITATION	I-disease
.	O

3)	O
STATUS	O
POST	O
FALL	B-disease
.	O

4)	O
HISTORY	O
OF	O
TRANSIENT	B-disease
ISCHEMIC	I-disease
ATTACK	I-disease
/	O
CEREBROVASCULAR	B-disease
ACCIDENT	I-disease
.	O

5)	O
RIGHT	B-disease
LOWER	I-disease
EXTREMITY	I-disease
WOUND	I-disease
.	O

6)	O
ATRIAL	B-disease
FIBRILLATION	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
88	O
year-old	O
woman	O
undergoing	O
treatment	O
for	O
a	B-disease
right	I-disease
lower	I-disease
extremity	I-disease
cellulitis	I-disease
who	O
was	O
transferred	O
from	O
Child	O
for	O
worsening	B-disease
cellulitis	I-disease
and	O
new	B-disease
confusion	I-disease
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
severe	B-disease
aortic	I-disease
stenosis	I-disease
and	O
was	O
recently	O
admitted	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
a	O
Nafcillin	B-disease
sensitive	I-disease
Staphylococcus	I-disease
aureus	I-disease
cellulitis	I-disease
of	I-disease
the	I-disease
right	I-disease
leg	I-disease
treated	O
with	O
a	O
course	O
of	O
Nafcillin	O
and	O
Levofloxacin	O
.	O

There	O
was	O
also	O
a	B-disease
right	I-disease
leg	I-disease
fluid	I-disease
collection	I-disease
that	O
was	O
incised	O
and	O
drained	O
on	O
August	O
1	O
,	O
1998	O
.	O

The	O
patient	O
was	O
sent	O
to	O
rehabilitation	O
on	O
Levofloxacin	O
orally	O
.	O

Although	O
details	O
were	O
not	O
available	O
at	O
the	O
time	O
of	O
admission	O
,	O
apparently	O
,	O
she	O
had	O
done	O
well	O
until	O
the	O
24	O
hours	O
proceeding	O
admission	O
when	O
the	B-disease
cellulitis	I-disease
was	O
felt	O
to	O
be	O
worsening	O
.	O

She	O
had	O
also	O
been	O
noted	O
to	O
be	O
confused	B-disease
and	O
combative	B-disease
during	O
that	O
24	O
hour	O
period	O
.	O

As	O
her	O
baseline	O
mental	O
status	O
is	O
completely	O
alert	O
and	O
oriented	O
,	O
this	O
caused	O
concern	O
amongst	O
the	O
staff	O
of	O
the	O
rehabilitation	O
center	O
and	O
the	O
patient	O
was	O
transferred	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1)	O
Aortic	B-disease
stenosis	I-disease
,	I-disease
severe	I-disease
,	O
echocardiogram	O
in	O
July	O
of	O
1998	O
with	O
a	O
peak	O
gradient	O
of	O
6-8	O
mm	O
of	O
mercury	O
,	O
aortic	O
valve	O
area	O
calculated	O
to	O
be	O
0.5	O
cm	O
squared	O
by	O
the	O
continuity	O
equation	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
congestive	B-disease
heart	I-disease
failure	I-disease
.	O

Calculated	O
ejection	O
fraction	O
was	O
45-50%	O
.	O

2)	O
Mitral	B-disease
regurgitation	I-disease
,	O
2+	O
on	O
July	O
of	O
1998	O
echocardiogram	O
.	O

3)	O
History	O
of	O
atrial	B-disease
fibrillation	I-disease
.	O

4)	O
History	O
of	O
cerebrovascular	B-disease
disease	I-disease
.	O

5)	O
Hypertension	B-disease
.	O

6)	O
History	O
of	O
temporal	B-disease
arteritis	I-disease
on	O
chronic	O
steroids	O
.	O

7)	O
History	O
of	O
colitis	B-disease
.	O

8)	O
History	O
of	O
vertebral	B-disease
body	I-disease
fractures	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1)	O
Digoxin	O
0.125	O
mg	O
p.o.	O
q.	O
day	O
.	O

2)	O
Lasix	O
80	O
mg	O
p.o.	O
b.i.d.	O

3)	O
Aspirin	O
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

4)	O
Coumadin	O
2	O
mg	O
p.o.	O
q.h.s.	O

5)	O
Zaroxolyn	O
2.5	O
mg	O
p.o.	O
q.	O
day	O
.	O

6)	O
Toprol	O
XL	O
50	O
mg	O
p.o.	O
q.	O
day	O
.	O

7)	O
Potassium	O
20	O
mEq	O
p.o.	O
q.	O
day	O
.	O

8)	O
Prednisone	O
5	O
mg	O
p.o.	O
q.o.d.	O

9)	O
Fosamax	O
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

10)	O
Levofloxacin	O
250	O
mg	O
p.o.	O
q.	O
day	O
.	O

11)	O
Axid	O
150	O
mg	O
p.o.	O
b.i.d.	O

12)	O
Buspar	O
5	O
mg	O
p.o.	O
t.i.d.	O

13)	O
Zyrtec	O
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
had	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
presently	O
staying	O
at	O
the	O
Gangistown	O
Hospital	O
Center	O
.	O

She	O
has	O
a	O
son	O
who	O
is	O
actively	O
involved	O
in	O
her	O
care	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Physical	O
examination	O
on	O
admission	O
revealed	O
an	O
elderly	O
woman	O
,	O
sleeping	O
,	O
responsive	O
only	O
to	O
noxious	O
stimuli	O
after	O
having	O
received	O
some	O
sedation	O
in	O
the	O
emergency	O
department	O
.	O

Vital	O
signs	O
:	O

Heart	O
rate	O
60	O
,	O
respiratory	O
rate	O
18	O
,	O
blood	O
pressure	O
116/80	O
,	O
temperature	O
97.1	O
degrees	O
,	O
oxygen	O
saturation	O
93%	O
on	O
room	O
air	O
.	O

Head	O
and	O
neck	O
examination	O
was	O
benign	O
.	O

Skin	O
examination	O
was	O
notable	O
for	O
a	B-disease
leg	I-disease
ulcer	I-disease
and	O
cellulitis	B-disease
to	O
be	O
delineated	O
below	O
.	O

There	O
were	O
no	O
spider	B-disease
angiomata	I-disease
.	O

Neck	O
was	O
supple	O
with	O
no	O
thyromegaly	B-disease
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

The	O
heart	O
examination	O
revealed	O
that	O
the	O
patient	O
had	O
a	B-disease
sustained	I-disease
PMI	I-disease
which	O
was	O
located	O
in	O
the	O
left	O
mid	O
clavicular	O
line	O
,	O
S1	O
,	O
near	B-disease
complete	I-disease
obliteration	I-disease
of	I-disease
the	I-disease
second	I-disease
heart	I-disease
sound	I-disease
by	O
a	B-disease
two	I-disease
out	I-disease
of	I-disease
six	I-disease
high	I-disease
pitched	I-disease
murmur	I-disease
peaking	O
at	O
mid	O
to	O
late	O
systole	O
and	O
heard	O
across	O
the	O
precordium	O
.	O

It	O
radiates	O
to	O
both	O
carotids	O
bilaterally	O
.	O

There	O
was	O
also	O
a	B-disease
blowing	I-disease
holosystolic	I-disease
murmur	I-disease
heard	O
at	O
the	O
patient	O
&apos;s	O
apex	O
to	O
axilla	O
.	O

There	O
was	O
no	O
S3	B-disease
appreciated	O
.	O

Vascular	O
examination	O
was	O
notable	O
for	O
1+	B-disease
carotid	I-disease
impulses	I-disease
which	O
were	O
diminished	O
and	O
delayed	O
and	O
the	O
above	O
mentioned	O
transmitted	B-disease
cardiac	I-disease
murmurs	I-disease
.	O

Abdominal	O
examination	O
revealed	O
that	O
the	O
abdomen	O
was	O
soft	O
,	O
non-tender	B-disease
,	O
non-distended	B-disease
,	O
no	O
organomegaly	B-disease
,	O
no	O
masses	B-disease
,	O
normal	O
active	O
bowel	O
sounds	O
.	O

The	O
patient	O
&apos;s	O
extremity	O
examination	O
was	O
notable	O
for	O
erythema	B-disease
of	I-disease
the	I-disease
right	I-disease
calf	I-disease
with	O
a	B-disease
small	I-disease
ulcer	I-disease
with	O
a	O
relatively	O
clean	O
base	O
.	O

Neurological	O
examination	O
revealed	O
that	O
the	O
patient	O
was	O
quite	B-disease
sedated	I-disease
at	O
this	O
time	O
having	O
received	O
some	O
medications	O
.	O

She	O
was	O
arousable	O
only	O
to	O
painful	O
stimuli	O
.	O

Her	O
pupils	O
were	O
reactive	O
bilaterally	O
.	O

Her	O
face	O
was	O
symmetric	O
.	O

She	O
had	O
an	O
intact	O
gag	O
reflex	O
.	O

She	O
was	O
able	O
to	O
move	O
all	O
four	O
of	O
her	O
extremities	O
in	O
response	O
to	O
pain	O
.	O

Her	O
deep	O
tendon	O
reflexes	O
were	O
slightly	O
diminished	O
at	O
1+	O
bilaterally	O
,	O
but	O
symmetric	O
.	O

LABORATORY	O
:	O

The	O
patient	O
&apos;s	O
laboratory	O
data	O
on	O
admission	O
is	O
as	O
follows	O
:	O

Sodium	O
was	O
142	O
,	O
potassium	O
3.3	O
,	O
chloride	O
99	O
,	O
BUN	O
23	O
,	O
creatinine	O
1.1	O
.	O

AST	O
was	O
25	O
,	O
alkaline	O
phosphatase	O
130	O
,	O
total	O
bilirubin	O
3.2	O
,	O
albumin	O
3.4	O
,	O
calcium	O
8.8	O
.	O

Digoxin	O
level	O
was	O
0.8	O
.	O

Hematocrit	O
was	O
33.0	O
,	O
platelet	O
count	O
627	O
,	O
white	O
blood	O
cell	O
count	O
10,000	O
,	O
MCV	O
79.8	O
.	O

Coagulation	O
studies	O
revealed	O
a	O
PT	O
of	O
17.4	O
seconds	O
with	O
an	O
INR	O
of	O
2.1	O
,	O
PTT	O
25.5	O
.	O

The	O
patient	O
&apos;s	O
admission	O
chest	O
x-ray	O
revealed	O
no	O
infiltrate	B-disease
,	O
no	O
congestive	B-disease
heart	I-disease
failure	I-disease
.	O

Head	O
CT	O
scan	O
performed	O
in	O
the	O
emergency	O
department	O
revealed	O
no	O
bleed	B-disease
.	O

Urinalysis	O
revealed	O
trace	B-disease
microscopic	I-disease
hematuria	I-disease
with	O
47	O
red	O
blood	O
cells	O
per	O
high	O
powered	O
field	O
,	O
1+	B-disease
bacteria	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

1)	O
Mental	O
status	O
changes	O
:	O

On	O
admission	O
to	O
the	O
emergency	O
room	O
,	O
the	O
patient	O
was	O
somewhat	O
argumentative	B-disease
and	O
confused	B-disease
as	O
well	O
as	O
uncooperative	B-disease
with	I-disease
procedures	I-disease
.	O

A	O
neurologic	O
work-up	O
was	O
undertaken	O
which	O
included	O
a	O
CT	O
scan	O
of	O
the	O
head	O
which	O
revealed	O
no	O
acute	B-disease
bleed	I-disease
and	O
a	O
lumbar	O
puncture	O
which	O
revealed	O
a	O
glucose	O
of	O
72	O
,	O
protein	O
65	O
,	O
white	O
blood	O
cell	O
count	O
19	O
,	O
red	O
blood	O
cell	O
count	O
11,500	O
with	O
no	O
evidence	O
of	O
xanthrochromasia	B-disease
.	O

The	O
Neurology	O
Service	O
evaluated	O
the	O
patient	O
who	O
felt	O
that	O
her	B-disease
agitation	I-disease
was	O
most	O
likely	O
due	O
to	O
infection	B-disease
,	O
her	O
multiple	O
medications	O
,	O
or	O
her	B-disease
metabolic	I-disease
condition	I-disease
.	O

The	O
patient	O
&apos;s	O
mental	O
status	O
slowly	O
began	O
to	O
recover	O
,	O
however	O
on	O
the	O
morning	O
of	O
the	O
first	O
day	O
of	O
admission	O
,	O
August	O
16	O
,	O
1998	O
,	O
the	O
patient	O
was	O
found	O
after	O
having	O
fallen	O
.	O

A	O
neurological	O
examination	O
was	O
performed	O
which	O
revealed	O
no	O
abnormality	B-disease
and	O
imaging	O
included	O
a	O
head	O
scan	O
which	O
revealed	O
no	O
bleed	B-disease
and	O
a	O
cervical	O
spine	O
series	O
which	O
revealed	O
degenerative	B-disease
joint	I-disease
disease	I-disease
but	O
no	O
obvious	B-disease
fracture	I-disease
.	O

The	O
patient	O
decided	O
not	O
to	O
pursue	O
further	O
testing	O
with	O
a	O
neck	O
CT	O
scan	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
the	O
patient	O
&apos;s	O
mental	O
status	O
is	O
back	O
to	O
its	O
baseline	O
.	O

2)	O
Right	B-disease
lower	I-disease
extremity	I-disease
cellulitis	I-disease
:	O

The	O
patient	O
was	O
evaluated	O
by	O
the	O
Surgical	O
Service	O
who	O
felt	O
that	O
the	B-disease
wound	I-disease
was	O
clean	O
with	O
some	B-disease
erythema	I-disease
but	O
without	O
evidence	O
of	O
true	B-disease
cellulitis	I-disease
.	O

The	O
patient	O
&apos;s	O
antibiotics	O
were	O
discontinued	O
with	O
the	O
thought	O
that	O
prolonged	O
antibiotics	O
only	O
put	O
her	O
at	O
more	O
risk	O
for	O
infection	B-disease
.	O

3)	O
Cardiac	O
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
critical	B-disease
aortic	I-disease
stenosis	I-disease
and	O
mitral	B-disease
regurgitation	I-disease
.	O

Fortunately	O
,	O
these	O
issues	O
were	O
not	O
active	O
during	O
the	O
present	O
admission	O
.	O

4)	O
Status	O
post	O
fall	B-disease
:	O

The	O
patient	O
did	O
fall	O
while	O
inhouse	O
.	O

A	O
head	O
CT	O
scan	O
and	O
cervical	O
spine	O
series	O
were	O
negative	O
.	O

The	O
patient	O
appeared	O
to	O
have	O
no	O
deficits	B-disease
at	O
the	O
time	O
of	O
discharge	O
.	O

5)	O
Atrial	B-disease
fibrillation	I-disease
:	O

The	O
patient	O
&apos;s	O
Coumadin	O
was	O
continued	O
.	O

6)	O
Abnormal	B-disease
liver	I-disease
function	I-disease
tests	I-disease
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
elevated	B-disease
bilirubins	I-disease
in	O
the	O
3	O
range	O
and	O
mildly	B-disease
elevated	I-disease
alkaline	I-disease
phosphatase	I-disease
consistent	O
with	O
a	O
cholestatic	B-disease
picture	I-disease
.	O

These	O
liver	O
function	O
tests	O
will	O
be	O
followed	O
closely	O
as	O
an	O
outpatient	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1)	O
Aspirin	O
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

2)	O
Digoxin	O
0.125	O
mg	O
p.o.	O
q.	O
AM	O
.	O

3)	O
Lasix	O
40	O
mg	O
p.o.	O
b.i.d.	O

4)	O
Zaroxolyn	O
0.25	O
mg	O
p.o.	O
q.	O
day	O
.	O

5)	O
Prednisone	O
5	O
mg	O
p.o.	O
q.o.d.	O

6)	O
Coumadin	O
2	O
mg	O
p.o.	O
q.h.s.	O

7)	O
Kay	O
Ciel	O
20	O
mEq	O
p.o.	O
q.	O
day	O
.	O

8)	O
Fosamax	O
10	O
mg	O
p.o.	O
q.	O
day	O
.	O

9)	O
Amitriptyline	O
10	O
mg	O
p.o.	O
q.h.s.	O

10)	O
Buspar	O
5	O
mg	O
p.o.	O
t.i.d.	O

FOLLOW-UP	O
:	O

The	O
patient	O
will	O
be	O
followed	O
at	O
rehabilitation	O
by	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Both	O
.	O

Dictated	O
By	O
:	O

TIA	O
BREUNMULL	O
,	O
M.D.	O
OH29	O

Attending	O
:	O

RA	O
S.	O
BOTH	O
,	O
M.D.	O
YT79	O
WH234/2364	O

Batch	O
:	O

4025	O

Index	O
No.	O
FSYAMR79X6	O

D	O
:	O

08/18/98	O

T	O
:	O

08/18/98	O

Admission	O
Date	O
:	O

2011-12-26	O

Discharge	O
Date	O
:	O

2012-01-26	O

Date	O
of	O
Birth	O
:	O

1958-04-03	O

Sex	O
:	O

F	O

Service	O
:	O

NOTE	O
:	O

This	O
is	O
an	O
addendum	O
to	O
the	O
discharge	O
summary	O
for	O
the	O
admission	O
starting	O
2012-01-05	O
.	O

The	O
patient	O
was	O
discharged	O
on	O
2012-01-26	O
.	O

ADDENDUM	O
HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
had	O
stage	B-disease
1	I-disease
sacral	I-disease
decubitus	I-disease
on	I-disease
her	I-disease
buttocks	I-disease
.	O

This	O
was	O
treated	O
with	O
wound	O
care	O
using	O
Eucerin	O
cream	O
and	O
also	O
patient	O
was	O
treated	O
with	O
lidocaine	O
jelly	O
for	O
pain	O
control	O
.	O

The	O
patient	O
was	O
seen	O
by	O
the	O
wound	O
care	O
nurse	O
and	O
the	B-disease
decubitus	I-disease
ulcer	I-disease
was	O
felt	O
to	O
be	O
mild	O
,	O
but	O
was	O
causing	O
the	O
patient	O
a	O
lot	O
of	O
discomfort	B-disease
and	O
the	O
wound	O
care	O
nurse	O
Ivy	O
Rose	O
lidocaine	O
jelly	O
.	O

With	O
regard	O
to	O
the	B-disease
patient	I-disease
's	I-disease
chronic	I-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
,	O
the	O
patient	O
's	O
respiratory	O
status	O
improved	O
throughout	O
the	O
remainder	O
of	O
her	O
hospital	O
course	O
.	O

The	O
patient	O
had	O
no	O
shortness	B-disease
of	I-disease
breath	I-disease
or	O
cough	B-disease
on	O
discharge	O
.	O

The	O
patient	O
was	O
oxygenating	O
well	O
on	O
her	O
home	O
O2	O
dose	O
of	O
2	O
liters	O
per	O
minute	O
.	O

The	O
patient	O
overall	O
continued	O
to	O
improve	O
,	O
but	O
remained	O
physically	B-disease
decompensated	I-disease
and	O
the	O
patient	O
was	O
transferred	O
to	O
Waltham/Weston	O
Hospital	O
Rehabilitation	O
Hospital	O
for	O
intensive	O
physical	O
therapy	O
.	O

DISCHARGE	O
MEDICATIONS	O
are	O
the	O
same	O
with	O
the	O
addition	O
of	O
viscous	O
lidocaine	O
jelly	O
to	O
be	O
applied	O
to	O
buttock	O
prn	O
and	O
viscous	O
lidocaine	O
swish	O
and	O
swallow	O
tid	O
prn	O
before	O
meals	O
.	O

Timothy	O
E	O
Woolfolk	O
,	O
M.D.	O

18-858	O

Dictated	O
By	O
:	O
Robert	O
C.	O
Warren	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-01-26	O
09:56	O

T	O
:	O
2012-01-26	O
09:58	O

JOB	O
#:	O

48146	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kevin	O
Arthur	O
on	O
:	O
Tony	O
2012-01-27	O
6:52	O
AM	O

(	O
End	O
of	O
Report	O
)	O

130959255	O

FIH	O

1431063	O

10119/hy66	O

738478	O

6/15/1994	O
12:00:00	O
AM	O

RIGHT	B-disease
OCCIPITAL	I-disease
HEMORRHAGIC	I-disease
STROKE	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

6-15-94	O

DISCHARGE	O
DATE	O
:	O

6-26-94	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-disease
occipital	I-disease
hemorrhagic	I-disease
stroke	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Ms.	O
Tlandkotesmitskote	O
is	O
a	O
patient	O
who	O
came	O
complaining	O
of	O
feeling	O
dizzy	B-disease
and	O
bumping	O
into	O
objects	O
on	O
her	O
left	O
side	O
.	O

She	O
is	O
a	O
seventy-one	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-disease
who	O
is	O
in	O
otherwise	O
good	O
health	O
.	O

This	O
morning	O
while	O
on	O
a	O
cruise	O
ship	O
,	O
she	O
was	O
eating	O
breakfast	O
when	O
she	O
suddenly	O
noticed	O
she	O
could	O
not	O
see	O
a	O
roll	O
on	O
her	O
plate	O
although	O
she	O
knew	O
that	O
it	O
was	O
there	O
.	O

She	O
also	O
felt	O
dizzy	B-disease
and	O
the	O
room	O
was	O
spinning	O
.	O

While	O
walking	O
,	O
she	O
kept	O
bumping	O
into	O
object	O
on	O
her	O
left	O
side	O
.	O

She	O
also	O
complained	O
of	O
a	B-disease
dull	I-disease
,	I-disease
right	I-disease
sided	I-disease
headache	I-disease
over	I-disease
the	I-disease
right	I-disease
eyebrow	I-disease
.	O

Symptoms	B-disease
lasted	O
about	O
five	O
hours	O
and	O
then	O
gradually	O
resolved	O
except	O
for	O
the	B-disease
change	I-disease
in	I-disease
vision	I-disease
.	O

She	O
denied	O
having	O
any	O
weakness	B-disease
,	O
numbness	B-disease
,	O
or	O
pain	B-disease
.	O

She	O
also	O
denies	O
having	O
hoarseness	B-disease
,	O
difficulties	B-disease
in	I-disease
finding	I-disease
words	I-disease
,	O
speaking	O
,	O
hiccups	B-disease
,	O
or	O
diplopia	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
past	O
medical	O
history	O
is	O
significant	O
for	O
hypertension	B-disease
.	O

The	O
past	O
surgical	O
history	O
is	O
negative	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Atenolol	O
,	O
25	O
mg	O
PO	O
qd	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

On	O
review	O
of	O
systems	O
,	O
the	O
patient	O
denied	O
any	O
history	O
of	O
transient	B-disease
ischemic	I-disease
attacks	I-disease
.	O

FAMILY	O
HISTORY	O
:	O

Father	O
and	O
mother	O
died	O
in	O
their	O
eighties	O
of	O
heart	B-disease
disease	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
denied	O
using	O
tobacco	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	O
examination	O
,	O
she	O
was	O
a	O
very	O
pleasant	O
,	O
moderately	O
obese	O
female	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

She	O
was	O
afebrile	B-disease
and	O
her	O
vital	O
signs	O
were	O
stable	O
.	O

The	O
head	O
was	O
normocephalic	O
and	O
atraumatic	B-disease
.	O

The	O
pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
.	O

The	O
tympanic	O
membranes	O
were	O
gray	O
.	O

The	O
fundi	O
were	O
sharp	O
.	O

The	O
neck	O
was	O
supple	O
with	O
full	O
range	O
of	O
movement	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
,	O
without	O
rales	B-disease
or	O
wheezes	B-disease
.	O

The	O
heart	O
had	O
a	O
recovery	O
regular	O
rate	O
and	O
rhythm	O
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

Extremities	O
revealed	O
2+	B-disease
pitting	I-disease
edema	I-disease
in	I-disease
the	I-disease
knees	I-disease
bilaterally	I-disease
.	O

The	O
neurological	O
examination	O
revealed	O
that	O
the	O
patient	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
and	O
time	O
.	O

She	O
was	O
able	O
to	O
subtract	O
serial	O
sevens	O
,	O
remember	O
three	O
out	O
of	O
three	O
objects	O
after	O
five	O
minutes	O
,	O
and	O
there	O
was	O
notable	B-disease
aphasia	I-disease
or	O
word	B-disease
finding	I-disease
difficulty	I-disease
.	I-disease

The	O
cranial	O
nerves	O
showed	O
pupils	O
were	O
bilaterally	O
active	O
from	O
3	O
to	O
2	O
mm	O
.	O

There	O
was	O
a	B-disease
dense	I-disease
hemianopsia	I-disease
on	I-disease
the	I-disease
left	I-disease
side	I-disease
.	O

The	O
extra	O
ocular	O
muscles	O
were	O
intact	O
bilaterally	O
.	O

Corneals	O
were	O
present	O
bilaterally	O
.	O

Sensation	O
was	O
intact	O
to	O
light	O
touch	O
and	O
pin	O
prick	O
bilaterally	O
.	O

Face	O
was	O
symmetric	O
.	O

Eye	O
closing	O
was	O
tight	O
.	O

Hearing	O
was	O
intact	O
bilaterally	O
.	O

Palate	O
was	O
midline	O
.	O

Gag	O
was	O
intact	O
.	O

The	O
sternocleidomastoid	O
and	O
trapezius	O
had	O
good	O
strength	O
.	O

Tongue	O
was	O
midline	O
.	O

Strength	O
was	O
5/5	O
in	O
bilateral	O
upper	O
extremities	O
and	O
bilateral	O
lower	O
extremities	O
in	O
detail	O
.	O

There	O
was	O
no	O
pronator	B-disease
drift	I-disease
.	O

Sensation	O
was	O
intact	O
to	O
light	O
touch	O
,	O
pin	O
prick	O
,	O
and	O
proprioception	O
.	O

Cerebellar	O
examination	O
revealed	O
in	O
intention	B-disease
tremor	I-disease
on	I-disease
the	I-disease
right	I-disease
side	I-disease
.	O

The	O
patient	O
had	O
considerable	B-disease
difficulty	I-disease
with	I-disease
left	I-disease
finger-to-nose	I-disease
movement	I-disease
,	O
most	O
likely	O
secondary	O
to	O
hemianopsia	B-disease
.	O

There	O
was	O
no	O
nystagmus	B-disease
,	O
except	O
for	O
some	B-disease
fine	I-disease
fast	I-disease
beat	I-disease
nystagmus	I-disease
bilateral	I-disease
extremes	I-disease
of	I-disease
abduction	I-disease
.	O

Reflexes	O
were	O
symmetric	O
and	O
2+	O
bilaterally	O
at	O
the	O
biceps	O
tendon	O
,	O
2+	O
bilaterally	O
at	O
brachial	O
radialis	O
,	O
2+	O
bilaterally	O
at	O
the	O
patellar	O
tendon	O
,	O
1+	O
bilaterally	O
Achilles	O
tendon	O
.	O

The	O
toes	O
were	O
downgoing	O
bilaterally	O
.	O

Gait	O
:	O

patient	O
had	O
difficulty	B-disease
with	I-disease
tandem	I-disease
gait	I-disease
and	O
fell	O
forward	O
while	O
standing	O
on	O
his	O
his	O
toes	O
.	O

Otherwise	O
,	O
the	O
gait	O
was	O
normal	O
.	O

LABORATORY	O
DATA	O
:	O

Laboratory	O
studies	O
on	O
admission	O
demonstrated	O
a	O
sodium	O
of	O
144	O
,	O
potassium	O
4.1	O
,	O
chloride	O
106	O
,	O
bicarbonate	O
20.0	O
,	O
BUN	O
and	O
creatinine	O
12/0.7	O
,	O
glucose	O
99	O
,	O
white	O
blood	O
count	O
of	O
5.7	O
,	O
hematocrit	O
of	O
40.6	O
,	O
platelet	O
count	O
of	O
226	O
,	O
prothrombin	O
time	O
was	O
9.4	O
,	O
partial	O
thromboplastin	O
time	O
was	O
29	O
.	O

The	O
computerized	O
tomography	O
scan	O
was	O
performed	O
and	O
showed	O
a	B-disease
right	I-disease
occipital	I-disease
hemorrhage	I-disease
.	O

SUMMARY	O
:	O

The	O
patient	O
is	O
a	O
seventy-one	O
year	O
old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-disease
who	O
now	O
presents	O
with	O
a	B-disease
right	I-disease
occipital	I-disease
hemorrhagic	I-disease
stroke	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
hospital	O
for	O
further	O
evaluation	O
and	O
work	O
up	O
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Intermediate	O
Care	O
Unit	O
in	O
the	O
Neurology	O
Intensive	O
Care	O
Unit	O
.	O

However	O
,	O
she	O
was	O
soon	O
moved	O
out	O
of	O
there	O
as	O
her	O
examination	O
appeared	O
to	O
be	O
stable	O
.	O

A	O
Neurosurgery	O
Service	O
consultation	O
was	O
obtained	O
and	O
they	O
felt	O
that	O
no	O
surgical	O
intervention	O
was	O
required	O
.	O

The	O
patient	O
underwent	O
a	O
number	O
of	O
tests	O
.	O

She	O
had	O
a	O
magnetic	O
resonance	O
imaging	O
study	O
and	O
magnetic	O
resonance	O
imaging	O
angiogram	O
performed	O
which	O
showed	O
a	B-disease
large	I-disease
hemorrhagic	I-disease
lesion	I-disease
on	I-disease
the	I-disease
occipital	I-disease
lobe	I-disease
.	O

There	O
was	O
no	O
clear	B-disease
enhancing	I-disease
mass	I-disease
,	O
but	O
follow	O
up	O
was	O
suggested	O
.	O

So	O
an	O
magnetic	O
resonance	O
imaging	O
angiogram	O
was	O
obtained	O
and	O
showed	O
the	B-disease
right	I-disease
parietal	I-disease
occipital	I-disease
hemorrhage	I-disease
.	O

The	O
MRA	O
showed	O
mild	B-disease
narrowing	I-disease
of	I-disease
the	I-disease
left	I-disease
ICA	I-disease
just	O
distal	O
to	O
the	O
bifurcation	O
.	O

There	O
was	O
also	O
scattered	B-disease
T2	I-disease
hyperintense	I-disease
foci	I-disease
within	I-disease
the	I-disease
periventricular	I-disease
and	I-disease
left	I-disease
frontal	I-disease
white	I-disease
matter	I-disease
consistent	O
with	O
small	B-disease
vessel	I-disease
disease	I-disease
,	O
gliosis	B-disease
or	O
demyelination	B-disease
.	O

A	O
Holter	O
monitor	O
was	O
obtained	O
and	O
showed	O
that	O
the	O
patient	O
was	O
in	O
normal	O
sinus	O
rhythm	O
.	O

The	O
heart	O
rate	O
was	O
53	O
to	O
106	O
.	O

There	O
were	O
some	B-disease
very	I-disease
rare	I-disease
atrial	I-disease
premature	I-disease
contractions	I-disease
.	O

There	O
were	O
no	O
ventricular	B-disease
premature	I-disease
contractions	I-disease
.	O

An	O
echocardiogram	O
was	O
obtained	O
and	O
showed	O
that	O
the	O
ejection	O
fraction	O
was	O
60%	O
and	O
there	O
was	O
no	O
thrombus	B-disease
.	O

It	O
was	O
felt	O
to	O
be	O
within	O
normal	O
limits	O
.	O

Over	O
the	O
ensuing	O
days	O
,	O
the	O
patient	O
had	O
several	O
episodes	O
of	O
confusion	B-disease
at	O
night	O
.	O

However	O
,	O
these	O
gradually	O
resolved	O
.	O

She	O
also	O
developed	O
what	O
appeared	O
to	O
be	O
urinary	B-disease
tract	I-disease
infection	I-disease
and	O
was	O
placed	O
on	O
PO	O
Bactrim	O
.	O

By	O
6-26-94	O
,	O
the	O
patient	O
was	O
felt	O
to	O
be	O
ready	O
for	O
discharge	O
.	O

At	O
that	O
time	O
,	O
she	O
was	O
afebrile	B-disease
and	O
her	O
vital	O
signs	O
were	O
stable	O
.	O

She	O
was	O
tolerating	O
a	O
regular	O
diet	O
.	O

She	O
was	O
awake	O
,	O
alert	O
and	O
oriented	O
to	O
person	O
,	O
place	O
,	O
and	O
time	O
.	O

She	O
continued	O
to	O
have	O
a	B-disease
dense	I-disease
left	I-disease
hemianopsia	I-disease
,	O
but	O
otherwise	O
was	O
neurologically	O
intact	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
with	O
Santea	O
Gehawhi	O
General	O
Hospital	O
care	O
and	O
instructed	O
to	O
follow	O
up	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
was	O
discharged	O
on	O
Tenormin	O
,	O
25	O
mg	O
PO	O
qd	O
;	O
Bactrim	O
DS	O
,	O
one	O
PO	O
bid	O
x5	O
days	O
.	O

TATAJO	O
SEE	O
,	O
M.D.	O

TR	O
:	O

ba	O
/	O
bmot	O

DD	O
:	O

8-4-94	O

TD	O
:	O

08/06/94	O

CC	O
:	O

879492218	O
YC	O

53470378	O

3210349	O

6/26/2004	O
12:00:00	O
AM	O

PNEUMONIA	B-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/26/2004	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/08/2004	O

ATTENDING	O
:	O

MALTA	O
FYFEZEISLEITZ	O
MD	O

CHIEF	O
COMPLAINT	O
:	O

Shortness	B-disease
of	I-disease
breath	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
38-year-old	O
gentleman	O
,	O
Spanish-speaking	O
,	O
from	O
the	O
Taheimpromong	O
,	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
presents	O
with	O
shortness	B-disease
of	I-disease
breath	I-disease
x	O
2	O
months	O
as	O
well	O
as	O
a	B-disease
dry	I-disease
cough	I-disease
x	O
1	O
month	O
.	O

The	O
patient	O
was	O
in	O
his	O
usual	O
state	O
of	O
health	O
until	O
two	O
months	O
prior	O
to	O
admission	O
when	O
he	O
began	O
to	O
notice	O
shortness	B-disease
of	I-disease
breath	I-disease
on	O
climbing	O
flights	O
of	O
stairs	O
.	O

He	O
stated	O
that	O
this	O
became	O
worse	O
over	O
the	O
last	O
month	O
until	O
he	O
was	O
noted	O
to	O
be	O
short	B-disease
of	I-disease
breath	I-disease
at	O
rest	O
.	O

He	O
also	O
states	O
that	O
he	O
has	O
had	O
a	B-disease
dry	I-disease
and	I-disease
nonproductive	I-disease
cough	I-disease
for	O
one	O
month	O
.	O

He	O
denied	O
any	O
fevers	B-disease
,	O
chills	B-disease
,	O
or	O
night	B-disease
sweats	I-disease
.	O

No	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
or	O
diarrhea	B-disease
.	O

He	O
did	O
note	O
some	B-disease
weight	I-disease
loss	I-disease
over	O
the	O
past	O
several	O
months	O
,	O
though	O
the	O
amount	O
was	O
unknown	O
.	O

He	O
denied	O
any	O
contact	O
with	O
TB	O
positive	O
patients	O
.	O

He	O
describes	O
a	O
negative	O
PPD	O
one	O
year	O
prior	O
to	O
admission	O
when	O
he	O
was	O
in	O
prison	O
for	O
one	O
week	O
.	O

He	O
did	O
travel	O
to	O
the	O
Taheimpromong	O
,	O
last	O
in	O
01/2004	O
for	O
three	O
weeks	O
.	O

He	O
did	O
note	O
multiple	O
female	O
sexual	O
partners	O
,	O
although	O
described	O
using	O
condoms	O
except	O
with	O
his	O
wife	O
.	O

He	O
denies	O
any	O
IV	O
drug	O
use	O
,	O
did	O
describe	O
cocaine	O
use	O
last	O
two	O
months	O
ago	O
.	O

He	O
did	O
drink	O
alcohol	O
three	O
drinks	O
per	O
day	O
,	O
no	O
withdrawal	B-disease
symptoms	I-disease
.	O

In	O
emergency	O
room	O
,	O
he	O
was	O
noted	O
to	O
be	O
afebrile	O
with	O
stable	O
vital	O
signs	O
,	O
was	O
treated	O
with	O
IV	O
fluids	O
,	O
azithromycin	O
,	O
and	O
cefuroxime	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

None	O
.	O

MEDICATIONS	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
currently	O
with	O
a	O
friend	O
,	O
he	O
is	O
from	O
the	O
Taheimpromong	O
and	O
has	O
lived	O
here	O
for	O
13	O
years	O
,	O
he	O
does	O
note	O
multiple	O
sexual	O
partners	O
,	O
although	O
he	O
notes	O
using	O
condoms	O
with	O
everyone	O
except	O
his	O
wife	O
,	O
he	O
reportedly	O
had	O
a	O
negative	O
PPD	O
during	O
his	O
prison	O
stay	O
one	O
year	O
ago	O
for	O
one	O
week	O
.	O

He	O
traveled	O
to	O
the	O
Taheimpromong	O
last	O
in	O
01/2004	O
for	O
one	O
month	O
.	O

He	O
does	O
drink	O
alcohol	O
three	O
drinks	O
per	O
day	O
,	O
denies	O
any	O
current	O
tobacco	O
use	O
.	O

FAMILY	O
HISTORY	O
:	O

Sister	O
with	O
bone	B-disease
cancer	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
UPON	O
ADMISSION	O
:	O

Temperature	O
97.4	O
,	O
heart	O
rate	O
100	O
,	O
blood	O
pressure	O
142/89	O
,	O
and	O
O2	O
saturation	O
94%	O
on	O
room	O
air	O
.	O

General	O
exam	O
revealed	O
a	O
well-developed	O
,	O
well-nourished	O
gentleman	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

HEENT	O
exam	O
revealed	O
sclerae	B-disease
to	O
be	O
injected	O
.	O

Pupils	O
equal	O
,	O
round	O
,	O
and	O
reactive	O
to	O
light	O
.	O

No	O
lymphadenopathy	B-disease
was	O
noted	O
in	O
the	O
neck	O
,	O
there	O
was	O
a	O
question	O
of	O
right	B-disease
axillary	I-disease
lymphadenopathy	I-disease
.	O

Chest	O
exam	O
reveals	O
coarse	B-disease
rhonchi	I-disease
with	O
some	B-disease
bibasilar	I-disease
crackles	I-disease
.	O

Abdominal	O
exam	O
revealed	O
soft	O
,	O
nontender	O
,	O
and	O
nondistended	O
abdomen	O
.	O

Heart	O
exam	O
was	O
regular	O
rate	O
and	O
rhythm	O
,	O
tachycardic	B-disease
,	O
with	O
a	B-disease
flat	I-disease
jugular	I-disease
venous	I-disease
pressure	I-disease
.	O

His	O
extremities	O
were	O
without	O
cyanosis	B-disease
,	O
clubbing	B-disease
,	O
or	O
edema	B-disease
.	O

His	O
skin	O
was	O
clear	O
,	O
without	O
rashes	B-disease
.	O

There	O
is	O
no	O
hepatosplenomegaly	B-disease
noted	O
on	O
abdominal	O
exam	O
.	O

Neuro	O
exam	O
was	O
alert	O
and	O
oriented	O
x	O
3	O
.	O

LABORATORY	O
DATA	O
UPON	O
ADMISSION	O
:	O

Sodium	O
139	O
,	O
potassium	O
3.5	O
,	O
chloride	O
103	O
,	O
bicarbonate	O
25	O
,	O
BUN	O
9	O
,	O
creatinine	O
0.9	O
,	O
and	O
glucose	O
83	O
.	O

White	O
blood	O
cell	O
count	O
11.2	O
,	O
hematocrit	O
43.2	O
,	O
and	O
platelets	O
447,000	O
.	O

EKG	O
upon	O
admission	O
:	O

Sinus	B-disease
tachycardia	I-disease
at	O
100	O
.	O

Chest	O
x-ray	O
upon	O
admission	O
:	O

Diffuse	B-disease
interstitial	I-disease
process	I-disease
/	O
consolidation	B-disease
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEM	O
:	O

1.	O
Pulmonary	O
/	O
Infectious	O
Disease	O
:	O

The	O
patient	O
&apos;s	O
differential	O
diagnosis	O
included	O
initially	O
a	O
question	O
of	O
an	B-disease
atypical	I-disease
pneumonia	I-disease
or	O
PCP	B-disease
.	O

His	O
PPD	O
has	O
been	O
negative	O
one	O
year	O
prior	O
to	O
admission	O
,	O
PPD	O
was	O
rechecked	O
during	O
this	O
admission	O
and	O
was	O
negative	O
.	O

He	O
was	O
ruled	O
out	O
for	O
tuberculosis	B-disease
with	O
an	O
induced	O
sputum	O
x	O
3	O
,	O
which	O
showed	O
no	O
AFB	B-disease
.	O

Chest	O
CT	O
showed	O
bibasilar	B-disease
diffuse	I-disease
infiltrates	I-disease
,	O
PCP	O
was	O
negative	O
.	O

Thus	O
initially	O
he	O
had	O
been	O
started	O
on	O
prednisone	O
and	O
Bactrim	O
,	O
this	O
was	O
discontinued	O
.	O

He	O
was	O
continued	O
on	O
azithromycin	O
and	O
cefuroxime	O
until	O
bronchoscopy	O
results	O
were	O
known	O
,	O
negative	O
.	O

Thus	O
they	O
were	O
discontinued	O
.	O

He	O
initially	O
had	O
refused	O
HIV	O
testing	O
,	O
however	O
,	O
was	O
finally	O
consented	O
,	O
HIV	B-disease
was	O
noted	O
to	O
be	O
negative	O
.	O

Pulmonary	O
consult	O
was	O
invited	O
,	O
initially	O
the	O
patient	O
refused	O
bronchoscopy	O
,	O
however	O
,	O
did	O
agree	O
to	O
it	O
during	O
his	O
hospital	O
stay	O
.	O

The	O
results	O
were	O
negative	O
for	O
Micro	B-disease
,	O
most	O
likely	O
diagnosis	O
as	O
per	O
review	O
of	O
pathology	O
is	O
organizing	B-disease
pneumonia	I-disease
with	O
possible	O
diagnosis	O
of	O
BOOP	B-disease
and	O
chronic	B-disease
inhalational	I-disease
injury	I-disease
was	O
a	O
possibility	O
.	O

The	O
patient	O
required	O
supplemental	O
oxygen	O
to	O
keep	O
his	O
oxygen	O
saturation	O
greater	O
than	O
93%	O
.	O

Ambulatory	O
saturation	O
was	O
82%	O
on	O
room	O
air	O
.	O

He	O
was	O
treated	O
with	O
supportive	O
medical	O
therapy	O
for	O
his	B-disease
cough	I-disease
.	O

He	O
was	O
to	O
follow	O
up	O
with	O
pulmonary	O
as	O
an	O
outpatient	O
.	O

2.	O
Cardiovascular	O
:	O

Echocardiogram	O
was	O
checked	O
to	O
rule	O
out	O
CHF	B-disease
,	O
showed	O
LVH	B-disease
and	O
trace	B-disease
TR	I-disease
,	O
ejection	O
fraction	O
of	O
60%	O
without	O
any	O
pulmonary	B-disease
hypertension	I-disease
.	O

3.	O
Heme	O

/ID	O
:	O

Hepatitis	O
serologies	O
were	O
negative	O
.	O

4.	O
FEN	O
:	O

The	O
patient	O
was	O
kept	O
on	O
a	O
house	O
diet	O
.	O

His	O
electrolytes	O
were	O
repeated	O
p.r.n.	O

5.	O
Prophylaxis	O
:	O

Lovenox	O
.	O

6.	O
Code	O
status	O
:	O

Full	O
.	O

7.	O
Disposition	O
:	O

The	O
patient	O
was	O
discharged	O
to	O
home	O
in	O
satisfactory	O
condition	O
with	O
home	O
oxygen	O
.	O

Multiple	O
conversations	O
were	O
had	O
with	O
the	O
patient	O
as	O
well	O
as	O
an	O
interpreter	O
stating	O
the	O
importance	O
of	O
not	O
smoking	O
and	O
keeping	O
flames	O
away	O
from	O
his	O
oxygen	O
tank	O
.	O

He	O
was	O
sent	O
home	O
with	O
LDAMC	O
services	O
to	O
help	O
with	O
his	O
medications	O
as	O
well	O
as	O
oxygen	O
education	O
.	O

He	O
was	O
told	O
to	O
call	O
a	O
doctor	O
or	O
come	O
to	O
the	O
emergency	O
room	O
should	O
he	O
have	O
any	B-disease
further	I-disease
troubles	I-disease
,	O
breathing	O
,	O
chest	B-disease
pain	I-disease
,	O
or	O
fevers	B-disease
.	O

He	O
was	O
to	O
follow	O
up	O
with	O
Dr.	O
Malta	O
at	O
Firmert	O
Hospital	O
on	O
07/23/04	O
at	O
3:00	O
p.m.	O
,	O
as	O
well	O
as	O
Dr.	O
Shawn	O
Leick	O
at	O
the	O
Stonho	O
Health	O
Care	O
pulmonary	O
division	O
as	O
directed	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Prednisone	O
60	O
mg	O
p.o.	O
q.a.m.	O

2.	O
Bactrim	O
double	O
strength	O
one	O
tablet	O
p.o.	O
q.d.	O
for	O
PCP	O
prophylaxis	O
during	O
his	O
steroid	O
course	O
.	O

eScription	O
document	O
:	O

0-3054851	O
WEBCtug	O
Tel	O

CC	O
:	O

Mata	O
Fyfezeisleitz	O
MD	O
Verla	O

Dictated	O
By	O
:	O

KOTEHARBE	O
,	O
THRYNE	O

Attending	O
:	O

FYFEZEISLEITZ	O
,	O
MATA	O
Dictation	O
ID	O
5149122	O

D	O
:	O

11/06/04	O

T	O
:	O

11/07/04	O

Admission	O
Date	O
:	O

2019-09-27	O

Discharge	O
Date	O
:	O

2019-10-07	O

Date	O
of	O
Birth	O
:	O

1959-01-27	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	I-disease
Drugs	I-disease

Attending	O
:	O
Luis	O
JG	O
Lavoie	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

exertional	B-disease
angina	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

10-01	O
CABG	O
x	O
3	O

History	O
of	O
Present	O
Illness	O
:	O

60	O
yo	O
M	O
with	O
exertional	B-disease
angina	I-disease
->	O
positive	B-disease
ETT	I-disease
->	O
cath	O
with	O
severe	B-disease
3VD	I-disease

Past	O
Medical	O
History	O
:	O

HTN	B-disease

DM	B-disease

cataracts	B-disease
s/p	O
removal	O
of	O
in	O
Mayotte	O
c/b	O
enucleated	O
CMED	O
CSRU	O

urinary	B-disease
incontinence	I-disease

Social	O
History	O
:	O

farmer	O
in	O
Mayotte	O

-	O
tob	O

-	O
etoh	O

lives	O
with	O
wife	O
and	O
oldest	O
son	O

Family	O
History	O
:	O

father	O
with	O
?	O
Mi	B-disease
at	O
unknown	O
age	O

Physical	O
Exam	O
:	O

NAD	O
76	O
184/87	O
18	O

Teeth	B-disease
in	I-disease
poor	I-disease
repair	I-disease

lungs	O
ctab	O
ant	O
/	O
lat	O

distant	B-disease
heart	I-disease
sounds	I-disease
,	O
RRR	O

Abdomen	O
benign	O

extrem	B-disease
warm	I-disease
,	O
no	O
edema	B-disease
,	O
no	O
varicosities	B-disease
,	O
2+	O
pedal	O
pulses	O

Pertinent	O
Results	O
:	O

2019-10-07	O
05:30	O
AM	O
BLOOD	O
WBC	O
-	O
6.5	O
RBC	O
-	O
3.23	O
*	O
Hgb	O
-	O
9.5	O
*	O
Hct	O
-	O
27.6	O
*	O
MCV	O
-	O
86	O
MCH	O
-	O
29.4	O
MCHC	O
-	O
34.4	O
RDW	O
-	O
14.0	O
Plt	O
Ct	O
-	O
356	O
#	O

2019-10-07	O
05:30	O
AM	O
BLOOD	O
Plt	O
Ct	O
-	O
356	O
#	O

2019-10-04	O
06:50	O
AM	O
BLOOD	O
PT	O
-	O
13.2	O
*	O
PTT	O
-	O
32.1	O
INR(PT)	O
-	O
1.2	O
*	O

2019-10-07	O
05:30	O
AM	O
BLOOD	O
Glucose	O
-	O
156	O
*	O
UreaN	O
-	O
20	O
Creat	O
-	O
1.0	O
Na	O
-	O
140	O
K	O
-	O
3.8	O
Cl	O
-	O
99	O
HCO3	O
-	O
31	O
AnGap	O
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

He	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2019-10-01	O
where	O
he	O
underwent	O
a	O
CABG	O
x	O
3	O
.	O

He	O
was	O
transferred	O
to	O
the	O
CMED	O
CCU	O
in	O
critical	O
but	O
stable	O
condition	O
.	O

He	O
was	O
extubated	O
by	O
POD	O
#1	O
.	O

He	O
was	O
weaned	O
from	O
his	O
vasoactive	O
drips	O
and	O
transferred	O
to	O
the	O
floor	O
on	O
POD	O
#2	O
.	O

He	O
was	O
seen	O
by	O
speech	O
and	O
swallowing	O
who	O
recommended	O
NPO	O
,	O
he	O
then	O
underwent	O
a	O
video	O
swallow	O
after	O
which	O
he	O
was	O
changed	O
to	O
a	O
diet	O
of	O
thin	O
liquids	O
and	O
soft	O
solids	O
,	O
and	O
felt	O
that	O
his	O
eeating	O
may	O
be	O
limited	O
by	O
his	B-disease
loose	I-disease
teeth	I-disease
.	O

Dentistry	O
and	O
OMFS	O
were	O
consulted	O
,	O
and	O
he	O
had	O
four	O
front	O
teeth	O
removed	O
on	O
10-04	O
.	O

He	O
did	O
well	O
post	O
operatively	O
and	O
he	O
was	O
ready	O
for	O
discharge	O
on	O
2019-10-07	O
.	O

Medications	O
on	O
Admission	O
:	O

lisinopril	O
,	O
protonix	O
,	O
glipizide	O
,	O
metformin	O
,	O
asa	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Docusate	O
Sodium	O
150	O
mg	O
/	O
15	O
mL	O
Liquid	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
QS	O
1	O
month	O
*	O
Refills	O
:*	O
0	O
*	O

5.	O
Oxycodone	O
-	O
Acetaminophen	O
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
every	O
4-6	O
hours	O
as	O
needed	O
for	O
pain	B-disease
.	O

Disp	O
:*	O
50	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Clopidogrel	O
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Glipizide	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Lisinopril	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Hydrochlorothiazide	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

CAD	B-disease

HTN	B-disease

DM	B-disease

cataracts	B-disease
s/p	O
removal	O
c/b	O
enucleated	O
left	O
CMED	O
CSRU	O

urinary	B-disease
incontinence	I-disease

?	O
TIA	B-disease

Discharge	O
Condition	O
:	O

Good	O
.	O

Discharge	O
Instructions	O
:	O

Call	O
with	O
fever	B-disease
,	O
redness	B-disease
or	O
drainage	B-disease
from	I-disease
incision	I-disease
or	O
weight	B-disease
gain	I-disease
more	O
than	O
2	O
pounds	O
in	O
one	O
day	O
or	O
five	O
in	O
one	O
week	O
.	O

Shower	O
,	O
no	O
baths	O
,	O
no	O
lotions	O
,	O
creams	O
or	O
powders	O
to	O
incisions	B-disease
.	O

No	O
lifting	O
more	O
than	O
10	O
pounds	O
or	O
driving	O
until	O
follow	O
up	O
with	O
surgeon	O
.	O

Followup	O
Instructions	O
:	O

Dr.	O
Dewhurst	O
2	O
weeks	O

Dr.	O
Burns	O
4	O
weeks	O

Chad	O
Barbara	O
MD	O
49-703	O

Completed	O
by	O
:	O
Theresa	O
Leonore	O
NP	O
80-BXH	O
2019-10-07	O
@	O
1229	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Eugene	O
Offutt	O
on	O
:	O
MON	O
2019-10-07	O
12:44	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2010-10-04	O

Discharge	O
Date	O
:	O

2010-10-17	O

Date	O
of	O
Birth	O
:	O

1929-11-09	O

Sex	O
:	O

F	O

Service	O
:	O

There	O
will	O
be	O
further	O
addendum	O
.	O

Respiratory	B-disease
distress	I-disease
-	O
On	O
10-12	O
,	O
the	O
patient	O
was	O
transferred	O
to	O
Medicine	O
Intensive	O
Care	O
Unit	O
secondary	O
to	O
respiratory	B-disease
distress	I-disease
.	O

In	O
the	O
Medicine	O
Intensive	O
Care	O
Unit	O
,	O
the	O
patient	O
was	O
initially	O
placed	O
on	O
high-flow	O
60%	O
oxygen	O
face	O
mask	O
and	O
they	O
diuresed	O
approximately	O
5	O
liters	O
off	O
into	O
the	O
intravenous	O
Lasix	O
.	O

The	O
patient	O
actually	O
was	O
improved	O
.	O

She	O
came	O
back	O
to	O
the	O
floor	O
on	O
10-14	O
.	O

Since	O
then	O
the	O
patient	O
's	O
oxygenation	O
has	O
been	O
improving	O
and	O
today	O
,	O
10-17	O
,	O
she	O
is	O
requiring	O
.5	O
liters	O
of	O
keep	O
her	O
saturations	O
above	O
94	O
.	O

The	O
patient	O
continues	O
to	O
be	O
diuresed	O
with	O
approximately	O
20	O
mg	O
of	O
Lasix	O
a	O
day	O
and	O
she	O
has	O
had	O
good	O
urine	O
output	O
.	O

Anemia	B-disease
-	O
The	O
patient	O
's	O
hematocrit	O
dropped	O
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
the	O
mid	O
20s	O
and	O
she	O
received	O
one	O
unit	O
of	O
packed	O

red	O
blood	O
cells	O
with	O
a	O
good	O
response	O
up	O
to	O
30	O
.	O

Hypotension	B-disease
-	O
On	O
the	O
night	O
of	O
10-16	O
,	O
the	O
patient	O
was	O
diuresed	O
with	O
20	O
mg	O
of	O
intravenous	O
Lasix	O
.	O

This	O
is	O
the	O
normal	O
dose	O
that	O
she	O
puts	O
out	O
too	O
.	O

The	O
patient	O
became	O
hypotensive	B-disease
into	O
the	O
70	O
s	O
without	O
any	B-disease
symptoms	I-disease
.	O

Her	O
oxygen	O
saturations	O
were	O
greater	O
than	O
94%	O
at	O
the	O
time	O
.	O

The	O
patient	O
was	O
given	O
250	O
cc	O
of	O
normal	O
saline	O
and	O
her	O
blood	O
pressure	O
responded	O
coming	O
back	O
up	O
to	O
the	O
high	O
90	O
s.	O

No	O
further	O
episodes	O
of	O
hypotension	B-disease
were	O
noted	O
.	O

As	O
of	O
the	O
time	O
of	O
this	O
dictation	O
,	O
on	O
2010-10-17	O
,	O
the	O
patient	O
appears	O
to	O
be	O
getting	O
better	O
.	O

Recent	O
chest	O
x-ray	O
shows	O
resolving	B-disease
right	I-disease
lower	I-disease
lobe	I-disease
pneumonia	I-disease
.	O

She	O
continues	O
on	O
her	O
Prednisone	O
taper	O
for	O
her	B-disease
asthma	I-disease
and	O
this	O
is	O
day	O
#	O
14	O
of	O
antibiotics	O
.	O

MARK	O
Shorter	O
,	O
M.D.	O

94-264	O

Dictated	O
By	O
:	O
Donna	O
Q	O
Fisher	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-10-17	O
12:22	O

T	O
:	O
2010-10-17	O
17:21	O

JOB	O
#:	O

33371	O

(	O
End	O
of	O
Report	O
)	O

245317863	O
WGH	O

9156109	O

780576	O

0720567	O

04/20/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

KOORSKOTE	O
,	O
RETCO	O

MRN	O
:	O

9156109	O

Age	O
:	O

26y	O

REGISTRATION	O
DATE	O
:	O

04/20/2005	O
10:30	O
PM	O

Provider	O
:	O

HE	O
HERDES	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O
PCP	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

04/21/2005	O
05:25	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

RLQ	B-disease
PAIN	I-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
kidney	B-disease
stones	I-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

likely	O
recently	B-disease
passed	I-disease
kidney	I-disease
stone	I-disease

Treatment	O
Rendered	O
:	O

history	O
,	O
physical	O
,	O
lab	O
,	O
Abdominal	O
CT	O
scan	O

Discharge	O
Medications	O
:	O

Motrin	O
as	O
needed	O

Follow	O
up	O
Service	O
:	O

Please	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
within	O
the	O
next	O
week	O
.	O

Also	O
please	O
follow	O
up	O
with	O
urology	O
regarding	O
management	O
of	O
your	B-disease
kidney	I-disease
stones	I-disease
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
return	O
if	O
your	B-disease
symptoms	I-disease
return	O
,	O
you	O
develop	O
a	B-disease
fever	I-disease
.	O

PCP	O
Name	O
:	O

KOTEKOTEPRUESS	O
,	O
SUSNUM	O

Provider	O
Number	O
:	O

43264	O

This	O
report	O
was	O
created	O
by	O
HERDES	O
,	O
NEWSHALIE	O
04/21/2005	O
06:47	O
AM	O

Admission	O
Date	O
:	O

2015-10-26	O

Discharge	O
Date	O
:	O

2015-10-30	O

Date	O
of	O
Birth	O
:	O

1998-01-05	O

Sex	O
:	O

M	O

Service	O
:	O

SURGERY	O

Allergies	O
:	O

Sulfa	O
(	O
Sulfonamides	O
)	O
/	O
Penicillins	O

Attending	O
:	O
Mary	O
T	O
Davis	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

s/p	O
Pedestrian	O
struck	O
by	O
auto	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

2015-10-27	O
Open	O
reduction	O
and	O
internal	O
fixation	O
of	O
right	B-disease
tib/fib	I-disease
fractures	I-disease

History	O
of	O
Present	O
Illness	O
:	O

17	O
yo	O
male	O
pedestrian	O
who	O
was	O
struck	O
by	O
auto	O
at	O
unknown	O
speed	O
;	O
+LOC	B-disease
.	O

He	O
was	O
medflighted	O
to	O
The	O
Hospital	O
for	O
Orthopedics	O
for	O
ongoing	O
trauma	O
care	O
.	O

Upon	O
arrival	O
GCS	O
15	O
,	O
alert	O
and	O
oriented	O
x3	O
.	O

Past	O
Medical	O
History	O
:	O

Attention	B-disease
deficit	I-disease
disorder	I-disease
(	O
diagnosed	O
@	O
14	O
yrs	O
of	O
age	O
)	O

Social	O
History	O
:	O

High	O
school	O
student	O

Resides	O
with	O
parents	O
and	O
siblings	O

Family	O
History	O
:	O

Noncontributory	O

Pertinent	O
Results	O
:	O

2015-10-26	O
08:48	O
PM	O

GLUCOSE	O
-	O
101	O
LACTATE	O
-	O
2.9	O
*	O
NA+	O
-	O
142	O
K+	O
-	O
3.6	O
CL-	O
-	O
102	O
TCO2	O
-	O
26	O

2015-10-26	O
08:34	O
PM	O

UREA	O
N	O
-	O
12	O
CREAT	O
-	O
1.0	O

2015-10-26	O
08:34	O
PM	O

AMYLASE	O
-	O
44	O

2015-10-26	O
08:34	O
PM	O

ASA	O
-	O
NEG	O
ETHANOL	O
-	O
NEG	O
ACETMNPHN	O
-	O
NEG	O
bnzodzpn	O
-	O
NEG	O
barbitrt	O
-	O
NEG	O
tricyclic	O
-	O
NEG	O

2015-10-26	O
08:34	O
PM	O

WBC	O
-	O
16.0	O
*	O
RBC	O
-	O
4.89	O
HGB	O
-	O
14.5	O
HCT	O
-	O
40.4	O
MCV	O
-	O
83	O
MCH	O
-	O
29.7	O
MCHC	O
-	O
35.9	O
*	O
RDW	O
-	O
13.4	O

2015-10-26	O
08:34	O
PM	O

PLT	O
COUNT	O
-	O
247	O

2015-10-26	O
08:34	O
PM	O

PT	O
-	O
12.7	O
PTT	O
-	O
23.8	O
INR(PT)	O
-	O
1.1	O

CT	O
HEAD	O
W/O	O
CONTRAST	O

Reason	O
:	O
STUCK	O
BY	O
AUTO	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

56	O
year	O
old	O
man	O
s/p	O
struck	O
by	O
auto	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

eval	O
for	O
bleed	B-disease

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
Struck	O
by	O
car	O
.	O

COMPARISONS	O
:	O
None	O
.	O

TECHNIQUE	O
:	O
Axial	O
MDCT	O
images	O
of	O
the	O
brain	O
without	O
IV	O
contrast	O
.	O

FINDINGS	O
:	O
There	O
is	O
a	B-disease
linear	I-disease
nondepressed	I-disease
right	I-disease
temporal	I-disease
calvarial	I-disease
fracture	I-disease
extending	O
into	O
the	O
mastoid	O
process	O
.	O

There	O
is	O
a	B-disease
small	I-disease
subdural	I-disease
hematoma	I-disease
with	O
components	O
of	O
pneumocephalus	B-disease
tracking	O
from	O
the	O
mastoid	O
air	O
cells	O
.	O

There	O
is	O
no	O
shift	B-disease
of	I-disease
normally	I-disease
midline	I-disease
structures	I-disease
.	O

There	O
is	O
also	O
a	B-disease
left	I-disease
occipital	I-disease
scalp	I-disease
contusion	I-disease
but	O
no	O
associated	B-disease
skull	I-disease
fracture	I-disease
.	O

Prominent	O
sutures	O
in	O
this	O
young	O
patient	O
,	O
the	O
right	O
calvarial	O
suture	O
extending	O
into	O
the	O
right	O
temporal	O
bones	O
appears	O
more	O
prominent	O
than	O
its	O
counterpart	O
on	O
the	O
left	O
,	O
however	O
,	O
does	O
not	O
appear	O
to	O
represent	O
an	B-disease
acute	I-disease
fracture	I-disease
.	O

No	O
other	B-disease
acute	I-disease
fractures	I-disease
are	O
appreciated	O
.	O

There	O
is	O
small	O
amount	O
of	O
mucosal	B-disease
thickening	I-disease
in	I-disease
the	I-disease
sphenoid	I-disease
sinuses	I-disease
.	O

No	O
air-fluid	O
levels	O
to	O
suggest	O
occult	B-disease
facial	I-disease
fractures	I-disease
.	O

Orbits	O
are	O
unremarkable	O
.	O

IMPRESSION	O
:	O
Linear	B-disease
right	I-disease
temporal	I-disease
calvarial	I-disease
fracture	I-disease
extending	O
into	O
the	O
mastoid	O
process	O
with	O
small	B-disease
associated	I-disease
right	I-disease
posterior	I-disease
convexity	I-disease
subdural	I-disease
hematoma	I-disease
and	O
pneumocephalus	B-disease
.	O

Discussed	O
with	O
trauma	O
team	O
during	O
the	O
study	O
.	O

CT	O
C-SPINE	O
W/O	O
CONTRAST	O

Reason	O
:	O
STUCK	O
BY	O
AUTO	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

56	O
year	O
old	O
man	O
s/p	O
struck	O
by	O
auto	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

eval	O
for	O
fx	B-disease

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
18-year-old	O
hit	O
by	O
car	O
.	O

Head	B-disease
injury	I-disease
to	I-disease
the	I-disease
occiput	I-disease
.	O

COMPARISONS	O
:	O
None	O
.	O

TECHNIQUE	O
:	O
Axial	O
MDCT	O
images	O
of	O
the	O
cervical	O
spine	O
with	O
coronal	O
and	O
sagittal	O
reformats	O
without	O
IV	O
contrast	O
.	O

FINDINGS	O
:	O
C1	O
through	O
T1	O
are	O
well	O
visualized	O
.	O

There	O
is	O
normal	O
alignment	O
of	O
the	O
cervical	O
vertebral	O
bodies	O
without	O
acute	B-disease
fracture	I-disease
or	O
traumatic	B-disease
malalignment	I-disease
.	O

The	O
posterior	O
elements	O
are	O
intact	O
.	O

There	O
is	O
no	O
significant	B-disease
prevertebral	I-disease
soft	I-disease
tissue	I-disease
swelling	I-disease
.	O

The	O
C1-C2	O
relationship	O
is	O
within	O
normal	O
limits	O
.	O

The	O
dens	O
is	O
intact	O
.	O

The	O
lung	O
apices	O
are	O
clear	O
without	O
pneumothorax	B-disease
.	O

The	O
upper	O
ribs	O
are	O
intact	O
.	O

There	O
is	O
a	B-disease
linear	I-disease
right	I-disease
temporal	I-disease
calvarial	I-disease
fracture	I-disease
extending	O
into	O
the	O
right	O
temporal	O
bones	O
.	O

This	O
appears	O
to	O
stop	O
short	O
of	O
the	O
carotid	O
canal	O
.	O

Multiple	O
posterior	O
right	O
-	O
sided	O
mastoid	O
air	O
cells	O
are	O
opacified	B-disease
with	I-disease
blood	I-disease
.	O

IMPRESSION	O
:	O

1)	O
No	O
acute	B-disease
cervical	I-disease
spine	I-disease
fracture	I-disease
.	O

2)	O
Linear	B-disease
right	I-disease
temporal	I-disease
calvarial	I-disease
fracture	I-disease
extending	O
into	O
the	O
mastoid	O
with	O
a	B-disease
small	I-disease
right	I-disease
posterior	I-disease
convexity	I-disease
subdural	I-disease
hematoma	I-disease
and	O
pneumocephalus	B-disease
;	O
see	O
head	O
CT	O
report	O
.	O

CHEST	O
(	O
PA	O
&	O
LAT	O
)	O

Reason	O
:	O
Please	O
r/o	O
acute	B-disease
process	I-disease
.	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

17	O
year	O
old	O
man	O
with	O
post-op	B-disease
fever	I-disease
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Please	O
r/o	O
acute	B-disease
process	I-disease
.	O

INDICATION	O
:	O
Postoperative	B-disease
fever	I-disease
.	O

COMPARISONS	O
:	O
Comparison	O
is	O
made	O
to	O
2015-10-27	O
.	O

TECHNIQUE	O
:	O
PA	O
and	O
lateral	O
views	O
of	O
the	O
chest	O
.	O

FINDINGS	O
:	O
The	O
heart	O
is	O
of	O
normal	O
size	O
.	O

Mediastinal	O
and	O
hilar	O
contours	O
are	O
within	O
normal	O
limits	O
.	O

The	O
lung	O
fields	O
are	O
clear	O
.	O

There	O
are	O
no	O
pleural	B-disease
effusions	I-disease
or	O
focal	B-disease
consolidations	I-disease
.	O

There	O
is	O
no	O
evidence	O
of	O
CHF	B-disease
.	O

IMPRESSION	O
:	O
No	O
evidence	O
of	O
significant	B-disease
abnormality	I-disease
.	O

TIB	O
/	O
FIB	O
(	O
AP	O
&	O
LAT	O
)	O
SOFT	O
TISSUE	O

Reason	O
:	O
eval	O
for	O
alignment	O
,	O
post	O
op	O
changes	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

56	O
year	O
old	O
man	O
with	O
open	B-disease
RLE	I-disease
fx	I-disease
now	O
s/p	O
fixation	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

eval	O
for	O
alignment	O
,	O
post	O
op	O
changes	O

INDICATION	O
:	O
Fracture	B-disease
.	O
Assess	O
for	O
alignment	O
.	O

RIGHT	O
TIBIA	O
/	O
FIBULA	O
,	O
AP	O
AND	O
LATERAL	O
VIEWS	O
:	O
An	O
intramedullary	O
rod	O
is	O
seen	O
fixating	O
a	B-disease
proximal	I-disease
diaphyseal	I-disease
comminuted	I-disease
tibial	I-disease
fracture	I-disease
with	O
six	O
proximal	O
and	O
two	O
distal	O
screws	O
.	O

Additionally	O
,	O
a	O
side	O
plate	O
is	O
seen	O
medially	O
fixating	O
the	B-disease
fracture	I-disease
.	O

There	O
is	O
a	B-disease
non-displaced	I-disease
comminuted	I-disease
fracture	I-disease
of	I-disease
the	I-disease
proximal	I-disease
fibular	I-disease
diaphysis	I-disease
.	O

There	O
is	O
surrounding	O
soft	B-disease
tissue	I-disease
swelling	I-disease
.	O

Os	O
trigonum	O
is	O
visualized	O
.	O

IMPRESSION	O
:	O
Comminuted	B-disease
proximal	I-disease
tibiofibular	I-disease
fractures	I-disease
status	O
post	O
ORIF	O
of	O
the	O
tibia	O
with	O
an	O
intramedullary	O
rod	O
and	O
side	O
plate	O
.	O

No	O
evidence	O
of	O
immediate	B-disease
hardware	I-disease
complication	I-disease
.	O

CT	O
HEAD	O
W/O	O
CONTRAST	O

Reason	O
:	O
follow	O
up	O
ct	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

17	O
year	O
old	O
man	O
with	O
pneumocephalus	B-disease
s/p	O
CMED	O
CCU	O
v.	O
mvc	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

follow	O
up	O
ct	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

CLINICAL	O
HISTORY	O
:	O
History	O
of	O
pneumocephalus	B-disease
status	O
post	O
pedestrian	O
versus	O
motor	O
vehicle	O
collision	O
.	O

Follow	O
up	O
CT	O
scan	O
.	O

COMPARISON	O
:	O
Non-contrast	O
head	O
CT	O
from	O
2015-10-27	O
.	O

TECHNIQUE	O
:	O
Non-contrast	O
head	O
CT	O
.	O

FINDINGS	O
:	O
The	O
previously	O
noted	O
subdural	B-disease
hemorrhage	I-disease
in	I-disease
the	I-disease
right	I-disease
posterior	I-disease
fossa	I-disease
appears	O
less	O
conspicuous	O
.	O

The	O
pneumocephalus	B-disease
adjacent	O
to	O
the	B-disease
linear	I-disease
skull	I-disease
fracture	I-disease
appears	O
to	O
have	O
decreased	O
in	O
size	O
.	O

There	O
are	O
persistent	B-disease
bifrontal	I-disease
and	I-disease
right	I-disease
parietal	I-disease
hemorrhagic	I-disease
contusions	I-disease
with	O
surrounding	B-disease
edema	I-disease
and	O
possible	O
small	B-disease
left	I-disease
frontal	I-disease
subarachnoid	I-disease
hemorrhage	I-disease
(	O
adjacent	O
to	O
falx	O
)	O
which	O
are	O
largely	O
unchanged	O
.	O

There	O
is	O
no	O
shift	B-disease
of	I-disease
normally	I-disease
midline	I-disease
structures	I-disease
or	O
hydrocephalus	B-disease
.	O

The	O
ventricles	O
,	O
cisterns	O
and	O
sulci	O
are	O
normal	O
.	O

The	O
air-	O
fluid	O
level	O
in	O
the	O
right	O
sphenoid	O
sinus	O
and	O
bilateral	B-disease
opacification	I-disease
of	I-disease
the	I-disease
mastoid	I-disease
air	I-disease
cells	I-disease
are	O
unchanged	O
.	O

IMPRESSION	O
:	O

1.	O
Decreased	O
size	O
of	O
right	B-disease
posterior	I-disease
subdural	I-disease
hemorrhage	I-disease
.	O

2.	O
Multifocal	B-disease
hemorrhagic	I-disease
contusions	I-disease
and	O
surrounding	B-disease
edema	I-disease
are	O
largely	O
unchanged	O
.	O

Brief	O
Hospital	O
Course	O
:	O

He	O
was	O
admitted	O
to	O
the	O
trauma	O
service	O
.	O
Orthopedics	O
and	O
Neurosurgery	O
were	O
consulted	O
because	O
of	O
his	B-disease
injuries	I-disease
.	O

His	B-disease
Neurosurgical	I-disease
issues	I-disease
were	O
nonoperative	O
;	O
he	O
was	O
loaded	O
with	O
Dilantin	O
;	O
serial	O
head	O
CT	O
scans	O
were	O
performed	O
and	O
were	O
stable	O
.	O

He	O
will	O
need	O
to	O
follow	O
up	O
with	O
Dr.	O
Mckinney	O
in	O
4	O
weeks	O
for	O
repeat	O
head	O
imaging	O
and	O
continue	O
with	O
Dilantin	O
for	O
one	O
month	O
.	O

His	B-disease
right	I-disease
tib	I-disease
/	I-disease
fib	I-disease
fracture	I-disease
was	O
repaired	O
by	O
Orthopedics	O
on	O
10-27	O
;	O
postoperatively	O
there	O
were	O
no	O
complications	B-disease
.	O

Weight	O
bearing	O
status	O
was	O
increased	O
to	O
weight	O
bearing	O
as	O
tolerated	O
.	O

He	O
was	O
fitted	O
with	O
a	O
hinged	O
Mcdonald	O
brace	O
for	O
his	B-disease
LLE	I-disease
.	O

He	O
will	O
need	O
to	O
continue	O
on	O
Lovenox	O
injections	O
for	O
at	O
least	O
4-6	O
weeks	O
.	O

He	O
was	O
transfused	O
with	O
3	O
u	O
packed	O
cells	O
for	O
a	O
hematocrit	O
of	O
21	O
,	O
post	O
transfusion	O
HCT	O
was	O
26.1	O
;	O
there	O
was	O
a	O
questionable	O
transfusion	B-disease
reaction	I-disease
at	O
the	O
end	O
of	O
his	O
first	O
unit	O
of	O
packed	O
cells	O
;	O
he	O
did	O
subsequently	O
receive	O
the	O
remaining	O
2	O
units	O
without	O
any	B-disease
further	I-disease
reaction	I-disease
.	O

Physical	O
and	O
Occupational	O
therapy	O
were	O
consulted	O
and	O
have	O
recommended	O
home	O
with	O
services	O
.	O

Medications	O
on	O
Admission	O
:	O

None	O

Allergic	B-disease
to	O
PCN	O
and	O
Sulfa	O

Discharge	O
Medications	O
:	O

1.	O
Phenytoin	O
50	O
mg	O
Tablet	O
,	O
Chewable	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Chewable	O
PO	O
three	O
times	O
a	O
day	O
for	O
1	O
months	O
.	O

Disp	O
:*	O
180	O
Tablet	O
,	O
Chewable	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Oxycodone	O
5	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-disease
.	O

Disp	O
:*	O
75	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

4.	O
Magnesium	O
Hydroxide	O
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
constipation	B-disease
.	O

5.	O
Lovenox	O
40	O
mg	O
/	O
0.4	O
mL	O
Syringe	O
Sig	O
:	O
0.4	O
ML	O
's	O
Subcutaneous	O
once	O
a	O
day	O
for	O
30	O
days	O
.	O

Disp	O
:*	O
30	O
*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

s/p	O
Pedestrian	O
Struck	O
by	O
Auto	O

Subdural	B-disease
hematoma	I-disease

Skull	B-disease
fracture	I-disease

Right	B-disease
comminuted	I-disease
tibia	I-disease
/	I-disease
fibula	I-disease
fracture	I-disease

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

Return	O
to	O
the	O
emergency	O
room	O
if	O
you	O
develop	O
fevers	B-disease
,	O
chills	B-disease
,	O
severe	B-disease
headaches	I-disease
,	O
visual	B-disease
disturbances	I-disease
,	O
nause	B-disease
,	O
vomiting	B-disease
and	O
/	O
or	O
any	B-disease
other	I-disease
symptoms	I-disease
that	O
are	O
concerning	O
to	O
you	O
.	O

You	O
will	O
need	O
to	O
conrtinue	O
with	O
your	O
Lovenox	O
injections	O
for	O
at	O
least	O
4-6	O
weeks	O
as	O
instructed	O
by	O
Orthopedics	O

Followup	O
Instructions	O
:	O

Follow	O
up	O
with	O
Dr.	O
Garza	O
,	O
Orthopaedics	O
in	O
10-14	O
days	O
,	O
call	O
953	O
6923	O
for	O
an	O
appointment	O
.	O

Follow	O
up	O
with	O
Dr.	O
Melendez	O
,	O
Neurosurgery	O
in	O
4	O
weeks	O
;	O
call	O
745	O
8256	O
ext	O
-	O
6468	O
for	O
an	O
appointment	O
.	O

Inform	O
the	O
office	O
that	O
you	O
will	O
need	O
a	O
repeat	O
head	O
CT	O
scan	O
for	O
this	O
appointment	O
.	O

Lori	O
Dorothy	O
MD	O
79-290	O

Completed	O
by	O
:	O
Christopher	O
Sandy	O
NP	O
80-BYL	O
2015-11-03	O
@	O
1526	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Muriel	O
Zech	O
on	O
:	O
WED	O
2015-11-04	O
11:30	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-09-03	O

Discharge	O
Date	O
:	O

2017-10-10	O

Date	O
of	O
Birth	O
:	O

1946-12-27	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	I-disease
Drugs	I-disease

Attending	O
:	O
Donald	O
R	O
Virgil	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	B-disease
of	I-disease
Breath	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Endotracheal	O
Intubation	O

Central	O
Venous	O
Catheter	O
and	O
Swan	O
Ganz	O
catheter	O
placement	O

Arterial	O
Line	O
Placement	O

Right	O
sided	O
thoracentesis	O

History	O
of	O
Present	O
Illness	O
:	O

70	O
y/o	O
male	O
with	O
h/o	O
CAD	B-disease
s/p	O
LAD	O
PTCA	O
33	O
yrs	O
ago	O
,	O
COPD	B-disease
,	O
T2DM	B-disease
,	O
and	O
AICD	B-disease
pocket	I-disease
infection	I-disease
who	O
presented	O
to	O
the	O
Juan	O
on	O
2017-09-03	O
with	O
worsening	B-disease
SOB	I-disease
x	O
5	O
days	O
and	O
feeling	O
"	O
cloudy	O
."	O

The	O
patient	O
was	O
currently	O
at	O
Hubbard	O
Regional	O
Hospital	O
and	O
began	O
to	O
develop	O
worsening	B-disease
SOB	I-disease
for	O
the	O
past	O
5	O
days	O
.	O

This	O
AM	O
while	O
talking	O
with	O
his	O
daughter	O
on	O
the	O
phone	O
,	O
he	O
was	O
noted	O
to	O
desaturate	O
into	O
the	O
high	O
80s	O
and	O
he	O
was	O
brought	O
to	O
the	O
The	O
Hospital	O
for	O
Orthopedics	O
Juan	O
for	O
further	O
evaluation	O
.	O

The	O
patient	O
states	O
that	O
he	O
has	O
felt	O
"	O
cloudy	B-disease
"	O
of	O
late	O
which	O
seems	O
to	O
relate	O
to	O
his	B-disease
worsening	I-disease
SOB	I-disease
.	O

He	O
is	O
not	O
ambulatory	O
and	O
is	O
very	B-disease
deconditioned	I-disease
secondary	O
to	O
several	B-disease
complications	I-disease
within	O
the	O
past	O
two	O
months	O
related	O
to	O
an	B-disease
AICD	I-disease
pocket	I-disease
infection	I-disease
.	O

He	O
denies	O
any	B-disease
CP	I-disease
,	O
N/V/D	B-disease
,	O
abdominal	B-disease
pain	I-disease
,	O
or	O
HA	B-disease
.	O

He	O
states	O
that	O
he	O
only	O
uses	O
one	O
pillow	O
to	O
sleep	O
but	O
admits	O
to	O
sleeping	O
at	O
about	O
30	O
degrees	O
at	O
rehab	O
.	O

In	O
the	O
Juan	O
,	O
his	O
VS	O
were	O
97.8	O
150/80	O
88	O
12	O
89-94%	O
3L	O
NC	O
.	O

He	O
was	O
given	O
Percocet	O
for	O
back	B-disease
pain	I-disease
,	O
Lasix	O
80	O
mg	O
IV	O
,	O
and	O
Combivent	O
neb	O
.	O

For	O
unclear	O
reasons	O
,	O
he	O
was	O
placed	O
on	O
a	O
NRB	O
in	O
the	O
Juan	O
.	O

Upon	O
arrival	O
to	O
the	O
CCU	O
,	O
he	O
was	O
hemodynamically	O
stable	O
.	O

He	O
was	O
quickly	O
weaned	O
to	O
3L	O
O2	O
via	O
NC	O
,	O
O2	O
sats	O
100%	O
.	O

Past	O
Medical	O
History	O
:	O

-	O
AICD	B-disease
Pocket	I-disease
infection	I-disease
c/b	O
MSSA	B-disease
bacteremia	I-disease
,	O
pericardial	B-disease
effusion	I-disease
s/p	O
mediastinal	O
exploration	O
,	O
evacuation	O
of	O
pericardial	B-disease
effusion	I-disease
&	O
hematoma	B-disease
(	O
2017-07-24	O
)	O

-	O
Ischemic	B-disease
colitis	I-disease
and	O
ischemic	B-disease
liver	I-disease
2017-06-22	O
(	O
post	O
air	B-disease
embolism	I-disease
from	O
post	O
mediastinal	O
exploration	O
)	O

-	O
CAD	B-disease
s/p	O
LAD	O
PTCA	O
33	O
years	O
ago	O

-	O
T2DM	B-disease
c/b	O
neuropathy	B-disease
and	O
nephropathy	B-disease

-	O
COPD	B-disease

-	O
Hypothyroidism	B-disease

-	O
CVA	B-disease

-	O
s/p	O
Bovine	O
AVR	O
1999	O

-	O
Hyperlipidemia	B-disease

-	O
GERD	B-disease

-	O
Chronic	B-disease
LBP	I-disease

-	O
Lumbar	B-disease
sympathectomy	I-disease

Social	O
History	O
:	O

The	O
patient	O
is	O
a	O
retired	O
truck	O
driver	O
.	O

He	O
is	O
currently	O
married	O
,	O
has	O
10	O
children	O
.	O

No	O
smoking	O
for	O
last	O
5	O
years	O
.	O

Prior	O
to	O
that	O
smoked	O
2	O
packs	O
a	O
day	O
.	O

No	O
EtOH	O
or	O
IVDU	O
.	O

Family	O
History	O
:	O

Sister	O
with	O
diabetes	B-disease
.	O

No	O
other	O
known	O
family	O
hx	O
.	O

Physical	O
Exam	O
:	O

Vitals	O
:	O

97.6	O
95/48	O
71	O
98%	O
4L	O
NC	O

General	O
:	O

Oriented	O
to	O
person	O
and	O
time	O
.	O

Slight	B-disease
confustion	I-disease
with	O
place	O
but	O
oriented	O
with	O
some	O
re-direction	O
.	O

HEENT	O
:	O

NC/AT	O
.	O

MM	O
dry	O
.	O

OP	O
clear	O
.	O

PERRLA	O
.	O

EOMI	O
.	O

Neck	O
:	O

JVD	B-disease
difficult	O
to	O
access	O
02-23	O
increased	B-disease
neck	I-disease
girth	I-disease
.	O

CV	O
:	O

S1	O
,	O
S2	O
with	O
Grade	B-disease
II/VI	I-disease
SEM	I-disease
.	O
+S3	B-disease
.	O

Pulm	O
:	O

Crackles	B-disease
halfway	I-disease
up	I-disease
lung	I-disease
fields	I-disease
B/L	I-disease
.	O

Abd	O
:	O

Soft	O
,	O
NT/ND	B-disease
with	O
normoactive	O
BS	O
.	O

Ext	O
:	O

2+	O
pitting	B-disease
edema	I-disease
to	I-disease
knees	I-disease
B/L	I-disease
.	O

Pertinent	O
Results	O
:	O

Admission	O
Labs	O
:	O

2017-09-03	O
PT	O
-	O
13.8	O
*	O
PTT	O
-	O
33.1	O
INR	O
(	O
PT	O
)-	O
1.2	O
*	O

2017-09-03	O
PLT	O
COUNT	O
-	O
124	O
*	O

2017-09-03	O
HYPOCHROM	O
-	O
2+	O
ANISOCYT	O
-	O
1+	O
MACROCYT	O
-	O
2+	O

2017-09-03	O
NEUTS	O
-	O
79.5	O
*	O
LYMPHS	O
-	O
9.9	O
*	O
MONOS	O
-	O
4.9	O
EOS	O
-	O
5.4	O
*	O
BASOS	O
-	O
0.2	O

2017-09-03	O
WBC	O
-	O
9.1	O
RBC	O
-	O
2.77	O
*	O
HGB	O
-	O
8.8	O
*	O
HCT	O
-	O
27.2	O
*	O
MCV	O
-	O
99	O
*	O
MCH	O
-	O
31.9	O
MCHC	O
-	O
32.4	O
RDW	O
-	O
18.0	O
*	O

2017-09-03	O
CK	O
-	O
MB	O
-	O
Not	O
Done	O
proBNP	O
-	O
2656	O
*	O

2017-09-03	O
CK	O
(	O
CPK	O
)-	O
16	O
*	O

2017-09-03	O
GLUCOSE	O
-	O
206	O
*	O
UREA	O
N	O
-	O
28	O
*	O
CREAT	O
-	O
1.8	O
*	O
SODIUM	O
-	O
135	O
POTASSIUM	O
-	O
4.1	O
CHLORIDE	O
-	O
85	O
*	O
TOTAL	O
CO2	O
-	O
42	O
*	O
ANION	O
GAP	O
-	O
12	O

2017-09-03	O
CK	O
-	O
MB	O
-	O
Not	O
Done	O
cTropnT	O
-	O
0.22	O
*	O

2017-09-03	O
CK	O
(	O
CPK	O
)-	O
38	O

Discharge	O
Labs	O
:	O

2017-10-10	O
:	O

INR	O
3.5	O
,	O
PT	O
32.5	O
,	O
PTT	O
41	O

Imaging	O
Studies	O
:	O

1.	O
CXR	O
(	O
PA/Lateral	O
)	O
2017-09-03	O

Congestive	B-disease
heart	I-disease
failure	I-disease
with	O
bilateral	B-disease
effusions	I-disease
(	O
R	O
>	O
L	O
)	O
,	O
with	O
possible	O
underlying	B-disease
consolidation	I-disease
in	I-disease
the	I-disease
RLL	I-disease
and	O
to	O
a	O
lesser	O
degree	O
the	O
RML	O
and	O
LLL	O
.	O

2.	O
CXR	O
2017-09-04	O

Compared	O
to	O
PA	O
and	O
lateral	O
chest	O
of	O
the	O
prior	O
day	O
.	O

Right-sided	O
PICC	O
line	O
with	O
its	O
tip	O
in	O
the	O
distal	O
SVC	O
.	O

The	O
heart	O
is	O
markedly	B-disease
enlarged	I-disease
.	O

There	O
remains	O
a	B-disease
large	I-disease
right	I-disease
and	I-disease
small	I-disease
left	I-disease
pleural	I-disease
effusion	I-disease
,	O
not	O
significantly	O
changed	O
.	O

Patient	O
remains	O
in	O
congestive	B-disease
heart	I-disease
failure	I-disease
,	O
though	O
it	O
may	O
be	O
slightly	O
improved	O
compared	O
to	O
the	O
prior	O
study	O
.	O

Underlying	B-disease
infectious	I-disease
consolidation	I-disease
in	I-disease
the	I-disease
right	I-disease
lower	I-disease
lobe	I-disease
not	O
excluded	O
.	O

3.	O
Echo	O
2017-09-04	O

The	O
left	O
atrium	O
is	O
mildly	B-disease
dilated	I-disease
.	O

There	O
is	O
mild	B-disease
symmetric	I-disease
left	I-disease
ventricular	I-disease
hypertrophy	I-disease
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

LV	O
systolic	O
function	O
appears	O
depressed	B-disease
.	O

Resting	B-disease
regional	I-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
include	O
inferior	B-disease
and	I-disease
inferolateral	I-disease
hypokinesis	I-disease
.	O

Right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
and	O
free	O
wall	O
motion	O
may	O
be	O
mildly	B-disease
impaired	I-disease
.	O

The	O
aortic	O
root	O
is	O
mildly	B-disease
dilated	I-disease
.	O

The	O
ascending	O
aorta	O
is	O
mildly	B-disease
dilated	I-disease
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

A	O
bioprosthetic	O
aortic	O
valve	O
prosthesis	O
is	O
present	O
.	O

The	O
aortic	O
prosthesis	O
leaflets	O
appear	O
to	O
move	O
normally	O
.	O

The	O
transaortic	O
gradient	O
is	O
normal	O
for	O
this	O
prosthesis	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

The	O
left	O
ventricular	O
inflow	O
pattern	O
suggests	O
a	B-disease
restrictive	I-disease
filling	I-disease
abnormality	I-disease
,	O
with	O
elevated	B-disease
left	I-disease
atrial	I-disease
pressure	I-disease
.	O

Transmitral	O
Doppler	O
and	O
tissue	O
velocity	O
imaging	O
are	O
consistent	O
with	O
Grade	B-disease
III/IV	I-disease
(	I-disease
severe	I-disease
)	I-disease
left	I-disease
ventricular	I-disease
diastolic	I-disease
dysfunction	I-disease
.	O

The	O
tricuspid	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

There	O
is	O
mild	B-disease
pulmonary	I-disease
artery	I-disease
systolic	I-disease
hypertension	I-disease
.	O

There	O
is	O
no	O
pericardial	B-disease
effusion	I-disease
.	O

Compared	O
with	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
2017-08-14	O
,	O
ventricular	O
function	O
is	O
now	O
similar.	O

EF	O
35-40%	O
.	O

4.	O
Echo	O
2017-09-14	O

The	O
left	O
atrium	O
is	O
mildly	B-disease
dilated	I-disease
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

Overall	O
left	O
ventricular	O
systolic	O
function	O
cannot	O
be	O
reliably	O
assessed	O
.	O

3l	O
.	O

The	O
aortic	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

There	O
is	O
no	O
pericardial	B-disease
effusion	I-disease
.	O

Compared	O
with	O
the	O
prior	O
study	O
(	O
images	O
reviewed	O
)	O
of	O
2017-09-04	O
,	O
there	O
is	O
probably	O
no	O
significant	O
change	O
.	O

All	O
cultures	O
,	O
including	O
BCx	O
,	O
UCx	O
,	O
pleural	O
fluid	O
culture	O
,	O
and	O
wound	O
culture	O
have	O
been	O
negative	O
.	O

5.	O
CT	O
Chest	O
2017-09-16	O
:	O

1.	O
Increasing	B-disease
large	I-disease
right-sided	I-disease
pleural	I-disease
effusion	I-disease
and	O
pulmonary	B-disease
edema	I-disease
.	O

Scattered	B-disease
parenchymal	I-disease
opacities	I-disease
in	I-disease
the	I-disease
left	I-disease
lower	I-disease
lobe	I-disease
represent	O
superimposed	B-disease
infection	I-disease
vs	O
atelectasis	B-disease
.	O

There	O
is	O
no	O
evidence	O
of	O
abscess	B-disease
.	O

6.	O
2017-09-28	O
Chest	O
X	O
Ray	O
:	O

SINGLE	O
AP	O
VIEW	O
OF	O
THE	O
CHEST	O
.	O

There	O
has	O
been	O
almost	O
complete	O
resolution	O
of	O
pulmonary	B-disease
edema	I-disease
.	O

A	B-disease
small	I-disease
right	I-disease
pleural	I-disease
effusion	I-disease
has	O
decreased	O
in	O
size	O
.	O

Mild	B-disease
cardiomegaly	I-disease
is	O
stable	O
.	O

There	O
is	O
no	O
pneumothorax	B-disease
.	O

Right	O
PIC	O
catheter	O
tip	O
ends	O
in	O
the	O
lower	O
SVC	O
.	O

Patient	O
is	O
post	O
median	O
sternotomy	O
.	O

IMPRESSION	O
:	O

Almost	O
complete	O
resolution	O
of	O
pulmonary	B-disease
edema	I-disease
.	O

7.	O
2017-09-29	O
CT	O
Head	O
:	O

FINDINGS	O
:	O

There	O
is	O
no	O
evidence	O
of	O
intraaxial	B-disease
or	I-disease
extraaxial	I-disease
hemorrhage	I-disease
,	O
mass	B-disease
effect	I-disease
,	O
shift	B-disease
of	I-disease
normally	I-disease
midline	I-disease
structures	I-disease
,	O
or	O
acute	B-disease
major	I-disease
or	I-disease
minor	I-disease
vascular	I-disease
territorial	I-disease
infarction	I-disease
.	O

The	O
ventricles	O
and	O
sulci	O
are	O
mildly	B-disease
prominent	I-disease
,	O
but	O
stable	O
in	O
size	O
and	O
appearance	O
.	O

The	O
gray-white	O
matter	O
differentiation	O
is	O
preserved	O
.	O

Again	O
seen	O
are	O
subtle	B-disease
hypodensities	I-disease
within	I-disease
the	I-disease
periventricular	I-disease
white	I-disease
matter	I-disease
which	O
is	O
an	O
indication	O
of	O
chronic	B-disease
microvascular	I-disease
ischemic	I-disease
changes	I-disease
,	O
stable	O
.	O

Extensive	B-disease
carotid	I-disease
artery	I-disease
calcifications	I-disease
are	O
identified	O
.	O

The	O
visualized	O
paranasal	O
sinuses	O
are	O
clear	O
.	O

The	O
surrounding	O
osseous	O
and	O
soft	O
tissue	O
structures	O
are	O
unremarkable	O
.	O

IMPRESSION	O
:	O

No	O
evidence	O
of	O
acute	B-disease
or	I-disease
chronic	I-disease
infarction	I-disease
.	O

Stable	B-disease
microvascular	I-disease
ischemic	I-disease
changes	I-disease
in	I-disease
the	I-disease
periventricular	I-disease
white	I-disease
matter	I-disease
.	O

8.	O
2017-09-30	O
EEG	O
:	O

IMPRESSION	O
:	O

Abnormal	B-disease
EEG	I-disease
due	O
to	O
the	B-disease
moderately	I-disease
slow	I-disease
posterior	I-disease
background	I-disease
and	O
occasional	O
bursts	O
of	O
generalized	B-disease
slowing	I-disease
.	O

These	O
findings	O
indicate	O
a	B-disease
widespread	I-disease
encephalopathic	I-disease
condition	I-disease
affecting	O
both	O
cortical	O
and	O
subcortical	O
structures	O
.	O

Medications	O
,	O
metabolic	B-disease
disturbances	I-disease
,	O
and	O
infection	B-disease
are	O
among	O
the	O
most	O
common	O
causes	O
.	O

No	O
prominent	B-disease
focal	I-disease
abnormalities	I-disease
were	O
evident	O
,	O
and	O
there	O
were	O
no	O
epileptiform	B-disease
features	I-disease
.	O

The	O
cardiac	O
monitor	O
showed	O
occasional	B-disease
irregularities	I-disease
in	O
a	O
PACED	O
rhythm	O
.	O

Brief	O
Hospital	O
Course	O
:	O

A/P	O
:	O

70	O
y/o	O
male	O
with	O
h/o	O
CAD	B-disease
,	O
T2DM	B-disease
,	O
hyperlipidemia	B-disease
,	O
and	O
COPD	B-disease
who	O
presented	O
to	O
the	O
Juan	O
on	O
2017-09-03	O
with	O
worsening	B-disease
SOB	I-disease
x	O
5	O
days	O
from	O
Morton	O
Hospital	O
&	O
Medical	O
Center	O
.	O

Pt.	O
was	O
initially	O
admitted	O
to	O
CCU	O
on	O
2017-09-03	O
,	O
transferred	O
to	O
Pendleton	O
on	O
2017-09-05	O
,	O
triggered	O
on	O
2017-09-10	O
for	O
hypotension	B-disease
with	O
BP	O
67/38	O
and	O
transferred	O
back	O
to	O
CCU	O
on	O
2017-09-10	O
.	O

He	O
remained	O
fluid	B-disease
overloaded	I-disease
and	O
a	O
swan	O
catheter	O
was	O
placed	O
.	O

The	O
following	O
issues	O
were	O
addressed	O
during	O
this	O
hospital	O
admission	O
:	O

1#	O
Cardiac	O
:	O

Pump	O

The	O
patient	O
was	O
initially	O
admitted	O
for	O
likely	O
CHF	B-disease
exacerbation	I-disease
.	O

He	O
was	O
started	O
on	O
a	O
lasix	O
gtt	O
the	O
night	O
of	O
admission	O
with	O
a	O
good	O
response	O
.	O

He	O
continued	O
to	O
diurese	O
and	O
he	O
was	O
moved	O
to	O
the	O
floor	O
since	O
he	O
no	O
longer	O
required	O
intensive	O
level	O
care	O
.	O

While	O
on	O
the	O
floor	O
,	O
he	O
continued	O
to	O
be	O
diuresed	O
.	O

After	O
several	O
days	O
,	O
he	O
became	O
hypotensive	B-disease
and	O
triggered	O
for	O
BPs	O
60s/30s	O
.	O

He	O
was	O
given	O
IVF	O
without	O
an	O
adequate	O
response	O
in	O
his	O
pressures	O
.	O

He	O
was	O
transferred	O
back	O
to	O
the	O
CCU	O
and	O
started	O
on	O
a	O
dopamine	O
gtt	O
.	O

He	O
diuresed	O
well	O
on	O
the	O
dopamine	O
gtt	O
and	O
his	O
BP	O
was	O
supported	O
.	O

Gradually	O
,	O
the	O
dopamine	O
gtt	O
was	O
weaned	O
.	O

However	O
,	O
he	O
still	O
appeared	O
volume	B-disease
overloaded	I-disease
with	O
minimal	O
improvement	O
in	O
his	B-disease
oxygen	I-disease
requirement	I-disease
.	O

A	O
swan	O
was	O
placed	O
for	O
a	O
more	O
accurate	O
picture	O
of	O
his	O
volume	O
status	O
and	O
he	O
was	O
volume	B-disease
overloaded	I-disease
by	O
swan	O
numbers	O
with	O
an	B-disease
elevated	I-disease
PAD	I-disease
and	O
elevated	B-disease
CVP	I-disease
without	O
an	O
obtainable	O
wedge	O
pressure	O
.	O

He	O
also	O
had	O
a	B-disease
high	I-disease
CO	I-disease
and	O
low	B-disease
SVR	I-disease
suggestive	O
of	O
sepsis	B-disease
,	O
but	O
he	O
never	O
had	O
an	B-disease
elevated	I-disease
WBC	I-disease
and	O
was	O
afebrile	B-disease
during	O
his	O
entire	O
hospital	O
admission	O
with	O
negative	O
blood	O
,	O
urine	O
,	O
wound	O
,	O
and	O
pleural	O
fluid	O
cultures	O
.	O

The	O
Lasix	O
drip	O
was	O
eventually	O
changed	O
to	O
IV	O
Lasix	O
boluses	O
,	O
with	O
a	O
net	O
diuresis	O
of	O
over	O
36	O
liters	O
for	O
the	O
hospital	O
stay	O
.	O

He	O
was	O
then	O
transitioned	O
to	O
oral	O
Lasix	O
for	O
maintainence	O
.	O

The	O
patient	O
had	O
an	O
echo	O
on	O
2017-09-04	O
with	O
the	O
results	O
above	O
in	O
detail	O
.	O

It	O
was	O
unchanged	O
in	O
comparison	O
to	O
2017-08-14	O
with	O
similar	O
ventricular	O
function	O
and	O
inferior	B-disease
and	I-disease
inferolateral	I-disease
hypokinesis	I-disease
.	O

The	O
patient	O
had	O
another	O
echo	O
on	O
2017-09-14	O
with	O
no	O
new	O
changes	O
.	O

At	O
discharge	O
the	O
patient	O
was	O
thought	O
to	O
be	O
euvolemic	O
,	O
satting	O
well	O
on	O
room	O
air	O
and	O
without	O
peripheral	B-disease
edema	I-disease
.	O

His	O
dry	O
weight	O
is	O
70.4	O
kg	O
.	O

Ischemia	B-disease

The	O
patient	O
had	O
an	B-disease
initial	I-disease
troponin	I-disease
bump	I-disease
on	O
admission	O
which	O
was	O
most	O
likely	O
secondary	O
to	O
CHF	B-disease
exacerbation	I-disease
.	O

He	O
was	O
continued	O
on	O
Aspirin	O
,	O
Metoprolol	O
and	O
Lipitor	O
with	O
no	O
further	B-disease
issues	I-disease
.	O

Rhythm	O

The	O
patient	O
is	O
completely	B-disease
pacer-dependent	I-disease
,	O
being	O
epicardially	O
paced	O
at	O
70	O
.	O

He	O
is	O
on	O
Amiodarone	O
for	O
post-op	B-disease
afib	I-disease
and	O
this	O
was	O
continued	O
this	O
entire	O
admission	O
.	O

His	O
underlying	O
rhythm	O
is	O
atrial	B-disease
flutter	I-disease
;	O
it	O
was	O
unclear	O
whether	O
he	O
had	O
previously	O
been	O
cardioverted	O
.	O

Anti-coagulation	O
was	O
started	O
with	O
Warfarin	O
5	O
mg	O
with	O
a	O
goal	O
of	O
2-3	O
and	O
a	O
plan	O
for	O
cardioversion	O
in	O
6	O
weeks	O
.	O

The	O
patient	O
's	O
INR	O
became	O
supratherapeutic	B-disease
and	O
Coumadin	O
was	O
held	O
.	O

His	O
coumadin	O
was	O
transitioned	O
to	O
2	O
mg	O
and	O
then	O
1	O
mg	O
.	O

His	O
INR	O
continued	O
to	O
flucuate	O
.	O

He	O
was	O
discharged	O
on	O
1	O
mg	O
,	O
but	O
a	O
stable	O
regimen	O
had	O
not	O
been	O
achieved	O
.	O

His	O
INR	O
will	O
have	O
to	O
be	O
monitored	O
closely	O
unitl	O
his	O
levels	O
are	O
stable	O
.	O

His	O
INR	O
goal	O
is	O
02-24	O
.	O

2#	O
SOB	B-disease
on	O
admission	O
:	O

Likely	O
due	O
to	O
CHF	B-disease
exacerbation	I-disease
,	O
with	O
diuresis	O
of	O
over	O
36	O
L	O
during	O
his	O
admission	O
.	O

He	O
had	O
4	O
surgeries	O
(	O
3	O
cardiac	O
surgeries	O
)	O
earlier	O
in	O
the	O
summer	O
,	O
so	O
it	O
is	O
likely	O
that	O
he	O
required	O
copious	O
IVF	O
hydration	O
surrounding	O
these	O
procedures	O
which	O
may	O
have	O
been	O
the	O
cause	O
of	O
his	B-disease
massive	I-disease
fluid	I-disease
overload	I-disease
.	O

It	O
appears	O
that	O
his	O
diet	O
was	O
regulated	O
at	O
rehab	O
but	O
there	O
is	O
concern	O
for	O
medication	B-disease
non-compliance	I-disease
at	O
rehab	O
,	O
per	O
previous	O
discharge	O
summaries	O
.	O

On	O
discharge	O
,	O
the	O
patient	O
was	O
maintained	O
on	O
standing	O
diuretics	O
as	O
well	O
as	O
PRN	O
nebs	O
and	O
INH	O
COPD	O
meds	O
.	O

3#	O
Metabolic	B-disease
Alkalosis	I-disease
/	O
Hypochloremia	B-disease
:	O

Etiology	O
most	O
likely	O
a	O
combination	O
of	O
contraction	B-disease
alkalosis	I-disease
and	O
/	O
or	O
post-hypercapnia	B-disease
.	O

This	O
acutely	O
worsened	O
on	O
2017-09-18	O
,	O
when	O
the	O
patient	O
was	O
found	O
to	O
have	O
mental	B-disease
status	I-disease
changes	I-disease
and	O
an	O
ABG	O
revealed	O
a	O
CO2	O
of	O
over	O
100	O
,	O
likley	O
due	O
to	O
a	B-disease
depressed	I-disease
respiratory	I-disease
drive	I-disease
secondary	O
to	O
sedatives	O
given	O
for	O
agitation	B-disease
on	O
top	O
of	O
a	B-disease
preexisting	I-disease
alkalosis	I-disease
.	O

The	O
patient	O
was	O
therefore	O
intubated	O
for	O
ventilation	O
,	O
and	O
continued	O
to	O
be	O
diuresed	O
.	O

His	O
CO2	O
improved	O
and	O
he	O
was	O
extubated	O
after	O
a	O
few	O
days	O
.	O

All	O
sedating	O
medications	O
were	O
held	O
and	O
serial	O
ABGs	O
were	O
trended	O
to	O
follow	O
the	O
resolution	O
of	O
the	B-disease
metabolic	I-disease
alkalosis	I-disease
.	O

4#	O
Pleural	B-disease
effusions	I-disease
:	O
s/p	O
right	O
thoracentesis	O
on	O
2017-09-06	O
,	O
1600	O
mL	O
of	O
serosanguinous	B-disease
fluid	I-disease
removed	O
from	O
right	O
pleural	O
space	O
.	O

Gram	O
stain	O
and	O
cultures	O
were	O
negative	O
,	O
cytology	O
was	O
negative	O
.	O

The	B-disease
right	I-disease
pleural	I-disease
effusion	I-disease
slowly	O
re-accumulated	O
after	O
tap	O
but	O
resolved	O
after	O
continued	O
diuresis	O
.	O

Repeat	O
CXR	O
showed	O
improvement	O
of	O
the	B-disease
effusion	I-disease
and	O
on	O
discharge	O
he	O
had	O
been	O
breathing	O
well	O
on	O
room	O
air	O
without	O
complications	B-disease

5#	O
T2DM	B-disease
:	O

The	O
patient	O
was	O
started	O
on	O
Glargine	O
for	O
tighter	O
glycemic	O
control	O
and	O
was	O
covered	O
with	O
an	O
insulin	O
sliding	O
scale	O
.	O

He	O
was	O
monitored	O
with	O
QID	O
fingersticks	O
.	O

His	O
blood	O
sugars	O
were	O
in	O
the	O
100s	O
on	O
discharge	O
.	O

6#	O
Hyperlipidemia	B-disease
:	O

The	O
patient	O
was	O
continued	O
on	O
his	O
statin	O
.	O

7#	O
COPD	B-disease
:	O

The	O
patient	O
was	O
continued	O
on	O
nebs	O

8#	O
MS	B-disease
changes	I-disease
:	O

The	O
patient	O
has	O
a	O
history	O
of	O
baseline	B-disease
dementia	I-disease
which	O
was	O
confounded	O
by	O
delerium	B-disease
in	O
the	O
face	O
of	O
metabolic	B-disease
abnormalities	I-disease
.	O

His	O
mental	O
status	O
improved	O
as	O
his	O
metabolic	O
process	O
was	O
resolved	O
as	O
detailed	O
above	O
.	O

Neurology	O
was	O
also	O
consulted	O
and	O
a	O
head	O
CT	O
showed	O
old	B-disease
lacunar	I-disease
infarcts	I-disease
but	O
no	O
acute	O
causes	O
for	O
a	B-disease
change	I-disease
in	I-disease
mental	I-disease
status	I-disease
.	O

An	O
EEG	O
showed	O
mild	B-disease
encephalopathy	I-disease
,	O
but	O
no	O
other	O
findings	O
.	O

His	O
mental	O
status	O
did	O
clear	O
somewhat	O
with	O
the	O
addition	O
of	O
standing	O
lactulose	O
;	O
he	O
was	O
discharged	O
on	O
this	O
medication	O
.	O

9#	O
Hypothyroidism	B-disease
:	O

The	O
patient	O
was	O
continued	O
on	O
his	O
outpatient	O
dose	O
of	O
Levothyroxine	O
.	O

10#	O
?	O
UTI	B-disease
:	O

The	O
patient	O
was	O
started	O
on	O
levofloxacin	O
at	O
Newton-Wellesley	O
Hospital	O
for	O
a	O
question	O
of	O
UTI	B-disease
based	O
on	O
U/A	O
positive	O
for	O
WBC	O
.	O

UCx	O
during	O
this	O
hospitalization	O
were	O
negative	O
and	O
Levofloxacin	O
was	O
d/c	O
'd	O
.	O

11#	O
Chronic	B-disease
lower	I-disease
back	I-disease
pain	I-disease
:	O

The	O
patient	O
was	O
treated	O
with	O
a	O
Lidocaine	O
patch	O
and	O
Percocet	O
prn	O
.	O

Stronger	O
narcotics	O
were	O
avoided	O
given	O
somnolence	B-disease
and	O
MS	B-disease
changes	I-disease
.	O

12#	O
Wound	O
Care	O
:	O

The	O
patient	O
has	O
left	B-disease
chest	I-disease
wound	I-disease
and	O
left	B-disease
gluteal	I-disease
pressure	I-disease
ulcer	I-disease
.	O

Wound	O
care	O
was	O
consulted	O
on	O
2017-09-05	O
and	O
they	O
made	O
several	O
recommendations	O
.	O

For	O
the	B-disease
left	I-disease
gluteal	I-disease
pressure	I-disease
ulcer	I-disease
,	O
they	O
recommended	O
gentle	O
cleansing	O
with	O
normal	O
saline	O
or	O
commercial	O
wound	O
cleaner	O
,	O
thin	O
layer	O
of	O
Duoderm	O
gel	O
,	O
air	O
dry	O
,	O
allevyn	O
foam	O
adhesive	O
over	O
the	O
site	O
,	O
and	O
change	O
every	O
2	O
days	O
or	O
prn	O
.	O

For	O
the	B-disease
left	I-disease
chest	I-disease
wound	I-disease
,	O
they	O
recommended	O
cleansing	O
with	O
commercial	O
wound	O
cleanser	O
,	O
pat	O
dry	O
,	O
pack	O
aquacel	O
AG	O
rope	O
and	O
moisten	O
with	O
saline	O
,	O
cover	O
with	O
dry	O
gauze	O
and	O
change	O
daily	O
.	O

These	O
recommendations	O
were	O
followed	O
throughout	O
the	O
admission	O
.	O

13#	O
Voiding	O
:	O

Pt.	O
failed	O
multiple	O
attempts	O
to	O
void	O
on	O
his	O
own	O
.	O

Case	O
was	O
discussed	O
with	O
neurology	O
.	O

He	O
was	O
started	O
on	O
finsateride	O
on	O
the	O
day	O
prior	O
to	O
admission	O
.	O

He	O
is	O
scheduled	O
to	O
follow	O
up	O
with	O
urology	O
to	O
address	O
this	O
issue	O
.	O

Until	O
then	O
,	O
his	O
foley	O
should	O
remain	O
in	O
place	O
.	O

14#	O
Code	O
:	O

The	O
patient	O
was	O
full	O
code	O
during	O
admission	O
.	O

Medications	O
on	O
Admission	O
:	O

Levothyroxine	O
100	O
mcg	O
PO	O
daily	O

Duloxetine	O
20	O
mg	O
PO	O
QHS	O

Ondansetron	O
PRN	O

Percocet	O
1	O
tab	O
PRN	O

Senna	O
PRN	O

Colace	O
PRN	O

Lasix	O
80	O
mg	O
PO	O
BID	O

Lactulose	O
PRN	O

Lidocaine	O
patch	O

Nystatin	O
powder	O

Gabapentin	O
300	O
mg	O
PO	O
TID	O

Alb	O
nebs	O

Fluticasone	O
/	O
Salmeterol	O

Tiotropium	O
Bromide	O

Spironolactone	O
25	O
mg	O
PO	O
daily	O

Epoetin	O
4000	O
units	O
MWF	O

RISS	O

Amiodarone	O
200	O
mg	O
PO	O
daily	O

Calcium	O
Acetate	O
667	O
mg	O
PO	O
TID	O

SubQ	O
Heparin	O

Pantoprazole	O
40	O
mg	O
PO	O
daily	O

Simvastatin	O
40	O
mg	O
PO	O
QHS	O

ASA	O
81	O
mg	O
PO	O
daily	O

MVI	O

Tylenol	O
PRN	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
Constipation	B-disease
.	O

Disp	O
:*	O
90	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Levothyroxine	O
100	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Duloxetine	O
20	O
mg	O
Capsule	O
,	O
Delayed	O
Release(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
QHS	O
(	O
once	O
a	O
day	O
(	O
at	O
bedtime	O
)	O
)	O
.	O

4.	O
Lactulose	O
10	O
g	O
/	O
15	O
mL	O
Syrup	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

5.	O
Fluticasone	O
-	O
Salmeterol	O
100-50	O
mcg	O
/	O
Dose	O
Disk	O
with	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Disk	O
with	O
Device	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
qs	O
Disk	O
with	O
Device	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

6.	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule	O
,	O
w/	O
Inhalation	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
Inhalation	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

7.	O
Amiodarone	O
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Calcium	O
Acetate	O
667	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
TID	O
W/MEALS	O
(	O
3	O
TIMES	O
A	O
DAY	O
WITH	O
MEALS	O
)	O
.	O

Disp	O
:*	O
90	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Oxycodone	O
-	O
Acetaminophen	O
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4-6H	O
(	O
every	O
4	O
to	O
6	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-disease
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Multivitamin	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
tablets	O
*	O
Refills	O
:*	O
2	O
*	O

11.	O
Miconazole	O
Nitrate	O
2	O
%	O
Powder	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Appl	O
Topical	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

12.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

13.	O
Simvastatin	O
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
QHS	O
(	O
once	O
a	O
day	O
(	O
at	O
bedtime	O
)	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

14.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

15.	O
Lidocaine	O
5	O
%(	O
700	O
mg	O
/	O
patch	O
)	O
Adhesive	O
Patch	O
,	O
Medicated	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Adhesive	O
Patch	O
,	O
Medicated	O
Topical	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
qs	O
Adhesive	O
Patch	O
,	O
Medicated	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

16.	O
Furosemide	O
40	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

17.	O
Ferrous	O
Sulfate	O
325	O
(	O
65	O
)	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

18.	O
Epoetin	O
Alfa	O
4,000	O
unit/mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
QMOWEFR	O
(	O
Monday	O
-	O
Wednesday	O
-	O
Friday	O
)	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

19.	O
Spironolactone	O
25	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

20.	O
Albuterol	O
90	O
mcg/Actuation	O
Aerosol	O
Sig	O
:	O
4-6	O
Puffs	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
.	O

Disp	O
:*	O
qs	O
*	O
Refills	O
:*	O
2	O
*	O

21.	O
Metoprolol	O
Succinate	O
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24HR	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

22.	O
Finasteride	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

23.	O
Gabapentin	O
300	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

Disp	O
:*	O
60	O
Capsule	O
(	O
s	O
)*	O
Refills	O
:*	O
2	O
*	O

24.	O
Warfarin	O
1	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
at	O
bedtime	O
:	O
Please	O
monitor	O
INR	O
with	O
goal	O
02-24	O
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Discharge	O
Diagnosis	O
:	O

Primary	O
:	O

Congestive	B-disease
Heart	I-disease
Failure	I-disease
exacerbation	I-disease

Secondary	O
:	O

Coronary	B-disease
Artery	I-disease
Disease	I-disease

Hypertension	B-disease

Type	B-disease
2	I-disease
Diabetes	I-disease
Mellitus	I-disease

Chronic	B-disease
Obstructive	I-disease
Pulmonary	I-disease
Disease	I-disease

Discharge	O
Condition	O
:	O

The	O
patient	O
was	O
discharged	O
hemodynamicallly	O
stable	O
,	O
afebrile	B-disease
with	O
appropriate	O
follow	O
up	O
.	O

Discharge	O
Instructions	O
:	O

During	O
this	O
admission	O
you	O
have	O
been	O
treated	O
for	O
a	B-disease
CHF	I-disease
exacerbation	I-disease
.	O

Weigh	O
yourself	O
every	O
morning	O
,	O
call	O
MD	O
if	O
weight	O
increases	O
by	O
>	O
3	O
lbs	O
in	O
2	O
days	O
.	O

Adhere	O
to	O
2	O
gm	O
sodium	O
diet	O

Fluid	O
Restriction	O
:	O

1500	O
mL	O

1.	O
Please	O
take	O
all	O
medications	O
as	O
prescribed	O
.	O

2.	O
Please	O
keep	O
all	O
follow	O
up	O
appointments	O
.	O

3.	O
Please	O
call	O
your	O
PCP	O
C.	O
Lettinga	O
or	O
seek	O
medical	O
attention	O
in	O
the	O
Juan	O
if	O
you	O
experience	O
worsening	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
,	O
chest	B-disease
pain	I-disease
,	O
dizziness	B-disease
,	O
passing	B-disease
out	I-disease
,	O
or	O
any	B-disease
other	I-disease
concerning	I-disease
symptom	I-disease
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
C.	O
Lettinga	O
(	O
572	O
8343	O
)	O
on	O
10-10	O
at	O
1:00	O
PM	O

Please	O
follow	O
up	O
with	O
Dr.	O
Parker	O
in	O
cardiology	O
(	O
(	O
216	O
)	O
660-0019	O
)	O
on	O
10-17	O
at	O
4:45	O
PM	O

Please	O
follow	O
up	O
with	O
Dr.	O
Frye	O
in	O
cardiololgy	O
(	O
(	O
216	O
)	O
660-0019	O
)	O
on	O
10-09	O
at	O
2:15	O
PM	O
.	O

Please	O
follow	O
up	O
with	O
Urology	O
on	O
10-16	O
@	O
1:50	O
PM	O
on	O
the	O
3rd	O
floor	O
of	O
the	O
Maricle	O
Building	O
,	O
east	O
campus	O
of	O
Lahey	O
Clinic	O
-	O
North	O
Shore	O

Ronald	O
Lyman	O
MD	O
77-979	O

Completed	O
by	O
:	O
Bristol	O
MD	O
47-191	O
2017-10-10	O
@	O
1058	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Ronald	O
G.	O
Elston	O
on	O
:	O
WED	O
2017-10-11	O
5:03	O
PM	O

(	O
End	O
of	O
Report	O
)	O

402389409	O
WGH	O

2852246	O

946048	O

3205820	O

10/18/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

SLENTPEASEBUMPS	O
,	O
LISSSOND	O

MRN	O
:	O

2852246	O

Age	O
:	O

52y	O

REGISTRATION	O
DATE	O
:	O

10/18/2005	O
02:43	O
PM	O

Provider	O
:	O

APT	O
SHUFF	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

N	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

10/18/2005	O
15:50	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

S	O
/	O
P	O
MVA	O

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
motor	O
vehicle	O
accident	O
-	O
trauma	B-disease
(	O
English	O
)	O
.	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
sprains	B-disease
,	O
fractures	B-disease
and	O
bruises	B-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

s	O
/	O
p	O
motor	O
vehicle	O
accident	O
,	O
muscle	B-disease
contusions	I-disease

Treatment	O
Rendered	O
:	O

xray	O
-	O
no	O
evidence	O
of	O
fracture	B-disease

Discharge	O
Medications	O
:	O

motrin	O
600	O
mg	O
every	O
8	O
hours	O
for	O
pain	B-disease
-	O
please	O
take	O
with	O
food	O
in	O
your	O
stomach	O

Follow	O
up	O
Service	O
:	O

Please	O
call	O
your	O
primary	O
care	O
doctor	O
next	O
week	O
and	O
arrange	O
for	O
follow	O
up	O
next	O
week	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
use	O
ice	O
to	O
sore	B-disease
areas	I-disease
for	O
the	O
next	O
few	O
days	O
.	O

If	O
you	O
develop	O
trouble	B-disease
breathing	I-disease
,	O
worsening	B-disease
pain	I-disease
,	O
vomiting	B-disease
or	O
any	B-disease
other	I-disease
concerns	I-disease
please	O
return	O
to	O
the	O
ED	O
for	O
further	O
evaluation	O
.	O

Do	O
no	O
strenuous	O
activity	O
or	O
heavy	O
lifting	O
for	O
the	O
next	O
few	O
days	O
.	O

PCP	O
Name	O
:	O

CLOPKOORSFONGAYLES	O
,	O
NORBMADE	O

Provider	O
Number	O
:	O

26318	O

This	O
report	O
was	O
created	O
by	O
SHUFF	O
,	O
RONRIN	O
10/18/2005	O
03:53	O
PM	O

814743340	O
RWH	O

3393103	O

501370	O

9041109	O

5/13/2006	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

TRICHEPRAKEJESC	O
,	O
BETLA	O

UNIT	O
NUMBER	O
:	O

381-75-78	O

ADMISSION	O
DATE	O
:	O

05/13/2006	O

DISCHARGE	O
DATE	O
:	O

05/16/2006	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Chest	B-disease
pain	I-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Coronary	B-disease
artery	I-disease
disease	I-disease
;	O
hypertension	B-disease
;	O
hyperlipidemia	B-disease
;	O
sleep	B-disease
apnea	I-disease
;	O
diabetes	B-disease
type	I-disease
2	I-disease
.	O

PROCEDURES	O
:	O

Adenosine	O
stress	O
test	O
.	O

Part	O
1	O
of	O
a	O
sleep	O
study	O
.	O

Coronary	O
angiogram	O
.	O

Chest	O
CT	O
.	O

Chest	O
x-ray	O
.	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

The	O
patient	O
is	O
a	O
55-year-old	O
gentleman	O
with	O
a	O
history	O
of	O
CAD	B-disease
status	O
post	O
non	B-disease
ST	I-disease
elevation	I-disease
MI	I-disease
in	O
11/17	O
who	O
presents	O
with	O
chest	B-disease
pain	I-disease
X	O
48	O
hours	O
.	O

He	O
went	O
to	O
Padrugmoff	O
Hospital	O
Emergency	O
Room	O
.	O

He	O
has	O
a	O
history	O
of	O
hypertension	B-disease
,	O
diabetes	B-disease
,	O
and	O
high	B-disease
cholesterol	I-disease
.	O

In	O
2003	O
,	O
he	O
had	O
a	B-disease
non	I-disease
ST	I-disease
elevation	I-disease
MI	I-disease
,	O
came	O
to	O
the	O
RWH	O
,	O
and	O
had	O
a	O
cath	O
done	O
,	O
which	O
showed	O
a	B-disease
40%	I-disease
RCA	I-disease
,	O
which	O
was	O
hazy	B-disease
.	O

An	O
IVUS	O
was	O
done	O
,	O
and	O
it	O
was	O
felt	O
that	O
it	O
was	O
more	O
severe	O
.	O

He	O
underwent	O
a	O
PTC	O
stenting	O
of	O
an	O
RCA	O
with	O
a	O
Vision	O
stent	O
,	O
3	O
x	O
18	O
.	O

Diagonal	O
1	O
also	O
had	O
a	B-disease
99%	I-disease
stenosis	I-disease
.	O

There	O
was	O
no	O
other	B-disease
noted	I-disease
disease	I-disease
.	O

Since	O
then	O
,	O
the	O
patient	O
has	O
occasional	B-disease
chest	I-disease
pain	I-disease
with	O
emotional	B-disease
stress	I-disease
,	O
when	O
he	O
is	O
angry	O
or	O
upset	O
.	O

Yesterday	O
morning	O
,	O
he	O
developed	O
intermittent	B-disease
substernal	I-disease
chest	I-disease
pain	I-disease
with	O
radiation	B-disease
to	I-disease
the	I-disease
left	I-disease
shoulder	I-disease
that	O
worsened	O
with	O
any	O
activity	O
and	O
any	O
motion	O
of	O
his	O
shoulders	O
.	O

It	O
progressed	O
over	O
the	O
course	O
of	O
the	O
day	O
requiring	O
less	O
movement	O
.	O

He	O
also	O
became	O
short	B-disease
of	I-disease
breath	I-disease
with	O
climbing	O
a	O
flight	O
of	O
stairs	O
.	O

He	O
denies	O
diaphoresis	B-disease
or	O
nausea	B-disease
.	O

He	O
went	O
to	O
the	O
Padrugmoff	O
Hospital	O
Emergency	O
Room	O
after	O
trying	O
nitroglycerin	O
at	O
home	O
.	O

However	O
,	O
his	O
nitroglycerin	O
was	O
old	O
and	O
the	O
script	O
was	O
expired	O
.	O

In	O
the	O
ER	O
,	O
he	O
received	O
3	O
sublingual	O
nitroglycerins	O
and	O
1	O
mg	O
of	O
Dilaudid	O
.	O

After	O
that	O
,	O
he	O
was	O
pain-free	B-disease
.	O

Lopressor	O
IV	O
was	O
given	O
to	O
control	O
his	O
heart	O
rate	O
.	O

He	O
also	O
received	O
Lipitor	O
80	O
mg	O
,	O
Plavix	O
300	O
,	O
heparin	O
IV	O
,	O
integrelin	O
double	O
bolus	O
,	O
followed	O
by	O
a	O
drip	O
.	O

Apparently	O
once	O
his	B-disease
pain	I-disease
was	O
free	O
,	O
his	O
EKG	O
was	O
noted	O
to	O
have	O
hyperacute	B-disease
T-wave	I-disease
anteriorly	I-disease
without	O
progression	B-disease
.	O

He	O
was	O
transferred	O
to	O
the	O
Ro	O
Woodma	O
Healthcare	O
for	O
further	O
cardiac	O
care	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Diabetes	B-disease
;	O
hypertension	B-disease
;	O
hyperlipidemia	B-disease
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Include	O
Lisinopril	O
5	O
mg	O
p.o.	O
every	O
day	O
;	O
nitroglycerin	O
sublingual	O
p.r.n.;	O
Toprol	O
XL	O
100	O
mg	O
p.o.	O
every	O
day	O
;	O
Plavix	O
75	O
mg	O
p.o.	O
every	O
day	O
;	O
Avandia	O
4	O
mg	O
p.o.	O
every	O
day	O
;	O
Lipitor	O
40	O
mg	O
p.o.	O
every	O
day	O
;	O
TriCor	O
145	O
mg	O
p.o.	O
every	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
is	O
married	O
.	O

He	O
does	O
have	O
a	O
lot	O
of	O
anxiety	B-disease
.	O

Socially	O
he	O
drinks	O
alcohol	O
.	O

He	O
does	O
not	O
smoke	O
.	O

He	O
has	O
2	O
daughters	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
ruled	O
out	O
for	O
an	B-disease
MI	I-disease
with	O
negative	O
CK	O
X4	O
and	O
negative	O
troponin	O
X4	O
.	O

He	O
was	O
taken	O
to	O
the	O
Cardiac	O
Catheterization	O
Lab	O
where	O
cath	O
showed	O
top-normal	O
LVEDP	O
at	O
12	O
;	O
no	O
AF	B-disease
;	O
widely	B-disease
patent	I-disease
RCA	I-disease
stent	I-disease
;	O
mild	B-disease
CAD	I-disease
in	I-disease
the	I-disease
left	I-disease
coronary	I-disease
artery	I-disease
symptom	I-disease
;	O
widely	B-disease
patent	I-disease
diagonal	I-disease
1	I-disease
at	O
the	O
site	O
of	O
prior	O
PTCA	O
.	O

He	O
received	O
an	O
Angio-Seal	O
to	O
the	O
right	O
common	O
femoral	O
artery	O
.	O

He	O
then	O
underwent	O
a	O
CT	O
scan	O
to	O
rule	O
out	O
a	B-disease
PE	I-disease
.	O

That	O
test	O
was	O
negative	O
.	O

He	O
underwent	O
lower	O
extremity	O
study	O
to	O
rule	O
out	O
a	B-disease
DVT	I-disease
in	I-disease
both	I-disease
legs	I-disease
.	O

That	O
was	O
negative	O
.	O

He	O
was	O
noted	O
to	O
have	O
an	O
episode	O
of	O
desaturation	B-disease
into	I-disease
the	I-disease
80%	I-disease
range	I-disease
while	O
sleeping	O
.	O

Pulmonary	O
consult	O
was	O
done	O
,	O
and	O
it	O
was	O
felt	O
that	O
the	O
patient	O
should	O
undergo	O
a	O
formal	O
sleep	O
study	O
,	O
full	O
PFTs	O
,	O
and	O
a	O
repeat	O
CT	O
scan	O
in	O
1	O
year	O
to	O
assess	O
for	O
pulmonary	B-disease
nodule	I-disease
that	O
was	O
seen	O
.	O

However	O
,	O
please	O
note	O
that	O
this	B-disease
nodule	I-disease
has	O
been	O
stable	O
over	O
time	O
.	O

The	O
patient	O
also	O
complained	O
of	O
intermittent	B-disease
right	I-disease
neck	I-disease
swelling	I-disease
,	O
and	O
recommendations	O
are	O
to	O
consider	O
a	O
CT	O
scan	O
with	O
contrast	O
to	O
evaluate	O
nodes	B-disease
in	I-disease
his	I-disease
neck	I-disease
.	O

On	O
physical	O
exam	O
today	O
,	O
the	O
patient	O
did	O
not	O
have	O
any	B-disease
swelling	I-disease
,	O
and	O
he	O
states	O
that	O
he	O
did	O
not	O
feel	O
the	B-disease
swelling	I-disease
was	O
present	O
.	O

The	O
patient	O
underwent	O
an	O
adenosine	O
stress	O
test	O
,	O
where	O
he	O
exercised	O
for	O
4	O
minutes	O
,	O
reaching	O
65%	O
of	O
predicted	O
heart	O
rate	O
.	O

He	O
did	O
not	O
have	O
chest	B-disease
pain	I-disease
.	O

EKG	O
was	O
negative	O
for	O
ischemia	B-disease
.	O

The	O
myocardial	O
perfusion	O
images	O
show	O
no	O
definite	O
evidence	O
of	O
ischemia	B-disease
.	O

The	O
LV	O
contractile	O
function	O
was	O
normal	O
.	O

There	O
was	O
mild	B-disease
posterior	I-disease
vasal	I-disease
thinning	I-disease
.	O

It	O
is	O
not	O
clearly	O
outside	O
normal	O
limits	O
.	O

He	O
underwent	O
an	O
echocardiogram	O
,	O
which	O
showed	O
an	O
EF	O
of	O
60%	O
.	O

There	O
was	O
no	O
evidence	O
of	O
MVP	B-disease
.	O

There	O
was	O
trace	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

There	O
was	O
no	O
evidence	O
of	O
LA	B-disease
dilatation	I-disease
.	O

There	O
was	O
no	O
aortic	B-disease
stenosis	I-disease
.	O

There	O
was	O
trace	B-disease
aortic	I-disease
insufficiency	I-disease
.	O

The	O
LV	O
cavity	O
size	O
was	O
normal	O
.	O

The	O
systolic	O
function	O
was	O
within	O
normal	O
limits	O
.	O

There	O
was	O
no	O
evidence	O
of	O
LV	B-disease
hypertrophy	I-disease
.	O

There	O
was	O
no	O
obvious	O
segmental	B-disease
wall-motion	I-disease
abnormality	I-disease
.	O

There	O
was	O
no	O
evidence	O
of	O
pericardial	B-disease
effusion	I-disease
.	O

The	O
right	O
ventricle	O
was	O
not	O
dilated	B-disease
.	O

The	O
systolic	O
function	O
was	O
within	O
normal	O
limits	O
.	O

The	O
patient	O
underwent	O
a	O
sleep	O
study	O
,	O
the	O
first	O
part	O
,	O
which	O
showed	O
that	O
he	O
had	O
75	B-disease
respiratory	I-disease
events	I-disease
observed	O
with	O
apnea	B-disease
,	O
hypopnea	O
index	O
of	O
11	O
an	O
hour	O
.	O

The	O
mean	O
heart	O
rate	O
was	O
68	O
.	O

They	O
felt	O
that	O
there	O
was	O
obstruction	B-disease
and	O
possible	O
obstruction	B-disease
to	I-disease
airflow	I-disease
generating	O
some	B-disease
obstructive	I-disease
apnea	I-disease
,	O
as	O
well	O
as	O
partial	B-disease
obstructive	I-disease
events	I-disease
.	O

They	O
recommended	O
that	O
the	O
patient	O
may	O
benefit	O
from	O
a	O
trial	O
of	O
continuous	O
positive	O
pressure	O
at	O
the	O
bedside	O
.	O

The	O
patient	O
has	O
been	O
scheduled	O
to	O
have	O
the	O
second	O
part	O
of	O
the	O
sleep	O
study	O
done	O
on	O
June	O
18	O
,	O
2006	O
,	O
at	O
8:30	O
p.m.	O
at	O
RWH	O
in	O
the	O
Esley	O
Community	O
Hospital	O
,	O
10th	O
floor	O
sleep	O
lab	O
,	O
phone	O
number	O
133-225-1257	O
.	O

Prior	O
to	O
discharge	O
today	O
,	O
he	O
underwent	O
PFTs	O
.	O

The	O
results	O
of	O
the	O
PFTs	O
are	O
unavailable	O
at	O
the	O
time	O
of	O
this	O
dictation	O
.	O

Based	O
on	O
all	O
the	O
tests	O
above	O
,	O
it	O
was	O
felt	O
that	O
the	O
patient	O
was	O
stable	O
for	O
discharge	O
home	O
.	O

His	O
blood	O
pressure	O
was	O
114	O
to	O
123/62	O
.	O

Heart	O
rate	O
69	O
to	O
80	O
.	O

Room	O
air	O
saturation	O
96%	O
.	O

Temperature	O
97.9	O
.	O

Lung	O
sounds	O
clear	O
bilaterally	O
.	O

Heart	O
sounds	O
:	O

Regular	O
rate	O
and	O
rhythm	O
;	O
S1-S2	O
;	O
positive	O
S4	O
;	O
no	O
murmur	B-disease
.	O

Abdomen	O
:	O

Soft	O
,	O
nontender	O
,	O
nondistended	O
;	O
no	O
guarding	B-disease
;	O
no	O
masses	B-disease
;	O
positive	O
bowel	O
sounds	O
X4	O
.	O

Right	O
groin	O
status	B-disease
post	I-disease
catheterization	I-disease
showed	O
no	O
hematoma	B-disease
or	O
bruit	B-disease
.	O

Lower	O
extremity	O
pulses	O
were	O
intact	O
without	O
any	O
edema	B-disease
.	O

Lab	O
values	O
:	O

Sodium	O
139	O
;	O
potassium	O
4.1	O
;	O
BUN	O
15	O
;	O
creatinine	O
1.1	O
;	O
magnesium	O
1.6	O
;	O
SGPT	O
19	O
;	O
SGOT	O
20	O
;	O
alkaline	O
phosphatase	O
66	O
;	O
total	O
bilirubin	O
0.6	O
;	O
direct	O
bilirubin	O
0.2	O
;	O
total	O
cholesterol	O
234	O
;	O
triglycerides	O
274	O
;	O
HDL	O
44	O
;	O
LDL	O
135	O
;	O
hemoglobin	O
A1c	O
6.7	O
;	O
white	O
cell	O
count	O
6.1	O
;	O
hematocrit	O
36.4	O
;	O
platelet	O
count	O
201	O
.	O

During	O
the	O
hospital	O
course	O
,	O
the	O
patient	O
was	O
started	O
on	O
a	O
PPI	O
,	O
Nexium	O
,	O
for	O
concerns	O
of	O
acid	B-disease
reflux	I-disease
.	O

Also	O
,	O
a	O
long	O
discussion	O
was	O
taken	O
with	O
the	O
patient	O
as	O
most	O
of	O
his	B-disease
chest	I-disease
discomfort	I-disease
happens	O
when	O
he	O
is	O
quite	O
anxious	B-disease
.	O

He	O
used	O
Ativan	O
in	O
the	O
hospital	O
,	O
which	O
helped	O
him	O
.	O

The	O
patient	O
was	O
advised	O
that	O
he	O
needs	O
to	O
speak	O
with	O
his	O
PCP	O
about	O
medication	O
for	O
antianxiety	O
and	O
/	O
or	O
further	O
testing	O
or	O
counseling	O
to	O
help	O
control	O
his	B-disease
anxiety	I-disease
level	I-disease
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Nitroglycerin	O
1	O
tablet	O
sublingual	O
q.	O
5	O
minutes	O
X3	O
p.r.n.	O
chest	B-disease
pain	I-disease
.	O

TriCor	O
145	O
mg	O
p.o.	O
every	O
day	O
.	O

Lipitor	O
40	O
mg	O
p.o.	O
every	O
day	O
.	O

Plavix	O
75	O
mg	O
p.o.	O
every	O
day	O
.	O

Aspirin	O
325	O
mg	O
p.o.	O
every	O
day	O
.	O

Lisinopril	O
5	O
mg	O
p.o.	O
every	O
day	O
.	O

Avandia	O
4	O
mg	O
p.o.	O
every	O
day	O
.	O

Toprol	O
XL	O
100	O
mg	O
p.o.	O
every	O
day	O
.	O

Prilosec	O
20	O
mg	O
p.o.	O
every	O
day	O
.	O

Ativan	O
0.5	O
mg	O
p.o.	O
b.i.d.	O
p.r.n.	O
anxiety	B-disease
.	O

The	O
patient	O
was	O
asked	O
to	O
follow	O
up	O
with	O
his	O
PCP	O
,	O
Dr.	O
Cora	O
Belbsnil	O
,	O
at	O
Necrestneysagiles	O
Medical	O
Center	O
in	O
a	O
period	O
of	O
1	O
to	O
2	O
weeks	O
.	O

He	O
was	O
asked	O
to	O
follow	O
up	O
with	O
Dr.	O
Riale	O
Tables	O
,	O
his	O
cardiologist	O
,	O
in	O
a	O
period	O
of	O
1	O
to	O
2	O
weeks	O
;	O
he	O
also	O
works	O
at	O
Necrestneysagiles	O
Medical	O
Center	O
.	O

The	O
patient	O
was	O
told	O
that	O
he	O
should	O
discus	O
with	O
his	O
PCP	O
further	O
GI	O
testing	O
,	O
as	O
well	O
as	O
medications	O
for	O
anxiety	B-disease
.	O

The	O
patient	O
will	O
need	O
to	O
have	O
a	O
followup	O
sleep	O
study	O
done	O
as	O
above	O
per	O
the	O
recommendations	O
based	O
on	O
the	O
results	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

RYROL	O
DALEDAE	O
,	O
NP	O

DICTATING	O
FOR	O
:	O

Unreviewed	O

_____________________________	O
NAA	O
NARICHA	O
EARLY	O
,	O
M.D.	O

TR	O
:	O

so	O

DD	O
:	O

05/16/2006	O

TD	O
:	O

05/17/2006	O
7:29	O
A	O
501370	O

cc	O
:	O

NAA	O
NARICHA	O
EARLY	O
,	O
M.D.	O

917989835	O
RWH	O

5427551	O

405831	O

9660879	O

01/09/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

STERPMOONE	O
,	O
NY	O

MRN	O
:	O

5427551	O

Age	O
:	O

37y	O

REGISTRATION	O
DATE	O
:	O

01/09/2002	O
01:27	O
PM	O

Provider	O
:	O

NONOK	O
AYREKEMPE	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Left	O
message	O
with	O
answering	O
service	O
or	O
PCP	O
office	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

01/09/2002	O
17:02	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

EVAL	O

Standardized	O
Discharge	O
Instructions	O
:	O

Schedule	O
outpatient	O
psychiatry	O
appointment	O
Necrestneysagiles	O
Medical	O
Center	O
.	O

Contact	O
BRIDC	O
BRESCA	O
DENONE	O
HEALTH	O
CARE	O
(	O
558-927-7217	O
)	O
for	O
appointment	O
w/	O
therapist	O
.	O

Needs	O
to	O
speak	O
w/	O
PCP	O
in	O
order	O
to	O
switch	O
provider	O
Diagnosis	O
:	O

PTSD	B-disease

Discharge	O
Medications	O
:	O

.5	O
Risperdal	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Continue	O
w/	O
Risperdal	O
per	O
new	O
psychiatrist	O

B	O
and	O
W	O
and	O
work	O
w/	O
therapist	O
re:	O
historical	O
issues	O
.	O

If	O
symptoms	B-disease
continue	O
to	O
be	O
overwhelming	B-disease
return	O
to	O
V	O
or	O
call	O
1-903-263-5797	O

PCP	O
Name	O
:	O

SHUFFNEG	O
,	O
SOA	O
W	O

Provider	O
Number	O
:	O

80157	O

This	O
report	O
was	O
created	O
by	O
AYREKEMPE	O
,	O
NONOK	O
01/09/2002	O
05:09	O
PM	O

351853846	O
WGH	O

8921553	O

92855	O

715722	O

3/24/1997	O
12:00:00	O
AM	O

GAIT	B-disease
DISORDER	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

PREHEPRIOR	O
,	O
NIENEMILEISELE	O

UNIT	O
NUMBER	O
:	O

372-41-54	O

ADMISSION	O
DATE	O
:	O

03/24/97	O

DISCHARGE	O
DATE	O
:	O

03/28/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Gait	B-disease
disorder	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
31-year-old	O
right-handed	O
female	O
with	O
right-sided	B-disease
greater	I-disease
than	I-disease
left-sided	I-disease
weakness	I-disease
and	O
difficulty	B-disease
walking	I-disease
for	O
several	O
days	O
.	O

She	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
3/20/97	O
when	O
she	O
experienced	O
the	O
fairly	O
sudden	O
onset	O
of	O
predominantly	O
right-sided	B-disease
arm	I-disease
and	I-disease
leg	I-disease
weakness	I-disease
and	O
ataxia	B-disease
.	O

She	O
was	O
standing	O
and	O
walking	O
with	O
her	O
friend	O
,	O
who	O
&quot;	O
had	O
to	O
catch	O
her	O
from	O
falling	O
down	O
&quot;	O
as	O
she	O
toppled	O
towards	O
the	O
right	O
.	O

She	O
evidently	O
recovered	O
from	O
the	B-disease
episode	I-disease
after	O
a	O
number	O
of	O
minutes	O
.	O

The	O
following	O
day	O
,	O
she	O
remained	O
in	O
bed	O
through	O
essentially	O
all	O
of	O
the	O
day	O
due	O
to	O
malaise	B-disease
with	O
no	O
specific	B-disease
deficits	I-disease
being	O
noted	O
.	O

In	O
the	O
subsequent	O
two	O
days	O
,	O
she	O
had	O
several	O
small	B-disease
spells	I-disease
of	I-disease
&quot;	I-disease
imbalance	I-disease
&quot;	O
,	O
particularly	O
towards	O
the	O
right	O
,	O
and	O
other	B-disease
symptoms	I-disease
included	O
diffuse	B-disease
and	I-disease
mainly	I-disease
frontal	I-disease
headaches	I-disease
and	O
mild	B-disease
neck	I-disease
soreness	I-disease
.	O

There	O
was	O
no	O
diplopia	B-disease
,	O
visual	B-disease
loss	I-disease
,	O
speech	B-disease
abnormality	I-disease
or	O
sensory	B-disease
change	I-disease
in	O
her	O
history	O
.	O

She	O
was	O
initially	O
evaluated	O
at	O
an	O
outside	O
hospital	O
emergency	O
room	O
,	O
and	O
then	O
transferred	O
to	O
Well	O
General	O
Hospital	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Is	O
notable	O
for	O
depression	B-disease
,	O
and	O
she	O
has	O
been	O
followed	O
regularly	O
by	O
Dr.	O
Freiermchird	O
of	O
Nash	O
Health	O
for	O
several	O
months	O
with	O
pharmacologic	O
treatment	O
,	O
which	O
is	O
apparently	O
working	O
well	O
.	O

Her	O
Doxepin	O
has	O
recently	O
been	O
increased	O
.	O

She	O
is	O
status	O
post	O
appendectomy	O
and	O
otherwise	O
has	O
no	O
remarkable	O
past	O
medical	O
history	O
.	O

ALLERGIES	O
:	O

Quinine	O
gives	O
her	O
a	B-disease
rash	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

The	O
only	O
medications	O
she	O
is	O
on	O
are	O
Paxil	O
30	O
mg	O
p.o.	O
q.day	O
,	O
Doxepin	O
25	O
mg	O
p.o.	O
q.day	O
,	O
and	O
Klonopin	O
2	O
mg	O
p.o.	O
q.h.s.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
currently	O
unemployed	O
,	O
but	O
until	O
recently	O
,	O
she	O
was	O
employed	O
at	O
a	O
bank	O
.	O

She	O
was	O
born	O
and	O
raised	O
in	O
Atonlaremont	O
Rockpo	O
.	O

There	O
is	O
a	O
history	O
of	O
childhood	O
abuse	O
.	O

She	O
does	O
not	O
drink	O
.	O

She	O
is	O
a	O
former	O
tobacco	O
user	O
and	O
takes	O
no	O
illicit	O
drugs	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
was	O
pleasant	O
,	O
in	O
no	O
acute	B-disease
distress	I-disease
;	O
blood	O
pressure	O
130/60	O
;	O
heart	O
rate	O
66	O
;	O
respirations	O
18	O
;	O
temperature	O
98	O
.	O

Her	O
thyroid	O
was	O
within	O
normal	O
limits	O
.	O

There	O
were	O
no	O
carotid	B-disease
or	I-disease
cervical	I-disease
bruits	I-disease
.	O

She	O
had	O
a	O
normal	O
S1	O
and	O
S2	O
and	O
regular	O
rate	O
and	O
rhythm	O
with	O
no	O
murmurs	B-disease
.	O

Her	O
lungs	O
were	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Her	O
abdomen	O
was	O
benign	O
.	O

Her	O
extremities	O
were	O
without	O
clubbing	B-disease
,	O
cyanosis	B-disease
,	O
edema	B-disease
,	O
or	O
rash	B-disease
;	O
there	O
were	O
some	O
older	O
hematomas	B-disease
in	I-disease
the	I-disease
bilaterally	I-disease
shins	I-disease
.	O

Mental	O
status	O
-	O
her	O
speech	O
was	O
fluent	O
without	O
errors	O
.	O

Her	O
affect	O
was	O
slightly	B-disease
inappropriate	I-disease
at	O
times	O
;	O
for	O
example	O
,	O
singing	B-disease
or	I-disease
humming	I-disease
along	I-disease
while	O
performing	O
some	O
of	O
the	O
motor	O
tasks	O
and	O
giving	O
the	O
impression	O
of	O
indifference	B-disease
to	O
the	B-disease
deficits	I-disease
that	O
were	O
demonstrated	O
on	O
the	O
examination	O
.	O

Her	O
memory	O
was	O
fully	O
intact	O
for	O
short-term	O
recollection	O
of	O
three	O
out	O
of	O
three	O
objects	O
at	O
five	O
minutes	O
with	O
excellent	O
naming	O
,	O
repetition	O
,	O
proverb	O
interpretation	O
,	O
and	O
ability	O
to	O
follow	O
commands	O
.	O

Visual	O
fields	O
were	O
full	O
to	O
confrontation	O
.	O

Her	O
left	O
pupil	O
was	O
7	O
mm	O
reacting	O
to	O
5	O
mm	O
.	O

Her	O
right	O
pupil	O
was	O
5.5	O
mm	O
reacting	O
to	O
4	O
mm	O
.	O

Her	O
extraocular	O
movements	O
were	O
intact	O
for	O
horizontal	O
and	O
vertical	O
pursuits	O
.	O

There	O
was	O
no	O
nystagmus	B-disease
and	O
no	O
ptosis	B-disease
.	O

Her	O
saccades	O
were	O
normal	O
.	O

Facial	O
strength	O
and	O
sensation	O
were	O
full	O
and	O
symmetric	O
.	O

Her	O
tongue	O
,	O
uvula	O
and	O
palate	O
were	O
midline	O
.	O

Shoulder	O
shrug	O
was	O
5/5	O
power	O
.	O

Motor	O
examination	O
revealed	O
5/5	O
power	O
in	O
all	O
groups	O
in	O
the	O
proximal	O
and	O
distal	O
upper	O
and	O
lower	O
extremities	O
.	O

There	O
was	O
no	O
drift	B-disease
.	O

There	O
was	O
normal	O
bulk	O
and	O
tone	O
.	O

She	O
had	O
slightly	B-disease
slow	I-disease
fine	I-disease
finger	I-disease
motility	I-disease
approximately	O
equal	O
bilaterally	O
,	O
although	O
this	O
was	O
extremely	O
difficult	O
to	O
reproduce	O
.	O

Sensory	O
-	O
intact	O
light	O
touch	O
,	O
temperature	O
,	O
and	O
vibration	O
overall	O
.	O

Reflexes	O
were	O
2+	O
throughout	O
in	O
the	O
upper	O
and	O
lower	O
extremities	O
,	O
and	O
toes	O
were	O
downgoing	O
.	O

There	O
was	O
no	O
jaw	B-disease
jerk	I-disease
and	O
no	O
Hoffman	O
&apos;s	O
sign	O
.	O

Coordination	O
-	O
toe	O
tap	O
was	O
slow	B-disease
bilaterally	I-disease
,	O
although	O
difficult	O
to	O
reproduce	O
,	O
and	O
at	O
best	O
,	O
was	O
essentially	O
within	O
normal	O
limits	O
.	O

On	O
standing	O
,	O
she	O
tended	O
to	O
fall	O
to	O
the	O
front	O
,	O
back	O
or	O
sides	O
without	O
trying	O
to	O
stop	O
her	O
fall	O
initially	O
,	O
and	O
extensive	O
gait	O
testing	O
was	O
deferred	O
due	O
to	O
concerns	O
for	O
safety	O
.	O

Her	O
heel-to-shin	O
and	O
finger-to-nose	O
testing	O
was	O
fully	O
intact	O
bilaterally	O
without	O
ataxia	B-disease
or	O
tremor	B-disease
.	O

LABORATORY	O
DATA	O
:	O

Were	O
unremarkable	O
with	O
normal	O
electrolytes	O
and	O
complete	O
blood	O
count	O
parameters	O
.	O

Her	O
erythrocyte	O
sedimentation	O
rate	O
was	O
12	O
.	O

Her	O
coagulation	O
parameters	O
were	O
normal	O
.	O

Head	O
CT	O
scan	O
without	O
contrast	O
showed	O
normal	O
brain	O
parenchyma	O
and	O
no	O
intracranial	B-disease
process	I-disease
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
her	B-disease
gait	I-disease
disorder	I-disease
with	O
other	O
notable	B-disease
findings	I-disease
on	O
examination	O
including	O
anisocoria	B-disease
,	O
which	O
,	O
by	O
the	O
patient	O
&apos;s	O
report	O
,	O
had	O
been	O
noted	O
several	O
months	O
earlier	O
.	O

A	O
magnetic	O
resonance	O
imaging	O
and	O
magnetic	O
resonance	O
angiogram	O
study	O
was	O
obtained	O
,	O
which	O
showed	O
no	O
clear	O
evidence	O
of	O
arterial	B-disease
dissections	I-disease
or	O
infarction	B-disease
or	O
other	B-disease
pathologic	I-disease
processes	I-disease
.	O

She	O
had	O
been	O
placed	O
on	O
heparin	O
initially	O
,	O
but	O
this	O
was	O
discontinued	O
after	O
the	O
magnetic	O
resonance	O
imaging	O
results	O
were	O
obtained	O
.	O

Posterior	O
transcranial	O
Doppler	O
studies	O
showed	O
normal	O
studies	O
of	O
both	O
vertebral	O
arteries	O
,	O
and	O
carotid	O
non-invasive	O
studies	O
showed	O
normal	O
right	O
and	O
left	O
carotid	O
bifurcations	O
.	O

On	O
the	O
second	O
hospital	O
day	O
,	O
her	B-disease
gait	I-disease
continued	O
to	O
be	O
markedly	B-disease
unstable	I-disease
,	O
although	O
with	O
no	O
consistent	O
pattern	O
in	O
terms	O
of	O
weakness	B-disease
or	O
directionality	O
of	O
falling	O
,	O
and	O
she	O
continued	O
to	O
have	O
no	O
reproducible	B-disease
upper	I-disease
extremity	I-disease
or	I-disease
lower	I-disease
extremity	I-disease
ataxia	I-disease
or	O
dysmetria	B-disease
.	O

She	O
was	O
seen	O
by	O
the	O
Psychiatry	O
Service	O
.	O

She	O
was	O
not	O
felt	O
to	O
be	O
acutely	B-disease
suicidal	I-disease
or	O
otherwise	O
in	O
need	O
of	O
acute	O
psychiatric	O
treatment	O
.	O

The	O
psychiatrist	O
also	O
noted	O
the	O
indifference	O
the	O
patient	O
evinced	O
regarding	O
her	B-disease
own	I-disease
symptomatology	I-disease
.	O

The	O
patient	O
was	O
evaluated	O
in	O
one	O
of	O
the	O
neurology	O
conferences	O
for	O
several	O
hours	O
,	O
and	O
during	O
this	O
time	O
,	O
showed	O
significant	O
improvement	O
while	O
receiving	O
gait	O
training	O
as	O
well	O
as	O
evaluation	O
;	O
in	O
particular	O
,	O
she	O
became	O
more	O
stable	O
with	O
counter-balancing	O
methods	O
.	O

This	O
trend	O
of	O
improvement	O
continued	O
,	O
and	O
she	O
was	O
discharged	O
in	O
stable	O
condition	O
.	O

She	O
will	O
follow	O
up	O
with	O
her	O
psychiatrist	O
,	O
Dr.	O
Freiermchird	O
(	O
Sone	O
Memorial	O
Hospital	O
)	O
on	O
a	O
regular	O
basis	O
,	O
and	O
she	O
can	O
follow	O
up	O
with	O
the	O
Neurology	O
Service	O
on	O
a	O
p.r.n.	O
basis	O
if	O
needed	O
.	O

She	O
will	O
continue	O
on	O
her	O
previous	O
outpatient	O
medical	O
regimen	O
.	O

NIREGE	O
MEMORY	O
,	O
M.D.	O

TR	O
:	O

bzo	O

DD	O
:	O

03/29/97	O

TD	O
:	O

03/31/97	O
12:36	O
P	O

cc	O
:	O

NYRI	O
A	O
MEMORY	O
,	O
M.D.	O

ASHELLRIETTE	O
NESSASU	O
THREATSVOT	O
,	O
M.D.	O

EJEAN	O
NADARC	O
FREIERMCHIRD	O
,	O
M.D.	O

01909607	O

Admission	O
Date	O
:	O

2010-06-28	O

Discharge	O
Date	O
:	O

2010-07-01	O

Date	O
of	O
Birth	O
:	O

1990-02-01	O

Sex	O
:	O

F	O

Service	O
:	O

ORTHOPEDIC	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
20-year-old	O
female	O
with	O
no	O
significant	O
past	O
medical	O
history	O
,	O
who	O
was	O
the	O
unrestrained	O
passenger	O
in	O
a	O
high	O
speed	O
rollover	O
motor	O
vehicle	O
accident	O
on	O
2010-06-27	O
.	O

By	O
report	O
,	O
the	O
patient	O
was	O
ejected	O
from	O
the	O
vehicle	O
on	O
impact	O
and	O
found	O
curled	O
in	O
the	O
fetal	O
position	O
at	O
the	O
rear	O
of	O
the	O
vehicle	O
at	O
the	O
scene	O
.	O

The	O
vehicle	O
was	O
noted	O
to	O
be	O
extensively	O
damaged	O
.	O

By	O
report	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
awake	O
,	O
but	O
confused	B-disease
at	O
the	O
scene	O
of	O
the	O
accident	O
with	O
no	O
memory	O
of	O
the	O
incident	O
.	O

She	O
was	O
immobilized	O
in	O
the	O
C-spine	O
collar	O
at	O
the	O
scene	O
of	O
the	O
accident	O
and	O
subsequently	O
transported	O
by	O
EMS	O
to	O
the	O
New	O
England	O
Sinai	O
Hospital	O
&	O
Rehab	O
Center	O
Emergency	O
Department	O
for	O
further	O
management	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Examination	O
on	O
presentation	O
to	O
the	O
emergency	O
room	O
revealed	O
the	O
following	O
:	O

Temperature	O
35.4	O
Celsius	O
,	O
blood	O
pressure	O
116/63	O
,	O
pulse	O
105	O
,	O
respiratory	O
rate	O
18	O
,	O
oxygen	O
saturation	O
98%	O
on	O
room	O
air	O
.	O

The	O
patient	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

Boston	O
Coma	O
Scale	O
of	O
15	O
.	O

Tympanic	O
membranes	O
were	O
noted	O
to	O
be	O
clear	O
.	O

Pupils	O
were	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
at	O
approximately	O
4	O
mm	O
.	O

The	O
patient	O
's	O
trachea	O
was	O
noted	O
to	O
be	O
midline	O
.	O

The	O
patient	O
's	O
lung	O
examination	O
revealed	O
the	O
lungs	O
to	O
be	O
clear	O
to	O
auscultation	O
bilaterally	O
,	O
no	O
crepitus	B-disease
,	O
and	O
a	B-disease
left	I-disease
clavicular	I-disease
deformity	I-disease
was	O
grossly	O
apparent	O
on	O
examination	O
.	O

CARDIAC	O
:	O

Cardiac	O
examination	O
demonstrated	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmurs	B-disease
,	O
rubs	B-disease
,	O
or	O
gallops	B-disease
.	O

ABDOMEN	O
:	O

Soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

RECTAL	O
:	O

Examination	O
was	O
guaiac	O
negative	O
with	O
good	O
rectal	O
tone	O
.	O

The	O
patient	O
's	O
pelvis	O
was	O
stable	O
to	O
AP	O
and	O
lateral	O
compression	O
.	O

A	B-disease
5	I-disease
cm	I-disease
laceration	I-disease
was	O
noted	O
over	O
the	O
patient	O
's	O
occiput	O
on	O
further	O
inspection	O
with	O
no	O
exposed	B-disease
underlying	I-disease
bone	I-disease
.	O

Right	O
upper	O
extremity	O
examination	O
demonstrated	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
function	O
.	O

Left	O
upper	O
extremity	O
examination	O
demonstrated	O
no	O
gross	B-disease
deformities	I-disease
,	O
tenderness	B-disease
to	O
palpation	O
in	O
the	O
mid	O
forearm	O
,	O
intact	O
motor	O
function	O
in	O
the	O
median	O
,	O
radial	O
,	O
and	O
ulnar	O
nerve	O
distributions	O
,	O
intact	O
sensation	O
to	O
light	O
touch	O
in	O
the	O
median	O
and	O
radial	O
nerve	O
distributions	O
,	O
decreased	B-disease
sensation	I-disease
in	I-disease
the	I-disease
ulnar-nerve	I-disease
distribution	I-disease
,	O
warm	O
and	O
well	O
perfused	O
limb	O
with	O
2+	O
radial	O
pulses	O
.	O

Right	O
lower	O
extremity	O
examination	O
demonstrated	O
mild	B-disease
swelling	I-disease
and	O
ecchymosis	B-disease
of	I-disease
the	I-disease
right	I-disease
posterior	I-disease
thigh	I-disease
and	O
approximately	O
a	B-disease
3	I-disease
cm	I-disease
laceration	I-disease
in	I-disease
the	I-disease
lower	I-disease
leg	I-disease
,	O
expressive	O
of	O
moderate	O
amounts	O
of	O
standard	O
sterile	O

fashion	O
.	O

No	O
gross	B-disease
deformities	I-disease
.	O

Motor	O
,	O
sensory	O
,	O
and	O
vascular	O
examinations	O
were	O
intact	O
in	O
all	O
distributions	O
.	O

Left	O
lower	O
extremity	O
examination	O
demonstrated	O
no	O
gross	B-disease
deformities	I-disease
and	O
intact	O
motor	O
,	O
sensory	O
,	O
and	O
vascular	O
examinations	O
in	O
all	O
distributions	O
.	O

Radiographic	O
studies	O
demonstrated	O
an	B-disease
inferior	I-disease
displaced	I-disease
left	I-disease
midclavicular	I-disease
fracture	I-disease
,	O
no	O
evidence	O
of	O

pneumothorax	B-disease
.	O

Trauma	O
series	O
demonstrated	O
no	O
evidence	O
of	O
a	B-disease
pelvic	I-disease
fracture	I-disease
.	O

Head	O
CT	O
demonstrated	O
no	O
evidence	O
of	O
intracranial	B-disease
bleeding	I-disease
.	O

Trauma	O
CT	O
demonstrated	O
mild	B-disease
pulmonary	I-disease
contusions	I-disease
,	O
but	O
no	O
pelvic	B-disease
fracture	I-disease
.	O

Cervical	O
spine	O
imaging	O
demonstrated	O
no	O
evidence	O
of	O
cervical	B-disease
spine	I-disease
injury	I-disease
.	O

Right	O
tibial-fibular	O
film	O
series	O
demonstrated	O
no	O
evidence	O
of	O
fracture	B-disease
displacement	I-disease
.	O

Left	O
humerus	O
film	O
series	O
demonstrated	O
no	O
evidence	O
of	O
fracture	B-disease
or	O
displacement	B-disease
.	O

Right	O
foot	O
and	O
femur	O
series	O
demonstrated	O
no	O
evidence	O
of	O
fracture	B-disease
displacement	I-disease
.	O

Left	O
forearm	O
and	O
wrist	O
series	O
demonstrated	O
transverse	B-disease
mid	I-disease
shaft	I-disease
radial	I-disease
fracture	I-disease
with	O
ulnar	B-disease
displacement	I-disease
.	O

Diagnosis	O
peritoneum	O
lavage	O
times	O
two	O
was	O
negative	O
for	O
any	O
signs	O
of	O
intra-abdominal	B-disease
bleeding	I-disease
.	O

LABORATORY	O
DATA	O
:	O

Studies	O
on	O
admission	O
revealed	O
the	O
following	O
:	O

White	O
blood	O
cell	O
12.9	O
,	O
hemoglobin	O
11.5	O
,	O
hematocrit	O
32.8	O
,	O
platelet	O
count	O
197,000	O
,	O
sodium	O
141	O
,	O
potassium	O
3.6	O
,	O
chloride	O
110	O
,	O
bicarbonate	O
21	O
,	O
BUN	O
20	O
,	O
creatinine	O
0.7	O
,	O
glucose	O
189	O
,	O
PT	O
13.3	O
,	O
INR	O
1.2	O
,	O
PTT	O
30.0	O
,	O
amylase	O
57	O
,	O
arterial	O
blood	O
gas	O
7.32	O
,	O
35	O
,	O
159	O
,	O
19	O
,	O
-7	O
.	O

Urinalysis	O
was	O
within	O
normal	O
limits	O
with	O
6	O
to	O
10	O
red	O
blood	O
cells	O
.	O

Toxicology	O
screen	O
was	O
negative	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
evaluated	O
by	O
the	O
Trauma	O
Service	O
in	O
the	O
emergency	O
room	O
,	O
where	O
she	O
received	O
four	O
liters	O

crystalloid	O
and	O
four	O
units	O
packed	O
red	O
blood	O
cells	O
with	O
good	O
response	O
.	O

In	O
addition	O
,	O
the	O
patient	O
received	O
the	O
above-described	O
diagnostic	O
procedures	O
,	O
which	O
demonstrated	O
injuries	B-disease
limited	O
to	O
a	B-disease
posterior	I-disease
scalp	I-disease
laceration	I-disease
,	O
left	B-disease
fractured	I-disease
clavicle	I-disease
,	O
left	B-disease
fractured	I-disease
radius	I-disease
,	O
right	B-disease
thigh	I-disease
hematoma	I-disease
,	O
and	O
right	B-disease
leg	I-disease
laceration	I-disease
.	O

The	O
patient	O
was	O
subsequently	O
admitted	O
to	O
the	O
Trauma	O
Service	O
on	O
2010-06-28	O
under	O
the	O
direction	O
of	O
Dr.	O
Lowery	O
.	O

Given	O
the	B-disease
patient	I-disease
's	I-disease
right	I-disease
thigh	I-disease
hematoma	I-disease
,	O
a	O
duplex	O
evaluation	O
of	O
the	O
right	O
lower	O
extremity	O
was	O
performed	O
on	O
2010-06-28	O
and	O
demonstrated	O
no	O
evidence	O
of	O
major	B-disease
arterial	I-disease
or	I-disease
venous	I-disease
injury	I-disease
in	O
the	O
level	O
of	O

the	O
right	O
inguinal	O
region	O
.	O

On	O
06-28	O
,	O
the	O
patient	O
was	O
also	O
cleared	O
for	O
removal	O
of	O
her	O
C-spine	O
collar	O
and	O
deemed	O
stable	O
for	O
transfer	O
to	O
the	O
Orthopedic	O
Service	O
under	O
the	O
direction	O
of	O
Dr.	O
Ronda	O
Lopez	O
.	O

The	O
patient	O
remained	O
stable	O
through	O
2010-06-29	O
at	O
which	O
point	O
she	O
was	O
sent	O
to	O
the	O
operating	O
room	O
to	O
undergo	O
a	O
left	O
radial	O
fracture	O
open	O
reduction	O
and	O
internal	O
fixation	O
procedure	O
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
demonstrated	O
a	O
postoperative	O
hematocrit	O
of	O
40.9	O
.	O

Of	O
note	O
,	O
the	B-disease
scalp	I-disease
and	I-disease
right	I-disease
lower	I-disease
leg	I-disease
lacerations	I-disease
were	O
closed	O
primarily	O
by	O
the	O
trauma	O
team	O
on	O
admission	O
and	O
on	O
hospital	O
day	O
#1	O
were	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
.	O

Nonoperative	O
treatment	O
was	O
elected	O
for	O
the	B-disease
patient	I-disease
's	I-disease
left	I-disease
clavicular	I-disease
fracture	I-disease
.	O

On	O
postoperative	O
day	O
#1	O
,	O
2010-06-30	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
clinically	O
stable	O
,	O
tolerating	O
oral	O
intake	O
,	O
and	O
expressive	O
of	O
adequate	O
amounts	O
of	O
urine	O
independent	O
of	O
a	O
Foley	O
catheter	O
.	O

The	B-disease
patient	I-disease
's	I-disease
head	I-disease
wound	I-disease
laceration	I-disease
was	O
noted	O
to	O
be	O
clean	O
and	O
dry	O
with	O
intact	O
staples	O
.	O

There	O
was	O
no	O
erythema	B-disease
or	O
purulence	B-disease
.	O

The	O
left	O
clavicle	O
was	O
noted	O
to	O
have	O
continued	B-disease
ecchymosis	I-disease
decreased	O
from	O
prior	O
examination	O
with	O
a	B-disease
minor	I-disease
stepoff	I-disease
and	O
mild	B-disease
tenderness	I-disease
to	O
palpation	O
decreased	O
from	O
prior	O
examinations	O
.	O

The	O
left	O
forearm	O
dressing	O
was	O
noted	O
to	O
be	O
in	O
place	O
,	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
no	O
saturation	B-disease
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
able	O
to	O
wiggle	O
her	O
fingers	O
with	O
intact	O
flexor	O
,	O
extensor	O
,	O
abductor	O
,	O
and	O
adductor	O
function	O
.	O

Mild	B-disease
swelling	I-disease
was	O
noted	O
in	O
the	O
left	O
hand	O
.	O

Sensation	O
was	O
intact	O
in	O
the	O
median	O
,	O
radius	O
,	O
and	O
ulnar-nerve	O
distributions	O
.	O

Fingers	O
were	O
warm	O
and	O
well	O
perfused	O
with	O
capillary	O
refill	O
less	O
than	O
3	O
seconds	O
.	O

The	B-disease
patient	I-disease
's	I-disease
right	I-disease
anterior	I-disease
tibial	I-disease
wound	I-disease
was	O
noted	O
to	O
be	O
clean	O
,	O
dry	O
,	O
and	O
intact	O
with	O
sutures	O
intact	O
and	O
no	O
erythema	B-disease
or	O
purulence	B-disease
noted	O
.	O

On	O
06-30	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
Occupational	O
Therapy	O
and	O
fitted	O
for	O
a	O
left	O
upper	O
extremity	O
splint	O
.	O

The	O
patient	O
was	O
also	O
administered	O
adaptive	O
training	O
for	O
activities	O
of	O
daily	O
life	O
and	O
advised	O
regarding	O
wound	O
care	O
.	O

In	O
addition	O
,	O
the	O
patient	O
was	O
also	O
fitted	O
with	O
a	O
figure-of-eight	O
clavicular	O
splint	O
and	O
instructed	O
in	O
its	O

proper	O
use	O
.	O

On	O
2010-07-01	O
,	O
the	O
patient	O
was	O
discharged	O
from	O
the	O
hospital	O
with	O
instructions	O
for	O
follow	O
up	O
care	O
on	O
return	O
to	O
the	O
United	O
Kingdom	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
is	O
to	O
be	O
discharged	O
to	O
home	O
.	O

DISCHARGE	O
STATUS	O
:	O

Stable	O
.	O

DIAGNOSIS	O
:	O

1.	O
Left	B-disease
transverse	I-disease
mid	I-disease
shaft	I-disease
radial	I-disease
fracture	I-disease
with	O
ulnar	B-disease
displacement	I-disease
status	O
post	O
left	O
radial	O
open	O
reduction	O
and	O
internal	O
fixation	O
.	O

2.	O
Left	B-disease
midclavicular	I-disease
fracture	I-disease
managed	O
nonoperatively	O
.	O

3.	O
Occipital	B-disease
scalp	I-disease
laceration	I-disease
.	O

4.	O
Right	B-disease
anterior	I-disease
tibial	I-disease
laceration	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Percocet	O
one	O
to	O
two	O
tablets	O
PO	O
q.4h.	O
to	O
6h.p.r.n.	O
pain	B-disease
.	O

FOLLOW-UP	O
CARE	O
:	O

The	O
patient	O
is	O
medically	O
cleared	O
for	O
a	O
flight	O
to	O
return	O
to	O
her	O
home	O
in	O
the	O
United	O
Kingdom	O
.	O

The	O
patient	O
is	O
to	O
maintain	O
her	O
figure-of-eight	O
clavicular	O
splint	O
and	O
left	O
posterior	O
forearm	O
splint	O
in	O
place	O
for	O
fourteen	O
days	O
following	O
discharge	O
.	O

The	B-disease
left	I-disease
forearm	I-disease
and	I-disease
right	I-disease
lower	I-disease
leg	I-disease
wound	I-disease
should	O
be	O
kept	O
clean	O
and	O
dry	O
with	O
regular	O
dressing	O
changes	O
with	O
dry	O
gauze	O
once	O
per	O
day	O
.	O

Scalp	B-disease
laceration	I-disease
should	O
be	O
kept	O
clean	O
and	O
dry	O
for	O
five	O
days	O
following	O
discharge	O
after	O
which	O
point	O
the	O
patient	O
may	O
once	O
wash	O
her	O
hair	O
.	O

Percocet	O
for	O
pain	B-disease
as	O
needed	O
.	O

The	O
patient	O
is	O
to	O
followup	O
with	O
an	O
orthopedist	O
in	O
the	O
United	O
Kingdom	O
fourteen	O
days	O
following	O
discharge	O
at	O
which	O
point	O
repeat	O
x-rays	O
of	O
her	O
left	O
forearm	O
should	O
be	O
obtained	O
and	O
her	O
left	O
forearm	O
scalp	O
and	O
right	O
lower	O
leg	O
sutures	O
and	O
staples	O
may	O
be	O
removed	O
.	O

Questions	O
regarding	O
follow	O
up	O
may	O
be	O
referred	O
to	O
Dr.	O
Ronda	O
Lopez	O
at	O
the	O
Ayer	O
Orthopedic	O
Group	O
.	O

Telephone	O
#:	O

(	O
658	O
)	O
842-8661	O
.	O

Ortiz	O
V	O
Baugher	O
,	O
M.D.	O

75-285	O

Dictated	O
By	O
:	O
Catherine	O
K	O
Thomas	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-06-30	O
17:18	O

T	O
:	O
2010-06-30	O
17:39	O

JOB	O
#:	O

03326	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kisha	O
Jones	O
on	O
:	O
Jose	O
2010-07-01	O
8:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

622086964	O

BH	O

8245338	O

356492	O

05/16/2004	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

WIERSTUPH	O
,	O
NORNAME	O
H	O

UNIT	O
NUMBER	O
:	O

370-15-25	O

ADMISSION	O
DATE	O
:	O

05/16/2004	O

DISCHARGE	O
DATE	O
:	O

05/26/2004	O

PRIMARY	O
DIAGNOSIS	O
:	O

Ovarian	B-disease
cancer	I-disease
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

Hypertension	B-disease
,	O
asthma	B-disease
,	O
obesity	B-disease
,	O
history	O
of	O
heart	B-disease
murmur	I-disease
,	O
hemorrhoids	B-disease
,	O
whooping	B-disease
cough	I-disease
as	O
a	O
child	O
.	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Total	O
abdominal	O
hysterectomy	O
,	O
bilateral	O
salpingooophorectomy	O
,	O
bilateral	O
lymph	O
node	O
dissection	O
,	O
omentectomy	O
,	O
lysis	O
of	O
adhesions	B-disease
,	O
removal	O
of	O
mass	B-disease
from	O
surface	O
of	O
transverse	O
colon	O
.	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

64-year-old	O
G5P5	O
postmenopausal	O
for	O
10	O
years	O
with	O
a	O
history	O
of	O
two	O
months	O
of	O
progressive	B-disease
abdominal	I-disease
distention	I-disease
,	O
crampy	B-disease
abdominal	I-disease
pain	I-disease
,	O
urinary	B-disease
frequency	I-disease
and	O
diarrhea	B-disease
.	O

The	O
patient	O
has	O
not	O
obtained	O
gynecologic	O
care	O
for	O
32	O
years	O
until	O
April	O
2004	O
when	O
an	O
increase	O
in	O
abdominal	B-disease
GERD	I-disease
and	O
urinary	B-disease
symptoms	I-disease
lead	O
her	O
to	O
initial	O
consultation	O
with	O
Dr.	O
Lentny	O
Farstnappsshee	O
in	O
Gobrew	O
Street	O
,	O
Denlandcobridclevena	O
,	O
West	O
Virginia	O
28880	O
.	O

At	O
that	O
time	O
a	O
pelvic	O
ultrasound	O
was	O
performed	O
showing	O
extensive	B-disease
fluid	I-disease
and	O
clear	B-disease
mass	I-disease
within	O
the	O
pelvi-abdominal	O
cavity	O
.	O

MRI	O
showed	O
a	B-disease
large	I-disease
fluid	I-disease
filled	I-disease
abdomen	I-disease
with	O
a	B-disease
relatively	I-disease
small	I-disease
mass	I-disease
measuring	O
about	O
5	O
to	O
6	O
cm	O
in	O
the	O
right	O
pelvis	O
.	O

At	O
this	O
point	O
she	O
had	O
an	B-disease
elevated	I-disease
CA	I-disease
125	O
at	O
440	O
and	O
came	O
to	O
Dr.	O
Chabechird	O
for	O
further	O
consultation	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-disease
,	O
asthma	B-disease
for	O
10	O
years	O
,	O
no	O
hospitalizations	O
,	O
obesity	B-disease
,	O
history	O
of	O
heart	B-disease
murmur	I-disease
,	O
hemorrhoids	B-disease
and	O
whooping	B-disease
cough	I-disease
as	O
a	O
child	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Tonsillectomy	O
in	O
1947	O
,	O
removal	O
of	O
a	B-disease
renal	I-disease
calculus	I-disease
in	O
1979	O
,	O
cholecystectomy	O
in	O
1986	O
.	O

OB-GYN	O
HISTORY	O
:	O

G5	O
,	O
P5	O
normal	O
Pap	O
smears	O
,	O
sexual	O
active	O
without	O
dyspareunia	B-disease
.	O

No	O
regular	O
breast	O
self	O
examination	O
,	O
has	O
not	O
had	O
a	O
mammogram	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

Included	O
Prinzide	O
12.5	O
mg	O
po	O
daily	O
,	O
albuterol	O
inhaler	O
prn	O

ALLERGIES	O
:	O

Demerol	O
.	O

The	O
patient	O
developed	O
ulceration	B-disease
after	O
IM	O
injection	O
.	O

She	O
also	O
has	O
food	B-disease
allergies	I-disease
to	O
raw	O
vegetables	O
as	O
well	O
as	O
some	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
throat	B-disease
constriction	I-disease
with	O
shrimp	O
.	O

FAMILY	O
HISTORY	O
:	O

Remarkable	O
for	O
colon	B-disease
cancer	I-disease
in	O
her	O
mother	O
and	O
maternal	O
grandfather	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
on	O
05/16/2004	O
for	O
bowel	O
preparation	O
before	O
the	O
surgery	O
.	O

On	O
05/17/2004	O
the	O
patient	O
underwent	O
atotal	O
abdominal	O
hysterectomy	O
,	O
bilateral	O
salpingooophorectomy	O
,	O
bilateral	O
node	O
dissection	O
,	O
omentectomy	O
,	O
lysis	O
of	O
adhesions	B-disease
,	O
removal	O
of	O
mass	B-disease
from	O
surface	O
of	O
transverse	O
colon	O
.	O

The	O
report	O
from	O
the	O
frozen	O
section	O
sent	O
in	O
the	O
surgery	O
came	O
back	O
with	O
poorly	B-disease
differentiated	I-disease
adenocarcinoma	I-disease
,	O
possibly	O
serous	B-disease
carcinoma	I-disease
of	I-disease
the	I-disease
ovary	I-disease
.	O

In	O
the	O
postoperative	O
recovery	O
room	O
the	O
patient	O
had	O
a	O
hematocrit	O
of	O
29.2	O
with	O
low	B-disease
urine	I-disease
output	I-disease
.	O

She	O
was	O
given	O
1	O
unit	O
of	O
packed	O
red	O
blood	O
cell	O
.	O

Her	O
urine	O
output	O
subsequently	O
increased	O
.	O

The	O
patient	O
was	O
transferred	O
to	O
the	O
floor	O
without	O
any	B-disease
complications	I-disease
.	O

She	O
had	O
an	O
uneventful	O
night	O
.	O

On	O
postoperative	O
day	O
one	O
,	O
the	O
patient	O
&apos;s	O
urine	O
culture	O
came	O
back	O
with	O
moderate	B-disease
E.	I-disease
coli	I-disease
.	O

She	O
was	O
started	O
on	O
Levofloxacin	O
500	O
mg	O
po	O
daily	O
.	O

The	O
patient	O
was	O
also	O
started	O
on	O
a	O
clear	O
diet	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
her	O
Foley	O
was	O
discontinued	O
.	O

The	O
patient	O
was	O
out	O
of	O
bed	O
.	O

She	O
was	O
tolerating	O
liquids	O
.	O

On	O
postoperative	O
day	O
three	O
,	O
the	O
patient	O
had	O
a	O
port	O
placed	O
.	O

She	O
also	O
had	O
one	O
episode	O
of	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

Achest	O
x-ray	O
done	O
at	O
that	O
time	O
showed	O
left	B-disease
pleural	I-disease
effusion	I-disease
and	O
small	B-disease
right	I-disease
pleural	I-disease
effusion	I-disease
,	O
not	O
pulmonary	B-disease
edema	I-disease
and	O
left	B-disease
lower	I-disease
lobe	I-disease
consolidations	I-disease
.	O

The	O
patient	O
was	O
afebrile	B-disease
,	O
her	O
vital	O
signs	O
were	O
stable	O
and	O
she	O
maintained	O
a	O
good	O
urine	O
output	O
.	O

She	O
also	O
had	O
an	O
episode	O
of	O
nausea	B-disease
with	O
some	B-disease
emesis	I-disease
,	O
after	O
being	O
treated	O
with	O
Zofran	O
with	O
no	B-disease
relief	I-disease
,	O
a	O
nasogastric	O
tube	O
was	O
placed	O
which	O
drained	O
1200	O
cc	O
of	O
bilious	B-disease
fluid	I-disease
.	O

On	O
postoperative	O
day	O
four	O
,	O
the	O
patient	O
continued	O
to	O
have	O
nasogastric	O
tube	O
in	O
place	O
.	O

A	O
repeat	O
chest	O
x-ray	O
done	O
for	O
dyspnea	B-disease
showed	O
persistent	B-disease
pleural	I-disease
effusion	I-disease
with	O
atelectasis	B-disease
versus	O
pneumonia	B-disease
.	O

Her	O
levofloxacin	O
was	O
continued	O
.	O

The	O
patient	O
tolerated	O
nasogastric	O
tube	O
clamping	O
trials	O
with	O
high	B-disease
residuals	I-disease
in	O
the	O
600	O
cc	O
range	O
.	O

The	O
patient	O
did	O
well	O
on	O
postoperative	O
day	O
five	O
and	O
six	O
.	O

She	O
was	O
started	O
on	O
clear	O
fluids	O
with	O
a	O
nasogastric	O
clamped	O
.	O

On	O
postoperative	O
day	O
seven	O
the	O
patient	O
diet	O
was	O
slowly	O
advanced	O
as	O
tolerated	O
.	O

She	O
was	O
also	O
started	O
on	O
Decadron	O
in	O
preparation	O
for	O
her	O
chemotherapy	O
.	O

On	O
postoperative	O
day	O
eight	O
which	O
is	O
Memorial	O
Day	O
the	O
patient	O
was	O
started	O
on	O
Carboplatin-Taxolchemo	O
therapy	O
,	O
which	O
she	O
tolerated	O
without	O
complication	B-disease
.	O

On	O
postoperative	O
nine	O
,	O
her	O
JP	O
drain	O
was	O
discontinued	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
that	O
afternoon	O
in	O
stable	O
condition	O
in	O
the	O
afternoon	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Dilaudid	O
2	O
to	O
4	O
mg	O
po	O
q3h	O
prn	O
pain	B-disease
,	O
Ativan	O
1	O
mg	O
po	O
q12h	O
prn	O
anxiety	B-disease
,	O
Zofran	O
8	O
mg	O
po	O
q8h	O
prn	O
nausea	B-disease
,	O
Compazine	O
10	O
mg	O
po	O
q6h	O
prn	O
nausea	B-disease
,	O
Decadron	O
20	O
mg	O
po	O
q6h	O
x	O
2	O
doses	O
.	O

The	O
patient	O
was	O
instructed	O
to	O
take	O
20	O
mg	O
at	O
11	O
pm	O
the	O
night	O
before	O
her	O
next	O
chemotherapy	O
and	O
8	O
am	O
on	O
the	O
morning	O
of	O
chemotherapy	O
.	O

Colace	O
100	O
mg	O
po	O
bid	O
,	O
Albuterol	O
inhalers	O
two	O
puffs	O
inhaled	O
qid	O
prn	O
wheezing	B-disease
and	O
asthma	B-disease
symptoms	I-disease
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

The	O
patient	O
was	O
instructed	O
to	O
follow	O
up	O
with	O
Dr.	O
Slaineaee	O
Chabechird	O
.	O

She	O
was	O
told	O
to	O
make	O
an	O
appointment	O
two	O
weeks	O
after	O
her	O
surgery	O
for	O
removal	O
of	O
her	O
retention	O
sutures	O
.	O

The	O
patient	O
was	O
discharged	O
home	O
in	O
stable	O
condition	O
.	O

NAUNGDAPHBERE	O
T.	O
BUMPSFOOKS	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O

SLAINEAEE	O
S	O
CHABECHIRD	O
,	O
JR	O
,	O
M.D.	O

06/04/2004	O
15:45	O

_____________________________	O
SLAINEAEE	O
S	O
CHABECHIRD	O
,	O
JR	O
,	O
M.D.	O

TR	O
:	O

fk	O

DD	O
:	O

05/26/2004	O

TD	O
:	O

05/27/2004	O
4:01	O
A	O
356492	O

cc	O
:	O

SLAINEAEE	O
S	O
CHABECHIRD	O
,	O
JR	O
,	O
M.D.	O

289811204	O

FIH	O

2696998	O

22684/ukjj	O

819579	O

4/16/1993	O
12:00:00	O
AM	O

RIGHT	B-disease
HIP	I-disease
,	I-disease
OSTEOARTHRITIS	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

4/16/93	O

DISCHARGE	O
DATE	O
:	O

4/23/93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Right	B-disease
hip	I-disease
,	I-disease
osteoarthritis	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
generally	O
healthy	O
85	O
year	O
old	O
female	O
,	O
who	O
has	O
had	O
a	O
five	O
year	O
history	O
of	O
right	B-disease
hip	I-disease
pain	I-disease
,	O
worsening	O
over	O
the	O
past	O
several	O
months	O
.	O

Her	B-disease
pain	I-disease
is	O
located	O
in	O
the	O
groin	O
and	O
thigh	O
.	O

It	O
is	O
aggravated	O
by	O
activity	O
and	O
improved	O
by	O
sitting	O
or	O
lying	O
down	O
.	O

It	O
is	O
associated	O
with	O
rest	B-disease
pain	I-disease
as	O
well	O
.	O

She	O
uses	O
a	O
cane	O
or	O
walker	O
for	O
ambulation	O
,	O
and	O
is	O
limited	O
to	O
one	O
to	O
two	O
blocks	O
.	O

She	O
does	O
stairs	O
one	O
at	O
a	O
time	O
and	O
only	O
with	O
help	O
.	O

She	O
has	O
difficulty	B-disease
with	I-disease
shoes	I-disease
and	I-disease
socks	I-disease
and	I-disease
foot	I-disease
care	I-disease
.	O

The	B-disease
patient	I-disease
&apos;s	I-disease
pain	I-disease
has	O
not	O
been	O
relieved	O
by	O
Darvocet	O
and	O
Advil	O
.	O

Radiographs	O
demonstrate	O
right	B-disease
hip	I-disease
osteoarthritis	I-disease
.	O

Having	O
failed	O
conservative	O
management	O
,	O
the	O
patient	O
presented	O
for	O
elective	O
right	O
total	O
hip	O
replacement	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypertension	B-disease
,	O
possible	O
peptic	B-disease
ulcer	I-disease
disease	I-disease
1959	O
,	O
history	O
of	O
left	B-disease
ankle	I-disease
and	I-disease
knee	I-disease
fractures	I-disease
,	O
1980	O
.	O

Recent	B-disease
urinary	I-disease
tract	I-disease
infection	I-disease
,	O
E.	B-disease
coli	I-disease
03/93	O
.	O

Recent	B-disease
herpes	I-disease
zoster	I-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

cholecystectomy	O
,	O
total	O
abdominal	O
hysterectomy	O
,	O
cataract	O
excision	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

hydrochlorothiazide	O
50	O
mg.	O
PO	O
qday	O
,	O
KayCiel	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

HABITS	O
:	O

The	O
patient	O
does	O
not	O
smoke	O
or	O
drink	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Negative	O
in	O
detail	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
an	O
elderly	O
woman	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

The	O
head	O
and	O
neck	O
exam	O
was	O
within	O
normal	O
limits	O
.	O

The	O
lungs	O
were	O
clear	O
to	O
auscultation	O
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
without	O
murmur	B-disease
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	O
,	O
nondistended	O
,	O
with	O
normal	O
active	O
bowel	O
sounds	O
.	O

Extremities	O
:	O

left	O
hip	O
110	O
degrees	O
of	O
flexion	O
,	O
0	O
degrees	O
of	O
extension	O
,	O
30	O
degrees	O
of	O
abduction	O
,	O
45	O
degrees	O
of	O
adduction	O
,	O
10	O
degrees	O
of	O
internal	O
rotation	O
and	O
flexion	O
,	O
45	O
degrees	O
of	O
external	O
rotation	O
and	O
flexion	O
.	O

Right	O
hip	O
90	O
degrees	O
of	O
flexion	O
,	O
minus	O
30	O
degrees	O
of	O
extension	O
,	O
20	O
degrees	O
of	O
abduction	O
,	O
30	O
degrees	O
of	O
adduction	O
,	O
less	O
than	O
5	O
degrees	O
of	O
internal	O
rotation	O
and	O
flexion	O
and	O
less	O
than	O
5	O
degrees	O
of	O
external	O
rotation	O
and	O
flexion	O
.	O

There	O
was	O
no	O
leg	B-disease
length	I-disease
discrepancy	I-disease
.	O

The	O
patient	O
&apos;s	O
gait	O
was	O
halting	O
,	O
stooped	O
and	O
slow	O
.	O

The	O
patient	O
used	O
the	O
cane	O
in	O
her	O
left	O
hand	O
.	O

The	O
patient	O
&apos;s	O
neurovascular	O
examination	O
was	O
intact	O
.	O

LABORATORY	O
DATA	O
:	O

the	O
sodium	O
was	O
140	O
,	O
potassium	O
3.7	O
,	O
chloride	O
96	O
,	O
bicarbonate	O
30	O
,	O
BUN	O
and	O
creatinine	O
14/0.9	O
,	O
glucose	O
105	O
,	O
hematocrit	O
42	O
,	O
white	O
blood	O
count	O
8.6	O
,	O
platelet	O
count	O
644,000	O
,	O
prothrombin	O
time	O
10.4	O
,	O
partial	O
thromboplastin	O
time	O
28.7	O
,	O
urinalysis	O
trace	B-disease
white	I-disease
blood	I-disease
cells	I-disease
,	O
slight	B-disease
occult	I-disease
red	I-disease
blood	I-disease
cells	I-disease
.	O

The	O
electrocardiogram	O
showed	O
normal	O
sinus	O
rhythm	O
at	O
a	O
rate	O
of	O
80	O
with	O
intraventricular	B-disease
conduction	I-disease
delay	I-disease
and	O
poor	B-disease
R	I-disease
wave	I-disease
progression	I-disease
.	O

There	O
were	O
no	O
acute	B-disease
ischemic	I-disease
changes	I-disease
.	O

The	O
chest	O
X-ray	O
showed	O
borderline	B-disease
cardiomegaly	I-disease
but	O
no	O
acute	B-disease
cardiac	I-disease
or	I-disease
pulmonary	I-disease
disease	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
Orthopedic	O
Service	O
on	O
4/16/93	O
.	O

On	O
that	O
day	O
she	O
underwent	O
clearance	O
from	O
the	O
Cardiology	O
Service	O
,	O
Dr.	O
Shuff	O
.	O

It	O
was	O
his	O
impression	O
that	O
the	B-disease
patient	I-disease
&apos;s	I-disease
hypertension	I-disease
was	O
controlled	O
on	O
hydrochlorothiazide	O
.	O

Given	O
the	B-disease
patient	I-disease
&apos;s	I-disease
low	I-disease
potassium	I-disease
level	I-disease
of	O
2.4	O
on	O
the	O
day	O
of	O
admission	O
,	O
he	O
suggested	O
supplementation	O
with	O
potassium	O
.	O

The	O
patient	O
was	O
cleared	O
from	O
surgery	O
from	O
a	O
cardiology	O
standpoint	O
.	O

On	O
the	O
following	O
morning	O
4/17/93	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
where	O
she	O
underwent	O
a	O
right	O
total	O
hip	O
replacement	O
,	O
using	O
a	O
hybrid	O
S-ROM	O
system	O
.	O

Postoperatively	O
,	O
the	O
patient	O
did	O
extremely	O
well	O
.	O

The	O
patient	O
was	O
seen	O
in	O
consultation	O
with	O
the	O
physical	O
therapy	O
service	O
initially	O
for	O
routine	O
rehabilitation	O
after	O
a	O
total	O
hip	O
replacement	O
.	O

Her	O
hemovac	O
drains	O
were	O
removed	O
on	O
postoperative	O
day	O
#	O
2	O
as	O
was	O
her	O
Foley	O
catheter	O
.	O

Her	O
hematocrit	O
remained	O
stable	O
in	O
the	O
low	O
to	O
mid	O
30	O
&apos;s	O
and	O
she	O
did	O
not	O
require	O
a	O
transfusion	O
.	O

The	O
patient	O
did	O
have	O
postoperatively	B-disease
hypokalemia	I-disease
to	O
a	O
level	O
of	O
2.7	O
and	O
subsequently	O
was	O
corrected	O
with	O
oral	O
and	O
intravenous	O
potassium	O
on	O
4/22/93	O
,	O
the	O
patient	O
underwent	O
a	O
duplex	O
ultrasound	O
examination	O
,	O
which	O
showed	O
no	O
evidence	O
of	O
of	O
deep	B-disease
venous	I-disease
thrombosis	I-disease
.	O

The	O
patient	O
&apos;s	O
Coumadin	O
was	O
thus	O
stopped	O
and	O
she	O
was	O
switched	O
to	O
Bufferin	O
.	O

The	O
patient	O
&apos;s	O
hospitalization	O
was	O
uncomplicated	O
.	O

She	O
was	O
discharged	O
to	O
the	O
Encharlea	O
Il	O
Medical	O
Center	O
in	O
New	O
Hampshire	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Right	B-disease
hip	I-disease
osteoarthritis	I-disease
,	O
status	O
post	O
right	O
total	O
hip	O
replacement	O
on	O
4/17/93	O
.	O

Hypertension	B-disease
.	O

Postoperative	B-disease
hypokalemia	I-disease
,	O
resolved	O
.	O

Postoperative	B-disease
confusion	I-disease
,	O
transient	O
and	O
resolved	O
spontaneously	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Satisfactory	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

hydrochlorothiazide	O
50	O
mg.	O
PO	O
qday	O
,	O
KayCiel	O
40	O
mEq.	O
b.i.d.	O
,	O
Ecotrin	O
1	O
tablet	O
qday	O
,	O
Ferrous	O
sulfate	O
325	O
mg.	O
PO	O
b.i.d.	O
,	O
Folate	O
1	O
mg.	O
PO	O
qday	O
,	O
multivitamins	O
one	O
tablet	O
qday	O
,	O
Tylenol	O
#	O
3	O
1	O
to	O
2	O
PO	O
q3hours	O
PRN	O
.	O

DISPOSITION	O
/	O
PLAN	O
ON	O
DISCHARGE	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
the	O
Encharlea	O
Il	O
Medical	O
Center	O
.	O

There	O
she	O
should	O
received	O
physical	O
therapy	O
to	O
consist	O
of	O
a	O
routine	O
post	O
total	O
hip	O
replacement	O
rehabilitation	O
protocol	O
,	O
with	O
emphasis	O
on	O
gait	O
training	O
,	O
partial	O
weight	O
bearing	O
on	O
the	O
right	O
lower	O
extremity	O
,	O
using	O
a	O
walker	O
or	O
crutches	O
.	O

The	O
patient	O
should	O
also	O
have	O
her	O
potassium	O
levels	O
checked	O
two	O
times	O
per	O
week	O
to	O
insure	O
that	O
she	O
is	O
not	O
becoming	O
hypokalemic	B-disease
.	O

The	O
patient	O
should	O
have	O
a	O
follow	O
up	O
appointment	O
arranged	O
with	O
Dr.	O
Level	O
.	O

LAYMIE	O
M	O
HE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

LILLBI	O
SERVICE	O
,	O
M.D.	O

TR	O
:	O

il	O
/	O
bmot	O

DD	O
:	O

4/22/93	O

TD	O
:	O

04/22/93	O

CC	O
:	O

Dr.	O
Lako	O
Service	O
STAT	O

688127038	O
EH	O

47449520	O

204512	O

3/5/2002	O
12:00:00	O
AM	O

TCA	B-disease
overdose	I-disease

DIS	O

Admission	O
Date	O
:	O

03/05/2002	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

03/07/2002	O

******	O
DISCHARGE	O
ORDERS	O
******	O

HULLEKOTE	O
,	O
AU	O
329-72-53-3	O
Z23	O

Room	O
:	O

29Z-191	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

03/07/02	O
AT	O
11:00	O
AM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

UPHMADRE	O
,	O
CIOUSALE	O
N.	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Rehabilitation	O

DISCHARGE	O
MEDICATIONS	O
:	O

FOLATE	O
(	O
FOLIC	O
ACID	O
)	O
1	O
MG	O
PO	O
QD	O
ZANTAC	O
(	O
RANITIDINE	O
HCL	O
)	O
150	O
MG	O
PO	O
BID	O
MVI	O
THERAPEUTIC	O
W	O
/	O
MINERALS	O
(	O
THERAP	O
VITS	O
/	O
MINERALS	O
)	O
1	O
TAB	O
PO	O
QD	O
THIAMINE	O
HCL	O
100	O
MG	O
PO	O
QD	O

DIET	O
:	O

No	O
Restrictions	O
Activity	O
-	O
As	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Ee	O
,	O
patient	O
to	O
arrange	O
,	O
No	O
Known	B-disease
Allergies	I-disease

ADMIT	O
DIAGNOSIS	O
:	O

TCA	B-disease
overdose	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
TCA	B-disease
overdose	I-disease

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
depression	B-disease
(	I-disease
depression	I-disease
)	I-disease

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

None	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

32	O
y	O
/	O
o	O
woman	O
with	O
h	O
/	O
o	O
anxiety	B-disease
and	O
depression	B-disease
and	O
prior	B-disease
suicide	I-disease
attempt	I-disease
presents	O
with	O
TCA	B-disease
and	I-disease
celexa	I-disease
overdose	I-disease
,	O
tremulous	B-disease
/	O
light-headed	B-disease
,	O
felt	O
better	O
post	O
charcoal	O
.	O

No	O
EKG	O
changes	O
,	O
marijuana	O
in	O
urine	O
,	O
HCO3	O
22	O
.	O

Transferred	O
to	O
floor	O
on	O
day	O
of	O
admission	O
with	O
no	O
acute	B-disease
medical	I-disease
issues	I-disease
;	O
awaiting	O
psych	O
eval	O
.	O

Not	O
actively	B-disease
suicidal	I-disease
.	O

3/7	O
--	O
repeat	O
HCO3	O
24	O
and	O
26	O
without	O
bicarb	O
drip	O
.	O

EKG	O
without	O
changes	O
.	O

Patient	O
felt	O
well	O
,	O
tolerating	O
POs	O
.	O

BEST	O
team	O
eval	O
found	O
bed	O
at	O
psych	O
rehab	O
facility	O
.	O

OF	O
NOTE	O
,	O
Nortriptyline	O
level	O
came	O
back	O
as	O
43	O
(	O
SUBTHERAPEUTIC	O
--	O
NORMAL	O
50-150	O
)	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

KOTEKEESECRANKBERF	O
,	O
LA	O
A.	O
,	O
M.D.	O
(	O
JG92	O
)	O
03/07/02	O
10:56	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

412141256	O

FIH	O

3833231	O

39626/6vf7	O

817292	O

10/3/1994	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

10-03-94	O

DISCHARGE	O
DATE	O
:	O

10-06-94	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
85	O
year	O
old	O
man	O
was	O
admitted	O
because	O
of	O
the	O
new	O
onset	O
of	O
focal	B-disease
left-sided	I-disease
seizure	I-disease
and	O
unresponsiveness	B-disease
.	O

He	O
had	O
a	O
past	O
history	O
of	O
ischemic	B-disease
cardiomyopathy	I-disease
with	O
an	O
ejection	O
fraction	O
of	O
10	O
,	O
mild	B-disease
aortic	I-disease
stenosis	I-disease
and	O
a	B-disease
right	I-disease
middle	I-disease
cerebral	I-disease
artery	I-disease
territory	I-disease
stroke	I-disease
in	O
07/94	O
.	O

He	O
was	O
at	O
Orlak	O
on	O
the	O
day	O
of	O
admission	O
and	O
was	O
found	O
unresponsive	B-disease
with	O
left	B-disease
tonic-clonic	I-disease
movements	I-disease
,	O
greater	O
in	O
the	O
arms	O
than	O
in	O
the	O
legs	O
.	O

He	O
was	O
transferred	O
to	O
Fairm	O
of	O
Ijordcompmac	O
Hospital	O
,	O
where	O
seizures	B-disease
were	O
stopped	O
with	O
2	O
mg	O
of	O
Ativan	O
.	O

He	O
was	O
loaded	O
with	O
IV	O
Dilantin	O
.	O

He	O
remained	O
unresponsive	B-disease
with	O
poor	B-disease
airway	I-disease
protection	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Eyes	O
were	O
deviated	O
to	O
the	O
left	O
.	O

He	O
was	O
flaccid	B-disease
bilaterally	I-disease
.	O

He	O
had	O
no	O
oculocephalic	B-disease
reflexes	I-disease
.	O

After	O
one	O
hour	O
his	O
eyes	O
were	O
midline	O
and	O
he	O
remained	O
unresponsive	B-disease
.	O

HOSPITAL	O
COURSE	O
:	O

By	O
the	O
patient	O
and	O
his	O
family	O
&apos;s	O
prior	O
wishes	O
,	O
the	O
patient	O
was	O
extubated	O
.	O

An	O
electroencephalogram	O
revealed	O
generalized	B-disease
slowing	I-disease
without	I-disease
ictal	I-disease
events	I-disease
.	O

He	O
had	O
no	O
carotid	B-disease
bruits	I-disease
.	O

He	O
had	O
stertorous	B-disease
breathing	I-disease
,	O
positional	B-disease
tremors	I-disease
of	I-disease
the	I-disease
left	I-disease
upper	I-disease
extremity	I-disease
,	O
a	B-disease
spastic	I-disease
left	I-disease
hemiparesis	I-disease
in	I-disease
flexion	I-disease
.	O

He	O
withdrew	O
both	O
legs	O
to	O
painful	O
stimuli	O
.	O

The	O
right	O
upper	O
extremity	O
was	O
flaccid	B-disease
and	O
paresthetic	B-disease
.	O

Again	O
,	O
comfort	O
measures	O
only	O
were	O
undertaken	O
as	O
per	O
the	O
patient	O
&apos;s	O
previous	O
wishes	O
and	O
the	O
family	O
&apos;s	O
current	O
insistence	O
.	O

At	O
1:15	O
PM	O
on	O
10/06/94	O
,	O
the	O
patient	O
was	O
found	O
unresponsive	B-disease
with	O
no	O
heart	B-disease
sounds	I-disease
,	O
carotid	B-disease
pulse	I-disease
,	O
respiratory	B-disease
excursions	I-disease
,	O
or	O
pupillary	B-disease
reactions	I-disease
.	O

His	O
family	O
was	O
notified	O
.	O

Consent	O
for	O
autopsy	O
was	O
denied	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Left	B-disease
middle	I-disease
cerebral	I-disease
artery	I-disease
territory	I-disease
cerebral	I-disease
infarction	I-disease
.	O

2.	O
Cardiomyopathy	B-disease
.	O

3.	O
Residual	O
of	O
previous	B-disease
right	I-disease
middle	I-disease
cerebral	I-disease
artery	I-disease
stroke	I-disease
.	O

RE	O
RHALTFETHFONGPOCE	O
,	O
M.D.	O

TR	O
:	O

cnm	O
/	O
bmot	O

DD	O
:	O

10-18-94	O

TD	O
:	O

10/19/94	O

CC	O
:	O

274230067	O
EH	O

11456974	O

175762	O

02/04/1990	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

02/04/1990	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

02/13/1990	O

PRINCIPLE	O
DIAGNOSIS	O
:	O

LEFT	B-disease
ROTATOR	I-disease
CUFF	I-disease
TEAR	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
52-year-old	O
right	O
handed	O
male	O
with	O
a	O
many	O
year	O
history	O
of	O
bilateral	B-disease
shoulder	I-disease
pain	I-disease
,	O
right	O
greater	O
than	O
left	O
.	O

He	O
has	O
steroid	O
injections	O
in	O
the	O
right	O
and	O
in	O
the	O
left	O
four	O
times	O
.	O

Arthrogram	O
in	O
the	O
distant	O
past	O
showed	O
a	B-disease
right	I-disease
rotator	I-disease
cuff	I-disease
tear	I-disease
and	O
he	O
now	O
has	O
increased	B-disease
pain	I-disease
in	I-disease
his	I-disease
left	I-disease
shoulder	I-disease
.	O

MRI	O
by	O
report	O
showed	O
bilateral	O
rotator	O
cuff	O
repairs	O
and	O
he	O
was	O
admitted	O
for	O
repair	O
of	O
the	O
left	O
rotator	O
cuff	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Back	B-disease
pain	I-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Ankle	O
surgery	O
times	O
two	O
on	O
the	O
right	O
.	O

Pilonidal	O
cyst	O
removal	O
.	O

MEDICATIONS	O
:	O

On	O
admission	O
included	O
Naprosyn	O
.	O

ALLERGIES	O
:	O

NO	O
KNOWN	B-disease
DRUG	I-disease
ALLERGIES	I-disease
.	O

HABITS	O
:	O

The	O
patient	O
smokes	O
two	O
packs	O
per	O
day	O
and	O
has	O
an	O
approximately	O
a	O
75-pack-year	O
history	O
of	O
smoking	O
.	O

He	O
has	O
a	O
history	O
of	O
drinking	O
which	O
he	O
discontinued	O
in	O
May	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
revealed	O
a	O
white	O
male	O
with	O
no	O
palpable	B-disease
adenopathy	I-disease
.	O

HEENT	O
exam	O
was	O
within	O
normal	O
limits	O
.	O

Lungs	O
revealed	O
occasional	B-disease
wheezing	I-disease
bilaterally	I-disease
at	O
both	O
bases	O
.	O

Heart	O
was	O
regular	O
with	O
a	B-disease
I	I-disease
/	I-disease
VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
without	O
jugular	B-disease
venous	I-disease
distention	I-disease
.	O

Pulses	O
were	O
2+	O
bilaterally	O
.	O

Abdomen	O
was	O
obese	B-disease
with	O
positive	O
bowel	O
sounds	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

Examination	O
of	O
his	O
shoulder	O
revealed	O
the	O
patient	O
to	O
be	O
able	O
to	O
flex	O
his	O
right	O
arm	O
to	O
170	O
degrees	O
,	O
internally	O
rotate	O
to	O
10	O
degrees	O
and	O
externally	O
rotate	O
to	O
40	O
degrees	O
with	O
positive	B-disease
joint	I-disease
tenderness	I-disease
.	O

All	O
range	O
of	O
motion	O
with	O
his	O
right	O
shoulder	O
was	O
painful	O
.	O

The	O
left	O
shoulder	O
was	O
identical	O
in	O
range	O
of	O
motion	O
and	O
was	O
also	O
painful	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
the	O
assessment	O
of	O
left	O
rotator	O
cuff	O
repair	O
and	O
he	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
the	O
day	O
of	O
admission	O
where	O
he	O
underwent	O
left	O
rotator	O
cuff	O
repair	O
under	O
general	O
endotracheal	O
tube	O
anesthesia	O
.	O

There	O
were	O
no	O
intraoperative	B-disease
complications	I-disease
.	O

His	O
postoperative	O
course	O
was	O
generally	O
unremarkable	O
except	O
for	O
a	O
prolonged	O
course	O
of	O
advancement	O
with	O
range	O
of	O
motion	O
of	O
his	O
left	O
shoulder	O
.	O

Occupational	O
therapy	O
became	O
involved	O
initially	O
and	O
he	O
remained	O
on	O
patient	O
controlled	O
analgesia	O
secondary	O
to	O
problems	O
with	O
left	B-disease
shoulder	I-disease
pain	I-disease
.	O

He	O
was	O
kept	O
in	O
the	O
hospital	O
for	O
an	O
extended	O
period	O
to	O
improve	O
his	O
postoperative	O
range	O
of	O
motion	O
.	O

However	O
,	O
he	O
was	O
eventually	O
able	O
to	O
achieve	O
forward	O
flexion	O
of	O
135	O
degrees	O
and	O
external	O
rotation	O
of	O
30	O
degrees	O
by	O
postoperative	O
day	O
number	O
eight	O
.	O

His	B-disease
wound	I-disease
remained	O
clean	O
and	O
dry	O
and	O
showed	O
no	O
signs	B-disease
of	I-disease
infection	I-disease
and	O
healed	O
well	O
.	O

However	O
,	O
his	O
course	O
was	O
otherwise	O
complicated	O
by	O
discovery	O
of	O
persistently	B-disease
elevated	I-disease
blood	I-disease
sugars	I-disease
and	O
Endocrinology	O
was	O
consulted	O
to	O
rule	O
out	O
possible	O
newly	B-disease
diagnosed	I-disease
diabetes	I-disease
.	O

His	O
hemoglobin	O
A1C	O
levels	O
actually	O
came	O
back	O
within	O
normal	O
limits	O
,	O
however	O
,	O
the	B-disease
wide	I-disease
excursions	I-disease
of	O
his	O
sugars	O
were	O
consistent	O
with	O
possible	O
diabetes	B-disease
.	O

He	O
was	O
placed	O
on	O
a	O
diabetic	O
diet	O
and	O
his	O
sugars	O
did	O
show	O
some	O
improvement	O
.	O

It	O
was	O
not	O
necessary	O
to	O
start	O
him	O
on	O
oral	O
hypoglycemics	O
or	O
insulin	O
.	O

He	O
also	O
complained	O
of	O
occasional	B-disease
spells	I-disease
and	O
jitteriness	B-disease
and	O
some	B-disease
orthostatic	I-disease
dizziness	I-disease
and	O
thus	O
Neurology	O
was	O
consulted	O
and	O
EMG	O
&apos;s	O
were	O
performed	O
which	O
were	O
normal	O
.	O

His	O
neurologist	O
was	O
contacted	O
,	O
Dr.	O
Cap	O
,	O
and	O
the	O
exact	O
of	O
his	O
problems	O
was	O
not	O
demonstrated	O
during	O
this	O
hospitalization	O
,	O
however	O
,	O
they	O
felt	O
that	O
this	O
could	O
possibly	O
be	O
an	B-disease
autonomic	I-disease
type	I-disease
neuropathy	I-disease
maybe	O
secondary	O
to	O
some	B-disease
underlying	I-disease
diabetic	I-disease
process	I-disease
.	O

Further	O
work-up	O
of	O
his	B-disease
neurologic	I-disease
conditions	I-disease
were	O
planned	O
as	O
an	O
outpatient	O
.	O

Thus	O
,	O
he	O
was	O
discharged	O
on	O
postoperative	O
day	O
number	O
eight	O
in	O
good	O
condition	O
with	O
a	B-disease
well	I-disease
healed	I-disease
left	I-disease
shoulder	I-disease
wound	I-disease
and	O
doing	O
well	O
with	O
occupational	O
therapy	O
with	O
plans	O
for	O
him	O
to	O
follow-up	O
with	O
Dr.	O
Necessary	O
.	O

DISPOSITION	O
:	O

MEDICATIONS	O
:	O

On	O
discharge	O
included	O
Valium	O
,	O
2	O
mg	O
po	O
t.i.d.;	O
Naprosyn	O
,	O
500	O
mg	O
po	O
b.i.d.	O
________________________________	O
ZV061/6138	O
TICENA	O
NECESSARY	O
,	O
M.D.	O
WO00	O

D	O
:	O

03/12/90	O

Batch	O
:	O

2280	O

Report	O
:	O

V1412C43	O

T	O
:	O

03/14/89	O

Dictated	O
By	O
:	O

VITA	O
THOSTERWEN	O
LINKEKOTEMONES	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2008-12-24	O

Discharge	O
Date	O
:	O

2009-02-06	O

Date	O
of	O
Birth	O
:	O

2008-12-24	O

Sex	O
:	O

F	O

Service	O
:	O

Neonatology	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Gerardo	O
is	O
the	O
1400	O
gm	O
product	O
of	O
a	O
32	O
05-03	O
week	O
twin	O
gestation	O
born	O
to	O
a	O
37	O
year	O
old	O
gravida	O
1	O
,	O
para	O
0	O
mother	O
.	O

Prenatal	O
laboratory	O
values	O
:	O

Maternal	O
blood	O
type	O
0-positive	O
,	O
DAT	O
negative	O
,	O
negative	O
,	O
RPR	O
nonreactive	O
.	O

The	O
mother	O
's	O
past	O
medical	O
history	O
is	O
significant	O
for	O
:	O

1.	O
Tuberculosis	B-disease
,	O
mother	O
was	O
treated	O
in	O
2001	O
according	O
to	O
chart	O
with	O
subsequent	O
negative	O
chest	O
x-ray	O
,	O
and	O

2.	O
Infertility	B-disease
.	O

The	O
pregnancy	O
was	O
complicated	O
by	O
twin	B-disease
gestation	I-disease
and	O
by	O
polyhydramnios	B-disease
with	O
apparent	O
duodenal	B-disease
atresia	I-disease
and	O
nuchal	O

thickening	B-disease
consistent	O
with	O
Trisomy	B-disease
21	I-disease
in	O
the	O
B	O
co-twin	O
.	O

Amniocentesis	O
was	O
not	O
performed	O
.	O

Maternal	B-disease
hypertension	I-disease
was	O
noted	O
in	O
the	O
doctor	O
's	O
office	O
and	O
Mom	O
was	O
referred	O
to	O
nonreassuring	O
fetal	O
tracing	O
,	O
necessitating	O
an	O
urgent	O
cesarean	O
section	O
.	O

Twin	O
#1	O
cried	O
spontaneously	O
at	O
birth	O
,	O
was	O
bulb	O
suctioned	O
and	O
received	O
Blow-by	O
oxygen	O
.	O

Apgars	O
were	O
8	O
at	O
one	O
minute	O
and	O
8	O
at	O
five	O
minutes	O
.	O

Twin	O
#1	O
was	O
noted	O
to	O
be	O
in	O
a	B-disease
breech	I-disease
presentation	I-disease
.	O

Sepsis	B-disease
risk	I-disease
factors	I-disease
:	O

No	O
fever	B-disease
,	O
no	O
fetal	B-disease
tachycardia	I-disease
,	O
rupture	B-disease
of	I-disease
membranes	I-disease
at	O
delivery	O
.	O

Group	O
B	O
Streptococcus	O
status	O
unknown	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Well-appearing	O
female	O
without	O
distress	B-disease
on	O
admission	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
had	O
a	O
weight	O
of	O
1400	O
gm	O
,	O
length	O
41.5	O
cm	O
and	O
head	O
circumference	O
of	O
29.25	O
cm	O
.	O

Anterior	O
fontanelle	O
,	O
soft	O
and	O
flat	O
,	O
palate	O
intact	O
,	O
nondysmorphic	B-disease
features	I-disease
.	O

Lungs	O
:	O
breath	O
sounds	O
clear	O
and	O
equal	O
bilaterally	O
,	O
no	O
retractions	B-disease
.	O

Heart	O
:	O
regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-disease
,	O
normal	O
S1	O
and	O
S2	O
,	O
pulses	O
2	O
+.	O

Abdomen	O
:	O
soft	O
,	O
nondistended	B-disease
.	O

Without	O
hepatosplenomegaly	B-disease
,	O
without	O
masses	B-disease
.	O

Normal	O
female	O
genitalia	O
.	O

Anus	O
patent	O
.	O

Positive	O
suck	O
,	O
positive	O
grasp	O
.	O

Skin	O
intact	O
.	O

Size	O
appropriate	O
for	O
gestational	O
age	O
,	O
32	O
week	O
female	O
.	O

SUMMARY	O
OF	O
HOSPITAL	O
COURSE	O
:	O

1.	O
Respiratory	O
-	O
Gerardo	O
was	O
initially	O
placed	O
in	O
nasal	O
cannula	O
oxygen	O
to	O
maintain	O
oxygen	O
saturation	O
greater	O
than	O
94	O
.	O

On	O
day	O
of	O
life	O
#1	O
,	O
caffeine	O
was	O
started	O
.	O

Gerardo	O
weaned	O
to	O
room	O
air	O
on	O
day	O
of	O
life	O
#6	O
.	O

Caffeine	O
was	O
discontinued	O
on	O
day	O
of	O
life	O
#19	O
.	O

Breath	O
sounds	O
,	O
clear	O
and	O
equal	O
,	O
without	O
retractions	B-disease
,	O
respiratory	O
rate	O
30	O
s	O
to	O
60	O
s.	O

2.	O
Cardiovascular	O
-	O
The	O
patient	O
has	O
been	O
cardiovascularly	O
stable	O
without	O
murmur	B-disease
.	O

3.	O
Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
-	O
Birthweight	O
was	O
1400	O
gm	O
,	O
25th	O
percentile	O
.	O

The	O
patient	O
was	O
initially	O
started	O
on	O
D10	O
/	O
W	O
at	O
80	O
cc	O
/	O
kg	O
/	O
day	O
.	O

She	O
began	O
enteral	O
feeds	O
on	O
day	O
of	O
life	O
#2	O
advancing	O
to	O
mother	O
's	O
breastmilk	O
30	O
with	O
ProMod	O
at	O
150	O
cc	O
/	O
kg	O
/	O
day	O
.	O

Baby	O
received	O
parenteral	O
nutrition	O
and	O
lipids	O
for	O
four	O
days	O
.	O

No	O
hypoglycemia	B-disease
issues	I-disease
noted	O
.	O

Baby	O
is	O
presently	O
tolerating	O
mother	O
's	O
breastmilk	O
with	O
Enfamil	O
powder	O
to	O
make	O
24	O
cal	O
/	O
oz	O
at	O
130	O
cc	O
/	O
kg	O
/	O
day	O
.	O

The	O
baby	O
is	O
breastfeeding	O
well	O
.	O

The	O
plan	O
is	O
for	O
alternating	O
feeds	O
.	O

4.	O
Gastrointestinal	O
,	O
genitourinary	O
-	O
Peak	O
bilirubin	O
8.5	O
,	O
phototherapy	O
times	O
24	O
hours	O
.	O

Rebound	O
bilirubin	O
6.4	O
.	O

5.	O
Hematology	O
-	O
Most	O
recent	O
hematocrit	O
was	O
42.8	O
on	O
50-05-25	O
.	O

The	O
baby	O
received	O
no	O
blood	O
products	O
.	O

6.	O
Infectious	O
disease	O
-	O
No	O
sepsis	B-disease
risk	I-disease
factors	I-disease
.	O

Initial	O
complete	O
blood	O
count	O
with	O
white	O
blood	O
cell	O
count	O
14	O
,	O
hemoglobin	O
21.6	O
,	O
hematocrit	O
62.9	O
,	O
65	O
neutrophils	O
,	O
no	O
bands	O
,	O
28	O
lymphocytes	O
.	O

Blood	O
cultures	O
negative	O
.	O

7.	O
Neurology	O
-	O
Normal	O
head	O
ultrasound	O
on	O
2009-01-08	O
.	O

8.	O
Sensory	O
-	O
Audiology	O
,	O
hearing	O
screening	O
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Baby	O
passed	O
hearing	O
test	O
on	O
2009-01-21	O
.	O

Follow	O
up	O
recommended	O
in	O
eight	O
months	O
.	O

Ophthalmology	O
:	O
eyes	O
were	O
examined	O
most	O
recently	O
on	O
2009-01-14	O
,	O
revealing	O
mature	O
retinal	O
vessels	O
.	O

A	O
follow	O
up	O
examination	O
is	O
recommended	O
in	O
six	O
to	O
eight	O
months	O
.	O

9.	O
Psychosocial	O
-	O
Bridgewater	O
State	O
Hospital	O
Center	O
's	O
social	O
work	O
involved	O
with	O
family	O
.	O

The	O
contact	O
social	O
worker	O
is	O
Barbara	O
Cole	O
and	O
she	O
can	O
be	O
reached	O
at	O
(	O
972	O
)	O
433-8086	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O
Home	O
.	O

PRIMARY	O
PEDIATRICIAN	O
:	O

Dr.	O
Vito	O
Dotzler	O
,	O
phone	O
(	O
259	O
)	O
579-8396	O
,	O
fax	O
898-3942	O
.	O

RECOMMENDATIONS	O
:	O

1.	O
Feeds	O
-	O
Breastfeeding	O
ad	O
lib	O
,	O
supplementing	O
with	O
Enfamil	O
24	O
or	O
breastmilk	O
24	O
cal	O
/	O
oz	O
made	O
with	O
1	O
tsp	O
of	O
Enfamil	O
powder	O
per	O
100	O
cc	O
of	O
breastmilk	O
.	O

2.	O
Medications	O
-	O
Poly-Vi-James	O
1	O
cc	O
p.o.	O
q.	O
day	O
;	O
Iron	O
or	O
Fer-In-James	O
0.2	O
cc	O
p.o.	O
q.	O
day	O
to	O
give	O
2	O
mg	O
/	O
kg	O
/	O
day	O

3.	O
Car	O
seat	O
screening	O
-	O
Passed	O
.	O

4.	O
State	O
newborn	O
screening	O
-	O
Last	O
on	O
2009-01-07	O
,	O
all	O
within	O
normal	O
range	O
.	O

5.	O
Immunizations	O
received	O
-	O
Hepatitis	O
B	O
vaccine	O
given	O
2009-01-22	O
.	O

6.	O
Immunizations	O
recommended	O
-	O

Synagis	O
respiratory	O
syncytial	O
virus	O
prophylaxis	O
should	O
be	O
considered	O
from	O
October	O
through	O
April	O
for	O
infants	O
who	O
meet	O

any	O
of	O
the	O
following	O
three	O
criteria	O
-	O

1.	O
Born	O
at	O
less	O
than	O
32	O
weeks	O
;	O

2.	O
Born	O
between	O
32	O
and	O
35	O
weeks	O
with	O
plans	O
for	O
daycare	O
during	O
respiratory	O
syncytial	O
virus	O
season	O
,	O
with	O
a	O
smoker	O
in	O
the	O
household	O
or	O
with	O
preschool	O
siblings	O
;	O
or	O

3.	O
With	O
chronic	B-disease
lung	I-disease
disease	I-disease
.	O

After	O
some	O
debate	O
,	O
we	O
concluded	O
that	O
Vetrano	O
was	O
not	O
at	O
unusually	O
high	O
risk	O
from	O
RSV	B-disease
,	O
but	O
that	O
her	O
sister	O
might	O
be	O
.	O

Vetrano	O
probably	O
does	O
not	O
need	O
Synagis	O
at	O
least	O
until	O
her	O
sibling	O
is	O
discharged	O
from	O
the	O
hospital	O
.	O

It	O
may	O
then	O
be	O
reasonable	O
to	O
treat	O
both	O
for	O
the	O
balance	O
of	O
the	O
RSV	O
season	O
.	O

Influenza	O
immunization	O
should	O
be	O
considered	O
annually	O
in	O
the	O
fall	O
for	O
preterm	O
infants	O
with	O
chronic	B-disease
lung	I-disease
disease	I-disease
once	O
they	O

reach	O
six	O
months	O
of	O
age	O
,	O
before	O
this	O
age	O
the	O
family	O
and	O
other	O
caregivers	O
should	O
be	O
considered	O
for	O
immunization	O
against	O

influenza	B-disease
to	O
protect	O
the	O
infant	O
.	O

7.	O
Follow	O
up	O
-	O
Follow	O
up	O
appointment	O
with	O
primary	O
pediatrician	O
within	O
five	O
days	O
of	O
discharge	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Prematurity	B-disease
,	O
former	O
32	O
4/7	O
weeks	O
,	O
Twin	O
#1	O

2.	O
Rule	O
out	O
sepsis	B-disease

Beverly	O
Q.	O
Bailey	O
,	O
M.D.	O
02-131	O

Dictated	O
By	O
:	O
Carmen	O
Y.R.	O
Martinez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-02-05	O
18:20	O

T	O
:	O
2009-02-05	O
18:39	O

JOB	O
#:	O

17371	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lizzie	O
Calkins	O
on	O
:	O
Adeline	O
2009-02-06	O
10:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2017-08-12	O

Discharge	O
Date	O
:	O

2017-08-16	O

Date	O
of	O
Birth	O
:	O

1995-02-03	O

Sex	O
:	O

F	O

Service	O
:	O
SURGERY	O

Allergies	O
:	O

Shellfish	O

Attending	O
:	O
Maria	O
X	O
White	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Motor	O
vehicle	O
accident	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

None	O

History	O
of	O
Present	O
Illness	O
:	O

22	O
year	O
old	O
female	O
transfer	O
from	O
outside	O
hospital	O
after	O
a	O
motor	O
vehicle	O
accident	O
with	O
diagnosed	B-disease
liver	I-disease
laceration	I-disease
by	O
CT	O
scan	O
.	O

Past	O
Medical	O
History	O
:	O

None	O

Social	O
History	O
:	O

Social	O
alcohol	O

Family	O
History	O
:	O

Non	O
pertinent	O
to	O
admission	O

Physical	O
Exam	O
:	O

Patient	O
was	O
alert	O
,	O
oriented	O
x3	O
.	O

Neck	O
with	O
cervical	O
collar	O
.	O

Left	B-disease
forarm	I-disease
and	I-disease
right	I-disease
knee	I-disease
abrasions	I-disease
.	O

Chest	O
clear	O
to	O
auscultation	O
bilateral	O
,	O
S1	O
S2	O
normal	O
and	O
with	O
no	O
murmors	B-disease
.	O

Abdominal	B-disease
pain	I-disease
predominally	O
on	O
the	O
right	O
upper	O
quadrant	O
,	O
no	O
signs	O
of	O
peritoneal	B-disease
irritation	I-disease
.	O

Pertinent	O
Results	O
:	O

2017-08-12	O
11:41	O
PM	O

GLUCOSE	O
-	O
74	O
UREA	O
N	O
-	O
9	O
CREAT	O
-	O
0.7	O
SODIUM	O
-	O
139	O
POTASSIUM	O
-	O
3.5	O
CHLORIDE	O
-	O
106	O
TOTAL	O
CO2	O
-	O
23	O
ANION	O
GAP	O
-	O
14	O

2017-08-12	O
11:41PM	O

ALT(SGPT)	O
-	O
241	O
*	O
AST(SGOT)	O
-	O
207	O
*	O
ALK	O
PHOS	O
-	O
51	O
TOT	O
BILI	O
-	O
0.8	O

2017-08-12	O
11:41	O
PM	O

CALCIUM	O
-	O
8.2	O
*	O
PHOSPHATE	O
-	O
3.1	O
MAGNESIUM	O
-	O
2.2	O

2017-08-12	O
03:15	O
PM	O

GLUCOSE	O
-	O
75	O
UREA	O
N	O
-	O
10	O
CREAT	O
-	O
0.6	O
SODIUM	O
-	O
137	O
POTASSIUM	O
-	O
3.7	O
CHLORIDE	O
-	O
103	O
TOTAL	O
CO2	O
-	O
23	O
ANION	O
GAP	O
-	O
15	O

2017-08-12	O
03:15	O
PM	O

ALT(SGPT)	O
-	O
318	O
*	O
AST(SGOT)	O
-	O
307	O
*	O
ALK	O
PHOS	O
-	O
61	O
TOT	O
BILI	O
-	O
0.9	O

2017-08-12	O
03:15	O
PM	O

WBC	O
-	O
8.3	O
RBC	O
-	O
3.64	O
*	O
HGB	O
-	O
12.6	O
HCT	O
-	O
36.1	O
MCV	O
-	O
99	O
*	O
MCH	O
-	O
34.7	O
*	O
MCHC	O
-	O
35.0	O
RDW	O
-	O
12.4	O

2017-08-12	O
03:15	O
PM	O

PT	O
-	O
11.6	O
PTT	O
-	O
26.0	O
INR(PT)	O
-	O
0.9	O

Brief	O
Hospital	O
Course	O
:	O

Patient	O
was	O
admited	O
,	O
pain	B-disease
was	O
managed	O
with	O
a	O
PCA	O
and	O
later	O
with	O
PO	O
medication	O
.	O

The	B-disease
liver	I-disease
laceration	I-disease
was	O
stable	O
,	O
no	O
sign	O
of	O
rupture	B-disease
or	O
further	B-disease
complication	I-disease
,	O
did	O
not	O
required	O
surgical	O
managment	O
.	O

The	O
liver	O
enzimes	O
come	O
down	O
,	O
no	O
signs	O
of	O
biliary	B-disease
stasis	I-disease
.	O

She	O
was	O
able	O
to	O
tolerate	O
diet	O
,	O
ambulate	O
,	O
having	O
a	O
bowel	O
movement	O
and	O
dischargo	O
home	O
in	O
good	O
conditions	O
.	O

Medications	O
on	O
Admission	O
:	O

None	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
4	O
days	O
.	O

Disp	O
:*	O
8	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Hydromorphone	O
2	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q2H	O
(	O
every	O
2	O
hours	O
)	O
as	O
needed	O
for	O
Pain	B-disease
for	O
4	O
days	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Motor	O
vehicle	O
accident	O

Discharge	O
Condition	O
:	O

Good	O

Discharge	O
Instructions	O
:	O

-	O
Follow	O
up	O
with	O
Trauma	O
Surgery	O
Clinic	O
with	O
the	O
Result	O
from	O
the	O
CT	O
scan	O
abdomen	O

-	O
Call	O
for	O
appointment	O
to	O
(	O
289	O
)	O
411-5387	O
for	O
the	O
Trauma	O
Clinic	O
and	O
Abdominal	O
CT	O
scan	O
of	O
the	O
Abdomen	O
in	O
4	O
weeks	O

-	O
If	O
any	B-disease
abdominal	I-disease
pain	I-disease
,	O
fever	B-disease
or	O
dizziness	B-disease
,	O
go	O
to	O
the	O
Emergency	O
Room	O

-	O
Avoid	O
contact	O
sport	O
until	O
seen	O
in	O
the	O
Clinic	O

-	O
Analgesic	O
(	O
Percocet	O
)	O
as	O
needed	O

Followup	O
Instructions	O
:	O

-	O
Trauma	O
Surgery	O
Clinic	O
in	O
four	O
weeks	O
with	O
CT	O
abdomen	O
results	O
.	O

Call	O
Trauma	O
Clinic	O
to	O
coordinate	O
the	O
study	O
,	O
result	O
and	O
appointment	O
dates	O
((	O
289	O
)	O
411-5387	O
).	O

Ida	O
Doris	O
MD	O
79-274	O

Completed	O
by	O
:	O
Jane	O
Ashmore	O
MD	O
50-063	O
2017-08-16	O
@	O
0950	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jennifer	O
Green	O
on	O
:	O
FRI	O
2017-09-01	O
1:04	O
PM	O

(	O
End	O
of	O
Report	O
)	O

284487129	O

CTMC	O

42669672	O

466333	O

01/16/1996	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Admission	O
Date	O
:	O

01/16/1996	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

01/20/1996	O

PROBLEM	O
LIST	O
:	O

1.	O
INSULIN	B-disease
DEPENDENT	I-disease
DIABETES	I-disease
MELLITUS	I-disease

2.	O
PRIOR	O
HISTORY	O
OF	O
ANTERIOR	B-disease
MYOCARDIAL	I-disease
INFARCTION	I-disease

3.	O
EPISODE	O
OF	O
PULMONARY	B-disease
EDEMA	I-disease

4.	O
HYPERCHOLESTEROLEMIA	B-disease

CHIEF	O
COMPLAINT	O
:	O

The	O
patient	O
is	O
a	O
40	O
year	O
old	O
male	O
with	O
a	O
history	O
of	O
prior	B-disease
anterior	I-disease
myocardial	I-disease
infarction	I-disease
and	O
insulin	B-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease
who	O
was	O
transferred	O
from	O
an	O
outside	O
hospital	O
after	O
an	O
episode	O
of	O
acute	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
pulmonary	B-disease
edema	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
has	O
a	O
history	O
four	O
years	O
ago	O
of	O
being	O
admitted	O
to	O
the	O
Etearal	O
Etsystems/	O
Hospital	O
after	O
suffering	O
an	B-disease
acute	I-disease
anterior	I-disease
myocardial	I-disease
infarction	I-disease
.	O

The	O
course	O
had	O
multiple	B-disease
complications	I-disease
requiring	O
pressors	O
.	O

He	O
had	O
a	O
cardiac	O
catheterization	O
performed	O
which	O
revealed	O
a	B-disease
three	I-disease
vessel	I-disease
coronary	I-disease
artery	I-disease
disease	I-disease
with	O
an	B-disease
occluded	I-disease
RCA	I-disease
,	O
70%-80%	B-disease
proximal	I-disease
LAD	I-disease
,	O
and	O
a	B-disease
high	I-disease
grade	I-disease
left	I-disease
circumflex	I-disease
lesion	I-disease
after	I-disease
the	I-disease
OM	I-disease
with	O
distal	B-disease
left	I-disease
circumflex	I-disease
occlusion	I-disease
.	O

The	O
patient	O
was	O
subsequently	O
medically	O
management	O
after	O
this	O
hospitalization	O
and	O
has	O
done	O
very	O
well	O
.	O

His	O
most	O
recent	O
echocardiogram	O
in	O
April	O
of	O
1996	O
showed	O
an	O
ejection	O
fraction	O
of	O
20%	O
with	O
a	B-disease
thin	I-disease
fibrotic	I-disease
septum	I-disease
with	O
akinesis	B-disease
and	O
moderately	B-disease
severe	I-disease
hypokinesis	I-disease
in	I-disease
all	I-disease
other	I-disease
regions	I-disease
except	O
for	O
the	O
lateral	O
wall	O
.	O

The	O
patient	O
also	O
had	O
an	O
electrocardiogram	O
in	O
April	O
of	O
1996	O
which	O
was	O
negative	O
following	O
,	O
however	O
was	O
at	O
a	O
low	O
workload	O
.	O

The	O
patient	O
&apos;s	O
was	O
most	O
recently	O
admitted	O
to	O
Centdick	O
Naco	O
Hospital	O
Medical	O
Center	O
on	O
Martin	O
Luther	O
King	O
Day	O
after	O
becoming	O
acutely	B-disease
short	I-disease
of	I-disease
breath	I-disease
after	O
a	O
five	O
minute	O
walk	O
.	O

He	O
had	O
no	O
chest	B-disease
pain	I-disease
,	O
palpitations	B-disease
,	O
diaphoresis	B-disease
,	O
or	O
nausea	B-disease
.	O

He	O
called	O
the	O
EMT	O
&apos;s	O
and	O
was	O
found	O
to	O
be	O
in	O
pulmonary	B-disease
edema	I-disease
by	O
chest	O
x-ray	O
at	O
Centdick	O
Naco	O
Hospital	O
Medical	O
Center	O
.	O

He	O
was	O
diuresed	O
and	O
ruled	O
out	O
for	O
myocardial	B-disease
infarction	I-disease
.	O

His	O
ECG	O
showed	O
no	O
ischemic	B-disease
changes	I-disease
.	O

He	O
was	O
then	O
transferred	O
to	O
the	O
Retelk	O
County	O
Medical	O
Center	O
for	O
further	O
management	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

(1)	O
Insulin	B-disease
dependent	I-disease
diabetes	I-disease
mellitus	I-disease
x	O
15	O
years	O
with	O
no	O
retinopathy	B-disease
or	O
foot	B-disease
lesions	I-disease
.	O

(2)	O
Bilateral	B-disease
cataracts	I-disease
.	O

(3)	O
In	O
1967	O
he	O
had	O
an	O
orchiopexy	O
for	O
undescended	B-disease
testicle	I-disease
.	O

(4)	O
Coronary	B-disease
artery	I-disease
disease	I-disease
as	O
above	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Aspirin	O
325	O
mg	O
p.o.	O
q.	O
day	O
,	O
Capoten	O
25	O
mg	O
p.o.	O
q.8h.	O
,	O
NPH	O
insulin	O
28	O
units	O
q.a.m.	O
and	O
10	O
units	O
q.p.m.	O
,	O
Regular	O
insulin	O
4	O
units	O
q.a.m.	O
and	O
4	O
units	O
q.p.m.	O
,	O
simvastatin	O
20	O
mg	O
p.o.	O
q.	O
day	O
,	O
digoxin	O
0.25	O
mg.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lives	O
with	O
his	O
two	O
brothers	O
and	O
is	O
on	O
disability	O
.	O

He	O
has	O
a	O
ten	O
pack	O
year	O
history	O
of	O
smoking	O
,	O
quit	O
in	O
1990	O
.	O

He	O
does	O
not	O
drink	O
alcohol	O
.	O

FAMILY	O
HISTORY	O
:	O

His	O
mother	O
and	O
father	O
both	O
died	O
secondary	O
to	O
myocardial	B-disease
infarction	I-disease
.	O

One	O
of	O
his	O
brothers	O
has	O
had	O
a	B-disease
myocardial	I-disease
infarction	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Temperature	O
100.3	O
,	O
heart	O
rate	O
76	O
,	O
blood	O
pressure	O
100/78	O
,	O
respiratory	O
rate	O
16	O
,	O
and	O
an	O
oxygen	O
saturation	O
of	O
96%	O
on	O
two	O
liters	O
.	O

NECK	O
:	O

No	O
jugular	B-disease
venous	I-disease
distention	I-disease
.	O

CHEST	O
:	O

Clear	O
to	O
auscultation	O
with	O
no	O
wheezes	B-disease
or	O
rales	B-disease
.	O

CARDIOVASCULAR	O
:	O

Regular	O
rate	O
and	O
rhythm	O
with	O
no	O
extra	B-disease
heart	I-disease
sounds	I-disease
and	O
no	O
murmurs	B-disease
.	O

ABDOMEN	O
:	O

Benign	O
.	O

EXTREMITIES	O
:	O

No	O
edema	B-disease
with	O
2+	O
pulses	O
.	O

LABORATORY	O
DATA	O
:	O

BUN	O
25	O
and	O
creatinine	O
1.4	O
.	O

White	O
count	O
6	O
and	O
hematocrit	O
41.5	O
.	O

PT	O
14.1	O
with	O
an	O
INR	O
of	O
1.4	O
,	O
PTT	O
36.7	O
.	O

Chest	O
x-ray	O
showed	O
no	O
infiltrates	B-disease
and	O
no	O
pulmonary	B-disease
edema	I-disease
.	O

Urinalysis	O
was	O
negative	O
.	O

Electrocardiogram	O
showed	O
normal	O
sinus	O
rhythm	O
at	O
63	O
with	O
normal	O
intervals	O
.	O

He	O
had	O
flat	B-disease
T	I-disease
waves	I-disease
in	I-disease
I	I-disease
and	I-disease
aVL	I-disease
,	O
which	O
were	O
unchanged	O
from	O
previous	O
ECG	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
for	O
further	O
management	O
of	O
his	B-disease
pulmonary	I-disease
edema	I-disease
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
possibly	O
had	O
a	O
worsening	O
of	O
his	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
and	O
therefore	O
underwent	O
cardiac	O
catheterization	O
on	O
01/17/96	O
.	O

At	O
cardiac	O
catheterization	O
he	O
had	O
an	O
RA	O
pressure	O
of	O
8	O
,	O
an	O
RV	O
pressure	O
of	O
52/10	O
,	O
PA	O
pressure	O
of	O
60/25	O
,	O
and	O
wedge	O
of	O
26	O
.	O

His	O
coronary	O
arteries	O
revealed	O
an	B-disease
80%	I-disease
stenosis	I-disease
and	O
a	B-disease
large	I-disease
OM	I-disease
.	O

The	O
dominant	O
left	O
circumflex	O
was	O
occluded	B-disease
with	O
left-to-left	B-disease
filling	I-disease
.	O

He	O
also	O
had	O
a	B-disease
50%	I-disease
LAD	I-disease
stenosis	I-disease
,	O
a	B-disease
100%	I-disease
large	I-disease
DT	I-disease
stenosis	I-disease
and	O
a	O
nondominant	O
RCA	O
with	O
left	O
RCA	O
collaterals	O
.	O

It	O
was	O
felt	O
that	O
this	O
cardiac	O
catheterization	O
was	O
not	O
significantly	O
changed	O
from	O
his	O
previous	O
catheterization	O
.	O

Given	O
his	B-disease
high	I-disease
right-sided	I-disease
filling	I-disease
pressure	I-disease
,	O
he	O
was	O
started	O
on	O
Lasix	O
for	O
diuresis	O
and	O
his	O
Captopril	O
was	O
increased	O
for	O
greater	O
afterload	O
reduction	O
.	O

It	O
was	O
felt	O
that	O
the	O
patient	O
should	O
have	O
an	O
augmented	O
medical	O
regimen	O
and	O
as	O
an	O
outpatient	O
undergo	O
an	O
exercise	O
tolerance	O
test	O
with	O
viability	O
evaluation	O
to	O
determine	O
whether	O
he	O
would	O
benefit	O
from	O
revascularization	O
.	O

He	O
was	O
restarted	O
on	O
Coumadin	O
for	O
his	B-disease
low	I-disease
ejection	I-disease
fraction	I-disease
and	O
started	O
on	O
diuresis	O
with	O
IV	O
Lasix	O
for	O
two	O
days	O
and	O
then	O
switched	O
to	O
an	O
oral	O
Lasix	O
regimen	O
.	O

DISPOSITION	O
:	O

He	O
was	O
discharged	O
to	O
home	O
in	O
stable	O
condition	O
and	O
feeling	O
well	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Insulin	O
NPH	O
10	O
units	O
q.p.m.	O
and	O
28	O
units	O
q.a.m.	O
,	O
insulin	O
Regular	O
4	O
units	O
q.a.m.	O
and	O
4	O
units	O
q.p.m.	O
,	O
aspirin	O
325	O
mg	O
p.o.	O
q.	O
day	O
,	O
digoxin	O
0.25	O
mg	O
p.o.	O
q.	O
day	O
,	O
simvastatin	O
20	O
mg	O
p.o.	O
q.	O
day	O
,	O
captopril	O
37.5	O
mg	O
p.o.	O
t.i.d.	O
,	O
Coumadin	O
5	O
mg	O
p.o.	O
q.h.s.	O
,	O
Lasix	O
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

FOLLOW-UP	O
:	O

He	O
is	O
to	O
see	O
Dr.	O
Ench	O
in	O
two	O
weeks	O
to	O
check	O
his	O
PT	O
and	O
INR	O
,	O
also	O
to	O
check	O
for	O
potassium	O
.	O

Dictated	O
By	O
:	O

CA	O
X.	O
SCGACH	O
,	O
M.D.	O
YG59	O

Attending	O
:	O

JEMALKYLE	O
J.	O
EHKOTE	O
,	O
M.D.	O
BI7	O
PJ387/3762	O

Batch	O
:	O

37377	O

Index	O
No.	O
WDXZUZ7Y9B	O

D	O
:	O

01/20/96	O

T	O
:	O

01/20/96	O

638157550	O
SC	O

97308722	O

6261929	O

1/22/2005	O
12:00:00	O
AM	O

gastritis	B-disease

DIS	O

Admission	O
Date	O
:	O

01/22/2005	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/24/2005	O

******	O
DISCHARGE	O
ORDERS	O
******	O

AKOTE	O
,	O
NAO	O
630-65-64-5	O
Q39	O

Room	O
:	O

70B-157	O

Service	O
:	O

GGI	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/24/05	O
AT	O
07:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

GAETZFREIERM	O
,	O
DENA	O
DA	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

AMOXICILLIN	O
1,000	O
MG	O
PO	O
BID	O
X	O
28	O
doses	O

Instructions	O
:	O

for	O
H.Pylori	B-disease
.	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

May	O
be	O
taken	O
without	O
regard	O
to	O
meals	O

CLARITHROMYCIN	O
500	O
MG	O
PO	O
BID	O
X	O
28	O
doses	O

Instructions	O
:	O

h.pylori	O
tx	O
.	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Take	O
with	O
food	O

Alert	O
overridden	O
:	O

Override	O
added	O
on	O
01/23/05	O
by	O
DAINSAYLESNOORT	O
,	O
AGER	O
,	O
M.D.	O
,	O
PH.D.	O

SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	O
and	O
CLARITHROMYCIN	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	O
and	O
CLARITHROMYCIN	O

Reason	O
for	O
override	O
:	O

will	O
monitor	O
.	O

HYDROCHLOROTHIAZIDE	O
25	O
MG	O
PO	O
QD	O
ZOCOR	O
(	O
SIMVASTATIN	O
)	O
40	O
MG	O
PO	O
QHS	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Avoid	O
grapefruit	O
unless	O
MD	O
instructs	O
otherwise	O
.	O

Override	O
Notice	O
:	O

Override	O
added	O
on	O
01/23/05	O
by	O
DAINSAYLESNOORT	O
,	O
AGER	O
,	O
M.D.	O
,	O
PH.D.	O
on	O
order	O
for	O
CLARITHROMYCIN	O
PO	O
(	O
ref	O
#	O
99052380	O
)	O

SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	O
and	O
CLARITHROMYCIN	O

POTENTIALLY	O
SERIOUS	O
INTERACTION	O
:	O

SIMVASTATIN	O
and	O
CLARITHROMYCIN	O

Reason	O
for	O
override	O
:	O

will	O
monitor	O
.	O

POTASSIUM	O
CHLORIDE	O
SLOW	O
REL.	O
(	O
KCL	O
SLOW	O
RELEASE	O
)	O
40	O
MEQ	O
PO	O
QD	O
As	O
per	O
SC	O

Potassium	O
Chloride	O
Policy	O
:	O

each	O
20	O
mEq	O
dose	O
to	O
be	O
given	O
with	O
4	O
oz	O
of	O
fluid	O
COZAAR	O
(	O
LOSARTAN	O
)	O
50	O
MG	O
PO	O
QD	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

2	O

LAMICTAL	O
(	O
LAMOTRIGINE	O
)	O
150	O
MG	O
PO	O
BID	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

5	O

WELLBUTRIN	O
SR	O
(	O
BUPROPION	O
HCL	O
SUSTAINED	O
RELEASE	O
)	O
200	O
MG	O
PO	O
BID	O

Number	O
of	O
Doses	O
Required	O
(	O
approximate	O
)	O
:	O

4	O

ESOMEPRAZOLE	O
20	O
MG	O
PO	O
BID	O
X	O
28	O
doses	O

Instructions	O
:	O

H.	O
Pylori	O
tx	O
.	O

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Resume	O
regular	O
exercise	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr.	O
Gaetzfreierm	O
1-2	O
weeks	O
,	O

ALLERGY	O
:	O

PERCOCET	O
,	O
IV	O
Contrast	O
,	O
LISINOPRIL	O
,	O
ATENOLOL	O

ADMIT	O
DIAGNOSIS	O
:	O

Gastritis	B-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O
Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
gastritis	B-disease

OTHER	O
DIAGNOSIS	O
;	O
Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
Obesity	B-disease
HTN	B-disease
High	B-disease
Cholesterol	I-disease
Tobacco	O
Fhx	O
of	O
CAD	B-disease
ETT	O
12/94	O
(	O
-	O
)	O
ischemia	B-disease
ECHO	O
02/89	O
nl	O
ETT	O
03/89	O
,	O
07/90	O
c	O
/	O
w	O
ND	B-disease
ische	I-disease

Takes	O
hubby	O
&apos;s	O
sl	O
ntg	O
Barium	O
Swallow	O
04/89	O
(	O
-	O
)	O
UGI	O
06/91	O
(	O
-	O
)	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

MRI	O
HIDA	O
CT	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

The	O
pt	O
is	O
a	O
55yo	O
F	O
s	O
/	O
p	O
Roux	O
en	O
Y	O
GBP	O
in	O
12/20	O
presenting	O
to	O
the	O
ED	O
this	O
AM	O
c	O
/	O
o	O
mod	B-disease
severe	I-disease
midepigastric	I-disease
pain	I-disease
.	O

She	O
notes	O
that	O
she	O
has	O
had	O
this	B-disease
pain	I-disease
since	O
Thursday	O
,	O
and	O
that	O
it	O
becomes	O
much	O
worse	O
within	O
15	O
min	O
of	O
consuming	O
a	O
meal	O
.	O

She	O
has	O
also	O
had	O
intermittent	B-disease
post-prandial	I-disease
nausea	I-disease
/	I-disease
satiety	I-disease
for	O
which	O
she	O
had	O
been	O
scheduled	O
for	O
an	O
outpt	O
EGD	O
with	O
GI	O
on	O
2/8	O
.	O

She	O
describes	O
the	B-disease
pain	I-disease
as	O
band-like	O
/	O
radiating	O
to	O
both	O
sides	O
but	O
not	O
the	O
back	O
.	O

Her	B-disease
pain	I-disease
currently	O
is	O
5/10	O
.	O

ROS	O
(	O
-	O
)	O
emesis	B-disease
/	O
BRBPR/melena	B-disease
/	O
fever/chills	B-disease
/	O
sob	B-disease
.	O

Pt	O
was	O
seen	O
by	O
GI	O
on	O
13	O
EGD	O
was	O
performed	O
HD2	O
which	O
was	O
negative	O
for	O
gastritis	B-disease
,	O
stricture	B-disease
or	O
ulcer	B-disease
.	O

Pt	O
was	O
found	O
to	O
be	O
H.	B-disease
Pylori	I-disease
positive	I-disease
and	O
therefore	O
was	O
started	O
on	O
empiric	O
treatment	O
.	O

Afferent	O
limb	O
of	O
the	O
roux	O
en	O
y	O
anastamosis	O
was	O
visualized	O
however	O
the	O
efferent	O
limb	O
could	O
not	O
be	O
explored	O
.	O

Pt	O
had	O
HIDA	O
scan	O
which	O
was	O
negative	O
for	O
obstruction	B-disease
,	O
and	O
CT	O
was	O
unremarkable	O
.	O

Pt	O
was	O
tolerating	O
regular	O
diet	O
by	O
HD4	O
,	O
and	O
GI	O
felt	O
that	O
further	O
workup	O
could	O
be	O
continued	O
as	O
an	O
outpatient	O
.	O

Pt	O
was	O
therefore	O
discharged	O
home	O
in	O
stable	O
condition	O
,	O
voiding	O
,	O
ambulating	O
and	O
eating	O
without	O
difficulty	O
.	O

Plans	O
to	O
follow	O
up	O
with	O
outpatient	O
MRA	O
to	O
rule	O
out	O
ischemic	O
causes	O
of	O
post	B-disease
prandial	I-disease
pain	I-disease
,	O
as	O
well	O
as	O
HIDA	O
with	O
CK	O
challenge	O
to	O
evaluate	O
for	O
biliary	B-disease
dyskinesia	I-disease
without	O
stasis	O
.	O

Pt	O
will	O
finish	O
course	O
of	O
H.	O
pylori	O
treatment	O
as	O
well	O
.	O

ADDITIONAL	O
COMMENTS	O
:	O

If	O
fevers	B-disease
,	O
chills	B-disease
,	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
diarrhea	B-disease
,	O
increasing	B-disease
pain	I-disease
with	I-disease
food	I-disease
please	O
call	O
Dr.	O
Gaetzfreierm	O
&apos;s	O
office	O
or	O
PCP	O
.	O

If	O
severe	O
,	O
then	O
proceed	O
to	O
ER	O
for	O
evaluation	O
.	O

Will	O
need	O
to	O
call	O
for	O
outpatient	O
MRA	O
and	O
HIDA	O
with	O
CCK	O
challenge	O
to	O
evaluate	O
biliary	O
system	O
and	O
mesenteric	O
vasculature	O
.	O

Please	O
continue	O
taking	O
the	O
antibiotics	O
for	O
H.	B-disease
Pylori	I-disease
for	O
full	O
course	O
(	O
26	O
more	O
days	O
)	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

DOUETSHUFF	O
,	O
DE	O
CLEEE	O
,	O
M.D.	O
(	O
CP85	O
)	O
01/24/05	O
06:53	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

Admission	O
Date	O
:	O

2015-06-04	O

Discharge	O
Date	O
:	O

2015-06-08	O

Date	O
of	O
Birth	O
:	O

1958-03-17	O

Sex	O
:	O

F	O

Service	O
:	O

CCU	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
57	O
-	O
year-old	O
female	O
with	O
a	O
history	O
of	O
hypertension	B-disease
and	O
hypercholesterolemia	B-disease
but	O
no	O
prior	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
history	I-disease
who	O
presented	O
with	O
chest	B-disease
pain	I-disease
.	O

The	O
patient	O
reports	O
the	B-disease
pain	I-disease
began	O
at	O
4:00	O
p.m.	O
on	O
the	O
day	O
of	O
admission	O
.	O

She	O
reports	O
that	O
it	O
had	O
essentially	O
started	O
earlier	O
in	O
the	O
day	O
with	O
some	B-disease
GERD-like	I-disease
symptoms	I-disease
.	O

She	O
had	O
taken	O
Maalox	O
but	O
had	O
no	O
relief	O
with	O
this	O
.	O

The	B-disease
pain	I-disease
was	O
intermittent	O
through	O
the	O
day	O
and	O
then	O
at	O
4:00	O
p.m.	O
increased	O
and	O
was	O
also	O
associated	O
with	O
nausea	B-disease
and	O
diaphoresis	B-disease
.	O

She	O
reports	O
that	O
the	B-disease
pain	I-disease
shot	O
through	O
her	O
back	O
.	O

The	O
patient	O
has	O
never	O
had	O
these	B-disease
symptoms	I-disease
in	O
the	O
past	O
.	O

She	O
arrived	O
in	O
the	O
Emergency	O
Room	O
at	O
8:00	O
p.m.	O

At	O
that	O
time	O
,	O
the	B-disease
pain	I-disease
was	O
unremitting	O
.	O

In	O
the	O
Emergency	O
Room	O
,	O
the	O
patient	O
was	O
given	O
Lopressor	O
,	O
nitroglycerin	O
,	O
and	O
aspirin	O
.	O

A	O
TP3A	O
inhibitor	O
was	O
not	O
given	O
for	O
concern	O
for	O
dissection	B-disease
.	O

The	O
patient	O
was	O
found	O
to	O
have	O
5057	O
E.	O
Sixth	O
Blvd.	O
elevations	B-disease
in	I-disease
I	I-disease
,	I-disease
aVL	I-disease
,	I-disease
and	I-disease
V1	I-disease
through	I-disease
V2	I-disease
and	O
ST	B-disease
depressions	I-disease
in	I-disease
II	I-disease
,	I-disease
III	I-disease
,	I-disease
and	I-disease
aVF	I-disease
.	O

The	O
patient	O
was	O
taken	O
emergently	O
to	O
the	O
Cardiac	O
Catheterization	O
Laboratory	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Hypertension	B-disease
.	O

2.	O
Hypercholesterolemia	B-disease
.	O

3.	O
Chondrocalcinosis	B-disease
.	O

4.	O
Carpal	B-disease
tunnel	I-disease
syndrome	I-disease
.	O

5.	O
GERD	B-disease
.	O

ADMISSION	O
MEDICATIONS	O
:	O

1.	O
Atenolol	O
25	O
.	O

2.	O
Crestor	O
10	O
q.d.	O

3.	O
Uniretic	O
15/25	O
.	O

ALLERGIES	O
:	O
The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O
The	O
patient	O
denied	O
tobacco	O
.	O

The	O
patient	O
denied	O
alcohol	O
or	O
other	O
drug	O
use	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
Vital	O
signs	O
:	O

On	O
admission	O
,	O
the	O
patient	O
was	O
afebrile	B-disease
,	O
blood	O
pressure	O
146/88	O
,	O
pulse	O
71	O
,	O
respirations	O
18	O
.	O

General	O
:	O
The	O
patient	O
was	O
a	O
well	O
appearing	O
female	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Cardiac	O
:	O
Regular	O
rate	O
and	O
rhythm	O
,	O
normal	O
S1	O
,	O
S2	O
.	O

No	O
murmurs	B-disease
were	O
appreciated	O
.	O

Lungs	O
:	O
Clear	O
to	O
auscultation	O
bilaterally	O
.	O

Abdomen	O
:	O
Soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
,	O
good	O
bowel	O
sounds	O
.	O

Extremities	O
:	O
There	O
was	O
no	O
edema	B-disease
in	I-disease
the	I-disease
extremities	I-disease
.	O

The	O
dorsalis	O
pedis	O
pulses	O
were	O
2+	O
bilaterally	O
.	O

LABORATORY	O
AND	O
RADIOLOGIC	O
DATA	O
:	O
On	O
admission	O
,	O
white	O
count	O
10.8	O
,	O
hematocrit	O
38.2	O
,	O
platelets	O
324,000	O
.	O

HOSPITAL	O
COURSE	O
:	O

1.	O
CORONARY	B-disease
ARTERY	I-disease
DISEASE	I-disease
:	O
The	O
patient	O
was	O
taken	O
to	O
Cardiac	O
Catheterization	O
where	O
she	O
was	O
found	O
to	O
have	O
two	B-disease
vessel	I-disease
disease	I-disease
.	O

The	O
proximal	O
LAD	O
was	O
found	O
to	O
have	O
a	B-disease
90%	I-disease
lesion	I-disease
with	O
a	O
septal	O
branch	O
with	O
a	B-disease
95%	I-disease
stenosis	I-disease
and	O
a	O
diagonal	O
branch	O
with	O
99%	B-disease
stenosis	I-disease
.	O

The	O
patient	O
had	O
twin	O
LAD	O
stents	O
to	O
the	O
LAD	O
diagonal	O
and	O
LAD	O
septal	O
branches	O
with	O
Taxus	O
stents	O
.	O

This	O
restored	O
flow	O
appropriately	O
.	O

The	O
patient	O
also	O
had	O
proximal	B-disease
RCA	I-disease
lesion	I-disease
of	I-disease
80%	I-disease
and	O
a	B-disease
mid	I-disease
RCA	I-disease
lesion	I-disease
of	I-disease
80-90%	I-disease
which	O
were	O
not	O
intervened	O
upon	O
.	O

The	O
patient	O
was	O
given	O
an	O
aspirin	O
and	O
Plavix	O
and	O
in	O
addition	O
started	O
on	O
a	O
beta	O
Elmore	O
,	O
Maxine	O
ACE	O
inhibitor	O
,	O
and	O
these	O
were	O
titrated	O
up	O
as	O
her	O
blood	O
pressure	O
tolerated	O
.	O

Given	O
the	O
fact	O
that	O
the	O
patient	O
had	O
issues	O
with	O
muscle	B-disease
cramping	I-disease
with	O
Atorvastatin	O
in	O
the	O
past	O
,	O
she	O
was	O
started	O
on	O
Pravastatin	O
which	O
should	O
give	O
less	O
of	O
these	B-disease
side	I-disease
effects	I-disease
.	O

The	O
patient	O
will	O
follow-up	O
with	O
Cardiology	O
in	O
one	O
months	O
time	O
for	O
further	O
management	O
of	O
her	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
and	O
further	O
evaluation	O
of	O
her	B-disease
remaining	I-disease
RCA	I-disease
lesions	I-disease
.	O

2.	O
PUMP	O
:	O
The	O
patient	O
had	O
an	O
echocardiogram	O
to	O
assess	O
her	O
LV	O
function	O
.	O

She	O
was	O
found	O
to	O
have	O
an	O
ejection	O
fraction	O
of	O
30-35%	O
as	O
well	O
as	O
an	B-disease
akinetic	I-disease
apex	I-disease
and	O
apical	B-disease
mid	I-disease
and	I-disease
septal	I-disease
akinesis	I-disease
.	O

Given	O
the	O
fact	O
that	O
the	O
patient	O
had	O
significant	B-disease
apical	I-disease
akinesis	I-disease
,	O
she	O
was	O
started	O
on	O
heparin	O
with	O
a	O
transition	O
to	O
Coumadin	O
for	O
anticoagulation	O
for	O
stroke	O
prevention	O
in	O
the	O
setting	O
of	O
apical	B-disease
akinesis	I-disease
.	O

On	O
discharge	O
,	O
the	O
patient	O
was	O
given	O
Lovenox	O
injections	O
which	O
should	O
be	O
continued	O
until	O
the	O
patient	O
reaches	O
a	O
therapeutic	O
dose	O
of	O
Coumadin	O
.	O

3.	O
RHYTHM	O
:	O
The	O
patient	O
was	O
monitored	O
on	O
telemetry	O
throughout	O
her	O
hospitalization	O
with	O
no	O
significant	B-disease
events	I-disease
.	O

The	O
patient	O
had	O
an	O
EP	O
evaluation	O
and	O
will	O
be	O
followed-up	O
by	O
Dr.	O
Welch	O
.	O

14-087	O
,	O
the	O
patient	O
had	O
a	O
signal-averaged	O
EKG	O
.	O

She	O
will	O
follow-up	O
with	O
Dr.	O
Welch	O
with	O
an	O
echocardiogram	O
on	O
2015-07-24	O
in	O
a	O
meeting	O
to	O
discuss	O
risk	O
stratification	O
for	O
sudden	B-disease
cardiac	I-disease
death	I-disease
and	O
possible	O
ICD	O
placement	O
.	O

4.	O
NEUROLOGY	O
:	O
The	O
patient	O
complained	O
of	O
left	B-disease
lower	I-disease
extremity	I-disease
weakness	I-disease
with	O
ambulation	O
two	O
days	O
after	O
her	O
cardiac	O
catheterization	O
.	O

The	O
patient	O
had	O
no	O
evidence	O
for	O
weakness	B-disease
on	O
examination	O
with	O
good	O
proximal	O
and	O
distal	O
strength	O
in	O
the	O
lower	O
extremities	O
as	O
well	O
as	O
intact	O
sensation	O
.	O

The	O
patient	O
worked	O
with	O
Physical	O
Therapy	O
and	O
was	O
able	O
to	O
ambulate	O
without	O
difficulty	O
.	O

She	O
was	O
also	O
able	O
to	O
ascend	O
stairs	O
without	O
difficulty	B-disease
.	O

The	O
patient	O
was	O
already	O
on	O
an	O
aspirin	O
and	O
Plavix	O
should	O
this	O
represent	O
a	B-disease
small	I-disease
stroke	I-disease
.	O

However	O
,	O
there	O
was	O
no	O
evidence	O
for	O
neurologic	B-disease
deficit	I-disease
on	O
examination	O
and	O
this	O
will	O
be	O
followed-up	O
by	O
her	O
primary	O
care	O
physician	O
.	O

5.	O
HEMATOLOGY	O
:	O
The	O
patient	O
was	O
discharged	O
on	O
Coumadin	O
for	O
apical	B-disease
akinesis	I-disease
and	O
stroke	B-disease
risk	I-disease
.	O

This	O
will	O
be	O
further	O
monitored	O
by	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Banks	O
,	O
who	O
will	O
adjust	O
her	O
Coumadin	O
dose	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O
Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O
To	O
home	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O
ST	B-disease
elevation	I-disease
myocardial	I-disease
infarction	I-disease
,	O
status	O
post	O
left	O
anterior	O
descending	O
artery	O
stent	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Aspirin	O
325	O
q.d.	O

2.	O
Lisinopril	O
5	O
q.d.	O

3.	O
Toprol	O
XL	O
100	O
q.d.	O

4.	O
Coumadin	O
5	O
q.d.	O

5.	O
Plavix	O
75	O
q.d.	O

6.	O
Lovenox	O
60	O
mg	O
b.i.d.	O
until	O
therapeutic	O
on	O
Coumadin	O
.	O

7.	O
Pravastatin	O
80	O
q.d.	O

FOLLOW-UP	O
PLANS	O
:	O
The	O
patient	O
will	O
follow-up	O
with	O
her	O
primary	O
care	O
physician	O
in	O
the	O
week	O
following	O
discharge	O
for	O
further	O
monitoring	O
of	O
her	O
INR	O
and	O
adjustment	O
of	O
her	O
Coumadin	O
dose	O
.	O

The	O
patient	O
will	O
also	O
follow-up	O
with	O
Electrophysiology	O
with	O
Dr.	O
Welch	O
on	O
2015-07-24	O
.	O

In	O
addition	O
to	O
this	O
,	O
the	O
patient	O
will	O
follow-up	O
with	O
Cardiology	O
,	O
Dr.	O
Foster	O
,	O
and	O
Dr.	O
Upshaw	O
,	O
on	O
2015-07-06	O
for	O
further	O
monitoring	O
.	O

Joshua	O
PINTO	O
,	O
M.D.	O
12.932	O

Dictated	O
By	O
:	O
Greg	O
E.	O
Riordan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2015-06-10	O
09:17	O

T	O
:	O
2015-06-12	O
16:28	O

JOB	O
#:	O

74717	O

Signed	O
electronically	O
by	O
:	O
DR.	O
David	O
PINTO	O
on	O
:	O
FRI	O
2015-06-19	O
5:36	O
PM	O

(	O
End	O
of	O
Report	O
)	O

493597270	O

CMC	O

86164445	O

3/17/1998	O
12:00:00	O
AM	O

ACUTE	B-disease
LEUKEMIA	I-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

03/17/1998	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

04/12/1998	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
68	O
year	O
old	O
with	O
acute	B-disease
leukemia	I-disease
.	O

The	O
patient	O
was	O
in	O
her	O
usual	O
state	O
of	O
health	O
until	O
about	O
three	O
weeks	O
prior	O
to	O
admission	O
when	O
she	O
began	O
to	O
notice	O
increased	B-disease
weakness	I-disease
and	O
bruising	B-disease
.	O

She	O
presented	O
to	O
a	O
Wood	O
Emergency	O
Department	O
six	O
days	O
prior	O
to	O
admission	O
.	O

Platelets	O
were	O
9,000	O
,	O
hemoglobin	O
9.5	O
,	O
temperature	O
was	O
100.4	O
.	O

The	O
patient	O
had	O
a	O
smear	O
there	O
consistent	O
with	O
ALL	B-disease
.	O

The	O
patient	O
was	O
transferred	O
to	O
Norri	O
Hospital	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

No	O
headache	B-disease
,	O
no	O
nausea	B-disease
,	O
vomiting	B-disease
or	O
diarrhea	B-disease
.	O

Some	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
with	O
allergies	B-disease
,	O
particularly	O
cats	O
.	O

No	O
chest	B-disease
pain	I-disease
.	O

The	O
patient	O
had	O
been	O
doing	O
aerobics	O
three	O
times	O
a	O
week	O
until	O
a	O
couple	O
of	O
weeks	O
before	O
admission	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
past	O
medical	O
history	O
is	O
significant	O
for	O
allergies	B-disease
,	O
depression	B-disease
and	O
anxiety	B-disease
,	O
pleural	B-disease
thickening	I-disease
/	O
asbestosis	B-disease
,	O
chronic	B-disease
left	I-disease
bundle	I-disease
branch	I-disease
block	I-disease
,	O
tonsillectomy	O
,	O
adenoidectomy	O
,	O
vein	O
stripping	O
(	O
1968	O
)	O
,	O
left	B-disease
wrist	I-disease
fracture	I-disease
(	O
1994	O
)	O
,	O
and	O
hypercholesterolemia	B-disease
.	O

ALLERGIES	O
:	O

The	B-disease
patient	I-disease
&apos;s	I-disease
allergies	I-disease
include	O
a	O
questionable	O
penicillin	B-disease
reaction	I-disease
;	O
however	O
,	O
the	O
patient	O
tolerated	O
Ampicillin	O
well	O
.	O

The	O
patient	O
does	O
not	O
recollect	O
what	O
her	B-disease
reaction	I-disease
to	O
penicillin	O
was	O
.	O

The	O
patient	O
also	O
had	O
a	O
history	O
of	O
platelet	B-disease
reaction	I-disease
.	O

FAMILY	O
HISTORY	O
:	O

The	O
patient	O
&apos;s	O
family	O
history	O
was	O
significant	O
for	O
a	O
brother	O
with	O
colon	B-disease
cancer	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
her	O
husband	O
and	O
she	O
has	O
three	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
&apos;s	O
physical	O
examination	O
revealed	O
a	O
well-developed	O
,	O
well-nourished	O
white	O
female	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

Vital	O
signs	O
:	O

Temperature	O
98.2	O
,	O
blood	O
pressure	O
134/80	O
,	O
respiratory	O
rate	O
22	O
,	O
pulse	O
102	O
.	O

HEENT	O
examination	O
was	O
normocephalic	O
and	O
atraumatic	B-disease
.	O

Cranial	O
nerves	O
II-XII	O
were	O
grossly	O
intact	O
.	O

There	O
was	O
decreased	B-disease
hearing	I-disease
bilaterally	I-disease
.	O

The	O
oropharynx	O
was	O
within	O
normal	O
limits	O
with	O
fillings	O
and	O
a	B-disease
partial	I-disease
upper	I-disease
plate	I-disease
.	O

The	O
neck	O
had	O
a	O
full	O
range	O
of	O
motion	O
,	O
no	O
lymphadenopathy	B-disease
.	O

The	O
chest	O
exam	O
was	O
clear	O
to	O
auscultation	O
.	O

Cardiac	O
exam	O
revealed	O
an	O
S1	O
and	O
an	O
S2	O
and	O
a	B-disease
diffuse	I-disease
2/6	I-disease
systolic	I-disease
murmur	I-disease
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-disease
and	O
nondistended	B-disease
with	O
no	O
guarding	B-disease
and	O
no	O
hepatosplenomegaly	B-disease
.	O

Bowel	O
sounds	O
were	O
present	O
.	O

The	O
skin	O
examination	O
revealed	O
the	O
right	O
breast	O
had	O
a	B-disease
dark	I-disease
two	I-disease
centimeter	I-disease
ecchymosis	I-disease
and	O
the	O
left	O
medial	O
thigh	O
had	O
two	O
pale	B-disease
blue	I-disease
two	I-disease
centimeter	I-disease
macules	I-disease
.	O

LABORATORY	O
DATA	O
:	O

Admitting	O
labs	O
were	O
:	O

Sodium	O
138	O
,	O
potassium	O
4.2	O
,	O
chloride	O
98	O
,	O
BUN	O
21	O
,	O
creatinine	O
0.7	O
,	O
glucose	O
117	O
,	O
white	O
blood	O
cell	O
count	O
13,200	O
,	O
hematocrit	O
22.5	O
,	O
platelet	O
count	O
40,000	O
.	O

AST	O
29	O
,	O
ALK	O
151	O
,	O
total	O
bilirubin	O
0.2	O
,	O
total	O
protein	O
7.2	O
,	O
albumin	O
4.3	O
,	O
globulins	O
2.9	O
,	O
calcium	O
8.9	O
.	O

PT	O
12.8	O
,	O
PTT	O
19.1	O
.	O

Peripheral	O
smear	O
revealed	O
blasts	O
of	O
62%	O
.	O

HOSPITAL	O
COURSE	O
:	O

A	O
Hickman	O
catheter	O
was	O
placed	O
and	O
the	O
patient	O
was	O
begun	O
on	O
chemotherapy	O
.	O

The	O
regimen	O
included	O
cyclophosphamide	O
,	O
daunorubicin	O
,	O
prednisone	O
,	O
Vincristine	O
and	O
PEG-asparaginase	O
.	O

The	O
patient	O
tolerated	O
the	O
chemotherapy	O
regimen	O
well	O
.	O

The	O
patient	O
began	O
neutropenic	B-disease
on	O
day	O
five	O
of	O
induction	O
.	O

The	O
patient	O
&apos;s	O
liver	O
function	O
tests	O
began	O
to	O
rise	O
and	O
she	O
began	O
to	O
experience	O
pulmonary	B-disease
symptoms	I-disease
including	O
increased	B-disease
crackles	I-disease
.	O

The	O
patient	O
began	O
to	O
spike	O
and	O
a	O
blood	O
culture	O
grew	O
out	O
Staphylococcusaureus	B-disease
.	O

The	O
patient	O
was	O
begun	O
on	O
Gentamicin	O
,	O
Vancomycin	O
and	O
Piperacillin	O
,	O
which	O
was	O
changed	O
to	O
Gentamicin	O
and	O
Ceftazidime	O
.	O

The	O
patient	O
continued	O
to	O
spike	O
and	O
was	O
enrolled	O
in	O
a	O
randomized	O
trial	O
,	O
the	O
patient	O
was	O
randomized	O
to	O
AmBisome	O
antifungal	O
treatment	O
.	O

An	O
abdominal	O
MRI	O
was	O
performed	O
to	O
assess	O
continued	O
elevated	B-disease
liver	I-disease
enzymes	I-disease
;	O
however	O
,	O
the	O
MRI	O
was	O
negative	O
.	O

The	O
patient	O
was	O
begun	O
on	O
Nafcillin	O
due	O
to	O
continued	O
spiking	O
.	O

The	O
patient	O
began	O
to	O
experience	O
urinary	B-disease
retention	I-disease
and	O
was	O
straight	O
catheterized	O
.	O

Thepatient	O
developed	O
a	O
possible	O
drug	B-disease
rash	I-disease
and	O
Nafcillin	O
was	O
changed	O
to	O
Ancef	O
.	O

The	O
patient	O
became	O
constipated	B-disease
;	O
this	O
resolved	O
with	O
laxatives	O
.	O

The	O
patient	O
improved	O
significantly	O
and	O
was	O
thought	O
to	O
be	O
ready	O
for	O
discharge	O
by	O
the	O
11th	O
of	O
April	O
.	O

She	O
will	O
follow	O
up	O
with	O
her	O
primary	O
oncologists	O
,	O
Dr	O
A	O
and	O
Dr	O
Dark	O
,	O
at	O
IVMC	O
,	O
after	O
her	O
discharge	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

The	O
patient	O
&apos;s	O
discharge	O
medications	O
include	O
the	O
following	O
:	O

1)	O
Albuterol	O
inhaler	O
two	O
puffs	O
q.i.d.	O
p.r.n.	O
breathing	B-disease
difficulties	I-disease
.	O

2)	O
Calcium	O
gluconate	O
1000	O
mg	O
p.o.	O
q	O
day	O
.	O

3)	O
Cefazolin	O
one	O
gram	O
IV	O
q.8h.	O
x	O
13days	O
.	O

4)	O
Colace	O
100	O
mg	O
p.o.	O
b.i.d.	O

5)	O
Lasix	O
40	O
mg	O
p.o.	O
q	O
day	O
.	O

6)	O
Lactulose	O
30	O
milliliters	O
p.o.	O
q.2h.	O
p.r.n.	O
constipation	B-disease
.	O

7)	O
Magnesium	O
hydroxide	O
30	O
milliliters	O
p.o.	O
q	O
day	O
.	O

8)	O
Miracle	O
Creamtopical	O
q	O
day	O
p.r.n.	O
skin	B-disease
irritation	I-disease
.	O

9)	O
Sarna	O
topical	O
b.i.d.	O
p.r.n.	O
itching	B-disease
.	O

10)	O
Senna	O
tablets	O
,	O
two	O
tablets	O
p.o.	O
b.i.d.	O

11)	O
Simethicone	O
80	O
mg	O
p.o.	O
q.i.d.	O
p.r.n.	O
gas	B-disease
pain	I-disease
.	O

12)	O
Citrucel	O
one	O
tablespoon	O
p.o.	O
q	O
day	O
.	O

13)	O
K-Dur	O
10	O
mEq	O
x	O
three	O
,	O
p.o.	O
b.i.d.	O

14)	O
Zoloft	O
25	O
mg	O
p.o.	O
q	O
day	O
.	O

15)	O
Peridex	O
30	O
cc	O
p.o.	O
b.i.d.	O
x	O
14	O
days	O
.	O

16)	O
Robituss	O
in	O
AC	O
five	O
to	O
ten	O
milliliters	O
p.o.	O
q.h.s.	O
p.r.n.	O
cough	B-disease
.	O

Dictated	O
By	O
:	O

AZEL	O
HIBBSKAYS	O
,	O
M.D.	O
CF66	O

Attending	O
:	O

TELSHEY	O
K.	O
SWATLLEEBTIK	O
,	O
M.D.	O
NJ38	O
ME089/6922	O

Batch	O
:	O

43792	O

Index	O
No.	O
CHDNIR25	O
OK	O

D	O
:	O

05/13/98	O

T	O
:	O

05/13/98	O

950452368	O

CTMC	O

25445040	O

808386	O

5/9/1998	O
12:00:00	O
AM	O

EXTERNAL	B-disease
WOUND	I-disease
INFECTIONS	I-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

05/09/1998	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

05/25/1998	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

STERNAL	B-disease
WOUND	I-disease
INFECTION	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
74-year-old	O
woman	O
,	O
well	O
known	O
to	O
the	O
cardiac	O
surgery	O
service	O
,	O
readmitted	O
from	O
Glasmif/putdi	O
Health	O
Network	O
with	O
sternal	B-disease
wound	I-disease
infection	I-disease
.	O

She	O
has	O
been	O
previously	O
hospitalized	O
on	O
12	O
April	O
1998	O
for	O
the	B-disease
same	I-disease
diagnosis	I-disease
.	O

She	O
is	O
now	O
coming	O
for	O
surgical	O
treatment	O
,	O
wound	O
debridement	O
,	O
and	O
possible	O
wound	O
closure	O
with	O
bilateral	O
pectoralis	O
flap	O
.	O

She	O
underwent	O
coronary	O
artery	O
bypass	O
graft	O
times	O
two	O
with	O
saphenous	O
vein	O
graft	O
on	O
29	O
March	O
1998	O
.	O

Of	O
note	O
,	O
the	O
patient	O
is	O
status	B-disease
post	I-disease
lymphoma	I-disease
with	O
treatment	O
of	O
chemotherapy	O
and	O
radiation	O
six	O
years	O
ago	O
,	O
and	O
is	O
an	B-disease
insulin-dependent	I-disease
diabetic	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Insulin-dependent	B-disease
diabetes	I-disease
mellitus	I-disease
,	O
lymphoma	B-disease
as	O
above	O
,	O
ulcerative	B-disease
colitis	I-disease
,	O
melanoma	B-disease
status	O
post	O
excision	O
in	O
right	O
upper	O
extremity	O
,	O
hypertension	B-disease
,	O
hypothyroidism	B-disease
,	O
congestive	B-disease
heart	I-disease
failure	I-disease
,	O
and	O
coronary	B-disease
artery	I-disease
disease	I-disease
with	O
bypass	O
grafting	O
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

She	O
is	O
status	O
post	O
left	O
knee	O
replacement	O
and	O
status	O
post	O
multiple	O
prior	O
surgeries	O
and	O
reconstruction	O
of	O
the	O
knee	O
.	O

Status	O
post	O
cholecystectomy	O
,	O
lumbar	O
diskectomy	O
,	O
and	O
tonsillectomy	O
with	O
adenoidectomy	O
.	O

ALLERGIES	O
:	O

Erythromycin	O
,	O
vancomycin	O
,	O
and	O
Bacitracin	O
.	O

ADMISSION	O
MEDICATIONS	O
:	O

Elavil	O
50	O
mg	O
p.o.	O
q.h.s.	O
,	O
coated	O
aspirin	O
325	O
mg	O
p.o.	O
p.day	O
,	O
Tegretol	O
100	O
mg	O
p.o.	O
b.i.d.	O
,	O
Ancef	O
1	O
gm	O
IV	O
q.12h.	O
times	O
seven	O
days	O
,	O
Vasotec	O
5	O
mg	O
p.o.	O
q.day	O
,	O
Synthroid	O
0.025	O
mg	O
p.o.	O
q.day	O
,	O
Asacol	O
400	O
mg	O
q.a.m.	O
and	O
800	O
mg	O
q.p.m.	O
,	O
Lopressor	O
25	O
mg	O
p.o.	O
b.i.d.	O
,	O
Prilosec	O
20	O
mg	O
p.o.	O
q.day	O
,	O
and	O
insulin	O
70/30	O
26	O
units	O
in	O
the	O
morning	O
and	O
12	O
units	O
at	O
night	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
was	O
admitted	O
with	O
a	O
blood	O
pressure	O
of	O
140/80	O
,	O
temperature	O
101.3	O
,	O
pulse	O
84	O
,	O
and	O
respiratory	O
rate	O
22	O
.	O

The	O
patient	O
is	O
obese	B-disease
with	O
unremarkable	O
physical	O
examination	O
except	O
for	O
a	B-disease
systolic	I-disease
murmur	I-disease
,	O
I	B-disease
/	I-disease
VI	I-disease
and	I-disease
erythema	I-disease
over	I-disease
the	I-disease
sternal	I-disease
wound	I-disease
and	O
upper	O
third	O
.	O

The	B-disease
wound	I-disease
had	O
a	B-disease
beefy	I-disease
red	I-disease
cellulitic	I-disease
area	I-disease
surrounding	O
an	O
open	O
area	O
,	O
blanching	O
to	O
touch	O
.	O

There	O
was	O
no	O
purulence	B-disease
or	O
discharge	B-disease
noted	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
placed	O
on	O
IV	O
antibiotics	O
,	O
Ancef	O
1	O
gm	O
q.8h.	O

On	O
10	O
May	O
1998	O
,	O
she	O
underwent	O
sternal	O
wound	O
debridement	O
and	O
closure	O
,	O
performed	O
by	O
Dr.	O
Falccouette	O
and	O
Dr.	O
Shuffzeln	O
.	O

The	O
patient	O
was	O
switched	O
to	O
ampicillin	O
,	O
gentamicin	O
,	O
and	O
clindamycin	O
,	O
according	O
to	O
the	O
culture	O
,	O
Enterococci	B-disease
and	O
Staphylococcus	B-disease
in	O
the	B-disease
wound	I-disease
.	O

Due	O
to	O
the	B-disease
persistent	I-disease
fevers	I-disease
,	O
the	O
patient	O
underwent	O
vancomycin	O
desensitization	O
in	O
the	O
surgical	O
Intensive	O
Care	O
Unit	O
followed	O
by	O
a	O
change	O
of	O
antibiotics	O
to	O
vancomycin	O
and	O
levofloxacin	O
.	O

Further	O
cultures	O
from	O
sputum	O
and	O
urine	O
revealed	O
yeast	B-disease
sensitive	O
to	O
Diflucan	O
,	O
which	O
was	O
administered	O
shortly	O
after	O
.	O

Because	O
of	O
expected	O
long	O
term	O
antibiotic	O
administration	O
,	O
a	O
PICC	O
line	O
was	O
placed	O
and	O
the	O
patient	O
was	O
prepared	O
for	O
transfer	O
back	O
to	O
Fo	O
Hospital	O
.	O

As	O
a	B-disease
small	I-disease
complication	I-disease
,	O
the	O
patient	O
opened	O
a	B-disease
left	I-disease
ankle	I-disease
wound	I-disease
post	O
saphenous	O
vein	O
harvest	O
,	O
which	O
persists	O
up	O
until	O
now	O
and	O
is	O
of	O
a	O
size	O
2	O
x	O
1	O
cm	O
.	O

Due	O
to	O
difficult	B-disease
ambulation	I-disease
,	O
the	O
patient	O
developed	O
a	B-disease
small	I-disease
ulcer	I-disease
in	I-disease
the	I-disease
sacral	I-disease
area	I-disease
,	O
which	O
was	O
treated	O
with	O
Duoderm	O
dressing	O
.	O

During	O
the	O
course	O
of	O
hospitalization	O
,	O
the	O
patient	O
was	O
followed	O
by	O
cardiac	O
surgery	O
,	O
cardiology	O
,	O
infectious	O
disease	O
,	O
allergy	O
,	O
and	O
medicine	O
,	O
including	O
GI	O
teams	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Elavil	O
by	O
mouth	O
15	O
mg	O
every	O
night	O
,	O
Dulcolax	O
rectally	O
10	O
mg	O
once	O
a	O
day	O
,	O
Tegretol	O
by	O
mouth	O
100	O
mg	O
twice	O
a	O
day	O
,	O
Benadryl	O
by	O
mouth	O
25	O
mg	O
three	O
times	O
a	O
day	O
,	O
Colace	O
by	O
mouth	O
200	O
mg	O
twice	O
a	O
day	O
,	O
Vasotec	O
by	O
mouth	O
10	O
mg	O
twice	O
a	O
day	O
,	O
EOC	O
/	O
LOC	O
p.r./p.o.	O
one	O
each	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-disease
,	O
Lasix	O
by	O
mouth	O
80	O
mg	O
every	O
morning	O
,	O
insulin	O
regular	O
according	O
to	O
insulin	O
scale	O
,	O
Synthroid	O
by	O
mouth	O
25	O
mcg	O
once	O
a	O
day	O
,	O
Maalox	O
Plus	O
Extra	O
Strength	O
by	O
mouth	O
15	O
ml	O
every	O
six	O
hours	O
as	O
needed	O
for	O
indigestion	B-disease
,	O
Milk	O
of	O
Magnesia	O
by	O
mouth	O
30	O
ml	O
once	O
a	O
day	O
as	O
needed	O
for	O
constipation	B-disease
,	O
Asacol	O
by	O
mouth	O
400	O
mg	O
every	O
morning	O
,	O
Asacol	O
800	O
mg	O
every	O
night	O
,	O
Lopressor	O
by	O
mouth	O
25	O
mg	O
twice	O
a	O
day	O
,	O
Miracle	O
cream	O
topically	O
on	O
skin	O
once	O
a	O
day	O
,	O
nystatin	O
swish	O
and	O
swallow	O
by	O
mouth	O
5	O
ml	O
four	O
times	O
a	O
day	O
,	O
Percocet	O
by	O
mouth	O
one	O
tab	O
every	O
four	O
hours	O
as	O
needed	O
for	O
pain	B-disease
,	O
and	O
vancomycin	O
by	O
infusion	O
1	O
gm	O
every	O
18	O
hours	O
;	O
instructions	O
in	O
250	O
ml	O
slow	O
IV	O
infusion	O
over	O
one	O
hour	O
.	O

Note	O
,	O
please	O
draw	O
blood	O
for	O
vancomycin	O
levels	O
on	O
25	O
May	O
1998	O
,	O
before	O
the	O
next	O
dose	O
,	O
to	O
get	O
the	O
trough	O
level	O
.	O

Keep	O
vancomycin	O
trough	O
between	O
10-20	O
,	O
but	O
not	O
less	O
due	O
to	O
desensitization	B-disease
.	O

Vancomycin	O
levels	O
should	O
be	O
checked	O
every	O
third	O
day	O
for	O
four	O
to	O
six	O
weeks	O
,	O
according	O
to	O
IMD	O
.	O

Nizatidine	O
by	O
mouth	O
150	O
mg	O
twice	O
a	O
day	O
,	O
insulin	O
70/30	O
human	O
injection	O
under	O
skin	O
12	O
units	O
every	O
night	O
,	O
insulin	O
70/30	O
human	O
injection	O
subcutaneous	O
26	O
units	O
every	O
morning	O
,	O
Lovenox	O
injection	O
under	O
skin	O
40	O
mg	O
once	O
a	O
day	O
,	O
and	O
levofloxacin	O
by	O
mouth	O
250	O
mg	O
once	O
a	O
day	O
.	O

Dictated	O
By	O
:	O

NALA	O
BEST	O
,	O
M.D.	O
KJ76	O

Attending	O
:	O

JOFREDD	O
N.	O
FALCCOUETTE	O
,	O
M.D.	O
CA8	O
XX584/6088	O

Batch	O
:	O

3679	O

Index	O
No.	O
W9YYL76XV1	O

D	O
:	O

05/25/98	O

T	O
:	O

05/25/98	O

CC	O
:	O

1.	O
LAELK	O
MEMORIAL	O
HOSPITAL	O

Admission	O
Date	O
:	O

2017-09-22	O

Discharge	O
Date	O
:	O

2017-09-27	O

Date	O
of	O
Birth	O
:	O

2017-09-22	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O
CSRU	O

HISTORY	O
:	O

Peggy	O
Hammock	O
is	O
a	O
full	O
term	O
baby	O
boy	O
born	O
at	O
38	O
1/7	O
weeks	O
by	O
repeat	O
cesarean	O
section	O
to	O
a	O
34	O
year	O
old	O
gravida	O
III	O
,	O
now	O
para	O
II	O
mother	O
.	O

Serologies	O
include	O
blood	O
type	O
O	O
negative	O
,	O
antibody	O
negative	O
,	O
RPR	O
nonreactive	O
.	O

Hepatitis	O
B	O
surface	O
antigen	O
negative	O
,	O
rubella	O
immune	O
.	O

Group	O
B	O
strep	O
screening	O
was	O
negative	O
.	O

Pregnancy	O
was	O
uncomplicated	B-disease
until	O
an	O
occurrence	O
of	O
HSV	B-disease
outbreak	I-disease
occurred	O
on	O
2017-09-13	O
approximately	O
one	O
week	O
prior	O
to	O
delivery	O
.	O

Pregnancy	O
was	O
also	O
complicated	O
by	O
maternal	O
history	O
of	O
depression	B-disease
for	O
which	O
mother	O
received	O
Zoloft	O
.	O

On	O
day	O
of	O
delivery	O
mother	O
presented	O
in	O
spontaneous	B-disease
labor	I-disease
.	O

There	O
were	O
no	O
sepsis	B-disease
risk	I-disease
factors	I-disease
.	O

GBS	O
negative	O
.	O

No	O
maternal	B-disease
fever	I-disease
.	O

Rupture	B-disease
of	I-disease
membranes	I-disease
at	O
time	O
of	O
delivery	O
.	O

Delivery	O
was	O
by	O
repeat	O
cesarean	O
section	O
and	O
Apgars	O
of	O
8	O
and	O
9	O
were	O
given	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
.	O

Baby	O
appeared	O
well	O
and	O
went	O
to	O
the	O
newborn	O
nursery	O
and	O
was	O
breast	O
feeding	O
and	O
undergoing	O
routine	O
newborn	O
care	O
.	O

On	O
the	O
newborn	O
nursery	O
the	O
mother	O
called	O
the	O
nurse	O
for	O
concern	O
of	O
baby	O
turning	O
dusky	B-disease
while	O
feeding	O
.	O

She	O
called	O
the	O
nurses	O
and	O
patted	O
the	O
infant	O
on	O
the	O
back	O
.	O

This	B-disease
episode	I-disease
was	O
also	O
accompanied	O
by	O
gagging	B-disease
motions	I-disease
noted	O
of	O
the	O
infant	O
.	O

A	B-disease
second	I-disease
episode	I-disease
occurred	O
where	O
the	O
baby	O
turned	O
pale	B-disease
.	O

Mother	O
thought	O
the	O
baby	O
just	O
did	O
not	O
look	O
right	O
.	O

The	O
baby	O
did	O
not	O
turn	O
blue	B-disease
at	O
that	O
time	O
.	O

The	O
Neonatal	O
Intensive	O
Care	O
Unit	O
was	O
notified	O
and	O
the	O
baby	O
was	O
transferred	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
for	O
further	O
evaluation	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
to	O
the	O
Neonatal	O
Intensive	O
Care	O
Unit	O
:	O

Full	O
term	O
well	O
appearing	O
infant	O
with	O
some	B-disease
facial	I-disease
jaundice	I-disease
,	O
overall	O
pink	O
,	O
warm	O
and	O
well	O
perfused	O
,	O
alert	O
and	O
responsive	O
.	O

Anterior	O
fontanelle	O
is	O
soft	O
,	O
open	O
and	O
flat	O
.	O

Ears	O
are	O
normally	O
set	O
.	O

Red	O
reflexes	O
noted	O
bilaterally	O
.	O

He	O
had	O
a	O
left	O
pupil	O
that	O
was	O
in	O
unequal	B-disease
in	I-disease
size	I-disease
with	O
a	B-disease
keyhole	I-disease
appearance	I-disease
consistent	O
with	O
a	B-disease
coloboma	I-disease
.	O

The	O
nares	O
were	O
patent	O
.	O

Palate	O
was	O
intact	O
.	O

Mucous	O
membranes	O
were	O
moist	O
and	O
pink	O
.	O

His	O
neck	O
was	O
supple	O
without	O
masses	B-disease
or	O
bruits	B-disease
.	O

Lungs	O
were	O
clear	O
to	O
auscultation	O
and	O
equal	O
.	O

Comfortable	O
respiratory	O
pattern	O
.	O

Cardiovascular	O
:	O

Regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-disease
.	O

2	O
plus	O
femoral	O
pulses	O
were	O
noted	O
.	O

Abdomens	O
oft	O
with	O
positive	O
bowel	O
sounds	O
.	O

Genitourinary	O
:	O

Infant	O
was	O
circumcised	O
in	O
the	O
newborn	O
nursery	O
which	O
was	O
healing	O
well	O
.	O

Testes	O
were	O
descended	O
bilaterally	O
.	O

Extremities	O
were	O
pink	O
and	O
well	O
perfused	O
.	O

Neurologic	O
:	O

Tone	O
was	O
appropriate	O
for	O
gestational	O
age	O
with	O
equal	O
strength	O
,	O
symmetric	O
reflexes	O
.	O

HOSPITAL	O
COURSE	O
BY	O
SYSTEMS	O
:	O

Respiratory	O
:	O

The	O
infant	O
was	O
placed	O
on	O
a	O
cardiopulmonary	O
monitor	O
upon	O
admission	O
to	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
with	O
pulse	O
oximetry	O
.	O

He	O
was	O
noted	O
to	O
have	O
an	O
episode	O
of	O
desaturation	B-disease
related	O
to	O
feeding	O
with	O
desaturations	B-disease
in	O
the	O
70	O
percent	O
.	O

This	O
resolved	O
spontaneously	O
when	O
the	O
bottle	O
was	O
pulled	O
from	O
the	O
baby	O
's	O
mouth	O
.	O

Jule	O
remained	O
in	O
room	O
air	O
without	O
any	O
evidence	O
of	O
respiratory	B-disease
distress	I-disease
and	O
was	O
without	O
any	B-disease
further	I-disease
dusky	I-disease
spells	I-disease
or	O
pale	B-disease
episodes	I-disease
in	O
the	O
48	O
hours	O
prior	O
to	O
discharge	O
.	O

Cardiovascular	O
:	O

Renee	O
remained	O
cardiovascularly	O
stable	O
with	O
AP	O
s	O
noted	O
to	O
be	O
120	O
to	O
130	O
s.	O

Blood	O
pressure	O
84/43	O
with	O
a	O
mean	O
of	O
59	O
.	O

Fluid	O
,	O
electrolytes	O
and	O
nutritions	O
:	O

The	O
baby	O
had	O
been	O
breast	O
feeding	O
ad	O
lib	O
in	O
the	O
Newborn	O
Nursery	O
.	O

He	O
continued	O
to	O
feed	O
ad	O
lib	O
while	O
a	O
patient	O
in	O
the	O
Newborn	O
Intensive	O
Care	O
Unit	O
.	O

He	O
was	O
fed	O
with	O
a	O
bottle	O
occasionally	O
by	O
his	O
dad	O
and	O
had	O
a	O
vigorous	O
suck	O
and	O
was	O
noted	O
to	O
have	O
some	B-disease
discoordination	I-disease
of	I-disease
his	I-disease
suck	I-disease
while	O
breathing	O
at	O
the	O
initial	O
onset	O
of	O
feeding	O
time	O
.	O

This	O
resolved	O
with	O
removal	O
of	O
the	O
bottle	O
from	O
the	O
baby	O
's	O
mouth	O
.	O

Breast	O
feeding	O
was	O
limited	O
to	O
four	O
to	O
five	O
minutes	O
on	O
each	O
side	O
per	O
recommendation	O
of	O
neurology	O
after	O
their	O
evaluation	O
to	O
try	O
and	O
minimize	O
incidence	O
of	O
gastroesophageal	B-disease
reflux	I-disease
.	O

Weight	O
at	O
time	O
of	O
discharge	O
is	O
3.13	O
kilograms	O
.	O

Birth	O
weight	O
was	O
3.29	O
kilograms	O
in	O
the	O
75th	O
percentile	O
.	O

Head	O
circumference	O
was	O
34.5	O
cm	O
,	O
75th	O
percentile	O
,	O
and	O
length	O
was	O
50.7	O
cm	O
,	O
also	O
the	O
75th	O
percentile	O
.	O

Gastrointestinal	O
:	O

Baby	O
was	O
noted	O
to	O
have	O
frequent	B-disease
spitting	I-disease
episodes	I-disease
.	O

This	O
was	O
minimized	O
with	O
limitation	O
of	O
volume	O
at	O
each	O
feed	O
with	O
frequent	O
feeding	O
.	O

He	O
had	O
normal	O
voiding	O
and	O
stooling	O
patterns	O
.	O

The	O
baby	O
demonstrated	O
mild	B-disease
physiologic	I-disease
jaundice	I-disease
with	O
a	O
serum	O
bilirubin	O
obtained	O
on	O
day	O
of	O
life	O
three	O
which	O
was	O
6.7	O
with	O
a	O
direct	O
of	O
0.2	O
.	O

Mother	O
's	O
blood	O
type	O
is	O
O	O
negative	O
.	O

Infant	O
's	O
blood	O
type	O
was	O
O	O
positive	O
and	O
Coombs	O
was	O
noted	O
to	O
be	O
negative	O
.	O

Hematologic	O
:	O

In	O
addition	O
a	O
complete	O
blood	O
count	O
was	O
obtained	O
on	O
admission	O
with	O
a	O
white	O
count	O
of	O
10.1	O
with	O
43	O
polys	O
and	O
0	O
bands	O
.	O

Hematocrit	O
was	O
noted	O
to	O
47.5	O
with	O
platelets	O
of	O
257,000	O
.	O

There	O
were	O
no	O
blood	O
products	O
received	O
during	O
hospitalization	O
.	O

Infectious	O
disease	O
:	O

A	O
blood	O
culture	O
was	O
obtained	O
upon	O
admission	O
and	O
Ampicillin	O
and	O
Gentamicin	O
were	O
given	O
for	O
48	O
hours	O
with	O
blood	O
cultures	O
remaining	O
sterile	O
.	O

Antibiotics	O
were	O
discontinued	O
on	O
day	O
of	O
life	O
three	O
and	O
infant	O
has	O
remained	O
clinically	O
well	O
off	O
antibiotics	O
.	O

Neurology	O
:	O

Neurology	O
was	O
consulted	O
due	O
to	O
the	O
concern	O
for	O
seizures	B-disease
in	O
the	O
setting	O
of	O
dusky	B-disease
episodes	I-disease
.	O

Neurology	O
evaluated	O
the	O
baby	O
and	O
found	O
the	O
baby	O
to	O
have	O
a	O
normal	O
neurological	O
examination	O
.	O

An	O
EEG	O
was	O
performed	O
.	O

The	O
EEG	O
showed	O
transient	B-disease
sharp	I-disease
waves	I-disease
in	I-disease
the	I-disease
left	I-disease
front	I-disease
,	O
left	O
occipital	O
and	O
right	O
parietal	O
regions	O
.	O

There	O
was	O
no	O
electrographic	O
evidence	O
of	O
seizure	B-disease
activity	I-disease
noted	O
.	O

Sensory	O
:	O

Hearing	O
screening	O
was	O
performed	O
with	O
automated	O
auditory	O
brain	O
stem	O
responses	O
.	O

Baby	O
passed	O
in	O
both	O
ears	O
on	O
09-23	O
.	O

Ophthalmology	O
:	O

Ophthalmology	O
was	O
consulted	O
due	O
to	O
the	O
presence	O
of	O
a	B-disease
coloboma	I-disease
into	O
the	O
left	O
CMED	O
.	O

Ophthalmology	O
noted	O
that	O
this	B-disease
left	I-disease
Martha	I-disease
coloboma	I-disease
was	O
likely	O
an	B-disease
isolated	I-disease
anomaly	I-disease
in	O
the	O
absence	O
of	O
other	B-disease
pathology	I-disease
.	O

Follow	O
up	O
as	O
below	O
.	O

Psychosocial	O
:	O

Cambridge	O
Health	O
Alliance	O
social	O
worker	O
was	O
involved	O
with	O
this	O
family	O
.	O

She	O
may	O
be	O
reached	O
at	O
(	O
756	O
)	O
599-4849	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Good	O
.	O

DISCHARGE	O
DISPOSITION	O
:	O

To	O
home	O
with	O
parents	O
.	O

Primary	O
pediatrician	O
is	O
Dr.	O
Satterlund	O
of	O
Westborough	O
Pediatrics	O
.	O

Telephone	O
number	O
is	O
(	O
739	O
)	O
520-0347	O
.	O

Fax	O
number	O
is	O
(	O
617	O
)	O
455-4585	O
.	O

Appointment	O
is	O
on	O
Lyon	O
,	O
10-30	O
.	O

CARE	O
AND	O
RECOMMENDATIONS	O
:	O

Feeds	O
are	O
breast	O
feeding	O
P.O.	O
ad	O
lib	O
.	O

Medications	O
are	O
Tri-Vi-Michael	O
1	O
cc	O
by	O
mouth	O
each	O
day	O
.	O

Newborn	O
state	O
screen	O
was	O
sent	O
on	O
day	O
of	O
life	O
three	O
.	O

Results	O
are	O
pending	O
.	O

Immunizations	O
received	O
are	O
hepatitis	O
B	O
vaccine	O
given	O
on	O
09-26	O
.	O

Follow	O
up	O
appointments	O
scheduled	O
:	O

Neurology	O
follow	O
up	O
with	O
Dr.	O
Workman	O
is	O
scheduled	O
for	O
2017-10-20	O
at	O
12:30	O
pm	O
at	O
the	O
Addison	O
Gilbert	O
Hospital	O
of	O
Oak	O
Bluffs	O
,	O
Ison	O
11	O
.	O

Phone	O
number	O
is	O
209-604-1402	O
.	O

Follow	O
up	O
ophthalmology	O
appointment	O
is	O
with	O
Dr.	O
Jundt	O
on	O
Ison	O
4	O
at	O
the	O
Addison	O
Gilbert	O
Hospital	O
of	O
Oak	O
Bluffs	O
in	O
three	O
months	O
.	O

Appointment	O
to	O
be	O
scheduled	O
by	O
mom	O
.	O

Telephone	O
number	O
is	O
444	O
7700	O
.	O

Boston	O
Regional	O
Medical	O
Centerr	O
Visiting	O
Nurse	O
Association	O
has	O
been	O
asked	O
to	O
visit	O
this	O
family	O
at	O
home	O
to	O
follow	O
up	O
on	O
feeding	O
and	O

parenting	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Full	O
term	O
male	O
infant	O
with	O
cyanosis	B-disease
episodes	I-disease
.	O

Rule	O
out	O
sepsis	B-disease
.	O

Left	B-disease
coloboma	I-disease
.	O

Rule	O
out	O
seizures	B-disease
.	O

Lucile	O
Virgina	O
,	O
MD	O
50AAD	O

Dictated	O
By	O
:	O
Sherry	O
G	O
Christie	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2017-09-27	O
17:51:44	O

T	O
:	O
2017-09-27	O
18:26:21	O

Job	O
#:	O
75510	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marcus	O
N	O
Schartz	O
on	O
:	O
Maxine	O
2017-09-28	O
9:34	O
AM	O

(	O
End	O
of	O
Report	O
)	O

555509347	O
PUMC	O

7264645	O

16649	O

8815716	O

8/31/2004	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

THON	O
MERI	O
CINKGUAY	O

UNIT	O
NUMBER	O
:	O

069-81-00	O

ADMISSION	O
DATE	O
:	O

20040831	O

DISCHARGE	O
DATE	O
:	O

20040903	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	O
Delivery	O
With	O
Second	B-disease
Degree	I-disease
Laceration	I-disease

ASSOCIATED	O
DIAGNOSES	O
:	O

Low	B-disease
Lying	I-disease
Placenta	I-disease
;	O
Past	O
Medical	O
History	O
,	O
history	O
of	O
;	O
Urinary	B-disease
Tract	I-disease
Infection	I-disease
,	O
history	O
of	O

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	O
Vertex	O
Vaginal	O
Delivery	O

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Routine	O
Post	O
Partum	O
Care	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Active	B-disease
Labor	I-disease

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	O
66	O
HEENT	O
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
COR	O
NORMAL	O
ABDOMEN	O
NORMAL	O
EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
NORMAL	O
CERVIX	O
NORMAL	O
OS	O
NORMAL	O
ADNEXAE	O
NORMAL	O
UTERUS	O
NORMAL	O
UTERINE	O
SIZE	O
IN	O
WEEKS	O
NORMAL	O
12	O

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
34	O
year	O
old	O
Gravida	O
1	O
Para	O
0000	O
was	O
admitted	O
to	O
the	O
Bap	O
Spald	O
Hospital	O
Obstetrical	O
service	O
on	O
08/31/2004	O
at	O
06:00	O
am	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

active	B-disease
labor	I-disease
.	O

She	O
delivered	O
a	O
3550	O
gram	O
male	O
infant	O
on	O
08/31/2004	O
at	O
09:33	O
pm	O
with	O
apgar	O
scores	O
of	O
9	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
41.0	O
weeks	O
gestation	O
via	O
spontaneous	O
vertex	O
vaginal	O
delivery	O
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

chorioamnionitis	B-disease
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

nuchal	B-disease
cord	I-disease
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
09/03/2004	O
at	O
12:07	O
pm	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

Cinpipecoursspi	O
Hospital	O
Health	O
Center	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS/RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	O
And	O
Folate	O
(	O
Fam	O
Pren	O
Forte	O
)	O

Electronically	O
Signed	O
:	O

Pada	O
Post	O
,	O
MD	O

09/03/2004	O
9:51:35	O
PM	O

Admission	O
Date	O
:	O

2016-03-04	O

Discharge	O
Date	O
:	O

2016-03-22	O

Date	O
of	O
Birth	O
:	O

1930-03-23	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
85	O
year	O
old	O
man	O
initially	O
admitted	O
to	O
the	O
Plastic	O
Surgery	O
Service	O
for	O
evaluation	O
of	O
a	B-disease
left	I-disease
facial	I-disease
mass	I-disease
.	O

Subsequently	O
,	O
CMED	O
CCU	O
was	O
consulted	O
and	O
he	O
was	O
transferred	O
to	O
our	O
Service	O
postoperatively	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

His	O
past	O
medical	O
history	O
is	O
significant	O
for	O
prostate	B-disease
cancer	I-disease
,	O
benign	B-disease
prostatic	I-disease
hypertrophy	I-disease
,	O
hypothyroidism	B-disease
,	O
status	O
post	O
radiation	O
for	O
non	B-disease
Hodgkin	I-disease
's	I-disease
lymphoma	I-disease
,	O
chronic	B-disease
painless	I-disease
hematuria	I-disease
,	O
degenerative	B-disease
joint	I-disease
disease	I-disease
and	O
history	O
of	O
a	B-disease
murmur	I-disease
.	O

Last	O
colonoscopy	O
,	O
five	O
years	O
ago	O
.	O

Dementia	B-disease
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
:	O

1.	O
Levothyroxine	O
.	O

2.	O
Lasix	O
.	O

3.	O
Proscar	O
.	O

4.	O
Aeroseb	O
.	O

5.	O
Ancef	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
examination	O
,	O
he	O
is	O
afebrile	B-disease
.	O

Vital	O
signs	O
,	O
stable	O
.	O

Elderly	O
man	O
,	O
somewhat	B-disease
cachectic	I-disease
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
,	O
polypoid	B-disease
lesion	I-disease
just	O
inferior	O
to	O
the	O
left	O
zygoma	O
,	O
elevated	O
superiorly	O
,	O
with	O
visible	B-disease
bone	I-disease
.	O

No	O
exudate	B-disease
.	O

Minimal	B-disease
bleeding	I-disease
.	O

Regular	O
rate	O
and	O
rhythm	O
.	O

Clear	O
to	O
auscultation	O
.	O

Nontender	B-disease
,	O
nondistended	B-disease
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
initially	O
admitted	O
to	O
CMED	O
for	O
resection	O
and	O
repair	O
of	O
this	B-disease
left	I-disease
facial	I-disease
lesion	I-disease
.	O

He	O
also	O
had	O
consults	O
from	O
Urology	O
for	O
his	B-disease
hematuria	I-disease
as	O
well	O
as	O
Medicine	O
preoperatively	O
and	O
CMED	O
CCU	O
.	O

He	O
went	O
to	O
the	O
Operating	O
Room	O
on	O
2016-03-10	O
with	O
Urology	O
for	O
hematuria	B-disease
where	O
he	O
had	O
a	O
cystoscopy	O
transurethral	O
resection	O
of	O
prostate	O
placement	O
.	O

He	O
then	O
went	O
to	O
the	O
Operating	O
Room	O
on	O
2016-03-14	O
where	O
he	O
had	O
resection	O
of	O
the	B-disease
left	I-disease
face	I-disease
squamous	I-disease
cell	I-disease
cancer	I-disease
by	O
Dr.	O
Langhorne	O
and	O
split	O
thickness	O
and	O
full	O
thickness	O
skin	O
grafting	O
of	O
the	B-disease
defects	I-disease
on	O
2016-03-14	O
.	O

He	O
tolerated	O
the	O
procedure	O
well	O
with	O
no	O
complications	B-disease
except	O
postoperatively	O
,	O
his	O
voice	O
was	O
hoarse	B-disease
.	O

On	O
scoping	O
him	O
he	O
had	O
significant	B-disease
supraglottic	I-disease
edema	I-disease
.	O

He	O
was	O
kept	O
in	O
the	O
Unit	O
for	O
observation	O
of	O
his	O
airway	O
and	O
b.i.d.	O
laryngoscopy	O
.	O

This	O
revealed	O
some	B-disease
supraglottic	I-disease
edema	I-disease
which	O
revealed	O
with	O
time	O
,	O
without	O
further	O
intervention	O
.	O

He	O
was	O
followed	O
by	O
Plastic	O
Surgery	O
for	O
his	O
split	O
thickness	O
skin	O
graft	O
and	O
his	O
bolster	O
was	O
discontinued	O
on	O
postoperative	O
day	O
#5	O
with	O
good	O
take	O
up	O
of	O
his	O
skin	O
graft	O
.	O

Urology	O
also	O
followed	O
him	O
and	O
kept	O
him	O
on	O
antibiotics	O
until	O
postoperative	O
day	O
#7	O
at	O
which	O
point	O
antibiotics	O
were	O
discontinued	O
.	O

His	O

Foley	O
was	O
also	O
discontinued	O
.	O

He	O
is	O
being	O
discharged	O
to	O
rehabilitation	O
to	O
follow	O
up	O
for	O
XRT	O
given	O
the	O
fact	O
that	O
his	O
pathology	O
revealed	O
squamous	B-disease
cell	I-disease
cancer	I-disease
extending	O
deep	O
to	O
the	O
margin	O
as	O
well	O
as	O
positive	B-disease
level	I-disease
II	I-disease
nodes	I-disease
.	O

Dr.	O
Navarrete	O
has	O
been	O
e-mailed	O
and	O
his	O
secretary	O
contacted	O
for	O
as	O
soon	O
as	O
possible	O
appointment	O
for	O
XRT	O
follow	O
up	O
.	O

He	O
should	O
also	O
follow	O
up	O
with	O
Dr.	O
Rankin	O
and	O
Dr.	O
Langhorne	O
.	O

He	O
is	O
being	O
discharged	O
,	O
most	O
likely	O
,	O
to	O
Falmouth	O
Hospital	O
.	O

John	O
P	O
Friend	O
,	O
M.D.	O

11-466	O

Dictated	O
By	O
:	O
Frances	O
P	O
Sheets	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2016-03-22	O
12:20	O

T	O
:	O
2016-03-22	O
12:23	O

JOB	O
#	O
:	O
80013	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jermaine	O
X	O
Reynolds	O
on	O
:	O
Andrea	O
2016-06-30	O
3:46	O
PM	O

(	O
End	O
of	O
Report	O
)	O

212512774	O
WGH	O

6218589	O

29021	O

9923207	O

10/31/2004	O
12:00:00	O
AM	O

OB	O
Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O
OB	O
EMR	O
L	O
and	O
D	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

RIASHWAN	O
BERLNI	O
VALLEY	O

UNIT	O
NUMBER	O
:	O

130-93-91	O

ADMISSION	O
DATE	O
:	O

20041031	O

DISCHARGE	O
DATE	O
:	O

20041103	O

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
:	O

Vaginal	O
Delivery	O
With	O
Second	B-disease
Degree	I-disease
Laceration	I-disease

ASSOCIATED	O
DIAGNOSES	O
:	O

Abnormal	B-disease
Laboratory	I-disease
Result	I-disease
;	O
Abnormal	B-disease
Pap	I-disease
Test	I-disease
;	O
Monilial	B-disease
Vaginitis	I-disease

PRINCIPAL	O
PROCEDURE	O
OR	O
OPERATION	O
:	O

Spontaneous	O
Vertex	O
Vaginal	O
Delivery	O

ASSOCIATED	O
PROCEDURES	O
OR	O
OPERATIONS	O
:	O

POSTPARTUM	O
DIAGNOSTIC	O
PROCEDURES	O
:	O

None	O

POSTPARTUM	O
THERAPEUTIC	O
PROCEDURES	O
:	O

None	O

OTHER	O
POSTPARTUM	O
THERAPIES	O
:	O

Routine	O
Post	O
Partum	O
Care	O

HISTORY	O
AND	O
REASON	O
FOR	O
HOSPITALIZATION	O
:	O

Premature	B-disease
Rupture	I-disease
Of	I-disease
Membranes	I-disease

PHYSICAL	O
EXAMINATION	O
:	O

HEIGHT	O
63	O
HEENT	O
NORMAL	O
MOUTH	O
NORMAL	O
NECK	O
NORMAL	O
BREASTS	O
NORMAL	O
No	O
masses	B-disease
NIPPLES	O
NORMAL	O
CHEST	O
NORMAL	O
CTA	O
bilat	O
,	O
neg	O
wheezing	B-disease
COR	O
NORMAL	O
NSR	O
,	O
no	O
murmur	B-disease
ABDOMEN	O
Gravid	B-disease
,	O
vtx	O
.	O

EFW	O
=	O
7#	O
.	O

FHTs	O
140s	O
w/	O
reactivity	O
.	O

Mild	B-disease
irreg.	I-disease
ctx	I-disease
.	O

EXTREM	O
NORMAL	O
SKIN	O
NORMAL	O
NODES	O
NORMAL	O
VULVA	O
NORMAL	O
VAGINA	O
Leaking	O
copious	B-disease
amounts	I-disease
clear	I-disease
fluid	I-disease
.	O

Fluid	O
amnioswab	O
and	O
fern	B-disease
positive	I-disease
.	O

SSE	O
and	O
digital	O
exam	O
deferred	O
CERVIX	O
digital	O
exam	O
deferred	O
at	O
time	O
of	O
admission	O
OS	O
NORMAL	O
see	O
above	O
ADNEXAE	O
NORMAL	O
non-palp	O
d	O
/	O
t	O
advanced	B-disease
gest	I-disease
UTERUS	I-disease
Gravid	I-disease
,	O
vtx	O
.	O

EFW	O
=	O
7#	O
.	O

FHTs	O
140s	O
w/	O
reactivity	O
.	O

Ctx	O
q	O
6	O
&apos;	O
.	O

UTERINE	O
SIZE	O
IN	O
WEEKS	O
38	O

HOSPITAL	O
COURSE	O
(	O
include	O
complications	O
if	O
any	O
)	O
:	O

This	O
27	O
year	O
old	O
Gravida	O
1	O
Para	O
0000	O
was	O
admitted	O
to	O
the	O
Life	O
Valley	O
Medical	O
Center	O
Obstetrical	O
service	O
on	O
10/31/2004	O
at	O
08:45	O
pm	O
for	O
the	O
indication	O
(	O
s	O
)	O
:	O

premature	B-disease
rupture	I-disease
of	I-disease
membranes	I-disease
.	O

She	O
delivered	O
a	O
3235	O
gram	O
male	O
infant	O
on	O
11/01/2004	O
at	O
09:31	O
am	O
with	O
apgar	O
scores	O
of	O
9	O
and	O
9	O
at	O
one	O
and	O
five	O
minutes	O
respectively	O
at	O
39.0	O
weeks	O
gestation	O
via	O
spontaneous	O
vertex	O
vaginal	O
delivery	O
.	O

During	O
her	O
labor	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

During	O
her	O
delivery	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

Postpartum	O
she	O
encountered	O
the	O
following	O
complication	O
(	O
s	O
)	O
:	O

none	O
.	O

She	O
was	O
discharged	O
on	O
11/03/2004	O
at	O
11:18	O
am	O
in	O
good	O
condition	O
.	O

DISCHARGE	O
ORDERS	O
(	O
medications	O
instructions	O
to	O
patient	O
,	O
follow-up	O
care	O
)	O
:	O

DISCHARGE	O
ACTIVITY	O
:	O

No	O
Restrictions	O

DISCHARGE	O
DIET	O
:	O

No	O
Restrictions	O

POSTPARTUM	O
DISPOSITION	O
:	O

Home	O
With	O
Self-Care	O
(	O
Routine	O
Discharge	O
)	O

POSTPARTUM	O
CARE	O
SITE	O
:	O

La	O
Community	O
Hospital	O

POSTPARTUM	O
RETURN	O
APPOINTMENT	O
(	O
DAYS	O
)	O
:	O

42	O

BREAST	O
FEEDING	O
AT	O
DISCHARGE	O
:	O

Yes	O

POSTPARTUM	O
RH	O
IMMUNE	O
GLOBULIN	O
:	O

Not	O
Indicated	O

POSTPARTUM	O
MEASLES	O
/	O
MUMPS	O
/	O
RUBELLA	O
VACCINE	O
:	O

Not	O
Indicated	O

MEDICATION	O
(	O
S	O
)	O
ON	O
DISCHARGE	O
:	O

Multivitamins	O
And	O
Folate	O

Electronically	O
Signed	O
:	O

Fyfe	O
,	O
Lan	O
S	O
11/03/2004	O
11:19:27	O
AM	O

018636330	O
DH	O

5425710	O

123524	O

0144918	O

6/2/2005	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

KOTE	O
,	O
OA	O

UNIT	O
NUMBER	O
:	O

509-22-30	O

ADMISSION	O
DATE	O
:	O

06/02/2005	O

DISCHARGE	O
DATE	O
:	O

06/05/2005	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

C5-6	B-disease
disc	I-disease
herniation	I-disease
with	O
cord	B-disease
compression	I-disease
and	O
myelopathy	B-disease
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Microscopic	O
anterior	O
cervical	O
diskectomy	O
at	O
C5-6	O
and	O
fusion	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
63-year-old	O
female	O
with	O
a	O
three-year	O
history	O
of	O
bilateral	B-disease
hand	I-disease
numbness	I-disease
and	O
occasional	B-disease
weakness	I-disease
.	O

Within	O
the	O
past	O
year	O
,	O
these	B-disease
symptoms	I-disease
have	O
progressively	O
gotten	O
worse	O
,	O
to	O
encompass	O
also	O
her	O
feet	O
.	O

She	O
had	O
a	O
workup	O
by	O
her	O
neurologist	O
and	O
an	O
MRI	O
revealed	O
a	B-disease
C5-6	I-disease
disc	I-disease
herniation	I-disease
with	O
cord	B-disease
compression	I-disease
and	O
a	B-disease
T2	I-disease
signal	I-disease
change	I-disease
at	O
that	O
level	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
hypertension	B-disease
,	O
hyperlipidemia	B-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Lipitor	O
,	O
Flexeril	O
,	O
hydrochlorothiazide	O
and	O
Norvasc	O
.	O

ALLERGIES	O
:	O

She	O
has	O
no	O
known	B-disease
drug	I-disease
allergy	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
smokes	O
one	O
pack	O
per	O
day	O
x45	O
years	O
.	O

She	O
occasionally	O
drinks	O
alcohol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

She	O
had	O
5/5	O
strength	O
in	O
bilateral	O
upper	O
and	O
lower	O
extremities	O
.	O

She	O
had	O
a	O
Hoffman	O
&apos;s	O
sign	O
greater	O
on	O
the	O
right	O
than	O
the	O
left	O
and	O
she	O
had	O
10	B-disease
beats	I-disease
of	I-disease
clonus	I-disease
in	O
the	O
right	O
foot	O
and	O
3-5	B-disease
beats	I-disease
in	I-disease
the	I-disease
left	I-disease
foot	I-disease
.	O

She	O
had	O
hyperreflexia	B-disease
in	O
both	O
the	O
bilateral	O
upper	O
and	O
lower	O
extremities	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
tolerated	O
a	O
C5-6	O
ACDF	O
by	O
Dr.	O
Miezetri	O
Gach	O
quite	O
well	O
.	O

She	O
had	O
a	O
postoperative	O
CT	O
scan	O
that	O
revealed	O
partial	B-disease
decompression	I-disease
of	I-disease
the	I-disease
spinal	I-disease
canal	I-disease
and	O
good	O
placement	O
of	O
her	O
hardware	O
.	O

Immediately	O
postop	O
,	O
her	O
exam	O
only	O
improved	O
slightly	O
in	O
her	B-disease
hyperreflexia	I-disease
.	O

She	O
was	O
ambulating	O
by	O
postoperative	O
day	O
number	O
two	O
.	O

She	O
tolerated	O
a	O
regular	O
diet	O
.	O

Her	B-disease
pain	I-disease
was	O
under	O
good	O
control	O
with	O
PO	O
pain	O
medications	O
and	O
she	O
was	O
deemed	O
suitable	O
for	O
discharge	O
.	O

DISCHARGE	O
ORDERS	O
:	O

The	O
patient	O
was	O
asked	O
to	O
call	O
Dr.	O
Miezetri	O
Gach	O
&apos;s	O
office	O
for	O
a	O
follow-up	O
appointment	O
and	O
wound	O
check	O
.	O

She	O
is	O
asked	O
to	O
call	O
with	O
any	O
fevers	B-disease
,	O
chills	B-disease
,	O
increasing	B-disease
weakness	I-disease
or	O
numbness	B-disease
or	O
any	O
bowel	B-disease
and	I-disease
bladder	I-disease
disruption	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

She	O
was	O
discharged	O
on	O
the	O
following	O
medications	O
.	O

1.	O
Colace	O
,	O
100	O
mg	O
PO	O
bid	O
.	O

2.	O
Zantac	O
,	O
150	O
mg	O
PO	O
bid	O
.	O

3.	O
Percocet	O
,	O
5/325	O
,	O
1-2	O
tabs	O
PO	O
q4-6h	O
prn	O
pain	B-disease
.	O

4.	O
Lipitor	O
,	O
10	O
mg	O
PO	O
daily	O
.	O

5.	O
Hydrochlorothiazide	O
,	O
25	O
mg	O
PO	O
daily	O
.	O

6.	O
Norvasc	O
,	O
5	O
mg	O
PO	O
daily	O
.	O

LALIND	O
KOTE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
MIEZETRI	O
NIMIRY	O
POP	O
,	O
M.D.	O
08/01/2005	O
18:50	O

_____________________________	O
MIEZETRI	O
NIMIRY	O
POP	O
,	O
M.D.	O

TR	O
:	O

qg	O

DD	O
:	O

07/30/2005	O

TD	O
:	O

07/31/2005	O
9:43	O
A	O
123524	O

cc	O
:	O

MIEZETRI	O
NIMIRY	O
POP	O
,	O
M.D.	O

888428725	O
RWH	O

0712675	O

695770	O

6153969	O

11/4/2006	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

CRITCHE	O
,	O
NIFREDEDRHET	O

MRN	O
:	O

0712675	O

Age	O
:	O

40y	O

REGISTRATION	O
DATE	O
:	O

11/04/2006	O
12:17	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
CRITCHE	O
,	O
NIFREDEDRHET	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
11/04/2006	O
12:17	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
CP	B-disease
SOB	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
admitted	O
as	O
an	O
inpatient	O
to	O
Ro	O
Woodma	O
Healthcare	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
DREISSNEIGH	O
,	O
LIRU	O
and	O
the	O
preliminary	O
admitting	O
diagnosis	O
is	O
CP	B-disease
,	O
R	O
/	O
O	O
MI	B-disease
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

DREISSNEIGH	O
,	O
LIRU	O

Provider	O
Number	O
:	O

33616	O

Admission	O
Date	O
:	O

2011-01-19	O

Discharge	O
Date	O
:	O

2011-01-25	O

Date	O
of	O
Birth	O
:	O

1943-01-22	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

INDICATION	O
FOR	O
ADMISSION	O
:	O

Transfer	O
from	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
for	O
an	O
endoscopic	O
retrogram	O
cholangiopancreatography	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Eugene	O
is	O
a	O
67	O
year	O
old	O
male	O
with	O
a	O
remote	O
history	O
of	O
chronic	B-disease
pancreatitis	I-disease
due	O
to	O
alcohol	O
abuse	O
30	O
years	O
ago	O
,	O
who	O
is	O
transferred	O
now	O
from	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
for	O
an	O
ERCP	O
and	O
work-up	O
for	O
a	B-disease
cystic	I-disease
lesion	I-disease
at	O
the	O
head	O
of	O
his	O
pancreas	O
on	O
CT	O
scan	O
shown	O
at	O
the	O
outside	O
hospital	O
.	O

The	O
patient	O
presented	O
initially	O
to	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
at	O
the	O
end	O
of	O
December	O
for	O
abdominal	B-disease
pain	I-disease
,	O
and	O
was	O
found	O
to	O
have	O
pancreatitis	B-disease
.	O

During	O
this	O
admission	O
,	O
two	O
CT	O
scans	O
had	O
shown	O
a	O
question	O
of	O
an	B-disease
enlargement	I-disease
of	I-disease
the	I-disease
head	I-disease
of	I-disease
his	I-disease
pancreas	I-disease

versus	O
early	B-disease
pseudocyst	I-disease
.	O

The	O
patient	O
was	O
discharged	O
home	O
early	O
from	O
this	O
admission	O
due	O
to	O
family	O
needs	O
.	O

While	O
at	O
home	O
,	O
the	O
patient	O
did	O
not	O
do	O
well	O
and	O
could	O
tolerate	O
minimal	O
food	O
intake	O
and	O
lost	O
about	O
20	O
pounds	O
in	O
one	O
month	O
.	O

On	O
an	O
office	O
visit	O
on	O
01-14	O
,	O
the	O
patient	O
was	O
found	O
to	O
have	O
significantly	B-disease
elevated	I-disease
alkaline	I-disease
phosphatase	I-disease
.	O

That	O
evening	O
,	O
the	O
patient	O
again	O
developed	O
abdominal	B-disease
pain	I-disease
"	O
like	O
his	B-disease
pancreatitis	I-disease
"	O
with	O
nausea	B-disease
and	O
vomiting	B-disease
,	O
for	O
which	O
he	O
was	O
admitted	O
to	O
the	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
.	O

In	O
the	O
Emergency	O
Department	O
at	O
the	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
vomited	O
some	O
heme	O
positive	O
material	O
.	O

His	O
complete	O
blood	O
count	O
showed	O
11%	B-disease
bandemia	I-disease
with	O
a	O
total	O
white	O
count	O
of	O
10	O
.	O

A	O
HIDA	O
scan	O
showed	O
no	B-disease
flow	I-disease
,	O
question	O
of	O
pancreatitis	B-disease
versus	O
common	B-disease
bile	I-disease
duct	I-disease
obstruction	I-disease
.	O

His	O
electrocardiogram	O
showed	O
a	O
normal	O
sinus	O
rhythm	O
.	O

A	O
chest	O
x-ray	O
was	O
unremarkable	O
.	O

During	O
his	O
admission	O
to	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
,	O
the	O
patient	O
had	O
dropped	O
his	O
hematocrit	O
to	O
the	O
30	O
s	O
with	O
recorded	B-disease
melena	I-disease
.	O

He	O
received	O
an	O
MRCP	O
which	O
was	O
negative	O
for	O
evidence	O
of	O
stones	B-disease
.	O

An	O
ultrasound	O
showed	O
normal	O
gallbladder	O
with	O
no	O
wall	B-disease
thickening	I-disease
but	O
a	B-disease
dilated	I-disease
common	I-disease
bile	I-disease
duct	I-disease
of	O
8	O
mm	O
measured	O
on	O
CT	O
scan	O
.	O

The	O
patient	O
had	O
an	O
attempted	O
ERCP	O
on	O
01-18	O
,	O
which	O
was	O
unsuccessful	O
due	O
to	O
a	B-disease
long	I-disease
nipple	I-disease
like	I-disease
papilla	I-disease
.	O

He	O
was	O
therefore	O
transferred	O
to	O
Saints	O
Medical	O
Center	O
for	O
endoscopic	O
retrogram	O
cholangiopancreatography	O
.	O

The	O
patient	O
's	O
blood	O
cultures	O
at	O
outside	O
hospital	O
grew	O
out	O
Streptococcus	B-disease
sanguis-gordonii	I-disease
on	O
01-18	O
.	O

This	O
was	O
sensitive	O
to	O
Clindamycin	O
,	O
Erythromycin	O
,	O
penicillin	O
S	O
and	O
Vancomycin	O
.	O

Prior	O
to	O
this	O
result	O
,	O
the	O
patient	O
had	O
already	O
been	O
on	O
Ampicillin	O
,	O
Sulbactam	O
and	O
Gentamycin	O
.	O

It	O
appears	O
from	O
the	O
Discharge	O
summary	O
that	O
the	O
patient	O
was	O
placed	O
on	O
Unasyn	O
3	O
grams	O
intravenously	O
every	O
six	O
hours	O
after	O
his	O
ERCP	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Type	B-disease
2	I-disease
diabetes	I-disease
mellitus	I-disease
.	O

2.	O
Right	B-disease
rotator	I-disease
cuff	I-disease
injury	I-disease
.	O

3.	O
Gastroesophageal	B-disease
reflux	I-disease
disease	I-disease
with	O
esophageal	O
dilatation	O
for	O
stricture	B-disease
.	O

4.	O
Recent	B-disease
pancreatitis	I-disease
;	O
prior	O
history	O
for	O
recurrent	B-disease
pancreatitis	I-disease
30	O
years	O
ago	O
from	O
alcohol	O
.	O

5.	O
History	O
of	O
Streptococcemia	B-disease
in	O
the	O
year	O
2008	O
;	O
source	O
was	O
unclear	O
but	O
presumed	O
to	O
be	O
urinary	O
.	O

6.	O
Status	O
post	O
tonsillectomy	O
as	O
a	O
child	O
.	O

MEDICATIONS	O
AT	O
HOME	O
:	O

1.	O
Prilosec	O
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

2.	O
Flomax	O
4	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Humalog	O
75/25	O
,	O
subcutaneously	O
.	O

4.	O
Regular	O
insulin	O
15	O
units	O
q.	O
a.m.	O
and	O
14	O
units	O
q.	O
p.m.	O

MEDICATIONS	O
ON	O
ADMISSION	O
FROM	O
TRANSFER	O
:	O

1.	O
Unasyn	O
3	O
grams	O
intravenous	O
every	O
six	O
hours	O
.	O

2.	O
NPH	O
10	O
units	O
subcutaneously	O
every	O
morning	O
and	O
8	O
units	O
subcutaneously	O
every	O
evening	O
.	O

3.	O
Flomax	O
0.4	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Prilosec	O
30	O
mg	O
p.o.	O
q.	O
day	O
.	O

5.	O
Regular	O
insulin	O
sliding	O
scale	O
.	O

6.	O
Tylenol	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
is	O
allergic	B-disease
to	O
Ciprofloxacin	O
,	O
morphine	O
sulfate	O
and	O
Droperidol	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
his	O
disabled	O
wife	O
who	O
has	O
a	B-disease
psychiatric	I-disease
condition	I-disease
.	O

He	O
had	O
a	O
history	O
of	O
alcohol	O
abuse	O
but	O
has	O
been	O
sober	O
for	O
30	O
years	O
.	O

He	O
is	O
a	O
retired	O
painter	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
showed	O
a	O
temperature	O
of	O
97.1	O
F.	O
;	O
heart	O
rate	O
of	O
65	O
;	O
blood	O
pressure	O
of	O
146/74	O
;	O
respiratory	O
rate	O
of	O
20	O
;	O
oxygen	O
saturation	O
98%	O
on	O
three	O
liters	O
and	O
95%	O
on	O
room	O
air	O
.	O

The	O
patient	O
was	O
alert	O
,	O
awake	O
and	O
oriented	O
,	O
pleasant	O
,	O
and	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
and	O
throat	O
examination	O
revealed	O
mucous	O
membranes	O
that	O
were	O
moist	O
.	O

The	O
patient	O
has	O
two	O
teeth	O
.	O

He	O
has	O
fine	O
dental	O
hygiene	O
.	O

He	O
had	O
no	O
icterus	B-disease
.	O

Cardiovascular	O
system	O
revealed	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmurs	B-disease
or	O
gallops	B-disease
and	O
regular	O
rate	O
and	O
rhythm	O
.	O

Pulmonary	O
examination	O
revealed	O
lungs	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Abdominal	O
examination	O
revealed	O
an	O
abdomen	O
that	O
is	O
nondistended	B-disease
,	O
nontender	B-disease
.	O

He	O
had	O
normoactive	O
bowel	O
sounds	O
.	O

His	O
liver	O
span	O
was	O
8	O
cm	O
.	O

The	O
antrum	O
was	O
palpable	O
3	O
cm	O
below	O
the	O
costal	O
margin	O
.	O

The	O
spleen	O
tip	O
was	O
palpable	O
.	O

There	O
was	O
no	O
rebound	B-disease
;	O
no	O
Munos	B-disease
sign	I-disease
.	O

Extremities	O
reveal	O
no	O
edema	B-disease
,	O
no	O
swelling	B-disease
.	O

Neurologic	O
examination	O
revealed	O
an	O
alert	O
and	O
oriented	O
individual	O
.	O

His	O
face	O
was	O
symmetric	O
;	O
tongue	O
was	O
midline	O
.	O

His	O
language	O
was	O
fluent	O
and	O
normal	O
.	O

The	O
patient	O
was	O
moving	O
all	O
four	O
extremities	O
with	O
ease	O
.	O

There	O
was	O
no	O
formal	O
strength	O
test	O
done	O
.	O

LABORATORY	O
:	O

Studies	O
revealed	O
a	O
hematocrit	O
of	O
32.6	O
,	O
white	O
count	O
of	O
6.0	O
.	O

His	O
platelet	O
count	O
was	O
267	O
.	O

His	O
MCV	O
was	O
88	O
,	O
red	O
cell	O
distribution	O
was	O
13.4	O
.	O

Chemistry	O
on	O
admission	O
showed	O
a	O
sodium	O
of	O
141	O
,	O
potassium	O
of	O
4.3	O
,	O
chloride	O
of	O
107	O
,	O
bicarbonate	O
of	O
25	O
,	O
BUN	O
of	O
4	O
,	O
creatinine	O
of	O
0.6	O
and	O
a	O
sugar	O
of	O
177	O
.	O

Liver	O
function	O
tests	O
revealed	O
an	O
ALT	O
of	O
31	O
,	O
AST	O
of	O
36	O
,	O
alkaline	O
phosphatase	O
of	O
509	O
.	O

Total	O
bilirubin	O
was	O
0.8	O
.	O

Albumin	O
was	O
2.6	O
.	O

His	O
blood	O
cultures	O
were	O
drawn	O
and	O
pending	O
.	O

Urinalysis	O
revealed	O
trace	B-disease
glucose	I-disease
,	O
no	O
ketones	B-disease
,	O
no	O
red	B-disease
cells	I-disease
,	O
no	O
white	B-disease
cells	I-disease
and	O
less	O
than	O
one	O
epithelial	O
cells	O
.	O

COURSE	O
IN	O
HOSPITAL	O
:	O

The	O
patient	O
was	O
taken	O
down	O
to	O
the	O
endoscopic	O
retrogram	O
cholangiopancreatogram	O
upon	O
admission	O
.	O

On	O
this	O
examination	O
,	O
the	O
patient	O
was	O
found	O
to	O
have	O
mild	B-disease
biliary	I-disease
stricture	I-disease
most	O
likely	O
secondary	O
to	O
chronic	B-disease
pancreatitis	I-disease
.	O

Cytology	O
was	O
obtained	O
.	O

He	O
was	O
also	O
found	O
to	O
have	O
dilated	B-disease
pancreatic	I-disease
ducts	I-disease
with	O
calcifications	B-disease
consistent	O
with	O
chronic	B-disease
pancreatitis	I-disease
.	O

The	O
patient	O
underwent	O
a	O
percutaneous	O
sphincterotomy	O
extended	O
to	O
a	O
full	O
sphincterectomy	O
.	O

He	O
also	O
had	O
successful	O
extraction	O
of	O
stone	B-disease
fragments	I-disease
.	O

The	O
patient	O
tolerated	O
this	O
procedure	O
well	O
and	O
had	O
no	O
complications	B-disease
.	O

The	O
patient	O
subsequently	O
underwent	O
a	O
CT	O
scan	O
angiogram	O
with	O
Pancreas	O
protocol	O
to	O
assess	O
the	O
pseudocyst	B-disease
versus	O
enlarged	B-disease
pancreas	I-disease
head	I-disease
.	O

The	O
results	O
of	O
this	O
study	O
indicated	O
that	O
this	O
structure	O
at	O
the	O
head	O
of	O
his	O
pancreas	O
is	O
most	O
likely	O
a	B-disease
forming	I-disease
pseudocyst	I-disease
;	O
however	O
,	O
the	O
suspicion	O
of	O
malignancy	B-disease
is	O
still	O
possible	O
and	O
the	O
patient	O
underwent	O
an	O
ultrasound	O
guided	O
biopsy	O
of	O
this	B-disease
mass	I-disease
on	O
2011-01-20	O
.	O

The	O
cytology	O
for	O
this	O
biopsy	O
is	O
still	O
pending	O
.	O

The	O
patient	O
recovered	O
well	O
status	O
post	O
these	O
two	O
procedures	O
.	O

He	O
had	O
no	O
complications	B-disease
and	O
no	O
subsequently	B-disease
pancreatitis	I-disease
.	O

His	O
alkaline	O
phosphatase	O
and	O
all	B-disease
the	I-disease
other	I-disease
abnormal	I-disease
liver	I-disease
function	I-disease
tests	I-disease
were	O
resolving	O
.	O

He	O
had	O
no	O
pain	B-disease
and	O
did	O
not	O
require	O
any	O
pain	O
medications	O
.	O

He	O
was	O
tolerating	O
food	O
very	O
well	O
and	O
was	O
afebrile	B-disease
throughout	O
admission	O
.	O

With	O
regards	O
to	O
the	B-disease
patient	I-disease
's	I-disease
documented	I-disease
Strep	I-disease
septicemia	I-disease
in	O
the	O
outside	O
hospital	O
,	O
the	O
Infectious	O
Disease	O
Team	O
was	O
formally	O
consulted	O
.	O

Upon	O
obtaining	O
more	O
information	O
from	O
Rehab	O
Hospital	O
of	O
the	O
Cape	O
&	O
Islands	O
Hospital	O
,	O
it	O
appears	O
that	O
the	O
patient	O
had	O
two	O
out	O
of	O
four	O
bottles	O
growing	O
out	O
Streptococcus	B-disease
sanguis	I-disease
in	O
the	O
outside	O
hospital	O
.	O

The	O
patient	O
appeared	O
to	O
have	O
been	O
covered	O
by	O
Ampicillin	O
,	O
Gentamycin	O
and	O
then	O
Unasyn	O
in	O
the	O
outside	O
hospital	O
.	O

The	O
patient	O
,	O
on	O
admission	O
,	O
was	O
placed	O
on	O
Ampicillin	O
,	O
Gentamycin	O
and	O
Flagyl	O
.	O

With	O
repeated	O
blood	O
cultures	O
that	O
were	O
negative	O
,	O
the	O
patient	O
was	O
reduced	O
to	O
single	O
Mckenzie	O
of	O
intravenous	O
Ampicillin	O
.	O

For	O
this	B-disease
documented	I-disease
septicemia	I-disease
,	O
this	O
patient	O
went	O
for	O
a	O
endocarditis	O
work-up	O
.	O

He	O
had	O
a	O
transthoracic	O
echocardiogram	O
which	O
revealed	O
no	O
vegetations	B-disease
.	O

On	O
this	O
echocardiogram	O
,	O
he	O
was	O
found	O
to	O
have	O
mildly	B-disease
dilated	I-disease
left	I-disease
atrium	I-disease
,	O
mild	B-disease
symmetric	I-disease
left	I-disease
ventricular	I-disease
hypertrophy	I-disease
,	O
and	O
a	O
normal	O
ejection	O
fraction	O
of	O
greater	O
than	O
55%	O
.	O

There	O
were	O
no	O
other	B-disease
abnormalities	I-disease
noted	O
on	O
this	O
study	O
.	O

The	O
patient	O
then	O
underwent	O
a	O
transesophageal	O
echocardiogram	O
on	O
01-24	O
.	O

On	O
this	O
echocardiogram	O
,	O
he	O
was	O
again	O
noted	O
to	O
not	O
have	O
any	O
evidence	O
for	O
valvular	B-disease
vegetations	I-disease
.	O

A	B-disease
complex	I-disease
plaque	I-disease
was	O
found	O
in	O
the	O
aortic	O
arch	O
in	O
the	O
descending	O
thoracic	O
aorta	O
,	O
although	O
this	B-disease
plaque	I-disease
is	O
non-mobile	O
.	O

There	O
was	O
focal	B-disease
mitral	I-disease
valve	I-disease
prolapse	I-disease
noted	O
without	O
pathologic	B-disease
mitral	I-disease
regurgitation	I-disease
.	O

The	O
patient	O
was	O
noted	O
to	O
have	O
trace	B-disease
aortic	I-disease
regurgitation	I-disease
.	O

A	O
Panorex	O
x-ray	O
of	O
his	O
two	O
teeth	O
were	O
obtained	O
and	O
a	O
Dental	O
Consultation	O
was	O
done	O
.	O

The	O
patient	O
was	O
thought	O
to	O
have	O
normal	O
dental	O
hygiene	O
and	O
low	O
suspicion	O
for	O
a	O
source	O
of	O
his	B-disease
alpha	I-disease
septicemia	I-disease
from	I-disease
his	I-disease
mouth	I-disease
.	O

Infectious	O
Disease	O
Department	O
as	O
well	O
as	O
Cardiology	O
had	O
recommended	O
a	O
formal	O
14	O
-	O
day	O
course	O
of	O
intravenous	O
antibiotics	O
to	O
treat	O
a	B-disease
documented	I-disease
alpha	I-disease
Streptococcal	I-disease
septicemia	I-disease
from	O
outside	O
hospital	O
blood	O
cultures	O
.	O

The	O
patient	O
's	O
insurance	O
company	O
,	O
however	O
,	O
would	O
not	O
pay	O
for	O
home	O
antibiotics	O
.	O

After	O
much	O
discussion	O
with	O
the	O
patient	O
,	O
the	O
patient	O
was	O
informed	O
of	O
the	O
risks	O
of	O
not	O
finishing	O
a	O
14	O
day	O
course	O
of	O
intravenous	O
antibiotics	O
and	O
chose	O
to	O
go	O
home	O
.	O

He	O
had	O
three	O
days	O
of	O
antibiotics	O
remaining	O
at	O
the	O
time	O
of	O
discharge	O
.	O

It	O
was	O
discussed	O
with	O
the	O
patient	O
to	O
send	O
him	O
out	O
on	O
Augmentin	O
500	O
mg	O
three	O
times	O
a	O
day	O
for	O
ten	O
more	O
days	O
.	O

He	O
was	O
to	O
follow-up	O
with	O
his	O
primary	O
care	O
physician	O
within	O
two	O
to	O
three	O
days	O
for	O
repeat	O
laboratory	O
studies	O
and	O
blood	O
cultures	O
.	O

He	O
was	O
to	O
return	O
to	O
the	O
hospital	O
with	O
any	O
signs	O
of	O
shaking	B-disease
chills	B-disease
or	O
fever	B-disease
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Pancreatitis	B-disease
status	O
post	O
endoscopic	O
retrogram	O
cholangiopancreatography	O
and	O
sphincterotomy	O
.	O

2.	O
Alpha	B-disease
Streptococcus	I-disease
septicemia	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Augmentin	O
500	O
mg	O
p.o.	O
three	O
times	O
a	O
day	O
times	O
ten	O
days	O
.	O

2.	O
Flomax	O
0.4	O
mg	O
p.o.	O
q.	O
day	O
.	O

3.	O
Prilosec	O
20	O
mg	O
p.o.	O
q.	O
day	O
.	O

4.	O
Humalog	O
and	O
Regular	O
insulin	O
subcutaneously	O
.	O

Hallo	O
MING	O
LI	O
,	O
M.D.	O

40-963	O

Dictated	O
By	O
:	O
Annie	O
D.	O
Martinez	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-01-25	O
14:08	O

T	O
:	O
2011-01-26	O
11:30	O

JOB	O
#:	O

09167	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dorothy	O
L.	O
Brennan	O
on	O
:	O
Russell	O
2011-01-27	O
11:38	O
AM	O

(	O
End	O
of	O
Report	O
)	O

544907529	O
RWH	O

2746299	O

006349	O

700114	O

4/4/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

JESCWIERST	O
,	O
MA	O

MRN	O
:	O

2746299	O

Age	O
:	O

55y	O

REGISTRATION	O
DATE	O
:	O

04/04/2002	O
01:09	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
JESCWIERST	O
,	O
MA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Ro	O
Woodma	O
Healthcare	O
on	O
04/04/2002	O
01:09	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
EPIGASTRIC	B-disease
PAIN	I-disease
/	O
ABD	B-disease
PAIN	I-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
RO	O
WOODMA	O
HEALTHCARE	O
.	O

The	O
patient	O
&apos;s	O
preliminary	O
admitting	O
physician	O
is	O
PRIESDOUET	O
,	O
CH	O
J	O
and	O
the	O
preliminary	O
diagnosis	O
is	O
CHOLECYSTITIS	B-disease
.	O

Please	O
note	O
this	O
information	O
may	O
have	O
been	O
updated	O
on	O
the	O
inpatient	O
unit	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
662-747-1199	O
.	O

PCP	O
Name	O
:	O

GRENDZISKLEEB	O
,	O
FACISA	O
T	O

Provider	O
Number	O
:	O

11181	O

Admission	O
Date	O
:	O

2018-05-24	O

Discharge	O
Date	O
:	O

2018-05-29	O

Date	O
of	O
Birth	O
:	O

1964-03-11	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Keflex	O
/	O
Heparin	O
Agents	O

Attending	O
:	O
James	O
F.	O
Bard	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O
pt	O
sent	O
to	O
ER	O
after	O
routine	O
F/U	O
for	O
UE	B-disease
DVT	I-disease
with	O
vascular	O
surgery	O
.	O

In	O
ER	O
c/o	O
dyspnea	B-disease
and	O
was	O
noted	O
to	O
have	O
mental	B-disease
status	I-disease
changes	I-disease
.	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O
none	O
this	O
admission	O

AVR	O
(	O
tissue	O
)	O
05-14	O

History	O
of	O
Present	O
Illness	O
:	O

s/p	O
AVR	O
05-14	O
.	O

Postop	O
course	O
c/b	O
right	B-disease
upper	I-disease
extremity	I-disease
DVT	I-disease
and	O
postop	B-disease
Afib	I-disease
.	O

Discharged	O
home	O
05-19	O
with	O
instructions	O
to	O
f/u	O
in	O
vascular	O
clinic	O
.	O

Had	O
vascular	O
clinic	O
f/u	O
on	O
day	O
of	O
admission	O
.	O

At	O
that	O
time	O
had	O
UE	O
duplex	O
which	O
revealed	O
RUE	B-disease
DVT	I-disease
involving	O
IJ	O
,	O
Axillary	O
,	O
subclav	O
,	O
brachial	O
,	O
and	O
basilic	O
veins	O
.	O

Then	O
referred	O
to	O
ER	O
for	O
Tx	O

Past	O
Medical	O
History	O
:	O

s/p	O
AVR	O
(	O
#27	O
pericardial	O
)	O

post-op	B-disease
Afib	I-disease

HTN	B-disease

renal	B-disease
calculi	I-disease

?	O
sleep	B-disease
apnea	I-disease

seasonal	B-disease
allergies	I-disease

s/p	O
2	O
surgs.	O
for	O
spermatocele	B-disease

s/p	O
oral	O
surgery	O

Social	O
History	O
:	O
lives	O
with	O
partner	O

professor	O
/	O
Kyra	O
social	O
worker	O

quit	O
smoking	O
20	O
years	O
ago	O

occasional	O
ETOH	O

Family	O
History	O
:	O

non-contributory	O
for	O
premature	B-disease
CAD	I-disease
;	O
father	O
had	O
MI	B-disease
in	O
his	O
70	O
's	O

Physical	O
Exam	O
:	O

admission	O
PE	O

VS	O
:	O
HR	O
103	O
BP	O
162/69	O
RR	O
14	O
Sat	O
92%	O
RA	O

Neuro	O
:	O
MAE	O
,	O
Follows	O
commands	O
,	O
slightly	B-disease
confused	I-disease

Heent	O
:	O
PERRL/EOMI	O
,	O
no	O
JVD	B-disease

Resp	O
:	O
CTAB	O

CV	O
:	O
RRR	O
S1-S2	O
,	O
no	O
murmur	B-disease
.	O

Sternum	O
stable	O

Abdm	O
:	O
soft	O
NT	B-disease
/	O
ND	B-disease
/	O
NABS	O

Ext	O
:	O
+	O
distal	O
pulses	O
,	O
no	O
edema	B-disease

Discharge	O
PE	O

VS	O
:	O
T	O
99	O
HR	O
68	O
BP	O
113/72	O
RR	O
18	O
Sat	O
98%	O
RA	O

Gen	O
:	O
comforable	O

Neuro	O
:	O
A&Ox3	O
,	O
MAE	O
,	O
Follows	O
Commands	O

Resp	O
:	O
CTA-bilat	O

CV:RRR	O
S1-S2	O
,	O
no	O
MRG	B-disease

Resp:CTA-bilat	O

Abdm	O
:	O
soft	O
,	O
NT/ND/NABS	B-disease

Ext	O
:	O
warm	O
well	O
perfused	O
No	O
CCE	B-disease

Pertinent	O
Results	O
:	O

2018-05-24	O
08:55	O
PM	O

GLUCOSE	O
-	O
193	O
*	O
UREA	O
N	O
-	O
23	O
*	O
CREAT	O
-	O
1.2	O
SODIUM	O
-	O
138	O
POTASSIUM	O
-	O
4.6	O
CHLORIDE	O
-	O
101	O
TOTAL	O
CO2	O
-	O
21	O
*	O
ANION	O
GAP	O
-	O
21	O
*	O

2018-05-24	O
08:55	O
PM	O

CALCIUM	O
-	O
8.8	O
PHOSPHATE	O
-	O
3.9	O
MAGNESIUM	O
-	O
2.4	O

2018-05-24	O
08:55	O
PM	O

PT	O
-	O
15.0	O
*	O
PTT	O
-	O
107.1	O
*	O
INR	O
(	O
PT	O
)-	O
1.3	O
*	O

2018-05-24	O
01:25	O
PM	O

WBC	O
-	O
13.3	O
*#	O
RBC	O
-	O
3.45	O
*	O
HGB	O
-	O
10.6	O
*	O
HCT	O
-	O
30.5	O
*	O
MCV	O
-	O
88	O
MCH	O
-	O
30.6	O
MCHC	O
-	O
34.7	O
RDW	O
-	O
12.7	O

2018-05-28	O
01:40	O
PM	O

BLOOD	O
WBC	O
-	O
12.9	O
*	O
RBC	O
-	O
3.37	O
*	O
Hgb	O
-	O
10.4	O
*	O
Hct	O
-	O
29.4	O
*	O
MCV	O
-	O
87	O
MCH	O
-	O
30.8	O
MCHC	O
-	O
35.3	O
*	O
RDW	O
-	O
13.3	O
Plt	O
Ct	O
-	O
345	O

2018-05-29	O
11:34	O
AM	O

BLOOD	O
PT	O
-	O
39.1	O
*	O
INR	O
(	O
PT	O
)-	O
4.4	O
*	O

2018-05-25	O
09:00	O
AM	O

BLOOD	O
HEPARIN	O
DEPENDENT	O
ANTIBODIES	O
-	O
positive	O

Brief	O
Hospital	O
Course	O
:	O

Pt	O
admitted	O
05-24	O
from	O
ER	O
after	O
positive	B-disease
RUE	I-disease
DVT	I-disease
finding	O
in	O
vascular	O
lab	O
.	O

During	O
ER	O
evaluation	O
pt	O
was	O
noted	O
to	O
have	O
some	O
degree	O
of	O
dyspnea	B-disease
as	O
well	O
as	O
mental	B-disease
status	I-disease
changes	I-disease
,	O
including	O
loss	B-disease
of	I-disease
short	I-disease
term	I-disease
memory	I-disease
and	O
brief	B-disease
unresponsive	I-disease
period	I-disease
after	O
one	O
dose	O
of	O
IV	O
Benadry	O
and	O
steroids	O
prior	O
to	O
CT	O
scan	O
.	O

The	O
CT	O
was	O
negative	O
for	O
CVA	B-disease
but	O
positive	O
for	O
Pulmonary	B-disease
embolism	I-disease
.	O

He	O
was	O
transferred	O
to	O
CSRU	O
for	O
evaluation	O
.	O

Neurology	O
was	O
consulted	O
and	O
the	O
pt	O
also	O
had	O
MRI	O
which	O
was	O
negative	O
.	O

The	O
pt	O
was	O
begun	O
on	O
heparin	O
gtt	O
and	O
was	O
noted	O
to	O
have	O
platelet	B-disease
drop	I-disease
>	O
50%	O
after	O
infusion	O
began	O
,	O
hepain	O
was	O
d/c	O
'd.	O

Argatroban	O
was	O
started	O
abd	O
a	O
HIT	O
panel	O
was	O
sent	O
,	O
HIT	O
panel	O
was	O
positive	B-disease
.	O

Hematology	O
was	O
consulted	O
.	O

By	O
the	O
following	O
mornig	O
all	B-disease
mental	I-disease
status	I-disease
changes	I-disease
had	O
cleared	O
and	O
the	O
pt	O
was	O
transferred	O
to	O
the	O
floors	O
for	O
continued	O
care	O
.	O

Over	O
the	O
next	O
several	O
days	O
the	O
patient	O
was	O
maintained	O
on	O
Argatrobanwhile	O
coumadin	O
therapy	O
was	O
initiated	O
.	O

On	O
HD#6	O
the	O
pt	O
had	O
a	O
therapeudic	O
INR	O
(	O
4.4	O
)	O
off	O
Argatroban	O
and	O
wad	O
discharged	O
home	O
.	O

He	O
was	O
to	O
have	O
f/u	O
INR	O
check	O
with	O
Dr	O
Lewis	O
on	O
05-31	O
.	O

Additionally	O
the	O
pt	O
should	O
f/u	O
with	O
the	O
hematology	O
clinic	O
.	O

Medications	O
on	O
Admission	O
:	O

ASA	O
81	O
'	O

Atorvastatin	O
10	O
'	O

Lisinopril	O
5	O
'	O

Lopressor	O
50	O
"	O

Amiodarone	O
200	O
'	O

Discharge	O
Medications	O
:	O

1.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

2.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

3.	O
Metoprolol	O
Tartrate	O
50	O
mg	O
Tablet	O
Sig	O
:One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
.	O

4.	O
Amoxicillin-Pot	O
Clavulanate	O
875-125	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
for	O
10	O
days	O
.	O

Disp	O
:*	O
20	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Amiodarone	O
200	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
)	O
.	O

6.	O
Warfarin	O
2	O
mg	O
Tablet	O
Sig	O
:	O
1.5	O
Tablets	O
PO	O
as	O
directed	O
:	O
3	O
mg	O
1943-05-29	O
and	O
6/1	O
then	O
as	O
directed	O
by	O
Dr	O
Mace	O
.	O

Disp	O
:*	O
100	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O
s/p	O
AVR	O
05-14	O
(	O
tissue	O
)	O
readmitted	O
05-24	O
w/	O
pulmonary	B-disease
embolism	I-disease
,	O
RUE	B-disease
DVT	I-disease
,	O
HIT	B-disease
positive	I-disease

PMH	O
:	O
HTN	B-disease
,	O
Renal	B-disease
calculi	I-disease
,	O
sleep	B-disease
apnea	I-disease
,	O

Discharge	O
Condition	O
:	O
good	O

Discharge	O
Instructions	O
:	O
keep	O
wounds	B-disease
clean	O
and	O
dry	O
.	O

OK	O
to	O
shower	O
,	O
no	O
bathing	O
or	O
swimming	O
.	O

Take	O
all	O
medications	O
as	O
prescribed	O
.	O

Follow-up	O
INR	O
to	O
be	O
drawn	O
06-01	O
,	O
by	O
Dr	O
Lewis	O
@	O
597-4427	O

Followup	O
Instructions	O
:	O

Dr	O
Pessolano	O
in	O
3	O
days	O

Dr	O
Arnold	O
in	O
3	O
weeks	O

Hematology	O
clinic	O
in	O
1-2	O
weeks	O

Messersmith	O
della	O
Blore	O
MD	O
27-337	O

Completed	O
by	O
:	O
MARK	O
Yvonne	O
NP	O
80-AUO	O
2018-05-29	O
@	O
1552	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Edward	O
von	O
der	O
Torros	O
on	O
:	O
WED	O
2018-06-20	O
2:58	O
PM	O

(	O
End	O
of	O
Report	O
)	O

979440029	O
RWH	O

2027705	O

618070	O

3030191	O

06/11/2005	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

ELKSFALCBAINKIH	O
,	O
ON	O

MRN	O
:	O

2027705	O

Age	O
:	O

47y	O

REGISTRATION	O
DATE	O
:	O

06/11/2005	O
12:08	O
PM	O

Provider	O
:	O

BURLTIS	O
TROWELKS	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

E-mail	O

PCP	O
Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Note	O
Date	O
/	O
Time	O
:	O

06/11/2005	O
21:46	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

BODY	B-disease
SHAKING	I-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
back	B-disease
pain	I-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

back	B-disease
pain/	I-disease
mechanical	B-disease
fall	I-disease

Treatment	O
Rendered	O
:	O

Pt	O
&apos;s	O
labs	O
were	O
checked	O
,	O
he	O
was	O
seen	O
by	O
Neurology	O
,	O
and	O
he	O
received	O
a	O
spine	O
MRI	O
which	O
was	O
negative	O
.	O

He	O
received	O
Rx	O
for	O
potassium	O
to	O
help	O
with	O
cramps	B-disease
.	O

Advised	O
to	O
contact	O
Pain	O
service	O
for	O
repeat	O
injections	O
,	O
F	O
/	O
U	O
with	O
Neurology	O
,	O
explore	O
PT	O
,	O
massage	O
therapy	O
.	O

Discharge	O
Medications	O
:	O

K-Dur	O
20meq	O
PO	O
QD	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

F	O
/	O
U	O
with	O
Dr.	O
Wierstkotea	O
within	O
1	O
week	O
.	O

F	O
/	O
U	O
with	O
Neurology	O
,	O
pain	O
service	O
to	O
schedule	O
an	O
appt	O
.	O

PCP	O
Name	O
:	O

WIERSTKOTEA	O
,	O
JETA	O

Provider	O
Number	O
:	O

50927	O

This	O
report	O
was	O
created	O
by	O
TROWELKS	O
,	O
BURLTIS	O
06/11/2005	O
09:52	O
PM	O

693008750	O

HLGMC	O

6001356	O

014235	O

9/18/2001	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

HUHTLAND	O
,	O
CIE	O

MRN	O
:	O

6001356	O

Age	O
:	O

82y	O

REGISTRATION	O
DATE	O
:	O

09/18/2001	O
10:52	O
AM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
HUHTLAND	O
,	O
CIE	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Heaonboburg	O
Linpack	O
Grant	O
Medical	O
Center	O
on	O
09/18/2001	O
10:52	O
AM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
WHEEZES	B-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
&apos;s	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
HEAONBOBURG	O
LINPACK	O
GRANT	O
MEDICAL	O
CENTER	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
SAPSCLYSS	O
,	O
LEO	O
R	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
PNEUMONIA	B-disease
,	O
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
605-304-8547	O
.	O

PCP	O
Name	O
:	O

SC	O
,	O
JUSONKIM	O
N	O

Provider	O
Number	O
:	O

96078	O

989519730	O
WGH	O

4708487	O

265076	O

4927849	O

05/09/2004	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

GINSLENT	O
,	O
A	O
L	O

UNIT	O
NUMBER	O
:	O

537-43-35	O

ADMISSION	O
DATE	O
:	O

05/09/2004	O

DISCHARGE	O
DATE	O
:	O

05/16/2004	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Colon	B-disease
cancer	I-disease
.	O

ASSOCIATED	O
DIAGNOSES	O
:	O

History	O
of	O
diverticulitis	B-disease
,	O
status	O
post	O
cholecystectomy	O
,	O
status	O
post	O
appendectomy	O
,	O
and	O
hypertension	B-disease
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Transverse	O
colectomy	O
for	O
tumor	B-disease
.	O

ASSOCIATED	O
PROCEDURES	O
:	O

None	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
an	O
84-year-old	O
woman	O
with	O
a	O
history	O
of	O
diverticulitis	B-disease
who	O
was	O
found	O
to	O
have	O
colon	B-disease
cancer	I-disease
on	O
colonoscopy	O
,	O
which	O
was	O
performed	O
in	O
March	O
of	O
2004	O
.	O

An	B-disease
invasive	I-disease
moderately	I-disease
differentiated	I-disease
adenocarcinoma	I-disease
was	O
noted	O
in	O
the	O
transverse	O
colon	O
at	O
80	O
cm	O
.	O

The	O
patient	O
reports	O
a	O
history	O
of	O
bloating	B-disease
and	O
flatulence	B-disease
as	O
well	O
as	O
increased	B-disease
fatigue	I-disease
.	O

She	O
has	O
also	O
had	O
some	B-disease
discomfort	I-disease
in	I-disease
her	I-disease
left	I-disease
lower	I-disease
abdomen	I-disease
and	O
notes	O
diarrhea	B-disease
every	O
4-5	O
days	O
.	O

She	O
says	O
that	O
her	O
appetite	O
is	O
good	O
and	O
has	O
noted	O
no	O
weight	B-disease
loss	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Cholecystectomy	O
in	O
1994	O
,	O
colonoscopy	O
2004	O
,	O
status	O
post	O
tonsillectomy	O
,	O
status	O
post	O
appendectomy	O
,	O
status	O
post	O
ORIF	O
of	O
left	O
wrist	O
,	O
status	O
post	O
left	O
ear	O
surgery	O
,	O
NSVD	O
x5	O
,	O
and	O
hypertension	B-disease
.	O

MEDICATIONS	O
:	O

Premarin	O
vaginal	O
once	O
a	O
month	O
,	O
enalapril	O
,	O
Tylenol	O
,	O
vitamins	O
,	O
and	O
Halcion	O
at	O
night	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

She	O
is	O
married	O
and	O
lives	O
in	O
an	O
assisted	O
living	O
facility	O
with	O
her	O
husband	O
.	O

She	O
has	O
five	O
grown	O
children	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
exam	O
she	O
is	O
afebrile	B-disease
.	O

Her	O
vital	O
signs	O
are	O
stable	O
.	O

Baseline	O
blood	O
pressure	O
of	O
144/61	O
,	O
heart	O
rate	O
of	O
73	O
,	O
and	O
oxygen	O
saturation	O
of	O
96%	O
on	O
room	O
air	O
.	O

She	O
is	O
a	O
pleasant	O
well	O
appearing	O
elderly	O
woman	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

Lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Heart	O
is	O
regular	O
without	O
murmurs	B-disease
,	O
rubs	B-disease
,	O
or	O
gallops	B-disease
.	O

Abdomen	O
is	O
soft	O
,	O
nontender	B-disease
,	O
and	O
nondistended	B-disease
.	O

Her	O
extremities	O
are	O
without	O
edema	B-disease
and	O
are	O
warm	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
consented	O
for	O
surgery	O
and	O
on	O
the	O
day	O
of	O
admission	O
was	O
taken	O
to	O
the	O
operating	O
room	O
for	O
transverse	O
colectomy	O
for	O
tumor	B-disease
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
there	O
are	O
no	O
complications	B-disease
.	O

Her	O
postoperative	O
course	O
was	O
unremarkable	O
.	O

She	O
was	O
maintained	O
on	O
an	O
epidural	O
and	O
PCA	O
for	O
pain	B-disease
control	I-disease
.	O

She	O
was	O
kept	O
NPO	O
initially	O
and	O
her	O
diet	O
was	O
slowly	O
advanced	O
as	O
tolerated	O
.	O

When	O
she	O
was	O
taking	O
clear	O
liquids	O
,	O
her	O
pain	O
medication	O
was	O
switched	O
to	O
p.o.	O
pain	O
regimen	O
with	O
good	O
affect	O
.	O

For	O
blood	O
pressure	O
control	O
she	O
was	O
maintained	O
on	O
metoprolol	O
at	O
the	O
request	O
of	O
her	O
primary	O
care	O
physician	O
and	O
enalapril	O
was	O
discontinued	O
.	O

With	O
the	O
help	O
of	O
physical	O
therapy	O
the	O
patient	O
was	O
ambulated	O
and	O
on	O
postoperative	O
seven	O
,	O
with	O
the	O
patient	O
tolerating	O
a	O
post	O
surgical	O
soft	O
diet	O
and	O
with	O
pain	B-disease
well	O
controlled	O
on	O
oral	O
pain	O
medications	O
,	O
she	O
was	O
discharged	O
to	O
rehabilitation	O
facility	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Tylenol	O
650	O
mg	O
p.o.	O
q.4.h.	O
p.r.n.	O
pain	B-disease
.	O

2.	O
Metoprolol	O
25	O
mg	O
p.o.	O
b.i.d.	O

3.	O
Motrin	O
400	O
mg	O
p.o.	O
b.i.d.	O
p.r.n.	O
pain	B-disease
.	O

4.	O
Halcion	O
0.25	O
mg	O
p.o.	O
at	O
night	O
.	O

5.	O
Dulcolax	O
10	O
to	O
20	O
mg	O
PR	O
b.i.d.	O
p.r.n.	O
constipation	B-disease
.	O

6.	O
Senna	O
2	O
tablets	O
p.o.	O
b.i.d.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

Consume	O
a	O
diet	O
as	O
tolerated	O
avoiding	O
carbonated	O
beverages	O
.	O

Her	O
activity	O
level	O
is	O
as	O
tolerated	O
.	O

She	O
is	O
to	O
contact	O
Dr.	O
Warm	O
&apos;s	O
office	O
to	O
schedule	O
a	O
follow	O
up	O
appointment	O
.	O

She	O
is	O
to	O
also	O
call	O
the	O
office	O
if	O
she	O
has	O
any	O
fever	B-disease
greater	I-disease
than	I-disease
101	I-disease
,	O
bleeding	B-disease
from	I-disease
the	I-disease
surgical	I-disease
wounds	I-disease
,	O
or	O
pus	B-disease
from	I-disease
the	I-disease
wounds	I-disease
.	O

She	O
is	O
to	O
be	O
maintained	O
on	O
metoprolol	O
for	O
blood	O
pressure	O
control	O
and	O
the	O
restarting	O
of	O
her	O
ACE	O
inhibitor	O
is	O
to	O
be	O
decided	O
by	O
her	O
primary	O
care	O
physician	O
.	O

ALEN	O
L	O
CREDKOTE	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

Electronically	O
Signed	O
OIE	O
LIMOR	O
WARM	O
,	O
M.D.	O
05/18/2004	O
11:28	O

_____________________________	O
OIE	O
LIMOR	O
WARM	O
,	O
M.D.	O

TR	O
:	O

ep	O

DD	O
:	O

05/16/2004	O

TD	O
:	O

05/16/2004	O
7:28	O
A	O
265076	O

cc	O
:	O

OIE	O
LIMOR	O
WARM	O
,	O
M.D.	O
CH	O
GILD	O
WARM	O
,	O
M.D.	O

145980160	O

FIH	O

6382196	O

94916/ly7e	O

289653	O

06/30/1993	O
12:00:00	O
AM	O

PROSTATE	B-disease
CANCER	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

06-30-93	O

DISCHARGE	O
DATE	O
:	O

07-06-93	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Prostate	B-disease
cancer	I-disease
.	O

SPECIAL	O
PROCEDURES	O
AND	O
OPERATIONS	O
:	O

Radical	O
retropubic	O
prostatectomy	O
,	O
bilateral	O
lymph	O
node	O
dissection	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
67	O
year	O
old	O
white	O
male	O
with	O
a	O
recent	O
history	O
of	O
urinary	B-disease
frequency	I-disease
Q2-3H	O
,	O
stranguria	B-disease
,	O
nocturia	B-disease
x	O
3-4	O
per	O
night	O
.	O

He	O
was	O
found	O
on	O
physical	O
exam	O
to	O
have	O
an	B-disease
asymmetric	I-disease
prostate	I-disease
with	O
prominence	B-disease
on	I-disease
the	I-disease
left	I-disease
and	O
a	O
question	O
of	O
a	B-disease
nodule	I-disease
.	O

Repeat	O
exam	O
one	O
month	O
later	O
showed	O
a	B-disease
firm	I-disease
left-sided	I-disease
lobe	I-disease
.	O

Transrectal	O
ultrasound	O
showed	O
a	B-disease
hypoechoic	I-disease
left-sided	I-disease
mass	I-disease
in	I-disease
the	I-disease
peripheral	I-disease
zone	I-disease
.	O

A	O
biopsy	O
showed	O
moderately	B-disease
to	I-disease
poorly	I-disease
differentiated	I-disease
Grade	I-disease
III-IV	I-disease
adenocarcinoma	I-disease
on	I-disease
the	I-disease
left	I-disease
.	O

The	O
right	O
lobe	O
was	O
within	O
normal	O
limits	O
.	O

This	O
was	O
done	O
on	O
05/05/93	O
at	O
FIH	O
.	O

He	O
also	O
had	O
a	O
3-4	O
year	O
history	O
of	O
impotence	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Significant	O
for	O
non-insulin	B-disease
diabetes	I-disease
mellitus	I-disease
,	O
for	O
which	O
he	O
takes	O
Diabeta	O
,	O
one	O
QD	O
;	O
right	B-disease
eye	I-disease
cataract	I-disease
,	O
operated	O
on	O
three	O
years	O
ago	O
.	O

ALLERGIES	O
:	O

He	O
is	O
allergic	B-disease
to	O
Motrin	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Diabeta	O
,	O
one	O
QD	O
.	O

SOCIAL	O
HISTORY	O
:	O

No	O
smoking	O
history	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

He	O
was	O
a	O
well	O
developed	O
,	O
well	O
nourished	O
white	O
male	O
.	O

HEENT	O
:	O

within	O
normal	O
limits	O
.	O

His	O
neck	O
was	O
supple	O
with	O
no	O
jugular	B-disease
venous	I-disease
distention	I-disease
or	O
thyromegaly	B-disease
.	O

Chest	O
was	O
clear	O
to	O
percussion	O
and	O
auscultation	O
.	O

Heart	O
:	O

regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
and	O
S2	O
,	O
no	O
murmurs	B-disease
.	I-disease

The	O
abdomen	O
was	O
soft	O
and	O
non-tender	B-disease
with	O
no	O
masses	B-disease
or	O
organomegaly	B-disease
.	O

No	O
costovertebral	B-disease
angle	I-disease
tenderness	I-disease
.	O

His	O
genitourinary	O
exam	O
showed	O
an	O
uncircumcised	O
male	O
with	O
normal	O
scrotal	O
contents	O
.	O

Rectal	O
:	O

There	O
was	O
a	B-disease
firm	I-disease
nodule	I-disease
in	O
the	O
left	O
lobe	O
of	O
the	O
prostate	O
in	O
the	O
lateral	O
aspect	O
.	O

Extremities	O
:	O

No	O
clubbing	B-disease
,	I-disease
cyanosis	B-disease
or	O
edema	B-disease
.	O

Pulses	O
2+	O
.	O

Neurological	O
:	O

Nonfocal	O
.	O

LABORATORY	O
DATA	O
:	O

Sodium	O
141	O
,	O
potassium	O
4.1	O
,	O
chloride	O
104	O
,	O
bicarbonate	O
28.8	O
,	O
BUN	O
17	O
,	O
creatinine	O
0.9	O
,	O
glucose	O
118	O
.	O

His	O
white	O
blood	O
count	O
was	O
7100	O
,	O
hematocrit	O
35.9	O
,	O
platelet	O
count	O
258,000	O
.	O

PT	O
9.4/10.3	O
,	O
PTT	O
27	O
.	O

His	O
urinalysis	O
showed	O
marked	B-disease
occult	I-disease
blood	I-disease
and	O
positive	B-disease
white	I-disease
blood	I-disease
cell	I-disease
screen	I-disease
but	O
was	O
otherwise	O
negative	O
.	O

His	O
chest	O
X-ray	O
was	O
normal	O
.	O

EKG	O
:	O

normal	O
sinus	O
rhythm	O
at	O
73	O
beats	O
per	O
minute	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
brought	O
to	O
the	O
operating	O
room	O
on	O
06/30/93	O
after	O
informed	O
consent	O
was	O
obtained	O
.	O

A	O
radical	O
retropubic	O
prostatectomy	O
with	O
bilateral	O
lymph	O
node	O
dissection	O
was	O
done	O
.	O

He	O
was	O
afebrile	B-disease
postoperatively	O
with	O
vital	O
signs	O
stable	O
.	O

His	O
potassium	O
was	O
3.7	O
and	O
his	O
hematocrit	O
33	O
.	O

His	O
postoperative	O
course	O
was	O
remarkable	O
for	O
a	B-disease
low	I-disease
grade	I-disease
temperature	I-disease
to	O
101.7	O
.	O

His	O
blood	O
cultures	O
and	O
chest	O
X-ray	O
were	O
negative	O
.	O

He	O
had	O
flatus	O
on	O
postoperative	O
day	O
#	O
3	O
.	O

His	O
Jackson-Pratt	O
drained	O
about	O
35-40	O
cc	O
per	O
day	O
and	O
was	O
discontinued	O
on	O
postoperative	O
day	O
#	O
3	O
.	O

His	O
hematocrit	O
on	O
07/03	O
was	O
28.1	O
.	O

On	O
that	O
day	O
he	O
was	O
slightly	B-disease
diaphoretic	I-disease
with	O
some	B-disease
tachycardia	I-disease
to	O
100	O
.	O

The	O
remaining	O
unit	O
of	O
autologous	O
packed	O
red	O
blood	O
cells	O
was	O
transfused	O
.	O

A	O
cardiology	O
consult	O
was	O
obtained	O
for	O
this	O
episode	O
of	O
diaphoresis	B-disease
with	O
tachycardia	B-disease
,	O
as	O
well	O
as	O
for	O
an	O
EKG	O
being	O
read	O
as	O
having	O
anterolateral	B-disease
changes	I-disease
.	O

He	O
had	O
no	O
symptoms	B-disease
of	O
chest	B-disease
pain	I-disease
or	O
myocardial	B-disease
ischemia	I-disease
.	O

A	O
repeat	O
EKG	O
showed	O
no	O
changes	B-disease
.	O

He	O
subsequently	O
did	O
well	O
,	O
with	O
a	O
repeat	O
hematocrit	O
of	O
34.3	O
after	O
the	O
transfusion	O
.	O

His	O
creatinine	O
was	O
1.2	O
on	O
postoperative	O
day	O
#	O
5	O
.	O

On	O
postoperative	O
day	O
#	O
6	O
his	B-disease
low	I-disease
grade	I-disease
temperature	I-disease
resolved	O
.	O

His	O
vital	O
signs	O
were	O
stable	O
.	O

He	O
was	O
discharged	O
home	O
on	O
Percocet	O
and	O
Keflex	O
.	O

He	O
was	O
discharged	O
in	O
good	O
condition	O
.	O

He	O
will	O
follow	O
up	O
with	O
Dr.	O
Iechalette	O
Cancer	O
in	O
his	O
office	O
.	O

SIE	O
ROOM	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

IECHALETTE	O
ROOM	O
,	O
M.D.	O

TR	O
:	O

btt	O
/	O
bmot	O

DD	O
:	O

07-07-93	O

TD	O
:	O

07/08/93	O

CC	O
:	O

Dr.	O
Na	O
Dussmum	O

Admission	O
Date	O
:	O

2013-05-18	O

Discharge	O
Date	O
:	O

2013-05-24	O

Date	O
of	O
Birth	O
:	O

1811-08-19	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	I-disease
Drugs	I-disease

Attending	O
:	O
Sarah	O
Q.	O
George	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Hip	B-disease
fracture	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

OPERATIVE	O
PROCEDURE	O
:	O

1.	O
Closed	O
reduction	O
of	O
right	O
hip	O
with	O
open	O
placement	O
of	O
dynamic	O
hip	O
screw	O
,	O
right	O
hip	O
.	O

2.	O
Examination	O
under	O
anesthesia	O
with	O
placement	O
of	O
splint	O
,	O
right	O
elbow	O
.	O

PROCEDURE	O
#2	O
:	O

1.	O
Exploratory	O
laparotomy	O
with	O
drainage	O
of	O
intra-abdominal	B-disease
abscess	I-disease
and	O
peritonitis	B-disease
with	O
gross	B-disease
soilage	I-disease
with	I-disease
bile	I-disease
and	I-disease
gastric	I-disease
contents	I-disease
.	O

2.	O
Exposure	O
and	O
wide	O
drainage	O
of	O
perforated	B-disease
posterior	I-disease
duodenal	I-disease
ulcer	I-disease
with	O
internal	O
and	O
external	O
drainage	O
.	O

3.	O
Feeding	O
jejunostomy	O
.	O

4.	O
Tube	O
gastrostomy	O
.	O

5.	O
Placement	O
of	O
a	O
right	O
femoral	O
arterial	O
line	O
.	O

History	O
of	O
Present	O
Illness	O
:	O

90	O
yo	O
F	O
with	O
MMP	B-disease
(	O
see	O
below	O
)	O
who	O
sustained	O
a	B-disease
mechanical	I-disease
fall	I-disease
down	O
stairs	O
resulting	O
in	O
a	B-disease
hip	I-disease
and	I-disease
arm	I-disease
fracture	I-disease
.	O

Fall	B-disease
was	O
witnessed	O
by	O
daughter	O
.	O

Nicholas	B-disease
seizures	I-disease
,	O
no	O
LOC	B-disease
,	O
no	O
head	B-disease
or	I-disease
neck	I-disease
trauma	I-disease
.	O

Patient	O
denies	O
CP	B-disease
,	O
SOB	B-disease
,	O
light	B-disease
headedness	I-disease
,	O
or	O
dizziness	B-disease
prior	O
to	O
of	O
after	O
the	B-disease
fall	I-disease
.	O

She	O
fell	O
on	O
her	O
R	O
side	O
and	O
had	O
a	O
great	O
deal	O
of	O
pain	B-disease
in	I-disease
her	I-disease
R	I-disease
arm	I-disease
and	I-disease
hip	I-disease
.	O

Presented	O
to	O
Taunton	O
and	O
found	O
to	O
have	O
R	B-disease
humerus	I-disease
and	I-disease
R	I-disease
hip	I-disease
fx	I-disease
.	O

Ct	O
of	O
head	O
and	O
neck	O
neg	O
for	O
fx	B-disease
,	O
bleed	B-disease
,	O
and	O
dislocation	B-disease
.	O

Past	O
Medical	O
History	O
:	O

1.	O
Coronary	B-disease
artery	I-disease
disease	I-disease
status	O
post	O
non-ST-elevation	B-disease
myocardial	I-disease
infarction	I-disease
in	O
2009-05-05	O
,	O
status	O
post	O
cardiac	O
catheterization	O
with	O
left	O
anterior	O
descending	O
artery	O
stent	O
placement	O
in	O
05/2001	O
.	O

2.	O
CHF	B-disease
with	O
an	O
ejection	O
fraction	O
of	O
40-45%	O
02-09	O

3.	O
Diabetes	B-disease
type	I-disease
2	I-disease
.	O

4.	O
Anemia	B-disease
,	O
transfusion	B-disease
dependent	I-disease
every	O
three	O
months	O
.	O

Hct	O
28	O
b/l	O

5.	O
Polymyalgia	B-disease
rheumatica	I-disease
.	O

6.	O
Hypertension	B-disease
.	O

7.	O
Hypothyroidism	B-disease
.	O

8.	O
Chronic	B-disease
renal	I-disease
insufficiency	I-disease
with	O
a	O
b/l	O
creatinine	O
of	O
1.4	O
.	O

9.	O
History	O
of	O
syncope	B-disease
and	O
first	B-disease
degree	I-disease
A-V	I-disease
heart	I-disease
block	I-disease
with	O
beta	O
blocker	O
therapy	O
.	O

10.	O
History	O
of	O
lower	B-disease
gastrointestinal	I-disease
bleed	I-disease
in	O
2009-06-05	O
.	O

11.	O
spinal	B-disease
stenosis	I-disease

12.	O
Pacemaker	O
-	O
DDD	O
dual	O
chamber	O
rate	O
response	O
pacemaker	O
2011-08-22	O
for	O
symptomatic	B-disease
bradycardia	I-disease

Social	O
History	O
:	O

Lives	O
alone	O
in	O
elderly	O
housing	O
,	O
a	O
daughter	O
in	O
the	O
area	O
,	O
two	O
children	O
and	O
exercises	O
two	O
times	O
a	O
week	O
by	O
walking	O
and	O
stretching	O
.	O

no	O
,	O
tob	O
,	O
no	O
etoh	O
,	O
no	O
drugs	O

Family	O
History	O
:	O

Noncontributory	O

Physical	O
Exam	O
:	O

at	O
admission	O

T	O
96.0	O
BP	O
177/61	O
P	O
70	O
R	O
18	O
O2	O
97	O
on	O
RA	O

Gen	O
-	O
somnolent	B-disease
,	O
confused	B-disease

HEENT	O
-	O
PERRL	O
,	O
OP	O
clear	O
,	O
EOMI	O

Cor	O
-	O
rrr	O
,	O
no	O
m/r/g	B-disease

Chest	O
-	O
CTAB	O
anteriorly	O

Abd	O
-	O
s/nt/nd	B-disease
+BS	O

Ext	O
-	O
2	O
+	O
edema	B-disease
to	I-disease
knees	I-disease
,	O
warm	O
2	O
+	O
pulses	O
,	O
pain	B-disease
in	I-disease
R	I-disease
arm	I-disease
and	I-disease
R	I-disease
hip	I-disease

Pertinent	O
Results	O
:	O

2013-05-18	O
06:00	O
PM	O
GLUCOSE	O
-	O
188	O
*	O
UREA	O
N	O
-	O
48	O
*	O
CREAT	O
-	O
1.3	O
*	O
SODIUM	O
-	O
138	O
POTASSIUM	O
-	O
4.0	O
CHLORIDE	O
-	O
106	O
TOTAL	O
CO2	O
-	O
21	O
*	O
ANION	O
GAP	O
-	O
15	O

2013-05-18	O
06:00	O
PM	O
CK(CPK)	O
-	O
32	O

2013-05-18	O
06:00	O
PM	O
CK-MB	O
-	O
NotDone	O

2013-05-18	O
06:00	O
PM	O
WBC	O
-	O
14.9	O
*#	O
RBC	O
-	O
2.91	O
*	O
HGB	O
-	O
8.5	O
*	O
HCT	O
-	O
24.7	O
*	O
MCV	O
-	O
85	O
MCH	O
-	O
29.3	O
MCHC	O
-	O
34.5	O
RDW	O
-	O
14.6	O

2013-05-18	O
06:00	O
PM	O
NEUTS	O
-	O
87.9	O
*	O
BANDS	O
-	O
0	O
LYMPHS	O
-	O
6.3	O
*	O
MONOS	O
-	O
5.7	O
EOS	O
-	O
0.1	O
BASOS	O
-	O
0	O

2013-05-18	O
06:00	O
PM	O
HYPOCHROM	O
-	O
1	O
+	O
ANISOCYT	O
-	O
NORMAL	O
POIKILOCY	O
-	O
NORMAL	O
MACROCYT	O
-	O
NORMAL	O
MICROCYT	O
-	O
NORMAL	O
POLYCHROM	O
-	O
NORMAL	O

2013-05-18	O
06:00	O
PM	O
PLT	O
SMR	O
-	O
NORMAL	O
PLT	O
COUNT	O
-	O
216	O

2013-05-18	O
06:00	O
PM	O
PT	O
-	O
13.3	O
PTT	O
-	O
26.4	O
INR(PT)	O
-	O
1.2	O
EKG	O
-	O
NSR	O
64	O
,	O
1st	B-disease
deg	I-disease
block	I-disease
,	O
LAD	B-disease
,	O
new	B-disease
TWI	I-disease
inf/lat	I-disease
leads	I-disease
,	O
new	B-disease
ST	I-disease
depressions	I-disease
V4-6	I-disease

Echo	O
02-09	O

1.	O
The	O
left	O
atrium	O
is	O
moderately	B-disease
dilated	I-disease
.	O

The	O
left	O
atrium	O
is	O
elongated	B-disease
.	O

2.	O
The	O
left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

There	O
is	O
mild	B-disease
regional	I-disease
left	I-disease
ventricular	I-disease
systolic	I-disease
dysfunction	I-disease
.	O

Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	B-disease
depressed	I-disease
.	O

Resting	B-disease
regional	I-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
include	O
inferolateral	B-disease
,	I-disease
inferior	I-disease
and	I-disease
mid	I-disease
septal	I-disease
hypokinesis	I-disease
.	O

3.	O
Right	O
ventricular	O
chamber	O
size	O
is	O
normal	O
.	O

Right	O
ventricular	O
systolic	O
function	O
is	O
normal	O
.	O

4.	O
The	O
aortic	O
valve	O
leaflets	O
(	O
3	O
)	O
are	O
mildly	B-disease
thickened	I-disease
.	O

No	O
aortic	B-disease
regurgitation	I-disease
present	O
.	O

5.	O
The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

Moderate	B-disease
(	I-disease
2	I-disease
+)	I-disease
mitral	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

6.	O
There	O
is	O
moderate	B-disease
pulmonary	I-disease
artery	I-disease
systolic	I-disease
hypertension	I-disease
.	O

7.	O
There	O
is	O
no	O
pericardial	B-disease
effusion	I-disease
.	O

Compared	O
with	O
the	O
findings	O
of	O
the	O
prior	O
study	O
(	O
tape	O
reviewed	O
)	O
of	O
2009-06-05	O
,	O
the	O
LV	O
function	O
has	O
improved	O
with	O
an	O
improvementt	O
in	O
function	O
of	O
the	O
apex	O
,	O
septal	O
and	O
anterior	O
walls	O
.	O

New	B-disease
inferior	I-disease
and	I-disease
inferolateral	I-disease
wall	I-disease
motion	I-disease
abnormalities	I-disease
with	O
more	B-disease
severe	I-disease
mitral	I-disease
regurgitation	I-disease
present	O
.	O

Cath	O
2001	O

1.	O
Coronary	O
angiography	O
demonstrated	O
single	B-disease
vessel	I-disease
disease	I-disease
in	I-disease
a	I-disease
right	I-disease
dominant	I-disease
system	I-disease
.	O

The	O
left	O
main	O
was	O
normal	O
.	O

The	O
LAD	O
had	O
serial	B-disease
90%	I-disease
lesions	I-disease
proximally	I-disease
,	O
involving	O
the	O
origin	O
of	O
the	O
first	O
diagonal	O
,	O
which	O
was	O
occluded	B-disease
and	O
filled	O
via	O
left	O
to	O
left	O
collaterals	O
.	O

The	O
mid-distal	O
LAD	O
was	O
underfilled	B-disease
initially	O
but	O
was	O
without	O
obstructive	B-disease
disease	I-disease
.	O

The	O
non-dominant	O
circumflex	O
system	O
had	O
no	O
hemodynamically	B-disease
significant	I-disease
stenoses	I-disease
.	O

The	O
dominant	O
RCA	O
was	O
a	O
large	O
vessel	O
with	O
no	O
significant	B-disease
disease	I-disease
.	O

2.	O
Resting	O
hemodynamics	O
revealed	O
elevated	B-disease
right	I-disease
and	I-disease
left	I-disease
sided	I-disease
filling	I-disease
pressures	I-disease
with	O
a	O
mean	O
RA	O
pressure	O
of	O
12	O
mm	O
Hg	O
and	O
a	O
mean	O
wedge	O
pressure	O
24	O
mm	O
Hg	O
.	O

Moderate	B-disease
pulmonary	I-disease
hypertension	I-disease
was	O
present	O
with	O
a	O
PA	O
of	O
52/28	O
.	O

The	O
cardiac	O
index	O
was	O
preserved	O
at	O
3.0	O
L	O
/	O
min	O
/	O
m2	O
.	O

3.	O
Left	O
ventriculography	O
was	O
not	O
performed	O
due	O
to	O
the	O
presence	O
of	O
moderate	B-disease
renal	I-disease
insufficiency	I-disease
(	O
creatinine	O
1.6	O
).	O

4.	O
Successful	O
PTCA	O
and	O
stenting	O
of	O
the	O
proximal	O
LAD	O
with	O
overlapping	O
2.25	O
x	O
13	O
mm	O
and	O
2.25	O
x	O
18	O
mm	O
Hepacoat	O
stents	O
with	O
no	O
residual	B-disease
stenosis	I-disease
or	O
dissection	B-disease
and	O
normal	O
flow	O
(	O
see	O
PTCA	O
comments	O
).	O

FINAL	O
DIAGNOSIS	O
:	O

1.	O
One	B-disease
vessel	I-disease
coronary	I-disease
artery	I-disease
disease	I-disease
.	O

2.	O
Moderately	B-disease
elevated	I-disease
right	I-disease
and	I-disease
left	I-disease
sided	I-disease
filling	I-disease
pressures	I-disease
.	O

3.	O
Successful	O
stenting	O
of	O
the	O
proximal	O
LAD	O
.	O

Hematology	O

COMPLETE	O
BLOOD	O
COUNT	O
WBC	O
RBC	O
Hgb	O
Hct	O
MCV	O
MCH	O
MCHC	O
RDW	O
Plt	O
Ct	O

2013-05-24	O
09:40	O
AM	O
19.3	O
*	O
4.46	O
13.1	O
39.2	O
88	O
29.4	O
33.5	O
14.4	O
159	O

2013-05-24	O
12:52	O
AM	O
19.8	O
*#	O
4.73	O
13.8	O
42.1	O
#	O
89	O
29.3	O
32.9	O
14.3	O
147	O
*	O

DIFFERENTIAL	O
Neuts	O
Bands	O
Lymphs	O
Monos	O
Eos	O
Baso	O
Atyps	O
Metas	O

2013-05-22	O
06:15	O
AM	O
90.0	O
*	O
0	O
5.6	O
*	O
4.2	O
0.1	O
0.2	O

RED	O
CELL	O
MORPHOLOGY	O
Hypochr	O
Anisocy	O
Poiklo	O
Macrocy	O
Microcy	O
Polychr	O

2013-05-22	O
06:15	O
AM	O
NORMAL	O
NORMAL	O
NORMAL	O
NORMAL	O
NORMAL	O
NORMAL	O

BASIC	O
COAGULATION	O
(	O
PT	O
,	O
PTT	O
,	O
PLT	O
,	O
INR	O
)	O
PT	O
PTT	O
Plt	O
Smr	O
Plt	O
Ct	O
INR(PT)	O
LPlt	O

2013-05-24	O
09:40	O
AM	O
159	O
1	O
+	O

2013-05-24	O
09:40	O
AM	O
14.9	O
*	O
1	O
31.9	O
1.5	O

1	O
NOTE	O
NEW	O
NORMAL	O
RANGE	O
AS	O
OF	O
12	O
AM	O
2013-05-04	O

2013-05-24	O
12:52	O
AM	O
147	O
*	O

2013-05-24	O
12:52	O
AM	O
14.6	O
*	O
1	O
33.8	O
1.4	O

1	O
NOTE	O
NEW	O
NORMAL	O
RANGE	O
AS	O
OF	O
12	O
AM	O
2013-05-04	O

Chemistry	O

RENAL	O
&	O
GLUCOSE	O
Glucose	O
UreaN	O
Creat	O
Na	O
K	O
Cl	O
HCO3	O
AnGap	O

2013-05-24	O
09:40	O
AM	O
192	O
*	O
87	O
*	O
2.4	O
*	O
146	O
*	O
5.1	O
114	O
*	O
16	O
*	O
21	O
*	O

2013-05-24	O
12:52	O
AM	O
160	O
*	O
86	O
*	O
2.6	O
*	O
148	O
*	O
4.4	O
115	O
*	O
14	O
*	O
1	O
23	O
*	O

1	O
VERIFIED	O
BY	O
DILUTION	O

NOTIFIED	O
Y.	O
Welch	O
-	O
TSICU	O
140	O
AM	O
2013-05-24	O

ENZYMES	O
&	O
BILIRUBIN	O
ALT	O
AST	O
LD(LDH)	O
CK(CPK)	O
AlkPhos	O
Amylase	O
TotBili	O
DirBili	O

2013-05-24	O
07:40	O
AM	O
628	O
*	O

2013-05-24	O
12:52	O
AM	O
22	O
65	O
*	O
739	O
*	O
52	O
81	O
1.0	O

OTHER	O
ENZYMES	O
&	O
BILIRUBINS	O
Lipase	O

2013-05-24	O
12:52	O
AM	O
17	O

CPK	O
ISOENZYMES	O
CK-MB	O
MB	O
Indx	O
cTropnT	O

2013-05-24	O
07:40	O
AM	O
15	O
*	O
2.4	O

2013-05-24	O
12:52	O
AM	O
14	O
*	O
1.9	O
0.12	O
*	O
1	O

1	O
CTROPNT	O
>	O
0.10	O
NG/ML	O
SUGGESTS	O
ACUTE	B-disease
MI	I-disease

CHEMISTRY	O
TotProt	O
Albumin	O
Globuln	O
Calcium	O
Phos	O
Mg	O
UricAcd	O
Iron	O
Cholest	O

2013-05-24	O
09:40	O
AM	O
8.3	O
*	O
5.4	O
*	O
2.1	O

2013-05-24	O
12:52	O
AM	O
2.1	O
*	O
7.7	O
*	O
5.1	O
*#	O
1.6	O

LIPID	O
/	O
CHOLESTEROL	O
Triglyc	O
HDL	O
CHOL/HD	O
LDLcalc	O

2013-05-19	O
09:20	O
AM	O
1603	O
-	O
5419	O
LDL(CALC)	O
INVALID	O
IF	O
TRIG	O
>	O
400	O
OR	O
NON-FASTING	O
SAMPLE	O
LAB	O
USE	O
ONLY	O
GreenHd	O

2013-05-18	O
06:00	O
PM	O
HOLD1	O

1	O
HOLD	O

DISCARD	O
GREATER	O
THAN	O
4	O
HOURS	O
OLD	O

Blood	O
Gas	O

BLOOD	O
GASES	O
Type	O
Temp	O
Rates	O
Tidal	O
V	O
PEEP	O
FiO2	O
O2	O
Flow	O
pO2	O
pCO2	O
pH	O
calHCO3	O
Base	O
XS	O
AADO2	O
REQ	O
O2	O
Intubat	O
Vent	O

2013-05-24	O
07:58	O
AM	O
ART	O
102	O
36	O
7.26	O
*	O
17	O
*	O
-9	O

2013-05-24	O
04:31	O
AM	O
ART	O
36.4	O
16	O
/	O
662-15484	O
*	O
7.26	O
*	O
16	O
*	O
-10	O

ASSIST	O
/	O
CON1	O
INTUBATED	O

1	O
ASSIST	O
/	O
CONTROL	O

2013-05-24	O
12:58	O
AM	O
ART	O
147	O
*	O
39	O
7.22	O
*	O
1	O
17	O
*	O
-11	O

1	O
VERIFIED	O

PROVIDER	O
NOTIFIED	O
PER	O
CURRENT	O
LAB	O
POLICY	O

WHOLE	O
BLOOD	O
,	O
MISCELLANEOUS	O
CHEMISTRY	O
Glucose	O
Lactate	O
Na	O
K	O
Cl	O
calHCO3	O

2013-05-24	O
07:58	O
AM	O
4.5	O
*	O
1	O

1	O
VERIFIED	O

2013-05-24	O
04:31	O
AM	O
5.1	O
*	O
1	O

1	O
VERIFIED	O

2013-05-24	O
12:58	O
AM	O
6.2	O
*	O
1	O

1	O
VERIFIED	O

HEMOGLOBLIN	O
FRACTIONS	O
(	O
COOXIMETRY	O
)	O
Hgb	O
calcHCT	O
O2	O
Sat	O
COHgb	O
MetHgb	O

2013-05-23	O
09:36	O
PM	O
11.4	O
*	O
34	O
73	O
1	O
1	O

2013-05-23	O
01:08	O
PM	O
10.9	O
*	O
33	O
96	O

CALCIUM	O
freeCa	O

2013-05-23	O
09:36	O
PM	O
1.00	O
*	O

2013-05-23	O
01:08	O
PM	O
1.22	O

RADIOLOGY	O
Final	O
Report	O

CT	O
ABDOMEN	O
W/O	O
CONTRAST	O
2013-05-23	O
5:46	O
PM	O

CT	O
ABDOMEN	O
W/O	O
CONTRAST	O
;	O
CT	O
PELVIS	O
W/O	O
CONTRAST	O

Reason	O
:	O
Please	O
eval	O
for	O
perf	B-disease
/	I-disease
ischemic	I-disease
bowel	I-disease

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

92	O
year	O
old	O
woman	O
with	O
MS	B-disease
changes	I-disease
,	O
abd	B-disease
pain	I-disease
hypotension	B-disease
and	O
bloody	B-disease
lavage	I-disease
on	O
Lovenox+ASA	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Please	O
eval	O
for	O
perf	B-disease
/	I-disease
ischemic	I-disease
bowel	I-disease

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
renal	B-disease
failure	I-disease

INDICATION	O
:	O
94-year-old	O
woman	O
with	O
mental	B-disease
status	I-disease
changes	I-disease
,	O
now	O
with	O
abdominal	B-disease
pain	I-disease
and	O
hypertension	B-disease
.	O

TECHNIQUE	O
:	O
A	O
multidetector	O
scanner	O
was	O
used	O
to	O
obtain	O
contiguous	O
axial	O
images	O
from	O
the	O
lung	O
bases	O
to	O
the	O
pubic	O
symphysis	O
.	O

Neither	O
IV	O
nor	O
oral	O
contrast	O
were	O
used	O
.	O

CT	O
OF	O
THE	O
ABDOMEN	O
WITHOUT	O
IV	O
CONTRAST	O
:	O
There	O
are	O
bilateral	B-disease
pleural	I-disease
effusions	I-disease
,	O
right	O
greater	O
the	O
left	O
;	O
there	O
is	O
compressive	B-disease
atelectasis	I-disease
at	I-disease
the	I-disease
left	I-disease
lung	I-disease
base	I-disease
.	O

There	O
are	O
coronary	B-disease
vascular	I-disease
calcifications	I-disease
.	O

A	O
nasogastric	O
tube	O
is	O
seen	O
coiling	O
in	O
the	O
stomach	O
.	O

A	O
dual	O
chamber	O
pacemaker	O
is	O
seen	O
with	O
leads	O
terminating	O
in	O
the	O
right	O
atrium	O
and	O
right	O
ventricle	O
.	O

Nasogastric	O
tube	O
is	O
seen	O
coiling	O
in	O
the	O
stomach	O
,	O
with	O
its	O
tip	O
at	O
the	O
pylorus	O
.	O

Allowing	O
for	O
the	O
limitations	O
of	O
this	O
noncontrast	O
study	O
,	O
the	O
liver	O
,	O
pancreas	O
,	O
adrenals	O
,	O
stomach	O
are	O
unremarkable	O
.	O

A	B-disease
1.8	I-disease
cm	I-disease
exophytic	I-disease
renal	I-disease
cyst	I-disease
is	O
seen	O
on	O
the	O
left	O
.	O

A	B-disease
similar	I-disease
lesion	I-disease
is	O
seen	O
on	O
the	O
right	O
,	O
measuring	O
2.2	O
cm	O
.	O

The	O
aorta	O
is	O
normal	O
in	O
caliber	O
,	O
with	O
vascular	B-disease
calcifications	I-disease
.	O

A	B-disease
small	I-disease
amount	I-disease
of	I-disease
free	I-disease
fluid	I-disease
is	O
seen	O
tracking	O
around	O
the	O
liver	O
,	O
right	O
pericolic	O
gutter	O
,	O
along	O
the	O
mesentery	O
and	O
surrounding	O
the	O
right	O
colon	O
,	O
which	O
is	O
collapsed	O
.	O

A	B-disease
small	I-disease
amount	I-disease
of	I-disease
nondependent	I-disease
free	I-disease
air	I-disease
is	O
seen	O
in	O
the	O
anterior	O
aspect	O
of	O
the	O
abdomen	O
.	O

The	O
remainder	O
of	O
the	O
bowel	O
loops	O
are	O
fluid	O
filled	O
,	O
and	O
nondilated	B-disease
.	O

CT	O
OF	O
THE	O
PELVIS	O
WITHOUT	O
IV	O
CONTRAST	O
:	O
As	O
previously	O
noted	O
,	O
there	O
is	O
a	B-disease
small	I-disease
amount	I-disease
of	I-disease
free	I-disease
fluid	I-disease
surrounding	O
the	O
right	O
colon	O
,	O
tracking	O
along	O
the	O
mesentery	O
and	O
into	O
the	O
pelvis	O
.	O

A	B-disease
small	I-disease
amount	I-disease
of	I-disease
free	I-disease
air	I-disease
is	O
seen	O
in	O
the	O
nondependent	O
portion	O
of	O
the	O
pelvis	O
.	O

Vascular	B-disease
calcifications	I-disease
are	O
seen	O
in	O
the	O
abdominal	O
aorta	O
and	O
iliac	O
arteries	O
.	O

Subcutaneous	B-disease
edema	I-disease
is	O
noted	O
in	O
the	O
lower	O
abdomen	O
and	O
pelvis	O
.	O

A	O
catheter	O
is	O
seen	O
entering	O
the	O
left	O
inguinal	O
region	O
and	O
coursing	O
along	O
the	O
iliac	O
vessels	O
,	O
terminating	O
in	O
the	O
left	O
pelvis	O
.	O

Osseous	O
structures	O
are	O
remarkable	O
for	O
degenerative	B-disease
changes	I-disease
of	I-disease
the	I-disease
spine	I-disease
,	O
and	O
a	B-disease
fracture	I-disease
of	I-disease
the	I-disease
proximal	I-disease
right	I-disease
humerus	I-disease
,	O
with	O
orthopedic	O
hardware	O
causing	O
beam	B-disease
hardening	I-disease
artifact	I-disease
.	O

IMPRESSION	O
:	O

1.	O
A	O
small	O
amount	O
of	O
free	B-disease
air	I-disease
and	I-disease
free	I-disease
fluid	I-disease
in	I-disease
the	I-disease
pelvis	I-disease
and	I-disease
abdomen	I-disease
,	O
mostly	O
along	O
the	O
right	O
pericolic	O
gutter	O
and	O
surrounding	O
the	O
ascending	O
colon	O
,	O
concerning	O
for	O
perforation	B-disease
.	O

Other	O
bowel	O
loops	O
are	O
unremarkable	O
on	O
this	O
limited	O
study	O
.	O

This	O
was	O
discussed	O
with	O
Dr.	O
Jason	O
Long	O
at	O
approximately	O
6:30	O
p.m.	O
,	O
2013-05-23	O
.	O

2.	O
Bilateral	B-disease
pleural	I-disease
effusions	I-disease
,	O
right	O
greater	O
than	O
left	O
,	O
with	O
left-sided	B-disease
compressive	I-disease
atelectasis	I-disease
.	O

3.	O
Right	B-disease
proximal	I-disease
humeral	I-disease
fracture	I-disease
status	O
post	O
fixation	O
.	O

The	O
study	O
and	O
the	O
report	O
were	O
reviewed	O
by	O
the	O
staff	O
radiologist	O
.	O

DR.	O
Billy	O
L.	O
Boender	O

DR.	O
Pat	O
K.	O
Walton	O

Approved	O
:	O
FRI	O
2013-05-24	O
4:01	O
PM	O

Brief	O
Hospital	O
Course	O
:	O

95	O
yo	O
F	O
with	O
MMP	B-disease
who	O
sustained	O
a	B-disease
mechanical	I-disease
fall	I-disease
down	O
stairs	O
resulting	O
in	O
a	B-disease
hip	I-disease
and	I-disease
arm	I-disease
fracture	I-disease
.	O

1)	O
s/p	O
Fall	B-disease
-	O
unlikely	O
to	O
be	O
mechanical	O
in	O
nature	O
.	O

Patient	O
has	O
injuries	B-disease
to	I-disease
her	I-disease
shoulder	I-disease
and	I-disease
hip	I-disease
.	O

2)	O
CV	O
-	O
Patient	O
has	O
CAD	B-disease
and	O
CHF	B-disease
with	O
a	B-disease
low	I-disease
hct	I-disease
and	O
major	B-disease
trauma	I-disease
.	O

She	O
also	O
has	O
new	B-disease
changes	I-disease
on	I-disease
EKG	I-disease
.	O

On	O
pressor	O
to	O
hold	O
mean	O
60	O
.	O

3)	O
Anemia	B-disease
-	O
patient	O
transfusion	B-disease
dependant	I-disease
with	O
a	O
baseline	O
of	O
28	O
.	O

-	O
transfuse	O
2	O
units	O
today	O
,	O
with	O
lasix	O

4)	O
GERD	B-disease
-	O
PPI	O

5)	O
DM	B-disease
-	O
glipizide	O
,	O
ISS	O

6)	O
PMR	B-disease
-	O
cont	O
prednisone	O

7)	O
GI	O
:	O
Ms.	O
Pimental	O
is	O
an	O
unfortunate	O
95	O
year	O
old	O
woman	O
,	O
status	O
post	O
a	B-disease
recent	I-disease
fall	I-disease
necessitating	O
right	O
ORIF	O
of	O
the	O
hip	O
and	O
right	B-disease
wrist	I-disease
fracture	I-disease
ORIF	O
,	O
who	O
was	O
in	O
the	O
hospital	O
for	O
this	O
event	O
,	O
when	O
it	O
was	O
noted	O
that	O
she	O
had	O
abdominal	B-disease
pain	I-disease
,	O
distention	B-disease
and	O
coffee	B-disease
ground	I-disease
emesis	I-disease
with	O
worsening	B-disease
mental	I-disease
status	I-disease
and	O
renal	B-disease
failure	I-disease
.	O

CT	O
scan	O
was	O
obtained	O
and	O
this	O
revealed	O
free	B-disease
air	I-disease
and	O
massive	B-disease
ascites	I-disease
.	O

Pt	O
underwent	O
surgery	O
on	O
05-23	O

1.	O
Exploratory	O
laparotomy	O
with	O
drainage	O
of	O
intra-abdominal	B-disease
abscess	I-disease
and	O
peritonitis	B-disease
with	O
gross	B-disease
soilage	I-disease
with	I-disease
bile	I-disease
and	I-disease
gastric	I-disease
contents	I-disease
.	O

2.	O
Exposure	O
and	O
wide	O
drainage	O
of	O
perforated	B-disease
posterior	I-disease
duodenal	I-disease
ulcer	I-disease
with	O
internal	O
and	O
external	O
drainage	O
.	O

3.	O
Feeding	O
jejunostomy	O
.	O

4.	O
Tube	O
gastrostomy	O
.	O

Continue	O
to	O
deteriorate	O
spiking	B-disease
fevers	I-disease
with	O
ventilatory	O
support	O
on	O
pressors	O
to	O
hold	O
the	O
bp.	O
with	O
no	O
improvement	O
in	O
mental	O
staus	O
was	O
made	O
CMO	O
5/20/5	O
.	O

Expired	O
at	O
5	O
pm	O

Medications	O
on	O
Admission	O
:	O

lasix	O
alt	O
40	O
mg	O
and	O
20	O
mg	O
qday	O

levothyrox	O
50	O
mcg	O
qday	O

lisinopril	O
5	O
mg	O
qday	O

famotidine	O
20	O
mg	O
qday	O

fe	O
so4	O
325	O
mg	O
qday	O

asa	O
325	O
mg	O
qday	O

toprol	O
xl	O
25	O
mg	O
qday	O

glipizide	O
5	O
mg	O
qday	O

imdur	O
60	O
mg	O
qdau	O

prednisone	O
5	O
mg	O
qday	O

tylenol	O

Discharge	O
Disposition	O
:	O

Expired	B-disease

Discharge	O
Diagnosis	O
:	O

MULTIORGAN	B-disease
FAILURE	I-disease

DUODENAL	B-disease
PERFORATION	I-disease

MULTIPLE	B-disease
TRAUMA	I-disease

Discharge	O
Condition	O
:	O

deceased	O

Followup	O
Instructions	O
:	O

none	O

Frank	O
Linda	O
MD	O
44-897	O

Completed	O
by	O
:	O
Deanna	O
Patague	O
MD	O
48-130	O
2013-05-24	O
@	O
1820	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Marta	O
Keever	O
on	O
:	O
FRI	O
2013-06-21	O
9:40	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2012-01-20	O

Discharge	O
Date	O
:	O

2012-01-23	O

Date	O
of	O
Birth	O
:	O

1947-09-21	O

Sex	O
:	O

M	O

Service	O
:	O

UROLOGY	O

PREOPERATIVE	O
DIAGNOSIS	O
:	O

Prostate	B-disease
cancer	I-disease
.	O

ADMITTING	O
DIAGNOSIS	O
:	O

Status	O
post	O
radical	O
retropubic	O
prostatectomy	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
64	O
year	O
old	O
gentleman	O
with	O
a	O
history	O
of	O
elevated	B-disease
PSA	I-disease
,	O
prostate	B-disease
cancer	I-disease
.	O

He	O
was	O
diagnosed	O
with	O
needle	O
biopsy	O
on	O
either	O
side	O
of	O
the	O
prostate	O
with	O
3+3	O
equals	O
6	O
on	O
the	O
right	O
side	O
and	O
3+4	O
equals	O
7	O
on	O
the	O
left	O
side	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
underwent	O
radical	O
retropubic	O
prostatectomy	O
on	O
2012-01-20	O
.	O

Dr.	O
Marie	O
Anderson	O
performed	O
the	O
surgery	O
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
.	O

On	O
postoperative	O
day	O
number	O
one	O
,	O
he	O
was	O
administered	O
1	O
mg	O
Coumadin	O
per	O
protocol	O
as	O
well	O
as	O
on	O
the	O
operative	O
day	O
1	O
mg	O
of	O
Coumadin	O
.	O

The	O
patient	O
was	O
advanced	O
to	O
regular	O
diet	O
on	O
postoperative	O
day	O
one	O
.	O

His	O
laboratories	O
were	O
checked	O
and	O
his	O
hematocrit	O
was	O
noted	O
to	O
be	O
stable	O
.	O

He	O
was	O
made	O
to	O
ambulate	O
on	O
postoperative	O
day	O
one	O
.	O

His	B-disease
pain	I-disease
was	O
well	O
controlled	O
with	O
oral	O
medication	O
at	O
this	O
time	O
.	O

On	O
postoperative	O
day	O
two	O
,	O
he	O
continued	O
to	O
convalesce	O
as	O
planned	O
.	O

His	O
intravenous	O
fluids	O
were	O
discontinued	O
at	O
this	O
time	O
.	O

He	O
was	O
on	O
a	O
house	O
diet	O
and	O
tolerating	O
it	O
well	O
at	O
this	O
time	O
as	O
well	O
.	O

His	O
Penrose	O
drain	O
was	O
discontinued	O
at	O
this	O
time	O
.	O

He	O
was	O
ready	O
for	O
discharge	O
home	O
on	O
postoperative	O
day	O
three	O
.	O

He	O
was	O
discharged	O
home	O
with	O
a	O
Foley	O
catheter	O
and	O
he	O
will	O
follow-up	O
with	O
Dr.	O
Ross	O
in	O
one	O
to	O
two	O
weeks	O
.	O

COMPLICATIONS	O
DURING	O
STAY	O
:	O

None	O
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
.	O

Terry	O
CR	O
Dennis	O
,	O
M.D.	O

68-233	O

Dictated	O
By	O
:	O
Tracy	O
C	O
Rea	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-04-28	O
17:18	O

T	O
:	O
2012-05-01	O
20:32	O

JOB	O
#:	O

21454	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Antonio	O
Hall	O
on	O
:	O
FRI	O
2012-05-04	O
7:48	O
AM	O

(	O
End	O
of	O
Report	O
)	O

306968218	O
YC	O

24803748	O

3232251	O

1/20/2003	O
12:00:00	O
AM	O

IUP	O
at	O
36	O
weeks	O
,	O
delivered	O

DIS	O

Admission	O
Date	O
:	O

01/20/2003	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

01/24/2003	O

******	O
DISCHARGE	O
ORDERS	O
******	O

KOTEROSTREUKOTE	O
,	O
ARO	O
MA	O
O.	O
965-81-64-6	O
U94	O

Room	O
:	O

HSN28-1050	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

01/24/03	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

Attending	O
evaluation	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

HOUGHTBREUN	O
,	O
TESANT	O
E.	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

TYLENOL	O
(	O
ACETAMINOPHEN	O
)	O
650	O
MG	O
PO	O
Q4H	O
PRN	O
PAIN	B-disease
COLACE	O
(	O
DOCUSATE	O
SODIUM	O
)	O
100	O
MG	O
PO	O
BID	O
PRN	O
Constipation	B-disease
IBUPROFEN	O
600	O
MG	O
PO	O
Q4-6H	O
PRN	O
PAIN	B-disease
MILK	O
OF	O
MAGNESIA	O
(	O
MAGNESIUM	O
HYDROXIDE	O
)	O
30	O
MILLILITERS	O
PO	O
QD	O
PRN	O
Constipation	B-disease
PERCOCET	O
1-2	O
TAB	O
PO	O
Q4H	O
PRN	O
PAIN	B-disease

DIET	O
:	O

No	O
Restrictions	O

ACTIVITY	O
:	O

Walking	O
as	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Houghtbreun	O
6	O
weeks	O
,	O
No	O
Known	B-disease
Allergies	I-disease

ADMIT	O
DIAGNOSIS	O
:	O

Repeat	B-disease
C	I-disease
/	I-disease
S	I-disease
PPS	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
IUP	B-disease
at	O
36	O
weeks	O
,	O
delivered	O

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O
IUP	B-disease
at	O
36	O
weeks	O
.	O

insulin	B-disease
dependent	I-disease
gestational	I-disease
diabetic	I-disease
,	O
prior	B-disease
C	I-disease
/	I-disease
S	I-disease
,	O
RSAP	B-disease

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O

Anesthesia	O
:	O

Spinal	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

NONE	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G4	O
T2	O
P0	O
A1	O
L2	O
Estimated	O

EDC	O
:	O

Maternal	O
transfer	O
:	O

No	O

Baby	O
1	O

MRN	O
:	O

23548875	O

Delivery	O
date	O
:	O

01/20/03	O
10:49	O
AM	O

Apgars	O
9,9	O

Weight	O
:	O

6lb	O
5	O
oz	O
2863	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

HOUGHTBREUN	O
,	O
TESANT	O
E.	O
,	O
M.D.	O
(	O
EV89	O
)	O
01/20/03	O
12:26	O
PM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

270045381	O

BH	O

6676757	O

650129	O

10/10/1997	O
12:00:00	O
AM	O

LEFT	B-disease
PROXIMAL	I-disease
HUMERUS	I-disease
FRACTURE	I-disease
.	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

DISCHARGE	O
SUMMARY	O
NAME	O
:	O

JUNK	O
,	O
KACHOLERA	O

UNIT	O
NUMBER	O
:	O

482-31-51	O

ADMISSION	O
DATE	O
:	O

10/10/97	O

DISCHARGE	O
DATE	O
:	O

10/23/97	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

Left	B-disease
proximal	I-disease
humerus	I-disease
fracture	I-disease
.	O

ASSOCIATED	O
DIAGNOSIS	O
:	O

Adult-onset	B-disease
diabetes	I-disease
mellitus	I-disease
x	O
40	O
years	O
,	O
history	O
of	O
silent	B-disease
myocardial	I-disease
infarction	I-disease
,	O
coronary	O
artery	O
bypass	O
graft	O
(	O
three	O
vessels	O
in	O
1987	O
)	O
,	O
history	O
of	O
chronic	B-disease
,	I-disease
stable	I-disease
angina	I-disease
pectoris	I-disease
,	O
Fournier	B-disease
&apos;s	I-disease
gangrene	I-disease
versus	O
necrotizing	B-disease
fasciitis	I-disease
,	O
congestive	B-disease
heart	I-disease
failure	I-disease
in	O
03/97	O
while	O
in	O
the	O
hospital	O
for	O
a	B-disease
rib	I-disease
fracture	I-disease
,	O
glaucoma	B-disease
,	O
diabetic	B-disease
retinopathy	I-disease
with	O
blindness	B-disease
in	I-disease
the	I-disease
right	I-disease
eye	I-disease
,	O
history	O
of	O
gastric	O
stapling	O
,	O
left	B-disease
rib	I-disease
fracture	I-disease
,	O
right	O
femur	O
surgery	O
.	O

PRINCIPAL	O
PROCEDURE	O
:	O

Left	O
shoulder	O
hemiarthroplasty	O
.	O

OTHER	O
PROCEDURES	O
:	O

Upper	O
endoscopy	O
x	O
2	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
65-year-old	O
male	O
with	O
a	O
past	O
medical	O
history	O
of	O
diabetes	B-disease
mellitus	I-disease
,	O
three-vessel	O
coronary	O
artery	O
bypassgraft	O
,	O
congestive	B-disease
heart	I-disease
failure	I-disease
,	O
who	O
presents	O
with	O
a	B-disease
humeral	I-disease
fracture	I-disease
.	O

The	O
patient	O
is	O
admitted	O
for	O
preoperative	O
and	O
orthopedic	O
evaluations	O
.	O

The	O
patient	O
presented	O
with	O
a	B-disease
comminuted	I-disease
fracture	I-disease
of	I-disease
the	I-disease
proximal	I-disease
left	I-disease
humerus	I-disease
when	O
he	O
slipped	O
over	O
the	O
stairs	O
,	O
about	O
to	O
board	O
an	O
airplane	O
back	O
to	O
Jeglas	O
Blvd.	O
,	O
Jolouisrowarlihis	O
,	O
Alabama	O
86071	O
.	O

The	B-disease
fracture	I-disease
was	O
seen	O
by	O
Orthopedics	O
and	O
was	O
reduced	O
.	O

During	O
conscious	O
sedation	O
,	O
the	O
patient	O
developed	O
bigeminy	B-disease
(	O
the	O
patient	O
was	O
sedated	O
,	O
did	O
not	O
feel	O
chest	B-disease
pain	I-disease
or	O
shortness	B-disease
of	I-disease
breath	I-disease
)	O
.	O

The	O
patient	O
presented	O
to	O
Bri	O
Health	O
in	O
order	O
to	O
be	O
evaluated	O
for	O
preoperative	O
clearance	O
.	O

He	O
was	O
reported	O
to	O
have	O
had	O
a	B-disease
myocardial	I-disease
infarction	I-disease
in	O
the	O
past	O
(	O
EKG	O
positive	O
for	O
ischemia	B-disease
,	O
exercise	O
tolerance	O
test	O
positive	O
,	O
cardiac	O
catheterization	O
positive	O
,	O
the	O
patient	O
is	O
now	O
status	O
posta	O
three-vessel	O
coronary	O
artery	O
bypass	O
graft	O
in	O
1987	O
)	O
.	O

The	O
patient	O
also	O
hada	O
history	O
of	O
arrhythmia	B-disease
,	O
found	O
approximately	O
ten	O
years	O
ago	O
,	O
unknown	O
what	O
type	O
.	O

The	O
patient	O
was	O
on	O
coumadin	O
recently	O
,	O
?	O
whether	O
for	O
the	O
arrhythmia	B-disease
.	O

Coumadin	O
was	O
reportedly	O
discontinued	O
approximately	O
six	O
months	O
ago	O
secondary	O
to	O
planned	O
surgery	O
for	O
diabetic	B-disease
retinopathy	I-disease
and	O
glaucoma	B-disease
.	O

The	O
patient	O
did	O
not	O
have	O
chest	B-disease
pain	I-disease
until	O
approximately	O
1-1/2	O
years	O
ago	O
,	O
when	O
he	O
began	O
to	O
have	O
chest	B-disease
tightness	I-disease
(	I-disease
pressure	I-disease
)	I-disease
approximately	O
every	O
three	O
months	O
with	O
stress	B-disease
.	O

The	O
patient	O
has	O
no	O
chest	B-disease
pain	I-disease
when	O
walking	O
slowly	O
and	O
can	O
walk	O
approximately	O
1.5	O
miles	O
.	O

He	O
can	O
climb	O
approximately	O
three	O
flights	O
of	O
stairs	O
before	O
becoming	O
short	B-disease
of	I-disease
breath	I-disease
.	O

He	O
does	O
become	O
slightly	B-disease
short	I-disease
of	I-disease
breath	I-disease
when	O
lifting	O
furniture	O
.	O

On	O
the	O
day	O
of	O
admission	O
,	O
when	O
he	O
fell	O
,	O
the	O
patient	O
was	O
experiencing	O
no	O
chest	B-disease
pain	I-disease
,	O
no	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
and	O
had	O
no	O
loss	B-disease
of	I-disease
consciousness	I-disease
,	O
no	O
head	B-disease
trauma	I-disease
with	I-disease
fall	I-disease
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

No	O
fevers	B-disease
or	O
chills	B-disease
,	O
no	O
chest	B-disease
pain	I-disease
,	O
no	O
shortness	B-disease
of	I-disease
breath	I-disease
.	O

The	O
patient	O
has	O
stable	B-disease
three-pillow	I-disease
orthopnea	I-disease
and	O
occasional	B-disease
paroxysmal	I-disease
nocturnal	I-disease
dyspnea	I-disease
.	O

He	O
has	O
a	B-disease
chronic	I-disease
cough	I-disease
with	O
clear	B-disease
sputum	I-disease
.	O

No	O
hemoptysis	B-disease
,	O
hematemesis	B-disease
,	O
abdominal	B-disease
pain	I-disease
,	O
black	B-disease
or	I-disease
tarry	I-disease
stools	I-disease
,	O
dysuria	B-disease
/	O
frequency/urgency	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Some	O
type	O
of	O
cardiac	B-disease
arrhythmia	I-disease
,	O
diagnosed	O
approximately	O
ten	O
years	O
ago	O
.	O

History	O
of	O
coronary	B-disease
artery	I-disease
disease	I-disease
status	O
post	O
silent	B-disease
myocardial	I-disease
infarction	I-disease
in	O
the	O
past	O
and	O
three-vessel	O
coronary	O
artery	O
bypass	O
graft	O
in	O
1987	O
.	O

The	O
patient	O
has	O
been	O
experiencing	O
chronic	B-disease
,	I-disease
stable	I-disease
angina	I-disease
pectoris	I-disease
over	O
the	O
past	O
one	O
to	O
one	O
and	O
a	O
half	O
years	O
approximately	O
once	O
every	O
three	O
months	O
.	O

History	O
of	O
congestive	B-disease
heart	I-disease
failure	I-disease
,	O
diagnosed	O
approximately	O
eight	O
years	O
ago	O
.	O

Diabetes	B-disease
mellitus	I-disease
for	O
approximately	O
40	O
years	O
.	O

Fournier	B-disease
&apos;s	I-disease
gangrene	I-disease
versus	O
necrotizing	B-disease
fasciitis	I-disease
.	O

Glaucoma	B-disease
.	O

Diabetic	B-disease
retinopathy	I-disease
with	O
the	O
patient	O
blind	B-disease
in	I-disease
right	I-disease
eye	I-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Cholecystectomy	O
.	O

Status	O
post	O
gastric	O
stapling	O
.	O

Left	B-disease
rib	I-disease
fracture	I-disease
.	O

Right	O
femur	O
surgery	O
approximately	O
two	O
years	O
ago	O
.	O

Righteye	O
surgery	O
for	O
glaucoma	B-disease
in	O
05/97	O
.	O

Laser	O
surgery	O
for	O
retinopathy	B-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Humulin	O
70/30	O
with	O
30	O
units	O
subq.q.a.m.	O
and	O
20	O
units	O
subq.q.p.m.	O
Vasotec	O
20	O
mg.	O
q.	O
a.m.	O
Prozac	O
40	O
mg.	O
q.d.	O
Lasix	O
40	O
mg.	O
q.d.	O
K-Dur	O
approximately	O
28	O
?	O
mEq	O
q.d.	O
Atropine	O
1%	O
1	O
GTT	O
OD	O
b.i.d.	O
Ocufen	O
0.03%	O
1	O
GTT	O
OD	O
t.i.d.	O
Ventolin	O
metered-dose	O
inhaler	O
.	O

ALLERGIES	O
:	O

no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

TOBACCO	O
:	O

Formerly	O
smoked	O
3	O
packs	O
per	O
day	O
x	O
25	O
years	O
;	O
2	O
cigars	O
per	O
day	O
x	O
approximately	O
6	O
months	O
.	O

He	O
quit	O
all	O
tobacco	O
approximately	O
27	O
years	O
ago	O
.	O

ETOH	O
:	O

Rare	O
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
is	O
retired	O
,	O
lives	O
with	O
his	O
wife	O
and	O
one	O
son	O
,	O
who	O
is	O
47	O
years	O
old	O
and	O
had	O
multiple	B-disease
myeloma	I-disease
and	O
renal	B-disease
failure	I-disease
.	O

PHYSICAL	O
EXAMINATION	O
:	O

The	O
patient	O
is	O
alert	O
and	O
oriented	O
and	O
has	O
a	O
sling	O
for	O
his	B-disease
left	I-disease
humeral	I-disease
fracture	I-disease
.	O

Blood	O
pressure	O
120/70	O
,	O
temperature	O
97.8	O
F	O
,	O
pulse	O
68	O
,	O
respirations	O
22	O
,	O
Sa02	O
on	O
2	O
L	O
94%	O
.	O

HEENT	O
:	O

Right-sided	B-disease
ptosis	I-disease
,	O
right	O
eye	O
not	O
reactive	O
to	O
light	O
,	O
cataract	B-disease
present	O
,	O
patient	O
blind	B-disease
in	I-disease
that	I-disease
eye	I-disease
,	O
left	O
eye	O
reactive	O
to	O
light	O
,	O
cataract	B-disease
also	O
present	O
in	O
that	O
eye	O
.	O

Extraocular	O
movements	O
-	O
conjugated	O
eye	O
movement	O
intact	O
.	O

Oropharynx	O
moist	O
,	O
without	O
lesions	B-disease
.	O

Mild	B-disease
right	I-disease
facial	I-disease
droop	I-disease
.	O

Sensation	O
intact	O
.	O

No	O
slurred	B-disease
speech	I-disease
.	O

Cardiac	O
:	O

regular	O
rate	O
and	O
rhythm	O
,	O
no	O
murmur	B-disease
appreciated	O
,	O
normal	O
S1	O
and	O
S2	O
.	O

Chest	O
/	O
lungs	O
:	O

The	O
patient	O
is	O
diffusely	B-disease
wheezy	I-disease
upon	O
presentation	O
.	O

Abdomen	B-disease
distended	I-disease
,	O
mild	B-disease
tenderness	I-disease
on	I-disease
the	I-disease
left	I-disease
,	O
bowel	O
sounds	O
present	O
,	O
nohepatosplenomegaly	B-disease
.	O

Extremities	O
:	O

1+	B-disease
edema	I-disease
of	I-disease
the	I-disease
ankles	I-disease
,	O
pulses	O
present	O
bilaterally	O
.	O

No	O
calf	B-disease
tenderness	I-disease
.	O

Rectal	O
:	O

Guaiac	O
negative	O
.	O

Neurological	O
:	O

Non-focal	O
,	O
except	O
unable	O
to	O
assess	O
left	O
upper	O
extremity	O
secondary	O
to	O
the	B-disease
patient	I-disease
&apos;s	I-disease
broken	I-disease
humeral	I-disease
fracture	I-disease
.	O

LABORATORY	O
DATA	O
:	O

sodium	O
135	O
,	O
potassium	O
4.1	O
,	O
chloride	O
101	O
,	O
C02	O
28.4	O
,	O
BUN	O
17	O
,	O
creatinine	O
1.0	O
,	O
glucose	O
302	O
,	O
calcium	O
8.6	O
,	O
phosphorus	O
2.5	O
,	O
magnesium	O
1.6	O
,	O
total	O
protein	O
6.7	O
,	O
albumin	O
3.3	O
,	O
globulin	O
3.4	O
,	O
uric	O
acid	O
6.3	O
,	O
totalbilirubin	O
.7	O
,	O
alkaline	O
phosphatase	O
93	O
,	O
SGOT	O
20	O
,	O
LDH	O
258	O
,	O
CPK	O
95	O
,	O
whiteblood	O
count	O
15.3	O
,	O
hematocrit	O
49.7	O
,	O
platelet	O
count	O
159	O
,	O
MCV	O
98	O
.	O

RADIOLOGIC	O
STUDIES	O
:	O

Chest	O
x-ray	O
10/10/97	O
:	O

Elevated	B-disease
left	I-disease
hemidiaphragm	I-disease
of	O
uncertain	O
etiology	O
or	O
duration	O
.	O

Postoperative	B-disease
changes	I-disease
of	I-disease
the	I-disease
sternum	I-disease
and	I-disease
media	I-disease
stinum	I-disease
were	O
seen	O
and	O
no	O
acute	B-disease
pulmonary	I-disease
disease	I-disease
was	O
visualized	O
.	O

The	O
patient	O
also	O
had	O
a	O
shoulder	O
film	O
done	O
on	O
10/10/97	O
that	O
showed	O
a	B-disease
severely	I-disease
comminuted	I-disease
fracture	I-disease
of	I-disease
the	I-disease
proximal	I-disease
left	I-disease
humerus	I-disease
with	O
proximal	B-disease
distraction	I-disease
.	O

A	B-disease
lucency	I-disease
and	I-disease
irregularity	I-disease
of	I-disease
the	I-disease
glenoid	I-disease
,	O
possibly	O
representing	O
a	B-disease
fracture	I-disease
,	O
was	O
also	O
seen	O
,	O
and	O
a	O
CT	O
scan	O
was	O
therefore	O
obtained	O
in	O
order	O
to	O
evaluate	O
this	O
area	O
.	O

This	O
CT	O
scan	O
,	O
done	O
also	O
on	O
10/10/97	O
,	O
again	O
showed	O
the	B-disease
severely	I-disease
comminuted	I-disease
fracture	I-disease
of	I-disease
the	I-disease
proximal	I-disease
left	I-disease
humerus	I-disease
.	O

Two	B-disease
major	I-disease
fracture	I-disease
fragments	I-disease
were	O
seen	O
at	O
the	O
humeral	O
head	O
,	O
articulating	O
with	O
the	O
glenoid	O
fossa	O
.	O

The	B-disease
fracture	I-disease
fragments	I-disease
retained	O
their	O
proper	O
site	O
of	O
articulation	O
with	O
the	O
glenoid	O
fossa	O
.	O

Innumerable	B-disease
smaller	I-disease
fracture	I-disease
fragments	I-disease
were	O
interposed	O
between	O
the	B-disease
fracture	I-disease
fragment	I-disease
and	O
the	O
distal	O
humeral	O
shaft	O
.	O

The	O
glenoid	O
fossa	O
was	O
intact	O
.	O

No	O
scapular	B-disease
fractures	I-disease
were	O
present	O
.	O

EKG	O
:	O

normal	O
sinus	O
rhythm	O
at	O
72	O
beats	O
/	O
minute	O
,	O
intraventricular	B-disease
conduction	I-disease
delay	I-disease
,	O
Q	O
-	O
waves	O
seen	O
in	O
II	O
,	O
III	O
,	O
and	O
AVF	O
with	O
probable	O
old	B-disease
inferior	I-disease
myocardial	I-disease
infarction	I-disease
.	O

T	O
-	O
waves	O
were	O
also	O
noted	O
to	O
be	O
inverted	O
in	O
I	O
and	O
AVL	O
.	O

Ventricular	B-disease
bigeminy	I-disease
was	O
also	O
seen	O
.	O

HOSPITAL	O
COURSE	O
AND	O
TREATMENT	O
:	O

1.	O
ORTHOPEDICS	O
:	O

The	O
patient	O
has	O
a	B-disease
severely	I-disease
comminuted	I-disease
fracture	I-disease
of	I-disease
the	I-disease
proximal	I-disease
left	I-disease
humerus	I-disease
.	O

He	O
is	O
status	O
post	O
a	O
hemiarthroplasty	O
on	O
10/17/97	O
.	O

He	O
received	O
Ancef	O
preoperatively	O
.	O

Physical	O
Therapy	O
has	O
been	O
seeing	O
the	O
patient	O
and	O
putting	O
him	O
through	O
passive	O
external	O
rotation	O
to	O
the	O
neutral	O
position	O
of	O
the	O
left	O
shoulder	O
and	O
forward	O
flexion	O
with	O
physical	O
therapy	O
assistance	O
.	O

Brittle	B-disease
bones	I-disease
were	O
noted	O
during	O
the	O
operation	O
.	O

A	O
bone	O
density	O
scan	O
would	O
be	O
recommended	O
as	O
an	O
outpatient	O
,	O
in	O
order	O
to	O
evaluate	O
this	O
.	O

2.	O
NEUROLOGICAL	O
:	O

The	O
patient	O
has	O
right	B-disease
facial	I-disease
droop	I-disease
,	O
right	B-disease
ptosis	I-disease
,	O
stable	O
and	O
present	O
for	O
greater	O
than	O
one	O
year	O
.	O

3.	O
CARDIOVASCULAR	O
:	O

No	O
chest	B-disease
pain	I-disease
,	O
no	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
1+	B-disease
ankle	I-disease
edema	I-disease
.	O

The	O
patient	O
was	O
ruled	O
out	O
for	O
a	B-disease
myocardial	I-disease
infarction	I-disease
,	O
given	O
his	B-disease
fall	I-disease
at	O
the	O
airport	O
and	O
bigeminy	B-disease
seen	O
on	O
electrocardiogram	O
that	O
he	O
developed	O
during	O
conscious	O
sedation	O
during	O
reduction	O
of	O
the	O
fracture	O
.	O

Cardiology	O
was	O
consulted	O
and	O
aspirin	O
and	O
beta	O
blocker	O
added	O
to	O
his	O
regimen	O
,	O
as	O
well	O
as	O
chest	O
wall	O
nitroglycerin	O
around	O
the	O
time	O
of	O
surgery	O
,	O
which	O
was	O
subsequently	O
discontinued	O
.	O

An	O
adenosine	O
SESTAMIBI	O
was	O
performed	O
on	O
10/12/97	O
,	O
which	O
showed	O
a	O
negative	O
electrocardiogram	O
for	O
ischemia	B-disease
and	O
cardiac	O
perfusion	O
scans	O
,	O
with	O
a	B-disease
moderate-sized	I-disease
,	I-disease
dense	I-disease
,	I-disease
fixed	I-disease
inferior	I-disease
defect	I-disease
indicative	O
of	O
scar	B-disease
.	O

A	B-disease
small	I-disease
/	I-disease
moderate-sized	I-disease
,	I-disease
mild-intensity	I-disease
,	I-disease
reversible	I-disease
posterior	I-disease
lateral	I-disease
defect	I-disease
was	O
also	O
seen	O
,	O
indicative	O
of	O
mild	B-disease
/	I-disease
moderate	I-disease
ischemia	I-disease
.	O

An	O
echocardiogram	O
was	O
performed	O
on	O
Columbus	O
Day	O
which	O
showed	O
an	O
ejection	O
fraction	O
of	O
50%	O
,	O
left	B-disease
atrial	I-disease
enlargement	I-disease
,	O
thickening	B-disease
of	I-disease
the	I-disease
aortic	I-disease
wall	I-disease
consistent	O
with	O
atherosclerotic	B-disease
changes	I-disease
,	O
left	O
ventricle	O
size	O
,	O
and	O
systolic	O
function	O
within	O
normal	O
limits	O
.	O

Cardiac	O
monitor	O
was	O
placed	O
on	O
the	O
patient	O
,	O
given	O
the	B-disease
bigeminy	I-disease
,	O
and	O
he	O
did	O
rule	O
out	O
for	O
myocardial	B-disease
infarction	I-disease
.	O

Cardiology	O
recommended	O
that	O
in	O
addition	O
to	O
the	O
medications	O
already	O
stated	O
above	O
,	O
his	O
hematocrit	O
be	O
kept	O
greater	O
than	O
30	O
.	O

After	O
his	O
procedure	O
on	O
10/17/97	O
,	O
elevated	B-disease
CPKs	I-disease
were	O
noted	O
on	O
10/19/97	O
to	O
10/20/97	O
,	O
and	O
the	O
first	O
level	O
was	O
744	O
,	O
CPK	O
#	O
2	O
635	O
,	O
and	O
CPK	O
#	O
3	O
461	O
.	O

MB	B-disease
fractionations	I-disease
of	O
the	O
CPKs	O
were	O
all	O
negative	O
and	O
were	O
thought	O
to	O
be	O
secondary	O
to	O
the	O
patient	O
&apos;s	O
beginning	O
physical	O
therapy	O
on	O
10/19/97	O
,	O
and	O
all	O
muscular	O
in	O
origin	O
.	O

4.	O
GASTROENTEROLOGY	O
:	O

GI	O
was	O
consulted	O
on	O
10/15/97	O
for	O
melena	B-disease
,	O
decreased	B-disease
hematocrit	I-disease
prior	O
to	O
his	O
humeral	O
fixation	O
surgery	O
.	O

Upper	O
endoscopy	O
x	O
2	O
were	O
done	O
.	O

The	O
first	O
was	O
on	O
10/15/97	O
,	O
which	O
showed	O
clotted	B-disease
blood	I-disease
in	I-disease
the	I-disease
esophagus	I-disease
.	O

The	O
stomach	O
had	O
evidence	O
of	O
prior	O
surgery	O
and	O
old	B-disease
blood	I-disease
in	I-disease
the	I-disease
stomach	I-disease
.	O

It	O
was	O
thought	O
that	O
the	B-disease
blood	I-disease
in	I-disease
the	I-disease
esophagus	I-disease
was	O
secondary	O
to	O
a	O
possible	O
Mallory-Weiss	B-disease
tear	I-disease
.	O

A	O
second	O
endoscopy	O
was	O
also	O
performed	O
several	O
days	O
later	O
,	O
in	O
order	O
to	O
rule	O
out	O
a	B-disease
gastric	I-disease
ulcer	I-disease
,	O
and	O
also	O
because	O
the	O
patient	O
had	O
had	O
another	O
episode	O
of	O
melena	B-disease
.	O

A	B-disease
gastric	I-disease
ulcer	I-disease
was	O
found	O
and	O
this	O
was	O
biopsied	O
and	O
pathology	O
is	O
pending	O
at	O
this	O
time	O
.	O

This	O
report	O
needs	O
to	O
be	O
followed	O
up	O
,	O
and	O
will	O
be	O
available	O
at	O
Bri	O
Health	O
in	O
the	O
Pathology	O
Department	O
some	O
time	O
within	O
the	O
next	O
three	O
to	O
seven	O
days	O
.	O

The	O
patient	O
also	O
needs	O
a	O
repeat	O
endoscopy	O
and	O
a	O
GI	O
follow-up	O
appointment	O
inapproximately	O
two	O
months	O
.	O

I	O
have	O
spoken	O
with	O
the	O
patient	O
in	O
detail	O
,	O
and	O
he	O
will	O
be	O
getting	O
in	O
touch	O
with	O
his	O
primary-care	O
physician	O
,	O
Dr.	O
Fordwoodall	O
Stick	O
,	O
in	O
Ranegei	O
Pkwy	O
,	O
Verertliet	O
,	O
South	O
Carolina	O
62156	O
.	O

The	O
patient	O
is	O
to	O
arrange	O
follow	O
up	O
with	O
a	O
GI	O
doctor	O
in	O
Jotar	O
Boulevard	O
,	O
Cunahtampfordama	O
,	O
South	O
Dakota	O
62848	O
through	O
his	O
primary-care	O
physician	O
.	O

The	O
patient	O
was	O
initially	O
on	O
Cimetidine	O
and	O
Carafate	O
here	O
at	O
Bri	O
Health	O
,	O
and	O
then	O
switched	O
to	O
Prilosec	O
20	O
mg	O
bid	O
.	O

5.	O
PULMONARY	O
:	O

The	O
patient	O
&apos;s	O
admitting	O
chest	O
x-ray	O
showed	O
an	B-disease
elevated	I-disease
left	I-disease
hemidiaphragm	I-disease
consistent	O
with	O
atelectasis	B-disease
versus	O
splinting	B-disease
on	I-disease
that	I-disease
side	I-disease
.	O

Incentive	O
spirometry	O
was	O
started	O
.	O

Albuterol	O
and	O
Atrovent	O
nebulizers	O
were	O
done	O
.	O

The	O
patient	O
received	O
chest	O
physical	O
therapy	O
bid	O
.	O

6.	O
ENDOCRINE	O
:	O

The	O
patient	O
needs	O
still	O
better	O
diabetes	O
control	O
.	O

He	O
has	O
been	O
somewhat	O
noncompliant	O
with	O
his	O
diet	O
(	O
eating	O
Pringle	O
&apos;s	O
in	O
the	O
room	O
)	O
.	O

His	O
NPH	O
was	O
recently	O
increased	O
today	O
(	O
10/23/97	O
)	O
to	O
24	O
units	O
in	O
the	O
a.m.	O
and	O
14	O
units	O
in	O
the	O
p.m.	O
with	O
CZI	O
sliding-scale	O
coverage	O
.	O

7.	O
INFECTIOUS	O
DISEASE	O
:	O

The	O
patient	O
urinalysis	O
on	O
10/19/97	O
showed	O
moderate	B-disease
occult	I-disease
blood	I-disease
,	O
pH	O
5	O
,	O
albumin	O
1+	O
,	O
white	O
blood	O
cells	O
present	O
,	O
2-50	O
red	O
blood	O
cell	O
,	O
10-20	O
white	O
blood	O
cells	O
,	O
few	B-disease
bacteria	I-disease
,	O
and	O
moderate	B-disease
bladder	I-disease
epithelial	I-disease
cells	I-disease
.	O

Floxin	O
200	O
mg	O
po	O
bid	O
was	O
begun	O
.	O

However	O
,	O
his	O
urine	O
culture	O
from	O
the	O
same	O
day	O
remained	O
negative	O
,	O
and	O
this	O
was	O
discontinued	O
two	O
days	O
later	O
.	O

A	O
repeat	O
urinalysis	O
on	O
10/22/97	O
was	O
negative	O
.	O

8.	O
RENAL	O
:	O

After	O
the	O
patient	O
&apos;s	O
procedure	O
,	O
he	O
was	O
felt	O
to	O
be	O
volume	B-disease
overloaded	I-disease
.	O

He	O
was	O
given	O
Lasix	O
40	O
mg	O
IV	O
x	O
1	O
and	O
also	O
had	O
Nitro	O
paste	O
around	O
the	O
time	O
of	O
his	O
surgery	O
and	O
beta	O
blocker	O
.	O

The	O
patient	O
became	O
slightly	B-disease
hypotensive	I-disease
on	O
the	O
night	O
of	O
10/18/97	O
with	O
systolic	O
blood	O
pressures	O
in	O
the	O
80s	O
to	O
90s.	O

His	O
BUN/	O
creatinine	O
rose	O
from	O
16/1.2	O
on	O
10/18/97	O
to	O
25/1.9	O
on	O
10/18/97	O
to	O
22/9.1	O
to	O
today	O
&apos;s	O
labs	O
,	O
which	O
are	O
15/0.7	O
on	O
10/23/97	O
.	O

9.	O
HEMATOLOGY	O
:	O

The	O
patient	O
transfused	O
2	O
units	O
on	O
10/15/97	O
for	O
a	O
hematocrit	O
of	O
27.6	O
.	O

The	O
patient	O
transfused	O
2	O
units	O
of	O
10/16/97	O
for	O
a	O
hematocrit	O
of	O
30.03	O
.	O

The	O
patient	O
transfused	O
1	O
unit	O
on	O
10/18/97	O
for	O
a	O
hematocrit	O
of	O
29.4	O
.	O

The	O
patient	O
transfused	O
1	O
unit	O
on	O
10/19/97	O
for	O
a	O
hematocrit	O
of	O
27.9	O
.	O

The	O
patient	O
transfused	O
2	O
units	O
on	O
10/20/97	O
for	O
a	O
hematocrit	O
of	O
28.2.10	O
.	O

FEN	O
:	O

Repleting	O
potassium	O
,	O
magnesium	O
,	O
phosphorus	O
as	O
needed	O
.	O

The	O
patient	O
was	O
noted	O
to	O
be	O
slightly	B-disease
hyponatremic	I-disease
over	O
the	O
past	O
few	O
days	O
,	O
with	O
sodiums	O
in	O
the	O
128-132	O
range	O
,	O
but	O
this	O
was	O
secondary	O
to	O
elevated	B-disease
glucose	I-disease
fingerstick	I-disease
blood	I-disease
sugars	I-disease
.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
,	O
good	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

NPH	O
insulin	O
24	O
units	O
subq.	O
q.	O
a.m.	O
NPH	O
insulin	O
14	O
units	O
subq.	O
q.	O
p.m.	O
CZI	O
sliding	O
scale	O
on	O
a	O
q.	O
a.c.	O
and	O
q.	O
h.s.	O
fingerstick	O
basis	O
with	O
the	O
following	O
scale	O
:	O

FBS	O
less	O
than	O
200	O
=	O
0	O
units	O
of	O
CZI	O
FBS	O
201-250	O
=	O
2	O
units	O
of	O
CZI	O
FBS	O
251-300	O
=	O
4	O
units	O
of	O
CZI	O
FBS	O
301-350	O
=	O
6	O
units	O
of	O
CZI	O
FBS	O
351-400	O
=	O
8	O
units	O
of	O
CZI	O
FBS	O
greater	O
than	O
400	O
=	O
10	O
units	O
of	O
CZI	O
.	O

Atropine	O
sulfate	O
1	O
GTT	O
1%	O
OD	O
b.i.d.	O

Ocufen	O
0.03%	O
1	O
GTT	O
OD	O
t.i.d.	O
Vasotec	O
20	O
mg.	O
p.o.q.	O
a.m.	O
Prozac	O
40	O
mg.p.o.q.	O
a.m.	O

Oxygen	O
2-4	O
L	O
to	O
keep	O
Sa02	O
greater	O
than	O
or	O
equal	O
to	O
94-95%	O
and	O
wean	O
as	O
tolerated	O
.	O

Colace	O
100	O
mg.	O
p.o.	O
t.i.d.	O
Senokot	O
1	O
p.o.	O
q.	O
h.s.	O
Nystatin	O
powder	O
to	O
affected	B-disease
area	I-disease
t.i.d.	O
Lopressor	O
25	O
mg.	O
p.o.	O
b.i.d.	O
Atrovent	O
0.8/2.5	O
c.c.	O
normal	O
saline	O
nebulizers	O
q.	O
8	O
h.	O
Albuterol	O
2.5/5	O
c.c.	O
normal	O
saline	O
nebulizers	O
q.	O
4	O
h.	O
with	O
q.	O
2	O
h.	O
p.r.n.	O
Percocet	O
1-2	O
p.o.	O
q.	O
4	O
h.	O
p.r.n.	O
pain	B-disease
.	O

Prilosec	O
20	O
mg.	O
p.o.	O
b.i.d.	O
Vexol	O
1%	O
1	O
GTT	O
OD	O
b.i.d.	O
Lasix	O
40	O
mg.	O
p.o.	O
q.d.	O
KCl	O
20	O
mEq	O
p.o.	O
q.d.	O
Tylenol	O
650	O
mg.	O
p.o.	O
q.	O
12	O
h.	O
p.r.n.	O
Ativan	O
1	O
mg.	O
p.o.	O
q.	O
h.s.	O
p.r.n.	O

SAY	O
REKE	O
,	O
M.D.	O

TR	O
:	O

vr	O

DD	O
:	O

TD	O
:	O

10/23/97	O
3:05	O

Pcc	O
:	O

NABETH	O
NA	O
GLYNCRED	O
,	O
M.D.	O
MI	O
T	O
THULRO	O
,	O
M.D.	O
/	O
Fordwoodall	O
Stick	O
,	O
M.D.	O
7922	O

Fordknoxtall	O
Illinois	O

Admission	O
Date	O
:	O

2010-08-26	O

Discharge	O
Date	O
:	O

2010-09-02	O

Date	O
of	O
Birth	O
:	O

1961-06-26	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Robert	O
Mackey	O
is	O
a	O
49	O
year	O
old	O
gentleman	O
with	O
a	O
22	O
year	O
history	O
of	O
diabetes	B-disease
mellitus	I-disease
.	O

He	O
has	O
a	O
history	O
of	O
peripheral	B-disease
neuropathy	I-disease
,	O
kidney	O
transplantation	O
in	O
2003	O
secondary	O
to	O
diabetic	B-disease
nephropathy	I-disease
,	O
as	O
well	O
as	O
throat	B-disease
cancer	I-disease
in	O
2004	O
treated	O
with	O
local	O
resection	O
and	O
radical	O
neck	O
dissection	O
on	O
the	O
left	O
as	O
well	O
as	O
postoperative	O
radiation	O
.	O

Mr.	O
Mackey	O
also	O
had	O
signs	B-disease
and	I-disease
symptoms	I-disease
consistent	O
with	O
cervical	B-disease
myelopathy	I-disease
;	O
a	O
cervical	O
MRI	O
scan	O
showed	O
very	O
impressive	B-disease
disc	I-disease
herniations	I-disease
at	I-disease
C5-C6	I-disease
,	O
less	O
so	O
at	O
C4-C5	O
,	O
with	O
clear	B-disease
cut	I-disease
cord	I-disease
compression	I-disease
,	O
particularly	O
on	O
the	O
right	O
side	O
C5-C6	O
.	O

Therefore	O
,	O
he	O
was	O
admitted	O
for	O
C4-C5	O
and	O
C5-C6	O
anterior	O
diskectomy	O
with	O
autologous	O
bone	O
graft	O
and	O
instrumented	O
fusion	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Postoperative	O
physical	O
examination	O
demonstrated	O
that	O
he	O
was	O
afebrile	B-disease
at	O
97	O
degrees	O
;	O
blood	O
pressure	O
145/80	O
;	O
pulse	O
60	O
;	O
respiratory	O
rate	O
10	O
;	O
100%	O
on	O
a	O
non-rebreather	O
.	O

He	O
was	O
awake	O
,	O
alert	O
,	O
uncomfortable	B-disease
secondary	O
to	O
incisional	B-disease
tenderness	I-disease
at	O
neck	B-disease
site	I-disease
as	O
well	O
as	O
right	B-disease
iliac	I-disease
graft	I-disease
site	I-disease
.	O

The	B-disease
wounds	I-disease
were	O
clean	O
,	O
dry	O
and	O
intact	O
,	O
and	O
flat	O
.	O

HOSPITAL	O
COURSE	O
:	O

While	O
in	O
the	O
PACU	O
,	O
Anesthesia	O
was	O
called	O
because	O
the	O
patient	O
became	O
dyspneic	B-disease
and	O
tachypneic	B-disease
and	O
his	O
SAO2	O
dropped	O
to	O
89%	O
.	O

His	O
respiratory	O
rate	O
was	O
30	O
on	O
face	O
mask	O
.	O

Interoperatively	O
,	O
he	O
was	O
positive	O
two	O
liters	O
with	O
a	O
stable	O
blood	O
pressure	O
and	O
heart	O
rate	O
,	O
although	O
requiring	O
some	O
neo-synephrine	O
interoperatively	O
.	O

He	O
responded	O
to	O
intravenous	O
Lasix	O
with	O
3.2	O
liters	O
of	O
urine	O
output	O
as	O
well	O
as	O
marked	O
clinical	O
improvement	O
.	O

The	O
etiology	O
for	O
his	B-disease
congestive	I-disease
heart	I-disease
failure	I-disease
was	O
determined	O
likely	O
to	O
be	O
diastolic	B-disease
dysfunction	I-disease
from	O
increased	B-disease
heart	I-disease
rate	I-disease
as	O
well	O
as	O
excess	B-disease
volume	I-disease
.	O

No	O
definite	O
evidence	O
for	O
significant	B-disease
myocardial	I-disease
ischemia	I-disease
,	O
although	O
cardiac	O
enzymes	O
were	O
sent	O
and	O
he	O
ruled	O
out	O
for	O
myocardial	B-disease
infarction	I-disease
.	O

He	O
was	O
admitted	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
where	O
his	O
respiratory	O
and	O
cardiac	O
status	O
was	O
monitored	O
carefully	O
.	O

He	O
was	O
given	O
Lasix	O
to	O
continue	O
to	O
diurese	O
the	B-disease
excess	I-disease
volume	I-disease
.	O

He	O
was	O
also	O
put	O
on	O
Lopressor	O
150	O
mg	O
twice	O
a	O
day	O
.	O

Also	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
O2	O
saturation	O
was	O
closely	O
monitored	O
.	O

The	O
patient	O
became	O
agitated	B-disease
with	O
both	O
tent	O
and	O
Bi-PAP	O
machine	O
,	O
although	O
continued	O
to	O
saturate	O
well	O
.	O

He	O
was	O
transferred	O
to	O
Medicine	O
the	O
morning	O
of	O
2010-08-30	O
,	O
for	O
continued	O
medical	O
management	O
post	O
surgery	O
.	O

On	O
the	O
day	O
of	O
transfer	O
,	O
the	O
patient	O
was	O
noted	O
to	O
be	O
confused	B-disease
with	O
waxing	B-disease
and	I-disease
waning	I-disease
sensorium	I-disease
;	O
thus	O
,	O
a	O
delirium	O
work-up	O
was	O
initiated	O
looking	O
for	O
precipitants	O
.	O

1.	O
When	O
his	O
O2	O
saturation	O
was	O
monitored	O
,	O
his	O
pulse	O
oximetry	O
remained	O
in	O
the	O
90s	O
during	O
his	O
stay	O
.	O

2.	O
His	O
non-essential	O
medications	O
that	O
may	O
have	O
been	O
contributing	O
to	O
his	B-disease
change	I-disease
in	I-disease
mental	I-disease
status	I-disease
were	O
discontinued	O
;	O
those	O
included	O
Temocillin	O
,	O
Nortriptyline	O
,	O
Haldol	O
,	O
Lorazepam	O
,	O
Venlafaxine	O
,	O
Bupropion	O
,	O
and	O
Gabapentin	O
.	O

In	O
addition	O
,	O
his	O
cyclosporin	O
levels	O
were	O
checked	O
.	O

3.	O
Hypo	B-disease
or	I-disease
hyperglycemia	I-disease
:	O

Mahoney	O
had	O
been	O
following	O
with	O
their	O
appreciated	O
recommendations	O
on	O
glucose	O
control	O
.	O

Finger	O
sticks	O
were	O
in	O
the	O
150	O
s	O
when	O
acutely	B-disease
agitated	I-disease
,	O
therefore	O
,	O
it	O
was	O
not	O
determined	O
that	O
glucose	O
levels	O
were	O
contributory	O
.	O

4.	O
Infectious	B-disease
causes	I-disease
were	O
evaluated	O
.	O

He	O
was	O
febrile	B-disease
in	O
the	O
Intensive	O
Care	O
Unit	O
to	O
101.0	O
F.	O
;	O
yet	O
,	O
chest	O
x-ray	O
,	O
blood	O
cultures	O
,	O
urinalysis	O
and	O
urine	O
cultures	O
were	O
all	O
negative	O
for	O
sources	O
.	O

A	O
lumbar	O
puncture	O
was	O
considered	O
,	O
although	O
not	O
performed	O
due	O
to	O
the	O
fact	O
that	O
the	O
cerebrospinal	O
fluid	O
was	O
not	O
breached	O
during	O
the	O
procedure	O
.	O

5.	O
Mass	B-disease
effect	I-disease
was	O
considered	O
,	O
although	O
no	O
focal	B-disease
deficits	I-disease
were	O
ever	O
noted	O
on	O
examination	O
and	O
due	O
to	O
the	B-disease
fluctuating	I-disease
sensorium	I-disease
,	O
it	O
was	O
determined	O
that	O
there	O
was	O
no	O
severe	B-disease
underlying	I-disease
structural	I-disease
abnormality	I-disease
.	O

A	O
head	O
and	O
neck	O
CT	O
scan	O
,	O
non-contrast	O
,	O
were	O
ordered	O
though	O
to	O
evaluate	O
for	O
such	B-disease
processes	I-disease
.	O

No	O
acute	B-disease
intracranial	I-disease
hemorrhages	I-disease
or	O
midline	B-disease
shifts	I-disease
were	O
noted	O
,	O
although	O
a	B-disease
soft	I-disease
tissue	I-disease
mass	I-disease
was	O
noted	O
at	O
the	O
level	O
of	O
C2	O
.	O

This	O
was	O
determined	O
to	O
be	O
within	O
the	O
normal	O
expected	O
changes	O
post	O
surgery	O
.	O

6.	O
Trauma	B-disease
was	O
also	O
considered	O
.	O

The	O
patient	O
was	O
found	O
out	O
of	O
bed	O
but	O
no	O
signs	O
of	O
head	B-disease
trauma	I-disease
,	O
no	O
loss	B-disease
of	I-disease
consciousness	I-disease
.	O

Throughout	O
his	O
stay	O
,	O
Chem-10	O
was	O
monitored	O
.	O

There	O
were	O
no	O
electrolytes	B-disease
or	I-disease
mineral	I-disease
abnormalities	I-disease
that	O
could	O
explain	O
his	B-disease
delirium	I-disease
.	O

Liver	O
function	O
tests	O
were	O
checked	O
,	O
only	O
total	O
bilirubin	O
was	O
slightly	B-disease
elevated	I-disease
at	O
1.6	O
.	O

TSH	O
was	O
within	O
normal	O
limits	O
as	O
was	O
B12	O
and	O
folate	O
.	O

RPR	O
evaluating	O
for	O
possible	O
neurologic	B-disease
syphilis	I-disease
was	O
also	O
checked	O
.	O

The	O
assay	O
was	O
nonreactive	O
.	O

An	O
EEG	O
was	O
also	O
considered	O
to	O
rule	O
out	O
non-convulsive	B-disease
status	I-disease
epilepticus	I-disease
,	O
although	O
again	O
this	O
did	O
not	O
seem	O
to	O
be	O
a	O
likely	O
cause	O
.	O

On	O
the	O
evening	O
of	O
the	O
22nd	O
,	O
the	O
patient	O
became	O
acutely	B-disease
agitated	I-disease
,	O
threatening	O
to	O
leave	O
,	O
and	O
also	O
threatening	O
to	O
harm	O
those	O
nurses	O
and	O
physicians	O
that	O
were	O
attempting	O
to	O
prevent	O
him	O
from	O
leaving	O
.	O

Security	O
was	O
notified	O
who	O
then	O
arrived	O
to	O
the	O
room	O
and	O
helped	O
to	O
place	O
the	O
patient	O
in	O
four-point	O

restraints	O
,	O
for	O
the	O
safety	O
of	O
both	O
the	O
patient	O
and	O
the	O
staff	O
of	O
the	O
hospital	O
.	O

The	O
restraints	O
were	O
weaned	O
off	O
overnight	O
although	O
he	O
became	O
acutely	B-disease
agitated	I-disease
and	O
they	O
were	O
replaced	O
early	O
on	O
08-31	O
.	O

Later	O
in	O
the	O
morning	O
on	O
08-31	O
,	O
the	O
patient	O
was	O
more	O
oriented	O
and	O
alert	O
,	O
and	O
asked	O
to	O
have	O
the	O
restraints	O
removed	O
.	O

They	O
were	O
taken	O
off	O
two	O
at	O
a	O
time	O
.	O

The	O
patient	O
continued	O
to	O
do	O
well	O
and	O
did	O
not	O
require	O
restraints	O
after	O
that	B-disease
event	I-disease
.	O

Intramuscular	O
as	O
well	O
as	O
intravenous	O
Haldol	O
were	O
ordered	O
p.r.n.	O
for	O
emergency	O
use	O
should	O
he	O
become	O
acutely	B-disease
agitated	I-disease
.	O

haldol	O
as	O
well	O
as	O
the	O
restraints	O
were	O
not	O
required	O
after	O
the	O
morning	O
of	O
the	O
23rd	O
.	O

Each	O
progressive	O
day,	O
Mr.	O
Donald	O
delirium	B-disease
abated	O
with	O
return	O
to	O
baseline	O
mental	O
status	O
early	O
on	O
09-01	O
.	O

The	O
likely	O
cause	O
of	O
the	B-disease
delirium	I-disease
was	O
a	O
combination	O
of	O
surgery	O
and	O
Intensive	O
Care	O
Unit	O
stay	O
in	O
addition	O
to	O
poly-pharmacy	O
.	O

Other	O
concerns	O
during	O
his	O
stay	O
was	O
his	O
kidney	O
function	O
,	O
due	O
to	O
his	O
renal	O
transplant	O
in	O
2003	O
.	O

His	O
immunosuppressive	O
therapy	O
was	O
continued	O
throughout	O
his	O
stay	O
;	O
his	O
creatinine	O
remained	O
approximately	O
2.3	O
to	O
2.4	O
;	O
he	O
has	O
a	B-disease
baseline	I-disease
renal	I-disease
insufficiency	I-disease
.	O

With	O
this	O
in	O
mind	O
,	O
when	O
obtaining	O
a	O
CT	O
scan	O
it	O
was	O
determined	O
that	O
contrast	O
would	O
not	O
be	O
the	O
best	O
option	O
.	O

While	O
the	O
patient	O
was	O
in	O
restraints	O
,	O
gentle	O
hydration	O
was	O
initiated	O
since	O
p.o.	O
intake	O
was	O
not	B-disease
adequate	I-disease
.	O

As	O
for	O
his	B-disease
diabetes	I-disease
mellitus	I-disease
,	O
the	O
Mahoney	O
Team	O
provided	O
updated	O
recommendations	O
each	O
day	O
,	O
adjusting	O
for	O
the	O
changing	O
p.o.	O
intake	O
.	O

The	O
only	O
other	B-disease
complaints	I-disease
from	O
Mr.	O
Mackey	O
during	O
his	O
stay	O
were	O
:	O

Soreness	B-disease
at	O
his	B-disease
operative	I-disease
sites	I-disease
,	O
for	O
which	O
he	O
was	O
given	O
p.r.n.	O
Tylenol	O
once	O
his	B-disease
delirium	I-disease
had	O
resolved	O
.	O

In	O
addition	O
,	O
he	O
also	O
complained	O
of	O
difficulty	B-disease
with	I-disease
swallowing	I-disease
,	O
necessitating	O
only	O
soft	O
and	O
liquid	O
diet	O
.	O

This	O
was	O
attributed	O
to	O
postoperative	B-disease
swelling	I-disease
and	O
changes	O
from	O
his	O
diskectomy	O
performed	O
2010-08-27	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
was	O
discharged	O
on	O
09-02	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
Follow-up	O
with	O
Dr.	O
Williams	O
on	O
Tuesday	O
,	O
09-07	O
,	O
at	O
noon	O
.	O

2.	O
Follow-up	O
with	O
Dr.	O
Michael	O
,	O
his	O
psychiatrist	O
,	O
on	O
Wednesday	O
,	O
09-08	O
.	O

3.	O
He	O
was	O
also	O
discharged	O
home	O
with	O
Visiting	O
Nurse	O
Association	O
for	O
Physical	O
Therapy	O
evaluation	O
of	O
home	O
safety	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Venlafaxine	O
XR	O
75	O
mg	O
q.	O
a.m.	O

2.	O
Furosemide	O
20	O
mg	O
q.o.d.	O

3.	O
Metoprolol	O
100	O
mg	O
twice	O
a	O
day	O
.	O

4.	O
Nitroglycerin	O
sublingual	O
0.3	O
mg	O
p.r.n.	O

5.	O
Cyclosporin	O
microemulsion	O
.	O

6.	O
Neoral	O
100	O
mg	O
twice	O
a	O
day	O
.	O

7.	O
Zithropren	O
50	O
mg	O
q.	O
day	O
.	O

8.	O
Prednisone	O
10	O
mg	O
q.	O
day	O
.	O

9.	O
Minoxidil	O
10	O
mg	O
twice	O
a	O
day	O
.	O

10.	O
Prilosec	O
20	O
mg	O
q.	O
day	O
.	O

11.	O
NPH	O
30	O
units	O
q.	O
a.m.	O
,	O
5	O
to	O
6	O
units	O
q.	O
p.m.	O

12.	O
Regular	O
insulin	O
5	O
units	O
q.	O
a.m.	O
and	O
3	O
to	O
5	O
units	O
q.	O
p.m.	O

13.	O
Wellbutrin	O
100	O
mg	O
q.	O
day	O
.	O

14.	O
Zocor	O
60	O
mg	O
q.	O
day	O
.	O

15.	O
Nitroglycerin	O
SR	O
2.5	O
mg	O
twice	O
a	O
day	O
.	O

He	O
was	O
instructed	O
to	O
hold	O
the	O
following	O
three	O
medications	O
that	O
he	O
took	O
prior	O
to	O
admission	O
:	O

Nortriptyline	O
10	O
mg	O
q.	O
h.s.	O
;	O
Flomax	O
0.4	O
mg	O
q.	O
h.s.	O
;	O
Neurontin	O
600	O
mg	O
three	O
times	O
a	O
day	O
.	O

He	O
was	O
instructed	O
not	O
to	O
restart	O
these	O
until	O
seen	O
by	O
Dr.	O
Ercek	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
C4-C5	O
,	O
C5-C6	O
,	O
anterior	O
microdiscectomy	O
and	O
fusion	O
with	O
right	O
iliac	O
bone	O
graft	O
.	O

For	O
completeness	O
,	O
the	O
patient	O
's	O
complete	O
past	O
medical	O
history	O
:	O

1.	O
End-stage	B-disease
renal	I-disease
disease	I-disease
secondary	O
to	O
type	B-disease
1	I-disease
diabetes	I-disease
mellitus	I-disease
;	O
status	O
post	O
renal	O
transplant	O
in	O
2003	O
.	O

2.	O
History	O
of	O
multiple	B-disease
urinary	I-disease
tract	I-disease
infections	I-disease
.	O

3.	O
Pyelonephritis	B-disease
.	O

4.	O
Creatinine	O
2.2	O
to	O
2.5	O
.	O

5.	O
Right	O
coronary	O
artery	O
stent	O
in	O
2008	O
;	O
ejection	O
fraction	O
60	O
to	O
65%	O
.	O

6.	O
Type	B-disease
1	I-disease
diabetes	I-disease
mellitus	I-disease
with	O
triopathy	B-disease
,	O
retinopathy	B-disease
,	O
neuropathy	B-disease
,	O
nephropathy	B-disease
.	O

7.	O
Benign	B-disease
prostatic	I-disease
hypertrophy	I-disease
status	O
post	O
transurethral	O
resection	O
of	O
the	O
prostate	O
;	O
self	O
catheterization	O
.	O

8.	O
Hypertension	B-disease
.	O

9.	O
Hypercholesterolemia	B-disease
.	O

10.	O
Hepatitis	B-disease
B	I-disease
.	O

11.	O
Throat	B-disease
cancer	I-disease
status	O
post	O
right	O
neck	O
dissection	O
and	O
XRT	O
in	O
2004	O
.	O

12.	O
Cerebral	B-disease
aneurysm	I-disease
.	O

13.	O
Left	O
prosthetic	O
CMED	O
CCU	O
.	O

ALLERGIES	O
:	O

Gentamicin	O
,	O
and	O
ibuprofen	O
.	O

Kenneth	O
Jeffrey	O
,	O
MD	O
89-808	O

Dictated	O
By	O
:	O
Michael	O
S	O
Bonham	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2010-09-02	O
18:23	O

T	O
:	O
2010-09-07	O
16:04	O

JOB	O
#:	O

36814	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Victoria	O
Williams	O
on	O
:	O
MON	O
2010-11-08	O
3:18	O
PM	O

(	O
End	O
of	O
Report	O
)	O

115026438	O
SC	O

23754357	O

049885	O

8/25/2002	O
12:00:00	O
AM	O

s	O
/	O
p	O
NSVD	O

DIS	O

Admission	O
Date	O
:	O

08/25/2002	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

08/27/2002	O

******	O
DISCHARGE	O
ORDERS	O
******	O

HEMPWIERST	O
,	O
E	O

904-74-17-7	O
Z57	O

Room	O
:	O

FXP2-288	O

Service	O
:	O

OBS	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

08/27/02	O
AT	O
10:00	O
AM	O

CONTINGENT	O
UPON	O

HO	O
evaluation	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

BAWNREEF	O
,	O
CENTEKANEELD	O
,	O
M.D.	O

DISPOSITION	O
:	O

Home	O

DISCHARGE	O
MEDICATIONS	O
:	O

DOCUSATE	O
SODIUM	O
100	O
MG	O
PO	O
BID	O
PRN	O
IBUPROFEN	O
200-600	O
MG	O
PO	O
Q4-6H	O
PRN	O
PAIN	B-disease

DIET	O
:	O

No	O
Restrictions	O

Activity	O
-	O
As	O
tolerated	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

OB	O
Clinic	O
2	O
weeks	O
and	O
6	O
weeks	O
,	O
No	O
Known	B-disease
Allergies	I-disease

ADMIT	O
DIAGNOSIS	O
:	O

postdates	B-disease
pregnancy	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
s	O
/	O
p	O
NSVD	B-disease

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

none	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

Primary	O
Anesthesia	O
:	O

Epidural	O
Secondary	O
Anesthesia	O
:	O

Local	O
Vaginal	O
delivery	O
:	O

Spontaneous	O
Episiotomy	O
:	O

Median	O
Placenta	O
:	O

Delivery	O
:	O

Manual	O
Condition	O
:	O

Normal	O
Delivering	O
Resident	O
/	O
Staff	O
:	O

GOINGNETHBUMPS	O
,	O
NANSO	O
R.	O
,	O
M.D.	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

G2	O
T0	O
P0	O
A1	O
L0	O
Estimated	O
EDC	O
:	O

02/03/02	O

Indications	O
for	O
induction	O
:	O

Post	B-disease
dates	I-disease

Maternal	O
transfer	O
:	O

No	O

Initial	O
newborn	O
exam	O
:	O

No	O
observed	B-disease
abnormalities	I-disease

Baby	O
1	O

MRN	O
:	O

70632019	O

Delivery	O
date	O
:	O

02/13/02	O
01:20	O
AM	O

Apgars	O
8,9	O

Weight	O
:	O

9lb	O
4	O
oz	O
4196	O
grams	O

Sex	O
:	O

Female	O

ADDITIONAL	O
COMMENTS	O
:	O

Nothing	O
in	O
the	O
vagina	O
for	O
6	O
weeks	O
-	O
no	O
tampons	O
,	O
no	O
douching	O
,	O
no	O
intercourse	O
.	O

If	O
you	O
experience	O
fever	B-disease
&gt;	O
100.4	O
,	O
bleeding	B-disease
&gt;	O
1	O
pad	O
/	O
hour	O
,	O
foul	B-disease
smelling	I-disease
discharge	I-disease
,	O
abdominal	B-disease
pain	I-disease
,	O
or	O
other	B-disease
worrisome	I-disease
symptoms	I-disease
,	O
please	O
call	O
your	O
doctor	O
or	O
return	O
to	O
the	O
hospital	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

GOINGNETHBUMPS	O
,	O
NANSO	O
R.	O
,	O
M.D.	O
(	O
HK18	O
)	O
02/14/02	O
08:39	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

156406283	O

HLGMC	O

7213645	O

64723/51cy	O

5/28/1993	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ADMISSION	O
DATE	O
:	O

5-28-93	O

DISCHARGE	O
DATE	O
:	O

6-4-93	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
58	O
year	O
old	O
right	O
hand	O
dominant	O
white	O
male	O
with	O
a	O
long	O
history	O
of	O
hypertension	B-disease
,	O
changed	O
his	O
medications	O
from	O
Aldomet	O
to	O
Clonidine	O
six	O
weeks	O
ago	O
.	O

The	O
patient	O
has	O
a	O
history	O
of	O
adult	B-disease
onset	I-disease
diabetes	I-disease
mellitus	I-disease
,	O
ankylosing	B-disease
spondylitis	I-disease
,	O
status	O
post	O
myocardial	B-disease
infarction	I-disease
in	O
&apos;96	O
(	O
?	O
)	O
now	O
with	O
acute	O
onset	O
of	O
left	B-disease
face	I-disease
and	I-disease
arm	I-disease
greater	I-disease
than	I-disease
leg	I-disease
hemiplegia	I-disease
and	O
primary	B-disease
hemisensory	I-disease
loss	I-disease
on	I-disease
the	I-disease
left	I-disease
.	O

Briefly	O
,	O
he	O
was	O
talking	O
to	O
a	O
friend	O
at	O
5:30	O
p.m.	O
the	O
day	O
prior	O
to	O
admission	O
,	O
when	O
he	O
had	O
to	O
grab	O
his	O
locker	O
and	O
sit	O
down	O
.	O

His	O
voice	O
became	O
slurred	B-disease
and	O
he	O
had	O
a	B-disease
mild	I-disease
central	I-disease
dull	I-disease
headache	I-disease
.	O

He	O
was	O
unable	O
to	O
move	O
the	O
left	O
side	O
of	O
his	O
body	O
and	O
felt	O
numb	B-disease
on	I-disease
that	I-disease
side	I-disease
.	O

He	O
was	O
taken	O
to	O
Wayskemedcalltown	O
Talmi	O
and	O
transferred	O
to	O
Heaonboburg	O
Linpack	O
Grant	O
Medical	O
Center	O
with	O
a	O
computerized	O
tomography	O
scan	O
showing	O
a	B-disease
1x2	I-disease
thalamic	I-disease
capsular	I-disease
hemorrhage	I-disease
without	O
superficial	B-disease
mass	I-disease
effect	I-disease
.	O

His	O
blood	O
pressure	O
was	O
220/110	O
there	O
.	O

He	O
denies	O
any	O
visual	B-disease
symptoms	I-disease
or	O
cortical-type	B-disease
symptoms	I-disease
.	O

He	O
is	O
a	O
heavy	O
smoker	O
and	O
drinks	O
2-3	O
shots	O
per	O
day	O
at	O
times	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Vasotec	O
40	O
mg	O
q.day	O
,	O
Soma	O
1	O
tablet	O
q.day	O
,	O
Demerolprn	O
,	O
Clonidine	O
.	O

ALLERGIES	O
:	O

The	O
patient	O
has	O
no	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

As	O
described	O
above	O
.	O

FAMILY	O
HISTORY	O
:	O

The	O
family	O
history	O
is	O
positive	O
for	O
diabetes	B-disease
mellitus	I-disease
,	O
positive	O
for	O
cancer	B-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
lives	O
with	O
two	O
people	O
in	O
Cinglendda	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	O
examination	O
,	O
patient	O
is	O
in	O
no	O
acute	B-disease
distress	I-disease
,	O
afebrile	B-disease
,	O
blood	O
pressure	O
134/80	O
,	O
heart	O
rate	O
80	O
and	O
regular	O
,	O
no	O
bruits	B-disease
.	O

Cardiovascular	O
exam	O
:	O

regular	O
rate	O
and	O
rhythm	O
with	O
a	B-disease
I/VI	I-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
.	O

His	O
lungs	O
were	O
clear	O
to	O
auscultation	O
and	O
percussion	O
.	O

The	O
abdomen	O
was	O
soft	O
and	O
non-tender	B-disease
,	O
obese	B-disease
,	O
with	O
normal	O
bowel	O
sounds	O
.	O

Back	O
and	O
neck	O
were	O
stiff	B-disease
and	O
sore	B-disease
,	O
without	O
localizing	B-disease
tenderness	I-disease
.	O

On	O
neurological	O
examination	O
,	O
mental	O
status	O
alert	O
and	O
oriented	O
x	O
three	O
,	O
good	O
memory	O
,	O
fluent	O
speech	O
,	O
good	O
repetition	O
and	O
naming	O
.	O

Able	O
to	O
describe	O
two	O
routes	O
from	O
house	O
to	O
the	O
CMH	O
.	O

The	O
cranial	O
nerves	O
showed	O
full	O
visual	O
fields	O
without	O
extinction	B-disease
,	O
pupils	O
5	O
to	O
3	O
bilaterally	O
and	O
equal	O
,	O
disks	O
flat	O
,	O
lower	B-disease
left	I-disease
facial	I-disease
decreased	I-disease
sensation	I-disease
to	I-disease
temperature	I-disease
,	O
pin	O
prick	O
on	O
the	O
left	O
V1	O
through	O
V3	O
,	O
tongue	O
deviates	O
to	O
the	O
left	O
,	O
good	O
gag	O
,	O
decreased	B-disease
shrug	I-disease
on	I-disease
the	I-disease
left	I-disease
.	O

Motor	O
examination	O
showed	O
full	O
power	O
on	O
the	O
right	O
arm	O
and	O
leg	O
,	O
could	O
barely	O
flex	O
fingers	O
of	O
the	O
left	O
hand	O
,	O
pulls	O
left	O
arm	O
medially	O
only	O
.	O

Left	O
leg	O
could	O
flex	O
2/5	O
and	O
wiggle	O
toes	O
.	O

On	O
sensory	O
examination	O
,	O
had	O
decreased	O
pin	O
prick	O
,	O
temperature	O
,	O
vibration	O
in	O
the	O
left	O
side	O
of	O
the	O
body	O
.	O

The	O
finger-to-nose	O
was	O
okay	O
on	O
the	O
right	O
.	O

On	O
reflex	O
examination	O
,	O
2	O
on	O
the	O
right	O
upper	O
extremity	O
,	O
2+	O
on	O
the	O
left	O
upper	O
extremity	O
,	O
2	O
on	O
the	O
right	O
knee	O
,	O
0	O
on	O
the	O
right	O
ankle	O
,	O
with	O
down	O
going	O
toe	O
on	O
the	O
right	O
.	O

Three	O
on	O
the	O
left	O
knee	O
,	O
4	O
on	O
the	O
left	O
ankle	O
with	O
upgoing	O
toe	O
and	O
clonus	B-disease
on	O
the	O
left	O
.	O

LABORATORY	O
DATA	O
:	O

Electrolytes	O
were	O
within	O
normal	O
limits	O
,	O
glucose	O
192	O
,	O
BUN	O
and	O
creatinine	O
9/0.7	O
,	O
hematocrit	O
49.5	O
,	O
white	O
blood	O
count	O
7.9	O
,	O
platelet	O
count	O
166,000	O
,	O
65%	O
polys	O
,	O
3	O
bands	O
,	O
24%	O
lymphs	O
.	O

The	O
electrocardiogram	O
showed	O
normal	O
sinus	O
rhythm	O
with	O
old	B-disease
Q	I-disease
wave	I-disease
inferior	I-disease
myocardial	I-disease
infarction	I-disease
.	O

Head	O
computerized	O
tomography	O
scan	O
showed	O
1.5	B-disease
to	I-disease
2	I-disease
centimeter	I-disease
bleed	I-disease
in	I-disease
the	I-disease
right	I-disease
thalamus	I-disease
extending	O
to	O
the	O
internal	O
capsule	O
with	O
mild	B-disease
distortion	I-disease
only	O
,	O
no	O
shift	B-disease
.	O

The	O
chest	O
X-ray	O
was	O
clear	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
floor	O
for	O
observation	O
.	O

The	O
neurological	O
examination	O
on	O
discharge	O
was	O
no	O
movement	B-disease
in	I-disease
the	I-disease
hand	I-disease
on	O
the	O
left	O
or	O
arm	O
.	O

Slight	O
abductive	O
and	O
adductive	O
movement	O
on	O
the	O
left	O
only	O
in	O
the	O
upper	O
extremity	O
.	O

On	O
the	O
lower	O
extremity	O
,	O
could	O
wiggle	O
toes	O
,	O
flexor	O
and	O
plantar	O
,	O
3+/5	O
,	O
quadriceps	O
4/5	O
on	O
the	O
left	O
.	O

2.	O
hypertension	B-disease
.	O

The	O
patient	O
was	O
managed	O
with	O
Vasotec	O
,	O
Nifedipine	O
and	O
Clonidine	O
with	O
blood	O
pressure	O
under	O
good	O
control	O
at	O
the	O
time	O
of	O
discharge	O
,	O
average	O
125	O
systolic	O
,	O
70	O
diastolic	O
,	O
heart	O
rate	O
of	O
72	O
.	O

Also	O
managed	O
with	O
Valium	O
5	O
mg	O
PO	O
t.i.d.	O

Muscle	B-disease
spasms	I-disease
were	O
managed	O
with	O
Flexeril	O
10	O
PO	O
t.i.d.	O

3.	O
diabetes	B-disease
mellitus	I-disease
.	O

The	O
patient	O
was	O
started	O
on	O
2.5	O
of	O
Micronase	O
with	O
resulting	O
sugars	O
as	O
low	O
as	O
63	O
,	O
decreased	O
to	O
1.25	O
mg	O
q.day	O
.	O

The	O
patient	O
is	O
discharged	O
in	O
fair	O
condition	O
with	O
medical	O
approval	O
to	O
the	O
Pasi	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

Vasotec	O
20	O
mg	O
PO	O
b.i.d.	O
,	O
Clonidine	O
0.2	O
mg	O
PO	O
b.i.d.	O
,	O
Nifedipine	O
20	O
mg	O
PO	O
t.i.d.	O
,	O
Flexeril	O
10	O
mg	O
PO	O
t.i.d.	O
,	O
Valium	O
5	O
mg	O
PO	O
t.i.d.	O
,	O
Micronase	O
1.25	O
mg	O
q.day	O
.	O

ADVERSE	O
DRUG	O
REACTIONS	O
:	O

The	O
patient	O
was	O
found	O
to	O
be	O
allergic	B-disease
to	O
Percocet	O
and	O
Percodan	O
during	O
his	O
hospital	O
course	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

Right	B-disease
thalamic	I-disease
hemorrhage	I-disease
,	O
hypertension	B-disease
,	O
diabetes	B-disease
mellitus	I-disease
.	O

ROBTHER	O
TIMES	O
,	O
M.D.	O

DICTATING	O
FOR	O
:	O

SHAA	O
LEFT	O
,	O
M.D.	O

TR	O
:	O

nj	O
/	O
bmot	O

DD	O
:	O

6-4-93	O

TD	O
:	O

06/04/93	O

CC	O
:	O

Dr.	O
Namarce	O
Aldridge	O
Pasi	O
STAT	O

Admission	O
Date	O
:	O

2009-08-17	O

Discharge	O
Date	O
:	O

2009-09-10	O

Date	O
of	O
Birth	O
:	O

1951-04-02	O

Sex	O
:	O

M	O

Service	O
:	O

BLUE	O
GENERAL	O
SURGERY	O

Attending	O
:	O
Terry	O
U	O
Cheatom	O
,	O
M.D.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Cordano	O
is	O
a	O
58-year-old	O
gentlemen	O
with	O
a	O
past	O
medical	O
history	O
significant	O
for	O
primary	B-disease
sclerosing	I-disease
cholangitis	I-disease
who	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
and	O
percutaneous	O
transhepatic	O
cholangiogram	O
.	O

The	O
most	O
recent	O
percutaneous	O
transluminal	O
coronary	O
angioplasty	O
was	O
done	O
in	O
2009-07-25	O
.	O

At	O
the	O
time	O
an	O
8	O
Caucasian	O
catheter	O
was	O
placed	O
in	O
the	O
common	O
hepatic/bioduct	O
for	O
external	O
drainage	O
.	O

The	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
also	O
showed	O
the	O
presence	O
proximal	O
common	O
bile	O
duct	O
.	O

Nodularities	B-disease
in	I-disease
the	I-disease
common	I-disease
bile	I-disease
duct	I-disease
visualized	O
by	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
was	O
also	O
worrisome	O
for	O
cholangiocarcinoma	B-disease
and	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Blue	O
General	O
Surgery	O
Service	O
for	O
possible	O
surgical	O
interventions	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Ulcerative	B-disease
colitis	I-disease
,	O
primary	B-disease
sclerosing	I-disease
cholangitis	I-disease
.	O

PAST	O
SURGICAL	O
HISTORY	O
:	O

Status	O
post	O
placement	O
of	O
percutaneous	O
transhepatic	O
biliary	O
drainage	O
with	O
placement	O
of	O
8	O
Caucasian	O
nephrostomy	O
catheter	O
in	O
the	O
common	O
bile	O
duct	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

1.	O
Ursodiol	O
600	O
mg	O
t.i.d.	O

2.	O
Ambien	O
5	O
mg	O
q.h.s.	O

PHYSICAL	O
EXAMINATION	O
ON	O
ADMISSION	O
:	O

The	O
patient	O
is	O
a	O
jaundiced	O
looking	O
gentlemen	O
in	O
no	O
acute	B-disease
distress	I-disease
.	O

The	O
head	O
is	O
normocephalic	O
,	O
atraumatic	B-disease
and	O
eyes	O
are	O
icteric	B-disease
.	O

The	O
neck	O
is	O
supple	O
with	O
no	O
lymphadenopathy	B-disease
.	O

The	O
chest	O
is	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

The	O
heart	O
has	O
a	O
regular	O
rate	O
and	O
rhythm	O
with	O
normal	O
S1	O
,	O
S2	O
.	O

There	O
is	O
no	O
murmurs	B-disease
.	O

The	O
abdomen	O
was	O
soft	O
,	O
nontender	B-disease
,	O
no	O
masses	B-disease
and	O
nondistended	B-disease
.	O

There	O
is	O
no	O
hepatosplenomegaly	B-disease
.	O

Rectal	O
exam	O
showed	O
no	O
masses	B-disease
and	O
is	O
guaiac	O
negative	O
.	O

The	O
extremities	O
have	O
distal	O
pulses	O
and	O
were	O
warm	O
and	O
well	O
perfused	O
.	O

Neurological	O
exam	O
was	O
grossly	O
intact	O
.	O

LABORATORY	O
STUDIES	O
AT	O
ADMISSION	O
:	O

A	O
white	O
blood	O
cell	O
count	O
of	O
14.2	O
,	O
hematocrit	O
of	O
35.3	O
,	O
platelet	O
count	O
of	O
449,000	O
.	O

Sodium	O
of	O
130	O
,	O
potassium	O
3.5	O
,	O
chloride	O
93	O
,	O
bicarbonate	O
28	O
,	O
BUN	O
15	O
,	O
creatinine	O
1.1,	O
prothrombin	O
time	O
14.1	O
,	O
partial	O
thrombin	O
time	O
29.7	O
.	O

INR	O
1.4	O
.	O

ALT	O
106	O
,	O
AST	O
149	O
,	O
alkaline	O
phosphatase	O
242	O
.	O

Total	O
bilirubin	O
10.1	O
,	O
amylase	O
90	O
and	O
lipase	O
112	O
.	O

RADIOLOGICAL	O
STUDIES	O
AT	O
TIME	O
OF	O
ADMISSION	O
:	O

Chest	O
x-ray	O
revealed	O
minimal	B-disease
left	I-disease
base	I-disease
atelectasis	I-disease
and	O
elevation	B-disease
of	I-disease
left	I-disease
hemidiaphragm	I-disease
.	O

A	O
CT	O
scan	O
with	O
po	O
contrast	O
showed	O
dilation	B-disease
of	I-disease
intrahepatic	I-disease
common	I-disease
bile	I-disease
duct	I-disease
which	O
is	O
improved	O
from	O
previous	O
studies	O
.	O

It	O
is	O
also	O
noted	O
that	O
there	O
was	O
splenomegaly	B-disease
.	O

HOSPITAL	O
COURSE	O
:	O

Mr.	O
Cordano	O
was	O
admitted	O
on	O
2009-08-17	O
for	O
a	O
replacement	O
of	O
transhepatic	O
biliary	O
drainage	O
catheter	O
.	O

At	O
that	O
time	O
,	O
cholangiogram	O
confirmed	O
that	O
there	O
was	O
a	B-disease
distal	I-disease
stricture	I-disease
of	I-disease
the	I-disease
common	I-disease
bile	I-disease
duct	I-disease
.	O

An	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
also	O
demonstrated	O
similar	O
findings	O

and	O
it	O
is	O
noted	O
there	O
was	O
nodularity	B-disease
in	I-disease
the	I-disease
common	I-disease
bile	I-disease
duct	I-disease
which	O
is	O
worrisome	O
for	O
cholangiocarcinoma	B-disease
.	O

Therefore	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
Operating	O
Room	O
on	O
2009-08-24	O
for	O
a	O
Whipple	O
procedure	O
versus	O
hepaticojejunostomy	O
.	O

On	O
exploration	O
of	O
the	O
abdomen	O
revealed	O
significant	B-disease
nodularity	I-disease
of	I-disease
the	I-disease
liver	I-disease
indicating	O
of	O
advanced	B-disease
cirrhosis	I-disease
.	O

Intraoperative	O
frozen	O
section	O
of	O
the	O
distal	O
and	O
proximal	O
common	O
bile	O
duct	O
in	O
the	O

region	B-disease
nodularity	I-disease
,	O
which	O
is	O
identified	O
previously	O
by	O
endoscopic	O
retrograde	O
cholangiopancreatography	O
,	O
and	O
regional	O
lymph	O
nodes	O
were	O
all	O
sent	O
to	O
pathology	O
.	O

They	O
were	O
all	O
negative	O
for	O
malignancy	B-disease
and	O
therefore	O
a	O
hepaticojejunostomy	O

was	O
performed	O
.	O

Cholangiogram	O
on	O
postoperative	O
day	O
number	O
two	O
showed	O
no	O
evidence	O
of	O
leakage	B-disease
at	I-disease
the	I-disease
anastomosis	I-disease
site	I-disease
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
he	O
was	O
sent	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

The	O
patient	O
's	O
postoperative	O
course	O
was	O
notable	O
for	O
an	B-disease
elevation	I-disease
in	O
white	O
blood	O
cell	O
count	O
peaking	O
at	O
30.0	O
on	O
postoperative	O
day	O
number	O
two	O
.	O

He	O
was	O
given	O
Unasyn	O
for	O
empiric	O
antibiotic	O
treatment	O
.	O

At	O
the	O
time	O
,	O
blood	O
,	O
urine	O
and	O
bile	O
was	O
sent	O
for	O
culture	O
,	O
which	O
were	O
all	O
negative	O
.	O

A	O
chest	O
x-ray	O
was	O
also	O
negative	O
for	O
any	B-disease
pneumonia	I-disease
.	O

Postoperatively	O
,	O
Mr.	O
Cordano	O
also	O
suffered	O
from	O
low	B-disease
urine	I-disease
output	I-disease
ranges	O
between	O
25	O
to	O
30	O
cc	O
per	O
hour	O
.	O

Fractional	O
excretion	O
of	O
sodium	O
was	O
less	O
than	O
1%	O
suggesting	O
a	B-disease
prerenal	I-disease
etiology	I-disease
.	O

The	O
sodium	O
creatinine	O
peaked	O
at	O
2.0	O
and	O
the	O
patient	O
was	O
treated	O
with	O
boluses	O
of	O
intravenous	O
fluid	O
and	O
intravenous	O
albumin	O
infusion	O
was	O
also	O
administered	O
.	O

He	O
responded	O
well	O
to	O
this	O
regimen	O
and	O
made	O
adequate	O
urine	O
output	O
.	O

At	O
the	O
same	O
time	O
,	O
the	O
patient	O
also	O
developed	O
distentions	B-disease
of	I-disease
the	I-disease
abdomen	I-disease
consistent	O
with	O
accumulation	B-disease
of	I-disease
ascitic	I-disease
fluid	I-disease
.	O

He	O
also	O
had	O
significant	B-disease
lower	I-disease
extremity	I-disease
and	I-disease
scrotum	I-disease
edema	I-disease
.	O

On	O
postoperative	O
day	O
number	O
eight	O
,	O
the	O
patient	O
's	O
oxygen	O
saturation	O
dropped	O
to	O
85%	O
on	O
room	O
air	O
and	O
he	O
was	O
transferred	O
to	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
for	O
fluid	O
management	O
.	O

Chest	O
x-ray	O
and	O
sputum	O
culture	O
obtained	O
at	O
the	O
time	O
were	O
negative	O
and	O
the	O
patient	O
was	O
treated	O
with	O
100%	O
nonrebreather	O
which	O
improved	O
his	O
oxygenation	O
.	O

While	O
he	O
is	O
in	O
the	O
Surgical	O
Intensive	O
Care	O
Unit	O
,	O
paracentesis	O
was	O
performed	O
and	O
it	O

revealed	O
greater	O
than	O
24,000	O
white	O
blood	O
cell	O
count	O
in	O
the	B-disease
ascites	I-disease
which	O
is	O
consistent	O
with	O
SVT	B-disease
.	O

He	O
was	O
given	O
Zosyn	O
for	O
empiric	O
treatment	O
.	O

Gram	O
stain	O
and	O
culture	O
of	O
the	B-disease
ascites	I-disease
failed	O
to	O
identify	O
any	B-disease
organism	I-disease
.	O

He	O
was	O
weaned	O
from	O
oxygen	B-disease
requirement	I-disease
and	O
was	O
continued	O
on	O
normal	O
saline	O
boluses	O
and	O

intravenous	O
albumin	O
for	O
treatment	O
of	O
prerenal	B-disease
azotemia	I-disease
.	O

Somatostatin	O
and	O
midodrine	O
were	O
also	O
given	O
for	O
this	B-disease
condition	I-disease
and	O
he	O
also	O
received	O
packed	O
red	O
blood	O
cells	O
.	O

On	O
postoperative	O
day	O
number	O
ten	O
,	O
the	O
patient	O
returned	O
to	O
the	O
floor	O
with	O
improved	O
renal	O
function	O
and	O
without	O
oxygen	B-disease
requirement	I-disease
.	O

The	O
somatostatin	O
and	O
the	O
midodrine	O
were	O
discontinued	O
and	O
the	O
regimen	O
of	O
Lasix	O
and	O
spironolactone	O
was	O
started	O
for	O
diuresis	O
.	O

His	O
creatinine	O
levels	O
trended	O
toward	O
normal	O
and	O
the	O
fractional	O
excretion	O
of	O
sodium	O
also	O
increased	O
indicating	O
a	O
resolution	O
of	O
the	B-disease
prerenal	I-disease
kidney	I-disease
failure	I-disease
.	O

On	O
postoperative	O
day	O
number	O
17	O
,	O
the	O
patient	O
was	O
discharged	O
.	O

At	O
the	O
time	O
he	O
took	O
good	O
po	O
.	O

He	O
has	O
a	O
PICC	O
line	O
in	O
place	O
for	O
continued	O
treatment	O
with	O
Rocephin	O
and	O
he	O
will	O
have	O
a	O
visiting	O
nurse	O
to	O
help	O
him	O
to	O
administer	O
these	O
medications	O
.	O

While	O
in	O
the	O
hospital	O
,	O
the	O
patient	O
received	O
initial	O
work-up	O
including	O
echocardiogram	O
,	O
electrocardiogram	O
and	O
serology	O
studies	O
to	O
be	O
listed	O
for	O
liver	O
transplant	O
.	O

MEDICATIONS	O
ON	O
DISCHARGE	O
:	O

1.	O
Rocephin	O
1	O
gram	O
q.d.	O

2.	O
Furosemide	O
10	O
mg	O
q.d.	O

3.	O
Spironolactone	O
100	O
mg	O
q.d.	O

4.	O
Ursodiol	O
600	O
mg	O
po	O
t.i.d.	O

CONDITION	O
ON	O
DISCHARGE	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
with	O
services	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

PSC	B-disease
,	O
status	O
post	O
hepaticojejunostomy	O
.	O

Hope	O
Raymond	O
,	O
M.D.	O
,	O
Ph.D.	O

02-366	O

Dictated	O
By	O
:	O
Alden	O
B.	O
Edwards	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2009-10-02	O
09:08	O

T	O
:	O
2009-10-02	O
09:08	O

JOB	O
#:	O

86749	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Mary	O
Jones	O
on	O
:	O
SUN	O
2009-10-04	O
1:08	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date:	O

2011-02-08	O

Discharge	O
Date	O
:	O

2011-02-14	O

Date	O
of	O
Birth	O
:	O

1953-05-15	O

Sex	O
:	O

M	O

Service	O
:	O

CMED	O

HISTORY	O
OF	O
THE	O
PRESENT	O
ILLNESS	O
:	O

Briefly	O
,	O
this	O
is	O
a	O
57-year-old	O
gentleman	O
with	O
a	O
history	O
of	O
COPD	B-disease
,	O
status	O
post	O
intubation	O
six	O
years	O
ago	O
but	O
not	O
on	O
home	O
02	O
with	O
recent	O
FEV1	O
27%	O
of	O
predicted	O
value	O
,	O
and	O
FEV1/FVC	O
ratio	O
56%	O
of	O
hypercholesterolemia	B-disease
,	O
who	O
was	O
admitted	O
for	O
COPD	B-disease
exacerbation	I-disease
and	O
worsening	O
of	O
upper	B-disease
respiratory	I-disease
tract	I-disease
infection	I-disease
symptoms	I-disease
for	O
a	O
week	O
prior	O
to	O
admission	O
.	O

He	O
was	O
afebrile	B-disease
with	O
stable	O
vital	O
signs	O
on	O
presentation	O
to	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
started	O
on	O
p.o.	O
steroids	O
and	O
to	O
CMED	O
for	O
management	O
of	O
COPD	B-disease
exacerbation	I-disease
but	O
he	O
appeared	O
in	O
more	B-disease
respiratory	I-disease
distress	I-disease
overnight	O
and	O
was	O
started	O
on	O
IV	O
Solu-Medrol	O
and	O
more	O
frequent	O
nebulizers	O
for	O
COPD	B-disease
.	O

He	O
was	O
also	O
started	O
on	O
antibiotics	O
for	O
possible	O
bronchitis	B-disease
or	O
community-acquired	B-disease
pneumonia	I-disease
.	O

Given	O
his	B-disease
tenuous	I-disease
respiratory	I-disease
status	I-disease
,	O
he	O
was	O
transferred	O
to	O
the	O
FICU	O
with	O
closer	O
observation	O
.	O

He	O
did	O
not	O
require	O
intubation	O
and	O
improved	O
with	O
q.	O
two	O
hour	O
nebulizers	O
and	O
chest	O
PT	O
.	O

He	O
was	O
again	O
transferred	O
to	O
the	O
CMED	O
Service	O
for	O
further	O
management	O
of	O
his	B-disease
COPD	I-disease
exacerbation	I-disease
.	O

He	O
was	O
continued	O
on	O
p.o.	O
prednisone	O
and	O
frequent	O
nebulizers	O
for	O
COPD	B-disease
.	O

He	O
was	O
evaluated	O
by	O
the	O
physical	O
therapist	O
in	O
the	O
hospital	O
and	O
was	O
found	O
to	O
desaturate	B-disease
to	O
84%	O
with	O
ambulating	O
on	O
room	O
air	O
.	O

Therefore	O
,	O
home	O
02	O
was	O
recommended	O
on	O
discharge	O
.	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O
.	O

DISCHARGE	O
STATUS	O
:	O

To	O
home	O
.	O

DISCHARGE	O
DIAGNOSIS	O
:	O

1.	O
Chronic	B-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
exacerbation	I-disease
.	O

2.	O
Bronchitis	B-disease
.	O

3.	O
Community-acquired	B-disease
pneumonia	I-disease
.	O

4.	O
Rule	O
out	O
myocardial	B-disease
infarction	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Flovent	O
two	O
puffs	O
b.i.d.	O

2.	O
Levofloxacin	O
500	O
mg	O
p.o.	O
q.d.	O
for	O
another	O
11	O
days	O
for	O
a	O
total	O
of	O
a	O
14	O
day	O
course	O
.	O

3.	O
Albuterol	O
inhaler	O
one	O
to	O
two	O
puffs	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O

4.	O
Aspirin	O
81	O
mg	O
p.o.	O
q.d.	O

5.	O
Salmeterol	O
one	O
to	O
two	O
puffs	O
b.i.d.	O

6.	O
Oxygen	O
2	O
liters	O
nasal	O
cannula	O
with	O
ambulating	O
as	O
needed	O
.	O

7.	O
Prednisone	O
taper	O
with	O
40	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
30	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
20	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
,	O
10	O
mg	O
p.o.	O
q.d.	O
for	O
two	O
days	O
.	O

DISCHARGE	O
FOLLOW-UP	O
:	O

The	O
patient	O
will	O
see	O
his	O
PCP	O
in	O
one	O
to	O
two	O
weeks	O
.	O

The	O
patient	O
will	O
also	O
see	O
his	O
pulmonologist	O
,	O
Dr.	O
Daniel	O
Bell	O
,	O
appointment	O
was	O
made	O
on	O
discharge	O
.	O

John	O
C	O
Stalnaker	O
,	O
M.D.	O

35-693	O

Dictated	O
By	O
:	O
Margaret	O
BT	O
Mahaffey	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-02-19	O
10:21	O

T	O
:	O
2011-02-21	O
18:42	O

JOB	O
#:	O

74873	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Kate	O
Gentry	O
on	O
:	O
MON	O
2011-03-07	O
4:08	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2018-10-25	O

Discharge	O
Date	O
:	O

2018-10-31	O

Date	O
of	O
Birth	O
:	O

1951-06-15	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	O
Drugs	O

Attending	O
:	O
Michael	O
D.	O
Christensen	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Shortness	B-disease
of	I-disease
Breath	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Coronary	O
Artery	O
Bypass	O
Graft	O
x3	O
(	O
Left	O
internal	O
mammary	O
->	O
left	O
anterior	O
descending	O
,	O
saphaneous	O
vein	O
graft	O
->	O
obtuse	O
marginal	O
,	O
saphaneous	O
vein	O
graft	O
->	O
posterior	O
descending	O
artery	O
)	O
2018-10-25	O

History	O
of	O
Present	O
Illness	O
:	O

67	O
y/o	O
male	O
with	O
worsening	B-disease
shortness	I-disease
of	I-disease
breath.	I-disease
Had	O
abnormal	B-disease
ETT	I-disease
and	O
referred	O
for	O
cath	O
.	O

Cath	O
revealed	O
severe	B-disease
3	I-disease
vessel	I-disease
disease	I-disease
.	O

Then	O
referred	O
for	O
surgical	O
intervention	O
.	O

Past	O
Medical	O
History	O
:	O

Carpal	B-disease
tunnel	I-disease
syndrome	I-disease
,	O
Hypertension	B-disease
,	O
Hyperlipidemia	B-disease
,	O
Arthritis	B-disease
,	O
h/o	O
Bell's	B-disease
Palsy	I-disease
,	O
HOH	B-disease
,	O
s/p	O
Tonsillectomy	O

Social	O
History	O
:	O

Denies	O
ETOH	O
,	O
rare	O
Tobacco	O
.	O

Electrician	O
.	O

Family	O
History	O
:	O

Father	O
with	O
MI	B-disease
in	O
50	O
's	O
and	O
underwent	O
CABG	O
.	O

Physical	O
Exam	O
:	O

VS	O
:	O
65	O
20	O
160/100	O
5	O
'	O
7	O
"	O
180	O
#	O

General	O
:	O
WD/WN	O
male	O
in	O
NAD	B-disease

HEENT	O
:	O
EOMI	O
,	O
PERRL	O
,	O
NC/AT	B-disease

Neck	O
:	O
Supple	O
,	O
FROM	O
,	O
-	O
JVD	B-disease
,	O
-	O
carotid	B-disease
bruits	I-disease

Chest	O
:	O
CTAB	O
-	O
w/r/r	B-disease

Heart	O
:	O
RRR	O
-	O
c/r/m/g	B-disease

Abd	O
:	O
Soft	O
,	O
NT/ND	B-disease
+BS	O

Ext	O
:	O
Warm	O
,	O
well-perfused	O
-	O
edema	B-disease
,	O
-	O
varicosities	B-disease

Neuro	O
:	O
A&Ox3	O
,	O
MAE	O
,	O
non-focal	O

Pertinent	O
Results	O
:	O

Echo	O
10-25	O
:	O
PRE-BYPASS	O
:	O
Left	O
ventricular	O
wall	O
thicknesses	O
are	O
normal	O
.	O

The	O
left	O
ventricular	O
cavity	O
size	O
is	O
normal	O
.	O

There	O
is	O
mild	B-disease
inferior	I-disease
wall	I-disease
hypokinesis	I-disease
.	O

There	O
is	O
akinesis	B-disease
/	O
dyskinesis	B-disease
and	O
thinning	B-disease
of	I-disease
the	I-disease
mid	I-disease
to	I-disease
distal	I-disease
inferior	I-disease
septum	I-disease
and	O
the	O
apex	O
.	O

Overall	O
left	O
ventricular	O
systolic	O
function	O
is	O
mildly	B-disease
depressed	I-disease
.	O

Right	O
ventricular	O
chamber	O
size	O
and	O
free	O
wall	O
motion	O
are	O
normal	O
.	O

The	O
descending	O
thoracic	O
aorta	O
is	O
mildly	B-disease
dilated	I-disease
.	O

There	O
are	O
simple	B-disease
atheroma	I-disease
in	I-disease
the	I-disease
descending	I-disease
thoracic	I-disease
aorta	I-disease
.	O

There	O
are	O
three	O
aortic	O
valve	O
leaflets	O
.	O

There	O
is	O
no	O
aortic	B-disease
valve	I-disease
stenosis	I-disease
.	O

No	O
aortic	B-disease
regurgitation	I-disease
is	O
seen	O
.	O

The	O
mitral	O
valve	O
leaflets	O
are	O
mildly	B-disease
thickened	I-disease
.	O

Trivial	B-disease
mitral	I-disease
regurgitation	I-disease
is	O
seen	O
.	O

POST-BYPASS	O
:	O
LV	O
and	O
RV	O
function	O
is	O
unchanged	O
.	O

Aorta	O
is	O
unchanged	O
.	O

Other	O
findings	O
are	O
unchanged	O
.	O

CXR	O
10-30	O
:	O
Left	B-disease
lower	I-disease
lobe	I-disease
atelectasis	I-disease
has	O
partially	O
cleared	O
.	O

Upper	O
lungs	O
are	O
clear	O
.	O

Mild	B-disease
postoperative	I-disease
widening	I-disease
of	I-disease
the	I-disease
cardiomediastinal	I-disease
silhouette	I-disease
is	O
stable	O
.	O

No	O
pneumothorax	B-disease
.	O

2018-10-25	O
11:15	O
AM	O
BLOOD	O
WBC	O
-	O
18.3	O
*#	O
RBC	O
-	O
3.42	O
*	O
Hgb	O
-	O
10.9	O
*	O
Hct	O
-	O
31.6	O
*	O
MCV	O
-	O
92	O
MCH	O
-	O
31.7	O
MCHC	O
-	O
34.4	O
RDW	O
-	O
13.3	O
Plt	O
Ct	O
-	O
134	O
*	O

2018-10-31	O
06:25	O
AM	O
BLOOD	O
WBC	O
-	O
13.6	O
*	O
RBC	O
-	O
2.72	O
*	O
Hgb	O
-	O
8.6	O
*	O
Hct	O
-	O
24.6	O
*	O
MCV	O
-	O
91	O
MCH	O
-	O
31.7	O
MCHC	O
-	O
35.0	O
RDW	O
-	O
14.0	O
Plt	O
Ct	O
-	O
314	O

2018-10-25	O
11:15	O
AM	O
BLOOD	O
PT	O
-	O
13.3	O
*	O
PTT	O
-	O
30.0	O
INR(PT)	O
-	O
1.2	O
*	O

2018-10-29	O
06:50	O
AM	O
BLOOD	O
PT	O
-	O
11.9	O
INR(PT)	O
-	O
1.0	O

2018-10-25	O
12:36	O
PM	O
BLOOD	O
UreaN	O
-	O
17	O
Creat	O
-	O
0.7	O
Cl	O
-	O
111	O
*	O
HCO3	O
-	O
23	O

2018-10-31	O
06:25	O
AM	O
BLOOD	O
Glucose	O
-	O
91	O
UreaN	O
-	O
19	O
Creat	O
-	O
0.8	O
Na	O
-	O
134	O
K	O
-	O
4.0	O
Cl	O
-	O
98	O
HCO3	O
-	O
26	O
AnGap	O
-	O
14	O

Brief	O
Hospital	O
Course	O
:	O

Mr.	O
Kammerer	O
was	O
a	O
same	O
day	O
admit	O
and	O
on	O
10-25	O
was	O
brought	O
to	O
the	O
operating	O
room	O
where	O
he	O
underwent	O
a	O
coronary	O
artery	O
bypass	O
graft	O
x	O
3	O
.	O

Please	O
see	O
operative	O
report	O
for	O
surgical	O
details	O
.	O

He	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
CSRU	O
for	O
invasive	O
monitoring	O
in	O
stable	O
condition	O
.	O

Later	O
on	O
op	O
day	O
he	O
was	O
weaned	O
from	O
sedation	O
,	O
awoke	O
neurologically	O
intact	O
,	O
and	O

extubated	O
.	O

Beta	O
blockers	O
and	O
diuretics	O
were	O
initiated	O
on	O
post-op	O
day	O
one	O
.	O

He	O
was	O
diuresed	O
towards	O
his	O
pre-op	O
weight	O
.	O

He	O
appeared	O
to	O
be	O
doing	O
well	O
and	O
was	O
transferred	O
to	O
the	O
SDU	O
on	O
this	O
day	O
.	O

He	O
did	O
have	O
burst	B-disease
of	I-disease
atrial	I-disease
fibrillation	I-disease
and	O
was	O
started	O
on	O
a	O
Amiodarone	O
gtt	O
.	O

His	O
beta	O
blockers	O
were	O
also	O
titrated	O
for	O
maximal	O
BP	O
and	O
HR	O
control	O
.	O

Chest	O
tubes	O
were	O
removed	O
on	O
post-op	O
day	O
two	O
and	O
epicardial	O
pacing	O
wires	O
on	O
post-op	O
day	O
three	O
.	O

Over	O
the	O
next	O
several	O
days	O
he	O
continued	O
to	O
improve	O
his	O
ambulation	O
and	O
mobility	O
with	O
physical	O
therapy	O
.	O

He	O
had	O
no	O
further	B-disease
episodes	I-disease
of	I-disease
AFIB	I-disease
while	O
on	O
po	O
Amiodarone	O
.	O

On	O
post-op	O
day	O
five	O
he	O
appeared	O
to	O
have	O
left	B-disease
arm	I-disease
phlebitis	I-disease
and	O
was	O
started	O
on	O
antibiotics	O
.	O

He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
six	O
with	O
antibiotics	O
and	O
appropriate	O
meds	O
.	O

He	O
will	O
have	O
VNA	O
services	O
and	O
make	O
the	O
appropriate	O
follow-up	O
appointments	O
.	O

Medications	O
on	O
Admission	O
:	O

Aspirin	O
81	O
mg	O
qd	O
,	O
Toprol	O
XL	O
50	O
mg	O
qd	O
,	O
MVI	O
,	O
Flexeril	O
10	O
mg	O
qhs	O
,	O
Plavix	O
75	O
mg	O
qd	O
(	O
last	O
on	O
10-18	O
)	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

2.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
0	O
*	O

3.	O
Ranitidine	O
HCl	O
150	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Oxycodone	O
-	O
Acetaminophen	O
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-disease
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

6.	O
Amiodarone	O
200	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
):	O
please	O
take	O
400	O
mg	O
twice	O
a	O
day	O
until	O
11-02	O
then	O
decrease	O
to	O
400	O
mg	O
once	O
a	O
day	O
for	O
1	O
week	O
and	O
then	O
decrease	O
to	O
200	O
mg	O
once	O
a	O
day	O
.	O

Disp	O
:*	O
40	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

7.	O
Metoprolol	O
Succinate	O
50	O
mg	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
Sustained	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Ferrous	O
Gluconate	O
300	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

9.	O
Ascorbic	O
Acid	O
500	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

10.	O
Cephalexin	O
500	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
for	O
6	O
days	O
:	O
please	O
complete	O
full	O
course	O
.	O

Disp	O
:*	O
24	O
Capsule	O
(s)*	O
Refills	O
:*	O
0	O
*	O

11.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
once	O
a	O
day	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

12.	O
Potassium	O
Chloride	O
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
2	O
weeks	O
.	O

Disp	O
:*	O
14	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
0	O
*	O

13.	O
Lisinopril	O
5	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
15	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-disease
artery	I-disease
disease	I-disease
s/p	O
Coronary	O
Artery	O
Bypass	O
Graft	O
x3	O

PMH	O
:	O
Carpal	B-disease
tunnel	I-disease
syndrome	I-disease
,	O
Hypertension	B-disease
,	O
Hyperlipidemia	B-disease
,	O
Arthritis	B-disease

Discharge	O
Condition	O
:	O

good	O

Discharge	O
Instructions	O
:	O

May	O
shower	O
,	O
no	O
baths	O
or	O
swimming	O

Monitor	O
wounds	B-disease
for	O
infection	B-disease
-	O
redness	B-disease
,	O
drainage	B-disease
,	O
or	O
increased	B-disease
pain	I-disease

Report	O
any	B-disease
fever	I-disease
greater	I-disease
than	I-disease
101	I-disease

Report	O
any	B-disease
weight	I-disease
gain	I-disease
of	O
greater	O
than	O
2	O
pounds	O
in	O
24	O
hours	O
or	O
5	O
pounds	O
in	O
a	O
week	O

No	O
creams	O
,	O
lotions	O
,	O
powders	O
,	O
or	O
ointments	O
to	O
incisions	B-disease

No	O
driving	O
for	O
approximately	O
one	O
month	O

No	O
lifting	O
more	O
than	O
10	O
pounds	O
for	O
10	O
weeks	O

Please	O
call	O
with	O
any	O
questions	O
or	O
concerns	O

Left	O
Arm	O
continue	O
with	O
elevation	O
,	O
ice	O
,	O
and	O
complete	O
all	O
antibiotics	O

Followup	O
Instructions	O
:	O

Dr	O
Day	O
in	O
4	O
weeks	O
((	O
469	O
)	O
587-0462	O
)	O
please	O
call	O
for	O
appointment	O

Dr	O
Miller	O
in	O
1	O
week	O
(	O
262-575-0600	O
)	O
please	O
call	O
for	O
appointment	O

Dr	O
Scott	O
Raines	O
in	O
2-3	O
weeks	O
please	O
call	O
for	O
appointment	O

Wound	O
check	O
appointment	O
4	O
East	O
as	O
instructed	O
by	O
nurse	O
(	O
280-5326	O
)	O

For	O
surgical	B-disease
incision	I-disease
and	O
left	O
arm	O

Craig	O
Douglas	O
MD	O
10-898	O

Completed	O
by	O
:	O
Reyes	O
Marengo	O
PA	O
80	O
-	O
BMD	O
2018-11-19	O
@	O
1536	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Jeffrey	O
Collins	O
on	O
:	O
WED	O
2018-11-21	O
9:28	O
AM	O

(	O
End	O
of	O
Report	O
)	O

425680098	O
SC	O

55925443	O

867222	O

8/7/1992	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Unsigned	O

DIS	O

Admission	O
Date	O
:	O

08/07/1992	O

Report	O
Status	O
:	O

Unsigned	O

Discharge	O
Date	O
:	O

08/10/1992	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
81	O
year	O
old	O
female	O
with	O
a	B-disease
right	I-disease
breast	I-disease
mass	I-disease
with	O
a	B-disease
discharge	I-disease
.	O

A	O
mammogram	O
of	O
the	O
right	O
breast	O
with	O
shadow	O
biopsy	O
was	O
negative	O
.	O

In	O
the	O
fall	O
of	O
1991	O
,	O
nipple	B-disease
changes	I-disease
and	O
discomfort	B-disease
was	O
again	O
noted	O
.	O

A	O
mmamogram	O
showed	O
no	O
change	O
on	O
right	O
,	O
but	O
new	O
biopsy	O
was	O
positive	O
.	O

On	O
the	O
left	O
,	O
there	O
was	O
a	B-disease
new	I-disease
shawdown	I-disease
but	O
the	O
biopsy	O
was	O
negative	O
.	O

The	O
patient	O
presents	O
now	O
for	O
right	O
modified	O
radical	O
mastectomy	O
with	O
impant	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Unremarkable	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

None	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

HABITS	O
:	O

Smoked	O
twenty	O
years	O
ago	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Clear	O
lungs	O
,	O
normal	O
heart	O
,	O
Pagett	O
&apos;s	O
type	O
changes	O
on	O
the	O
right	O
breast	O
and	O
left	O
breast	O
without	O
apparent	B-disease
masses	I-disease
with	O
scarring	B-disease
supra-areolar	I-disease
and	I-disease
infra-areolar	I-disease
.	O

A	B-disease
biopsy	I-disease
scar	I-disease
on	I-disease
the	I-disease
right	I-disease
breast	I-disease
from	O
1990	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
Operting	O
Room	O
on	O
8/7/92	O
,	O
where	O
a	O
right	O
modified	O
radical	O
mastectomy	O
was	O
performed	O
.	O

Subsequently	O
a	O
saline-filled	O
right	O
breast	O
implant	O
was	O
performed	O
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
extremely	O
well	O
.	O

Two	O
drains	O
were	O
used	O
.	O

One	O
drain	O
was	O
removed	O
on	O
postoperative	O
day	O
number	O
two	O
,	O
and	O
the	O
second	O
drain	O
she	O
will	O
be	O
discharged	O
to	O
home	O
with	O
.	O

DISPOSITION	O
:	O

The	O
patient	O
is	O
discharged	O
to	O
home	O
in	O
good	O
condiiton	O
.	O

Discharge	O
medications	O
include	O
Percocet	O
and	O
Colace	O
.	O

Folloowup	O
is	O
in	O
one	O
week	O
with	O
Dr.	O
Ralekote	O
.	O

DP337/1857	O
DETIASAIRE	O
KAYSJARDUHE	O
,	O
M.D.	O
PQ01	O

D	O
:	O

08/08/92	O

Batch	O
:	O

9736	O

Report	O
:	O

J3725F1	O

T	O
:	O

08/10/92	O

Dictated	O
By	O
:	O

LA	O
JESCCOT	O
,	O
M.D.	O
KC44	O

Admission	O
Date	O
:	O

2012-04-30	O

Discharge	O
Date	O
:	O

2012-05-14	O

Date	O
of	O
Birth	O
:	O

1956-11-04	O

Sex	O
:	O

M	O

Service	O
:	O

O-CMED	O
CCU	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
55	O
-	O
year-old	O
male	O
with	O
recently	B-disease
diagnosed	I-disease
abdominal	I-disease
carcinomatosis	I-disease
.	O

The	O
patient	O
presented	O
with	O
abdominal	B-disease
pain	I-disease
and	O
bloating	B-disease
and	O
was	O
found	O
to	O
have	O
a	B-disease
large	I-disease
omental	I-disease
mass	I-disease
.	O

Biopsy	O
revealed	O
adenocarcinoma	B-disease
.	O

Histochemical	O
stains	O
are	O
consistent	O
with	O
hepatobiliary	O
origin	O
.	O

Endoscopies	O
were	O
negative	O
except	O
for	O
an	B-disease
extrinsic	I-disease
mass	I-disease
present	I-disease
on	I-disease
the	I-disease
stomach	I-disease
.	O

The	O
patient	O
presents	O
with	O
increased	B-disease
abdominal	I-disease
pain	I-disease
and	O
poor	B-disease
oral	I-disease
intake	I-disease
as	O
well	O
as	O
generalized	B-disease
weakness	I-disease
.	O

On	O
presentation	O
,	O
the	O
patient	O
denied	O
chest	B-disease
pain	I-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
and	O
cough	B-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Benign	B-disease
prostatic	I-disease
hypertrophy	I-disease
.	O

2.	O
Osteoarthritis	B-disease
.	O

3.	O
Gastrointestinal	B-disease
adenocarcinoma	I-disease
(	O
as	O
noted	O
in	O
History	O
of	O
Present	O
Illness	O
)	O
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

Colace	O
,	O
Senna	O
,	O
Dulcolax	O
,	O
Tylenol	O
,	O
oxycodone	O
as	O
needed	O
,	O
Ambien	O
,	O
and	O
Protonix	O
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

FAMILY	O
HISTORY	O
:	O

Mother	O
had	O
adrenal	B-disease
cancer	I-disease
.	O

Father	O
had	O
coronary	B-disease
artery	I-disease
disease	I-disease
.	O

SOCIAL	O
HISTORY	O
:	O

The	O
patient	O
was	O
employed	O
as	O
a	O
salesman	O
.	O

He	O
denied	O
the	O
use	O
of	O
tobacco	O
and	O
drugs	O
.	O

He	O
uses	O
alcohol	O
occasionally	O
.	O

The	O
patient	O
is	O
married	O
with	O
two	O
children	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	O
of	O
systems	O
was	O
significant	O
for	O
progressive	B-disease
abdominal	I-disease
discomfort	I-disease
,	O
decreased	B-disease
oral	I-disease
intake	I-disease
,	O
and	O
weakness	B-disease
in	O
the	O
past	O
nine	O
weeks	O
.	O

PHYSICAL	O
EXAMINATION	O
ON	O
PRESENTATION	O
:	O

Physical	O
examination	O
revealed	O
temperature	O
was	O
96.9	O
,	O
heart	O
rate	O
was	O
121	O
,	O
blood	O
pressure	O
was	O
122/86	O
,	O
respiratory	O
rate	O
was	O
22	O
,	O
and	O
oxygen	O
saturation	O
was	O
96%	O
on	O
room	O
air	O
.	O

In	O
general	O
,	O
the	O
patient	O
looked	O
acutely	B-disease
and	I-disease
chronically	I-disease
ill	I-disease
.	O

Head	O
,	O
eyes	O
,	O
ears	O
,	O
nose	O
,	O
and	O
throat	O
examination	O
revealed	O
the	O
oropharynx	O
was	O
clear	O
.	O

Sclerae	O
were	O
anicteric	B-disease
.	O

Mucous	O
membranes	O
were	O
moist	O
.	O

Cardiovascular	O
examination	O
revealed	O
tachycardic	B-disease
first	I-disease
heart	I-disease
sound	I-disease
and	I-disease
second	I-disease
heart	I-disease
sound	I-disease
.	O

No	O
murmurs	B-disease
,	O
rubs	B-disease
,	O
or	O
gallops	B-disease
.	O

Lungs	O
revealed	O
decreased	B-disease
breath	I-disease
sounds	I-disease
and	O
dullness	B-disease
to	O
percussion	O
in	O
the	O
left	O
lung	O
base	O
.	O

The	O
abdomen	O
was	O
distended	B-disease
and	O
firm	B-disease
.	O

Positive	O
bowel	O
sounds	O
.	O

Extremity	O
examination	O
revealed	O
no	O
clubbing	B-disease
,	O
cyanosis	B-disease
,	O
or	O
edema	B-disease
.	O

IMPRESSION	O
:	O

This	O
was	O
a	O
55	O
-	O
year-old	O
gentleman	O
with	O
recently	B-disease
diagnosed	I-disease
abdominal	I-disease
carcinomatosis	I-disease
admitted	O
with	O
increased	B-disease
abdominal	I-disease
pain	I-disease
and	O
poor	B-disease
oral	I-disease
intake	I-disease
.	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
O-CMED	O
Service	O
for	O
further	O
management	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
was	O
admitted	O
to	O
the	O
O-CMED	O

Service	O
.	O

He	O
was	O
placed	O
on	O
a	O
patient-controlled	O
analgesia	O
for	O
pain	O
control	O
.	O

He	O
was	O
administered	O
intravenous	O
fluids	O
and	O
oral	O
diet	O
as	O
tolerated	O
.	O

On	O
the	O
night	O
of	O
05-01	O
,	O
the	O
patient	O
complained	O
of	O
increased	B-disease
vomiting	I-disease
.	O

He	O
also	O
complained	O
of	O
increased	B-disease
shortness	I-disease
of	I-disease
breath	I-disease
and	O
"	O
difficulty	B-disease
catching	I-disease
his	I-disease
breath	I-disease
."	O

On	O
room	O
air	O
,	O
the	O
patient	O
's	O
oxygen	O
saturation	O
was	O
80%	O
.	O

His	O
saturation	O
increased	O
to	O
87%	O
on	O
a	O
nonrebreather	O
.	O

A	O
chest	O
x-ray	O
disclosed	O
a	B-disease
left	I-disease
pleural	I-disease
effusion	I-disease
.	O

The	O
patient	O
was	O
bolused	O
with	O
intravenous	O
heparin	O
due	O
to	O
concern	O
for	O
pulmonary	B-disease
embolism	I-disease
.	O

The	O
patient	O
expressed	O
a	O
desire	O
to	O
be	O
full	O
code	O
,	O
so	O
he	O
was	O
transferred	O
to	O
the	O
Intensive	O
Care	O
Unit	O
.	O

The	O
patient	O
became	O
more	O
comfortable	O
being	O
seated	O
upright	O
with	O
nebulizer	O
treatments	O
.	O

An	O
angiogram	O
was	O
done	O
which	O
disclosed	O
possible	O
subsegmental	B-disease
pulmonary	I-disease
emboli	I-disease
of	I-disease
the	I-disease
upper	I-disease
lobes	I-disease
as	O
well	O
as	O
infiltrates	B-disease
consistent	O
with	O
aspiration	B-disease
pneumonia	I-disease
.	O

The	O
patient	O
was	O
placed	O
on	O
Flagyl	O
and	O
Levaquin	O
for	O
treatment	O
of	O
pneumonia	B-disease
.	O

He	O
was	O
continued	O
on	O
heparin	O
for	O
treatment	O
of	O
the	B-disease
pulmonary	I-disease
emboli	I-disease
.	O

While	O
in	O
the	O
Intensive	O
Care	O
Unit	O
,	O
the	O
patient	O
was	O
noted	O
to	O
have	O
increasing	B-disease
abdominal	I-disease
distention	I-disease
.	O

On	O
05-03	O
the	O
patient	O
underwent	O
an	O
abdominal	O
ultrasound	O
with	O
paracentesis	O
,	O
and	O
5	O
liters	O
of	O
fluid	B-disease
were	O
removed	O
.	O

On	O
05-04	O
,	O
the	O
patient	O
was	O
transferred	O
back	O
to	O
the	O
O-CMED	O
CSRU	O

Service	O
.	O

Due	O
to	O
persistent	B-disease
gastric	I-disease
secretions	I-disease
,	O
an	O
nasogastric	O
tube	O
was	O
placed	O
for	O
decompression	O
.	O

The	O
patient	O
was	O
noted	O
to	O
have	O
a	O
functional	O
ileus	O
.	O

Octreotide	O
was	O
initiated	O
in	O
an	O
attempt	O
to	O
decrease	O
the	B-disease
gastric	I-disease
secretions	I-disease
.	O

On	O
05-13	O
,	O
the	O
patient	O
's	O
respiratory	O
status	O
declined	O
further	O
.	O

He	O
was	O
noted	O
not	O
have	O
an	B-disease
increasing	I-disease
left-sided	I-disease
pleural	I-disease
effusion	I-disease
.	O

A	O
thoracentesis	O
was	O
done	O
with	O
removal	O
of	O
1.5	O
liters	O
of	O
fluid	B-disease
.	O

A	O
paracentesis	O
was	O
repeated	O
with	O
removal	O
of	O
2.5	O
liters	O
of	O
fluid	B-disease
.	O

On	O
the	O
night	O
of	O
05-13	O
,	O
the	O
patient	O
continued	O
to	O
decline	O
.	O

The	O
family	O
decided	O
to	O
pursue	O
comfort	O
measures	O
.	O

Morphine	O
was	O
administered	O
to	O
insure	O
patient	O
's	O
comfort	O
.	O

The	O
patient	O
expired	O
at	O
6	O
p.m.	O
on	O
05-14	O
.	O

FINAL	O
DISCHARGE	O
DIAGNOSES	O
:	O

1.	O
Gastrointestinal	B-disease
adenocarcinoma	I-disease
;	O
primary	O
unknown	O
(	O
likely	O
hepatobiliary	O
)	O
.	O

2.	O
Aspiration	B-disease
pneumonia	I-disease
.	O

3.	O
Pulmonary	B-disease
emboli	I-disease
.	O

4.	O
Hypoxia	B-disease
.	O

5.	O
Dehydration	B-disease
.	O

6.	O
Ileus	B-disease
.	O

Pearl	O
Y.	O
Simmons	O
,	O
M.D.	O
68-957	O

Dictated	O
By	O
:	O
Lynn	O
J	O
Crump	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2012-05-14	O
19:24	O

T	O
:	O
2012-05-19	O
05:00	O

JOB	O
#	O
:	O
79196	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Catherine	O
GOLDSTEIN	O
on	O
:	O
Andrea	O
2012-06-07	O
8:18	O
AM	O

(	O
End	O
of	O
Report	O
)	O

641557794	O
WGH	O

1460214	O

715884	O

957382	O

5/29/2000	O
12:00:00	O
AM	O

Discharge	O
Summary	O

Signed	O

DIS	O

Report	O
Status	O
:	O

Signed	O

DISCHARGE	O
SUMMARY	O

NAME	O
:	O

FREIERMPRATL	O
,	O
NI	O
L	O

UNIT	O
NUMBER	O
:	O

794-23-29	O

ADMISSION	O
DATE	O
:	O

05/29/2000	O

DISCHARGE	O
DATE	O
:	O

05/30/2000	O

PRINCIPAL	O
DIAGNOSIS	O
:	O
:	O

Non-toxic	B-disease
multinodular	I-disease
goiter	I-disease
.	O

ASSOCIATED	O
DIAGNOSES	O
;	O

Left	B-disease
thyroid	I-disease
occult	I-disease
papillary	I-disease
carcinoma	I-disease
.	O

Chronic	B-disease
lymphocytic	I-disease
thyroiditis	I-disease
,	O
status	O
post	O
right	O
total	O
and	O
left	O
subtotal	O
oophorectomy	O
,	O
asthma	B-disease
,	O
migraine	B-disease
,	O
history	O
of	O
Droperidol	B-disease
allergy	I-disease
.	O

PRINCIPAL	O
PROCEDURE	O
:	O
:	O

5-29-00	O
:	O

Thyroidectomy	O
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

The	O
patient	O
is	O
a	O
51	O
year-old	O
female	O
,	O
with	O
a	B-disease
non-toxic	I-disease
multinodular	I-disease
goiter	I-disease
.	O

She	O
has	O
developed	O
symptoms	B-disease
from	O
a	B-disease
right	I-disease
lower	I-disease
dominant	I-disease
nodule	I-disease
with	O
pressure	B-disease
discomfort	I-disease
in	I-disease
the	I-disease
neck	I-disease
.	O

She	O
has	O
no	O
dyspnea	B-disease
or	O
dysphagia	B-disease
.	O

She	O
is	O
euthyroid	O
.	O

There	O
is	O
no	O
family	O
history	O
of	O
thyroid	B-disease
cancer	I-disease
.	O

She	O
has	O
not	O
received	O
prior	O
radiation	O
exposure	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O
:	O

On	O
physical	O
exam	O
,	O
she	O
is	O
a	O
healthy-appearing	O
female	O
with	O
a	O
normal	O
voice	O
and	O
no	O
exophthalmos	B-disease
.	O

Vital	O
Signs	O
:	O

include	O
a	O
blood	O
pressure	O
of	O
174/84	O
,	O
respirations	O
14	O
,	O
pulse	O
89	O
,	O
temperature	O
98.9	O
,	O
O2	O
sat	O
98%	O
.	O

Pupils	O
equal	O
,	O
round	O
,	O
reactive	O
to	O
light	O
and	O
accommodation	O
,	O
and	O
extraocular	O
movements	O
intact	O
.	O
,	O
with	O
a	O
benign	O
oropharynx	O
.	O

Palpation	O
of	O
the	O
neck	O
discloses	O
a	B-disease
multinodular	I-disease
goiter	I-disease
,	O
larger	O
on	O
the	O
right	O
side	O
,	O
with	O
no	O
associated	B-disease
cervical	I-disease
lymphadenopathy	I-disease
.	O

Carotid	O
pulsations	O
are	O
normal	O
without	O
bruit	B-disease
.	O

Lungs	O
:	O

clear	O
to	O
auscultation	O
and	O
percussion	O
.	O

Bilaterally	O
without	O
stridor	B-disease
.	O

Her	O
heart	O
rhythm	O
is	O
regular	O
with	O
a	O
normal	O
S1-S2	O
,	O
and	O
no	O
murmur	B-disease
.	O

Abdomen	O
is	O
soft	O
,	O
non-tender	B-disease
,	O
with	O
no	O
organomegaly	B-disease
or	O
masses	B-disease
.	O

Her	O
deep	O
tendon	O
reflexes	O
are	O
symmetric	O
.	O

HOSPITAL	O
COURSE	O
:	O

On	O
5-29-00	O
,	O
she	O
underwent	O
thyroidectomy	O
with	O
removal	O
of	O
a	B-disease
3.3	I-disease
centimeter	I-disease
right	I-disease
lobe	I-disease
microfollicular	I-disease
adenoma	I-disease
and	O
left	O
lobe	O
6	O
mm	O
.	O

papillary	B-disease
carcinoma	I-disease
.	O

There	O
was	O
no	O
evidence	O
of	O
any	B-disease
middle	I-disease
compartment	I-disease
lymphadenopathy	I-disease
or	O
spread	O
of	O
the	B-disease
tumor	I-disease
outside	O
the	O
thyroid	O
.	O

She	O
had	O
an	O
uncomplicated	O
postoperative	O
recovery	O
period	O
.	O

Her	O
sutures	O
were	O
removed	O
on	O
postoperative	O
day	O
#	O
one	O
,	O
at	O
which	O
time	O
she	O
went	O
home	O
in	O
satisfactory	O
condition	O
.	O

DOCTOR	O
&apos;S	O
DISCHARGE	O
ORDERS	O
:	O

1.	O
Synthroid	O
0.125	O
mg.	O
daily	O
.	O

2.	O
She	O
will	O
see	O
Dr.	O
Days	O
in	O
his	O
office	O
in	O
two	O
weeks	O
.	O

3.	O
She	O
will	O
remove	O
the	O
neck	O
suture	O
lines	O
Steri-Strips	O
in	O
10	O
days	O
.	O

STELLRISH	O
L.	O
LIGHT	O
,	O
M.D.	O

Cc	O
:	O

Stellrish	O
L.	O
Days	O
,	O
M.D.	O
(	O
3	O
copies	O
)	O

Electronically	O
Signed	O
STELLRISH	O
LOISRA	O
LIGHT	O
,	O
M.D.	O
09/06/2000	O
04:20	O

TR	O
:	O

jrn	O

DD	O
:	O

08/16/2000	O

TD	O
:	O

08/20/2000	O
9:25	O
A	O

cc	O
:	O

STELLRISH	O
LOISRA	O
LIGHT	O
,	O
M.D.	O

Admission	O
Date	O
:	O

2013-10-29	O

Discharge	O
Date	O
:	O

2013-11-04	O

Date	O
of	O
Birth	O
:	O

1943-01-06	O

Sex	O
:	O

M	O

Service	O
:	O

CARDIOTHORACIC	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	I-disease
Drugs	I-disease

Attending	O
:	O
Angie	O
CM	O
Johnson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

Coronary	B-disease
artery	I-disease
disease	I-disease
requiring	O
surgical	O
intervention	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

CABG	O
x	O
5	O

History	O
of	O
Present	O
Illness	O
:	O

Mr.	O
Andersen	O
is	O
a	O
71-year-old	O
male	O
with	O
worsening	B-disease
anginal	I-disease
symptoms	I-disease
who	O
underwent	O
catheterization	O
that	O
showed	O
severe	B-disease
three-vessel	I-disease
disease	I-disease
.	O

He	O
is	O
presenting	O
for	O
revascularization	O
.	O

Past	O
Medical	O
History	O
:	O

DM2	B-disease
-	O
dx	O
'd	O
at	O
the	O
age	O
of	O
48	O

Arthritis	B-disease

HTN	B-disease

Tonsillectomy	O
around	O
the	O
age	O
of	O
10	O

Social	O
History	O
:	O

Quit	O
smoking	O
23	O
years	O
ago	O
,	O
occasional	O
ETOH	O
,	O
denies	O
illicit	O
drug	O
use	O
.	O

Lives	O
with	O
wife	O
,	O
retired	O
12	O
years	O
ago	O
after	O
working	O
as	O
electrician	O
for	O
Attleboro	O
Donald	O

Family	O
History	O
:	O

Father	O
died	O
of	O
colon	B-disease
cancer	I-disease
.	O

Mother	O
with	O
pacemaker	O
,	O
alive	O
at	O
91	O
years	O
old	O
.	O

Physical	O
Exam	O
:	O

Awake	O
and	O
alert	O
,	O
NAD	B-disease

HEENT	O
:	O
PERRLA	O
,	O
no	O
carotid	B-disease
bruits	I-disease

CV	O
:	O
RRR	O
,	O
no	O
M/R/G	B-disease

Lungs	O
:	O
CTA	O
b/l	O

Abd	O
:	O
Soft	O
,	O
NT/ND	B-disease
,	O
NABS	O

Ext	O
:	O
cool	O
,	O
no	O
varicosities	B-disease
,	O
1+	O
pedal	O
pulses	O

Pertinent	O
Results	O
:	O

2013-10-29	O
11:37	O
AM	O
BLOOD	O
WBC	O
-	O
11.4	O
*#	O
RBC	O
-	O
3.09	O
*#	O
Hgb	O
-	O
9.1	O
*#	O
Hct	O
-	O
27.5	O
*#	O
MCV	O
-	O
89	O
MCH	O
-	O
29.5	O
MCHC	O
-	O
33.3	O
RDW	O
-	O
14.6	O
Plt	O
Ct	O
-	O
180	O

2013-10-29	O
11:37	O
AM	O
BLOOD	O
PT	O
-	O
16.2	O
*	O
PTT	O
-	O
29.0	O
INR(PT)	O
-	O
1.7	O

2013-10-29	O
11:37	O
AM	O
BLOOD	O
Plt	O
Ct	O
-	O
180	O

2013-10-29	O
01:09	O
PM	O
BLOOD	O
Glucose	O
-	O
172	O
*	O
UreaN	O
-	O
11	O
Creat	O
-	O
0.9	O
Na	O
-	O
142	O
Cl	O
-	O
111	O
*	O
HCO3	O
-	O
22	O

2013-10-29	O
01:09	O
PM	O
BLOOD	O
Mg	O
-	O
2.6	O

Brief	O
Hospital	O
Course	O
:	O

The	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
on	O
2013-10-29	O
for	O
a	O
CABG	O
x5	O
.	O

Please	O
see	O
operative	O
note	O
for	O
full	O
details	O
.	O

The	O
patient	O
tolerated	O
this	O
procedure	O
well	O
.	O

He	O
was	O
taken	O
immediately	O
post-operatively	O
to	O
the	O
CSRU	O
.	O

He	O
was	O
extubated	O
that	O
night	O
.	O

The	O
did	O
well	O
in	O
the	O
ICU	O
.	O

His	O
central	O
line	O
and	O
chest	O
tubes	O
were	O
removed	O
on	O
post-op	O
day	O
#2	O
and	O
was	O
transferred	O
to	O
the	O
floor	O
in	O
stable	O
condition	O
.	O

On	O
post-op	O
day	O
#3	O
,	O
the	O
patient	O
's	O
pacing	O
wires	O
were	O
removed	O
,	O
and	O
his	O
lopressor	O
was	O
started	O
.	O

On	O
post-op	O
day	O
#4	O
,	O
the	O
patient	O
failed	O
the	O
first	O
of	O
his	O
void	O
trials	O
.	O

He	O
was	O
seen	O
and	O
cleared	O
by	O
physical	O
therapy	O
.	O

He	O
was	O
discharged	O
home	O
on	O
post-op	O
day	O
#6	O
in	O
stable	O
condition	O
with	O
a	O
foley	O
catheter	O
and	O
leg	O
bag	O
.	O

Medications	O
on	O
Admission	O
:	O

Avandia	O
8	O
mg	O
daily	O

Glipizide	O
10	O
mg	O
bid	O

Diovan	O
160	O
mg	O
daily	O

Metformin	O
500	O
mg	O
two	O
tabs	O
bid	O

Omeprazole	O
20	O
mg	O
q	O
PM	O

Discharge	O
Medications	O
:	O

1.	O
Docusate	O
Sodium	O
100	O
mg	O
Capsule	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
for	O
constipation	B-disease
.	O

Disp	O
:*	O
60	O
Capsule	O
(s)*	O
Refills	O
:*	O
2	O
*	O

2.	O
Aspirin	O
81	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O

3.	O
Oxycodone	O
-	O
Acetaminophen	O
5-325	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-disease
for	O
30	O
doses	O
.	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

4.	O
Atorvastatin	O
Calcium	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

5.	O
Rosiglitazone	O
Maleate	O
8	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Glipizide	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Tamsulosin	O
0.4	O
mg	O
Capsule	O
,	O
Sust.	O
Release	O
24	O
HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Capsule	O
,	O
Sust	O
.	O
Release	O
24	O
HR	O
PO	O
HS	O
(	O
at	O
bedtime	O
).	O

Disp	O
:*	O
30	O
Capsule	O
,	O
Sust.	O
Release	O
24	O
HR	O
(s)*	O
Refills	O
:*	O
0	O
*	O

8.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Furosemide	O
20	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
every	O
twelve	O
(	O
12	O
)	O
hours	O
.	O

Disp	O
:*	O
60	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

10.	O
Pantoprazole	O
Sodium	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
Q24H	O
(	O
every	O
24	O
hours	O
).	O

Disp	O
:*	O
30	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)(s)*	O
Refills	O
:*	O
2	O
*	O

11.	O
Potassium	O
Chloride	O
10	O
mEq	O
Capsule	O
,	O
Sustained	O
Release	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Capsule	O
,	O
Sustained	O
Release	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
).	O

Disp	O
:*	O
120	O
Capsule	O
,	O
Sustained	O
Release	O
(s)*	O
Refills	O
:*	O
2	O
*	O

Discharge	O
Disposition	O
:	O

Home	O
with	O
Service	O

Discharge	O
Diagnosis	O
:	O

Coronary	B-disease
artery	I-disease
disease	I-disease

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

Please	O
return	O
to	O
the	O
hospital	O
or	O
call	O
Dr.	O
Alvarado	O
's	O
office	O
if	O
you	O
experience	O
chills	B-disease
or	O
fever	B-disease
greater	I-disease
than	I-disease
101	I-disease
degrees	I-disease
F.	I-disease

Please	O
call	O
if	O
you	O
notice	O
redness	B-disease
,	O
swelling	B-disease
,	O
or	O
tenderness	B-disease
of	O
your	B-disease
chest	I-disease
wound	I-disease
,	O
or	O
if	O
it	O
begins	O
to	O
drain	O
pus	B-disease
.	O

No	O
heavy	O
lifting	O
or	O
driving	O
until	O
follow	O
up	O
with	O
Dr.	O
Mullins	O
.	O

You	O
may	O
shower	O
.	O

Wash	O
incision	B-disease
with	O
mild	O
soap	O
and	O
water	O
,	O
then	O
pat	O
dry	O
.	O

You	O
will	O
need	O
to	O
follow	O
up	O
with	O
your	O
primary	O
care	O
physician	O
/	O
urologist	O
prior	O
to	O
removal	O
of	O
your	O
urinary	O
catheter	O
.	O

Followup	O
Instructions	O
:	O

Provider	O
:	O
Mary	O
,	O
Francis	O
Z.	O
739-488-1975	O
Call	O
to	O
schedule	O
appointment	O
.	O

Please	O
follow	O
up	O
in	O
1	O
month	O
.	O

Provider	O
:	O
Laurie	O
,	O
Paul	O
G.	O
(	O
858	O
)	O
481-2816	O
Call	O
to	O
schedule	O
appointment	O
.	O

Please	O
follow	O
up	O
in	O
1	O
week	O
.	O

Bernice	O
Jessica	O
MD	O
95-512	O

Completed	O
by	O
:	O
Carol	O
Lydia	O
MD	O
27-960	O
2013-11-05	O
@	O
0029	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Elizabeth	O
GS	O
Vega	O
on	O
:	O
FRI	O
2013-12-06	O
12:28	O
PM	O

(	O
End	O
of	O
Report	O
)	O

891864133	O
RWH	O

4713221	O

093061	O

136986	O

3/17/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

CUCHSPARDCAMPMOTTELAMN	O
,	O
LARIN	O

MRN	O
:	O

4713221	O

Age	O
:	O

47y	O

REGISTRATION	O
DATE	O
:	O

03/17/2000	O
01:25	O
PM	O

Provider	O
:	O

VA	O
LARDESPRABLEYL	O

PRELIMINARY	O
REPORT	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

03/17/2000	O
16:31	O

Discharge	O
Status	O
:	O

Discharged	O

Patient	O
States	O
Complaint	O
:	O

R	O
/	O
O	O
HEMMOROIDS	B-disease

Diagnosis	O
:	O

perianal	B-disease
and	I-disease
perivaginal	I-disease
pruritis	I-disease

Treatment	O
Rendered	O
:	O

pelvic	O
exam	O

Discharge	O
Medications	O
:	O

none	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
call	O
(	O
994	O
)	O
944-4238	O
in	O
2-3	O
days	O
to	O
obtain	O
results	O
of	O
the	O
lab	O
tests	O
that	O
were	O
ordered	O
.	O

If	O
tests	O
are	O
positive	B-disease
,	O
follow	O
up	O
with	O
your	O
primary	O
care	O
doctor	O
of	O
gynecologist	O
.	O

This	O
report	O
was	O
created	O
by	O
LARDESPRABLEYL	O
,	O
VA	O
03/17/2000	O
04:33	O
PM	O

188543380	O

NVH	O

24217709	O

06/07/2000	O
12:00:00	O
AM	O

CHRONIC	B-disease
MYELOGENOUS	I-disease
LEUKEMIA	I-disease

Signed	O

DIS	O

Admission	O
Date	O
:	O

06/07/2000	O

Report	O
Status	O
:	O

Signed	O

Discharge	O
Date	O
:	O

07/02/2000	O

PRINCIPAL	O
DIAGNOSIS	O
:	O

CML	B-disease
.	O

OTHER	O
DIAGNOSES	O
:	O

1.	O
STATUS	O
POST	O
BONE	O
MARROW	O
TRANSPLANT	O
.	O

2.	O
INTRAPARENCHYMAL	B-disease
BLEED	I-disease
.	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

Mr.	O
Larsen	O
was	O
a	O
50-year-old	O
salesman	O
who	O
in	O
12/26	O
was	O
noted	O
to	O
have	O
an	B-disease
elevated	I-disease
platelet	I-disease
count	I-disease
of	O
778,000	O
.	O

He	O
was	O
found	O
to	O
have	O
CML	B-disease
.	O

He	O
was	O
admitted	O
on	O
06/07/00	O
for	O
a	O
matched	O
,	O
unrelated	O
donor	O
bone	O
marrow	O
transplant	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

Unremarkable	O
.	O

LABORATORY	O
DATA	O
:	O

White	O
blood	O
cell	O
count	O
of	O
24.409	O
and	O
platelets	O
of	O
956,000	O
.	O

HOSPITAL	O
COURSE	O
:	O

The	O
patient	O
received	O
his	O
bone	O
marrow	O
transplant	O
on	O
06/12/00	O
.	O

His	O
course	O
was	O
then	O
complicated	O
by	O
fevers	B-disease
and	O
neutropenia	B-disease
which	O
were	O
treated	O
with	O
antibiotics	O
and	O
a	B-disease
diffuse	I-disease
erythroderm	I-disease
felt	O
to	O
be	O
a	B-disease
drug	I-disease
reaction	I-disease
.	O

On	O
06/24/00	O
the	O
patient	O
was	O
found	O
to	O
have	O
pulmonary	B-disease
infiltrates	I-disease
and	O
some	B-disease
hemoptysis	I-disease
.	O

A	O
bronchoscopy	O
was	O
done	O
and	O
there	O
was	O
blood	B-disease
found	O
in	O
the	O
upper	O
airways	O
but	O
no	O
evidence	O
of	O
blood	B-disease
in	I-disease
alveoli	I-disease
so	O
it	O
was	O
not	O
felt	O
to	O
be	O
DAH	B-disease
.	O

On	O
06/26/00	O
due	O
to	O
agitation	B-disease
,	O
change	B-disease
in	I-disease
mental	I-disease
status	I-disease
and	O
increased	B-disease
respiratory	I-disease
distress	I-disease
,	O
the	O
patient	O
was	O
intubated	O
.	O

It	O
was	O
felt	O
at	O
that	O
time	O
that	O
the	B-disease
changing	I-disease
mental	I-disease
status	I-disease
and	O
respiratory	B-disease
distress	I-disease
might	O
be	O
due	O
to	O
a	O
combination	O
of	O
medication	O
and	O
worsening	B-disease
mucositis	I-disease
.	O

Although	O
the	O
patient	O
&apos;s	O
pain	O
and	O
sedation	O
meds	O
were	O
adjusted	O
he	O
continued	O
to	O
be	O
agitated	B-disease
and	O
there	O
was	O
difficulty	O
weaning	O
him	O
off	O
the	O
vent	O
.	O

Because	O
of	O
this	B-disease
continued	I-disease
agitation	I-disease
,	O
a	O
head	O
CT	O
was	O
performed	O
on	O
07/01/00	O
and	O
it	O
revealed	O
an	B-disease
intraparenchymal	I-disease
hemorrhage	I-disease
.	O

Neurosurgery	O
was	O
consulted	O
but	O
due	O
to	O
the	B-disease
severity	I-disease
of	I-disease
the	I-disease
bleed	I-disease
surgery	O
was	O
not	O
considered	O
an	O
option	O
.	O

The	O
patient	O
gradually	O
lost	O
brain	O
systolic	O
ejection	O
murmur	O
function	O
and	O
was	O
pronounced	O
dead	B-disease
on	O
07/02/00	O
.	O

Dictated	O
By	O
:	O

LAYMIE	O
LARSEN	O
,	O
M.D.	O
EM08	O

Attending	O
:	O

ANA	O
V.	O
A	O
,	O
M.D.	O
ZM0	O
LB414/6537	O

Batch	O
:	O

67043	O

Index	O
No.	O

EZCDQ560N8	O

D	O
:	O

07/19/00	O

T	O
:	O

07/20/00	O

Admission	O
Date	O
:	O

2014-10-21	O

Discharge	O
Date	O
:	O

2014-11-21	O

Date	O
of	O
Birth	O
:	O

1942-03-10	O

Sex	O
:	O

M	O

Service	O
:	O
SURGERY	O

Allergies	O
:	O

Iodine	O
;	O
Iodine	O
Containing	O

Attending	O
:	O
Dona	O
J.	O
O.	O
Anderson	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

s/p	O
Fall	O

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Tracheostomy	O
2014-11-11	O

Bronchoscopy	O
2014-11-05	O

Past	O
Medical	O
History	O
:	O

Atrial	B-disease
fibrillation	I-disease
(	O
on	O
Coumadin	O
)	O

Coronary	B-disease
Artery	I-disease
Disease	I-disease

Ulcerative	B-disease
Colitis	I-disease
w/	O
colostomy	O

Hypertension	B-disease

Pacemaker	O

CVA	B-disease
2012	O
w/	O
right	B-disease
sided	I-disease
weakness	I-disease

Cataracts	B-disease
,	O
s/p	O
cataract	O
surgery	O

s/p	O
TURP	O

Social	O
History	O
:	O

Lives	O
with	O
wife	O
;	O
+ETOH	O
use	O

Family	O
History	O
:	O

Noncontributory	O

Pertinent	O
Results	O
:	O

2014-10-21	O
08:10	O
PM	O

GLUCOSE	O
-	O
126	O
*	O
UREA	O
N	O
-	O
9	O
CREAT	O
-	O
0.8	O
SODIUM	O
-	O
135	O
POTASSIUM	O
-	O
3.4	O
CHLORIDE	O
-	O
99	O
TOTAL	O
CO2	O
-	O
25	O
ANION	O
GAP	O
-	O
14	O

2014-10-21	O
08:10	O
PM	O

CALCIUM	O
-	O
8.2	O
*	O
PHOSPHATE	O
-	O
2.1	O
*	O
MAGNESIUM	O
-	O
1.9	O

2014-10-21	O
08:10	O
PM	O

WBC	O
-	O
6.5	O
RBC	O
-	O
3.68	O
*	O
HGB	O
-	O
11.6	O
*	O
HCT	O
-	O
32.5	O
*	O
MCV	O
-	O
88	O
MCH	O
-	O
31.5	O
MCHC	O
-	O
35.6	O
*	O
RDW	O
-	O
13.6	O

2014-10-21	O
08:10	O
PM	O

PLT	O
COUNT	O
-	O
207	O

2014-10-21	O
08:10	O
PM	O

PT	O
-	O
15.0	O
*	O
PTT	O
-	O
31.3	O
INR(PT)	O
-	O
1.5	O

2014-10-21	O
02:56	O
PM	O

TYPE	O
-	O
ART	O
TEMP	O
-	O
36.6	O
RATES	O
-	O
14	O
/	O
TIDAL	O
VOL	O
-	O
550	O
PEEP	O
-	O
5	O
O2	O
-	O
100	O
PO2	O
-	O
416	O
*	O
PCO2	O
-	O
39	O
PH	O
-	O
7.41	O
TOTAL	O
CO2	O
-	O
26	O
BASE	O
XS	O
-	O
0	O
AADO2	O
-	O
279	O
REQ	O
O2	O
-	O
52	O
-	O
ASSIST	O
/	O
CON	O
INTUBATED	O
-	O
INTUBATED	O

2014-10-21	O
09:35	O
AM	O

ASA	O
-	O
NEG	O
ETHANOL	O
-	O
NEG	O
ACETMNPHN	O
-	O
NEG	O
bnzodzpn	O
-	O
NEG	O
barbitrt	O
-	O
NEG	O
tricyclic	O
-	O
NEG	O

2014-10-21	O
09:35	O
AM	O
URINE	O

bnzodzpn	O
-	O
NEG	O
barbitrt	O
-	O
NEG	O
opiates	O
-	O
NEG	O
cocaine	O
-	O
NEG	O
amphetmn	O
-	O
NEG	O
mthdone	O
-	O
NEG	O

CT	O
C	O
-	O
SPINE	O
W/O	O
CONTRAST	O

2014-10-21	O
9:59	O
AM	O

CT	O
C	O
-	O
SPINE	O
W/O	O
CONTRAST	O
;	O
CT	O
RECONSTRUCTION	O

Reason	O
:	O
72	O
male	O
s/p	O
fall	O
down	O
20	O
stairs	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
year	O
old	O
man	O
with	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

72	O
male	O
s/p	O
fall	O
down	O
20	O
stairs	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATIONS	O
:	O
Fall	O
down	O
20	O
stairs	O
.	O

TECHNIQUE	O
:	O
Noncontrast	O
cervical	O
spine	O
CT	O
.	O

COMPARISON	O
:	O
None	O
.	O

NOTE	O
:	O
This	O
study	O
was	O
initially	O
performed	O
on	O
2014-10-21	O
.	O

Findings	O
were	O
discussed	O
with	O
Dr.	O
Leanne	O
Vazquez	O
at	O
the	O
time	O
this	O
study	O
was	O
performed	O
,	O
but	O
the	O
study	O
was	O
not	O
dictated	O
until	O
the	O
morning	O
of	O
2014-10-22	O
,	O
due	O
to	O
PACS	O
malfunction	O
.	O

NONCONTRAST	O
CERVICAL	O
SPINE	O
CT	O
:	O
There	O
are	O
minimally	B-disease
displaced	I-disease
and	I-disease
comminuted	I-disease
fractures	I-disease
through	I-disease
the	I-disease
left	I-disease
C7	I-disease
and	I-disease
T1	I-disease
transverse	I-disease
processes	I-disease
.	O

The	O
margins	O
do	O
not	O
appear	O
to	O
extend	O
into	O
the	O
foramina	O
transversaria	O
.	O

Positioning	O
limits	O
assessment	O
of	O
alignment	O
due	O
to	O
extreme	B-disease
head	I-disease
tilting	I-disease
to	I-disease
the	I-disease
right	I-disease
,	O
but	O
this	O
is	O
likely	O
the	O
best	O
obtainable	O
secondary	O
to	O
intubation	O
and	O
nasogastric	O
tube	O
placement	O
.	O

Allowing	O
for	O
the	O
limitations	O
,	O
the	O
vertebral	O
bodies	O
are	O
normal	O
in	O
height	O
and	O
normally	O
aligned	O
.	O

There	O
is	O
no	O
atlantoaxial	B-disease
subluxation	I-disease
.	O

The	O
lateral	O
masses	O
of	O
C1	O
articulate	O
normally	O
about	O
the	O
odontoid	O
process	O
.	O

Prevertebral	B-disease
soft	I-disease
tissue	I-disease
swelling	I-disease
cannot	O
be	O
excluded	O
secondary	O
to	O
intubation	O
.	O

Extensive	B-disease
carotid	I-disease
arterial	I-disease
calcifications	I-disease
are	O
present	O
in	O
the	O
bulb	O
regions	O
bilaterally	O
.	O

Biapical	B-disease
lung	I-disease
scarring	I-disease
and	O
mild	B-disease
bronchiectasis	I-disease
are	O
present	O
.	O

Also	O
noted	O
is	O
sclerosis	B-disease
and	O
opacification	B-disease
of	I-disease
the	I-disease
visualized	I-disease
left	I-disease
mastoid	I-disease
air	I-disease
cells	I-disease
and	I-disease
mastoid	I-disease
tip	I-disease
,	O
likely	O
chronic	O
inflammatory	O

disease	B-disease
.	O

IMPRESSION	O
:	O
Minimally	B-disease
displaced	I-disease
,	I-disease
comminuted	I-disease
fractures	I-disease
of	I-disease
the	I-disease
left	I-disease
C7	I-disease
and	I-disease
T1	I-disease
transverse	I-disease
processes	I-disease
.	O

No	O
evidence	O
of	O
extension	B-disease
into	I-disease
the	I-disease
foramina	I-disease
transversaria	I-disease
.	O

CT	O
HEAD	O
W/O	O
CONTRAST	O

2014-10-21	O
9:42	O
AM	O

CT	O
HEAD	O
W/O	O
CONTRAST	O

Reason	O
:	O
bleed	B-disease
?	O

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
year	O
old	O
man	O
with	O
intraparenchymal	B-disease
bleed	I-disease
s/p	O
fall	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

bleed	B-disease
?	O

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
Intraparenchymal	B-disease
hemorrhage	I-disease
after	O
fall	O
.	O

Assess	O
for	O
hemorrhage	B-disease
.	O

TECHNIQUE	O
:	O
Non-contrast	O
head	O
CT	O
.	O

COMPARISON	O
:	O
No	O
prior	O
studies	O
are	O
available	O
.	O

By	O
report	O
,	O
the	O
patient	O
has	O
an	O
outside	O
study	O
.	O

Should	O
this	O
become	O
available	O
,	O
an	O
addendum	O
will	O
be	O
issued	O
to	O
this	O
report	O
following	O
the	O
comparison	O
with	O
the	O
outside	O
examination	O
.	O

NOTE	O
:	O
This	O
study	O
was	O
initially	O
performed	O
on	O
the	O
morning	O
of	O
10-21	O
,	O
and	O
is	O
being	O
dictated	O
on	O
the	O
morning	O
of	O
10-22	O
due	O
to	O
PACS	O
malfunction	O
.	O

Findings	O
were	O
called	O
to	O
Dr.	O
Leanne	O
Vazquez	O
on	O
the	O
morning	O
of	O
10-21	O
.	O

NON-CONTRAST	O
HEAD	O
CT	O
:	O
There	O
is	O
a	B-disease
small	I-disease
amount	I-disease
of	I-disease
hemorrhage	I-disease
within	O
the	O
occipital	O
horns	O
of	O
both	O
lateral	O
ventricles	O
,	O
right	O
greater	O
than	O
left	O
.	O

Located	O
within	O
the	O
atrium	O
of	O
the	O
right	O
lateral	O
ventricle	O
is	O
an	B-disease
18	I-disease
x	I-disease
10	I-disease
mm	I-disease
nodular	I-disease
area	I-disease
of	I-disease
increased	I-disease
density	I-disease
which	O
is	O
separate	O
from	O
the	O
choroid	O
plexus	O
.	O

There	O
is	O
no	O
evidence	O
of	O
surrounding	B-disease
edema	I-disease
.	O

There	O
is	O
diffuse	B-disease
brain	I-disease
atrophy	I-disease
and	O
chronic	B-disease
microvascular	I-disease
infarction	I-disease
throughout	I-disease
the	I-disease
white	I-disease
matter	I-disease
.	O

There	O
is	O
a	B-disease
remote	I-disease
right	I-disease
frontal	I-disease
infarct	I-disease
.	O

There	O
is	O
no	O
evidence	O
of	O
subarachnoid	B-disease
hemorrhage	I-disease
or	O
acute	B-disease
major	I-disease
vascular	I-disease
territorial	I-disease
infarction	I-disease
.	O

The	O
ventricles	O
do	O
not	O
appear	O
dilated	O
relative	O
to	O
the	O
sulci	O
,	O
and	O
there	O
is	O
no	O
shift	B-disease
of	I-disease
normally	I-disease
midline	I-disease
structures	I-disease
.	O

There	O
is	O
no	O
skull	B-disease
fracture	I-disease
.	O

There	O
is	O
opacification	B-disease
of	I-disease
the	I-disease
posterior	I-disease
nasal	I-disease
cavity	I-disease
and	I-disease
nasopharynx	I-disease
but	O
an	O
NG	O
tube	O
is	O
present	O
,	O
and	O
the	O
patient	O
is	O
intubated	O
.	O

Opacified	B-disease
and	I-disease
sclerotic	I-disease
left	I-disease
mastoid	I-disease
air	I-disease
cells	I-disease
are	O
noted	O
.	O

IMPRESSION	O
:	O

1.	O
Small	O
amount	O
of	O
intraventricular	B-disease
hemorrhage	I-disease
.	O

2.	O
Ovoid	B-disease
18	I-disease
-	I-disease
mm	I-disease
density	I-disease
within	I-disease
the	I-disease
atrium	I-disease
of	O
the	O
right	O
lateral	O
ventricle	O
.	O

This	O
could	O
represent	O
either	O
an	B-disease
atypically	I-disease
located	I-disease
blood	I-disease
clot	I-disease
or	O
an	B-disease
intraventricular	I-disease
mass	I-disease
,	O
and	O
further	O
evaluation	O
with	O
contrast	O
-	O
enhanced	O
MRI	O
of	O
the	O
brain	O
,	O
when	O
clinically	O
feasible	O
,	O
is	O
recommended	O
.	O

Results	O
were	O
discussed	O
with	O
Dr.	O
Leanne	O
Vazquez	O
in	O
the	O
early	O
afternoon	O
on	O
2014-10-21	O
.	O

CT	O
HEAD	O
W/O	O
CONTRAST	O

2014-11-14	O
12:34	O
PM	O

CT	O
HEAD	O
W/O	O
CONTRAST	O

Reason	O
:	O
altered	B-disease
mental	I-disease
status	I-disease

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
year	O
old	O
man	O
with	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

altered	B-disease
mental	I-disease
status	I-disease

CONTRAINDICATIONS	O
for	O
IV	O
CONTRAST	O
:	O
None	O
.	O

INDICATION	O
:	O
72-year-old	O
male	O
with	O
altered	B-disease
mental	I-disease
status	I-disease
.	O

TECHNIQUE	O
:	O
Axial	O
noncontrast	O
CT	O
scans	O
of	O
the	O
brain	O
were	O
obtained	O
.	O

Comparison	O
is	O
made	O
to	O
a	O
previous	O
study	O
from	O
2014-10-27	O
.	O

FINDINGS	O
:	O

There	O
are	O
numerous	O
areas	O
of	O
decreased	B-disease
attenuation	I-disease
in	I-disease
the	I-disease
periventricular	I-disease
and	I-disease
subcortical	I-disease
white	I-disease
matter	I-disease
of	O
both	O
cerebral	O
hemispheres	O
,	O
indicating	O
chronic	B-disease
microvascular	I-disease
infarction	I-disease
.	O

There	O
is	O
also	O
an	B-disease
old	I-disease
right	I-disease
frontal	I-disease
lobe	I-disease
cortical	I-disease
infarction	I-disease
.	O

A	B-disease
small	I-disease
right	I-disease
occipital	I-disease
lobe	I-disease
chronic	I-disease
infarction	I-disease
is	O
also	O
evident	O
.	O

There	O
is	O
a	B-disease
small	I-disease
amount	I-disease
of	I-disease
blood	I-disease
layering	I-disease
in	I-disease
both	I-disease
lateral	I-disease
ventricles	I-disease
,	O
and	O
this	O
has	O
decreased	O
since	O
the	O
previous	O
study	O
.	O

The	O
size	O
and	O
shape	O
of	O
the	O
ventricles	O
is	O
unchanged	O
.	O

No	O
new	B-disease
hemorrhage	I-disease
is	O
observed	O
.	O

There	O
is	O
opacification	B-disease
of	I-disease
the	I-disease
mastoid	I-disease
air	I-disease
cells	I-disease
,	O
greater	O
on	O
the	O
left	O
than	O
the	O
right	O
.	O

There	O
is	O
some	B-disease
fluid	I-disease
or	O
mucosal	B-disease
thickening	I-disease
in	I-disease
the	I-disease
ethmoid	I-disease
and	I-disease
sphenoid	I-disease
sinuses	I-disease
.	O

IMPRESSION	O
:	O
No	O
new	B-disease
cortical	I-disease
territorial	I-disease
infarction	I-disease
or	O
hemorrhage	B-disease
is	O
identified	O
.	O

There	O
is	O
decreased	B-disease
intraventricular	I-disease
blood	I-disease
,	O
compared	O
to	O
the	O
previous	O
study	O
,	O
and	O
there	O
are	O
no	O
signs	O
of	O
hydrocephalus	B-disease
.	O

CHEST	O
(	O
PORTABLE	O
AP	O
)	O

2014-11-12	O
9:10	O
AM	O

CHEST	O
(	O
PORTABLE	O
AP	O
)	O

Reason	O
:	O
Fever	B-disease
,	O
f/u	O
infiltrte	B-disease

UNDERLYING	O
MEDICAL	O
CONDITION	O
:	O

72	O
yo	O
M	O
with	O
rib	B-disease
fx	I-disease
s/p	O
trauma	B-disease
,	O
failure	O
on	O
previous	O
CXR	O
,	O
now	O
with	O
fever	B-disease
.	O

REASON	O
FOR	O
THIS	O
EXAMINATION	O
:	O

Fever	B-disease
,	O
f/u	O
infiltrte	B-disease

HISTORY	O
:	O
Trauma	B-disease
,	O
congestive	B-disease
heart	I-disease
failure	I-disease
,	O
fever	B-disease
,	O
pneumonia	B-disease
.	O

Portable	O
supine	O
chest	O
radiograph	O
shows	O
improvement	O
in	O
edema	B-disease
compared	O
to	O
studies	O
from	O
four	O
and	O
five	O
days	O
earlier	O
with	O
no	O
significant	B-disease
radiographic	I-disease
change	I-disease
in	O
right	B-disease
upper	I-disease
lobe	I-disease
consolidation	I-disease
consistent	O
with	O
pneumonia	B-disease
.	O

Some	B-disease
interstitial	I-disease
edema	I-disease
still	O
persists	O
,	O
but	O
there	O
is	O
no	O
central	B-disease
pulmonary	I-disease
vascular	I-disease
congestion	I-disease
.	O

Cardiac	O
size	O
is	O
unchanged	O
.	O

The	O
amount	O
of	O
fluid	B-disease
layering	I-disease
at	I-disease
the	I-disease
apices	I-disease
and	I-disease
the	I-disease
pleural	I-disease
spaces	I-disease
appear	O
slightly	O
decreased	O
.	O

Multiple	B-disease
left-sided	I-disease
rib	I-disease
fractures	I-disease
are	O
seen	O
.	O

Supporting	O
tubes	O
and	O
lines	O
are	O
in	O
unchanged	O
position	O
and	O
the	O
patient	O
has	O
a	O
single	O
lead	O
pacemaker	O
projected	O
on	O
the	O
left	O
.	O

Calcification	B-disease
is	O
seen	O
at	O
both	O
carotid	O
bifurcations	O
.	O

CONCLUSION	O
:	O
Improvement	O
in	O
congestion	B-disease
from	O
edema	B-disease
with	O
no	O
worsening	O
,	O
but	O
no	O
significant	O
improvement	O
,	O
in	O
the	B-disease
right	I-disease
upper	I-disease
lobe	I-disease
pneumonia	I-disease
.	O

Supporting	O
lines	O
and	O
tubes	O
in	O
unchanged	O
position	O
.	O

Brief	O
Hospital	O
Course	O
:	O

Admitted	O
to	O
TSICU	O
for	O
subarachnoid	B-disease
hemorrhage	I-disease
and	O
multiple	B-disease
spinal	I-disease
fractures	I-disease
.	O

Intubated	O
and	O
sedated	O
for	O
desats	B-disease
on	O
2014-10-27	O
.	O

Evaluated	O
by	O
neurosurgery	O
and	O
deemed	O
stable	O
on	O
2014-10-22	O
.	O

CT	O
head	O
remained	O
stable	O
for	O
SAH	B-disease
.	O

Evaluated	O
by	O
orthopedic	O
spine	O
surgeons	O
with	O
recommendations	O
for	O
soft	O
c-collar	O
for	O
comfort	O
.	O

In	O
TSICU	O
,	O
developed	O
MRSA	B-disease
pneumonia	I-disease
with	O
question	O
of	O
aspiration	B-disease
,	O
treated	O
Zosyn	O
-->	O
vanc	O
/	O
levo	O
-->	O
then	O
2	O
week	O
course	O
of	O
Linazolid	O
with	O
resolution	O
of	O
fevers	B-disease
and	O
decreased	B-disease
pulmonary	I-disease
secretions	I-disease
.	O

2014-11-11	O
:	O
Tracheostomy	O
performed	O
without	O
complication	B-disease
.	O

Patient	O
tolerated	O
decreasing	O
ventillary	O
support.	O

Mental	O
status	O
improved	O
with	O
the	O
discontinuation	O
of	O
his	O
bensodiazapines	O
.	O

Failed	B-disease
swallow	I-disease
study	I-disease
x	O
2	O
in	O
early	O
November	O
.	O

Decision	O
to	O
continue	O
Dobhoff	O
at	O
rehab	O
given	O
continued	O
clinical	O
improvement	O
and	O
his	O
poor	O
candidacy	O
for	O
G/J	O
tube	O
.	O

Communicating	O
by	O
speech	O
s/p	O
PMV	O
placement	O
.	O

Continued	O
in	O
Melrose-J	O
for	O
comfort	O
per	O
orthopedics	O
.	O

Stable	O
during	O
his	O
course	O
on	O
the	O
surgical	O
Beth	O
Israel	O
Deaconess	O
Hospital-Needham	O
.	O

Occasionally	O
required	O
Haldol	O
/	O
ativan	O
at	O
night	O
for	O
agitation	B-disease
.	O

Progressed	O
adequately	O
with	O
physical	O
/	O
occupational	O
therapy	O
,	O
however	O
was	O
noted	O
to	O
develop	O
an	B-disease
early	I-disease
bilateral	I-disease
upper	I-disease
extermity	I-disease
contracture	I-disease
at	I-disease
the	I-disease
elbows	I-disease
and	I-disease
wrists	I-disease
.	O

Serial	O
CT	O
head	O
revealed	O
decreased	B-disease
blood	I-disease
through	O
2014-11-14	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Heparin	O
(	O
Porcine	O
)	O
5,000	O
unit/mL	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Injection	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

2.	O
Lisinopril	O
15	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

3.	O
Lansoprazole	O
30	O
mg	O
Susp	O
,	O
Delayed	O
Release	O
for	O
Recon	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

4.	O
Linezolid	O
600	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q12H	O
(	O
every	O
12	O
hours	O
):	O
Last	O
dose	O
2014-11-20	O
.	O

5.	O
Metoprolol	O
Tartrate	O
25	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
TID	O
(	O
3	O
times	O
a	O
day	O
).	O

6.	O
Digoxin	O
125	O
mcg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

7.	O
Docusate	O
Sodium	O
150	O
mg	O
/	O
15	O
mL	O
Liquid	O
Sig	O
:	O
One	O
(	O
1	O
)	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

8.	O
Bisacodyl	O
5	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
)	O
as	O
needed	O
for	O
constipation	B-disease
.	O

9.	O
Magnesium	O
Hydroxide	O
400	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
Thirty	O
(	O
30	O
)	O
ML	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
consitpation	B-disease
.	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

Children	O
's	O
Hospital	O
of	O
Waltham	O

Discharge	O
Diagnosis	O
:	O

s/p	O
Fall	O

Subarachnoid	B-disease
hemorrhage	I-disease
w/	O
bilateral	B-disease
intraventricular	I-disease
hemorrhage	I-disease

Left	B-disease
T1	I-disease
transverse	I-disease
process	I-disease
fracture	I-disease

C7	B-disease
&	I-disease
T1	I-disease
mimimally	I-disease
displaced	I-disease
transverse	I-disease
process	I-disease
fracture	I-disease

Left	B-disease
rib	I-disease
fractures	I-disease
05-22	O

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

You	O
must	O
continue	O
to	O
wear	O
your	O
cervical	O
collar	O
for	O
the	O
next	O
4	O
weeks	O
(	O
through	O
12-11	O
).	O

Follow	O
up	O
with	O
Trauma	O
in	O
3-4	O
weeks	O
after	O
your	O
discharge	O
.	O

Follow	O
up	O
Instructions	O
:	O

Call	O
(	O
909	O
)	O
566-1185	O
to	O
schedule	O
appointment	O
in	O
Trauma	O
Clinic	O
in	O
3-4	O
weeks	O
.	O

Follow	O
up	O
with	O
Dr.	O
Topping	O
after	O
your	O
discharge	O
from	O
rehabilitation	O

Call	O
887	O
415	O
4220	O
to	O
schedule	O
an	O
appointment	O
with	O
Orthopedics	O
for	O
late	O
November	O
.	O

David	O
Thomas	O
MD	O
60-008	O

Completed	O
by	O
:	O
Russell	O
Anthony	O
Conner	O
MD	O
87-672	O
2014-11-21	O
@	O
1110	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Melissa	O
Higuera	O
on	O
:	O
SUN	O
2014-11-23	O
6:13	O
PM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2011-03-10	O

Discharge	O
Date	O
:	O

2011-03-15	O

Date	O
of	O
Birth	O
:	O

1927-10-26	O

Sex	O
:	O

F	O

Service	O
:	O

Medford	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
an	O
83	O
year	O
old	O
woman	O
with	O
a	O
history	O
of	O
hypertension	B-disease
who	O
presents	O
with	O
slurred	B-disease
speech	I-disease
when	O
dehydrated	B-disease
.	O

She	O
has	O
paraplegia	B-disease
secondary	O
to	O
HTLV	B-disease
exposure	I-disease
while	O
on	O
vacation	O
in	O
the	O
Bahamas	O
six	O
years	O
ago	O
.	O

She	O
presented	O
with	O
three	O
days	O
of	O
general	B-disease
malaise	I-disease
,	O
nausea	B-disease
,	O
vomiting	B-disease
,	O
shortness	B-disease
of	I-disease
breath	I-disease
,	O
cough	B-disease
productive	O
of	O
white	B-disease
sputum	I-disease
.	O

She	O
awoke	O
with	O
nausea	B-disease
on	O
the	O
day	O
of	O
admission	O
and	O
pleuritic	B-disease
chest	I-disease
pain	I-disease
.	O

She	O
reports	O
no	O
sick	O
contacts.	O

The	O
patient	O
has	O
some	B-disease
difficulty	I-disease
talking	O
and	O
grasping	O
right	O
hand	O
.	O

She	O
came	O
to	O
the	O
Emergency	O
Department	O
on	O
the	O
2011-03-10	O
,	O
with	O
temperature	O
of	O
99.0	O
F	O
.;	O
blood	O
pressure	O
of	O
97/50	O
;	O
heart	O
rate	O
100	O
;	O
respirations	O
27	O
;	O
O2	O
saturation	O
84%	O
on	O
room	O
air	O
and	O
94%	O
on	O
two	O
liters	O
.	O

The	O
patient	O
had	O
coarse	B-disease
rhonchi	I-disease
on	O
examination	O
.	O

Chest	O
x-ray	O
revealed	O
mild	B-disease
pulmonary	I-disease
edema	I-disease
.	O

Chest	O
CT	O
scan	O
was	O
negative	O
for	O
pulmonary	B-disease
embolism	I-disease
but	O
positive	O
for	O
consolidation	B-disease
.	O

She	O
was	O
started	O
on	O
Levofloxacin	O
but	O
the	O
patient	O
became	O
hypotensive	B-disease
at	O
that	O
point	O
with	O
blood	O
pressure	O
of	O
70/45	O
and	O
received	O
a	O
normal	O
saline	O
bolus	O
to	O
boost	O
her	O
blood	O
pressure	O
to	O
99/60	O
;	O
however	O
the	O
patient	O
was	O
admitted	O
to	O
the	O
Medical	O
Intensive	O
Care	O
Unit	O
for	O
overnight	O
observation	O
because	O
of	O
her	B-disease
somnolence	I-disease
and	O
hypotension	B-disease
.	O

She	O
was	O
transferred	O
to	O
the	O
Everett	O
Firm	O
on	O
the	O
2011-03-11	O
and	O
was	O
mentating	O
well	O
and	O
was	O
stable	O
for	O
transfer	O
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

1.	O
Positive	B-disease
lupus	I-disease
anti-coagulant	I-disease
.	O

2.	O
Basilar	B-disease
stenosis	I-disease
.	O

3.	O
Prior	B-disease
transient	I-disease
ischemic	I-disease
attacks	I-disease
.	O

4.	O
Right	O
medial	O
malleolus	O
repair	O
in	O
2004-08-05	O
.	O

5.	O
Paraplegia	B-disease
secondary	O
to	O
HTLV	B-disease
from	O
a	O
trip	O
to	O
the	O
Bahamas	O
five	O
to	O
six	O
years	O
ago	O
.	O

6.	O
Hypertension	B-disease
.	O

7.	O
Chronic	B-disease
diarrhea	I-disease
with	O
multiple	O
admissions	O
for	O
dehydration	B-disease
with	O
most	O
recent	O
one	O
on	O
2011-02-26	O
.	O

8.	O
Venous	B-disease
stasis	I-disease
.	O

9.	O
Depression	B-disease
.	O

10.	O
Seizure	B-disease
history	I-disease
on	O
Neurontin	O
.	O

11.	O
Left	O
CMED	O
cataract	O
surgery	O
in	O
2009-10-05	O
.	O

12.	O
Chronic	B-disease
muscle	I-disease
spasms	I-disease
.	O

ALLERGIES	O
:	O

Penicillin	O
for	O
which	O
she	O
reports	O
a	B-disease
rash	I-disease
and	O
dyspepsia	B-disease
when	O
taking	O
uncoated	O
aspirin	O
.	O

She	O
has	O
a	O
questionable	O
sensitivity	B-disease
to	O
iodine	O
.	O

MEDICATIONS	O
AS	O
OUTPATIENT	O
:	O

1.	O
Enteric-coated	O
aspirin	O
.	O

2.	O
Aggrenox	O
.	O

3.	O
Zanaflex	O
.	O

4.	O
Neurontin	O
300	O
mg	O
three	O
times	O
a	O
day	O
.	O

5.	O
Celexa	O
10	O
mg	O
daily	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
admission	O
examination	O
she	O
was	O
a	O
well	O
developed	O
,	O
well	O
nourished	O
female	O
in	O
no	O
apparent	B-disease
distress	I-disease
.	O

She	O
was	O
alert	O
and	O
oriented	O
times	O
three	O
.	O

Speech	O
was	O
fluent	O
.	O

Her	O
lungs	O
revealed	O
coarse	B-disease
bilateral	I-disease
rhonchi	I-disease
from	O
base	O
to	O
midline	O
.	O

Cardiovascular	O
examination	O
is	O
notable	O
for	O
a	O
regular	O
rate	O
and	O
rhythm	O
;	O
no	O
murmurs	B-disease
,	O
rubs	B-disease
or	O
gallops	B-disease
.	O

Abdomen	O
is	O
soft	O
and	O
obese	B-disease
,	O
nontender	B-disease
.	O

Normal	O
bowel	O
sounds	O
present	O
.	O

Extremities	O
notable	O
for	O
two	B-disease
plus	I-disease
lower	I-disease
extremity	I-disease
edema	I-disease
and	O
the	O
ankles	O
were	O
noted	O
to	O
be	O
in	O
pressure	O
stockings	O
.	O

LABORATORY	O
:	O

White	O
blood	O
cell	O
count	O
were	O
11.8	O
,	O
hematocrit	O
31.5	O
,	O
platelets	O
151	O
.	O

Chem-7	O
was	O
a	O
sodium	O
of	O
140	O
,	O
potassium	O
of	O
3.0	O
,	O
chloride	O
108	O
,	O
bicarbonate	O
24	O
,	O
BUN	O
22	O
,	O
creatinine	O
1.0	O
and	O
glucose	O
117	O
.	O

The	O
patient	O
also	O
had	O
a	O
head	O
CT	O
scan	O
in	O
the	O
Emergency	O
Department	O
before	O
coming	O
to	O
the	O
Unit	O
which	O
reported	O
no	O
recent	B-disease
bleed	I-disease
and	O
no	O
change	B-disease
from	O
a	O
prior	O
CT	O
scan	O
done	O
on	O
2011-03-04	O
.	O

EKG	O
is	O
notable	O
for	O
sinus	B-disease
tachycardia	I-disease
at	O
100	O
beats	O
per	O
minute	O
,	O
normal	O
axis	O
.	O

.....	O
done	O
on	O
02-24	O
,	O
notable	O
for	O
mid-basilar	B-disease
artery	I-disease
high-grade	I-disease
stenosis	I-disease
.	O

HOSPITAL	O
COURSE	O
:	O

After	O
transfer	O
to	O
the	O
Floor	O
,	O
the	O
patient	O
was	O
continued	O
on	O
Levofloxacin	O
for	O
a	O
ten	O
to	O
14	O
day	O
course	O
for	O
presumptive	O
pneumonia	B-disease
.	O

Due	O
to	O
her	B-disease
chronic	I-disease
diarrhea	I-disease
she	O
was	O
repleted	O
with	O
intravenous	O
fluids	O
.	O

For	O
her	B-disease
depression	I-disease
,	O
continued	O
on	O
Citalopram	O
10	O
mg	O
daily	O
.	O

For	O
her	B-disease
paraplegia	I-disease
and	O
associated	O
muscle	B-disease
spasticity	I-disease
she	O
was	O
continued	O
on	O
her	O
Zanaflex	O
.	O

For	O
deep	O
vein	O
thrombosis	O
prophylaxis	O
she	O
was	O
treated	O
with	O
subcutaneous	O
heparin	O
and	O
for	O
gastrointestinal	O
prophylaxis	O
she	O
was	O
treated	O
with	O
Protonix	O
.	O

She	O
was	O
also	O
evaluated	O
by	O
Physical	O
Therapy	O
and	O
Speech	O
and	O
Swallow	O
because	O
of	O
some	O
report	O
of	O
dysphagia	B-disease
.	O

Physical	O
Therapy	O
felt	O
that	O
the	O
patient	O
was	O
cleared	O
for	O
transfer	O
home	O
with	O
services	O
.	O

Occupational	O
Therapy	O
was	O
also	O
in	O
agreement	O
with	O
the	O
patient	O
's	O
disposition	O
home	O
with	O
services	O
.	O

The	O
patient	O
was	O
able	O
to	O
advance	O
her	O
diet	O
well	O
from	O
liquids	O
to	O
solids	O
,	O
however	O
,	O
she	O
was	O
plagued	O
with	O
a	B-disease
persistent	I-disease
cough	I-disease
and	O
some	B-disease
low	I-disease
grade	I-disease
fevers	I-disease
to	O
99.0	O
F	O
.	O

Speech	O
and	O
Swallow	O
evaluated	O
the	O
patient	O
at	O
bedside	O
and	O
recommended	O
advancing	O
to	O
regular	O
diet	O
with	O
regular	O
consistency	O
and	O
saw	O
no	O
evidence	O
of	O
any	B-disease
dysphagia	I-disease
.	O

There	O
was	O
some	O
question	O
regarding	O
restarting	O
of	O
the	O
patient	O
's	O
Coumadin	O
given	O
her	B-disease
positive	I-disease
lupus	I-disease
anti-coagulant	I-disease
status	I-disease
as	O
well	O
as	O
the	O
presence	O
of	O
her	B-disease
basilar	I-disease
artery	I-disease
stenosis	I-disease
.	O

The	O
patient	O
was	O
discharged	O
on	O
the	O
2011-03-15	O
on	O
the	O
following	O
medications	O
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

1.	O
Levofloxacin	O
250	O
mg	O
q.	O
day	O
for	O
ten	O
days	O
.	O

2.	O
Aspirin	O
/	O
dipyridamole	O
25/200	O
mg	O
capsules	O
taken	O
two	O
times	O
a	O
day	O
.	O

3.	O
Neurontin	O
300	O
mg	O
taken	O
three	O
times	O
a	O
day	O
.	O

4.	O
Subcutaneous	O
heparin	O
taken	O
5000	O
units	O
twice	O
a	O
day	O
.	O

5.	O
Albuterol	O
multiple	O
dose	O
inhalers	O
,	O
one	O
to	O
two	O
puffs	O
q.	O
six	O
hours	O
as	O
needed	O
.	O

6.	O
Atrovent	O
multiple	O
dose	O
inhalers	O
,	O
one	O
to	O
two	O
puffs	O
q.	O
six	O
hours	O
as	O
needed	O
.	O

7.	O
Citalopram	O
10	O
mg	O
q.	O
day	O
.	O

8.	O
Lisinopril	O
2.5	O
mg	O
once	O
a	O
day	O
.	O

9.	O
Trazodone	O
25	O
mg	O
q.	O
h.s.	O
p.r.n.	O

10.	O
Protonix	O
40	O
mg	O
q.	O
day	O
.	O

11.	O
Zanaflex	O
2	O
mg	O
twice	O
a	O
day	O
.	O

12.	O
Tylenol	O
325	O
mg	O
,	O
one	O
to	O
two	O
tablets	O
q.	O
four	O
to	O
six	O
hours	O
p.r.n.	O

13.	O
The	O
patient	O
was	O
also	O
discharged	O
with	O
the	O
restarting	O
of	O
warfarin	O
2	O
mg	O
daily	O
.	O

DISCHARGE	O
INSTRUCTIONS	O
:	O

1.	O
She	O
was	O
instructed	O
to	O
have	O
blood	O
drawn	O
by	O
the	O
Visiting	O
Nurses	O
Association	O
the	O
day	O
after	O
discharge	O
and	O
then	O
a	O
few	O
days	O
after	O
discharge	O
the	O
same	O
week	O
to	O
have	O
INR	O
.	O

Will	O
also	O
have	O
INR	O
checked	O
at	O
once	O
weekly	O
until	O
target	O
of	O
INR	O
of	O
2.0	O
to	O
3.0	O
is	O
reached	O
.	O

2.	O
The	O
patient	O
was	O
instructed	O
to	O
contact	O
Dr.	O
Ralph	O
at	O
(	O
428	O
)	O
678-6930	O
,	O
who	O
is	O
covering	O
for	O
her	O
primary	O
care	O
physician	O
,	O
Dr.	O
Erika	O
Witt	O
,	O
to	O
adjust	O
her	O
dosages	O
based	O
on	O
the	O
INR	O
levels	O
.	O

3.	O
The	O
patient	O
also	O
had	O
a	O
Gastrointestinal	O
Clinic	O
follow-up	O
on	O
2011-03-28	O
.	O

She	O
is	O
to	O
follow-up	O
with	O
Dr.	O
Geraldo	O
Davis	O
.	O

4.	O
She	O
was	O
also	O
instructed	O
to	O
follow-up	O
with	O
Dr.	O
Reid	O
from	O
Neurology	O
within	O
a	O
month	O
at	O
(	O
382	O
)	O
716	O
4151	O
,	O
given	O
her	B-disease
neurological	I-disease
deficits	I-disease
during	O
this	O
presentation	O
.	O

Brenda	O
L.	O
Nelson	O
,	O
M.D.	O

Dictated	O
By	O
:	O
Rodolfo	O
X	O
Gifford	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2011-04-18	O
16:17	O

T	O
:	O
2011-04-18	O
22:11	O

JOB	O
#:	O

46153	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dorothy	O
Donahue	O
on	O
:	O
TUE	O
2011-04-19	O
3:15	O
PM	O

(	O
End	O
of	O
Report	O
)	O

026350193	O
RWH	O

7093319	O

549304	O

8417371	O

6/5/2002	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

AASCOLESLENT	O
,	O
DIROD	O

MRN	O
:	O

7093319	O

Age	O
:	O

50y	O

REGISTRATION	O
DATE	O
:	O

06/05/2002	O
02:46	O
PM	O

Provider	O
:	O

RYBAM	O
SHOULDER	O

PRELIMINARY	O
REPORT	O

PCP	O
notified	O
by	O
MD	O
:	O

Left	O
message	O
with	O
answering	O
service	O
or	O
PCP	O
office	O

Benefits	O
Assigned	O
:	O

Y	O

Discharge	O
Date	O
/	O
Time	O
:	O

06/05/2002	O
16:17	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

L	B-disease
SHOULDER	I-disease
INJ	I-disease

Standardized	O
Discharge	O
Instructions	O
:	O

The	O
patient	O
was	O
given	O
printed	O
instructions	O
for	O
neck	B-disease
strains	I-disease
(	O
English	O
)	O
.	O

Diagnosis	O
:	O

Left	B-disease
Shoulder	I-disease
/	I-disease
Neck	I-disease
strain	I-disease
/	I-disease
sprain	I-disease
.	O

Treatment	O
Rendered	O
:	O

Dilaudid	O
2mg	O
PO	O
x	O
1	O
Flexeril	O
10	O
mg	O
x	O
1	O

Discharge	O
Medications	O
:	O

Flexeril	O
10mg	O
TID	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
follow-up	O
with	O
your	O
Orthopaedic	O
physician	O
on	O
Wednesday	O
6/9/02	O
as	O
previously	O
arranged	O
by	O
patient	O
.	O

Please	O
follow-up	O
with	O
PCP	O
.	O

Take	O
codeine	O
prescribed	O
by	O
PCP	O
with	O
food	O
and	O
water	O
to	O
prevent	O
nausea	B-disease
and	O
constipation	B-disease
.	O

Do	O
not	O
drive	O
if	O
taking	O
flexeril	O
and	O
codeine	O
.	O

PCP	O
Name	O
:	O

DOUET	O
,	O
LAH	O

Provider	O
Number	O
:	O

19061	O

This	O
report	O
was	O
created	O
by	O
SHOULDER	O
,	O
RYBAM	O
06/05/2002	O
04:26	O
PM	O

044687343	O
ELMVH	O

01719921	O

1626859	O

3/13/2006	O
12:00:00	O
AM	O

COPD	B-disease
flare	I-disease

DIS	O

Admission	O
Date	O
:	O

03/13/2006	O

Report	O
Status	O
:	O

Discharge	O
Date	O
:	O

03/19/2006	O

******	O
FINAL	O
DISCHARGE	O
ORDERS	O
******	O

FREIERMLINKENEIGHCAABLINFARST	O
,	O
ANEA	O

770-09-54-2	O
O32	O

Room	O
:	O

39K-128	O

Service	O
:	O

MED	O

DISCHARGE	O
PATIENT	O
ON	O
:	O

03/19/06	O
AT	O
01:00	O
PM	O

CONTINGENT	O
UPON	O

Not	O
Applicable	O

WILL	O
D	O
/	O
C	O
ORDER	O
BE	O
USED	O
AS	O
THE	O
D	O
/	O
C	O
SUMMARY	O
:	O

YES	O

Attending	O
:	O

ALBFYFEAYLES	O
,	O
LORRE	O
EZO	O
,	O
M.D.	O

CODE	O
STATUS	O
:	O

Full	O
code	O

DISPOSITION	O
:	O

Villeflardsbroo	O
Ands	O
Tho	O
Cardhako	O
General	O
Hospital	O

DISCHARGE	O
MEDICATIONS	O
:	O

ACETYLSALICYLIC	O
ACID	O
81	O
MG	O
PO	O
DAILY	O
ALBUTEROL	O
NEBULIZER	O
2.5	O
MG	O
NEB	O
Q4H	O
Starting	O
Today	O
(	O
03/17	O
)	O
PRN	O
Shortness	B-disease
of	I-disease
Breath	I-disease
LISINOPRIL	O
10	O
MG	O
PO	O
DAILY	O
NIFEREX-150	O
150	O
MG	O
PO	O
BID	O
PREDNISONE	O
Taper	O
PO	O
Give	O
50	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
40	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
30	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
20	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Give	O
10	O
mg	O
q	O
24	O
h	O
X	O
1	O
dose	O
(	O
s	O
)	O
,	O
then	O
Starting	O
Today	O
(	O
03/17	O
)	O
CLARITIN	O
(	O
LORATADINE	O
)	O
10	O
MG	O
PO	O
DAILY	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Avoid	O
grapefruit	O
unless	O
MD	O
instructs	O
otherwise	O
.	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O
SINGULAIR	O
(	O
MONTELUKAST	O
)	O
10	O
MG	O
PO	O
BEDTIME	O
ADVAIR	O
DISKUS	O
500/50	O
(	O
FLUTICASONE	O
PROPIONATE/...	O
)	O
1	O
PUFF	O
INH	O
BID	O
CALTRATE	O
+	O
D	O
1	O
TAB	O
PO	O
BID	O
LANTUS	O
(	O
INSULIN	O
GLARGINE	O
)	O
35	O
UNITS	O
SC	O
QAM	O
DUONEB	O
(	O
ALBUTEROL	O
AND	O
IPRATROPIUM	O
NEBULIZER	O
)	O
3/0.5	O
MG	O
NEB	O
Q6H	O
Starting	O
Today	O
(	O
03/17	O
)	O
PRN	O
Shortness	B-disease
of	I-disease
Breath	I-disease
,	O
Wheezing	B-disease
NOVOLOG	O
(	O
INSULIN	O
ASPART	O
)	O
4	O
UNITS	O
SC	O
AC	O

Instructions	O
:	O

standing	O
pre-meal	O
novolog	O
.	O

give	O
when	O
patient	O
will	O
eat	O
and	O
food	O
is	O
in	O
the	O
room	O
.	O

NOVOLOG	O
(	O
INSULIN	O
ASPART	O
)	O
Sliding	O
Scale	O
(	O
subcutaneously	O
)	O
SC	O
AC	O

Instructions	O
:	O

pre-meal	O
correction	O
dose	O
.	O

give	O
in	O
addition	O
to	O
standing	O
pre-meal	O
novolog	O
when	O
patient	O
will	O
eat	O
and	O
food	O
is	O
in	O
the	O
room	O
.	O

If	O
BS	O
is	O
less	O
than	O
125	O
,	O
then	O
give	O
0	O
units	O
subcutaneously	O
If	O
BS	O
is	O
125-150	O
,	O
then	O
give	O
2	O
units	O
subcutaneously	O
If	O
BS	O
is	O
151-200	O
,	O
then	O
give	O
3	O
units	O
subcutaneously	O
If	O
BS	O
is	O
201-250	O
,	O
then	O
give	O
4	O
units	O
subcutaneously	O
If	O
BS	O
is	O
251-300	O
,	O
then	O
give	O
6	O
units	O
subcutaneously	O
If	O
BS	O
is	O
301-350	O
,	O
then	O
give	O
8	O
units	O
subcutaneously	O
If	O
BS	O
is	O
351-400	O
,	O
then	O
give	O
10	O
units	O
subcutaneously	O
and	O
call	O
HO	O
Call	O
HO	O
if	O
BS	O
is	O
greater	O
than	O
400	O
PROTONIX	O
(	O
PANTOPRAZOLE	O
)	O
40	O
MG	O
PO	O
DAILY	O
COMBIVENT	O
(	O
IPRATROPIUM	O
AND	O
ALBUTEROL	O
SULFATE	O
)	O
2	O
PUFF	O
INH	O
QID	O
FOSAMAX	O
(	O
ALENDRONATE	O
)	O
70	O
MG	O
PO	O
QWEEK	O

Food	O
/	O
Drug	O
Interaction	O
Instruction	O

Give	O
on	O
an	O
empty	O
stomach	O
(	O
give	O
1hr	O
before	O
or	O
2hr	O
after	O
food	O
)	O

Take	O
with	O
8	O
oz	O
of	O
plain	O
water	O
SPIRIVA	O
(	O
TIOTROPIUM	O
)	O
18	O

MCG	O
INH	O
DAILY	O
DIET	O
:	O

House	O
/	O
Low	O
chol	O
/	O
low	O
sat.	O
fat	O

DIET	O
:	O

House	O
/	O
ADA	O
1800	O
cals	O
/	O
dy	O

ACTIVITY	O
:	O

walk	O
with	O
assist	O
per	O
PT	O
eval	O

FOLLOW	O
UP	O
APPOINTMENT	O
(	O
S	O
)	O
:	O

Dr	O
Zuknocegrend	O
PCP	O
4/24	O
130	O
,	O

Dr.	O
Pump	O
3/25/05	O
1:30	O
,	O

ALLERGY	O
:	O

NKA	O
ADMIT	O
DIAGNOSIS	O
:	O

COPD	B-disease
flare	I-disease

PRINCIPAL	O
DISCHARGE	O
DIAGNOSIS	O
;	O

Responsible	O
After	O
Study	O
for	O
Causing	O
Admission	O
)	O
COPD	B-disease
flare	I-disease

OTHER	O
DIAGNOSIS	O
;	O

Conditions	O
,	O
Infections	O
,	O
Complications	O
,	O
affecting	O
Treatment	O
/	O
Stay	O

COPD	B-disease
(	I-disease
chronic	I-disease
obstructive	I-disease
pulmonary	I-disease
disease	I-disease
)	I-disease
DM	B-disease
cervical	B-disease
DJD	I-disease
(	O
)	O
iron	B-disease
deficiency	I-disease
anemia	I-disease
(	I-disease
iron	I-disease
deficiency	I-disease
anemia	I-disease
)	I-disease
cervical	B-disease
and	I-disease
lumbar	I-disease
djd	I-disease
(	O
12	O
)	O
osa	B-disease
(	I-disease
sleep	I-disease
apnea	I-disease
)	I-disease
s	O
/	O
p	O
tb	O
treatment	O
(	O
5	O
)	O

OPERATIONS	O
AND	O
PROCEDURES	O
:	O

OTHER	O
TREATMENTS	O
/	O
PROCEDURES	O
(	O
NOT	O
IN	O
O.R.	O
)	O

na	O

BRIEF	O
RESUME	O
OF	O
HOSPITAL	O
COURSE	O
:	O

CC	O
:	O

weakness	B-disease

HPI	O
:	O

75	O
y	O
/	O
o	O
F	O
with	O
DM	B-disease
,	O
COPD	B-disease
on	O
2L	O
NC	O
and	O
Bipap	O
at	O
night	O
p	O
/	O
w	O
generalized	B-disease
weakness	I-disease
and	O
fatigue	B-disease
,	O
urinary	B-disease
incontinence	I-disease
and	O
shaking	B-disease
as	O
well	O
as	O
increased	B-disease
sputum	I-disease
production	I-disease
.	O

Per	O
daughter	O
these	B-disease
symptoms	I-disease
are	O
typical	O
of	O
COPD	B-disease
flare	I-disease
.	O

ROS	O
otherwise	O
negative	O
.	O

Admission	O
Status	O
:	O

ED	O
:	O

REc&apos;d	O
duonebs	O
,	O
solumedrol	O
125	O

Vitals	O
:	O

t97.5	O
,	O
hr	O
117	O
,	O
bp156/81	O
,	O
rr28	O
,	O
o2	O
sats	O
87%	O
RA	O
;	O
95%	O
4L	O

Exam	O
:	O

NAD	B-disease
,	O
pleasant	O
,	O
speaking	O
in	O
complete	O
sentences	O
,	O
poor	B-disease
air	I-disease
movement	I-disease
bilaterally	I-disease
,	O
L	O
&gt;	O
R	O
,	O
no	O
wheezes	B-disease
or	O
rales	B-disease
,	O
rrr	O
,	O
distant	O
,	O
abd	O
benign	O
,	O
no	O
edema	B-disease
,	O
alert	O
and	O
oriented	O
times	O
three	O
,	O
no	O
focal	B-disease
deficits	I-disease
,	O
conversant	O
Studies	O
:	O

-	O
EKG	O
sinus	O
92	O
,	O
no	O
ST	B-disease
changes	I-disease

-	O
CXR	O
no	O
focal	B-disease
consolidation	I-disease
or	O
edema	B-disease
,	O
old	B-disease
biapical	I-disease
scarring	I-disease
ABG	O
7.34/79/74	O
U	O
/	O
A	O
negative	O

Daily	O
Status	O
:	O

improving	O
,	O
but	O
still	B-disease
poor	I-disease
air	I-disease
movement	I-disease
,	O
diffusely	B-disease
wheezy	I-disease
on	O
exam	O
,	O
at	O
baseline	O
2L	O
o2	O
requirement	O

A	O
/	O
P	O
:	O

75	O
y	O
/	O
o	O
F	O
with	O
h	O
/	O
o	O
COPD	B-disease
c	O
/	O
b	O
frequent	B-disease
exacerbations	I-disease
p	O
/	O
w	O
typical	B-disease
flare	I-disease
symptoms	I-disease
.	O

Problem	O
List	O
:	O

CV	O
-	O
Ischemia	B-disease
ASA	O
,	O
lisinopril	O
Pump	O
no	O
evidence	O
of	O
failure	B-disease

Rhythm	O
Resp	O
-	O
COPD	B-disease

flare	B-disease
-	O
steroids	O
,	O
cont	O
prednisone	O
60	O
,	O
taper	O
slowly	O
as	O
tolerated	O
,	O
duonebs	O
,	O
advair	O
,	O
singulair	O
,	O
spiriva	O
,	O
claritin	O
azithromycin	O
for	O
atypical	B-disease
bronchitis	I-disease
to	O
complete	O
a	O
5	O
day	O
course	O
,	O
keep	O
o2	O
sat	O
90-94	O
,	O
home	O
nocturnal	O
CPAP	O
not	O
tolerated	O
in	O
house	O
,	O
does	O
well	O
on	O
nc	O
,	O
appears	O
ato	O
be	O
at	O
baseline	O

Renal	O
-	O

Cr	O
0.8	O
,	O
stress	B-disease
incontinence	I-disease
by	O
symptoms	B-disease
with	O
increased	B-disease
cough	I-disease
,	O
no	O
evidence	O
of	O
uti	B-disease
,	O
cont	O
to	O
closely	O
monitor	O

GI	O
-	O
Bowel	O
regimen	O

Heme	O
-	O
Chronic	B-disease
Fe	I-disease
deficiency	I-disease
anemia	I-disease
,	O
cont	O
iron	O

Endo	O
-	O
DM	B-disease
on	O
insulin	O
with	O
steroids	O

ID	O
-	O
afebrile	B-disease
,	O
no	O
wbc	O
,	O
started	O
on	O
Azithromycin	O
for	O
COPD	B-disease
flare	I-disease

FEN	O
-	O
ADA	O
diet	O

PPx	O
-	O
Lovenox	O
,	O
PPI	O

Dispo	O
-	O
to	O
rehab	O
when	O
resp	B-disease
status	I-disease
improved	O
,	O
PT	O
consulted	O

Code	O
-	O
FC	O

ADDITIONAL	O
COMMENTS	O
:	O

DISCHARGE	O
CONDITION	O
:	O

Stable	O

TO	O
DO	O
/	O
PLAN	O
:	O

f	O
/	O
u	O
with	O
PCP	O
and	O
Dr.	O
Pump	O
as	O
scheduled	O
,	O
return	O
to	O
ED	O
with	O
worsening	B-disease
sob	I-disease
or	O
increased	B-disease
cough	I-disease
or	O
sputum	B-disease
production	I-disease

No	O
dictated	O
summary	O

ENTERED	O
BY	O
:	O

TIKWELD	O
,	O
WILLAIDE	O
V.	O
,	O
M.D.	O
(	O
QT296	O
)	O
03/19/06	O
10:53	O
AM	O

******	O
END	O
OF	O
DISCHARGE	O
ORDERS	O
******	O

297228405	O
DH	O

0595721	O

777098	O

4177257	O

2/3/2004	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O
/	O
SUMMARY	O

CHIRDVOLN	O
,	O
IENA	O

MRN	O
:	O

0595721	O

Age	O
:	O

46y	O

REGISTRATION	O
DATE	O
:	O

02/03/2004	O
11:14	O
AM	O

Provider	O
:	O

AGE	O
SHUFF	O

PRELIMINARY	O
REPORT	O

Discharge	O
Date	O
/	O
Time	O
:	O

02/03/2004	O
19:12	O

Discharge	O
Status	O
:	O

Discharged	O

Condition	O
on	O
Discharge	O
:	O

Stable	O

Patient	O
States	O
Complaint	O
:	O

VAG	B-disease
BLEEDING	I-disease

Diagnosis	O
:	O

dysfunctional	B-disease
uterine	I-disease
bleeding	I-disease

Treatment	O
Rendered	O
:	O

pelvic	O
ultrasound	O
-	O
normal	O
ovaries	O
,	O
thickened	B-disease
endometrium	I-disease
hematocrit	O
-	O
33	O

Discharge	O
Medications	O
:	O

percocet	O
as	O
directed	O
for	O
pain	B-disease

Follow	O
up	O
Service	O
:	O

Please	O
follow	O
up	O
with	O
gynecology	O
-	O
you	O
will	O
need	O
to	O
have	O
your	B-disease
uterine	I-disease
bleeding	I-disease
evaluted	O

Please	O
call	O
gynecology	O
clinic	O
at	O
150-5825	O
to	O
arrange	O
for	O
follow	O
up	O
.	O

Disposition	O
,	O
Follow	O
up	O
and	O
Instructions	O
to	O
Patient	O
:	O

Please	O
return	O
to	O
the	O
ED	O
if	O
you	O
develop	O
any	B-disease
worsening	I-disease
pain	I-disease
,	O
vomiting	B-disease
or	O
fevers	B-disease
&gt;	O
101	O
.	O

If	O
you	O
are	O
unable	O
to	O
keep	O
down	O
liquids	O
or	O
have	O
any	B-disease
fainting	I-disease
episodes	I-disease
we	O
should	O
see	O
you	O
again	O
as	O
well	O
.	O

Otherwise	O
you	O
need	O
to	O
see	O
a	O
gynecologist	O
to	O
evaluate	O
this	B-disease
bleeding	I-disease
.	O

PCP	O
Name	O
:	O

REKE	O
,	O
ATOTA	O
S	O

Provider	O
Number	O
:	O

26024	O

This	O
report	O
was	O
created	O
by	O
SHUFF	O
,	O
RONRIN	O
02/03/2004	O
07:23	O
PM	O

Admission	O
Date	O
:	O

2015-12-03	O

Discharge	O
Date	O
:	O

2015-12-08	O

Date	O
of	O
Birth	O
:	O

1960-04-22	O

Sex	O
:	O

M	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Patient	O
recorded	O
as	O
having	O
No	O
Known	B-disease
Allergies	I-disease
to	O
Drugs	O

Attending	O
:	O
Geoffrey	O
F	O
Corney	O
,	O
M.D.	O

Chief	O
Complaint	O
:	O

bright	B-disease
red	I-disease
blood	I-disease
per	I-disease
rectum	I-disease

Major	O
Surgical	O
or	O
Invasive	O
Procedure	O
:	O

Colonoscopy	O

Virtual	O
colonoscopy	O

History	O
of	O
Present	O
Illness	O
:	O

55	O
yo	O
M	O
w/	O
h/o	O
recurrent	B-disease
bladder	I-disease
ca	I-disease
s/p	O
cystectomy	O
w/	O
ileal	O
conduit	O
p/w	O
BRBPR	B-disease
to	O
OSH	O
.	O

Hct	O
dropped	O
34	O
->	O
22	O
.	O

EGD	O
normal	O
.	O

Cscope	O
unable	O
to	O
complete	O
due	O
to	O
blood	B-disease
but	O
tics	B-disease
seen	O
.	O

Tagged	O
RBC	O
+	O
activity	O
in	O
RLQ	O
.	O

Transferred	O
to	O
Mediplex	O
Rehab	O
Hospital	O
ICU	O
where	O
Hct	O
has	O
remained	O
stable	O
.	O

Seen	O
by	O
GI	O
and	O
plan	O
is	O
to	O
continue	O
holding	O
anticoagulation	O
and	O
repeat	O
scope	O
on	O
Monday	O
.	O

Pt	O
feeling	O
well	O
,	O
denies	O
abd	B-disease
pain	I-disease
,	O
N/V	B-disease
,	O
LH	B-disease
,	O
SOB	B-disease
,	O
CP	B-disease
.	O

Past	O
Medical	O
History	O
:	O

Metastatic	B-disease
bladder	I-disease
CA	I-disease
now	O
in	O
remission	O
s/p	O
chemo/xrt	O
s/p	O
cystectomy	O
and	O
ileal	O
loop	O
urinary	O
diversion	O
and	O
also	O
radical	O
prstatectomy	O
with	O
bilateral	O
pelvic	O
lymph	O
node	O
dissection	O
.	O

b/l	B-disease
DVT	I-disease
s,	O
most	O
recent	O
seen	O
in	O
IVC	O
to	O
right	O
femoral	O
vein	O
s/p	O
IVC	O
filter	O
2015-01-15	O

Nephrolithiasis	B-disease
.	O

Anemia	B-disease
-	O
baseline	O
mid	O
30	O
s.	O

Social	O
History	O
:	O

From	O
Sao	O
Tome	O
originally	O
.	O

denies	O
smoking	O

works	O
at	O
a	O
deli	O
in	O
beaconhill	O
.	O

Family	O
History	O
:	O

denies	O
fh	O
of	O
bleeding	B-disease
or	O
clotting	B-disease
disorders	I-disease
.	O

Physical	O
Exam	O
:	O

per	O
admitting	O
resident	O
:	O

T	O
97.4	O
BP	O
100/62	O
P	O
56	O
RR	O
16	O

Mid	O
aged	O
man	O
in	O
NAD	B-disease

sclera	B-disease
anicteric	I-disease
,	O
MMM	O

supple	O
,	O
no	O
LAD	B-disease

CTAB	O

RRR	O
S1/S2	O
no	O
M	B-disease

soft	O
,	O
+BS	O
,	O
NT	B-disease
,	O
Midline	B-disease
surgical	I-disease
scar	I-disease
,	O
nephrostomy	O
bag	O
draining	O

yellowish	B-disease
urine	I-disease
in	I-disease
RLQ	I-disease

no	O
edema	B-disease
,	O
no	O
clubbing	B-disease

Pertinent	O
Results	O
:	O

2015-12-03	O
10:27	O
PM	O
GLUCOSE	O
-	O
88	O
UREA	O
N	O
-	O
12	O
CREAT	O
-	O
1.0	O
SODIUM	O
-	O
138	O
POTASSIUM	O
-	O
3.3	O
CHLORIDE	O
-	O
107	O
TOTAL	O
CO2	O
-	O
25	O
ANION	O
GAP	O
-	O
9	O

2015-12-03	O
10:27	O
PM	O
estGFR	O
-	O
Using	O
this	O

2015-12-03	O
10:27	O
PM	O
CALCIUM	O
-	O
8.7	O
PHOSPHATE	O
-	O
2.4	O
*	O
MAGNESIUM	O
-	O
1.5	O
*	O

2015-12-03	O
10:27	O
PM	O
WBC	O
-	O
8.4	O
RBC	O
-	O
2.98	O
*	O
HGB	O
-	O
9.3	O
*	O
HCT	O
-	O
26.3	O
*	O
MCV	O
-	O
88	O
MCH	O
-	O
31.1	O
MCHC	O
-	O
35.3	O
*	O
RDW	O
-	O
14.4	O

2015-12-03	O
10:27	O
PM	O
PLT	O
COUNT	O
-	O
164	O

2015-12-03	O
10:27	O
PM	O
PT	O
-	O
11.4	O
PTT	O
-	O
27.5	O
INR(PT)	O
-	O
1.0	O

Brief	O
Hospital	O
Course	O
:	O

55	O
year	O
old	O
man	O
with	O
history	O
of	O
metastatic	B-disease
bladder	I-disease
cancer	I-disease
and	O
recurrent	B-disease
DVT	I-disease
s	I-disease
on	O
Lovenox	O
admitted	O
with	O
lower	B-disease
GI	I-disease
bleeding	I-disease
.	O

Right	B-disease
lower	I-disease
quadrant	I-disease
source	I-disease
of	I-disease
bleed	I-disease
on	O
red	O
blood	O
cell	O
scan	O
.	O

Attempts	O
to	O
visualize	O
colon	O
by	O
conventional	O
and	O
CT	O
virtual	O
colonoscopy	O
failed	O
because	O
of	O
sigmoid	B-disease
angulation	I-disease
and	O
inadequate	O
preparation	O
,	O
respectively	O
.	O

On	O
Ct	O
scan	O
,	O
a	B-disease
right	I-disease
psoas	I-disease
mass	I-disease
,	O
most	O
consistent	O
with	O
a	B-disease
hematoma	I-disease
,	O
was	O
seen	O
.	O

Since	O
the	O
hematocrit	O
of	O
the	O
patient	O
was	O
stable	O
and	O
outside	O
records	O
from	O
2015-03-28	O
mentioned	O
a	B-disease
mass	I-disease
in	I-disease
the	I-disease
right	I-disease
pelvis	I-disease
,	O
the	O
patient	O
was	O
discharged	O
.	O

Lovenox	O
was	O
held	O
until	O
follow-up	O
with	O
primary	O
care	O
doctor	O
.	O

Also	O
,	O
a	O
repeat	O
outpatient	O
CT	O
colonoscopy	O
with	O
better	O
preparation	O
should	O
be	O
considered	O
.	O

Medications	O
on	O
Admission	O
:	O

Lovenox	O
0.6	O
mg	O
/	O
kg	O
SC	O
BID	O

Discharge	O
Medications	O
:	O

1.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
once	O
a	O
day	O
.	O

2.	O
Outpatient	O
Lab	O
Work	O

cbc	O
,	O
creatinine	O

Discharge	O
Disposition	O
:	O

Home	O

Discharge	O
Diagnosis	O
:	O

Primary	O
diagnosis	O
:	O

GIB	B-disease

Secondary	O
diagnosis	O
:	O

Metastatic	B-disease
,	I-disease
recurrent	I-disease
bladder	I-disease
cancer	I-disease

h/o	O
DVT	B-disease
s	I-disease

Discharge	O
Condition	O
:	O

Good	O
.	O

Stable	O
Hct	O
of	O
31	O
.	O

Discharge	O
Instructions	O
:	O

We	O
recommend	O
that	O
you	O
do	O
NOT	O
resume	O
your	O
lovenox	O
until	O
talking	O
to	O
your	O
PCP	O
,	O
Dr.	O
Jessie	O
.	O

You	O
likely	O
have	O
a	B-disease
bleeding	I-disease
source	I-disease
in	I-disease
your	I-disease
colon	I-disease
that	O
we	O
have	O
been	O
unable	O
to	O
visualize	O
.	O

The	B-disease
bleeding	I-disease
has	O
stopped	O
and	O
you	O
have	O
remained	O
hemodynamically	O
stable	O
and	O
your	O
hematocrit	O
is	O
stable	O
,	O
but	O
you	O
are	O
at	O
risk	O
of	O
bleeding	B-disease
from	O
this	O
source	O
again	O
with	O
anticoagulation	O
.	O

A	O
CT	O
scan	O
of	O
your	O
abdomen	O
showed	O
a	B-disease
right	I-disease
pelvic	I-disease
mass	I-disease
,	O
most	O
likely	O
a	B-disease
hematoma	I-disease
,	O
which	O
had	O
been	O
described	O
previously	O
in	O
2015-03-28	O
.	O

Please	O
continue	O
to	O
take	O
your	O
other	O
medications	O
as	O
prescribed	O
.	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
as	O
scheduled	O
.	O

Please	O
bring	O
your	O
outpatient	O
lab	O
results	O
to	O
your	O
PCP	O
(	O
Dr.	O
Hemler	O
)	O

Please	O
see	O
a	O
doctor	O
if	O
you	O
feel	O
dizzy	B-disease
,	O
or	O
have	O
blood	B-disease
in	I-disease
your	I-disease
stool	I-disease
again	O
.	O

Followup	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
S.	O
Saracino	O
on	O
2015-12-30	O
at	O
8:00	O
AM	O
.	O

Her	O
number	O
is	O
(	O
512	O
)	O
677-6547	O
.	O

Please	O
go	O
to	O
Dr.	O
Colombo	O
office	O
later	O
this	O
week	O
to	O
have	O
your	O
labs	O
drawn	O
and	O
sent	O
to	O
Dr.	O
Powell	O
.	O

James	O
Jennifer	O
MD	O
,	O
PHD	O
12-944	O

Completed	O
by	O
:	O
Kimberly	O
Sarah	O
MD	O
97-625	O
2015-12-08	O
@	O
1543	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Joanne	O
Gilbert	O
YANG	O
on	O
:	O
MON	O
2016-02-08	O
9:27	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2016-12-30	O

Discharge	O
Date	O
:	O

2017-01-13	O

Date	O
of	O
Birth	O
:	O

1960-09-05	O

Sex	O
:	O

M	O

Service	O
:	O

HISTORY	O
OF	O
PRESENT	O
ILLNESS	O
:	O

This	O
is	O
a	O
56	O
year	O
old	O
man	O
with	O
history	O
of	O
hypercholesterolemia	B-disease
and	O
type	B-disease
II	I-disease
diabetes	I-disease
mellitus	I-disease
.	O

He	O
has	O
a	O
recent	O
history	O
of	O
dyspnea	B-disease
on	O
exertion	O
on	O
exertional	B-disease
chest	I-disease
pain	I-disease
which	O
has	O
increased	O
over	O
the	O
last	O
several	O
weeks	O
and	O
is	O
relieved	O
by	O
sublingual	O
nitroglycerin	O
.	O

On	O
2016-06-26	O
,	O
he	O
had	O
a	B-disease
positive	I-disease
exercise	I-disease
tolerance	I-disease
test	I-disease
.	O

Cardiac	O
catheterization	O
at	O
the	O
end	O
of	O
October	O
revealed	O
a	B-disease
dilated	I-disease
aortic	I-disease
root	I-disease
to	O
4.4	O
cm	O
and	O
80%	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
mid	I-disease
left	I-disease
anterior	I-disease
descending	I-disease
at	O
the	O
bifurcation	O
involving	O
the	O
diagonal	O
branch	O
,	O
70%	B-disease
stenoses	I-disease
of	I-disease
the	I-disease
left	I-disease
circumflex	I-disease
and	I-disease
oblique	I-disease
marginal	I-disease
artery	I-disease
and	O
90%	B-disease
stenosis	I-disease
of	I-disease
the	I-disease
posterior	I-disease
descending	I-disease
artery	I-disease
.	O

His	O
atrioventricular	O
valve	O
gradient	O
was	O
27	O
with	O
an	O
AV	O
surface	O
area	O
of	O
.91	O
.	O

REVIEW	O
OF	O
SYSTEMS	O
:	O

Review	O
of	O
systems	O
shows	O
that	O
the	O
patient	O
denies	O
any	B-disease
orthopnea	I-disease
,	O
paroxysmal	B-disease
nocturnal	I-disease
dyspnea	I-disease
.	O

He	O
has	O
no	O
bleeding	B-disease
or	O
clotting	B-disease
problems	I-disease
.	O

Juanita	O
does	O
not	O
feel	O
any	B-disease
palpitations	I-disease
.	O

He	O
does	O
not	O
have	O
wheezing	B-disease
,	O
claudication	B-disease
or	O
gastrointestinal	B-disease
bleeding	I-disease
.	O

Nor	O
does	O
he	O
have	O
any	O
history	O
of	O
stroke	B-disease
like	I-disease
symptoms	I-disease
.	O

PAST	O
MEDICAL	O
HISTORY	O
:	O

Hypercholesterolemia	B-disease
.	O

Type	B-disease
II	I-disease
diabetes	I-disease
.	O

Recent	B-disease
pneumonia	I-disease
.	O

Remote	O
tobacco	O
use	O
.	O

Recent	B-disease
weight	I-disease
loss	I-disease
associated	O
with	O
the	B-disease
pneumonia	I-disease
.	O

Gastroesophageal	B-disease
reflux	I-disease
disease	I-disease
.	O

ALLERGIES	O
:	O

No	O
known	B-disease
drug	I-disease
allergies	I-disease
.	O

MEDICATIONS	O
ON	O
ADMISSION	O
:	O

One	O
aspirin	O
a	O
day	O
.	O

Nexium	O
40	O
mg	O
a	O
day	O
.	O

Carvedilol	O
6.125	O
mg	O
a	O
day	O
.	O

Glucophage	O
25	O
mg	O
once	O
a	O
day	O
.	O

Lipitor	O
10	O
mg	O
once	O
a	O
day	O
.	O

SOCIAL	O
HISTORY	O
:	O

He	O
lives	O
with	O
his	O
wife	O
and	O
works	O
as	O
a	O
drug	O
representative	O
for	O
Carvedilol	O
.	O

PHYSICAL	O
EXAMINATION	O
:	O

On	O
physical	O
examination	O
,	O
the	O
patient	O
is	O
afebrile	B-disease
.	O

Weight	O
is	O
82	O
kilograms	O
.	O

Blood	O
pressure	O
126/66	O
.	O

General	O
:	O

Active	O
,	O
well-developed	O
,	O
well-nourished	O
male	O
.	O

Head	O
and	O
neck	O
examination	O
:	O

No	O
bruits	B-disease
appreciated	O
.	O

Lungs	O
are	O
clear	O
to	O
auscultation	O
bilaterally	O
.	O

Heart	O
was	O
regular	O
rate	O
and	O
rhythm	O
.	O

S1	O
and	O
S2	O
.	O

3/6	B-disease
systolic	I-disease
ejection	I-disease
murmur	I-disease
throughout	O
his	O
precordium	O
.	O

His	O
abdomen	O
is	O
soft	O
,	O
nontender	B-disease
,	O
nondistended	B-disease
.	O

No	O
hepatosplenomegaly	B-disease
and	O
no	O
CVA	B-disease
tenderness	I-disease
.	O

Extremities	O
are	O
warm	O
,	O
well	O
perfused	O
,	O
no	O
cyanosis	B-disease
,	O
clubbing	B-disease
or	O

edema	B-disease
.	O

Palpable	O
dorsalis	O
pedis	O
pulses	O
.	O

No	O
varicosities	B-disease
noted	O
.	O

The	O
patient	O
was	O
also	O
noted	O
to	O
be	O
right	O
handed	O
.	O

HOSPITAL	O
COURSE	O
:	O

He	O
was	O
admitted	O
to	O
the	O
cardiac	O
surgery	O
service	O
for	O
an	O
elected	O
Bental	O
procedure	O
with	O
homograft	O
and	O
coronary	O
artery	O
bypass	O
graft	O
.	O

Once	O
consent	O
and	O
preoperative	O
evaluation	O
was	O
complete	O
,	O
he	O
was	O
taken	O
to	O
the	O
operating	O
room	O
.	O

Please	O
refer	O
to	O
the	O
previously	O
dictated	O
operative	O
note	O
of	O
2016-12-30	O
by	O
Dr.	O
Lawrence	O
.	O

Briefly	O
,	O
the	O
patient	O
was	O
taken	O
to	O
the	O
operating	O
room	O
to	O
repair	O
his	B-disease
critical	I-disease
aortic	I-disease
stenosis	I-disease
,	O
his	B-disease
coronary	I-disease
artery	I-disease
disease	I-disease
and	O
his	B-disease
significantly	I-disease
dilated	I-disease
ascending	I-disease
aortic	I-disease
aneurysm	I-disease
.	O

The	O
procedure	O
was	O
an	O
aortic	O
valve	O
replacement	O
with	O
a	O
tissue	O
valve	O
,	O
a	O
coronary	O
artery	O
bypass	O
graft	O
procedure	O
where	O
five	O
grafts	O
were	O
performed	O
.	O

The	O
left	O
internal	O
mammary	O
artery	O
was	O
connected	O
to	O
the	O
proximal	O
left	O
anterior	O
descending	O
and	O
saphenous	O
vein	O
grafts	O
were	O
connected	O
to	O
the	O
posterior	O
descending	O
artery	O
,	O
diagonal	O
branch	O
,	O
obtuse	O
marginal	O
and	O
distal	O
left	O
anterior	O
descending	O
.	O

Finally	O
,	O
a	O
super	O
coronary	O
arch	O
graft	O
was	O
implanted	O
.	O

This	O
was	O
a	O
....................	O
graft	O
.	O

Cardiopulmonary	O
bypass	O
time	O
was	O
234	O
minutes	O
.	O

His	O
aorta	O
was	O
cross	O
clamped	O
for	O
168	O
minutes	O
.	O

He	O
had	O
pharmacologic	O
circulatory	O
arrest	O
for	O
18	O
minutes	O
.	O

The	O
patient	O
tolerated	O
the	O
procedure	O
well	O
and	O
was	O
transferred	O
to	O
the	O
unit	O
,	O
intubated	O
on	O
Milrinone	O
,	O
Levophed	O
and	O
Propofol	O
drips	O
.	O

The	O
rest	O
of	O
the	O
hospital	O
stay	O
can	O
be	O
discussed	O
in	O
terms	O
of	O
system	O
based	O
approach	O
.	O

Pulmonary	O
:	O

The	O
patient	O
remained	O
intubated	O
until	O
postoperative	O
day	O
number	O
five	O
.	O

After	O
that	O
,	O
the	O
patient	O
had	O
no	O
major	B-disease
problems	I-disease
with	I-disease
his	I-disease
lungs	I-disease
.	O

His	O
oxygen	O
saturations	O
remained	O
good	O
and	O
he	O
did	O
not	O
require	O
supplemental	O
oxygen	O
more	O
than	O
a	O
couple	O
of	O
days	O
after	O
his	O
extubation	O
.	O

He	O
was	O
sent	O
to	O
the	O
floor	O
from	O
the	O
cardiac	O
surgery	O
recovery	O
unit	O
on	O
postoperative	O
day	O
number	O
seven	O
.	O

After	O
an	O
extended	O
stay	O
for	O
hemodynamic	O
monitoring	O
and	O
pressor	O
support	O
to	O
maintain	O
his	O
perfusion	O
.	O

Neurologic	O
:	O

The	B-disease
major	I-disease
neurologic	I-disease
event	I-disease
of	O
this	O
hospital	O
course	O
was	O
that	O
the	O
patient	O
was	O
slow	B-disease
to	I-disease
awake	I-disease
after	O
his	O
Propofol	O
drip	O
was	O
discontinued	O
.	O

Because	O
of	O
his	B-disease
confusion	I-disease
,	O
a	O
neurology	O
consult	O
was	O
obtained	O
and	O
subsequent	O
radiographic	O
imaging	O
revealed	O
chronic	B-disease
appearing	I-disease
infarcts	I-disease
in	I-disease
the	I-disease
right	I-disease
occipital	I-disease
lobe	I-disease
as	O
well	O
as	O
both	O
cerebellar	O
hemispheres	O
,	O
suggestive	O
of	O
more	B-disease
chronic	I-disease
infarcts	I-disease
,	O
as	O
well	O
as	O
an	O
area	O
in	O
the	O
left	O
corona	O
radiata	O
,	O
adjacent	O
to	O
the	O
left	O
lateral	O
ventricle	O
which	O
may	O
or	O
may	O
not	O
be	O
an	B-disease
acute	I-disease
infarct	I-disease
.	O

This	O
was	O
seen	O
on	O
the	O
CAT	O
scan	O
on	O
postoperative	O
day	O
number	O
one	O
,	O
12-31	O
.	O

As	O
the	O
patient	O
became	O
more	O
awake	O
,	O
he	O
still	O
remained	O
somewhat	B-disease
confused	I-disease
and	O
a	B-disease
little	I-disease
bit	I-disease
out	I-disease
of	I-disease
it	I-disease
.	O

In	O
addition	O
,	O
he	O
was	O
noted	O
to	O
have	O
a	B-disease
right	I-disease
sided	I-disease
hemiplegia	I-disease
.	O

Over	O
his	O
postoperative	O
course	O
,	O
Mr.	O
Douglass	O
has	O
gradually	O
been	O
able	O
to	O
utilize	O
more	O
and	O
more	O
of	O
his	O
right	O
side	O
and	O
with	O
the	O
assistance	O
of	O
physical	O
therapy	O
and	O
occupational	O
therapy	O
,	O
he	O
has	O
4	O
to	O
5	O
+	O
strength	O
in	O
his	O
right	O
hand	O
and	O
arm	O
and	O
about	O
4	O
+	O
strength	O
in	O
his	O
right	O
leg	O
.	O

He	O
is	O
able	O
to	O
walk	O
about	O
the	O
floor	O
on	O
the	O
days	O
prior	O
to	O
discharge	O
,	O
with	O
the	O
assistance	O
of	O
the	O
physical	O
therapist	O
and	O
nurses	O
.	O

In	O
addition	O
,	O
Mr.	O
Douglass	O
is	O
given	O
Trazodone	O
to	O
help	O
him	O
sleep	O
at	O
night	O
.	O

A	O
psychiatric	O
consult	O
was	O
also	O
obtained	O
due	O
to	O
his	O
mental	O
status	O
and	O
confusion	B-disease
postoperatively	O
but	O
his	B-disease
psychiatric	I-disease
issues	I-disease
are	O
mostly	O
related	O
to	O
his	B-disease
neurologic	I-disease
insults	I-disease
and	O
he	O
has	O
no	O
distinctive	B-disease
psychiatric	I-disease
disorder	I-disease
,	O
except	O
for	O
perhaps	O
postoperative	B-disease
delirium	I-disease
.	O

Cardiovascularly	O
,	O
the	O
patient	O
did	O
extremely	O
well	O
following	O
the	O
surgery	O
.	O

The	O
Levophed	O
drip	O
was	O
continued	O
until	O
postoperative	O
day	O
number	O
one	O
.	O

Milrinone	O
was	O
continued	O
until	O
postoperative	O
day	O
number	O
three	O
,	O
at	O
which	O
point	O
he	O
was	O
having	O
good	O
enough	O
cardiac	O
output	O
that	O
he	O
did	O
not	O
need	O
these	O
drips	O
to	O
help	O
maintain	O
his	O
blood	O
pressure	O
anymore	O
.	O

He	O
has	O
remained	O
without	O
any	B-disease
chest	I-disease
pain	I-disease
following	O
this	O
procedure	O
and	O
his	B-disease
sternal	I-disease
wound	I-disease
is	O
clean	O
,	O
dry	O
and	O
intact	O
at	O
the	O
end	O
of	O
the	O
procedure	O
.	O

In	O
addition	O
,	O
he	O
has	O
hypertension	B-disease
,	O
for	O
which	O
he	O
receives	O
Metoprolol	O
and	O
he	O
has	O
hypercholesterolemia	B-disease
,	O
for	O
which	O
he	O
receives	O
nothing	O
at	O
this	O
time	O
.	O

Pulmonary	O
:	O

The	O
patient	O
remained	O
intubated	O
until	O
postoperative	O
day	O
number	O
five	O
.	O

He	O
was	O
diuresed	O
and	O
was	O
soon	O
saturating	O
very	O
well	O
on	O
room	O
air	O
.	O

Gastrointestinal	O
:	O

The	O
patient	O
has	O
gastroesophageal	B-disease
reflux	I-disease
disease	I-disease
,	O
for	O
which	O
he	O
has	O
been	O
receiving	O
Zantac	O
as	O
an	O
inpatient	O
.	O

We	O
will	O
put	O
him	O
back	O
on	O
his	O
Nexium	O
.	O

In	O
addition	O
,	O
over	O
the	O
last	O
couple	O
of	O
days	O
prior	O
to	O
discharge	O
,	O
the	O
patient	O
did	O
appear	O
a	B-disease
little	I-disease
bit	I-disease
icteric	I-disease
.	O

Liver	O
function	O
tests	O
were	O
obtained	O
and	O
they	O
were	O
slightly	B-disease
elevated	I-disease
liver	I-disease
function	I-disease
tests	I-disease
and	O
ALT	O
was	O
44	O
,	O
AST	O
was	O
34	O
;	O
alkaline	O
phosphatase	O
was	O
199	O
,	O
within	O
normal	O
limits	O
.	O

Total	O
bilirubin	O
was	O
2.8	O
.	O

Amylase	O
was	O
108	O
and	O
lipase	O
was	O
213	O
.	O

A	O
right	O
upper	O
quadrant	O
ultrasound	O
did	O
not	O
reveal	O
any	B-disease
gallstones	I-disease
or	O
common	B-disease
bile	I-disease
duct	I-disease
dilatation	I-disease
indicative	O
of	O
cholecystitis	B-disease
or	O
cholelithiasis	B-disease
.	O

In	O
addition	O
,	O
the	O
patient	O
did	O
have	O
slightly	B-disease
elevated	I-disease
blood	I-disease
sugars	I-disease
over	O
the	O
last	O
couple	O
of	O
days	O
and	O
has	O
required	O
an	O
insulin	O
sliding	O
scale	O
and	O
basal	O
insulin	O
to	O
maintain	O
his	O
blood	O
sugars	O
at	O
a	O
more	O
appropriate	O
level	O
.	O

The	O
ideal	O
blood	O
sugar	O
levels	O
for	O
Mr.	O
Douglass	O
in	O
this	O
postoperative	O
period	O
should	O
be	O
less	O
than	O
140	O
.	O

Please	O
stay	O
on	O
top	O
of	O
the	O
sliding	O
scale	O
so	O
that	O
the	O
patient	O
can	O
keep	O
a	O
euglycemic	O
level	O
.	O

Hematologic	O
:	O

The	O
patient	O
,	O
during	O
this	O
admission	O
,	O
required	O
transfusion	O
of	O
three	O
units	O
of	O
packed	O
red	O
blood	O
cells	O
to	O
maintain	O
adequate	O
hematocrit	O
.	O

At	O
the	O
time	O
of	O
discharge	O
,	O
Mr.	O
Norman	O
hematocrit	O
is	O
at	O
40.7	O
.	O

Fluids	O
,	O
electrolytes	O
and	O
nutrition	O
:	O

The	O
patient	O
did	O
receive	O
a	O
significant	O
amount	O
of	O
diuresis	O
postoperatively	O
and	O
is	O
well	O
below	O
his	O
baseline	O
with	O
weight	O
,	O
most	O
likely	O
because	O
of	O
his	B-disease
inability	I-disease
to	I-disease
eat	I-disease
because	O
of	O
his	B-disease
stroke	I-disease
.	O

Once	O
he	O
was	O
coherent	O
enough	O
,	O
the	O
patient	O
was	O
evaluated	O
by	O
the	O
swallow	O
team	O
who	O

declared	O
him	O
at	O
first	O
an	B-disease
aspiration	I-disease
risk	I-disease
.	O

As	O
Mr.	O
Douglass	O
has	O
improved	O
from	O
his	B-disease
initial	I-disease
stroke	I-disease
,	O
he	O
has	O
become	O
more	O
lucid	O

and	O
is	O
less	O
of	O
an	B-disease
aspiration	I-disease
risk	I-disease
.	O

On	O
01-12	O
,	O
one	O
day	O
prior	O
to	O
discharge	O
,	O
he	O
was	O
cleared	O
by	O
the	O
swallow	O
team	O
to	O
eat	O

a	O
diet	O
as	O
he	O
wishes	O
.	O

He	O
is	O
going	O
out	O
on	O
a	O
cardiac	O
healthy	O
,	O
diabetic	O
diet	O
,	O
as	O
tolerated	O
with	O
Boost	O
supplements	O
.	O

Infectious	O
disease	O
:	O

The	O
patient	O
had	O
positive	B-disease
blood	I-disease
and	I-disease
urine	I-disease
cultures	I-disease
on	O
01-05	O
for	O
history	O
of	O
Methicillin	B-disease
resistant	I-disease
Staphylococcus	I-disease
aureus	I-disease
,	O
which	O
was	O
pan	O
sensitive	O
.	O

He	O
was	O
started	O
on	O
Oct.	O
25	O
for	O
this	B-disease
bug	I-disease
.	O

On	O
01-08	O
,	O
the	O
patient	O
's	O
central	O
venous	O
line	O
was	O
discontinued	O
.	O

The	O
catheterization	O
tip	O
also	O
grew	O
out	O
Serratia	B-disease
.	O

On	O
the	O
16th	O
,	O
a	O
urine	O
culture	O
was	O
obtained	O
and	O
did	O
grow	O
out	O
greater	O
than	O
100,000	O
colonies	O
of	O
E.	B-disease
coli	I-disease
which	O
was	O
intermittently	B-disease
resistant	I-disease
to	O
Ciprofloxacin	O
.	O

He	O
was	O
started	O
on	O
Bactrim	O
for	O
that	O
.	O

Please	O
continue	O
Mr.	O
David	O
Montero	O
for	O
one	O
month	O
to	O
fight	O
his	B-disease
blood	I-disease
borne	I-disease
infection	I-disease
,	O
to	O
prevent	O
seeding	O
of	O
his	O
aortic	O
graft	O
and	O
continue	O
Bactrim	O
for	O
ten	O
days	O
after	O
discharge	O
to	O
treat	O
the	B-disease
E.	I-disease
coli	I-disease
in	I-disease
his	I-disease
urine	I-disease
.	O

DISPOSITION	O
:	O

Mr.	O
Douglass	O
is	O
being	O
discharged	O
on	O
2017-01-13	O
to	O
a	O
rehabilitation	O
facility	O
in	O
good	O
condition	O
.	O

FOLLOW-UP	O
:	O

One	O
to	O
two	O
weeks	O
with	O
his	O
primary	O
care	O
physician	O
and	O
two	O
to	O
three	O
weeks	O
with	O
his	O
cardiologist	O
and	O
at	O
one	O
month	O
with	O
Dr.	O
Costello	O
.	O

DISCHARGE	O
DIAGNOSES	O
:	O

Coronary	B-disease
artery	I-disease
disease	I-disease
,	O
status	O
post	O
coronary	O
artery	O
bypass	O
graft	O
.	O

Critical	B-disease
aortic	I-disease
stenosis	I-disease
,	O
status	O
post	O
aortic	O
valve	O
replacement	O
.	O

Aortic	B-disease
arch	I-disease
aneurysm	I-disease
,	O
status	O
post	O
aortic	O
arch	O
graft	O
.	O

Acute	B-disease
postoperative	I-disease
delirium	I-disease
.	O

Perioperative	B-disease
stroke	I-disease
.	O

Chronic	B-disease
blood	I-disease
loss	I-disease
anemia	I-disease
and	O
chronic	O
RBC	O
transfusion	O
.	O

Urinary	B-disease
tract	I-disease
infection	I-disease
.	O

Hypercholesterolemia	B-disease
.	O

Type	B-disease
II	I-disease
diabetes	I-disease
.	O

Gastroesophageal	B-disease
reflux	I-disease
disease	I-disease
.	O

DISCHARGE	O
MEDICATIONS	O
:	O

Metoprolol	O
75	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

Captopril	O
12.5	O
mg	O
p.o.	O
three	O
times	O
a	O
day	O
.	O

Aspirin	O
81	O
mg	O
p.o.	O
q.	O
day	O
.	O

Plavix	O
75	O
mg	O
p.o.	O
q.	O
day	O
.	O

Heparin	O
5000	O
units	O
subcutaneous	O
twice	O
a	O
day	O
.	O

Metformin	O
1000	O
mg	O
extended	O
release	O
p.o.	O
q.	O
day	O
.	O

Humalog	O
Max	O
75/25	O
,	O
20	O
units	O
subcutaneous	O
once	O
a	O
day	O
in	O
the	O
morning	O
.	O

Levofloxacin	O
500	O
mg	O
p.o.	O
q.	O
day	O
.	O

Bactrim	O
DS	O
tabs	O
,	O
one	O
tablet	O
p.o.	O
q.	O
day	O
for	O
ten	O
days	O
.	O

Colace	O
100	O
mg	O
p.o.	O
twice	O
a	O
day	O
.	O

Hold	O
for	O
loose	B-disease
stools	I-disease
.	O

Nexium	O
40	O
mg	O
p.o.	O
q.	O
day	O
.	O

Trazodone	O
25	O
mg	O
p.o.	O
q	O
h.s.	O
as	O
needed	O
for	O
sleep	O
.	O

Lasix	O
20	O
mg	O
p.o.	O
q.	O
day	O
for	O
one	O
week	O
.	O

KCl	O
20	O
mg	O
p.o.	O
q.	O
day	O
for	O
one	O
week	O
.	O

Dolly	O
V	O
Blevins	O
,	O
M.D.	O

04-100	O

Dictated	O
By	O
:	O
Kenneth	O
O.	O
Hogan	O
,	O
M.D.	O

MEDQUIST36	O

D	O
:	O
2017-01-12	O
11:35	O

T	O
:	O
2017-01-13	O
05:30	O

JOB	O
#:	O

92344	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Dolly	O
D.F.	O
Sipes	O
on:	O
Roxane	O
2017-02-21	O
11:52	O
AM	O

(	O
End	O
of	O
Report	O
)	O

Admission	O
Date	O
:	O

2013-11-04	O

Discharge	O
Date	O
:	O

2013-11-16	O

Date	O
of	O
Birth	O
:	O

1930-12-19	O

Sex	O
:	O

F	O

Service	O
:	O

MEDICINE	O

Allergies	O
:	O

Sulfa	O
(	O
Sulfonamides	O
)	O
/	O
Penicillins	O
/	O
Macrodantin	O
/	O
Ivp	O
Dye	O
,	O
Iodine	O
Containing	O

Attending	O
:	O
Robert	O
E	O
Goldschmidt	O
,	O
M.D.	O

Addendum	O
:	O

Just	O
prior	O
to	O
discharge	O
on	O
11-14	O
,	O
pt	O
's	O
BP	O
was	O
found	O
to	O
be	O
70/40	O
P70	O
s	O
just	O
after	O
receiving	O
her	O
am	O
BP	O
meds	O
.	O

She	O
was	O
asymptomatic	B-disease
.	O

The	O
patient	O
was	O
kept	O
in	O
the	O
hospital	O
and	O
the	O
following	O
issues	O
were	O
addressed	O
:	O

1.	O
Hypotension	B-disease
:	O
The	O
patient	O
'd	O
pm	O
BP	O
meds	O
were	O
held	O
11-14	O
and	O
she	O
was	O
administered	O
1.5L	O
NS	O
over	O
the	O
course	O
of	O
the	O
day	O
with	O
subsequent	O
SBP	O
s	O
in	O
the	O
high	O
90	O
s,	O
low	O
100	O
s,.	O

The	B-disease
hypotension	I-disease
was	O
likely	O
due	O
to	O
volume	B-disease
depletion	I-disease
caused	O
by	O
her	B-disease
diarrhea	I-disease
/	O
loose	B-disease
stools	I-disease
in	O
addition	O
to	O
decreased	B-disease
PO	I-disease
intake	I-disease
secondary	O
to	O
her	B-disease
GERD	I-disease
and	O
thrush	B-disease
.	O

All	O
of	O
this	O
occurred	O
in	O
the	O
setting	O
of	O
aggressive	O
BP	O
management	O
with	O
metoprolol	O
25	O
BID	O
,	O
HCTZ	O
/	O
Triampterene	O
(	O
as	O
a	O
replacment	O
for	O
lasix	O
due	O
to	O
recurrent	B-disease
hypokalemia	I-disease
),	O
Benicar	O
20	O
mg	O
QD	O
,	O
and	O
Imdur	O
30	O
mg	O
QD	O
.	O

Infection	B-disease
/	O
sepsis	B-disease
was	O
not	O
likely	O
given	O
she	O
was	O
afebrile	B-disease
and	O
had	O
no	O
localizing	B-disease
sx	I-disease
with	O
an	O
improving	O
lung	O
exam	O
and	O
02	B-disease
requirement	I-disease
.	O

Given	O
the	B-disease
patient	I-disease
's	I-disease
recent	I-disease
RP	I-disease
bleed	I-disease
,	O
there	O
was	O
concern	O
for	O
a	B-disease
recurrent	I-disease
bleed	I-disease
.	O

Her	O
groin	O
exam	O
was	O
unchanged	O
.	O

Her	O
Hct	O
dropped	O
from	O
Hct	O
38.9	O
before	O
fluids	O
to	O
35.5	O
s/p	O
1.5L	O
NS	O
and	O
was	O
thought	O
to	O
be	O
dilutional	O
.	O

Repeat	O
hcts	O
were	O
stable	O
.	O

The	O
patient	O
was	O
kept	O
an	O
additional	O
two	O
days	O
to	O
follow	O
her	O
hcts	O
and	O
titrate	O
her	O
BP	O
meds	O
.	O

As	O
volume	B-disease
depletion	I-disease
was	O
thought	O
to	O
be	O
the	O
cause	O
of	O
her	B-disease
low	I-disease
BP	I-disease
,	O
only	O
the	O
BBlocker	O
was	O
restarted	O
.	O

She	O
was	O
also	O
placed	O
on	O
on	O
low	O
dose	O
spironolactone	O
as	O
a	O
K	O
sparing	O
diuretic	O
and	O
for	O
BP	O
control	O
in	O
addition	O
to	O
Toprol	O
XL	O
25	O
mg	O
QD	O
for	O
her	B-disease
coronary	I-disease
disease	I-disease
.	O

She	O
tolerated	O
these	O
meds	O
with	O
SBP	O
s	O
in	O
the	O
high	O
90	O
s	O
to	O
100	O
s	O
and	O
was	O
therefore	O
discharged	O
on	O
this	O
regimen	O
.	O

She	O
will	O
need	O
follow	O
up	O
with	O
her	O
PCP	O
within	O
B	O
week	O
after	O
discharge	O
from	O
the	O
extended	O
care	O
facility	O
for	O
further	O
BP	O
titration	O
and	O
monitoring	O
of	O
her	O
electrolytes	O
.	O

2.	O
Thrush	B-disease
:	O
This	O
is	O
likely	O
secondary	O
to	O
her	O
steroid	O
inhalers	O
and	O
PO	O
prednisone	O
for	O
COPD	B-disease
exacerbation	I-disease
.	O

She	O
was	O
started	O
on	O
nystatin	O
swish	O
and	O
swallow	O
QID	O
.	O

The	O
patient	O
was	O
encouraged	O
to	O
take	O
PO	O
liquids	O
to	O
prevent	O
volume	B-disease
depletion	I-disease
.	O

3.	O
diarrhea	B-disease
:	O
The	O
patient	O
has	O
been	O
having	O
loose	B-disease
stools	I-disease
at	O
night	O
and	O
was	O
guiac	B-disease
pos	I-disease
x	O
2	O
.	O

Stool	O
for	O
C.diff	O
toxin	O
was	O
sent	O
x	O
1	O
and	O
was	O
negative	O
.	O

Her	O
bowel	O
regimen	O
is	O
prn	O
.	O

Gastroenteritis	B-disease
is	O
possible	O
but	O
she	O
has	O
no	O
vomiting	B-disease
and	O
only	O
occ	B-disease
nausea	I-disease
with	O
meds	O
.	O

There	O
is	O
no	O
evidence	O
of	O
obstruction	B-disease
on	O
AXR	O
.	O

Therefore	O
,	O
the	O
cause	O
of	O
her	B-disease
mild	I-disease
diarrhea	I-disease
(	O
few	B-disease
loose	I-disease
BM	I-disease
/	O
liquid	B-disease
stool	I-disease
/	O
night	O
)	O
may	O
be	O
either	O
viral	B-disease
or	O
secondary	O
to	O
resolving	B-disease
abdominal	I-disease
hematoma	I-disease
with	O
resultant	O
irritation	B-disease
of	I-disease
GI	I-disease
system	I-disease
.	O

We	O
have	O
advised	O
a	O
BRAT	O
diet	O
.	O

4.	O
guiac	B-disease
pos	I-disease
stool	I-disease
:	O
Given	O
the	O
patient	O
's	O
sx	O
of	O
GERD	B-disease
,	O
current	O
PO	O
steroid	O
regimen	O
,	O
and	O
ASA	O
for	O
her	O
stents	O
,	O
the	O
ddx	O
for	O
her	B-disease
guiac	I-disease
positive	I-disease
stools	I-disease
would	O
include	O
gastritis	B-disease
/	O
gastric	B-disease
ulcer	I-disease
in	O
addition	O
to	O
lower	B-disease
GI	I-disease
pathology	I-disease
.	O

However	O
,	O
she	O
has	O
no	O
vomiting	B-disease
and	O
only	B-disease
mild	I-disease
nausea	I-disease
with	O
medications	O
.	O

She	O
also	O
has	O
no	O
gross	B-disease
blood	I-disease
per	I-disease
rectum	I-disease
and	O
her	O
hct	O
is	O
stable	O
.	O

Upon	O
discharge	O
the	O
patient	O
was	O
changed	O
to	O
a	O
BID	O
protonix	O
regimen	O
.	O

Dr.	O
Valerio	O
office	O
was	O
notified	O
about	O
the	O
patient	O
's	O
discharge	O
plans	O
and	O
status	O
.	O

She	O
will	O
need	O
outpatient	O
follow	O
up	O
for	O
her	B-disease
guiac	I-disease
pos	I-disease
stools	I-disease
with	O
endoscopy	O
vs	O
EGD	O
+/-	O
H.pylori	O
serologies	O
.	O

A	O
copy	O
of	O
this	O
dc	O
summary	O
will	O
be	O
faxed	O
to	O
her	O
PCP	O
to	O
ensure	O
proper	O
follow	O
up	O
.	O

Discharge	O
Medications	O
:	O

1.	O
Atorvastatin	O
10	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

2.	O
Pantoprazole	O
40	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
twice	O
a	O
day	O
.	O

3.	O
Acetaminophen	O
500	O
mg	O
Tablet	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Tablet	O
PO	O
Q6H	O
(	O
every	O
6	O
hours	O
).	O

Disp	O
:*	O
240	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

4.	O
Oxycodone	O
5	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
Q4H	O
(	O
every	O
4	O
hours	O
)	O
as	O
needed	O
for	O
pain	B-disease
.	O

Disp	O
:*	O
90	O
Tablet	O
(s)*	O
Refills	O
:*	O
0	O
*	O

5.	O
Fluticasone	O
50	O
mcg	O
/	O
Actuation	O
Aerosol	O
,	O
Spray	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Spray	O
Nasal	O
DAILY	O
(	O
Daily	O
).	O

6.	O
Fluticasone	O
110	O
mcg	O
/	O
Actuation	O
Aerosol	O
Sig	O
:	O
Two	O
(	O
2	O
)	O
Puff	O
Inhalation	O
BID	O
(	O
2	O
times	O
a	O
day	O
).	O

7.	O
Tiotropium	O
Bromide	O
18	O
mcg	O
Capsule	O
,	O
w/	O
Inhalation	O
Device	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Cap	O
Inhalation	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Cap	O
(s)*	O
Refills	O
:*	O
2	O
*	O

8.	O
Clopidogrel	O
75	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Disp	O
:*	O
30	O
Tablet	O
(s)*	O
Refills	O
:*	O
2	O
*	O

9.	O
Albuterol	O
Sulfate	O
0.083	O
%	O
Solution	O
Sig	O
:	O
One	O
(	O
1	O
)	O
puff	O
Inhalation	O
Q6H	O
(	O
every	O
6	O
hours	O
)	O
as	O
needed	O
for	O
shortness	B-disease
of	I-disease
breath	I-disease
or	O
wheezing	B-disease
.	O

Disp	O
:*	O
1	O
inhaler	O
*	O
Refills	O
:*	O
1	O
*	O

10.	O
Aluminum	O
-	O
Magnesium	O
Hydroxide	O
225-200	O
mg	O
/	O
5	O
mL	O
Suspension	O
Sig	O
:	O
15-30	O
ML	O
s	O
PO	O
PRN	O
(	O
as	O
needed	O
).	O

11.	O
Senna	O
8.6	O
mg	O
Tablet	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
PO	O
BID	O
(	O
2	O
times	O
a	O
day	O
)	O
as	O
needed	O
.	O

12.	O
Prednisone	O
10	O
mg	O
Tablet	O
Sig	O
:	O
1-2	O
Tablets	O
PO	O
DAILY	O
(	O
Daily	O
)	O
for	O
4	O
days	O
:	O
Please	O
take	O
two	O
pills	O
for	O
one	O
day	O
starting	O
11-17	O
,	O
then	O
take	O
one	O
pill	O
for	O
three	O
days	O
.	O

Disp	O
:*	O
5	O
Tablet	O
(s)*	O
Refills	O
:	O
*	O
0	O
*	O

13.	O
oxygen	O
continue	O
02	O
at	O
1L/min	O
continuous	O
to	O
keep	O
sats	O
in	O
90	O
's.	O

14.	O
Spironolactone	O
25	O
mg	O
Tablet	O
Sig	O
:	O
0.5	O
Tablet	O
PO	O
DAILY	O
(	O
Daily	O
).	O

15.	O
Metoprolol	O
Succinate	O
25	O
mg	O
Tablet	O
Sustained	O
Release	O
24HR	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
Sustained	O
Release	O
24HR	O
PO	O
DAILY	O
(	O
Daily	O
).	O

16.	O
Nystatin	O
100,000	O
unit	O
/	O
mL	O
Suspension	O
Sig	O
:	O
Ten	O
(	O
10	O
)	O
ML	O
PO	O
QID	O
(	O
4	O
times	O
a	O
day	O
)	O
for	O
7	O
days	O
.	O

17.	O
Aspirin	O
325	O
mg	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
Sig	O
:	O
One	O
(	O
1	O
)	O
Tablet	O
,	O
Delayed	O
Release	O
(	O
E.C.	O
)	O
PO	O
DAILY	O
(	O
Daily	O
).	O

Discharge	O
Disposition	O
:	O

Extended	O
Care	O

Facility	O
:	O

3133	O
W.	O
Third	O
Ave.	O
Rehab	O
&	O
Nursing	O
Center	O
-	O
Westwood	O
Lodge	O
Hospital	O

Discharge	O
Diagnosis	O
:	O

1)	O
Rapid	B-disease
atrial	I-disease
fibrillation	I-disease
with	O
demand	B-disease
ischemia	I-disease

2)	O
Retroperitoneal	B-disease
bleed	I-disease

Discharge	O
Condition	O
:	O

Stable	O

Discharge	O
Instructions	O
:	O

Please	O
follow	O
up	O
with	O
your	O
PCP	O
Richard	O
,	O
Kevin	O
Robinson	O
(	O
771	O
)	O
937-5400	O
upon	O
discharge	O
.	O

If	O
you	O
experience	O
CP	B-disease
,	O
SOB	B-disease
,	O
dizzyness	B-disease
,	O
or	O
any	B-disease
other	I-disease
symptoms	I-disease
that	O
concern	O
you	O
please	O
call	O
your	O
PCP	O
or	O
return	O
to	O
the	O
ER	O
.	O

Note	O
:	O
you	O
have	O
had	O
a	O
cardiac	O
stent	O
placed	O
during	O
this	O
admission	O
.	O

You	O
must	O
take	O
your	O
aspirin	O
and	O
plavix	O
every	O
day	O
to	O
prevent	O
failure	B-disease
of	I-disease
these	I-disease
stents	I-disease
which	O
could	O
be	O
life	O
threatening	O
.	O

Please	O
take	O
all	O
medications	O
as	O
prescribed	O
.	O

Followup	O
Instructions	O
:	O

1)	O
Please	O
follow	O
up	O
with	O
your	O
PCP	O
and	O
cardiologist	O
,	O
David	O
,	O
Larry	O
Robinson	O
(	O
771	O
)	O
937-5400	O
,	O
upon	O
discharge	O
.	O

2)	O
You	O
are	O
scheduled	O
to	O
have	O
your	O
staples	O
removed	O
on	O
2013-11-20	O
3:00	O
with	O
provider	O
:	O
Leah	O
,	O
Paula	O
G.	O
Wilson	O
SURGERY	O
(	O
NHB	O
)	O

Date	O
/	O
Time	O
:	O
2013-11-20	O
3:00	O
.	O

Lashonda	O
Christopher	O
MD	O
48-669	O

Completed	O
by	O
:	O
Jill	O
Kelly	O
MD	O
47-482	O
2013-11-16	O
@	O
1550	O

Signed	O
electronically	O
by	O
:	O
DR.	O
Lee	O
V.	O
Young	O
on	O
:	O
FRI	O
2013-12-20	O
4:59	O
PM	O

(	O
End	O
of	O
Report	O
)	O

655488444	O

BH	O

7432347	O

065055	O

2/10/2000	O
12:00:00	O
AM	O

ED	O
Discharge	O
Summary	O

Unsigned	O

DIS	O

Report	O
Status	O
:	O

Unsigned	O

ED	O
DISCHARGE	O
NOTIFICATION	O

FREIREKOTE	O
,	O
SONYLA	O

MRN	O
:	O

7432347	O

Age	O
:	O

35y	O

REGISTRATION	O
DATE	O
:	O

02/10/2000	O
03:19	O
PM	O

PRELIMINARY	O
REPORT	O

This	O
is	O
to	O
notify	O
you	O
that	O
your	O
patient	O
,	O
FREIREKOTE	O
,	O
SONYLA	O
arrived	O
in	O
the	O
Emergency	O
Department	O
at	O
Bri	O
Health	O
on	O
02/10/2000	O
03:19	O
PM	O
.	O

The	O
patient	O
presented	O
with	O
a	O
chief	O
complaint	O
of	O
FOUND	B-disease
DOWN	I-disease
.	O

Following	O
evaluation	O
and	O
treatment	O
,	O
the	O
patient	O
's	O
disposition	O
at	O
the	O
end	O
of	O
the	O
visit	O
was	O
ADMITTED	O
AS	O
AN	O
INPATIENT	O
TO	O
BRI	O
HEALTH	O
.	O

Your	O
patient	O
was	O
admitted	O
under	O
the	O
care	O
of	O
REEFRAUP	O
,	O
JA	O
Y	O
with	O
a	O
preliminary	O
diagnosis	O
of	O
SYNCOPE	B-disease
.	O

If	O
you	O
need	O
additional	O
information	O
please	O
call	O
442-025-0303	O
.	O

[	O
report	O
_	O
end	O
]	O

